activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	105376	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	COc1ccc(Nc2ccnc(Nc3ccc(OCC(O)CN(C)C)cc3)n2)cc1		CHEMBL101052	=	IC50	nM	36000.0	CHEMBL301	Homo sapiens	IC50	uM	36.0
	105376	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	COc1ccc(Nc2ccnc(Nc3ccc(OCC(O)CN(C)C)cc3)n2)cc1		CHEMBL101052	=	IC50	nM	36000.0	CHEMBL301	Homo sapiens	IC50	uM	36.0
	106512	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)c(Br)c3)ccc12)C1CC1		CHEMBL260416	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	IC50	nM	2.0
	107704	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	O=C(Nc1n[nH]c2nc(-c3nccs3)c(Br)cc12)C1CC1		CHEMBL261690	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	107706	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	O=C(Nc1n[nH]c2nc(-c3nccs3)c(Br)cc12)C1CCCC1		CHEMBL406644	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	108039	CHEMBL661130	Inhibition of Cyclin-dependent kinase 2	B	CC(C)C(CO)Nc1nc(NCc2cccc(O)c2)c2ncn(C(C)C)c2n1		CHEMBL84944	=	IC50	nM	30.0	CHEMBL301	Homo sapiens	IC50	uM	0.03
	108796	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	CN(C)CC(O)COc1ccc(Nc2ncc(Br)c(N(CCCC(F)(F)F)c3ccccc3)n2)cc1		CHEMBL419720	=	IC50	nM	200.0	CHEMBL301	Homo sapiens	IC50	uM	0.2
	108798	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	O=C(Nc1n[nH]c2cc(-c3ccc[nH]3)ccc12)C1CC1		CHEMBL260929	=	IC50	nM	497.0	CHEMBL301	Homo sapiens	IC50	nM	497.0
	108800	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	O=C(Nc1n[nH]c2nc(-c3cccs3)c(Br)cc12)C1CCCC1		CHEMBL407980	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	110543	CHEMBL661130	Inhibition of Cyclin-dependent kinase 2	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCO)nc21		CHEMBL86066	=	IC50	nM	8000.0	CHEMBL301	Homo sapiens	IC50	uM	8.0
	111576	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3cc(Cl)ccc3Cl)n2)cc1		CHEMBL101311	=	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	uM	1.0
	111578	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	Cc1ccc(Cl)c(Nc2cc(Nc3ccc(OCC(O)CN(C)C)cc3)ncn2)c1		CHEMBL100675	=	IC50	nM	22000.0	CHEMBL301	Homo sapiens	IC50	uM	22.0
	111580	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	CN(C)CC(O)COc1ccc(Nc2nccc(N(Cc3ccccc3)c3cc(Cl)ccc3Cl)n2)cc1		CHEMBL102008	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	111582	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	112982	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	CN(C)CC(O)COc1ccc(Nc2cc(Nc3ccccc3)ncn2)cc1		CHEMBL318188	>	IC50	nM	100000.0	CHEMBL301	Homo sapiens	IC50	uM	100.0
	112984	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	O=C(Nc1[nH]nc2cc(-c3ccc(O)nc3)ccc12)C1CC1		CHEMBL106060	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	112986	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	O=C(Nc1n[nH]c2nc(-c3cccs3)c(Br)cc12)C1CC1		CHEMBL260231	=	IC50	nM	639.0	CHEMBL301	Homo sapiens	IC50	nM	639.0
	114279	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3ccccc3C#N)n2)cc1		CHEMBL99689	=	IC50	nM	4000.0	CHEMBL301	Homo sapiens	IC50	uM	4.0
	114281	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	CN(C)CC(O)COc1ccc(Nc2cc(Nc3ccccc3Br)ncn2)cc1		CHEMBL100811	=	IC50	nM	28000.0	CHEMBL301	Homo sapiens	IC50	uM	28.0
	114283	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	Cc1ccc(F)c(Nc2cc(Nc3ccc(OCC(O)CN(C)C)cc3)ncn2)c1		CHEMBL328623	=	IC50	nM	81000.0	CHEMBL301	Homo sapiens	IC50	uM	81.0
	114285	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	O=C(Nc1n[nH]c2cc(-c3ccc(O)cc3)ccc12)C1CC1		CHEMBL260163	=	IC50	nM	5.0	CHEMBL301	Homo sapiens	IC50	nM	5.0
	114287	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1		CHEMBL101747	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	115400	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	O=C(Nc1n[nH]c2cc(-c3cccc(F)c3)ccc12)C1CC1		CHEMBL261660	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
Not Determined	115965	CHEMBL661131	Inhibition of Cyclin-dependent kinase 2 (No Data)	B	CC(C)C(CO)Nc1nc(NCc2ccccc2O)c2ncn(C(C)C)c2n1		CHEMBL83320		IC50	nM		CHEMBL301	Homo sapiens	IC50	uM	
	116837	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	O=C(Nc1n[nH]c2cc(-c3ccco3)ccc12)C1CC1		CHEMBL421207	=	IC50	nM	631.0	CHEMBL301	Homo sapiens	IC50	nM	631.0
	118042	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(-c3ccccc3)cc12)C1CC1		CHEMBL427909	=	IC50	nM	5.0	CHEMBL301	Homo sapiens	IC50	nM	5.0
	118044	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	118471	CHEMBL661130	Inhibition of Cyclin-dependent kinase 2	B	CC(C)n1cnc2c(NC3CCCC3)nc(NCCCO)nc21		CHEMBL315837	=	IC50	nM	900.0	CHEMBL301	Homo sapiens	IC50	uM	0.9
	119257	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	119259	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	119601	CHEMBL661130	Inhibition of Cyclin-dependent kinase 2	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	IC50	nM	800.0	CHEMBL301	Homo sapiens	IC50	uM	0.8
	120507	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	CN(C)CC(O)COc1ccc(Nc2nccc(N(CCC#N)c3cc(Cl)ccc3Cl)n2)cc1		CHEMBL101156	=	IC50	nM	3000.0	CHEMBL301	Homo sapiens	IC50	uM	3.0
	121677	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	Cc1cnc(Nc2ccc(OCC(O)CN(C)C)cc2)nc1Nc1ccccc1		CHEMBL101473	=	IC50	nM	8000.0	CHEMBL301	Homo sapiens	IC50	uM	8.0
	121679	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	O=C(Nc1n[nH]c2cc(-c3ccsc3)ccc12)C1CC1		CHEMBL260928	=	IC50	nM	484.0	CHEMBL301	Homo sapiens	IC50	nM	484.0
	121681	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	122915	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	Cc1ccc(Nc2ccnc(Nc3ccc(OCC(O)CN(C)C)cc3)n2)cc1		CHEMBL99687	=	IC50	nM	26000.0	CHEMBL301	Homo sapiens	IC50	uM	26.0
	122917	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	CN(C)CC(O)COc1ccc(Nc2cc(Nc3ccccc3F)ncn2)cc1		CHEMBL318485	>	IC50	nM	100000.0	CHEMBL301	Homo sapiens	IC50	uM	100.0
	122919	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	124143	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	124665	CHEMBL661130	Inhibition of Cyclin-dependent kinase 2	B	CC(C)n1cnc2c(N)nc(NCCCO)nc21		CHEMBL84140	=	IC50	nM	2400.0	CHEMBL301	Homo sapiens	IC50	uM	2.4
	125500	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	CN(C)CC(O)COc1ccc(Nc2nccc(N(CCCC(F)(F)F)c3cc(Cl)ccc3Cl)n2)cc1		CHEMBL101887	=	IC50	nM	12000.0	CHEMBL301	Homo sapiens	IC50	uM	12.0
	125502	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	CCN1CCN(CCCC(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL407981	=	IC50	nM	60.0	CHEMBL301	Homo sapiens	IC50	nM	60.0
	125504	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	O=C(Nc1[nH]nc2cc(-c3ccc4ncccc4c3)ccc12)C1CC1		CHEMBL103099	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	127000	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)c(Cl)c3)ccc12)C1CC1		CHEMBL259838	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	IC50	nM	2.0
	127002	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	128146	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	COc1ccccc1Nc1cc(Nc2ccc(OCC(O)CN(C)C)cc2)ncn1		CHEMBL101868	=	IC50	nM	85000.0	CHEMBL301	Homo sapiens	IC50	uM	85.0
	129334	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	CN(C)CC(O)COc1ccc(Nc2cc(Nc3cc(Cl)ccc3Cl)ncn2)cc1		CHEMBL322640	=	IC50	nM	22000.0	CHEMBL301	Homo sapiens	IC50	uM	22.0
	129336	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	CN(C)CC(O)COc1ccc(Nc2nccc(N(CC#N)c3cc(Cl)ccc3Cl)n2)cc1		CHEMBL430507	=	IC50	nM	700.0	CHEMBL301	Homo sapiens	IC50	uM	0.7
	129338	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	CN(C)CC(O)COc1ccc(Nc2ncc(Cl)c(Nc3ccccc3)n2)cc1		CHEMBL100391	=	IC50	nM	500.0	CHEMBL301	Homo sapiens	IC50	uM	0.5
	129340	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019	=	IC50	nM	62.0	CHEMBL301	Homo sapiens	IC50	nM	62.0
	130730	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	CN(C)CC(O)COc1ccc(Nc2cc(Nc3ccccc3Cl)ncn2)cc1		CHEMBL99647	=	IC50	nM	95000.0	CHEMBL301	Homo sapiens	IC50	uM	95.0
	130732	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	O=C(Nc1n[nH]c2cc(-c3ccoc3)ccc12)C1CC1		CHEMBL260243	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	131161	CHEMBL661130	Inhibition of Cyclin-dependent kinase 2	B	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21		CHEMBL280074	=	IC50	nM	1200.0	CHEMBL301	Homo sapiens	IC50	uM	1.2
	131958	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL101679	=	IC50	nM	6000.0	CHEMBL301	Homo sapiens	IC50	uM	6.0
	131960	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	C#CCN(c1ccnc(Nc2ccc(OCC(O)CN(C)C)cc2)n1)c1cc(Cl)ccc1Cl		CHEMBL322019	=	IC50	nM	2000.0	CHEMBL301	Homo sapiens	IC50	uM	2.0
	131962	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	O=C(Nc1[nH]nc2cc(-c3ccc(F)c(F)c3)ccc12)C1CC1		CHEMBL103112	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	131964	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	O=C(Nc1[nH]nc2cc(-c3cccc(F)c3F)ccc12)C1CC1		CHEMBL105213	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	133212	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	Cc1ccc(Nc2cc(Nc3ccc(OCC(O)CN(C)C)cc3)ncn2)cc1		CHEMBL102136	>	IC50	nM	100000.0	CHEMBL301	Homo sapiens	IC50	uM	100.0
	133214	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	Cc1ccc(Cl)c(Nc2ccnc(Nc3ccc(OCC(O)CN(C)C)cc3)n2)c1		CHEMBL99948	=	IC50	nM	5000.0	CHEMBL301	Homo sapiens	IC50	uM	5.0
	133216	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	CN(C)CC(O)COc1ccc(Nc2ncc(F)c(Nc3ccccc3)n2)cc1		CHEMBL98335	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	133218	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	IC50	nM	5.0	CHEMBL301	Homo sapiens	IC50	nM	5.0
	133600	CHEMBL661130	Inhibition of Cyclin-dependent kinase 2	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NC[C@@H](C)O)nc21		CHEMBL84436	=	IC50	nM	200.0	CHEMBL301	Homo sapiens	IC50	uM	0.2
	134406	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3ccccc3F)n2)cc1		CHEMBL101019	=	IC50	nM	7000.0	CHEMBL301	Homo sapiens	IC50	uM	7.0
	134408	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3ccccc3Br)n2)cc1		CHEMBL103633	=	IC50	nM	7000.0	CHEMBL301	Homo sapiens	IC50	uM	7.0
	134410	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3cccc(Cl)c3)n2)cc1		CHEMBL317629	=	IC50	nM	5000.0	CHEMBL301	Homo sapiens	IC50	uM	5.0
	134412	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	O=C(Nc1n[nH]c2cc(-c3ccc4[nH]ccc4c3)ccc12)C1CC1		CHEMBL261659	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	136825	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	COc1ccccc1Nc1ccnc(Nc2ccc(OCC(O)CN(C)C)cc2)n1		CHEMBL100664	=	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	uM	15.0
	136827	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	COc1ccc(Nc2cc(Nc3ccc(OCC(O)CN(C)C)cc3)ncn2)cc1		CHEMBL101779	>	IC50	nM	100000.0	CHEMBL301	Homo sapiens	IC50	uM	100.0
	138043	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	O=C(Nc1n[nH]c2nc(-c3ccccc3)c(Br)cc12)C1CC1		CHEMBL259270	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	138069	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	138071	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	O=C(Nc1n[nH]c2cc(-c3cccs3)ccc12)C1CC1		CHEMBL318522	=	IC50	nM	341.0	CHEMBL301	Homo sapiens	IC50	nM	341.0
	138073	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CCN(Cc2ccccc2)C1		CHEMBL317657	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	139321	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3ccc(Cl)cc3)n2)cc1		CHEMBL430854	=	IC50	nM	18000.0	CHEMBL301	Homo sapiens	IC50	uM	18.0
	139323	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	Cc1ccc(F)c(Nc2ccnc(Nc3ccc(OCC(O)CN(C)C)cc3)n2)c1		CHEMBL101468	=	IC50	nM	2000.0	CHEMBL301	Homo sapiens	IC50	uM	2.0
	139325	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3cc(C(F)(F)F)ccc3F)n2)cc1		CHEMBL101810	=	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	uM	1.0
	139327	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	CN(C)CC(O)COc1ccc(Nc2cc(Nc3cc(C(F)(F)F)ccc3F)ncn2)cc1		CHEMBL101557	=	IC50	nM	35000.0	CHEMBL301	Homo sapiens	IC50	uM	35.0
	139329	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	O=C(Nc1[nH]nc2cc(-c3ccccc3F)ccc12)C1CC1		CHEMBL280221	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	141555	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3ccccc3)n2)cc1		CHEMBL102047	=	IC50	nM	34000.0	CHEMBL301	Homo sapiens	IC50	uM	34.0
	141557	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	CN(C)CC(O)COc1ccc(Nc2ncc(Br)c(Nc3ccccc3)n2)cc1		CHEMBL419534	=	IC50	nM	300.0	CHEMBL301	Homo sapiens	IC50	uM	0.3
	141890	CHEMBL661130	Inhibition of Cyclin-dependent kinase 2	B	CC(C)n1cnc2c(NCc3ccccc3)ncnc21		CHEMBL85015	=	IC50	nM	4500.0	CHEMBL301	Homo sapiens	IC50	uM	4.5
	141942	CHEMBL661130	Inhibition of Cyclin-dependent kinase 2	B	CC(C)n1cnc2c(NC34CC5CC(CC(C5)C3)C4)nc(NCCCO)nc21		CHEMBL83719	>	IC50	nM	100000.0	CHEMBL301	Homo sapiens	IC50	uM	100.0
	144059	CHEMBL660784	Inhibitory concentration against cyclin-dependent kinase 2	B	CN(C)CC(O)COc1ccc(Nc2cc(Nc3ccc(Cl)cc3)ncn2)cc1		CHEMBL318461	>	IC50	nM	100000.0	CHEMBL301	Homo sapiens	IC50	uM	100.0
	144061	CHEMBL661128	Inhibitory concentration against cyclin-dependent kinase 2	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)ccc12)C1CC1		CHEMBL405145	=	IC50	nM	13.0	CHEMBL301	Homo sapiens	IC50	nM	13.0
	150203	CHEMBL664513	Percentage A2780 cells in G1 after 24 hr r at 20 nM (IC50)	F	CCc1cnc(CSc2cnc(NC(C)=O)s2)o1		CHEMBL125401	=	Cell cycle	nM	58.0	CHEMBL301	Homo sapiens	Cell cycle	nM	58.0
	150204	CHEMBL663759	Percentage A2780 cells in S-phase after 24 hr r at 20 nM (IC50)	F	CCc1cnc(CSc2cnc(NC(C)=O)s2)o1		CHEMBL125401	=	Cell cycle	nM	11.0	CHEMBL301	Homo sapiens	Cell cycle	nM	11.0
	150205	CHEMBL664514	Percentage A2780 cells in G2/M after 24 hr r at 20 nM (IC50)	F	CCc1cnc(CSc2cnc(NC(C)=O)s2)o1		CHEMBL125401	=	Cell cycle	nM	29.0	CHEMBL301	Homo sapiens	Cell cycle	nM	29.0
	150206	CHEMBL663758	Percentage A2780 cells in sub-G1 after 24 hr r at 20 nM (IC50)	F	CCc1cnc(CSc2cnc(NC(C)=O)s2)o1		CHEMBL125401	=	Cell cycle	nM	2.0	CHEMBL301	Homo sapiens	Cell cycle	nM	2.0
	150207	CHEMBL664515	Apoptotic A2780 cells after 24 hr r at 20 nM (IC50)	F	CCc1cnc(CSc2cnc(NC(C)=O)s2)o1		CHEMBL125401	=	Cell cycle	nM	6.0	CHEMBL301	Homo sapiens	Cell cycle	nM	6.0
	150208	CHEMBL663776	Percentage A2780 cells in G1 after 24 hr r at 295 nM (IC90)	F	CCc1cnc(CSc2cnc(NC(C)=O)s2)o1		CHEMBL125401	=	Cell cycle	nM	62.0	CHEMBL301	Homo sapiens	Cell cycle	nM	62.0
	150209	CHEMBL663778	Percentage A2780 cells in S-phase after 24 hr r at 295 nM (IC90)	F	CCc1cnc(CSc2cnc(NC(C)=O)s2)o1		CHEMBL125401	=	Cell cycle	nM	6.0	CHEMBL301	Homo sapiens	Cell cycle	nM	6.0
	150210	CHEMBL663777	Percentage A2780 cells in G2/M after 24 hr r at 295 nM (IC90)	F	CCc1cnc(CSc2cnc(NC(C)=O)s2)o1		CHEMBL125401	=	Cell cycle	nM	25.0	CHEMBL301	Homo sapiens	Cell cycle	nM	25.0
	150211	CHEMBL663780	Percentage A2780 cells in sub-G1 after 24 hr r at 295 nM (IC90)	F	CCc1cnc(CSc2cnc(NC(C)=O)s2)o1		CHEMBL125401	=	Cell cycle	nM	7.0	CHEMBL301	Homo sapiens	Cell cycle	nM	7.0
	150212	CHEMBL663779	Apoptotic A2780 cells after 24 hr r at 295 nM (IC90)	F	CCc1cnc(CSc2cnc(NC(C)=O)s2)o1		CHEMBL125401	=	Cell cycle	nM	16.0	CHEMBL301	Homo sapiens	Cell cycle	nM	16.0
	177072	CHEMBL663765	Percentage A2780 cells in G1 after 24 hr r at 5 nM (IC50)	F	CCc1cnc(CSc2cnc(NC(=O)Cc3cccnc3)s2)o1		CHEMBL129396	=	Cell cycle	nM	71.0	CHEMBL301	Homo sapiens	Cell cycle	nM	71.0
	177073	CHEMBL663767	Percentage A2780 cells in S-phase after 24 hr r at 5 nM (IC50)	F	CCc1cnc(CSc2cnc(NC(=O)Cc3cccnc3)s2)o1		CHEMBL129396	=	Cell cycle	nM	7.0	CHEMBL301	Homo sapiens	Cell cycle	nM	7.0
	177074	CHEMBL663766	Percentage A2780 cells in G2/M after 24 hr r at 5 nM (IC50)	F	CCc1cnc(CSc2cnc(NC(=O)Cc3cccnc3)s2)o1		CHEMBL129396	=	Cell cycle	nM	20.0	CHEMBL301	Homo sapiens	Cell cycle	nM	20.0
	177075	CHEMBL663768	Percentage A2780 cells in sub-G1 after 24 hr r at 5 nM (IC50)	F	CCc1cnc(CSc2cnc(NC(=O)Cc3cccnc3)s2)o1		CHEMBL129396	=	Cell cycle	nM	2.0	CHEMBL301	Homo sapiens	Cell cycle	nM	2.0
	177076	CHEMBL664512	Apoptotic A2780 cells after 24 hr r at 5 nM (IC50)	F	CCc1cnc(CSc2cnc(NC(=O)Cc3cccnc3)s2)o1		CHEMBL129396	=	Cell cycle	nM	4.0	CHEMBL301	Homo sapiens	Cell cycle	nM	4.0
	177077	CHEMBL663771	Percentage A2780 cells in G1 after 24 hr r at 29 nM (IC90)	F	CCc1cnc(CSc2cnc(NC(=O)Cc3cccnc3)s2)o1		CHEMBL129396	=	Cell cycle	nM	50.0	CHEMBL301	Homo sapiens	Cell cycle	nM	50.0
	177078	CHEMBL663773	Percentage A2780 cells in S-phase after 24 hr r at 29 nM (IC90)	F	CCc1cnc(CSc2cnc(NC(=O)Cc3cccnc3)s2)o1		CHEMBL129396	=	Cell cycle	nM	7.0	CHEMBL301	Homo sapiens	Cell cycle	nM	7.0
	177079	CHEMBL663772	Percentage A2780 cells in G2/M after 24 hr r at 29 nM (IC90)	F	CCc1cnc(CSc2cnc(NC(=O)Cc3cccnc3)s2)o1		CHEMBL129396	=	Cell cycle	nM	18.0	CHEMBL301	Homo sapiens	Cell cycle	nM	18.0
	177080	CHEMBL663775	Percentage A2780 cells in sub-G1 after 24 hr r at 2 nM (IC90)	F	CCc1cnc(CSc2cnc(NC(=O)Cc3cccnc3)s2)o1		CHEMBL129396	=	Cell cycle	nM	25.0	CHEMBL301	Homo sapiens	Cell cycle	nM	25.0
	177081	CHEMBL663774	Apoptotic A2780 cells after 24 hr r at 29 nM (IC90)	F	CCc1cnc(CSc2cnc(NC(=O)Cc3cccnc3)s2)o1		CHEMBL129396	=	Cell cycle	nM	69.0	CHEMBL301	Homo sapiens	Cell cycle	nM	69.0
	182068	CHEMBL663760	Percentage A2780 cells in G1 after 24 hr r at 330 nM (IC50)	F	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Cell cycle	nM	60.0	CHEMBL301	Homo sapiens	Cell cycle	nM	60.0
	182069	CHEMBL663762	Percentage A2780 cells in S-phase after 24 hr r at 330 nM (IC50)	F	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Cell cycle	nM	16.0	CHEMBL301	Homo sapiens	Cell cycle	nM	16.0
	182070	CHEMBL663761	Percentage A2780 cells in G2/M after 24 hr r at 330 nM (IC50)	F	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Cell cycle	nM	23.0	CHEMBL301	Homo sapiens	Cell cycle	nM	23.0
	182071	CHEMBL663764	Percentage A2780 cells in sb-G1 after 24 hr r at 330 nM (IC50)	F	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Cell cycle	nM	1.0	CHEMBL301	Homo sapiens	Cell cycle	nM	1.0
	182072	CHEMBL663763	Apoptotic A2780 cells after 24 hr r at 330 nM (IC50)	F	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Cell cycle	nM	1.0	CHEMBL301	Homo sapiens	Cell cycle	nM	1.0
	182073	CHEMBL663781	Percentage A2780 cells in G1 after 24 hr r at 2980 nM (IC90)	F	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Cell cycle	nM	61.0	CHEMBL301	Homo sapiens	Cell cycle	nM	61.0
	182074	CHEMBL664366	Percentage A2780 cells in S-phase after 24 hr r at 2980 nM (IC90)	F	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Cell cycle	nM	12.0	CHEMBL301	Homo sapiens	Cell cycle	nM	12.0
	182075	CHEMBL664365	Percentage A2780 cells in G2/M after 24 hr r at 2980 nM (IC90)	F	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Cell cycle	nM	25.0	CHEMBL301	Homo sapiens	Cell cycle	nM	25.0
	182076	CHEMBL664368	Percentage A2780 cells in sub-G1 after 24 hr r at 2980 nM (IC90)	F	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Cell cycle	nM	2.0	CHEMBL301	Homo sapiens	Cell cycle	nM	2.0
	182077	CHEMBL664367	Apoptotic A2780 cells after 24 hr r at 2980 nM (IC90)	F	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Cell cycle	nM	9.0	CHEMBL301	Homo sapiens	Cell cycle	nM	9.0
	219635	CHEMBL660781	Inhibition of Cyclin-Dependent Kinase 2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	IC50	nM	30.0	CHEMBL301	Homo sapiens	IC50	uM	0.03
	265814	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	CNc1nccc(-c2sc(C)nc2C)n1		CHEMBL46474	>	Ki	nM	20000.0	CHEMBL301	Homo sapiens	Ki	uM	20.0
	265817	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	Cc1nc(C)c(-c2ccnc(Nc3ccc(O)cc3)n2)s1		CHEMBL442957	=	Ki	nM	140.0	CHEMBL301	Homo sapiens	Ki	uM	0.14
	267078	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	Cc1nc(C)c(-c2ccnc(N)n2)s1		CHEMBL47302	=	Ki	nM	6500.0	CHEMBL301	Homo sapiens	Ki	uM	6.5
	267081	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	Cc1nc(C)c(-c2ccnc(Nc3ccccc3F)n2)s1		CHEMBL297447	=	Ki	nM	1200.0	CHEMBL301	Homo sapiens	Ki	uM	1.2
	267084	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	CNc1nc(C)c(-c2ccnc(Nc3cccc(O)c3)n2)s1		CHEMBL44119	=	Ki	nM	110.0	CHEMBL301	Homo sapiens	Ki	uM	0.11
	267087	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	Cc1nc(C)c(-c2ccnc(Nc3cccc(C#N)c3)n2)s1		CHEMBL47132	=	Ki	nM	300.0	CHEMBL301	Homo sapiens	Ki	uM	0.3
	268289	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	Cc1nc(C)c(-c2ccnc(Nc3cccc(N)c3)n2)s1		CHEMBL47636	=	Ki	nM	400.0	CHEMBL301	Homo sapiens	Ki	uM	0.4
	268292	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	Cc1nc(C)c(-c2ccnc(Nc3ccc(N(C)C)c(Cl)c3)n2)s1		CHEMBL433068	=	Ki	nM	100.0	CHEMBL301	Homo sapiens	Ki	uM	0.1
	269791	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(O)cc2)n1		CHEMBL431336	=	Ki	nM	30.0	CHEMBL301	Homo sapiens	Ki	uM	0.03
	274609	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	Cc1nc(C)c(-c2ccnc(Nc3cccc(O)c3)n2)s1		CHEMBL47527	=	Ki	nM	60.0	CHEMBL301	Homo sapiens	Ki	uM	0.06
	278282	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	Cc1nc(C)c(-c2ccnc(Nc3ccc(N(C)C)cc3)n2)s1		CHEMBL46817	=	Ki	nM	220.0	CHEMBL301	Homo sapiens	Ki	uM	0.22
	281877	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL298445	=	Ki	nM	2.0	CHEMBL301	Homo sapiens	Ki	uM	0.002
	284239	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N(C)C)cc2)n1		CHEMBL295398	=	Ki	nM	700.0	CHEMBL301	Homo sapiens	Ki	uM	0.7
	285474	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	Cc1nc(C)c(-c2ccnc(Nc3ccccc3Cl)n2)s1		CHEMBL44063	>	Ki	nM	20000.0	CHEMBL301	Homo sapiens	Ki	uM	20.0
	286580	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	CCNc1nc(C)c(-c2ccnc(Nc3cccc(O)c3)n2)s1		CHEMBL296666	>	Ki	nM	10000.0	CHEMBL301	Homo sapiens	Ki	uM	10.0
	286583	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	CNc1nc(C)c(-c2ccnc(Nc3cccc([N+](=O)[O-])c3)n2)s1		CHEMBL46429	=	Ki	nM	800.0	CHEMBL301	Homo sapiens	Ki	uM	0.8
	287755	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	Cc1nc(C)c(-c2ccnc(Nc3ccccc3)n2)s1		CHEMBL295127	=	Ki	nM	80.0	CHEMBL301	Homo sapiens	Ki	uM	0.08
	289068	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	CNc1nc(C)c(-c2ccnc(Nc3ccc(O)cc3)n2)s1		CHEMBL47590	=	Ki	nM	70.0	CHEMBL301	Homo sapiens	Ki	uM	0.07
	289071	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	Cc1nc(C)c(-c2ccnc(Nc3ccc(N(C)C)c([N+](=O)[O-])c3)n2)s1		CHEMBL295484	=	Ki	nM	20.0	CHEMBL301	Homo sapiens	Ki	uM	0.02
	291366	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	Cc1nc(C)c(-c2ccnc(N(C)c3cccc([N+](=O)[O-])c3)n2)s1		CHEMBL297614	>	Ki	nM	20000.0	CHEMBL301	Homo sapiens	Ki	uM	20.0
	292717	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	Cc1nc(C)c(-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)s1		CHEMBL47276	>	Ki	nM	20000.0	CHEMBL301	Homo sapiens	Ki	uM	20.0
	292720	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	Cc1nc(C)c(-c2ccnc(Nc3ccc(C(F)(F)F)cc3)n2)s1		CHEMBL48109	=	Ki	nM	290.0	CHEMBL301	Homo sapiens	Ki	uM	0.29
	293901	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	Cc1nc(C)c(-c2ccnc(Nc3cccc(F)c3)n2)s1		CHEMBL432116	=	Ki	nM	100.0	CHEMBL301	Homo sapiens	Ki	uM	0.1
	295273	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	Cc1nc(C)c(-c2ccnc(N(C)C)n2)s1		CHEMBL43828	>	Ki	nM	20000.0	CHEMBL301	Homo sapiens	Ki	uM	20.0
	295276	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	Cc1nc(N(C)C)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL46401	=	Ki	nM	60.0	CHEMBL301	Homo sapiens	Ki	uM	0.06
	296530	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	Cc1nc(C)c(-c2ccnc(Nc3ccc(Cl)cc3)n2)s1		CHEMBL45001	=	Ki	nM	2500.0	CHEMBL301	Homo sapiens	Ki	uM	2.5
	296533	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	Cc1nc(-c2ccccn2)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL409506	>	Ki	nM	20000.0	CHEMBL301	Homo sapiens	Ki	uM	20.0
	296536	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	Cc1nc(C)c(-c2ccnc(Nc3ccc([N+](=O)[O-])cc3)n2)s1		CHEMBL47690	=	Ki	nM	4100.0	CHEMBL301	Homo sapiens	Ki	uM	4.1
	297829	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	Cc1nc(C)c(-c2ccnc(Nc3ccccc3C(F)(F)F)n2)s1		CHEMBL48019	>	Ki	nM	20000.0	CHEMBL301	Homo sapiens	Ki	uM	20.0
	300436	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	Cc1nc(C)c(-c2ccnc(Nc3ccc(F)cc3)n2)s1		CHEMBL297412	=	Ki	nM	40.0	CHEMBL301	Homo sapiens	Ki	uM	0.04
	300439	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	C=CCNc1nc(C)c(-c2ccnc(Nc3cccc([N+](=O)[O-])c3)n2)s1		CHEMBL47249	=	Ki	nM	160.0	CHEMBL301	Homo sapiens	Ki	uM	0.16
	303932	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	Cc1nc(C)c(-c2ccnc(Nc3cccc(Cl)c3)n2)s1		CHEMBL44712	=	Ki	nM	670.0	CHEMBL301	Homo sapiens	Ki	uM	0.67
	303935	CHEMBL658107	Inhibitory activity against human CDK2 (Cyclin dependent kinase 2)	B	Cc1nc(C)c(-c2ccnc(Nc3cccc([N+](=O)[O-])c3)n2)s1		CHEMBL45408	=	Ki	nM	110.0	CHEMBL301	Homo sapiens	Ki	uM	0.11
	316958	CHEMBL662524	Inhibition of Cyclin-dependent kinase 2 (CDK2) at ATP concentration <Km	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCn1ccnn1		CHEMBL281872	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	328360	CHEMBL662525	Inhibition of Cyclin-dependent kinase 2 (CDK2) at ATP concentration <Km	F	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1.Cl		CHEMBL533849	>	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	347234	CHEMBL660783	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	Cc1ccc(N(CC#N)c2cc(Nc3ccc(OCC(O)CN(C)C)cc3)ncn2)c(Br)c1		CHEMBL421583	=	IC50	nM	3000.0	CHEMBL301	Homo sapiens	IC50	uM	3.0
	348501	CHEMBL660783	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	CN(C)CC(O)COc1ccc(Nc2cc(Nc3ccc(F)cc3F)ncn2)cc1		CHEMBL317281	=	IC50	nM	93000.0	CHEMBL301	Homo sapiens	IC50	uM	93.0
	349850	CHEMBL660783	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	CN(C)CC(O)COc1ccc(Nc2cc(Nc3ccccc3F)ncn2)cc1		CHEMBL318485	>	IC50	nM	100000.0	CHEMBL301	Homo sapiens	IC50	uM	100.0
	351311	CHEMBL660783	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	CN(C)CC(O)COc1ccc(Nc2cc(N(CC#N)c3cc(Cl)ccc3Cl)ncn2)cc1		CHEMBL101119	=	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	uM	1.0
	355669	CHEMBL660783	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	CN(C)CC(O)COc1ccc(Nc2cc(N(CCC#N)c3cc(Cl)ccc3Cl)ncn2)cc1		CHEMBL317378	=	IC50	nM	5000.0	CHEMBL301	Homo sapiens	IC50	uM	5.0
	359968	CHEMBL660783	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	Cc1ccccc1Nc1cc(Nc2ccc(OCC(O)CN(C)C)cc2)ncn1		CHEMBL418793	=	IC50	nM	39000.0	CHEMBL301	Homo sapiens	IC50	uM	39.0
	359970	CHEMBL660783	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	CN(C)CC(O)COc1ccc(Nc2cc(Nc3cc(Cl)ccc3Cl)ncn2)cc1		CHEMBL322640	=	IC50	nM	22000.0	CHEMBL301	Homo sapiens	IC50	uM	22.0
	362404	CHEMBL660783	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	COc1ccccc1Nc1cc(Nc2ccc(OCC(O)CN(C)C)cc2)ncn1		CHEMBL101868	=	IC50	nM	85000.0	CHEMBL301	Homo sapiens	IC50	uM	85.0
	362406	CHEMBL660783	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	CN(C)CC(O)COc1ccc(Nc2cc(N(Cc3ccccc3)c3cc(Cl)ccc3Cl)ncn2)cc1		CHEMBL316809	>	IC50	nM	100000.0	CHEMBL301	Homo sapiens	IC50	uM	100.0
	364054	CHEMBL660783	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	C#CCN(c1cc(Nc2ccc(OCC(O)CN(C)C)cc2)ncn1)c1cc(Cl)ccc1Cl		CHEMBL100945	=	IC50	nM	19000.0	CHEMBL301	Homo sapiens	IC50	uM	19.0
	369843	CHEMBL660783	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	CN(C)CC(O)COc1ccc(Nc2cc(Nc3ccccc3)ncn2)cc1		CHEMBL318188	>	IC50	nM	100000.0	CHEMBL301	Homo sapiens	IC50	uM	100.0
	369845	CHEMBL660783	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	CN(C)CC(O)COc1ccc(Nc2cc(Nc3ccccc3Br)ncn2)cc1		CHEMBL100811	=	IC50	nM	28000.0	CHEMBL301	Homo sapiens	IC50	uM	28.0
	371187	CHEMBL660783	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	CN(C)CC(O)COc1ccc(Nc2cc(Nc3cc(C(F)(F)F)ccc3F)ncn2)cc1		CHEMBL101557	=	IC50	nM	35000.0	CHEMBL301	Homo sapiens	IC50	uM	35.0
	376828	CHEMBL660783	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	CC(C)c1ccccc1Nc1cc(Nc2ccc(OCC(O)CN(C)C)cc2)ncn1		CHEMBL99699	=	IC50	nM	24000.0	CHEMBL301	Homo sapiens	IC50	uM	24.0
	376830	CHEMBL660783	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	CN(C)CC(O)COc1ccc(Nc2cc(Nc3c(F)cccc3F)ncn2)cc1		CHEMBL101558	=	IC50	nM	38000.0	CHEMBL301	Homo sapiens	IC50	uM	38.0
	382514	CHEMBL660783	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	CN(C)CC(O)COc1ccc(Nc2cc(Nc3ccccc3Cl)ncn2)cc1		CHEMBL99647	=	IC50	nM	95000.0	CHEMBL301	Homo sapiens	IC50	uM	95.0
	385348	CHEMBL660783	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	CN(C)CC(O)COc1ccc(Nc2cc(Nc3ccccc3[N+](=O)[O-])ncn2)cc1		CHEMBL316887	=	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	392929	CHEMBL661124	Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2)	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	IC50	nM	360.0	CHEMBL301	Homo sapiens	IC50	nM	360.0
	393977	CHEMBL661124	Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2)	B	CN1CCC(c2c(O)cc(O)c3c2O/C(=C\c2ccc(S(N)(=O)=O)cc2)C3=O)CC1		CHEMBL48362	=	IC50	nM	30.0	CHEMBL301	Homo sapiens	IC50	nM	30.0
	396725	CHEMBL661124	Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2)	B	COc1ccc2c(c1Cl)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271822	=	IC50	nM	54.0	CHEMBL301	Homo sapiens	IC50	nM	54.0
	396726	CHEMBL661124	Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2)	B	COc1ccc2[nH]c(O)c(/N=N/c3ccccc3)c2c1		CHEMBL85450	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	397929	CHEMBL661124	Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2)	B	O=C1Nc2ccc3ncsc3c2/C1=C/Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1276446	=	IC50	nM	9.7	CHEMBL301	Homo sapiens	IC50	nM	9.7
	401866	CHEMBL661124	Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2)	B	Oc1[nH]c2ccccc2c1/N=N/c1ccccc1		CHEMBL87527	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	403352	CHEMBL661124	Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2)	B	Oc1[nH]c2ccc(Br)cc2c1/N=N/c1ccccc1		CHEMBL314877	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	403353	CHEMBL661124	Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2)	B	CN1CCC(c2c(O)cc(O)c3c2O/C(=C\c2ccc([N+](=O)[O-])cc2)C3=O)CC1		CHEMBL45477	=	IC50	nM	310.0	CHEMBL301	Homo sapiens	IC50	nM	310.0
	409663	CHEMBL661124	Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2)	B	O=C1Nc2ccc3ncsc3c2/C1=C/Nc1ccc(S(=O)(=O)NCc2ccccc2)cc1		CHEMBL1964242	=	IC50	nM	5.6	CHEMBL301	Homo sapiens	IC50	nM	5.6
	413330	CHEMBL661124	Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2)	B	O=C1Nc2ccc3ncsc3c2/C1=C/Nc1ccc(S(=O)(=O)NCCO)cc1		CHEMBL1964246	=	IC50	nM	4.7	CHEMBL301	Homo sapiens	IC50	nM	4.7
	415797	CHEMBL661124	Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2)	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccc(Cl)cc21		CHEMBL412097	=	IC50	nM	22.0	CHEMBL301	Homo sapiens	IC50	nM	22.0
	415798	CHEMBL661124	Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2)	B	COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL409731	=	IC50	nM	2.1	CHEMBL301	Homo sapiens	IC50	nM	2.1
	417000	CHEMBL661124	Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2)	B	CN(C)S(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1964247	=	IC50	nM	4.6	CHEMBL301	Homo sapiens	IC50	nM	4.6
	419247	CHEMBL661124	Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2)	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	IC50	nM	310.0	CHEMBL301	Homo sapiens	IC50	nM	310.0
	419248	CHEMBL661124	Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2)	B	CN1CCC(c2c(O)cc(O)c3c2O/C(=C\c2ccccc2)C3=O)CC1		CHEMBL51709	=	IC50	nM	1280.0	CHEMBL301	Homo sapiens	IC50	nM	1280.0
	420589	CHEMBL661124	Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2)	B	Cc1ccc2c(c1Cl)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL411490	=	IC50	nM	13.0	CHEMBL301	Homo sapiens	IC50	nM	13.0
	422105	CHEMBL661124	Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2)	B	Cc1cccc2c1NC(=O)/C2=C\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL408131	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	422106	CHEMBL661124	Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2)	B	Cc1cc(Cl)cc2c1NC(=O)/C2=C\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL410517	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	422107	CHEMBL661124	Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2)	B	CNS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1964245	=	IC50	nM	5.6	CHEMBL301	Homo sapiens	IC50	nM	5.6
	422108	CHEMBL661124	Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2)	B	O=C1Nc2ccc3ncsc3c2/C1=C/Nc1ccc(S(=O)(=O)Nc2ccccc2)cc1		CHEMBL1964244	=	IC50	nM	4.3	CHEMBL301	Homo sapiens	IC50	nM	4.3
	423435	CHEMBL661124	Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3cc(CO)ccc32)cc1		CHEMBL410293	=	IC50	nM	61.0	CHEMBL301	Homo sapiens	IC50	nM	61.0
	423436	CHEMBL661124	Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	IC50	nM	2.8	CHEMBL301	Homo sapiens	IC50	nM	2.8
	424602	CHEMBL661124	Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3cccc(CO)c32)cc1		CHEMBL271137	=	IC50	nM	54.0	CHEMBL301	Homo sapiens	IC50	nM	54.0
	425833	CHEMBL661124	Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2)	B	Cc1c([N+](=O)[O-])ccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272667	=	IC50	nM	4.6	CHEMBL301	Homo sapiens	IC50	nM	4.6
	425834	CHEMBL661124	Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL269850	=	IC50	nM	690.0	CHEMBL301	Homo sapiens	IC50	nM	690.0
	425835	CHEMBL661124	Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2)	B	CN1CCC(c2c(O)cc(O)c3c2O/C(=C\c2ccccc2Cl)C3=O)CC1		CHEMBL48614	=	IC50	nM	3970.0	CHEMBL301	Homo sapiens	IC50	nM	3970.0
	428490	CHEMBL661124	Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2)	B	CC(=O)NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1964243	=	IC50	nM	75.0	CHEMBL301	Homo sapiens	IC50	nM	75.0
	473994	CHEMBL660704	Inhibitory activity against Cyclin-dependent kinase 2	B	O=C1Nc2cccc(C3CCNCC3)c2/C1=C/c1[nH]cc2c1CCNC2=O		CHEMBL58466	=	IC50	nM	49.0	CHEMBL301	Homo sapiens	IC50	uM	0.049
	473999	CHEMBL658939	In vitro inhibition of Cyclin-dependent kinase 2	B	CC(=O)OCCCOc1cc(-c2ccc[nH]2)c2c3c(ccc(F)c13)NC2=O		CHEMBL82020	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	474436	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	CS(=O)(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272389	=	IC50	nM	16.0	CHEMBL301	Homo sapiens	IC50	nM	16.0
	475051	CHEMBL660704	Inhibitory activity against Cyclin-dependent kinase 2	B	COc1ccc2c(c1)/C(=C/c1[nH]cc3c1CCOC3=O)C(=O)N2		CHEMBL300767	=	IC50	nM	40.0	CHEMBL301	Homo sapiens	IC50	uM	0.04
	476183	CHEMBL660704	Inhibitory activity against Cyclin-dependent kinase 2	B	O=C1Nc2cc(-c3ccccc3)ccc2/C1=C/c1[nH]cc2c1CCNC2=O		CHEMBL57325	=	IC50	nM	5700.0	CHEMBL301	Homo sapiens	IC50	uM	5.7
	477355	CHEMBL660704	Inhibitory activity against Cyclin-dependent kinase 2	B	NS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]cc3c1CCOC3=O)C(=O)N2		CHEMBL432491	=	IC50	nM	12.0	CHEMBL301	Homo sapiens	IC50	uM	0.012
	477367	CHEMBL658939	In vitro inhibition of Cyclin-dependent kinase 2	B	CC(=O)NCCNc1cc(-c2ccc[nH]2)c2c3c(ccc(F)c13)NC2=O		CHEMBL312273	=	IC50	nM	127.0	CHEMBL301	Homo sapiens	IC50	nM	127.0
	477907	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccc(O)cc4)c32)cc1		CHEMBL411865	=	IC50	nM	12.0	CHEMBL301	Homo sapiens	IC50	nM	12.0
	477908	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(-c4cc[nH]n4)c32)cc1		CHEMBL272684	=	IC50	nM	19.0	CHEMBL301	Homo sapiens	IC50	nM	19.0
	477909	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	IC50	nM	2.3	CHEMBL301	Homo sapiens	IC50	nM	2.3
	478714	CHEMBL660704	Inhibitory activity against Cyclin-dependent kinase 2	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]cc3c1CCOC3=O)C(=O)N2		CHEMBL60541	=	IC50	nM	4.0	CHEMBL301	Homo sapiens	IC50	uM	0.004
	479851	CHEMBL658939	In vitro inhibition of Cyclin-dependent kinase 2	B	NCCOc1cc(-c2ccc[nH]2)c2c3c(ccc(F)c13)NC2=O		CHEMBL311992	=	IC50	nM	12.0	CHEMBL301	Homo sapiens	IC50	nM	12.0
	479855	CHEMBL658939	In vitro inhibition of Cyclin-dependent kinase 2	B	Cc1cc(-c2ccc[nH]2)c2c3c(ccc(F)c13)NC2=O		CHEMBL82603	=	IC50	nM	376.0	CHEMBL301	Homo sapiens	IC50	nM	376.0
	480500	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	NC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410883	=	IC50	nM	4.5	CHEMBL301	Homo sapiens	IC50	nM	4.5
	481190	CHEMBL660704	Inhibitory activity against Cyclin-dependent kinase 2	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]cc3c1CCNC3=O)C(=O)N2		CHEMBL294884	=	IC50	nM	9.0	CHEMBL301	Homo sapiens	IC50	uM	0.009
	481774	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc([N+](=O)[O-])c32)cc1		CHEMBL409619	=	IC50	nM	2400.0	CHEMBL301	Homo sapiens	IC50	nM	2400.0
	481775	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	IC50	nM	8.9	CHEMBL301	Homo sapiens	IC50	nM	8.9
	482438	CHEMBL660704	Inhibitory activity against Cyclin-dependent kinase 2	B	O=C1Nc2cc(-c3ccccc3)ccc2/C1=C/c1[nH]cc2c1CCOC2=O		CHEMBL418301	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	483021	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(O)cc32)cc1		CHEMBL409690	=	IC50	nM	10.0	CHEMBL301	Homo sapiens	IC50	nM	10.0
	483671	CHEMBL660704	Inhibitory activity against Cyclin-dependent kinase 2	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1[nH]cc2c1CCOC2=O		CHEMBL301639	=	IC50	nM	88.0	CHEMBL301	Homo sapiens	IC50	uM	0.088
	483679	CHEMBL658939	In vitro inhibition of Cyclin-dependent kinase 2	B	O=C1Nc2ccc(F)c3c(OCCCO)cc(-c4ccc[nH]4)c1c23		CHEMBL79364	=	IC50	nM	18.0	CHEMBL301	Homo sapiens	IC50	nM	18.0
	484889	CHEMBL658939	In vitro inhibition of Cyclin-dependent kinase 2	B	COc1cc(-c2ccc[nH]2)c2c3c(ccc(F)c13)NC2=O		CHEMBL83775	=	IC50	nM	18.0	CHEMBL301	Homo sapiens	IC50	nM	18.0
	484893	CHEMBL658939	In vitro inhibition of Cyclin-dependent kinase 2	B	CC(C)Cc1cc(-c2ccc[nH]2)c2c3c(ccc(F)c13)NC2=O		CHEMBL83443	=	IC50	nM	124.0	CHEMBL301	Homo sapiens	IC50	nM	124.0
	485371	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	IC50	nM	43.0	CHEMBL301	Homo sapiens	IC50	nM	43.0
	485990	CHEMBL658939	In vitro inhibition of Cyclin-dependent kinase 2	B	O=C1Nc2ccc(F)c3c(NCCO)cc(-c4ccc[nH]4)c1c23		CHEMBL83499	=	IC50	nM	54.0	CHEMBL301	Homo sapiens	IC50	nM	54.0
	485994	CHEMBL658939	In vitro inhibition of Cyclin-dependent kinase 2	B	CC(C)(C)OC(=O)NCCNc1cc(-c2ccc[nH]2)c2c3c(ccc(F)c13)NC2=O		CHEMBL84284	=	IC50	nM	5500.0	CHEMBL301	Homo sapiens	IC50	nM	5500.0
	485995	CHEMBL658939	In vitro inhibition of Cyclin-dependent kinase 2	B	NCCSc1cc(-c2ccc[nH]2)c2c3c(ccc(F)c13)NC2=O		CHEMBL311464	=	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	nM	3.0
	486493	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	IC50	nM	46.0	CHEMBL301	Homo sapiens	IC50	nM	46.0
	487120	CHEMBL660704	Inhibitory activity against Cyclin-dependent kinase 2	B	O=C1Nc2cccc(C3CCNCC3)c2/C1=C/c1[nH]cc2c1CCOC2=O		CHEMBL58224	=	IC50	nM	9.0	CHEMBL301	Homo sapiens	IC50	uM	0.009
	487128	CHEMBL658939	In vitro inhibition of Cyclin-dependent kinase 2	B	CCN(CC)CCNc1cc(-c2ccc[nH]2)c2c3c(ccc(F)c13)NC2=O		CHEMBL84347	=	IC50	nM	294.0	CHEMBL301	Homo sapiens	IC50	nM	294.0
	487129	CHEMBL658939	In vitro inhibition of Cyclin-dependent kinase 2	B	CCc1cc(-c2ccc[nH]2)c2c3c(ccc(F)c13)NC2=O		CHEMBL82251	=	IC50	nM	72.0	CHEMBL301	Homo sapiens	IC50	nM	72.0
	487781	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Br)cc32)cc1		CHEMBL411491	=	IC50	nM	60.0	CHEMBL301	Homo sapiens	IC50	nM	60.0
	488356	CHEMBL658939	In vitro inhibition of Cyclin-dependent kinase 2	B	O=C1Nc2ccc(F)c3c(SCCO)cc(-c4ccc[nH]4)c1c23		CHEMBL83369	=	IC50	nM	14.0	CHEMBL301	Homo sapiens	IC50	nM	14.0
	489442	CHEMBL658939	In vitro inhibition of Cyclin-dependent kinase 2	B	O=C1Nc2ccc(F)c3c(S[C@H]4CCNC4)cc(-c4ccc[nH]4)c1c23		CHEMBL79498	=	IC50	nM	5.0	CHEMBL301	Homo sapiens	IC50	nM	5.0
	490037	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	CC(C)Oc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271160	=	IC50	nM	3.4	CHEMBL301	Homo sapiens	IC50	nM	3.4
	490038	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)cc1		CHEMBL272387	=	IC50	nM	43.0	CHEMBL301	Homo sapiens	IC50	nM	43.0
	490678	CHEMBL658939	In vitro inhibition of Cyclin-dependent kinase 2	B	NCC[S+]([O-])c1cc(-c2ccc[nH]2)c2c3c(ccc(F)c13)NC2=O		CHEMBL79356	=	IC50	nM	28.0	CHEMBL301	Homo sapiens	IC50	nM	28.0
	490682	CHEMBL658939	In vitro inhibition of Cyclin-dependent kinase 2	B	NCCS(=O)(=O)c1cc(-c2ccc[nH]2)c2c3c(ccc(F)c13)NC2=O		CHEMBL309767	=	IC50	nM	23.0	CHEMBL301	Homo sapiens	IC50	nM	23.0
	491906	CHEMBL660704	Inhibitory activity against Cyclin-dependent kinase 2	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]cc3c1CCNC3=O)C(=O)N2		CHEMBL58139	=	IC50	nM	68.0	CHEMBL301	Homo sapiens	IC50	uM	0.068
	492435	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	IC50	nM	1.5	CHEMBL301	Homo sapiens	IC50	nM	1.5
	493112	CHEMBL660704	Inhibitory activity against Cyclin-dependent kinase 2	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	IC50	nM	110.0	CHEMBL301	Homo sapiens	IC50	uM	0.11
	493116	CHEMBL658939	In vitro inhibition of Cyclin-dependent kinase 2	B	N#CCCc1cc(-c2ccc[nH]2)c2c3c(ccc(F)c13)NC2=O		CHEMBL415471	=	IC50	nM	5.0	CHEMBL301	Homo sapiens	IC50	nM	5.0
	493643	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(I)cc32)cc1		CHEMBL273060	=	IC50	nM	11.0	CHEMBL301	Homo sapiens	IC50	nM	11.0
	494216	CHEMBL660704	Inhibitory activity against Cyclin-dependent kinase 2	B	Cc1cccc2c1/C(=C/c1[nH]cc3c1CCOC3=O)C(=O)N2		CHEMBL57446	=	IC50	nM	270.0	CHEMBL301	Homo sapiens	IC50	uM	0.27
	494220	CHEMBL660704	Inhibitory activity against Cyclin-dependent kinase 2	B	COc1ccc2c(c1)NC(=O)/C2=C\c1[nH]cc2c1CCOC2=O		CHEMBL59073	=	IC50	nM	1500.0	CHEMBL301	Homo sapiens	IC50	uM	1.5
	494224	CHEMBL658939	In vitro inhibition of Cyclin-dependent kinase 2	B	NCCNc1cc(-c2ccc[nH]2)c2c3c(ccc(F)c13)NC2=O		CHEMBL82767	=	IC50	nM	12.0	CHEMBL301	Homo sapiens	IC50	nM	12.0
	495853	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccccc32)cc1		CHEMBL438721	=	IC50	nM	120.0	CHEMBL301	Homo sapiens	IC50	nM	120.0
	495854	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	NC(=O)c1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271778	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	496460	CHEMBL660704	Inhibitory activity against Cyclin-dependent kinase 2	B	O=C1Nc2ccc(C(=O)O)cc2/C1=C/c1[nH]cc2c1CCOC2=O		CHEMBL293068	=	IC50	nM	4.0	CHEMBL301	Homo sapiens	IC50	uM	0.004
	496464	CHEMBL660704	Inhibitory activity against Cyclin-dependent kinase 2	B	O=C1Nc2ccc(Br)cc2/C1=C/c1[nH]cc2c1CCOC2=O		CHEMBL292864	=	IC50	nM	190.0	CHEMBL301	Homo sapiens	IC50	uM	0.19
	496924	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	NS(=O)(=O)c1ccc(/N=N/c2c(O)[nH]c3cccc(I)c23)cc1		CHEMBL314397	=	IC50	nM	4.6	CHEMBL301	Homo sapiens	IC50	nM	4.6
	496925	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	CC(C)c1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL411426	=	IC50	nM	2.5	CHEMBL301	Homo sapiens	IC50	nM	2.5
	496926	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	Nc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271842	=	IC50	nM	74.0	CHEMBL301	Homo sapiens	IC50	nM	74.0
	498088	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1794054	=	IC50	nM	21.0	CHEMBL301	Homo sapiens	IC50	nM	21.0
	498089	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cc(Br)ccc32)cc1		CHEMBL271183	=	IC50	nM	43.0	CHEMBL301	Homo sapiens	IC50	nM	43.0
	499344	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(F)cc32)cc1		CHEMBL273061	=	IC50	nM	34.0	CHEMBL301	Homo sapiens	IC50	nM	34.0
	499345	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	CN(C)C(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL409868	=	IC50	nM	17.0	CHEMBL301	Homo sapiens	IC50	nM	17.0
	500036	CHEMBL660704	Inhibitory activity against Cyclin-dependent kinase 2	B	COc1ccc2c(c1)/C(=C/c1[nH]cc3c1CCNC3=O)C(=O)N2		CHEMBL417228	=	IC50	nM	250.0	CHEMBL301	Homo sapiens	IC50	uM	0.25
	500045	CHEMBL658939	In vitro inhibition of Cyclin-dependent kinase 2	B	O=C1Nc2ccc(F)c3ccc(-c4ccc[nH]4)c1c23		CHEMBL312018	=	IC50	nM	204.0	CHEMBL301	Homo sapiens	IC50	nM	204.0
	500049	CHEMBL658939	In vitro inhibition of Cyclin-dependent kinase 2	B	NCCCc1cc(-c2ccc[nH]2)c2c3c(ccc(F)c13)NC2=O		CHEMBL312726	=	IC50	nM	7.0	CHEMBL301	Homo sapiens	IC50	nM	7.0
	501313	CHEMBL660704	Inhibitory activity against Cyclin-dependent kinase 2	B	CC(C)NS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]cc3c1CCOC3=O)C(=O)N2		CHEMBL299032	=	IC50	nM	64.0	CHEMBL301	Homo sapiens	IC50	uM	0.064
	501317	CHEMBL658939	In vitro inhibition of Cyclin-dependent kinase 2	B	CCOc1cc(-c2ccc[nH]2)c2c3c(ccc(F)c13)NC2=O		CHEMBL310755	=	IC50	nM	77.0	CHEMBL301	Homo sapiens	IC50	nM	77.0
	501318	CHEMBL658939	In vitro inhibition of Cyclin-dependent kinase 2	B	O=C1Nc2ccc(F)c3c(OCCO)cc(-c4ccc[nH]4)c1c23		CHEMBL79848	=	IC50	nM	62.0	CHEMBL301	Homo sapiens	IC50	nM	62.0
	503204	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	CCOc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL411696	=	IC50	nM	93.0	CHEMBL301	Homo sapiens	IC50	nM	93.0
	503205	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4cccnc4)cc32)cc1		CHEMBL271953	=	IC50	nM	2.1	CHEMBL301	Homo sapiens	IC50	nM	2.1
	503827	CHEMBL658939	In vitro inhibition of Cyclin-dependent kinase 2	B	O=C1Nc2ccc(F)c3c(SC[C@@H]4CCCN4)cc(-c4ccc[nH]4)c1c23		CHEMBL442186	=	IC50	nM	18.0	CHEMBL301	Homo sapiens	IC50	nM	18.0
	504291	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	CCc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL411425	=	IC50	nM	7.9	CHEMBL301	Homo sapiens	IC50	nM	7.9
	504933	CHEMBL660704	Inhibitory activity against Cyclin-dependent kinase 2	B	O=C1Nc2ccc(C(=O)O)cc2/C1=C/c1[nH]cc2c1CCNC2=O		CHEMBL60990	=	IC50	nM	68.0	CHEMBL301	Homo sapiens	IC50	uM	0.068
	505586	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	CC(C)Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL411224	=	IC50	nM	1.2	CHEMBL301	Homo sapiens	IC50	nM	1.2
	505587	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	IC50	nM	75.0	CHEMBL301	Homo sapiens	IC50	nM	75.0
	506105	CHEMBL660704	Inhibitory activity against Cyclin-dependent kinase 2	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]cc3c1CCOC3=O)C(=O)N2		CHEMBL57256	=	IC50	nM	33.0	CHEMBL301	Homo sapiens	IC50	uM	0.033
	506109	CHEMBL660704	Inhibitory activity against Cyclin-dependent kinase 2	B	O=C1Nc2ccc(Br)cc2/C1=C/c1[nH]cc2c1CCNC2=O		CHEMBL57639	=	IC50	nM	530.0	CHEMBL301	Homo sapiens	IC50	uM	0.53
	506110	CHEMBL658939	In vitro inhibition of Cyclin-dependent kinase 2	B	O=C1Nc2ccc(F)c3c(S(=O)(=O)CCO)cc(-c4ccc[nH]4)c1c23		CHEMBL310529	=	IC50	nM	15.0	CHEMBL301	Homo sapiens	IC50	nM	15.0
	506161	CHEMBL665069	Inhibition of cyclin dependent kinase 2	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	IC50	nM	3300.0	CHEMBL301	Homo sapiens	IC50	uM	3.3
	506665	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	CCc1ccc2c(c1)NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271182	=	IC50	nM	21.0	CHEMBL301	Homo sapiens	IC50	nM	21.0
	507370	CHEMBL660704	Inhibitory activity against Cyclin-dependent kinase 2	B	O=C1Nc2cccc(CCO)c2/C1=C/c1[nH]cc2c1CCOC2=O		CHEMBL58483	=	IC50	nM	30.0	CHEMBL301	Homo sapiens	IC50	uM	0.03
	508708	CHEMBL660704	Inhibitory activity against Cyclin-dependent kinase 2	B	O=C1Nc2cccc(CCO)c2/C1=C/c1[nH]cc2c1CCNC2=O		CHEMBL445607	=	IC50	nM	340.0	CHEMBL301	Homo sapiens	IC50	uM	0.34
	509192	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(Oc4ccccc4)c32)cc1		CHEMBL409104	=	IC50	nM	13.0	CHEMBL301	Homo sapiens	IC50	nM	13.0
	509905	CHEMBL658939	In vitro inhibition of Cyclin-dependent kinase 2	B	NCCCNc1cc(-c2ccc[nH]2)c2c3c(ccc(F)c13)NC2=O		CHEMBL81196	=	IC50	nM	48.0	CHEMBL301	Homo sapiens	IC50	nM	48.0
	509909	CHEMBL658939	In vitro inhibition of Cyclin-dependent kinase 2	B	CC(C)(N)CNc1cc(-c2ccc[nH]2)c2c3c(ccc(F)c13)NC2=O		CHEMBL82768	=	IC50	nM	65.0	CHEMBL301	Homo sapiens	IC50	nM	65.0
	510434	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc([N+](=O)[O-])cc32)cc1		CHEMBL411886	=	IC50	nM	15.0	CHEMBL301	Homo sapiens	IC50	nM	15.0
	510998	CHEMBL660704	Inhibitory activity against Cyclin-dependent kinase 2	B	O=C1Nc2ccc(F)cc2/C1=C/c1[nH]cc2c1CCOC2=O		CHEMBL59110	=	IC50	nM	82.0	CHEMBL301	Homo sapiens	IC50	uM	0.082
	511002	CHEMBL660704	Inhibitory activity against Cyclin-dependent kinase 2	B	O=C1Nc2ccc(F)cc2/C1=C/c1[nH]cc2c1CCNC2=O		CHEMBL293113	=	IC50	nM	300.0	CHEMBL301	Homo sapiens	IC50	uM	0.3
	511500	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	COc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL260103	=	IC50	nM	12.0	CHEMBL301	Homo sapiens	IC50	nM	12.0
	511501	CHEMBL661123	Evaluated for inhibition of human cyclin dependent kinase 2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cc(Oc4ccccc4)ccc32)cc1		CHEMBL272885	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	512202	CHEMBL660706	Inhibition of CDK2 kinase	B	Cc1cccc(Cl)c1NC(=O)c1cnc(NC(=O)C2CC2)s1		CHEMBL131577	>	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	512210	CHEMBL658934	Selectivity against CDK2 kinase	B	Cc1cccc(Cl)c1NC(=O)c1cnc(NC(=O)C2CC2)s1		CHEMBL131577	>	Fold selectivity		700.0	CHEMBL301	Homo sapiens	Fold selectivity		700.0
	515460	CHEMBL658935	Inhibition of cyclin A activated Cyclin-dependent kinase 2 (CDK2)	B	CN1CCC(c2c(O)cc(O)c3c2O/C(=C\c2ccccc2Cl)C3=O)CC1		CHEMBL48614	=	IC50	nM	3970.0	CHEMBL301	Homo sapiens	IC50	uM	3.97
	516668	CHEMBL658935	Inhibition of cyclin A activated Cyclin-dependent kinase 2 (CDK2)	B	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H](O)C1		CHEMBL418203	=	IC50	nM	220.0	CHEMBL301	Homo sapiens	IC50	uM	0.22
	541706	CHEMBL658935	Inhibition of cyclin A activated Cyclin-dependent kinase 2 (CDK2)	B	CN1CCC(c2c(O)cc(O)c3c2O/C(=C\c2ccc(S(N)(=O)=O)cc2)C3=O)CC1		CHEMBL48362	=	IC50	nM	30.0	CHEMBL301	Homo sapiens	IC50	uM	0.03
	549303	CHEMBL658935	Inhibition of cyclin A activated Cyclin-dependent kinase 2 (CDK2)	B	CN1CCC(c2c(O)cc(O)c3c2O/C(=C\c2ccc(N4CCN(C)CC4)cc2)C3=O)CC1		CHEMBL46181	=	IC50	nM	2980.0	CHEMBL301	Homo sapiens	IC50	uM	2.98
	551663	CHEMBL658935	Inhibition of cyclin A activated Cyclin-dependent kinase 2 (CDK2)	B	CN1CCC(c2c(O)cc(O)c3c2O/C(=C\c2ccccc2)C3=O)CC1		CHEMBL51709	=	IC50	nM	1280.0	CHEMBL301	Homo sapiens	IC50	uM	1.28
	553005	CHEMBL658935	Inhibition of cyclin A activated Cyclin-dependent kinase 2 (CDK2)	B	CN1CCC(c2c(O)cc(O)c3c2O/C(=C\c2ccc([N+](=O)[O-])cc2)C3=O)CC1		CHEMBL45477	=	IC50	nM	310.0	CHEMBL301	Homo sapiens	IC50	uM	0.31
	553321	CHEMBL660785	Inhibitory concentration against cyclin-dependent kinase 2	B	CNS(=O)(=O)c1ccc(Nc2nccc(-c3cnc4ccccn34)n2)cc1		CHEMBL308853	<	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	uM	0.003
	553664	CHEMBL658108	Binding affinity towards cyclin dependent kinase-2 was determined	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL38425	=	cKi	nM	540.0	CHEMBL301	Homo sapiens	cKi	nM	540.0
	553665	CHEMBL843755	Selectivity ratio between CDK-2 to GSK-3	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL38425	=	Ratio		2842.0	CHEMBL301	Homo sapiens	Ratio		2842.0
	554914	CHEMBL658108	Binding affinity towards cyclin dependent kinase-2 was determined	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1		CHEMBL35785	=	cKi	nM	5.0	CHEMBL301	Homo sapiens	cKi	nM	5.0
	554915	CHEMBL843755	Selectivity ratio between CDK-2 to GSK-3	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1		CHEMBL35785	=	Ratio		62.0	CHEMBL301	Homo sapiens	Ratio		62.0
	554956	CHEMBL658936	Inhibition of Cyclin-dependent kinase 2 (CDK2/cyclin A)	B	CCOc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1	Outside typical range	CHEMBL40362	>	IC50	nM	200000.0	CHEMBL301	Homo sapiens	IC50	uM	200.0
	555684	CHEMBL660785	Inhibitory concentration against cyclin-dependent kinase 2	B	c1ccc(Nc2nccc(-c3cnc4ccccn34)n2)cc1		CHEMBL72672	<	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	uM	0.003
	556105	CHEMBL658936	Inhibition of Cyclin-dependent kinase 2 (CDK2/cyclin A)	B	Cc1nc2c(s1)C(=O)C=C(Nc1ccc(F)cc1)C2=O	Outside typical range	CHEMBL40326	>	IC50	nM	200000.0	CHEMBL301	Homo sapiens	IC50	uM	200.0
	556875	CHEMBL660785	Inhibitory concentration against cyclin-dependent kinase 2	B	COCCNS(=O)(=O)c1ccc(Nc2nccc(-c3cnc4ccc(Sc5ccccc5)cn34)n2)cc1		CHEMBL307808	=	IC50	nM	16.0	CHEMBL301	Homo sapiens	IC50	uM	0.016
	558049	CHEMBL660785	Inhibitory concentration against cyclin-dependent kinase 2	B	COCCNS(=O)(=O)c1ccc(Nc2nccc(-c3cnc4ccccn34)n2)cc1		CHEMBL309573	=	IC50	nM	12.0	CHEMBL301	Homo sapiens	IC50	uM	0.012
	558051	CHEMBL660785	Inhibitory concentration against cyclin-dependent kinase 2	B	CN(C)CCNS(=O)(=O)c1ccc(Nc2nccc(-c3cnc4ccccn34)n2)cc1		CHEMBL72548	=	IC50	nM	5.0	CHEMBL301	Homo sapiens	IC50	uM	0.005
	559315	CHEMBL660785	Inhibitory concentration against cyclin-dependent kinase 2	B	Cc1nc2ccccn2c1-c1ccnc(Nc2ccc(Cl)cc2)n1		CHEMBL73645	=	IC50	nM	620.0	CHEMBL301	Homo sapiens	IC50	uM	0.62
	561426	CHEMBL660785	Inhibitory concentration against cyclin-dependent kinase 2	B	COCCNS(=O)(=O)c1ccc(Nc2ncc(Cl)c(-c3cnc4ccccn34)n2)cc1		CHEMBL72464	<	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	uM	0.003
	562710	CHEMBL660785	Inhibitory concentration against cyclin-dependent kinase 2	B	Cc1nc2ccccn2c1-c1ccnc(Nc2cccc(Cl)c2)n1		CHEMBL73189	=	IC50	nM	150.0	CHEMBL301	Homo sapiens	IC50	uM	0.15
	562711	CHEMBL660785	Inhibitory concentration against cyclin-dependent kinase 2	B	NS(=O)(=O)c1ccc(Nc2nccc(-c3cnc4ccccn34)n2)cc1		CHEMBL73303	<	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	uM	0.003
	563166	CHEMBL658936	Inhibition of Cyclin-dependent kinase 2 (CDK2/cyclin A)	B	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21		CHEMBL280074	=	IC50	nM	7000.0	CHEMBL301	Homo sapiens	IC50	uM	7.0
	565024	CHEMBL660785	Inhibitory concentration against cyclin-dependent kinase 2	B	Cc1nc2ccccn2c1-c1ccnc(Nc2ccccc2Cl)n1		CHEMBL308848	=	IC50	nM	8800.0	CHEMBL301	Homo sapiens	IC50	uM	8.8
Not Determined	565481	CHEMBL658937	Inhibition of Cyclin-dependent kinase 2 (CDK2/cyclin A) (Not tested)	B			CHEMBL11359		IC50	nM		CHEMBL301	Homo sapiens	IC50	uM	
	566154	CHEMBL660785	Inhibitory concentration against cyclin-dependent kinase 2	B	CCSc1ccc2ncc(-c3ccnc(Nc4ccc(S(=O)(=O)NCCOC)cc4)n3)n2c1		CHEMBL73214	<	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	uM	0.003
	566701	CHEMBL658936	Inhibition of Cyclin-dependent kinase 2 (CDK2/cyclin A)	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1	Outside typical range	CHEMBL290904	>	IC50	nM	200000.0	CHEMBL301	Homo sapiens	IC50	uM	200.0
	567835	CHEMBL658936	Inhibition of Cyclin-dependent kinase 2 (CDK2/cyclin A)	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	IC50	nM	600.0	CHEMBL301	Homo sapiens	IC50	uM	0.6
	570008	CHEMBL660785	Inhibitory concentration against cyclin-dependent kinase 2	B	Cc1nc2ccccn2c1-c1ccnc(Nc2ccccc2)n1		CHEMBL72461	=	IC50	nM	210.0	CHEMBL301	Homo sapiens	IC50	uM	0.21
	572973	CHEMBL658108	Binding affinity towards cyclin dependent kinase-2 was determined	B	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL259744	=	cKi	nM	1695.0	CHEMBL301	Homo sapiens	cKi	nM	1695.0
	572974	CHEMBL843755	Selectivity ratio between CDK-2 to GSK-3	B	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL259744	=	Ratio		678.0	CHEMBL301	Homo sapiens	Ratio		678.0
	576700	CHEMBL658936	Inhibition of Cyclin-dependent kinase 2 (CDK2/cyclin A)	B	Cc1nc2c(s1)C(=O)C=C(Nc1ccccc1)C2=O	Outside typical range	CHEMBL38693	>	IC50	nM	200000.0	CHEMBL301	Homo sapiens	IC50	uM	200.0
	576706	CHEMBL658936	Inhibition of Cyclin-dependent kinase 2 (CDK2/cyclin A)	B	Cc1nc2c(s1)C(=O)C=C(Nc1ccc(I)cc1)C2=O	Outside typical range	CHEMBL142789	>	IC50	nM	200000.0	CHEMBL301	Homo sapiens	IC50	uM	200.0
	577468	CHEMBL660785	Inhibitory concentration against cyclin-dependent kinase 2	B	Clc1cccc(Nc2nccc(-n3cnc4ccccc43)n2)c1		CHEMBL74680	=	IC50	nM	680.0	CHEMBL301	Homo sapiens	IC50	uM	0.68
	577469	CHEMBL660785	Inhibitory concentration against cyclin-dependent kinase 2	B	CN(C)CCCNS(=O)(=O)c1ccc(Nc2nccc(-c3cnc4ccccn34)n2)cc1		CHEMBL71044	<	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	uM	0.003
	577944	CHEMBL658936	Inhibition of Cyclin-dependent kinase 2 (CDK2/cyclin A)	B	Cc1nc2c(s1)C(=O)C=C(Nc1ccc(O)cc1)C2=O	Outside typical range	CHEMBL140584	>	IC50	nM	200000.0	CHEMBL301	Homo sapiens	IC50	uM	200.0
	578271	CHEMBL662527	Inhibition of Cyclin-dependent kinase 2	B	C[C@H](O)CNc1cc(-c2[nH]c3cccnc3c2-c2ccc(F)cc2)ccn1		CHEMBL142425	>	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	578714	CHEMBL660785	Inhibitory concentration against cyclin-dependent kinase 2	B	COCCCNS(=O)(=O)c1ccc(Nc2nccc(-c3cnc4ccccn34)n2)cc1		CHEMBL73243	=	IC50	nM	4.0	CHEMBL301	Homo sapiens	IC50	uM	0.004
	581010	CHEMBL660785	Inhibitory concentration against cyclin-dependent kinase 2	B	Cc1nc2ccccn2c1-c1ccnc(Nc2ccc(S(N)(=O)=O)cc2)n1		CHEMBL72510	=	IC50	nM	38.0	CHEMBL301	Homo sapiens	IC50	uM	0.038
	581011	CHEMBL660785	Inhibitory concentration against cyclin-dependent kinase 2	B	COCCNS(=O)(=O)c1ccc(Nc2nccc(-c3cnc4ccc(Br)cn34)n2)cc1		CHEMBL73038	<	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	uM	0.003
	581403	CHEMBL658108	Binding affinity towards cyclin dependent kinase-2 was determined	B	O=C(Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12)C1CCCC1		CHEMBL287092	=	cKi	nM	5.0	CHEMBL301	Homo sapiens	cKi	nM	5.0
	581404	CHEMBL843755	Selectivity ratio between CDK-2 to GSK-3	B	O=C(Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12)C1CCCC1		CHEMBL287092	=	Ratio		45.0	CHEMBL301	Homo sapiens	Ratio		45.0
	584732	CHEMBL660785	Inhibitory concentration against cyclin-dependent kinase 2	B	CN(C)CCCN(C)S(=O)(=O)c1ccc(Nc2nccc(-c3cnc4ccccn34)n2)cc1		CHEMBL70824	=	IC50	nM	5.0	CHEMBL301	Homo sapiens	IC50	uM	0.005
	584734	CHEMBL660785	Inhibitory concentration against cyclin-dependent kinase 2	B	COCCNS(=O)(=O)c1ccc(Nc2ncc(Sc3ccccc3)c(-c3cnc4ccccn34)n2)cc1		CHEMBL72893	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	585279	CHEMBL658936	Inhibition of Cyclin-dependent kinase 2 (CDK2/cyclin A)	B	Cc1nc2c(s1)C(=O)C=C(Nc1ccc(Br)cc1)C2=O	Outside typical range	CHEMBL142788	>	IC50	nM	200000.0	CHEMBL301	Homo sapiens	IC50	uM	200.0
	586464	CHEMBL658936	Inhibition of Cyclin-dependent kinase 2 (CDK2/cyclin A)	B	COc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1	Outside typical range	CHEMBL143570	>	IC50	nM	200000.0	CHEMBL301	Homo sapiens	IC50	uM	200.0
	587626	CHEMBL658108	Binding affinity towards cyclin dependent kinase-2 was determined	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL39300	=	cKi	nM	450.0	CHEMBL301	Homo sapiens	cKi	nM	450.0
	587627	CHEMBL843755	Selectivity ratio between CDK-2 to GSK-3	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL39300	=	Ratio		474.0	CHEMBL301	Homo sapiens	Ratio		474.0
	589008	CHEMBL658936	Inhibition of Cyclin-dependent kinase 2 (CDK2/cyclin A)	B	Cc1nc2c(s1)C(=O)C=C(Nc1ccc(Cl)cc1)C2=O	Outside typical range	CHEMBL38694	>	IC50	nM	200000.0	CHEMBL301	Homo sapiens	IC50	uM	200.0
	591068	CHEMBL660785	Inhibitory concentration against cyclin-dependent kinase 2	B	Clc1cccc(Nc2nccc(-c3cnc4ccccn34)n2)c1		CHEMBL72509	=	IC50	nM	5.0	CHEMBL301	Homo sapiens	IC50	uM	0.005
	591069	CHEMBL660785	Inhibitory concentration against cyclin-dependent kinase 2	B	COCCNS(=O)(=O)c1ccc(Nc2ncc(Br)c(-c3cnc4ccccn34)n2)cc1		CHEMBL70808	<	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	uM	0.003
	591070	CHEMBL660785	Inhibitory concentration against cyclin-dependent kinase 2	B	COCCNS(=O)(=O)c1ccc(Nc2nccc(-c3cnc4ccc(C#N)cn34)n2)cc1		CHEMBL419634	<	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	uM	0.003
	622800	CHEMBL660780	Inhibition of Cyclin-dependent kinase 2 (CDK2)	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	IC50	nM	4.0	CHEMBL301	Homo sapiens	IC50	nM	4.0
	631764	CHEMBL662521	Selectivity for cyclin-dependent kinase 2, CDK2	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(P(=O)(O)CP(=O)(O)O)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL3084838	=	Selectivity		10.0	CHEMBL301	Homo sapiens	Selectivity		10.0
	641523	CHEMBL662522	Inhibition of Cyclin-dependent kinase 2	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	>	IC50	nM	8000.0	CHEMBL301	Homo sapiens	IC50	uM	8.0
	654943	CHEMBL660786	Inhibition of Cyclin-dependent kinase 2	B	COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC	Outside typical range	CHEMBL29197	=	IC50	nM	250000.0	CHEMBL301	Homo sapiens	IC50	uM	250.0
	791686	CHEMBL660782	Inhibition of Cyclin-dependent kinase 2	B	Cc1nc2ccccn2c1-c1ccnc(Nc2ccc(S(N)(=O)=O)cc2)n1		CHEMBL72510	<	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	uM	0.003
	792229	CHEMBL660787	Inhibition of Cyclin-dependent kinase 2 (CDK2)	B	Cc1cc(C)nc(Sc2cc(=O)c3c(O)cc(O)c(C4CCN(C)CC4O)c3o2)n1		CHEMBL323015	=	IC50	nM	40400.0	CHEMBL301	Homo sapiens	IC50	uM	40.4
	794937	CHEMBL660782	Inhibition of Cyclin-dependent kinase 2	B	Cc1nc2ccccn2c1-c1ccnc(NC(=O)C(F)(F)F)n1		CHEMBL102622	=	IC50	nM	95000.0	CHEMBL301	Homo sapiens	IC50	uM	95.0
	797739	CHEMBL660787	Inhibition of Cyclin-dependent kinase 2 (CDK2)	B	CN1CCC(c2c(O)cc(O)c3c2O/C(=C\c2ccc(S(N)(=O)=O)cc2)C3=O)CC1		CHEMBL48362	=	IC50	nM	30.0	CHEMBL301	Homo sapiens	IC50	uM	0.03
	803285	CHEMBL660782	Inhibition of Cyclin-dependent kinase 2	B	Cc1nc2ccccn2c1-c1ccnc(NC(=O)Nc2ccccc2)n1		CHEMBL317445	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	803287	CHEMBL660782	Inhibition of Cyclin-dependent kinase 2	B	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3ccccc3)n2)cc1		CHEMBL102047	=	IC50	nM	32000.0	CHEMBL301	Homo sapiens	IC50	uM	32.0
	804549	CHEMBL660782	Inhibition of Cyclin-dependent kinase 2	B	Cc1nc2ccccn2c1-c1ccnc(Nc2ccccc2)n1		CHEMBL72461	=	IC50	nM	36.0	CHEMBL301	Homo sapiens	IC50	uM	0.036
	810327	CHEMBL660787	Inhibition of Cyclin-dependent kinase 2 (CDK2)	B	CN1CCC(c2c(O)cc(O)c3c(=O)cc(Sc4ccccc4)oc23)C(O)C1		CHEMBL112050	=	IC50	nM	6590.0	CHEMBL301	Homo sapiens	IC50	uM	6.59
	811585	CHEMBL660787	Inhibition of Cyclin-dependent kinase 2 (CDK2)	B	CN1CCC(c2c(O)cc(O)c3c(=O)cc(Sc4ccccc4Cl)oc23)C(O)C1		CHEMBL113544	=	IC50	nM	2100.0	CHEMBL301	Homo sapiens	IC50	uM	2.1
	812840	CHEMBL660787	Inhibition of Cyclin-dependent kinase 2 (CDK2)	B	CN1CCC(c2c(O)cc(O)c3c(=O)cc(SC(C)(C)C)oc23)C(O)C1		CHEMBL112582	=	IC50	nM	1070.0	CHEMBL301	Homo sapiens	IC50	uM	1.07
	814806	CHEMBL660782	Inhibition of Cyclin-dependent kinase 2	B	Cc1nc2ccccn2c1-c1ccnc(Nc2ccc(OCC(O)CN(C)C)cc2)n1		CHEMBL102926	=	IC50	nM	32.0	CHEMBL301	Homo sapiens	IC50	uM	0.032
	815272	CHEMBL660787	Inhibition of Cyclin-dependent kinase 2 (CDK2)	B	CCSc1cc(=O)c2c(O)cc(O)c(C3CCN(C)CC3O)c2o1		CHEMBL326843	=	IC50	nM	3930.0	CHEMBL301	Homo sapiens	IC50	uM	3.93
	815967	CHEMBL660782	Inhibition of Cyclin-dependent kinase 2	B	CC(=O)Nc1nccc(-c2c(C)nc3ccccn23)n1		CHEMBL99842	=	IC50	nM	2900.0	CHEMBL301	Homo sapiens	IC50	uM	2.9
	816419	CHEMBL660787	Inhibition of Cyclin-dependent kinase 2 (CDK2)	B	CN1CCC(c2c(O)cc(O)c3c2O/C(=C\c2ccccc2)C3=O)CC1		CHEMBL51709	=	IC50	nM	1280.0	CHEMBL301	Homo sapiens	IC50	uM	1.28
	817348	CHEMBL660782	Inhibition of Cyclin-dependent kinase 2	B	Cc1nc2ccccn2c1-c1ccnc(N)n1		CHEMBL100979	=	IC50	nM	4000.0	CHEMBL301	Homo sapiens	IC50	uM	4.0
	822151	CHEMBL660787	Inhibition of Cyclin-dependent kinase 2 (CDK2)	B	CN1CCC(c2c(O)cc(O)c3c(=O)cc(Oc4ccccc4Cl)oc23)C(O)C1		CHEMBL326275	=	IC50	nM	2110.0	CHEMBL301	Homo sapiens	IC50	uM	2.11
	822152	CHEMBL660787	Inhibition of Cyclin-dependent kinase 2 (CDK2)	B	CN1CCC(c2c(O)cc(O)c3c2O/C(=C\c2ccc([N+](=O)[O-])cc2)C3=O)CC1		CHEMBL45477	=	IC50	nM	310.0	CHEMBL301	Homo sapiens	IC50	uM	0.31
	823352	CHEMBL660787	Inhibition of Cyclin-dependent kinase 2 (CDK2)	B	CN1CCC(c2c(O)cc(O)c3c2O/C(=C\c2ccccc2Cl)C3=O)CC1		CHEMBL48614	=	IC50	nM	3970.0	CHEMBL301	Homo sapiens	IC50	uM	3.97
	826658	CHEMBL660782	Inhibition of Cyclin-dependent kinase 2	B	Cc1ccc(F)c(Nc2ccnc(Nc3ccc(S(N)(=O)=O)cc3)n2)c1		CHEMBL103355	=	IC50	nM	6.0	CHEMBL301	Homo sapiens	IC50	uM	0.006
	830297	CHEMBL661129	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	Nc1cccc(-c2cc(Nc3ccc(S(N)(=O)=O)cc3)[nH]n2)c1		CHEMBL319831	=	IC50	nM	166.0	CHEMBL301	Homo sapiens	IC50	nM	166.0
	832577	CHEMBL661129	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	IC50	nM	9.1	CHEMBL301	Homo sapiens	IC50	nM	9.1
	834946	CHEMBL661129	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	CN(C)c1ccc(-c2cc(Nc3ccc(S(N)(=O)=O)cc3)[nH]n2)cc1		CHEMBL323326	>	IC50	nM	2000.0	CHEMBL301	Homo sapiens	IC50	nM	2000.0
	837392	CHEMBL661129	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	Nc1ccc(-c2cc(Nc3ccc(S(N)(=O)=O)cc3)[nH]n2)cc1		CHEMBL321517	=	IC50	nM	0.34	CHEMBL301	Homo sapiens	IC50	nM	0.34
	838649	CHEMBL661129	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	COc1cccc(-c2cc(Nc3ccc(S(N)(=O)=O)cc3)[nH]n2)c1		CHEMBL319685	=	IC50	nM	24.5	CHEMBL301	Homo sapiens	IC50	nM	24.5
	841106	CHEMBL661129	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(Br)cc3)[nH]n2)cc1		CHEMBL319903	=	IC50	nM	10.0	CHEMBL301	Homo sapiens	IC50	nM	10.0
	841108	CHEMBL661129	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(N4CCOCC4)c3)[nH]n2)cc1		CHEMBL103039	=	IC50	nM	490.0	CHEMBL301	Homo sapiens	IC50	nM	490.0
	841110	CHEMBL661129	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(NS(=O)(=O)c4ccccc4)c3)[nH]n2)cc1		CHEMBL319103	=	IC50	nM	10.7	CHEMBL301	Homo sapiens	IC50	nM	10.7
	850656	CHEMBL661129	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(Br)c3)[nH]n2)cc1		CHEMBL103285	=	IC50	nM	23.4	CHEMBL301	Homo sapiens	IC50	nM	23.4
	851716	CHEMBL661129	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	COc1ccc(-c2cc(Nc3ccc(S(N)(=O)=O)cc3)[nH]n2)cc1F		CHEMBL102241	=	IC50	nM	407.0	CHEMBL301	Homo sapiens	IC50	nM	407.0
	852815	CHEMBL661129	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	CS(=O)(=O)Nc1ccc(Nc2cc(-c3cccc(Br)c3)[nH]n2)cc1		CHEMBL418985	=	IC50	nM	602.0	CHEMBL301	Homo sapiens	IC50	nM	602.0
	853949	CHEMBL661129	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL103382	=	IC50	nM	17.4	CHEMBL301	Homo sapiens	IC50	nM	17.4
	853951	CHEMBL661129	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	IC50	nM	12.6	CHEMBL301	Homo sapiens	IC50	nM	12.6
	855041	CHEMBL661129	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	CS(=O)(=O)Nc1cccc(-c2cc(Nc3ccc(S(N)(=O)=O)cc3)[nH]n2)c1		CHEMBL421578	=	IC50	nM	10.7	CHEMBL301	Homo sapiens	IC50	nM	10.7
	863108	CHEMBL661129	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL329040	=	IC50	nM	871.0	CHEMBL301	Homo sapiens	IC50	nM	871.0
	863110	CHEMBL661129	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc([N+](=O)[O-])cc3)[nH]n2)cc1		CHEMBL317703	=	IC50	nM	0.33	CHEMBL301	Homo sapiens	IC50	nM	0.33
	863112	CHEMBL661129	In vitro inhibition of Cyclin-dependent kinase 2 was determined.	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)[nH]n2)cc1		CHEMBL321939	=	IC50	nM	61.6	CHEMBL301	Homo sapiens	IC50	nM	61.6
	910412	CHEMBL662526	Inhibition of Cyclin-dependent kinase 2 (CDK2)	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCOCCOCCOCCn1cc2c2cccnc21		CHEMBL340935	=	IC50	nM	2439.0	CHEMBL301	Homo sapiens	IC50	uM	2.439
	915719	CHEMBL662526	Inhibition of Cyclin-dependent kinase 2 (CDK2)	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCn1cc2c2cccnc21		CHEMBL340776	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	918239	CHEMBL662526	Inhibition of Cyclin-dependent kinase 2 (CDK2)	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCOCCOCCOCCn1cc2c2ccccc21		CHEMBL340259	=	IC50	nM	992.0	CHEMBL301	Homo sapiens	IC50	uM	0.992
	931180	CHEMBL662526	Inhibition of Cyclin-dependent kinase 2 (CDK2)	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCOCCn1cc2c2cccnc21		CHEMBL337642	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	952080	CHEMBL661127	Inhibition of Cyclin-dependent kinase 2 (CDK2) at 12.5 uM ATP	B	Nc1nc(N)c(N=O)c(OCC2CCCCC2)n1		CHEMBL303958	=	IC50	nM	2200.0	CHEMBL301	Homo sapiens	IC50	uM	2.2
	958721	CHEMBL661127	Inhibition of Cyclin-dependent kinase 2 (CDK2) at 12.5 uM ATP	B	NC(=O)c1ccc(Nc2nc(N)c(N=O)c(OCC3CCCCC3)n2)cc1		CHEMBL101801	=	IC50	nM	34.0	CHEMBL301	Homo sapiens	IC50	uM	0.034
	961037	CHEMBL661127	Inhibition of Cyclin-dependent kinase 2 (CDK2) at 12.5 uM ATP	B	NC(=O)c1ccc(Nc2nc(N)cc(OCC3CCCCC3)n2)cc1		CHEMBL319709	=	IC50	nM	59000.0	CHEMBL301	Homo sapiens	IC50	uM	59.0
	963547	CHEMBL661127	Inhibition of Cyclin-dependent kinase 2 (CDK2) at 12.5 uM ATP	B	CSc1ccc(Nc2nc(N)c(N=O)c(OCC3CCCCC3)n2)cc1		CHEMBL322568	=	IC50	nM	120.0	CHEMBL301	Homo sapiens	IC50	uM	0.12
	971312	CHEMBL661127	Inhibition of Cyclin-dependent kinase 2 (CDK2) at 12.5 uM ATP	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nc(OCC2CCCCC2)c1N=O		CHEMBL318999	=	IC50	nM	1.1	CHEMBL301	Homo sapiens	IC50	uM	0.0011
	973805	CHEMBL661127	Inhibition of Cyclin-dependent kinase 2 (CDK2) at 12.5 uM ATP	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	IC50	nM	5.4	CHEMBL301	Homo sapiens	IC50	uM	0.0054
	978648	CHEMBL661127	Inhibition of Cyclin-dependent kinase 2 (CDK2) at 12.5 uM ATP	B	Nc1nc(OCC2CCCCC2)c2nc[nH]c2n1		CHEMBL269881	=	IC50	nM	17000.0	CHEMBL301	Homo sapiens	IC50	uM	17.0
	984954	CHEMBL661127	Inhibition of Cyclin-dependent kinase 2 (CDK2) at 12.5 uM ATP	B	Nc1cc(OCC2CCCCC2)nc(Nc2ccc(S(N)(=O)=O)cc2)n1		CHEMBL104467	=	IC50	nM	2900.0	CHEMBL301	Homo sapiens	IC50	uM	2.9
	984956	CHEMBL661127	Inhibition of Cyclin-dependent kinase 2 (CDK2) at 12.5 uM ATP	B	Nc1nc(Nc2cccc(Br)c2)nc(OCC2CCCCC2)c1N=O		CHEMBL107530	=	IC50	nM	500.0	CHEMBL301	Homo sapiens	IC50	uM	0.5
	986273	CHEMBL661127	Inhibition of Cyclin-dependent kinase 2 (CDK2) at 12.5 uM ATP	B	COc1ccc(Nc2nc(N)c(N=O)c(OCC3CCCCC3)n2)cc1		CHEMBL102636	=	IC50	nM	220.0	CHEMBL301	Homo sapiens	IC50	uM	0.22
	1013632	CHEMBL660705	Inhibition of Cyclin-dependent kinase 2 (CDK2)	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2C1=O		CHEMBL1276127	=	IC50	nM	2200.0	CHEMBL301	Homo sapiens	IC50	uM	2.2
	1022802	CHEMBL660705	Inhibition of Cyclin-dependent kinase 2 (CDK2)	B	O=C1/C(=C2\Nc3ccccc3C2=O)Nc2ccccc21		CHEMBL599552	=	IC50	nM	70000.0	CHEMBL301	Homo sapiens	IC50	uM	70.0
	1026989	CHEMBL658938	Inhibition of Cyclin-dependent kinase 2	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1[C@H]1CC[C@@H]3O1		CHEMBL289422	=	IC50	nM	540.0	CHEMBL301	Homo sapiens	IC50	uM	0.54
	1070769	CHEMBL658932	Inhibition of Cyclin-dependent kinase 2 enzyme from starfish oocytes	B	Nc1cc(OCC2CCCCC2)nc(N)n1		CHEMBL71402	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	1075425	CHEMBL658933	Inhibition of Cyclin-dependent kinase 2 enzyme from starfish oocytes	B	Nc1nc(N)c(N=O)c(OCC2CCCCC2)n1		CHEMBL303958	=	Ki	nM	1300.0	CHEMBL301	Homo sapiens	Ki	uM	1.3
	1089099	CHEMBL874858	Inhibition of Cyclin-dependent kinase 2 enzyme from starfish oocytes	B	Nc1nc(OCC2CCCCC2)c2nc[nH]c2n1		CHEMBL269881	=	Ki	nM	12000.0	CHEMBL301	Homo sapiens	Ki	uM	12.0
	1099192	CHEMBL658109	Inhibition of Cyclin-dependent kinase 2 enzyme from starfish oocytes	B	c1nc(OCC2CCCCC2)c2nc[nH]c2n1		CHEMBL405551	=	IC50	nM	13000.0	CHEMBL301	Homo sapiens	IC50	uM	13.0
	1100331	CHEMBL658109	Inhibition of Cyclin-dependent kinase 2 enzyme from starfish oocytes	B	Cn1cnc2c(OCC3CCCCC3)nc(N)nc21		CHEMBL94794	>	IC50	nM	100000.0	CHEMBL301	Homo sapiens	IC50	uM	100.0
	1142480	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	O=C1Nc2ccc3ncsc3c2/C1=C/Nc1ccc(S(=O)(=O)NCc2ccccc2)cc1		CHEMBL1964242	=	IC50	nM	5.6	CHEMBL301	Homo sapiens	IC50	nM	5.6
	1142488	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	CNS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1234085	=	IC50	nM	560.0	CHEMBL301	Homo sapiens	IC50	nM	560.0
	1143809	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(/N=N/c2c(O)[nH]c3cccc(I)c23)cc1		CHEMBL314397	=	IC50	nM	4.6	CHEMBL301	Homo sapiens	IC50	nM	4.6
	1143811	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	IC50	nM	8.9	CHEMBL301	Homo sapiens	IC50	nM	8.9
	1145032	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccccc32)cc1		CHEMBL438721	=	IC50	nM	120.0	CHEMBL301	Homo sapiens	IC50	nM	120.0
	1145034	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL270132	=	IC50	nM	2.5	CHEMBL301	Homo sapiens	IC50	nM	2.5
	1145036	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	O=C1Nc2ccc3ncsc3c2/C1=C/Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1276446	=	IC50	nM	9.7	CHEMBL301	Homo sapiens	IC50	nM	9.7
	1145044	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	CNS(=O)(=O)Cc1ccc(N/N=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1234086	=	IC50	nM	5.7	CHEMBL301	Homo sapiens	IC50	nM	5.7
	1146499	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	CCc1ccc2c(c1)NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271182	=	IC50	nM	21.0	CHEMBL301	Homo sapiens	IC50	nM	21.0
	1146501	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	COCCOCCOCCOCCN(C)S(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1964249	=	IC50	nM	1.0	CHEMBL301	Homo sapiens	IC50	nM	1.0
	1149045	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	Cc1c([N+](=O)[O-])ccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272667	=	IC50	nM	4.6	CHEMBL301	Homo sapiens	IC50	nM	4.6
	1150272	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL269850	=	IC50	nM	690.0	CHEMBL301	Homo sapiens	IC50	nM	690.0
	1150274	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	IC50	nM	43.0	CHEMBL301	Homo sapiens	IC50	nM	43.0
	1150276	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(Oc4ccccc4)c32)cc1		CHEMBL409104	=	IC50	nM	13.0	CHEMBL301	Homo sapiens	IC50	nM	13.0
	1150278	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	IC50	nM	25.0	CHEMBL301	Homo sapiens	IC50	nM	25.0
	1151481	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccc(O)cc4)c32)cc1		CHEMBL411865	=	IC50	nM	12.0	CHEMBL301	Homo sapiens	IC50	nM	12.0
	1152636	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	CC(C)CC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL429142	=	IC50	nM	1.9	CHEMBL301	Homo sapiens	IC50	nM	1.9
	1152638	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4cccnc4)cc32)cc1		CHEMBL271953	=	IC50	nM	2.1	CHEMBL301	Homo sapiens	IC50	nM	2.1
	1152640	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cc(Br)ccc32)cc1		CHEMBL271183	=	IC50	nM	43.0	CHEMBL301	Homo sapiens	IC50	nM	43.0
	1152642	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4[nH]ncc4c32)cc1		CHEMBL272833	=	IC50	nM	13.0	CHEMBL301	Homo sapiens	IC50	nM	13.0
	1152644	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	O=C1Nc2ccc3ncsc3c2/C1=C/Nc1ccc(S(=O)(=O)N[n+]2ccc3ccccc3c2)cc1		CHEMBL2112297	=	IC50	nM	9.5	CHEMBL301	Homo sapiens	IC50	nM	9.5
	1152646	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	CN(C)CCNS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1964248	=	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	1153932	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3cccc(CO)c32)cc1		CHEMBL271137	=	IC50	nM	54.0	CHEMBL301	Homo sapiens	IC50	nM	54.0
	1153934	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	IC50	nM	46.0	CHEMBL301	Homo sapiens	IC50	nM	46.0
	1153936	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	COc1cccc(OC)c1CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271136	=	IC50	nM	1.7	CHEMBL301	Homo sapiens	IC50	nM	1.7
	1155249	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(/C=C/c4ccc(O)cc4)c32)cc1		CHEMBL272380	=	IC50	nM	9.3	CHEMBL301	Homo sapiens	IC50	nM	9.3
	1155251	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	CN(C)C(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL409868	=	IC50	nM	17.0	CHEMBL301	Homo sapiens	IC50	nM	17.0
	1155253	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	CN(C)S(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1964247	=	IC50	nM	4.6	CHEMBL301	Homo sapiens	IC50	nM	4.6
	1155255	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	O=C1Nc2ccc3ncsc3c2/C1=C/Nc1ccc(S(=O)(=O)NCCc2c[nH]cn2)cc1		CHEMBL1964251	=	IC50	nM	3.6	CHEMBL301	Homo sapiens	IC50	nM	3.6
	1156654	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc([N+](=O)[O-])c32)cc1		CHEMBL409619	=	IC50	nM	2400.0	CHEMBL301	Homo sapiens	IC50	nM	2400.0
	1156656	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL445945	=	IC50	nM	1.5	CHEMBL301	Homo sapiens	IC50	nM	1.5
	1157792	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	O=C1Nc2ccc3ncsc3c2/C1=C/Nc1ccc(S(=O)(=O)Nc2ccccc2)cc1		CHEMBL1964244	=	IC50	nM	4.3	CHEMBL301	Homo sapiens	IC50	nM	4.3
	1159240	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(O)cc32)cc1		CHEMBL409690	=	IC50	nM	10.0	CHEMBL301	Homo sapiens	IC50	nM	10.0
	1159242	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(S(=O)(=O)O)cc32)cc1		CHEMBL412091	=	IC50	nM	15.0	CHEMBL301	Homo sapiens	IC50	nM	15.0
	1159244	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3cc(CO)ccc32)cc1		CHEMBL410293	=	IC50	nM	61.0	CHEMBL301	Homo sapiens	IC50	nM	61.0
	1159246	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	CNS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1964245	=	IC50	nM	5.6	CHEMBL301	Homo sapiens	IC50	nM	5.6
	1159254	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	CS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1964260	=	IC50	nM	5.7	CHEMBL301	Homo sapiens	IC50	nM	5.7
	1159262	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	O=C1Nc2ccc3ncsc3c2/C1=C/Nc1ccc(CS(=O)(=O)NCCO)cc1		CHEMBL1964258	=	IC50	nM	13.0	CHEMBL301	Homo sapiens	IC50	nM	13.0
	1160477	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	CCOC(=O)c1cccc2c1/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL408210	=	IC50	nM	8.9	CHEMBL301	Homo sapiens	IC50	nM	8.9
	1160479	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	IC50	nM	1.6	CHEMBL301	Homo sapiens	IC50	nM	1.6
	1160487	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	O=C1Nc2ccc3ncsc3c2/C1=C/Nc1ccc(S(=O)(=O)NCCOCCO)cc1		CHEMBL1964259	=	IC50	nM	0.54	CHEMBL301	Homo sapiens	IC50	nM	0.54
	1161892	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	CS(=O)(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272389	=	IC50	nM	16.0	CHEMBL301	Homo sapiens	IC50	nM	16.0
	1161894	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	IC50	nM	75.0	CHEMBL301	Homo sapiens	IC50	nM	75.0
	1163394	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	O=C1Nc2ccc(-c3cnco3)cc2/C1=C/Nc1ccc2c(c1)CS(=O)(=O)C2		CHEMBL1234087	=	IC50	nM	8.9	CHEMBL301	Homo sapiens	IC50	nM	8.9
	1164791	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1794054	=	IC50	nM	21.0	CHEMBL301	Homo sapiens	IC50	nM	21.0
	1164793	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(S(=O)(=O)Nc2nccs2)cc1		CHEMBL1234088	=	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	1166069	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccc(Cl)cc21		CHEMBL412097	=	IC50	nM	22.0	CHEMBL301	Homo sapiens	IC50	nM	22.0
	1166071	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	Nc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271842	=	IC50	nM	74.0	CHEMBL301	Homo sapiens	IC50	nM	74.0
	1167445	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	CCc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL411425	=	IC50	nM	7.9	CHEMBL301	Homo sapiens	IC50	nM	7.9
	1167447	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	Cc1cc(C)c2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269846	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	1167449	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	CNS(=O)(=O)Cc1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1964256	=	IC50	nM	26.0	CHEMBL301	Homo sapiens	IC50	nM	26.0
	1168728	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	IC50	nM	2.3	CHEMBL301	Homo sapiens	IC50	nM	2.3
	1168730	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NC(=O)c1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271778	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	1168732	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	COc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL260103	=	IC50	nM	12.0	CHEMBL301	Homo sapiens	IC50	nM	12.0
	1168734	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4[nH]nnc4c32)cc1		CHEMBL271952	=	IC50	nM	9.5	CHEMBL301	Homo sapiens	IC50	nM	9.5
	1170042	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	CC(C)c1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL411426	=	IC50	nM	2.5	CHEMBL301	Homo sapiens	IC50	nM	2.5
	1170050	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(-c4cc[nH]n4)c32)cc1		CHEMBL272684	=	IC50	nM	19.0	CHEMBL301	Homo sapiens	IC50	nM	19.0
	1170052	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	Cc1cccc2c1NC(=O)/C2=C\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL408131	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	1170054	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4[nH]nc(Cl)c4c32)cc1		CHEMBL269882	=	IC50	nM	2.2	CHEMBL301	Homo sapiens	IC50	nM	2.2
	1171206	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	IC50	nM	310.0	CHEMBL301	Homo sapiens	IC50	nM	310.0
	1171208	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	N=C(N)NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1234089	=	IC50	nM	660.0	CHEMBL301	Homo sapiens	IC50	nM	660.0
	1172510	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(I)cc32)cc1		CHEMBL273060	=	IC50	nM	11.0	CHEMBL301	Homo sapiens	IC50	nM	11.0
	1172512	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	IC50	nM	12.0	CHEMBL301	Homo sapiens	IC50	nM	12.0
	1172514	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	IC50	nM	2.8	CHEMBL301	Homo sapiens	IC50	nM	2.8
	1172516	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	CS(=O)(=O)Cc1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL235849	=	IC50	nM	50.0	CHEMBL301	Homo sapiens	IC50	nM	50.0
	1173813	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	CC(C)(C)c1ccc2c(c1)NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271777	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	1173815	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	O=C1Nc2ccc3ncsc3c2/C1=C/Nc1ccc(S(=O)(=O)NCCO)cc1		CHEMBL1964246	=	IC50	nM	4.7	CHEMBL301	Homo sapiens	IC50	nM	4.7
	1173817	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	Cc1cccc(C)c1NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1964252	=	IC50	nM	281.0	CHEMBL301	Homo sapiens	IC50	nM	281.0
	1173819	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)Cc1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1964257	=	IC50	nM	7.5	CHEMBL301	Homo sapiens	IC50	nM	7.5
	1173976	CHEMBL662523	Inhibition of Cyclin-dependent kinase 2	B	CCN(CC)C/C=C/c1nc(O)c2c(ccc3nc(Nc4c(Cl)cccc4Cl)n(C)c32)c1C		CHEMBL281957	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	uM	1.0
	1175158	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Br)cc32)cc1		CHEMBL411491	=	IC50	nM	60.0	CHEMBL301	Homo sapiens	IC50	nM	60.0
	1175160	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	CC(C)Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL411224	=	IC50	nM	1.2	CHEMBL301	Homo sapiens	IC50	nM	1.2
	1175162	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(F)cc32)cc1		CHEMBL273061	=	IC50	nM	34.0	CHEMBL301	Homo sapiens	IC50	nM	34.0
	1175164	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)cc1		CHEMBL272387	=	IC50	nM	43.0	CHEMBL301	Homo sapiens	IC50	nM	43.0
	1175166	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL409731	=	IC50	nM	2.1	CHEMBL301	Homo sapiens	IC50	nM	2.1
	1175168	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	CN(c1ccccn1)S(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1964253	=	IC50	nM	5.6	CHEMBL301	Homo sapiens	IC50	nM	5.6
	1175170	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	CC(=O)NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1964243	=	IC50	nM	75.0	CHEMBL301	Homo sapiens	IC50	nM	75.0
	1176438	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	IC50	nM	1.5	CHEMBL301	Homo sapiens	IC50	nM	1.5
	1176440	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	nM	3.0
	1176448	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	Cc1cc(Cl)cc2c1NC(=O)/C2=C\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL410517	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	1176450	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	O=C1Nc2ccc3ncsc3c2/C1=C/Nc1ccc2c(c1)CS(=O)(=O)C2		CHEMBL391229	=	IC50	nM	14.0	CHEMBL301	Homo sapiens	IC50	nM	14.0
	1177754	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	IC50	nM	360.0	CHEMBL301	Homo sapiens	IC50	nM	360.0
	1177756	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc([N+](=O)[O-])cc32)cc1		CHEMBL411886	=	IC50	nM	15.0	CHEMBL301	Homo sapiens	IC50	nM	15.0
	1177758	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	COc1ccc2c(c1Cl)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271822	=	IC50	nM	54.0	CHEMBL301	Homo sapiens	IC50	nM	54.0
	1178972	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc(C(=O)O)cc32)cc1		CHEMBL272668	=	IC50	nM	28.0	CHEMBL301	Homo sapiens	IC50	nM	28.0
	1180348	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccc(-c3cnco3)cc21		CHEMBL411887	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	IC50	nM	2.0
	1180350	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410883	=	IC50	nM	4.5	CHEMBL301	Homo sapiens	IC50	nM	4.5
	1180352	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL407709	=	IC50	nM	7.1	CHEMBL301	Homo sapiens	IC50	nM	7.1
	1181715	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cc(Oc4ccccc4)ccc32)cc1		CHEMBL272885	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	1181717	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	Cc1ccc2c(c1Cl)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL411490	=	IC50	nM	13.0	CHEMBL301	Homo sapiens	IC50	nM	13.0
	1181719	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	N=C(N)NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1964255	=	IC50	nM	3.3	CHEMBL301	Homo sapiens	IC50	nM	3.3
	1183032	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	CCOc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL411696	=	IC50	nM	93.0	CHEMBL301	Homo sapiens	IC50	nM	93.0
	1183034	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	CC(C)Oc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271160	=	IC50	nM	3.4	CHEMBL301	Homo sapiens	IC50	nM	3.4
	1183036	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	IC50	nM	6.8	CHEMBL301	Homo sapiens	IC50	nM	6.8
	1183038	CHEMBL661125	Inhibitory activity against human cyclin-dependent kinase 2 (CDK2)	B	COCCOCCOCCOCCNS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1964250	=	IC50	nM	4.5	CHEMBL301	Homo sapiens	IC50	nM	4.5
	1185345	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Fc1ccc2c(c1)[nH]c1c(-c3ccccc3)nccc12		CHEMBL273905	=	Inhibition	%	57.0	CHEMBL301	Homo sapiens	Inhibition	%	57.0
	1185347	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Cc1nccc2c1[nH]c1cc(OCC(=O)OCc3ccccc3)ccc12		CHEMBL276789	=	Inhibition	%	57.0	CHEMBL301	Homo sapiens	Inhibition	%	57.0
	1186832	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Fc1ccc2c(c1)[nH]c1c(-c3ccccc3F)nccc12		CHEMBL274971	=	Inhibition	%	55.0	CHEMBL301	Homo sapiens	Inhibition	%	55.0
	1188042	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Clc1ccccc1-c1[nH]ccc2c3ccccc3nc1-2		CHEMBL280048	=	Inhibition	%	69.0	CHEMBL301	Homo sapiens	Inhibition	%	69.0
	1188044	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Clc1ccc(-c2[nH]ccc3c4ccccc4nc2-3)cc1		CHEMBL14363	=	Inhibition	%	48.0	CHEMBL301	Homo sapiens	Inhibition	%	48.0
	1189667	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	N#Cc1ccccc1-c1[nH]ccc2c3ccccc3nc1-2		CHEMBL14336	=	Inhibition	%	8.0	CHEMBL301	Homo sapiens	Inhibition	%	8.0
	1189669	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Cc1ccc(-c2[nH]ccc3c4ccccc4nc2-3)c(C)c1		CHEMBL429940	=	Inhibition	%	5.0	CHEMBL301	Homo sapiens	Inhibition	%	5.0
	1190779	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	CCCc1ncc(N)c2c1[nH]c1ccccc12		CHEMBL14489	=	Inhibition	%	22.0	CHEMBL301	Homo sapiens	Inhibition	%	22.0
	1192040	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	O=[N+]([O-])c1ccc(Cl)c(-c2[nH]ccc3c4ccccc4nc2-3)c1		CHEMBL14217	=	Inhibition	%	70.0	CHEMBL301	Homo sapiens	Inhibition	%	70.0
	1192059	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	CC(=O)OCCOc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL276806	=	Inhibition	%	23.0	CHEMBL301	Homo sapiens	Inhibition	%	23.0
	1193287	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Fc1ccc(-c2[nH]ccc3c4ccccc4nc2-3)cc1		CHEMBL279589	=	Inhibition	%	20.0	CHEMBL301	Homo sapiens	Inhibition	%	20.0
	1194605	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	O=[N+]([O-])c1ccccc1-c1[nH]ccc2c3ccccc3nc1-2		CHEMBL279760	=	Inhibition	%	43.0	CHEMBL301	Homo sapiens	Inhibition	%	43.0
	1197086	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	CCOc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL14475	=	Inhibition	%	43.0	CHEMBL301	Homo sapiens	Inhibition	%	43.0
	1198365	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	COc1ccc2c3c([nH]c2c1)C(C)=NCC3		CHEMBL340807	=	Inhibition	%	10.0	CHEMBL301	Homo sapiens	Inhibition	%	10.0
	1198373	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Cc1ccc2c(c1)[nH]c1c(-c3ccccc3F)nccc12		CHEMBL14330	=	Inhibition	%	36.0	CHEMBL301	Homo sapiens	Inhibition	%	36.0
	1198375	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	COC(=O)Cc1nccc2c1[nH]c1ccccc12		CHEMBL14156	=	Inhibition	%	11.0	CHEMBL301	Homo sapiens	Inhibition	%	11.0
	1199775	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	COc1ccc2[nH]c3c(C(=O)O)nccc3c2c1		CHEMBL280224	=	Inhibition	%	12.0	CHEMBL301	Homo sapiens	Inhibition	%	12.0
	1199777	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	CC(C)(C)c1[nH]ccc2c3ccccc3nc1-2		CHEMBL14402	=	Inhibition	%	50.0	CHEMBL301	Homo sapiens	Inhibition	%	50.0
	1199779	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Brc1ccccc1-c1[nH]ccc2c3ccccc3nc1-2		CHEMBL417080	=	Inhibition	%	10.0	CHEMBL301	Homo sapiens	Inhibition	%	10.0
	1199781	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Fc1ccc(-c2[nH]ccc3c4ccccc4nc2-3)c(F)c1		CHEMBL276752	=	Inhibition	%	56.0	CHEMBL301	Homo sapiens	Inhibition	%	56.0
	1199793	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	CCc1nccc2c1[nH]c1cc(F)ccc12		CHEMBL442140	=	Inhibition	%	54.0	CHEMBL301	Homo sapiens	Inhibition	%	54.0
	1201066	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	COc1ccc2[nH]c3c(C)nccc3c2c1		CHEMBL278193	=	Inhibition	%	2.0	CHEMBL301	Homo sapiens	Inhibition	%	2.0
	1201074	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Cc1nccc2c1[nH]c1cc(OCC(N)=O)ccc12		CHEMBL15008	=	Inhibition	%	15.0	CHEMBL301	Homo sapiens	Inhibition	%	15.0
	1202537	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	c1ccc(-c2[nH]ccc3c4ccccc4nc2-3)cc1		CHEMBL14338	=	Inhibition	%	13.0	CHEMBL301	Homo sapiens	Inhibition	%	13.0
	1202539	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Clc1cccc(-c2[nH]ccc3c4ccccc4nc2-3)c1		CHEMBL279761	=	Inhibition	%	32.0	CHEMBL301	Homo sapiens	Inhibition	%	32.0
	1202541	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	O=[N+]([O-])c1ccc(-c2[nH]ccc3c4ccccc4nc2-3)cc1		CHEMBL13876	=	Inhibition	%	31.0	CHEMBL301	Homo sapiens	Inhibition	%	31.0
	1202543	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Cc1nccc2c1[nH]c1cc(OCCN3C(=O)c4ccccc4C3=O)ccc12		CHEMBL14669	=	Inhibition	%	8.0	CHEMBL301	Homo sapiens	Inhibition	%	8.0
	1203834	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Cc1ccc2[nH]c3c(C)nccc3c2c1		CHEMBL280050	=	Inhibition	%	15.0	CHEMBL301	Homo sapiens	Inhibition	%	15.0
	1206510	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	CC1=NCCc2c1[nH]c1cc(O)ccc21		CHEMBL129177	=	Inhibition	%	13.0	CHEMBL301	Homo sapiens	Inhibition	%	13.0
	1210378	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Cc1nccc2c1[nH]c1ccc(F)cc12		CHEMBL14787	=	Inhibition	%	46.0	CHEMBL301	Homo sapiens	Inhibition	%	46.0
	1210380	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Cc1[nH]cnc1-c1[nH]ccc2c3ccc(F)cc3nc1-2		CHEMBL14466	=	Inhibition	%	51.0	CHEMBL301	Homo sapiens	Inhibition	%	51.0
	1210382	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Cc1[nH]cnc1-c1[nH]ccc2c3ccccc3nc1-2		CHEMBL273547	=	Inhibition	%	89.0	CHEMBL301	Homo sapiens	Inhibition	%	89.0
	1210392	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Cc1nccc2c1[nH]c1cc(OCCO)ccc12		CHEMBL14355	=	Inhibition	%	4.0	CHEMBL301	Homo sapiens	Inhibition	%	4.0
	1211803	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	CCCCOc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL279812	=	Inhibition	%	50.0	CHEMBL301	Homo sapiens	Inhibition	%	50.0
	1213057	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	O=[N+]([O-])c1ccc(-c2[nH]ccc3c4ccccc4nc2-3)cc1Cl		CHEMBL278266	=	Inhibition	%	4.0	CHEMBL301	Homo sapiens	Inhibition	%	4.0
	1213059	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Cc1nccc2c1[nH]c1cccc(C)c12		CHEMBL14616	=	Inhibition	%	30.0	CHEMBL301	Homo sapiens	Inhibition	%	30.0
	1214245	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Cc1nccc2c1[nH]c1cccc(F)c12		CHEMBL276792	=	Inhibition	%	55.0	CHEMBL301	Homo sapiens	Inhibition	%	55.0
	1215603	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Cc1nccc2c1[nH]c1cc(F)ccc12		CHEMBL14445	=	Inhibition	%	65.0	CHEMBL301	Homo sapiens	Inhibition	%	65.0
	1216870	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	CCCc1nccc2c1[nH]c1ccccc12		CHEMBL278683	=	Inhibition	%	43.0	CHEMBL301	Homo sapiens	Inhibition	%	43.0
	1216872	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Fc1cccc(-c2[nH]ccc3c4ccccc4nc2-3)c1		CHEMBL417619	=	Inhibition	%	6.0	CHEMBL301	Homo sapiens	Inhibition	%	6.0
	1216874	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	COc1ccc(-c2[nH]ccc3c4ccccc4nc2-3)cc1		CHEMBL14025	=	Inhibition	%	6.0	CHEMBL301	Homo sapiens	Inhibition	%	6.0
	1216876	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	N#Cc1cccc(-c2[nH]ccc3c4ccccc4nc2-3)c1		CHEMBL14311	=	Inhibition	%	31.0	CHEMBL301	Homo sapiens	Inhibition	%	31.0
	1216878	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	CCCNC(=O)Oc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL275203	=	Inhibition	%	61.0	CHEMBL301	Homo sapiens	Inhibition	%	61.0
	1218338	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	c1ccc2c(c1)[nH]c1c(-c3c[nH]cn3)nccc12		CHEMBL274452	=	Inhibition	%	30.0	CHEMBL301	Homo sapiens	Inhibition	%	30.0
	1219656	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	c1ccc2c(c1)[nH]c1cnccc12		CHEMBL275224	=	Inhibition	%	37.0	CHEMBL301	Homo sapiens	Inhibition	%	37.0
	1219658	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Inhibition	%	62.0	CHEMBL301	Homo sapiens	Inhibition	%	62.0
	1219668	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	O=[N+]([O-])c1cccc(-c2[nH]ccc3c4ccccc4nc2-3)c1		CHEMBL14375	=	Inhibition	%	19.0	CHEMBL301	Homo sapiens	Inhibition	%	19.0
	1219676	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	FC(F)(F)c1[nH]ccc2c3ccccc3nc1-2		CHEMBL274972	=	Inhibition	%	39.0	CHEMBL301	Homo sapiens	Inhibition	%	39.0
	1219678	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Cc1nccc2c1[nH]c1cc(OCCOC(=O)c3ccccc3)ccc12		CHEMBL14310	=	Inhibition	%	13.0	CHEMBL301	Homo sapiens	Inhibition	%	13.0
	1220888	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Cc1nccc2c1[nH]c1ccccc12		CHEMBL12014	=	Inhibition	%	47.0	CHEMBL301	Homo sapiens	Inhibition	%	47.0
	1220890	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	CC(C)c1nccc2c1[nH]c1ccccc12		CHEMBL14302	=	Inhibition	%	44.0	CHEMBL301	Homo sapiens	Inhibition	%	44.0
	1220892	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Fc1ccccc1-c1[nH]ccc2c3ccccc3nc1-2		CHEMBL14383	=	Inhibition	%	64.0	CHEMBL301	Homo sapiens	Inhibition	%	64.0
	1220894	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	COc1cccc(-c2[nH]ccc3c4ccccc4nc2-3)c1		CHEMBL266384	=	Inhibition	%	5.0	CHEMBL301	Homo sapiens	Inhibition	%	5.0
	1220896	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Cc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL14500	=	Inhibition	%	23.0	CHEMBL301	Homo sapiens	Inhibition	%	23.0
	1220913	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Cc1nccc2c1[nH]c1cc(OC(=O)NC3CCCCC3)ccc12		CHEMBL275407	=	Inhibition	%	53.0	CHEMBL301	Homo sapiens	Inhibition	%	53.0
	1220915	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Cc1nccc2c1[nH]c1cc(Oc3ncc(C(F)(F)F)cc3Cl)ccc12		CHEMBL14611	=	Inhibition	%	10.0	CHEMBL301	Homo sapiens	Inhibition	%	10.0
	1222188	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	N#Cc1ccc(-c2[nH]ccc3c4ccccc4nc2-3)cc1		CHEMBL14436	=	Inhibition	%	29.0	CHEMBL301	Homo sapiens	Inhibition	%	29.0
	1222192	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	CCCc1nccc2c1[nH]c1cc(F)ccc12		CHEMBL14441	=	Inhibition	%	60.0	CHEMBL301	Homo sapiens	Inhibition	%	60.0
	1223487	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Cc1nccc2c1[nH]c1ccc(OC(=O)c3ccccc3)cc12		CHEMBL14623	=	Inhibition	%	2.0	CHEMBL301	Homo sapiens	Inhibition	%	2.0
	1223495	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Cc1nccc2c1[nH]c1cc(OCCC3(C)OCC(C)(C)CO3)ccc12		CHEMBL14425	=	Inhibition	%	27.0	CHEMBL301	Homo sapiens	Inhibition	%	27.0
	1224817	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	Cc1[nH]ccc2c1[nH]c1cc(=O)ccc12		CHEMBL486817	=	Inhibition	%	69.0	CHEMBL301	Homo sapiens	Inhibition	%	69.0
	1224828	CHEMBL666137	Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM	B	CCOC(COc1ccc2c(c1)[nH]c1c(C)nccc12)OCC		CHEMBL14250	=	Inhibition	%	1.0	CHEMBL301	Homo sapiens	Inhibition	%	1.0
	1420766	CHEMBL828118	Inhibitory concentration for Cyclin-dependent kinase 2 was determined in the presence of 100 um ATP (Km 50 uM)	B	CN(C)S(=O)(=O)c1ccc(Nc2cc(N[C@H]3CC[C@H](N)CC3)nc3c(C#N)cnn23)cc1		CHEMBL360573	=	IC50	nM	7.0	CHEMBL301	Homo sapiens	IC50	uM	0.007
	1420769	CHEMBL828118	Inhibitory concentration for Cyclin-dependent kinase 2 was determined in the presence of 100 um ATP (Km 50 uM)	B	CN(C)S(=O)(=O)c1ccc(Nc2cc(N[C@H]3CC[C@H](N)CC3)nc3c(Cl)cnn23)cc1		CHEMBL367150	=	IC50	nM	8.0	CHEMBL301	Homo sapiens	IC50	uM	0.008
	1420772	CHEMBL828118	Inhibitory concentration for Cyclin-dependent kinase 2 was determined in the presence of 100 um ATP (Km 50 uM)	B	CN(C)S(=O)(=O)c1ccc(Nc2cc(N[C@H]3CC[C@H](N)CC3)nc3c(Br)cnn23)cc1		CHEMBL178785	=	IC50	nM	10.0	CHEMBL301	Homo sapiens	IC50	uM	0.01
	1420775	CHEMBL828118	Inhibitory concentration for Cyclin-dependent kinase 2 was determined in the presence of 100 um ATP (Km 50 uM)	B	CCN[C@H]1CC[C@H](Nc2cc(Nc3ccc(S(=O)(=O)N(C)C)cc3)n3ncc(C(C)C)c3n2)CC1		CHEMBL181293	=	IC50	nM	61.0	CHEMBL301	Homo sapiens	IC50	uM	0.061
	1420778	CHEMBL828118	Inhibitory concentration for Cyclin-dependent kinase 2 was determined in the presence of 100 um ATP (Km 50 uM)	B	CCN(CC)[C@H]1CC[C@H](Nc2cc(Nc3ccc(S(=O)(=O)N(C)C)cc3)n3ncc(C(C)C)c3n2)CC1		CHEMBL180714	=	IC50	nM	92.0	CHEMBL301	Homo sapiens	IC50	uM	0.092
	1420872	CHEMBL828118	Inhibitory concentration for Cyclin-dependent kinase 2 was determined in the presence of 100 um ATP (Km 50 uM)	B	CC(C)c1cnn2c(Nc3ccc(S(=O)(=O)N(C)C)cc3)cc(O[C@H]3CC[C@H](N)CC3)nc12		CHEMBL180814	=	IC50	nM	17.0	CHEMBL301	Homo sapiens	IC50	uM	0.017
	1420875	CHEMBL828118	Inhibitory concentration for Cyclin-dependent kinase 2 was determined in the presence of 100 um ATP (Km 50 uM)	B	CC(C)c1cnn2c(Nc3ccc(S(=O)(=O)N(C)C)cc3)cc(NC3CCCC(N)C3)nc12		CHEMBL181606	=	IC50	nM	2100.0	CHEMBL301	Homo sapiens	IC50	uM	2.1
	1420878	CHEMBL828118	Inhibitory concentration for Cyclin-dependent kinase 2 was determined in the presence of 100 um ATP (Km 50 uM)	B	CC(C)COc1cc(Nc2ccc(S(=O)(=O)N(C)C)cc2)n2ncc(C(C)C)c2n1		CHEMBL361231	=	IC50	nM	1200.0	CHEMBL301	Homo sapiens	IC50	uM	1.2
	1420881	CHEMBL828118	Inhibitory concentration for Cyclin-dependent kinase 2 was determined in the presence of 100 um ATP (Km 50 uM)	B	CC(C)COc1cc(Nc2ccc(S(C)(=O)=O)cc2)n2ncc(C(C)C)c2n1		CHEMBL178268	=	IC50	nM	1200.0	CHEMBL301	Homo sapiens	IC50	uM	1.2
	1420884	CHEMBL828118	Inhibitory concentration for Cyclin-dependent kinase 2 was determined in the presence of 100 um ATP (Km 50 uM)	B	CN(C)S(=O)(=O)c1ccc(Nc2cc(N[C@H]3CC[C@H](N)CC3)nc3c(Br)cnn23)cc1Cl		CHEMBL178769	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	IC50	uM	0.002
	1421299	CHEMBL828118	Inhibitory concentration for Cyclin-dependent kinase 2 was determined in the presence of 100 um ATP (Km 50 uM)	B	N[C@H]1CC[C@H](Nc2cc(Nc3ccc(S(=O)(=O)c4cccs4)cc3)n3ncc(Cl)c3n2)CC1		CHEMBL181114	=	IC50	nM	11.0	CHEMBL301	Homo sapiens	IC50	uM	0.011
	1421302	CHEMBL828118	Inhibitory concentration for Cyclin-dependent kinase 2 was determined in the presence of 100 um ATP (Km 50 uM)	B	N[C@H]1CC[C@H](Nc2cc(Nc3ccc(S(=O)(=O)c4ccccc4)cc3)n3ncc(Br)c3n2)CC1		CHEMBL361833	=	IC50	nM	16.0	CHEMBL301	Homo sapiens	IC50	uM	0.016
	1422456	CHEMBL828118	Inhibitory concentration for Cyclin-dependent kinase 2 was determined in the presence of 100 um ATP (Km 50 uM)	B	CC(C)c1cnn2c(Nc3ccc(S(=O)(=O)N(C)C)cc3)cc(N[C@H]3CC[C@H](N)CC3)nc12		CHEMBL361348	=	IC50	nM	59.0	CHEMBL301	Homo sapiens	IC50	uM	0.059
	1422459	CHEMBL828118	Inhibitory concentration for Cyclin-dependent kinase 2 was determined in the presence of 100 um ATP (Km 50 uM)	B	CN(C)S(=O)(=O)c1ccc(Nc2cc(N[C@H]3CC[C@H](N)CC3)nc3c(C4CCCC4)cnn23)cc1		CHEMBL178179	=	IC50	nM	4.0	CHEMBL301	Homo sapiens	IC50	uM	0.004
	1438958	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL182493	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1438962	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Cc1ccc2c(-c3ccnc(Nc4ccc(F)c(F)c4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL182326	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1439061	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL183064	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1439063	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Cc1ccc2c(-c3ccnc(Nc4ccc(Cl)c(C(F)(F)F)c4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL361038	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1439065	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	c1ccc(Nc2nccc(-c3c(C4CC4)nn4ncccc34)n2)cc1		CHEMBL362296	=	Ki	nM	3980.0	CHEMBL301	Homo sapiens	Ki	uM	3.98
	1439067	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Fc1ccc(Nc2nccc(-c3c(C4CC4)nn4ncccc34)n2)cc1F		CHEMBL185516	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1439069	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	c1ccc(Nc2nccc(-c3c(C4CCCCC4)nn4ncccc34)n2)cc1		CHEMBL273870	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1439071	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Fc1ccc(Nc2nccc(-c3c(C4CCCCC4)nn4ncccc34)n2)cc1F		CHEMBL185044	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1439073	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	COCCOc1cnn2ncc(-c3ccnc(Nc4cccc(OC)c4)n3)c2c1		CHEMBL180593	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1440865	CHEMBL828499	Inhibition of cyclin-dependent kinase 2	B	CCCCCC(=O)Nc1ncnc2oc(-c3ccc(OC)cc3)cc12		CHEMBL360878	>	IC50	nM	19000.0	CHEMBL301	Homo sapiens	IC50	uM	19.0
	1440868	CHEMBL828499	Inhibition of cyclin-dependent kinase 2	B	COc1ccc(-c2cc3c(NC(=O)CCSC)ncnc3o2)cc1		CHEMBL182560	>	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	1440871	CHEMBL828499	Inhibition of cyclin-dependent kinase 2	B	COc1ccc(-c2cc3c(NC(=O)C(C)C)ncnc3o2)cc1		CHEMBL183077	>	IC50	nM	21000.0	CHEMBL301	Homo sapiens	IC50	uM	21.0
	1440874	CHEMBL828499	Inhibition of cyclin-dependent kinase 2	B	COc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL362030	>	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	1440877	CHEMBL828499	Inhibition of cyclin-dependent kinase 2	B	COc1ccc(-c2cc3c(NC(=O)C4CCCC4)ncnc3o2)cc1		CHEMBL181959	>	IC50	nM	19000.0	CHEMBL301	Homo sapiens	IC50	uM	19.0
	1440880	CHEMBL828499	Inhibition of cyclin-dependent kinase 2	B	COc1ccc(-c2cc3c(NC(=O)CC4CCCC4)ncnc3o2)cc1		CHEMBL182891	>	IC50	nM	19000.0	CHEMBL301	Homo sapiens	IC50	uM	19.0
	1440883	CHEMBL828499	Inhibition of cyclin-dependent kinase 2	B	COc1ccc(-c2cc3c(NC(=O)C4CCCCC4)ncnc3o2)cc1		CHEMBL360340	>	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	1440886	CHEMBL828499	Inhibition of cyclin-dependent kinase 2	B	COc1ccc(-c2cc3c(NC(=O)N4CCOCC4)ncnc3o2)cc1		CHEMBL181147	>	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	1440889	CHEMBL828499	Inhibition of cyclin-dependent kinase 2	B	COc1ccc(-c2cc3c(NC(=O)N4CCCC4)ncnc3o2)cc1		CHEMBL181856	>	IC50	nM	21000.0	CHEMBL301	Homo sapiens	IC50	uM	21.0
	1440892	CHEMBL828499	Inhibition of cyclin-dependent kinase 2	B	COc1ccc(-c2cc3c(NC(=O)c4cccc(F)c4)ncnc3o2)cc1		CHEMBL427325	>	IC50	nM	21000.0	CHEMBL301	Homo sapiens	IC50	uM	21.0
	1441320	CHEMBL828499	Inhibition of cyclin-dependent kinase 2	B	COc1ccc(-c2cc3c(NC(=O)c4ccco4)ncnc3o2)cc1		CHEMBL183742	>	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	1441323	CHEMBL828499	Inhibition of cyclin-dependent kinase 2	B	O=C(Nc1ncnc2oc(-c3ccccc3)cc12)C1CC1		CHEMBL360534	>	IC50	nM	21000.0	CHEMBL301	Homo sapiens	IC50	uM	21.0
	1441326	CHEMBL828499	Inhibition of cyclin-dependent kinase 2	B	O=C(Nc1ncnc2oc(-c3ccc(Cl)cc3)cc12)C1CC1		CHEMBL182904	>	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	1441329	CHEMBL828499	Inhibition of cyclin-dependent kinase 2	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	>	IC50	nM	21000.0	CHEMBL301	Homo sapiens	IC50	uM	21.0
	1441332	CHEMBL828499	Inhibition of cyclin-dependent kinase 2	B	O=C(Nc1ncnc2oc(-c3ccc(F)cc3)cc12)C1CC1		CHEMBL183504	>	IC50	nM	19000.0	CHEMBL301	Homo sapiens	IC50	uM	19.0
	1441335	CHEMBL828499	Inhibition of cyclin-dependent kinase 2	B	O=C(Nc1ncnc2oc(-c3cccnc3)cc12)C1CC1		CHEMBL361196	=	IC50	nM	440.0	CHEMBL301	Homo sapiens	IC50	uM	0.44
	1441448	CHEMBL828499	Inhibition of cyclin-dependent kinase 2	B	O=C(Nc1ncnc2oc(-c3ccccc3)cc12)C1CCCC1		CHEMBL183038	>	IC50	nM	19000.0	CHEMBL301	Homo sapiens	IC50	uM	19.0
	1441452	CHEMBL828499	Inhibition of cyclin-dependent kinase 2	B	O=C(Nc1ncnc2oc(-c3ccc(Cl)cc3)cc12)C1CCCC1		CHEMBL183171	>	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	1441455	CHEMBL828499	Inhibition of cyclin-dependent kinase 2	B	Cc1ccc(-c2cc3c(NC(=O)C4CCCC4)ncnc3o2)cc1		CHEMBL182007	>	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	1441458	CHEMBL828499	Inhibition of cyclin-dependent kinase 2	B	O=C(Nc1ncnc2oc(-c3ccc(F)cc3)cc12)C1CCCC1		CHEMBL185922	>	IC50	nM	19000.0	CHEMBL301	Homo sapiens	IC50	uM	19.0
	1441910	CHEMBL828499	Inhibition of cyclin-dependent kinase 2	B	O=C(Nc1ncnc2oc(-c3cccnc3)cc12)C1CCCC1		CHEMBL182419	=	IC50	nM	450.0	CHEMBL301	Homo sapiens	IC50	uM	0.45
	1442658	CHEMBL828229	Inhibition of Cyclin dependent kinase 2	B	Cc1[nH]c(C(N)=O)c(C)c1-c1ccnc(Nc2ccc(F)cc2)n1		CHEMBL362722	=	Ki	nM	80.0	CHEMBL301	Homo sapiens	Ki	uM	0.08
	1442661	CHEMBL828229	Inhibition of Cyclin dependent kinase 2	B	Cc1[nH]c([N+](=O)[O-])c(C)c1-c1ccnc(Nc2ccc(F)cc2)n1		CHEMBL364767	=	Ki	nM	30.0	CHEMBL301	Homo sapiens	Ki	uM	0.03
	1442768	CHEMBL828229	Inhibition of Cyclin dependent kinase 2	B	Cc1[nH]c(Cl)c(C)c1-c1ccnc(Nc2ccc(F)cc2)n1		CHEMBL365245	=	Ki	nM	360.0	CHEMBL301	Homo sapiens	Ki	uM	0.36
	1442771	CHEMBL828229	Inhibition of Cyclin dependent kinase 2	B	Cc1[nH]c(Br)c(C)c1-c1ccnc(Nc2ccc(F)cc2)n1		CHEMBL185099	=	Ki	nM	270.0	CHEMBL301	Homo sapiens	Ki	uM	0.27
	1444458	CHEMBL828229	Inhibition of Cyclin dependent kinase 2	B	Cc1c[nH]c(C)c1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL364408	=	Ki	nM	50.0	CHEMBL301	Homo sapiens	Ki	uM	0.05
	1444461	CHEMBL828229	Inhibition of Cyclin dependent kinase 2	B	Cc1[nH]c(C#N)c(C)c1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL264345	=	Ki	nM	140.0	CHEMBL301	Homo sapiens	Ki	uM	0.14
	1444464	CHEMBL828229	Inhibition of Cyclin dependent kinase 2	B	Cc1ccc(Nc2nccc(-c3c(C)[nH]c(C#N)c3C)n2)cc1[N+](=O)[O-]		CHEMBL183158	=	Ki	nM	50.0	CHEMBL301	Homo sapiens	Ki	uM	0.05
	1444467	CHEMBL828229	Inhibition of Cyclin dependent kinase 2	B	Cc1[nH]c(C#N)c(C)c1-c1ccnc(Nc2ccc(O)cc2)n1		CHEMBL184253	=	Ki	nM	50.0	CHEMBL301	Homo sapiens	Ki	uM	0.05
	1444470	CHEMBL828229	Inhibition of Cyclin dependent kinase 2	B	Cc1[nH]c(C#N)c(C)c1-c1ccnc(Nc2cccc(O)c2)n1		CHEMBL360530	=	Ki	nM	30.0	CHEMBL301	Homo sapiens	Ki	uM	0.03
	1444473	CHEMBL828229	Inhibition of Cyclin dependent kinase 2	B	Cc1ccc(Nc2nccc(-c3c(C)[nH]c(C#N)c3C)n2)cc1O		CHEMBL359623	=	Ki	nM	130.0	CHEMBL301	Homo sapiens	Ki	uM	0.13
	1444476	CHEMBL828229	Inhibition of Cyclin dependent kinase 2	B	Cc1cc(Nc2nccc(-c3c(C)[nH]c(C#N)c3C)n2)ccc1F		CHEMBL185310	=	Ki	nM	90.0	CHEMBL301	Homo sapiens	Ki	uM	0.09
	1444479	CHEMBL828229	Inhibition of Cyclin dependent kinase 2	B	Cc1[nH]c(C#N)c(C)c1-c1ccnc(Nc2ccc(F)cc2)n1		CHEMBL185323	=	Ki	nM	100.0	CHEMBL301	Homo sapiens	Ki	uM	0.1
	1459648	CHEMBL832429	Inhibitory activity against Cyclin-dependent kinase 2 (CDK2)	B	Nc1nc2ccc(C(=O)c3c(F)cccc3F)cn2c1C(=O)c1c(F)cccc1F		CHEMBL189136	=	IC50	nM	122.0	CHEMBL301	Homo sapiens	IC50	nM	122.0
	1459757	CHEMBL832429	Inhibitory activity against Cyclin-dependent kinase 2 (CDK2)	B	Nc1nc2ccc(C(=O)c3ccccc3)cn2c1C(=O)c1c(F)cccc1F		CHEMBL362774	=	IC50	nM	1927.0	CHEMBL301	Homo sapiens	IC50	nM	1927.0
	1459758	CHEMBL832429	Inhibitory activity against Cyclin-dependent kinase 2 (CDK2)	B	Nc1nc2ccc(C(=O)c3ccccc3Cl)cn2c1C(=O)c1c(F)cccc1F		CHEMBL365209	=	IC50	nM	428.0	CHEMBL301	Homo sapiens	IC50	nM	428.0
	1459759	CHEMBL832429	Inhibitory activity against Cyclin-dependent kinase 2 (CDK2)	B	Nc1nc2ccc(C(=O)c3ccccc3C(F)(F)F)cn2c1C(=O)c1c(F)cccc1F		CHEMBL186401	=	IC50	nM	1068.0	CHEMBL301	Homo sapiens	IC50	nM	1068.0
	1459760	CHEMBL832429	Inhibitory activity against Cyclin-dependent kinase 2 (CDK2)	B	Cc1ccccc1C(=O)c1ccc2nc(N)c(C(=O)c3c(F)cccc3F)n2c1		CHEMBL186204	=	IC50	nM	1294.0	CHEMBL301	Homo sapiens	IC50	nM	1294.0
	1459909	CHEMBL832429	Inhibitory activity against Cyclin-dependent kinase 2 (CDK2)	B	COc1ccccc1C(=O)c1ccc2nc(N)c(C(=O)c3c(F)cccc3F)n2c1		CHEMBL188673	=	IC50	nM	603.0	CHEMBL301	Homo sapiens	IC50	nM	603.0
	1459910	CHEMBL832429	Inhibitory activity against Cyclin-dependent kinase 2 (CDK2)	B	Nc1nc2ccc(C(=O)c3ccccc3OC(F)(F)F)cn2c1C(=O)c1c(F)cccc1F		CHEMBL189512	=	IC50	nM	2171.0	CHEMBL301	Homo sapiens	IC50	nM	2171.0
	1459911	CHEMBL832429	Inhibitory activity against Cyclin-dependent kinase 2 (CDK2)	B	Nc1nc2ccc(C(=O)c3c(Cl)cccc3Cl)cn2c1C(=O)c1c(F)cccc1F		CHEMBL189350	=	IC50	nM	53.0	CHEMBL301	Homo sapiens	IC50	nM	53.0
	1459912	CHEMBL832429	Inhibitory activity against Cyclin-dependent kinase 2 (CDK2)	B	Nc1nc2ccc(C(=O)c3c(F)cccc3Cl)cn2c1C(=O)c1c(F)cccc1F		CHEMBL183941	=	IC50	nM	33.0	CHEMBL301	Homo sapiens	IC50	nM	33.0
	1459915	CHEMBL832429	Inhibitory activity against Cyclin-dependent kinase 2 (CDK2)	B	C=C(c1ccc2nc(N)c(C(=O)c3c(F)cccc3F)n2c1)c1c(F)cccc1F		CHEMBL365608	=	IC50	nM	63.0	CHEMBL301	Homo sapiens	IC50	nM	63.0
	1459918	CHEMBL832429	Inhibitory activity against Cyclin-dependent kinase 2 (CDK2)	B	N#C/C=C(/c1ccc2nc(N)c(C(=O)c3c(F)cccc3F)n2c1)c1c(F)cccc1F		CHEMBL364172	=	IC50	nM	160.0	CHEMBL301	Homo sapiens	IC50	nM	160.0
	1459921	CHEMBL832429	Inhibitory activity against Cyclin-dependent kinase 2 (CDK2)	B	N#C/C=C(\c1ccc2nc(N)c(C(=O)c3c(F)cccc3F)n2c1)c1c(F)cccc1F		CHEMBL189440	=	IC50	nM	896.0	CHEMBL301	Homo sapiens	IC50	nM	896.0
	1459922	CHEMBL832429	Inhibitory activity against Cyclin-dependent kinase 2 (CDK2)	B	Nc1nc2ccc(/C(=C/c3nn[nH]n3)c3c(F)cccc3F)cn2c1C(=O)c1c(F)cccc1F		CHEMBL185914	=	IC50	nM	1691.0	CHEMBL301	Homo sapiens	IC50	nM	1691.0
	1459925	CHEMBL832429	Inhibitory activity against Cyclin-dependent kinase 2 (CDK2)	B	Nc1nc2ccc(C(=O)c3c(F)cccc3F)cn2c1C(=O)c1ccccc1		CHEMBL189607	=	IC50	nM	324.0	CHEMBL301	Homo sapiens	IC50	nM	324.0
	1459928	CHEMBL832429	Inhibitory activity against Cyclin-dependent kinase 2 (CDK2)	B	COc1ccccc1C(=O)c1c(N)nc2ccc(C(=O)c3c(F)cccc3F)cn12		CHEMBL184115	=	IC50	nM	68.0	CHEMBL301	Homo sapiens	IC50	nM	68.0
	1460073	CHEMBL829257	Inhibitory activity against Cyclin-dependent kinase 2	B	Cc1cc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)nc(C)n1		CHEMBL364623	>	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	1461717	CHEMBL832429	Inhibitory activity against Cyclin-dependent kinase 2 (CDK2)	B	Nc1nc2ccc(C(=O)c3c(F)cccc3F)cn2c1C(=O)c1c(F)cccc1Cl		CHEMBL185854	=	IC50	nM	102.0	CHEMBL301	Homo sapiens	IC50	nM	102.0
	1462032	CHEMBL831696	Inhibition of human Cyclin-dependent kinase 2	B	CC(C)OC(=O)N1CCn2cc(C3=C(c4cnc5ccccn45)C(=O)NC3=O)c3cccc(c32)C1		CHEMBL363058	=	IC50	nM	3400.0	CHEMBL301	Homo sapiens	IC50	uM	3.4
	1462107	CHEMBL832429	Inhibitory activity against Cyclin-dependent kinase 2 (CDK2)	B	COc1cc(F)c(C(=O)c2c(N)nc3ccc(C(=O)c4c(F)cccc4F)cn23)c(F)c1		CHEMBL360596	=	IC50	nM	91.0	CHEMBL301	Homo sapiens	IC50	nM	91.0
	1462148	CHEMBL831696	Inhibition of human Cyclin-dependent kinase 2	B	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362588	=	IC50	nM	5400.0	CHEMBL301	Homo sapiens	IC50	uM	5.4
	1462170	CHEMBL831696	Inhibition of human Cyclin-dependent kinase 2	B	Cc1cc2c3c(c1)c(C1=C(c4cnc5ccccn45)C(=O)NC1=O)cn3CCN(C(=O)N1CCCCC1)C2		CHEMBL186290	>	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	1462283	CHEMBL831696	Inhibition of human Cyclin-dependent kinase 2	B	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL178737	=	IC50	nM	5300.0	CHEMBL301	Homo sapiens	IC50	uM	5.3
	1462299	CHEMBL831696	Inhibition of human Cyclin-dependent kinase 2	B	CN(C)C(=O)N1CCn2cc(C3=C(c4cnc5ccccn45)C(=O)NC3=O)c3cccc(c32)C1		CHEMBL362814	=	IC50	nM	2100.0	CHEMBL301	Homo sapiens	IC50	uM	2.1
	1462425	CHEMBL831696	Inhibition of human Cyclin-dependent kinase 2	B	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	=	IC50	nM	2800.0	CHEMBL301	Homo sapiens	IC50	uM	2.8
	1462511	CHEMBL832429	Inhibitory activity against Cyclin-dependent kinase 2 (CDK2)	B	Nc1nc2ccc(C(=O)c3c(F)cccc3F)cn2c1C(=S)c1ccccc1		CHEMBL365046	=	IC50	nM	214.0	CHEMBL301	Homo sapiens	IC50	nM	214.0
	1462534	CHEMBL832429	Inhibitory activity against Cyclin-dependent kinase 2 (CDK2)	B	Nc1nc2ccc(C(=O)c3c(F)cccc3F)cn2c1C(=S)c1c(F)cccc1F		CHEMBL186163	=	IC50	nM	26.0	CHEMBL301	Homo sapiens	IC50	nM	26.0
	1462666	CHEMBL832429	Inhibitory activity against Cyclin-dependent kinase 2 (CDK2)	B	COc1cc(F)c(C(=S)c2c(N)nc3ccc(C(=O)c4c(F)cccc4F)cn23)c(F)c1		CHEMBL185971	=	IC50	nM	29.0	CHEMBL301	Homo sapiens	IC50	nM	29.0
	1462669	CHEMBL832429	Inhibitory activity against Cyclin-dependent kinase 2 (CDK2)	B	Nc1nc2ccc(C(=O)c3c(Cl)cccc3Cl)cn2c1C(=O)c1c(F)cc(O)cc1F		CHEMBL363069	=	IC50	nM	52.0	CHEMBL301	Homo sapiens	IC50	nM	52.0
	1462670	CHEMBL832429	Inhibitory activity against Cyclin-dependent kinase 2 (CDK2)	B	CN(C)CCOc1cc(F)c(C(=O)c2c(N)nc3ccc(C(=O)c4c(Cl)cccc4Cl)cn23)c(F)c1		CHEMBL187969	=	IC50	nM	984.0	CHEMBL301	Homo sapiens	IC50	nM	984.0
	1462683	CHEMBL832429	Inhibitory activity against Cyclin-dependent kinase 2 (CDK2)	B	CN1CCN(CCOc2cc(F)c(C(=O)c3c(N)nc4ccc(C(=O)c5c(Cl)cccc5Cl)cn34)c(F)c2)CC1		CHEMBL186396	=	IC50	nM	812.0	CHEMBL301	Homo sapiens	IC50	nM	812.0
	1462684	CHEMBL832429	Inhibitory activity against Cyclin-dependent kinase 2 (CDK2)	B	Nc1nc2ccc(C(=O)c3c(Cl)cccc3Cl)cn2c1C(=O)c1c(F)cc(C(=O)O)cc1F		CHEMBL364631	=	IC50	nM	95.0	CHEMBL301	Homo sapiens	IC50	nM	95.0
	1462685	CHEMBL832429	Inhibitory activity against Cyclin-dependent kinase 2 (CDK2)	B	COc1cccc(OC)c1C(=S)c1c(N)nc2ccc(C(=O)c3c(F)cccc3F)cn12		CHEMBL188074	=	IC50	nM	462.0	CHEMBL301	Homo sapiens	IC50	nM	462.0
	1462795	CHEMBL832429	Inhibitory activity against Cyclin-dependent kinase 2 (CDK2)	B	NC(=O)c1cc(F)c(C(=O)c2c(N)nc3ccc(C(=O)c4c(Cl)cccc4Cl)cn23)c(F)c1		CHEMBL188392	=	IC50	nM	46.0	CHEMBL301	Homo sapiens	IC50	nM	46.0
	1463630	CHEMBL832429	Inhibitory activity against Cyclin-dependent kinase 2 (CDK2)	B	Nc1nc2ccc(C(=O)c3c(F)cccc3F)cn2c1C(=O)c1cccs1		CHEMBL186952	=	IC50	nM	547.0	CHEMBL301	Homo sapiens	IC50	nM	547.0
	1463631	CHEMBL832429	Inhibitory activity against Cyclin-dependent kinase 2 (CDK2)	B	Nc1nc2ccc(C(=O)c3c(F)cccc3F)cn2c1C(=O)c1ccc(Cl)cc1		CHEMBL183362	=	IC50	nM	1711.0	CHEMBL301	Homo sapiens	IC50	nM	1711.0
	1463765	CHEMBL832429	Inhibitory activity against Cyclin-dependent kinase 2 (CDK2)	B	Nc1nc2ccc(C(=O)c3c(F)cccc3F)cn2c1C(=O)c1ccncc1		CHEMBL363037	=	IC50	nM	2538.0	CHEMBL301	Homo sapiens	IC50	nM	2538.0
	1463766	CHEMBL832429	Inhibitory activity against Cyclin-dependent kinase 2 (CDK2)	B	Nc1nc2ccc(C(=O)c3c(F)cccc3F)cn2c1C(=O)c1c(Cl)cccc1Cl		CHEMBL186800	=	IC50	nM	121.0	CHEMBL301	Homo sapiens	IC50	nM	121.0
	1465916	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Cc1ccc2c(-c3ccnc(Nc4ccc(F)c(F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL364197	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1465920	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Cc1ccc2c(-c3ccnc(Nc4ccc(Cl)c(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL186010	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1465922	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccccc3)nn2n1		CHEMBL361723	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1465924	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3cccc(C(F)(F)F)c3)nn2n1		CHEMBL364539	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1465927	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Cc1ccc2c(-c3ccnc(Nc4ccc(F)c(F)c4)n3)c(-c3cccc(C(F)(F)F)c3)nn2n1		CHEMBL186195	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1465929	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Cc1ccc2c(-c3ccnc(Nc4ccc(Cl)c(C(F)(F)F)c4)n3)c(-c3cccc(C(F)(F)F)c3)nn2n1		CHEMBL184657	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1465931	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3cccc(C(F)(F)F)c3)nn2n1		CHEMBL189617	=	Ki	nM	5000.0	CHEMBL301	Homo sapiens	Ki	uM	5.0
	1465933	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL187272	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1465935	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1465937	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467146	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359554	=	Ki	nM	5.0	CHEMBL301	Homo sapiens	Ki	uM	0.005
	1467151	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	CN(c1ccccc1)c1nccc(-c2cnn3ncccc23)n1		CHEMBL360866	=	Ki	nM	19900.0	CHEMBL301	Homo sapiens	Ki	uM	19.9
Not Determined	1467154	CHEMBL830205	Binding affinity for human cyclin-dependent kinase 2; ND= Not determined	B	Cc1ccccc1Nc1nccc(-c2cnn3ncccc23)n1		CHEMBL366259		Ki	nM		CHEMBL301	Homo sapiens	Ki	uM	
	1467157	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Ki	nM	2.0	CHEMBL301	Homo sapiens	Ki	uM	0.002
	1467162	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	N#Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359794	=	Ki	nM	1.0	CHEMBL301	Homo sapiens	Ki	uM	0.001
	1467268	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	O=[N+]([O-])c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL188938	=	Ki	nM	20.0	CHEMBL301	Homo sapiens	Ki	uM	0.02
	1467271	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Ki	nM	10.0	CHEMBL301	Homo sapiens	Ki	uM	0.01
	1467275	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	CCC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL185871	=	Ki	nM	150.0	CHEMBL301	Homo sapiens	Ki	uM	0.15
	1467278	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	CC(C)(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL364587	=	Ki	nM	150.0	CHEMBL301	Homo sapiens	Ki	uM	0.15
	1467281	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	COc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1OC		CHEMBL186054	=	Ki	nM	50.0	CHEMBL301	Homo sapiens	Ki	uM	0.05
	1467286	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCO5)n3)c2c1		CHEMBL189455	=	Ki	nM	10.0	CHEMBL301	Homo sapiens	Ki	uM	0.01
	1467289	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Ki	nM	6.0	CHEMBL301	Homo sapiens	Ki	uM	0.006
	1467294	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Fc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1F		CHEMBL364370	=	Ki	nM	2.0	CHEMBL301	Homo sapiens	Ki	uM	0.002
	1467297	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCCO5)n3)c2c1		CHEMBL186708	=	Ki	nM	6.0	CHEMBL301	Homo sapiens	Ki	uM	0.006
	1467300	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Clc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1Cl		CHEMBL186890	=	Ki	nM	1.0	CHEMBL301	Homo sapiens	Ki	uM	0.001
	1467405	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	FC(F)(F)c1cc(Nc2nccc(-c3cnn4ncccc34)n2)ccc1Cl		CHEMBL188665	=	Ki	nM	10.0	CHEMBL301	Homo sapiens	Ki	uM	0.01
	1467410	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Ki	nM	10.0	CHEMBL301	Homo sapiens	Ki	uM	0.01
	1467414	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(C(F)(F)F)c1		CHEMBL360206	=	Ki	nM	10.0	CHEMBL301	Homo sapiens	Ki	uM	0.01
	1467419	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	FC(F)(F)c1cc(Br)cc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL365229	=	Ki	nM	10.0	CHEMBL301	Homo sapiens	Ki	uM	0.01
	1467422	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Fc1cc(F)cc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL184510	=	Ki	nM	1.0	CHEMBL301	Homo sapiens	Ki	uM	0.001
	1467427	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Clc1cc(Cl)cc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL361697	=	Ki	nM	310.0	CHEMBL301	Homo sapiens	Ki	uM	0.31
	1467432	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Cc1cc(C)cc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL186101	=	Ki	nM	3.0	CHEMBL301	Homo sapiens	Ki	uM	0.003
	1467437	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Oc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL187750	=	Ki	nM	8.0	CHEMBL301	Homo sapiens	Ki	uM	0.008
	1467540	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	COc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL189235	=	Ki	nM	160.0	CHEMBL301	Homo sapiens	Ki	uM	0.16
	1467543	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Ki	nM	1990.0	CHEMBL301	Homo sapiens	Ki	uM	1.99
	1467546	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	CCCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL187287	=	Ki	nM	1260.0	CHEMBL301	Homo sapiens	Ki	uM	1.26
	1467549	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	COc1cccc(Nc2nccc(-c3cnn4nc(OC)ccc34)n2)c1		CHEMBL188312	=	Ki	nM	60.0	CHEMBL301	Homo sapiens	Ki	uM	0.06
	1467553	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Ki	nM	190.0	CHEMBL301	Homo sapiens	Ki	uM	0.19
	1467556	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	COc1ccc2c(-c3ccnc(Nc4ccc(C#N)cc4)n3)cnn2n1		CHEMBL189352	=	Ki	nM	500.0	CHEMBL301	Homo sapiens	Ki	uM	0.5
	1467559	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	COc1ccc2c(-c3ccnc(Nc4ccc([N+](=O)[O-])cc4)n3)cnn2n1		CHEMBL186288	=	Ki	nM	20.0	CHEMBL301	Homo sapiens	Ki	uM	0.02
	1467562	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	COc1cc(Nc2nccc(-c3cnn4nc(OC)ccc34)n2)cc(OC)c1		CHEMBL188417	=	Ki	nM	190.0	CHEMBL301	Homo sapiens	Ki	uM	0.19
	1467565	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	COc1cc(Nc2nccc(-c3cnn4nc(OC)ccc34)n2)cc(C(F)(F)F)c1		CHEMBL187139	=	Ki	nM	790.0	CHEMBL301	Homo sapiens	Ki	uM	0.79
	1467568	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467571	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	COc1ccc2c(-c3ccnc(Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188205	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467671	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	COc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)cnn2n1		CHEMBL188785	=	Ki	nM	100.0	CHEMBL301	Homo sapiens	Ki	uM	0.1
	1467674	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL187006	=	Ki	nM	50.0	CHEMBL301	Homo sapiens	Ki	uM	0.05
	1467677	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Cc1ccc2c(-c3ccnc(Nc4ccc(C(F)(F)F)cc4)n3)cnn2n1		CHEMBL188303	=	Ki	nM	190.0	CHEMBL301	Homo sapiens	Ki	uM	0.19
	1467681	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	COc1cc(Nc2nccc(-c3cnn4nc(C)ccc34)n2)cc(C(F)(F)F)c1		CHEMBL186680	=	Ki	nM	20.0	CHEMBL301	Homo sapiens	Ki	uM	0.02
	1467684	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)cnn2n1		CHEMBL434337	=	Ki	nM	6.0	CHEMBL301	Homo sapiens	Ki	uM	0.006
	1467687	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Ki	nM	2500.0	CHEMBL301	Homo sapiens	Ki	uM	2.5
	1467690	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	c1ccc(-c2ccc3c(-c4ccnc(Nc5ccc6c(c5)OCCO6)n4)cnn3n2)cc1		CHEMBL186606	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467693	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	c1ccc(Nc2nccc(-c3c(-c4ccccc4)nn4ncccc34)n2)cc1		CHEMBL360408	=	Ki	nM	3980.0	CHEMBL301	Homo sapiens	Ki	uM	3.98
	1467697	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	FC(F)(F)c1cccc(Nc2nccc(-c3c(-c4ccccc4)nn4ncccc34)n2)c1		CHEMBL263448	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467701	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Fc1ccc(Nc2nccc(-c3c(-c4ccccc4)nn4ncccc34)n2)cc1F		CHEMBL439850	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467705	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Fc1cc(F)cc(Nc2nccc(-c3c(-c4ccccc4)nn4ncccc34)n2)c1		CHEMBL186476	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467807	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	FC(F)(F)c1cc(Nc2nccc(-c3c(-c4ccccc4)nn4ncccc34)n2)ccc1Cl		CHEMBL365251	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467809	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL363125	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467814	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL186425	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467816	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL189343	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467820	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL186166	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467822	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL189288	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467824	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467826	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL186116	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467828	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467830	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467832	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467834	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467837	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189665	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467839	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL365840	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467946	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467948	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467950	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL189135	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467952	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)c1		CHEMBL185910	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467954	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Fc1ccc(Nc2nccc(-c3c(-c4cccc(C(F)(F)F)c4)nn4ncccc34)n2)cc1F		CHEMBL184656	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467956	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467958	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)c1		CHEMBL187135	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467960	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467962	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	FC(F)(F)c1cccc(Nc2nccc(-c3c(-c4ccc(Cl)cc4)nn4ncccc34)n2)c1		CHEMBL362086	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467964	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(Cl)cc4)nn4ncccc34)n2)cc1F		CHEMBL364646	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467966	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	FC(F)(F)c1cc(Nc2nccc(-c3c(-c4ccc(Cl)cc4)nn4ncccc34)n2)ccc1Cl		CHEMBL189874	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467968	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL186826	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467970	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccccc3)nn2n1		CHEMBL434158	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1467974	CHEMBL827377	Binding affinity for human cyclin-dependent kinase 2	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	>	Ki	nM	19950.0	CHEMBL301	Homo sapiens	Ki	uM	19.95
	1475831	CHEMBL828493	Inhibitory concentration against selected kinase CDK2	B	CCn1c(-c2nonc2N)nc2cnccc21		CHEMBL189657	=	IC50	nM	169.0	CHEMBL301	Homo sapiens	IC50	nM	169.0
	1476109	CHEMBL830594	Percent inhibition against CDK2 at 10 uM using 100 uM ATP	B	CCn1c(-c2nonc2N)nc2cnccc21		CHEMBL189657	=	Inhibition	%	84.0	CHEMBL301	Homo sapiens	Inhibition	%	84.0
	1476647	CHEMBL828493	Inhibitory concentration against selected kinase CDK2	B	CCn1c(-c2nonc2N)nc2cncc(CNC3CCNCC3)c21		CHEMBL188434	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	1507729	CHEMBL829240	Inhibition of Cyclin-dependent kinase 2	B	O=C1Nc2ccc3ncsc3c2/C1=C/Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1276446	=	IC50	nM	10.0	CHEMBL301	Homo sapiens	IC50	uM	0.01
	1507731	CHEMBL829240	Inhibition of Cyclin-dependent kinase 2	B	Cc1nc2ccccn2c1-c1ccnc(Nc2ccc(OCC(O)CN(C)C)cc2)n1		CHEMBL102926	=	IC50	nM	10.0	CHEMBL301	Homo sapiens	IC50	uM	0.01
	1507732	CHEMBL829240	Inhibition of Cyclin-dependent kinase 2	B	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3cc(Cl)ccc3Cl)n2)cc1		CHEMBL101311	=	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	uM	1.0
	1507733	CHEMBL829240	Inhibition of Cyclin-dependent kinase 2	B	O=C1NC2C=CC=CC2/C1=C/Nc1ccc(S(=O)(=O)Nc2nccs2)cc1		CHEMBL191845	=	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	uM	1.0
	1512260	CHEMBL828533	Inhibition of human cyclin-dependent kinase 2	B	CONC(=O)c1cc(Nc2ncnn3cc(NC(=O)OCCCS(C)(=O)=O)c(C(C)C)c23)c(F)cc1F		CHEMBL195218	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	1512380	CHEMBL828533	Inhibition of human cyclin-dependent kinase 2	B	CONC(=O)c1cc(Nc2ncnn3cc(NC(=O)OCC4CCCO4)c(C(C)C)c23)c(F)cc1F		CHEMBL370266	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	1512517	CHEMBL828533	Inhibition of human cyclin-dependent kinase 2	B	CONC(=O)c1cc(Nc2ncnn3cc(-c4nnc(C)o4)c(C(C)C)c23)c(F)cc1F		CHEMBL365318	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	1512659	CHEMBL828533	Inhibition of human cyclin-dependent kinase 2	B	CONC(=O)c1cc(Nc2ncnn3cc(-c4nnc(C(F)F)o4)c(C(C)C)c23)c(F)cc1F		CHEMBL194498	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	1512800	CHEMBL828533	Inhibition of human cyclin-dependent kinase 2	B	CONC(=O)c1cc(Nc2ncnn3cc(-c4nnc(C(F)(F)S(C)(=O)=O)o4)c(C(C)C)c23)c(F)cc1F		CHEMBL195903	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	1513459	CHEMBL831667	Inhibition of cyclin-dependent kinase 2	B	O=C(Nc1ccc(Cl)c(COc2cccnc2)c1)c1cc(F)cc(N2CCOCC2)c1		CHEMBL194436	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	1515300	CHEMBL835598	Binding affinity for cyclin-dependent kinase 2	B	Nc1cncc(Cl)n1		CHEMBL191632	=	Affinity	uM	350.0	CHEMBL301	Homo sapiens	Affinity	uM	350.0
	1516908	CHEMBL830762	Selectivity for Cyclin-dependent kinase 2 by scintillation proximity assay	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccn4)c3)o2)c1		CHEMBL194176	=	Selectivity	uM	1.7	CHEMBL301	Homo sapiens	Selectivity	uM	1.7
Not Determined	1517047	CHEMBL832131	Selectivity for Cyclin-dependent kinase 2 by scintillation proximity assay; No data	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474		Selectivity			CHEMBL301	Homo sapiens	Selectivity	uM	
Not Determined	1517065	CHEMBL832131	Selectivity for Cyclin-dependent kinase 2 by scintillation proximity assay; No data	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4Cl)c3)o2)c1		CHEMBL191993		Selectivity			CHEMBL301	Homo sapiens	Selectivity	uM	
	1520549	CHEMBL831707	In vitro inhibitory concentration against cyclin-dependent kinase 2	B	CN(C)S(=O)(=O)c1ccc(Nc2ccc(C(=O)c3c(F)cccc3F)c(N)n2)cc1		CHEMBL193456	=	IC50	nM	500.0	CHEMBL301	Homo sapiens	IC50	uM	0.5
	1520558	CHEMBL831707	In vitro inhibitory concentration against cyclin-dependent kinase 2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)ccc1C(=O)c1c(F)cccc1F		CHEMBL193643	=	IC50	nM	180.0	CHEMBL301	Homo sapiens	IC50	uM	0.18
	1520581	CHEMBL831707	In vitro inhibitory concentration against cyclin-dependent kinase 2	B	CCCCOc1cc(Nc2ccc(S(N)(=O)=O)cc2)nc(N)c1C(=O)c1c(F)cccc1F		CHEMBL2113092	=	IC50	nM	84.0	CHEMBL301	Homo sapiens	IC50	uM	0.084
	1606851	CHEMBL882903	Inhibitory concentration against CDK2	B	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc(NC2CCCC2)c1C#N		CHEMBL383172	>	IC50	nM	100000.0	CHEMBL301	Homo sapiens	IC50	uM	100.0
Not Active	1650027	CHEMBL860890	Average Binding Constant for CDK2; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL301	Homo sapiens	Kd		
Not Active	1650028	CHEMBL860890	Average Binding Constant for CDK2; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707		Kd			CHEMBL301	Homo sapiens	Kd		
Not Active	1650029	CHEMBL860890	Average Binding Constant for CDK2; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL301	Homo sapiens	Kd		
Not Active	1650030	CHEMBL860890	Average Binding Constant for CDK2; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Kd			CHEMBL301	Homo sapiens	Kd		
Not Active	1650031	CHEMBL860890	Average Binding Constant for CDK2; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL301	Homo sapiens	Kd		
Not Active	1650032	CHEMBL860890	Average Binding Constant for CDK2; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL301	Homo sapiens	Kd		
Not Active	1650033	CHEMBL860890	Average Binding Constant for CDK2; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL301	Homo sapiens	Kd		
	1650034	CHEMBL860890	Average Binding Constant for CDK2; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Kd	nM	2900.0	CHEMBL301	Homo sapiens	Kd	uM	2.9
	1650035	CHEMBL860890	Average Binding Constant for CDK2; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	200.0	CHEMBL301	Homo sapiens	Kd	uM	0.2
	1651841	CHEMBL860890	Average Binding Constant for CDK2; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	8.1	CHEMBL301	Homo sapiens	Kd	uM	0.0081
Not Active	1651842	CHEMBL860890	Average Binding Constant for CDK2; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL301	Homo sapiens	Kd		
Not Active	1651843	CHEMBL860890	Average Binding Constant for CDK2; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL301	Homo sapiens	Kd		
Not Active	1651844	CHEMBL860890	Average Binding Constant for CDK2; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL301	Homo sapiens	Kd		
Not Active	1651845	CHEMBL860890	Average Binding Constant for CDK2; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL301	Homo sapiens	Kd		
	1651846	CHEMBL860890	Average Binding Constant for CDK2; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Kd	nM	3200.0	CHEMBL301	Homo sapiens	Kd	uM	3.2
Not Active	1651847	CHEMBL860890	Average Binding Constant for CDK2; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL301	Homo sapiens	Kd		
Not Active	1651848	CHEMBL860890	Average Binding Constant for CDK2; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL301	Homo sapiens	Kd		
Not Active	1651849	CHEMBL860890	Average Binding Constant for CDK2; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL301	Homo sapiens	Kd		
Not Active	1651850	CHEMBL860890	Average Binding Constant for CDK2; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828		Kd			CHEMBL301	Homo sapiens	Kd		
Not Active	1651851	CHEMBL860890	Average Binding Constant for CDK2; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965		Kd			CHEMBL301	Homo sapiens	Kd		
	1653640	CHEMBL861589	Inhibitory activity against CDK2	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	1658658	CHEMBL860303	Inhibitory activity against CDK2	B	NC1=NONC1N1N=NC(C(=O)N/N=C/c2ccncc2)C1CN1CCCCC1		CHEMBL197077	=	IC50	nM	96000.0	CHEMBL301	Homo sapiens	IC50	uM	96.0
	1658672	CHEMBL860303	Inhibitory activity against CDK2	B	NC1=NONC1N1N=NC(c2n[nH]c(-c3ccncc3)n2)C1CN1CCCCC1	Outside typical range	CHEMBL197226	>	IC50	nM	250000.0	CHEMBL301	Homo sapiens	IC50	uM	250.0
	1665754	CHEMBL860246	Inhibition of CDK2 at 10 uM	B	CN1C(=O)C(C(=O)Nc2nncs2)c2cc3occc3cc21		CHEMBL200906	=	Inhibition	%	2.0	CHEMBL301	Homo sapiens	Inhibition	%	2.0
	1678202	CHEMBL860872	Inhibitory activity against CDK2	B	COc1cc2c(Nc3ncc(CC(=O)Nc4cccc(F)c4)s3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL201307	=	IC50	nM	62000.0	CHEMBL301	Homo sapiens	IC50	uM	62.0
	1693229	CHEMBL867700	Inhibition of CDK2 using 100 uM ATP	B	Brc1cccc(-c2cc(NCc3ccncc3)n3nccc3n2)c1		CHEMBL204054	=	IC50	nM	1800.0	CHEMBL301	Homo sapiens	IC50	uM	1.8
	1693231	CHEMBL867700	Inhibition of CDK2 using 100 uM ATP	B	N[C@H]1CC[C@H](Nc2cc(Nc3ccc(S(=O)(=O)c4ccccc4)cc3)n3ncnc3n2)CC1		CHEMBL382607	=	IC50	nM	260.0	CHEMBL301	Homo sapiens	IC50	uM	0.26
	1693232	CHEMBL867700	Inhibition of CDK2 using 100 uM ATP	B	CS(=O)(=O)c1ccc(Nc2cc(N[C@H]3CC[C@H](N)CC3)nc3ncnn23)cc1		CHEMBL206659	=	IC50	nM	250.0	CHEMBL301	Homo sapiens	IC50	uM	0.25
	1693233	CHEMBL867700	Inhibition of CDK2 using 100 uM ATP	B	CN(C)S(=O)(=O)c1ccc(Nc2cc(N[C@H]3CC[C@H](N)CC3)nc3ncnn23)cc1		CHEMBL202695	=	IC50	nM	120.0	CHEMBL301	Homo sapiens	IC50	uM	0.12
	1693234	CHEMBL867700	Inhibition of CDK2 using 100 uM ATP	B	NS(=O)(=O)c1ccc(Nc2cc(N[C@H]3CC[C@H](N)CC3)nc3ncnn23)cc1		CHEMBL380331	=	IC50	nM	270.0	CHEMBL301	Homo sapiens	IC50	uM	0.27
	1693235	CHEMBL867700	Inhibition of CDK2 using 100 uM ATP	B	CCN(CC)c1cc(Nc2ccc(S(N)(=O)=O)cc2)n2ncnc2n1		CHEMBL203571	=	IC50	nM	400.0	CHEMBL301	Homo sapiens	IC50	uM	0.4
	1693236	CHEMBL867700	Inhibition of CDK2 using 100 uM ATP	B	NS(=O)(=O)c1ccc(Nc2cc(N[C@H]3CC[C@H](O)CC3)nc3ncnn23)cc1		CHEMBL203573	=	IC50	nM	7400.0	CHEMBL301	Homo sapiens	IC50	uM	7.4
	1693237	CHEMBL867700	Inhibition of CDK2 using 100 uM ATP	B	NS(=O)(=O)c1ccc(Nc2cc(NC3CCCCC3)nc3ncnn23)cc1		CHEMBL203569	=	IC50	nM	730.0	CHEMBL301	Homo sapiens	IC50	uM	0.73
	1693238	CHEMBL867700	Inhibition of CDK2 using 100 uM ATP	B	NS(=O)(=O)c1ccc(Nc2cc(OC3CCCCC3)nc3ncnn23)cc1		CHEMBL203407	=	IC50	nM	350.0	CHEMBL301	Homo sapiens	IC50	uM	0.35
	1693239	CHEMBL867700	Inhibition of CDK2 using 100 uM ATP	B	NS(=O)(=O)c1ccc(Nc2cc(OCC3CCCCC3)nc3ncnn23)cc1		CHEMBL206109	=	IC50	nM	11000.0	CHEMBL301	Homo sapiens	IC50	uM	11.0
	1693240	CHEMBL867700	Inhibition of CDK2 using 100 uM ATP	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	IC50	nM	80.0	CHEMBL301	Homo sapiens	IC50	nM	80.0
	1693241	CHEMBL867700	Inhibition of CDK2 using 100 uM ATP	B	Brc1cccc(-c2cc(NCc3ccncc3)n3ncnc3n2)c1		CHEMBL203006	=	IC50	nM	26000.0	CHEMBL301	Homo sapiens	IC50	uM	26.0
	1697686	CHEMBL866561	Protective index against Cdk2 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL203056	<	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1698006	CHEMBL866561	Protective index against Cdk2 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Cc3ccccc3)cc2)o1		CHEMBL383126	<	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1698007	CHEMBL866561	Protective index against Cdk2 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Oc3ccccc3)cc2)o1		CHEMBL206267	<	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1698008	CHEMBL866561	Protective index against Cdk2 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(-c3ccccc3)cc2)o1		CHEMBL205464	<	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1698009	CHEMBL866561	Protective index against Cdk2 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Br)cc2)o1		CHEMBL205463	<	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1698010	CHEMBL866561	Protective index against Cdk2 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(NCc2ccc3c(c2)OCO3)o1		CHEMBL202892	<	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1698011	CHEMBL866561	Protective index against Cdk2 at 10 uM by HTRF method	B	Cc1ccc(Nc2nnc(-c3c(NCc4ccncc4)ncn3C)o2)c(F)c1		CHEMBL379908	<	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1698012	CHEMBL866561	Protective index against Cdk2 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Cl)c(C(F)(F)F)c2)o1		CHEMBL205127	<	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1698013	CHEMBL866561	Protective index against Cdk2 at 10 uM by HTRF method	B	COc1ccc(Nc2nnc(-c3c(NCc4ccncc4)ncn3C)o2)cc1OC		CHEMBL378592	<	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1698014	CHEMBL866561	Protective index against Cdk2 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Cl)c(Cl)c2)o1		CHEMBL204874	<	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1698015	CHEMBL866561	Protective index against Cdk2 at 10 uM by HTRF method	B	Cc1ccccc1Nc1nnc(-c2c(NCc3ccncc3)ncn2C)o1		CHEMBL379239	<	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1698016	CHEMBL866561	Protective index against Cdk2 at 10 uM by HTRF method	B	COc1ccccc1Nc1nnc(-c2c(NCc3ccncc3)ncn2C)o1		CHEMBL204312	<	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1698017	CHEMBL866561	Protective index against Cdk2 at 10 uM by HTRF method	B	COc1cccc(Nc2nnc(-c3c(NCc4ccncc4)ncn3C)o2)c1		CHEMBL203796	<	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1698018	CHEMBL866561	Protective index against Cdk2 at 10 uM by HTRF method	B	Cc1cccc(Nc2nnc(-c3c(NCc4ccncc4)ncn3C)o2)c1		CHEMBL203789	<	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1698019	CHEMBL866561	Protective index against Cdk2 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2cccc(OC(F)(F)F)c2)o1		CHEMBL206538	<	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1698020	CHEMBL866561	Protective index against Cdk2 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(C(F)(F)F)cc2)o1		CHEMBL380131	<	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1698021	CHEMBL866561	Protective index against Cdk2 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(OC(F)(F)F)cc2)o1		CHEMBL383255	<	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1698022	CHEMBL866561	Protective index against Cdk2 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(OC(F)(F)Cl)cc2)o1		CHEMBL205884	<	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1698023	CHEMBL866561	Protective index against Cdk2 at 10 uM by HTRF method	B	CC(C)c1ccc(Nc2nnc(-c3c(NCc4ccncc4)ncn3C)o2)cc1		CHEMBL203119	<	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1698024	CHEMBL866561	Protective index against Cdk2 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(C(C)(C)C)cc2)o1		CHEMBL203731	<	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1698025	CHEMBL866561	Protective index against Cdk2 at 10 uM by HTRF method	B	Cn1cnc(NCc2cccc3ncccc23)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL378165	<	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1698026	CHEMBL866561	Protective index against Cdk2 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccc3ccccc3n2)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL204718	<	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1698027	CHEMBL866561	Protective index against Cdk2 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccc3[nH]ncc3c2)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL206118	<	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1698028	CHEMBL866561	Protective index against Cdk2 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccc(F)c(F)c2)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL203394	<	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1698029	CHEMBL866561	Protective index against Cdk2 at 10 uM by HTRF method	B	Cn1cnc(NCCc2ccc3c(c2)OCO3)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL382672	<	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1698030	CHEMBL866561	Protective index against Cdk2 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccccn2)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL202904	<	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1698031	CHEMBL866561	Protective index against Cdk2 at 10 uM by HTRF method	B	Cn1cnc(NCc2cccnc2)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL206742	<	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1709147	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	FC(F)(F)c1cccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)c1		CHEMBL383334	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709194	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	c1ccc(-c2ccc(Nc3nnc(-c4cccnc4CCc4ccncc4)o3)cc2)cc1		CHEMBL208229	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709195	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	c1cnc(CCc2ccncc2)c(-c2nnc(NCc3ccc4c(c3)OCO4)o2)c1		CHEMBL383123	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709196	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	Cc1ccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)cc1C(F)(F)F		CHEMBL382218	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709197	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	COc1ccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)cc1OC		CHEMBL382610	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709198	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	Clc1ccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)cc1Cl		CHEMBL204621	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709199	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	Cc1ccccc1Nc1nnc(-c2cccnc2CCc2ccncc2)o1		CHEMBL205869	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709200	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	COc1ccccc1Nc1nnc(-c2cccnc2CCc2ccncc2)o1		CHEMBL381704	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709201	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	COc1cccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)c1		CHEMBL205050	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709202	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	Cc1cccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)c1		CHEMBL204425	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709203	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	FC(F)(F)Oc1cccc(Nc2nnc(-c3cnccc3CCc3ccncc3)o2)c1		CHEMBL381293	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709204	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	FC(F)(F)Oc1cccc(Nc2nnc(-c3ccncc3CCc3ccncc3)o2)c1		CHEMBL205639	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709205	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	FC(F)(F)Oc1cccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)c1		CHEMBL206123	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709206	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	FC(F)(F)c1ccc(Nc2nnc(-c3cnccc3CCc3ccncc3)o2)cc1		CHEMBL205244	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709207	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	FC(F)(F)Oc1ccc(Nc2nnc(-c3cnccc3CCc3ccncc3)o2)cc1		CHEMBL207772	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709208	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	FC(F)(Cl)Oc1ccc(Nc2nnc(-c3cnccc3CCc3ccncc3)o2)cc1		CHEMBL382142	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709209	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	FC(F)(F)c1ccc(Nc2nnc(-c3ccncc3CCc3ccncc3)o2)cc1		CHEMBL208363	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709210	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	FC(F)(F)Oc1ccc(Nc2nnc(-c3ccncc3CCc3ccncc3)o2)cc1		CHEMBL383434	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709211	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	FC(F)(Cl)Oc1ccc(Nc2nnc(-c3ccncc3CCc3ccncc3)o2)cc1		CHEMBL205544	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709212	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	FC(F)(F)c1ccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)cc1		CHEMBL381182	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709213	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	FC(F)(F)Oc1ccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)cc1		CHEMBL380536	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709214	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	FC(F)(Cl)Oc1ccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)cc1		CHEMBL205502	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709215	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	CC(C)(C)c1ccc(Nc2nnc(-c3cc4ccccc4nc3CCc3ccncc3)o2)cc1		CHEMBL204846	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709216	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	CC(C)(C)c1ccc(Nc2nnc(-c3cnccc3CCc3ccncc3)o2)cc1		CHEMBL383333	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709217	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	CC(C)c1ccc(Nc2nnc(-c3ccncc3CCc3ccncc3)o2)cc1		CHEMBL207975	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709218	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	CC(C)(C)c1ccc(Nc2nnc(-c3ccncc3CCc3ccncc3)o2)cc1		CHEMBL204984	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709219	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	CC(C)c1ccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)cc1		CHEMBL377995	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709220	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	CC(C)(C)c1ccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)cc1		CHEMBL205325	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709221	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	c1ccc2ncc(Nc3nnc(-c4cc5ccccc5nc4CCc4ccncc4)o3)cc2c1		CHEMBL206670	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709222	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	c1cnc(CCc2ccncc2)c(-c2nnc(Nc3cnc4ccccc4c3)o2)c1		CHEMBL206136	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709223	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	FC(F)(F)c1cccc(Nc2nnc(-c3cccnc3CCc3cccc4ncccc34)o2)c1		CHEMBL205647	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709224	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	FC(F)(F)c1cccc(Nc2nnc(-c3cccnc3CCc3ccc4ccccc4n3)o2)c1		CHEMBL206089	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709225	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	FC(F)(F)c1cccc(Nc2nnc(-c3cccnc3CCc3ccc4[nH]ncc4c3)o2)c1		CHEMBL382797	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709226	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	FC(F)(F)c1cccc(Nc2nnc(-c3ccncc3CCCc3ccc4c(c3)OCO4)o2)c1		CHEMBL205684	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709227	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	Fc1ccc(CCc2ncccc2-c2nnc(Nc3cccc(C(F)(F)F)c3)o2)cc1F		CHEMBL207099	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709228	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	FC(F)(F)c1cccc(Nc2nnc(-c3cccnc3CCCc3ccc4c(c3)OCO4)o2)c1		CHEMBL207049	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709229	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	FC(F)(F)c1cccc(Nc2nnc(-c3cccnc3CCc3ccccn3)o2)c1		CHEMBL207821	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709230	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	FC(F)(F)c1cccc(Nc2nnc(-c3cccnc3CCc3cccnc3)o2)c1		CHEMBL380421	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709231	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	FC(F)(F)c1cccc(Nc2nnc(-c3cc4ccccc4nc3CCc3ccncc3)o2)c1		CHEMBL205901	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709232	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	FC(F)(F)c1cccc(Nc2nnc(-c3cnccc3CCc3ccncc3)o2)c1		CHEMBL205421	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1709233	CHEMBL864977	Inhibition of CDK2 at 10 uM	B	FC(F)(F)c1cccc(Nc2nnc(-c3ccncc3CCc3ccncc3)o2)c1		CHEMBL381577	>	PI	%	30.0	CHEMBL301	Homo sapiens	PI	%	30.0
	1723091	CHEMBL860196	Inhibition of CDK2	B	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	>	Ki	nM	8600.0	CHEMBL301	Homo sapiens	Ki	nM	8600.0
	1723092	CHEMBL860196	Inhibition of CDK2	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	>	Ki	nM	8600.0	CHEMBL301	Homo sapiens	Ki	nM	8600.0
	1723093	CHEMBL860196	Inhibition of CDK2	B	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	>	Ki	nM	8600.0	CHEMBL301	Homo sapiens	Ki	nM	8600.0
	1723094	CHEMBL860196	Inhibition of CDK2	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	>	Ki	nM	8600.0	CHEMBL301	Homo sapiens	Ki	nM	8600.0
	1723095	CHEMBL860196	Inhibition of CDK2	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Ki	nM	820.0	CHEMBL301	Homo sapiens	Ki	nM	820.0
	1723096	CHEMBL860196	Inhibition of CDK2	B	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	=	Ki	nM	1300.0	CHEMBL301	Homo sapiens	Ki	nM	1300.0
	1734730	CHEMBL865410	Inhibition of Cdk2	B	COc1cc(C)c(Sc2cnc(NC(=O)c3ccc(CNC(C)C(C)(C)C)cc3)s2)cc1C(=O)N1CCN(C(C)=O)CC1		CHEMBL209148	=	IC50	nM	29000.0	CHEMBL301	Homo sapiens	IC50	uM	29.0
	1736616	CHEMBL870941	Inhibition of CDK2	B	Cc1cc(-c2cnc(Nc3cnc(CN4CCN(C)CC4)cn3)s2)nc(OC2CCCCC2)n1		CHEMBL210540	=	IC50	nM	1700.0	CHEMBL301	Homo sapiens	IC50	nM	1700.0
	1736677	CHEMBL870941	Inhibition of CDK2	B	Cc1cc(-c2cnc(Nc3ccccn3)s2)nc(OC2CCCCC2)n1		CHEMBL427045	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	1736700	CHEMBL870941	Inhibition of CDK2	B	Cc1cnc(OC2CCCCC2)nc1-c1cnc(Nc2ccccn2)s1		CHEMBL212049	=	IC50	nM	270.0	CHEMBL301	Homo sapiens	IC50	nM	270.0
	1736722	CHEMBL870941	Inhibition of CDK2	B	c1ccc(Nc2ncc(-c3ccnc(OC4CCCCC4)n3)s2)nc1		CHEMBL424696	=	IC50	nM	14.0	CHEMBL301	Homo sapiens	IC50	nM	14.0
	1737601	CHEMBL869293	Inhibition of CDK2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	IC50	nM	2.0
	1737629	CHEMBL869293	Inhibition of CDK2	B	Nc1nc(Nc2ccc(S(=O)(=O)NC(=O)[C@H](N)CO)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL212264	=	IC50	nM	140.0	CHEMBL301	Homo sapiens	IC50	uM	0.14
	1737654	CHEMBL869293	Inhibition of CDK2	B	CCOC(=O)CCC(=O)NS(=O)(=O)c1ccc(Nc2nc(N)n(C(=O)c3c(F)cccc3F)n2)cc1		CHEMBL379193	=	IC50	nM	62.0	CHEMBL301	Homo sapiens	IC50	uM	0.062
	1737677	CHEMBL869293	Inhibition of CDK2	B	COCCOCC(=O)NS(=O)(=O)c1ccc(Nc2nc(N)n(C(=O)c3c(F)cccc3F)n2)cc1		CHEMBL210581	=	IC50	nM	247.0	CHEMBL301	Homo sapiens	IC50	uM	0.247
	1737711	CHEMBL869293	Inhibition of CDK2	B	NCC(=O)NS(=O)(=O)c1ccc(Nc2nc(N)n(C(=O)c3c(F)cccc3F)n2)cc1		CHEMBL378248	=	IC50	nM	120.0	CHEMBL301	Homo sapiens	IC50	uM	0.12
	1737756	CHEMBL869293	Inhibition of CDK2	B	CN1CCN(CCC(=O)NS(=O)(=O)c2ccc(Nc3nc(N)n(C(=O)c4c(F)cccc4F)n3)cc2)CC1		CHEMBL210765	=	IC50	nM	266.0	CHEMBL301	Homo sapiens	IC50	uM	0.266
	1737817	CHEMBL869293	Inhibition of CDK2	B	Nc1nc(Nc2ccc(S(=O)(=O)NC(=O)CCC(=O)O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL209280	=	IC50	nM	71.0	CHEMBL301	Homo sapiens	IC50	uM	0.071
	1737867	CHEMBL869293	Inhibition of CDK2	B	Nc1nc(Nc2ccc(S(=O)(=O)NC(=O)CCN3CCOCC3)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL378420	=	IC50	nM	118.0	CHEMBL301	Homo sapiens	IC50	uM	0.118
	1739117	CHEMBL866208	Inhibition of CDK2	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Ki	nM	46.0	CHEMBL301	Homo sapiens	Ki	nM	46.0
	1744507	CHEMBL867295	Inhibition of CDK2	B	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	>	Ki	nM	8600.0	CHEMBL301	Homo sapiens	Ki	uM	8.6
	1744653	CHEMBL866819	Inhibition of CDK2	B	O=C(NC1CC1)c1cc(NCc2cnc(Nc3ccccn3)s2)c(F)cc1F		CHEMBL377734	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	1744772	CHEMBL866819	Inhibition of CDK2	B	COc1ccc(C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)cc1OC		CHEMBL379495	=	IC50	nM	50.0	CHEMBL301	Homo sapiens	IC50	nM	50.0
	1748680	CHEMBL870356	Inhibition of CDK2	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3cc(OC)c(OCCCN4CCN(C)CC4)c(OC)c3)n2)c(OC)c1		CHEMBL386760	>	IC50	nM	40000.0	CHEMBL301	Homo sapiens	IC50	uM	40.0
	1751212	CHEMBL854531	Inhibition of CDK2	B	NC(=O)c1ccc(Nc2nc(N)c(N=O)c(OCC3CCCCC3)n2)cc1		CHEMBL101801	=	Ki	nM	2400.0	CHEMBL301	Homo sapiens	Ki	uM	2.4
	1751214	CHEMBL854531	Inhibition of CDK2	B	Nc1nc(OCC2CCCCC2)c2nc[nH]c2n1		CHEMBL269881	=	Ki	nM	1200.0	CHEMBL301	Homo sapiens	Ki	uM	1.2
	1751451	CHEMBL869155	Inhibition of CDK2	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3Cl)cn12		CHEMBL215652	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	1751452	CHEMBL869155	Inhibition of CDK2	B	CC(C)c1nnc2ccc(-c3ocnc3-c3cc(F)c(F)cc3F)cn12		CHEMBL213423	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	1751453	CHEMBL869155	Inhibition of CDK2	B	CCNc1nnc2ccc(-c3ocnc3-c3ccc(F)cc3)cn12		CHEMBL213451	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	1751454	CHEMBL869155	Inhibition of CDK2	B	CC(C)(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3F)cn12		CHEMBL212382	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	1751455	CHEMBL869155	Inhibition of CDK2	B	CC(C)(C)c1nnc2ccc(-c3ocnc3-c3cc(F)c(F)cc3F)cn12		CHEMBL212968	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	1751456	CHEMBL869155	Inhibition of CDK2	B	CC(C)c1nnc2ccc(-c3c[nH]nc3-c3cc(F)ccc3F)cn12		CHEMBL214198	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	1751641	CHEMBL869155	Inhibition of CDK2	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccccc3)cn12		CHEMBL379929	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	1760241	CHEMBL867447	Ratio of IC50 for CDK4 to CDK2/CycA3	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	Ratio IC50		200.0	CHEMBL301	Homo sapiens	Ratio IC50		200.0
	1760242	CHEMBL867446	Ratio of IC50 for CDK2 F82H/L83V/H84D/K89T mutant/CycA3 to CDK2/CycA3	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	Ratio IC50		15.0	CHEMBL301	Homo sapiens	Ratio IC50		15.0
	1760243	CHEMBL867445	Ratio of IC50 for CDK2 F82H/L83V/H84D mutant/CycA3 to CDK2/CycA3	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	Ratio IC50		13.0	CHEMBL301	Homo sapiens	Ratio IC50		13.0
	1760244	CHEMBL867444	Ratio of IC50 for CDK2 F82H mutant/CycA3 to CDK2/CycA3	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	Ratio IC50		4.0	CHEMBL301	Homo sapiens	Ratio IC50		4.0
	1760245	CHEMBL867443	Ratio of IC50 for CDK2 L83V/H84D mutant/CycA3 to CDK2/CycA3	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	Ratio IC50		3.0	CHEMBL301	Homo sapiens	Ratio IC50		3.0
	1760246	CHEMBL867442	Ratio of IC50 for CDK2 K89T mutant/CycA3 to CDK2/CycA3	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	Ratio IC50		1.0	CHEMBL301	Homo sapiens	Ratio IC50		1.0
	1760248	CHEMBL867440	Inhibition of CDK2 F82H/L83V/H84D/K89T mutant/CycA3	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	IC50	nM	120.0	CHEMBL301	Homo sapiens	IC50	nM	120.0
	1760249	CHEMBL867439	Inhibition of CDK2 F82H/L83V/H84D mutant/CycA3	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	IC50	nM	103.0	CHEMBL301	Homo sapiens	IC50	nM	103.0
	1760265	CHEMBL867438	Inhibition of CDK2 F82H mutant/CycA3	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	IC50	nM	33000.0	CHEMBL301	Homo sapiens	IC50	uM	33.0
	1760266	CHEMBL866168	Inhibition of CDK2 L83V/H84D mutant/CycA3	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	IC50	nM	21000.0	CHEMBL301	Homo sapiens	IC50	uM	21.0
	1760267	CHEMBL866170	Inhibition of CDK2 K89T mutant/CycA3	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	IC50	nM	8.9	CHEMBL301	Homo sapiens	IC50	nM	8.9
	1760268	CHEMBL866169	Inhibition of CDK2/CycA3	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	IC50	nM	8.1	CHEMBL301	Homo sapiens	IC50	nM	8.1
	1760281	CHEMBL866170	Inhibition of CDK2 K89T mutant/CycA3	B	Cc1ccc(Cl)c(N(CC#N)c2cc(Nc3ccc(OC[C@@H](O)CN(C)C)cc3)ncn2)c1		CHEMBL211514	=	IC50	nM	140.0	CHEMBL301	Homo sapiens	IC50	uM	0.14
	1760305	CHEMBL867439	Inhibition of CDK2 F82H/L83V/H84D mutant/CycA3	B	Cc1ccc(Cl)c(N(CC#N)c2cc(Nc3ccc(OC[C@@H](O)CN(C)C)cc3)ncn2)c1		CHEMBL211514	=	IC50	nM	7300.0	CHEMBL301	Homo sapiens	IC50	uM	7.3
	1760306	CHEMBL867440	Inhibition of CDK2 F82H/L83V/H84D/K89T mutant/CycA3	B	Cc1ccc(Cl)c(N(CC#N)c2cc(Nc3ccc(OC[C@@H](O)CN(C)C)cc3)ncn2)c1		CHEMBL211514	=	IC50	nM	640.0	CHEMBL301	Homo sapiens	IC50	uM	0.64
Not Determined	1760308	CHEMBL866168	Inhibition of CDK2 L83V/H84D mutant/CycA3	B	Cc1ccc(Cl)c(N(CC#N)c2cc(Nc3ccc(OC[C@@H](O)CN(C)C)cc3)ncn2)c1		CHEMBL211514		IC50			CHEMBL301	Homo sapiens	IC50		
Not Determined	1760309	CHEMBL867438	Inhibition of CDK2 F82H mutant/CycA3	B	Cc1ccc(Cl)c(N(CC#N)c2cc(Nc3ccc(OC[C@@H](O)CN(C)C)cc3)ncn2)c1		CHEMBL211514		IC50			CHEMBL301	Homo sapiens	IC50		
	1760310	CHEMBL866169	Inhibition of CDK2/CycA3	B	Cc1ccc(Cl)c(N(CC#N)c2cc(Nc3ccc(OC[C@@H](O)CN(C)C)cc3)ncn2)c1		CHEMBL211514	=	IC50	nM	2600.0	CHEMBL301	Homo sapiens	IC50	uM	2.6
	1769367	CHEMBL910893	Inhibition of CDK2	B	O=C(Nc1cc(CN[C@H]2Cc3ccc(Cl)cc3C2)n[nH]1)Nc1cccc2c1[C@@H]1CCCN1C2=O		CHEMBL336242	=	IC50	nM	440.0	CHEMBL301	Homo sapiens	IC50	nM	440.0
	1769370	CHEMBL910893	Inhibition of CDK2	B	O=C(Nc1ccccn1)Nc1cccc2c1[C@H]1CCCN1C2=O		CHEMBL141247	=	IC50	nM	80.0	CHEMBL301	Homo sapiens	IC50	nM	80.0
	1769373	CHEMBL910893	Inhibition of CDK2	B	C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2		CHEMBL215803	=	IC50	nM	3.4	CHEMBL301	Homo sapiens	IC50	nM	3.4
	1777418	CHEMBL908827	Inhibition of CDK2/Cyclin E	B	COc1cccc(C(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2N)c1		CHEMBL408439	>	Ki	nM	10000.0	CHEMBL301	Homo sapiens	Ki	uM	10.0
	1777430	CHEMBL908827	Inhibition of CDK2/Cyclin E	B	COc1ccccc1C(=O)c1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1N		CHEMBL383875	=	Ki	nM	5141.0	CHEMBL301	Homo sapiens	Ki	uM	5.141
	1777431	CHEMBL908827	Inhibition of CDK2/Cyclin E	B	Cc1ccccc1C(=O)c1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1N		CHEMBL437330	>	Ki	nM	10000.0	CHEMBL301	Homo sapiens	Ki	uM	10.0
	1777432	CHEMBL908827	Inhibition of CDK2/Cyclin E	B	CN1CCN(c2ccc(Nc3ncc(C(=O)c4ccccc4C(F)(F)F)c(N)n3)cc2)CC1		CHEMBL385039	>	Ki	nM	10000.0	CHEMBL301	Homo sapiens	Ki	uM	10.0
	1777433	CHEMBL908827	Inhibition of CDK2/Cyclin E	B	CN1CCN(c2ccc(Nc3ncc(C(=O)c4cccc(C(F)(F)F)c4)c(N)n3)cc2)CC1		CHEMBL214838	>	Ki	nM	10000.0	CHEMBL301	Homo sapiens	Ki	uM	10.0
	1777434	CHEMBL908827	Inhibition of CDK2/Cyclin E	B	CN1CCN(c2ccc(Nc3ncc(C(=O)c4cccc(F)c4)c(N)n3)cc2)CC1		CHEMBL214458	>	Ki	nM	10000.0	CHEMBL301	Homo sapiens	Ki	uM	10.0
	1777480	CHEMBL908827	Inhibition of CDK2/Cyclin E	B	COc1c(C(=O)c2cnc(NC3CCN(S(C)(=O)=O)CC3)nc2N)cc(F)c(F)c1F		CHEMBL214183	=	Ki	nM	495.0	CHEMBL301	Homo sapiens	Ki	uM	0.495
	1777481	CHEMBL908827	Inhibition of CDK2/Cyclin E	B	COc1cc(F)c(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL213713	=	Ki	nM	2.0	CHEMBL301	Homo sapiens	Ki	uM	0.002
	1777482	CHEMBL908827	Inhibition of CDK2/Cyclin E	B	COc1cc(F)c(F)cc1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL215086	=	Ki	nM	6.0	CHEMBL301	Homo sapiens	Ki	uM	0.006
	1777483	CHEMBL908827	Inhibition of CDK2/Cyclin E	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	=	Ki	nM	3.0	CHEMBL301	Homo sapiens	Ki	uM	0.003
	1777484	CHEMBL908827	Inhibition of CDK2/Cyclin E	B	CS(=O)(=O)N1CCC(Nc2ncc(C(=O)c3c(F)cccc3F)c(N)n2)CC1		CHEMBL265903	=	Ki	nM	15.0	CHEMBL301	Homo sapiens	Ki	uM	0.015
	1777485	CHEMBL908827	Inhibition of CDK2/Cyclin E	B	COc1cccc(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL385733	=	Ki	nM	13.0	CHEMBL301	Homo sapiens	Ki	uM	0.013
	1777486	CHEMBL908827	Inhibition of CDK2/Cyclin E	B	COc1ccc(Cl)cc1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL385373	=	Ki	nM	451.0	CHEMBL301	Homo sapiens	Ki	uM	0.451
	1777487	CHEMBL908827	Inhibition of CDK2/Cyclin E	B	COc1ccc(F)cc1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL268507	=	Ki	nM	7.0	CHEMBL301	Homo sapiens	Ki	uM	0.007
	1777488	CHEMBL908827	Inhibition of CDK2/Cyclin E	B	COc1cc(F)ccc1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL277351	=	Ki	nM	84.0	CHEMBL301	Homo sapiens	Ki	uM	0.084
	1777489	CHEMBL908827	Inhibition of CDK2/Cyclin E	B	CCOc1ccccc1C(=O)c1cnc(NC2CCN(C(C)=O)CC2)nc1N		CHEMBL216148	=	Ki	nM	2030.0	CHEMBL301	Homo sapiens	Ki	uM	2.03
	1777490	CHEMBL908827	Inhibition of CDK2/Cyclin E	B	CCOC(=O)N1CCC(Nc2ncc(C(=O)c3ccccc3C)c(N)n2)CC1		CHEMBL214433	=	Ki	nM	2166.0	CHEMBL301	Homo sapiens	Ki	uM	2.166
	1777491	CHEMBL908827	Inhibition of CDK2/Cyclin E	B	CCOC(=O)N1CCC(Nc2ncc(C(=O)c3ccccc3F)c(N)n2)CC1		CHEMBL214025	=	Ki	nM	3137.0	CHEMBL301	Homo sapiens	Ki	uM	3.137
	1777492	CHEMBL908827	Inhibition of CDK2/Cyclin E	B	CCS(=O)(=O)N1CCC(Nc2ncc(C(=O)c3ccccc3OC)c(N)n2)CC1		CHEMBL385190	=	Ki	nM	51.0	CHEMBL301	Homo sapiens	Ki	uM	0.051
	1777493	CHEMBL908827	Inhibition of CDK2/Cyclin E	B	COc1ccccc1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL216126	=	Ki	nM	24.0	CHEMBL301	Homo sapiens	Ki	uM	0.024
	1777494	CHEMBL908827	Inhibition of CDK2/Cyclin E	B	CCCC(=O)N1CCC(Nc2ncc(C(=O)c3ccccc3OC)c(N)n2)CC1		CHEMBL384356	=	Ki	nM	886.0	CHEMBL301	Homo sapiens	Ki	uM	0.886
	1777495	CHEMBL908827	Inhibition of CDK2/Cyclin E	B	COc1ccccc1C(=O)c1cnc(NC2CCN(C(C)=O)CC2)nc1N		CHEMBL217537	=	Ki	nM	327.0	CHEMBL301	Homo sapiens	Ki	uM	0.327
	1777496	CHEMBL908827	Inhibition of CDK2/Cyclin E	B	CCOC(=O)N1CCC(Nc2ncc(C(=O)c3ccccc3OC)c(N)n2)CC1		CHEMBL217443	=	Ki	nM	597.0	CHEMBL301	Homo sapiens	Ki	uM	0.597
	1777497	CHEMBL908827	Inhibition of CDK2/Cyclin E	B	CCNC(=O)N1CCC(Nc2ncc(C(=O)c3ccccc3OC)c(N)n2)CC1		CHEMBL385907	=	Ki	nM	1756.0	CHEMBL301	Homo sapiens	Ki	uM	1.756
	1777498	CHEMBL908827	Inhibition of CDK2/Cyclin E	B	COc1ccccc1C(=O)c1cnc(NC2CCN(C)CC2)nc1N		CHEMBL214831	>	Ki	nM	10000.0	CHEMBL301	Homo sapiens	Ki	uM	10.0
	1777499	CHEMBL908827	Inhibition of CDK2/Cyclin E	B	COc1ccccc1C(=O)c1cnc(NC2CCNCC2)nc1N		CHEMBL387448	=	Ki	nM	6266.0	CHEMBL301	Homo sapiens	Ki	uM	6.266
	1778608	CHEMBL912343	Inhibition of Cdk2	B	Cc1cc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)nc(C)n1		CHEMBL364623	>	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	nM	25000.0
	1778612	CHEMBL912343	Inhibition of Cdk2	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	IC50	nM	5000.0	CHEMBL301	Homo sapiens	IC50	nM	5000.0
	1779366	CHEMBL854976	Inhibition of CDK2 by SPA	B	Clc1ccc2c(c1Nc1ncnc3cc(OCCCN4CCCC4)cc(OC4CCOCC4)c13)OCO2		CHEMBL217090	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	1779388	CHEMBL854976	Inhibition of CDK2 by SPA	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	1781989	CHEMBL911839	Inhibition of CDK2/cyclin A	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	IC50	nM	462.0	CHEMBL301	Homo sapiens	IC50	uM	0.462
	1790565	CHEMBL856422	Inhibition of human recombinant CDK2	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Ki	nM	10000.0	CHEMBL301	Homo sapiens	Ki	uM	10.0
Active	1798737	CHEMBL907057	Inhibition of CDK2 kinase activity assessed as decrease in histone H1 phosphorylation in LNCaP cells at 50 nM after 72 hrs by Western blot analysis	F	C[C@@H]1CC[C@H]2[C@@H](C)[C@@H](CC(CNc3ccccc3)C[C@H]3O[C@@H]4O[C@@]5(C)CC[C@H]6[C@H](C)CC[C@@H]([C@H]3C)[C@]64OO5)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4		CHEMBL373822		Activity			CHEMBL301	Homo sapiens	Activity		
Active	1798746	CHEMBL907057	Inhibition of CDK2 kinase activity assessed as decrease in histone H1 phosphorylation in LNCaP cells at 50 nM after 72 hrs by Western blot analysis	F	CCOP(=O)(OCC)OCC(C[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@]42OO3)C[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@]42OO3		CHEMBL375378		Activity			CHEMBL301	Homo sapiens	Activity		
Active	1798747	CHEMBL907057	Inhibition of CDK2 kinase activity assessed as decrease in histone H1 phosphorylation in LNCaP cells at 50 nM after 72 hrs by Western blot analysis	F	C[C@@H]1CC[C@H]2[C@@H](C)[C@@H](CC(COP(=O)(Oc3ccccc3)Oc3ccccc3)C[C@H]3O[C@@H]4O[C@@]5(C)CC[C@H]6[C@H](C)CC[C@@H]([C@H]3C)[C@]64OO5)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4		CHEMBL219245		Activity			CHEMBL301	Homo sapiens	Activity		
	1812462	CHEMBL911350	Inhibition of CDK2	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	IC50	nM	1584.89	CHEMBL301	Homo sapiens	Log IC50		-5.8
	1816521	CHEMBL911991	Inhibition of CDK2 at 1 uM	B	O=C1NCc2c3c(c4[nH]c5ccccc5c4c21)Cc1ccccc1-3		CHEMBL148471	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	Inhibition	%	30.0
	1816542	CHEMBL911991	Inhibition of CDK2 at 1 uM	B	O=C1NCc2c1c1c3ccccc3sc1c1[nH]c3ccccc3c21		CHEMBL221536	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	Inhibition	%	30.0
	1816543	CHEMBL911991	Inhibition of CDK2 at 1 uM	B	O=C1NCc2c1c1c(c3[nH]c4ccccc4c23)Cc2ccccc2-1		CHEMBL357490	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	Inhibition	%	30.0
	1816544	CHEMBL911991	Inhibition of CDK2 at 1 uM	B	O=C1NCc2c3c(c4[nH]c5ccccc5c4c21)CCc1ccccc1-3		CHEMBL374581	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	Inhibition	%	30.0
	1816545	CHEMBL911991	Inhibition of CDK2 at 1 uM	B	O=C1NC(=O)c2c1c1c(c3[nH]c4ccccc4c23)CCc2ccccc2-1		CHEMBL386636	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	Inhibition	%	30.0
	1820572	CHEMBL917089	Inhibition of CDK2	B	O=C(N[C@H](CO)c1ccc(F)c(Cl)c1)c1cc(-c2n[nH]cc2-c2cccc(Cl)c2)c[nH]1		CHEMBL387385	>	Ki	nM	4000.0	CHEMBL301	Homo sapiens	Ki	uM	4.0
	1824461	CHEMBL913842	Inhibition of Cdk2	B	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	>	Ki	nM	10000.0	CHEMBL301	Homo sapiens	Ki	uM	10.0
	1824598	CHEMBL913842	Inhibition of Cdk2	B	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	=	Ki	nM	5760.0	CHEMBL301	Homo sapiens	Ki	uM	5.76
	1824699	CHEMBL913842	Inhibition of Cdk2	B	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	>	Ki	nM	10000.0	CHEMBL301	Homo sapiens	Ki	uM	10.0
	1841821	CHEMBL913893	Inhibition of CDK2	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	IC50	nM	5000.0	CHEMBL301	Homo sapiens	IC50	nM	5000.0
	1856946	CHEMBL920653	Inhibition of CDK2	B	C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br	Outside typical range	CHEMBL228043	>	IC50	nM	500000.0	CHEMBL301	Homo sapiens	IC50	uM	500.0
	1857659	CHEMBL918818	Inhibition of CDK2 at 100 uM	B	O=C1Nc2c(Br)cc(Br)cc2C1=O		CHEMBL388579	=	Inhibition	%	44.0	CHEMBL301	Homo sapiens	Inhibition	%	44.0
	1891155	CHEMBL905895	Inhibition at CDK2	B	NC(=O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL242237	=	IC50	nM	2700.0	CHEMBL301	Homo sapiens	IC50	uM	2.7
	1898271	CHEMBL887684	Inhibition of CDK2	B	Cc1cc(Nc2ncnc3cnc(N4CCOCC4)cc23)ccc1Oc1ccc(C(=O)NCC(C)(C)C)cc1		CHEMBL375671	>	Activity	uM	10.0	CHEMBL301	Homo sapiens	Activity	uM	10.0
	1960500	CHEMBL892530	Inhibition of CDK2	B	NC1=NC(=O)/C(=C/c2ccc3ncccc3c2)S1		CHEMBL396377	=	Ki	nM	2000.0	CHEMBL301	Homo sapiens	Ki	uM	2.0
	1960523	CHEMBL892530	Inhibition of CDK2	B	O=C1N=C(N[C@@H]2C[C@H]2c2ccccc2)S/C1=C\c1ccc2ncccc2c1		CHEMBL235345	>	Ki	nM	2000.0	CHEMBL301	Homo sapiens	Ki	uM	2.0
	1960524	CHEMBL892530	Inhibition of CDK2	B	O=C1N=C(NCc2cccs2)S/C1=C\c1ccc2ncccc2c1		CHEMBL393929	=	Ki	nM	340.0	CHEMBL301	Homo sapiens	Ki	uM	0.34
	1963774	CHEMBL897015	Inhibition of CDK2	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	IC50	nM	40000.0	CHEMBL301	Homo sapiens	IC50	uM	40.0
	1963775	CHEMBL897015	Inhibition of CDK2	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2ccccc12		CHEMBL122701	=	IC50	nM	4000.0	CHEMBL301	Homo sapiens	IC50	uM	4.0
	1963776	CHEMBL897015	Inhibition of CDK2	B	O=c1cc(-c2ccc(O)c(O)c2)oc2ccccc12	Outside typical range	CHEMBL222556	>	IC50	nM	500000.0	CHEMBL301	Homo sapiens	IC50	uM	500.0
	1963777	CHEMBL897015	Inhibition of CDK2	B	O=c1cc(-c2ccc(O)c(O)c2)oc2c(O)c(O)ccc12	Outside typical range	CHEMBL222541	>	IC50	nM	500000.0	CHEMBL301	Homo sapiens	IC50	uM	500.0
	1963778	CHEMBL897015	Inhibition of CDK2	B	O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL151	=	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	1963779	CHEMBL897015	Inhibition of CDK2	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)ccc12		CHEMBL31574	=	IC50	nM	5000.0	CHEMBL301	Homo sapiens	IC50	uM	5.0
	1963780	CHEMBL897015	Inhibition of CDK2	B	Cc1cc(N2C(=O)CN(C)C2=O)c2oc(-c3ccc(O)c(O)c3)c(O)c(=O)c2c1		CHEMBL232556	=	IC50	nM	56.0	CHEMBL301	Homo sapiens	IC50	uM	0.056
	1963781	CHEMBL897015	Inhibition of CDK2	B	Cc1cc(N2C(=O)CNC2=O)c2oc(-c3ccc(O)c(O)c3)c(O)c(=O)c2c1		CHEMBL232353	=	IC50	nM	4000.0	CHEMBL301	Homo sapiens	IC50	uM	4.0
	1963782	CHEMBL897015	Inhibition of CDK2	B	Cc1cc(N2C(=O)CCCC2=O)c2oc(-c3ccc(O)c(O)c3)c(O)c(=O)c2c1		CHEMBL232939	=	IC50	nM	4400.0	CHEMBL301	Homo sapiens	IC50	uM	4.4
	1963783	CHEMBL897015	Inhibition of CDK2	B	Cc1cc(N2C(=O)CCC2=O)c2oc(-c3ccc(O)c(O)c3)c(O)c(=O)c2c1		CHEMBL232743	=	IC50	nM	1500.0	CHEMBL301	Homo sapiens	IC50	uM	1.5
	1963784	CHEMBL897015	Inhibition of CDK2	B	Cc1cc(N2CCCC2=O)c2oc(-c3ccc(O)c(O)c3)c(O)c(=O)c2c1		CHEMBL232934	=	IC50	nM	1600.0	CHEMBL301	Homo sapiens	IC50	uM	1.6
	1963785	CHEMBL897015	Inhibition of CDK2	B	Cc1cc(N2CCN(C)CC2)c2oc(-c3ccc(O)c(O)c3)c(O)c(=O)c2c1		CHEMBL232737	=	IC50	nM	640.0	CHEMBL301	Homo sapiens	IC50	uM	0.64
	1963786	CHEMBL897015	Inhibition of CDK2	B	Cc1cc(N2CCCCC2)c2oc(-c3ccc(O)c(O)c3)c(O)c(=O)c2c1		CHEMBL232736	=	IC50	nM	2600.0	CHEMBL301	Homo sapiens	IC50	uM	2.6
	1963787	CHEMBL897015	Inhibition of CDK2	B	Cc1cc(N2CCCC2)c2oc(-c3ccc(O)c(O)c3)c(O)c(=O)c2c1		CHEMBL232735	=	IC50	nM	3000.0	CHEMBL301	Homo sapiens	IC50	uM	3.0
	1963788	CHEMBL897015	Inhibition of CDK2	B	CCN(CC)c1cc(C)cc2c(=O)c(O)c(-c3ccc(O)c(O)c3)oc12		CHEMBL231928	=	IC50	nM	1600.0	CHEMBL301	Homo sapiens	IC50	uM	1.6
	1963789	CHEMBL897015	Inhibition of CDK2	B	Cc1cc(N)c2oc(-c3ccc(O)c(O)c3)c(O)c(=O)c2c1		CHEMBL232123	=	IC50	nM	630.0	CHEMBL301	Homo sapiens	IC50	uM	0.63
	1963797	CHEMBL897015	Inhibition of CDK2	B	Cc1cc(N2CCCS2(=O)=O)c2oc(-c3ccc(O)c(C(F)(F)F)c3)c(O)c(=O)c2c1		CHEMBL233153	=	IC50	nM	1700.0	CHEMBL301	Homo sapiens	IC50	uM	1.7
	1963798	CHEMBL897015	Inhibition of CDK2	B	Cc1cc(N2CCCS2(=O)=O)c2oc(-c3ccc(O)c(C#N)c3)c(O)c(=O)c2c1		CHEMBL233152	=	IC50	nM	1400.0	CHEMBL301	Homo sapiens	IC50	uM	1.4
	1963799	CHEMBL897015	Inhibition of CDK2	B	Cc1cc(N2CCCS2(=O)=O)c2oc(-c3ccc(O)c(Br)c3)c(O)c(=O)c2c1		CHEMBL392776	=	IC50	nM	75.0	CHEMBL301	Homo sapiens	IC50	uM	0.075
	1963800	CHEMBL897015	Inhibition of CDK2	B	Cc1cc(N2CCCS2(=O)=O)c2oc(-c3ccc(O)c(Cl)c3)c(O)c(=O)c2c1		CHEMBL392775	=	IC50	nM	190.0	CHEMBL301	Homo sapiens	IC50	uM	0.19
	1963801	CHEMBL897015	Inhibition of CDK2	B	Cc1cc(N2CCCS2(=O)=O)c2oc(-c3ccc(O)cc3)c(O)c(=O)c2c1		CHEMBL232749	=	IC50	nM	250.0	CHEMBL301	Homo sapiens	IC50	uM	0.25
	1963802	CHEMBL897015	Inhibition of CDK2	B	Cc1cc(N2CCCS2(=O)=O)c2oc(-c3ccc(O)c(O)c3)c(O)c(=O)c2c1		CHEMBL232557	=	IC50	nM	87.0	CHEMBL301	Homo sapiens	IC50	uM	0.087
	1964158	CHEMBL897074	Inhibition of CDK2	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	<	IC50	nM	10000.0	CHEMBL301	Homo sapiens	pIC50		5.0
	1964246	CHEMBL897074	Inhibition of CDK2	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	<	IC50	nM	10000.0	CHEMBL301	Homo sapiens	pIC50		5.0
	1966324	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1ccccn1		CHEMBL232800	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966940	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1nnnn1CCc1ccncc1		CHEMBL233829	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966941	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	CC(C)(C)c1ccc(NC(=O)c2nnnn2CCc2ccncc2)cc1		CHEMBL233828	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966942	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1nnnn1CCc1ccncc1		CHEMBL233827	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966943	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1nnnn1CCc1ccncc1		CHEMBL234205	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966944	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1nnnn1CCc1ccncc1		CHEMBL393001	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966945	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1nc2ccccc2n1CCc1ccncc1		CHEMBL234013	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966946	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1nc2ccccc2n1CCc1ccncc1		CHEMBL234012	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966947	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1nc2ccccc2n1CCc1ccncc1		CHEMBL233826	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966948	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1nccn1CCc1ccncc1		CHEMBL233825	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966949	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	CC(C)(C)c1ccc(NC(=O)c2nccn2CCc2ccncc2)cc1		CHEMBL233824	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966950	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1nccn1CCc1ccncc1		CHEMBL391104	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966951	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1nccn1CCc1ccncc1		CHEMBL234203	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966952	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1nccn1CCc1ccncc1		CHEMBL234202	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966953	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1cc2ccccc2n1CCc1ccncc1		CHEMBL391103	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966954	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1cc2ccccc2n1CCc1ccncc1		CHEMBL234201	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966955	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	Cc1nn(CCc2ccncc2)c(C(=O)Nc2ccc(OC(F)(F)F)cc2)c1C		CHEMBL234011	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966956	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	Cc1nn(CCc2ccncc2)c(C(=O)Nc2ccc(Cl)cc2)c1C		CHEMBL391102	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966957	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	Cc1cc(C(=O)Nc2ccc(OC(F)(F)F)cc2)n(CCc2ccncc2)n1		CHEMBL392331	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966958	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	Cc1cc(C(=O)Nc2ccc(Cl)cc2)n(CCc2ccncc2)n1		CHEMBL234010	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966959	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	COc1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1OC		CHEMBL234009	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966960	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1ccc(Cl)c(Cl)c1)c1ccnn1CCc1ccncc1		CHEMBL392330	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966961	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1ccnn1CCc1ccncc1		CHEMBL233823	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966962	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)c1ccnn1CCc1ccncc1		CHEMBL233822	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966963	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1ccc2cn[nH]c2c1)c1ccnn1CCc1ccncc1		CHEMBL392329	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966964	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1ccc2[nH]ncc2c1)c1ccnn1CCc1ccncc1		CHEMBL233821	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966965	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1cnc2ccccc2c1)c1ccnn1CCc1ccncc1		CHEMBL391069	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966966	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1ccc(OCc2ccccc2)cc1)c1ccnn1CCc1ccncc1		CHEMBL233631	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966967	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1ccc(Oc2ccccc2)cc1)c1ccnn1CCc1ccncc1		CHEMBL392313	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966968	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1ccc(-c2ccccc2)cc1)c1ccnn1CCc1ccncc1		CHEMBL399606	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966969	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	CC(C)c1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1		CHEMBL236420	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966970	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	CC(C)(C)c1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1		CHEMBL399605	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966971	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1cccc(OC(F)(F)Cl)c1)c1ccnn1CCc1ccncc1		CHEMBL236419	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966972	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1cccc(OC(F)(F)F)c1)c1ccnn1CCc1ccncc1		CHEMBL236206	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966973	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1ccnn1CCc1ccncc1		CHEMBL236205	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966974	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	CCc1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1		CHEMBL392935	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966975	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1ccnn1CCc1ccncc1		CHEMBL392934	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966976	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1c[nH]cn1		CHEMBL237680	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966977	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1noc2ccccc12		CHEMBL237679	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966978	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1cnoc1		CHEMBL232802	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966979	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	COc1ccc(CCn2nccc2C(=O)Nc2ccc(Cl)cc2)cc1OC		CHEMBL234864	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966980	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1ccc(F)c(F)c1		CHEMBL393006	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966981	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	CC1C=C2OCOC2=C(CCn2nccc2C(=O)Nc2ccc(Cl)cc2)C1		CHEMBL234863	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966982	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1ccncc1		CHEMBL397323	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1966983	CHEMBL897524	Inhibition of Cdk2 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1cccnc1		CHEMBL397322	>	Activity	%	30.0	CHEMBL301	Homo sapiens	Activity	%	30.0
	1968064	CHEMBL895285	Inhibition of CDK2 at 10 uM	B	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1cccs1)n2CCCN		CHEMBL233338	=	Inhibition	%	7.0	CHEMBL301	Homo sapiens	Inhibition	%	7.0
	1970851	CHEMBL896714	Inhibition of CDK2	B	N=C1NC(=O)/C(=C/c2ccc(-c3ccc(S(N)(=O)=O)cc3)o2)S1		CHEMBL233149	=	IC50	nM	180.0	CHEMBL301	Homo sapiens	IC50	uM	0.18
	1970852	CHEMBL896714	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(-c2ccc(/C=C3\SC(=O)NC3=O)o2)cc1		CHEMBL232148	=	IC50	nM	27000.0	CHEMBL301	Homo sapiens	IC50	uM	27.0
	1970853	CHEMBL896714	Inhibition of CDK2	B	C/C(=C1/SC(=N)NC1=O)c1ccc(-c2ccc(S(N)(=O)=O)cc2)o1		CHEMBL231950	=	IC50	nM	30.0	CHEMBL301	Homo sapiens	IC50	uM	0.03
	1970854	CHEMBL896714	Inhibition of CDK2	B	N=C1NC(=O)/C(=C/c2ccc(-c3ccc(S(N)(=O)=O)c(Cl)c3)o2)S1		CHEMBL396614	=	IC50	nM	570.0	CHEMBL301	Homo sapiens	IC50	uM	0.57
	1970855	CHEMBL896714	Inhibition of CDK2	B	N=C1NC(=O)/C(=C/c2ccc(-c3ccc(S(N)(=O)=O)c(C(F)(F)F)c3)o2)S1		CHEMBL233970	=	IC50	nM	610.0	CHEMBL301	Homo sapiens	IC50	uM	0.61
	1970856	CHEMBL896714	Inhibition of CDK2	B	N=C1NC(=O)/C(=C/c2ccc(-c3ccc(C(N)=O)cc3)o2)S1		CHEMBL233765	=	IC50	nM	9300.0	CHEMBL301	Homo sapiens	IC50	uM	9.3
	1970857	CHEMBL896714	Inhibition of CDK2	B	N=C1NC(=O)/C(=C/c2ccc(-c3ccc(S(=O)(=O)N4CCOCC4)cc3)o2)S1	Outside typical range	CHEMBL233763	=	IC50	nM	150000.0	CHEMBL301	Homo sapiens	IC50	uM	150.0
	1970858	CHEMBL896714	Inhibition of CDK2	B	N=C1NC(=O)/C(=C/c2ccc(-c3ccc(S(=O)(=O)N4CCNCC4)cc3)o2)S1		CHEMBL391493	=	IC50	nM	2900.0	CHEMBL301	Homo sapiens	IC50	uM	2.9
	1970859	CHEMBL896714	Inhibition of CDK2	B	CN(C)CCNS(=O)(=O)c1ccc(-c2ccc(/C=C3\SC(=N)NC3=O)o2)cc1		CHEMBL233554	=	IC50	nM	570.0	CHEMBL301	Homo sapiens	IC50	uM	0.57
	1970860	CHEMBL896714	Inhibition of CDK2	B	CNS(=O)(=O)c1ccc(-c2ccc(/C=C3\SC(=N)NC3=O)o2)cc1		CHEMBL233553	=	IC50	nM	120.0	CHEMBL301	Homo sapiens	IC50	uM	0.12
	1970861	CHEMBL896714	Inhibition of CDK2	B	N=C1NC(=O)/C(=C/c2ccc(-c3ccc(C(=O)O)cc3)o2)S1		CHEMBL233349	=	IC50	nM	47000.0	CHEMBL301	Homo sapiens	IC50	uM	47.0
	1970862	CHEMBL896714	Inhibition of CDK2	B	N=C1NC(=O)/C(=C/c2ccc(-c3ccccc3[N+](=O)[O-])o2)S1		CHEMBL396360	=	IC50	nM	19000.0	CHEMBL301	Homo sapiens	IC50	uM	19.0
	1975551	CHEMBL898639	Inhibition of CDK2/cyclin A at 1 uM	B	O=C1NC(=O)c2c1c1c3cc(Cl)ccc3[nH]c1c1cccn21		CHEMBL392052	=	Inhibition	%	69.0	CHEMBL301	Homo sapiens	Inhibition	%	69.0
	1975558	CHEMBL898639	Inhibition of CDK2/cyclin A at 1 uM	B	O=C1NC(=O)c2c1c1c3cc(Br)ccc3[nH]c1c1cccn21		CHEMBL238625	=	Inhibition	%	88.0	CHEMBL301	Homo sapiens	Inhibition	%	88.0
	1986220	CHEMBL899840	Inhibition of CDK2	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	nM	30000.0
	1989376	CHEMBL898058	Inhibition of CDK2 at 1 uM	B	CC(C)NCc1ccc(Nc2cc(-c3ccc(-c4ccc(O)cc4O)cc3)[nH]n2)cc1		CHEMBL398606	=	Inhibition	%	31.0	CHEMBL301	Homo sapiens	Inhibition	%	31.0
	2011590	CHEMBL902108	Inhibition of CDK2	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	2011597	CHEMBL902108	Inhibition of CDK2	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL241682	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	2021689	CHEMBL903565	Inhibition of human CDK2	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	IC50	nM	17782.79	CHEMBL301	Homo sapiens	Log IC50		-4.75
	2030546	CHEMBL886373	Inhibition of CDK2 by IMAP technology	B	CCNC(=O)N1CCC(Nc2ncc(C#N)c(-c3c[nH]c4cc(F)ccc34)n2)CC1		CHEMBL248370	=	IC50	nM	412.0	CHEMBL301	Homo sapiens	IC50	nM	412.0
	2030586	CHEMBL886373	Inhibition of CDK2 by IMAP technology	B	CCNC(=O)N1CCC(Nc2nccc(-c3c(-c4ccccc4)[nH]c4ccccc34)n2)CC1		CHEMBL245936	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	2030587	CHEMBL886373	Inhibition of CDK2 by IMAP technology	B	CCNC(=O)N1CCC(Nc2nccc(-c3c(C(C)C)[nH]c4ccccc34)n2)CC1		CHEMBL391794	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	2030588	CHEMBL886373	Inhibition of CDK2 by IMAP technology	B	CC1CCN(NC(=O)N2CCC(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)CC2)CC1		CHEMBL245935	=	IC50	nM	6652.0	CHEMBL301	Homo sapiens	IC50	nM	6652.0
	2030589	CHEMBL886373	Inhibition of CDK2 by IMAP technology	B	CC1CCN(C(=O)N2CCC(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)CC2)CC1		CHEMBL245733	=	IC50	nM	1895.0	CHEMBL301	Homo sapiens	IC50	nM	1895.0
	2030590	CHEMBL886373	Inhibition of CDK2 by IMAP technology	B	CN(C)CC(=O)N1CCC(Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)CC1		CHEMBL245732	=	IC50	nM	1126.0	CHEMBL301	Homo sapiens	IC50	nM	1126.0
	2030591	CHEMBL886373	Inhibition of CDK2 by IMAP technology	B	CNCC(=O)N1CCC(Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)CC1		CHEMBL393861	=	IC50	nM	2672.0	CHEMBL301	Homo sapiens	IC50	nM	2672.0
	2030592	CHEMBL886373	Inhibition of CDK2 by IMAP technology	B	CC(=O)NCC(=O)N1CCC(Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)CC1		CHEMBL245535	=	IC50	nM	551.0	CHEMBL301	Homo sapiens	IC50	nM	551.0
	2030593	CHEMBL886373	Inhibition of CDK2 by IMAP technology	B	CN1CCN(C(=O)N2CCC(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)CC2)CC1		CHEMBL245534	=	IC50	nM	5281.0	CHEMBL301	Homo sapiens	IC50	nM	5281.0
	2030594	CHEMBL886373	Inhibition of CDK2 by IMAP technology	B	CN(C)C(=O)N1CCC(Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)CC1		CHEMBL393659	=	IC50	nM	4358.0	CHEMBL301	Homo sapiens	IC50	nM	4358.0
	2030595	CHEMBL886373	Inhibition of CDK2 by IMAP technology	B	CNC(=O)CN1CCC(Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)CC1		CHEMBL245336	=	IC50	nM	123.0	CHEMBL301	Homo sapiens	IC50	nM	123.0
	2030596	CHEMBL886373	Inhibition of CDK2 by IMAP technology	B	CNC(=O)CN1CCC[C@@H](Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)C1		CHEMBL392615	=	IC50	nM	612.0	CHEMBL301	Homo sapiens	IC50	nM	612.0
	2030597	CHEMBL886373	Inhibition of CDK2 by IMAP technology	B	CCNC(=O)N1CCC[C@@H](Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)C1		CHEMBL245335	=	IC50	nM	1264.0	CHEMBL301	Homo sapiens	IC50	nM	1264.0
	2030598	CHEMBL886373	Inhibition of CDK2 by IMAP technology	B	CNC(=O)CN1CCC[C@H](Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)C1		CHEMBL245334	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	2030599	CHEMBL886373	Inhibition of CDK2 by IMAP technology	B	CCNC(=O)N1CCC[C@H](Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)C1		CHEMBL392614	=	IC50	nM	555.0	CHEMBL301	Homo sapiens	IC50	nM	555.0
	2030600	CHEMBL886373	Inhibition of CDK2 by IMAP technology	B	CCNC(=O)N1CCC(Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)C1		CHEMBL246544	=	IC50	nM	2483.0	CHEMBL301	Homo sapiens	IC50	nM	2483.0
	2030601	CHEMBL886373	Inhibition of CDK2 by IMAP technology	B	CCNC(=O)N1CCC(Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL392613	=	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	2030602	CHEMBL886373	Inhibition of CDK2 by IMAP technology	B	CCNC(=O)N1CCC(Nc2nccc(-c3cnc4ccccn34)n2)CC1		CHEMBL246543	=	IC50	nM	4219.0	CHEMBL301	Homo sapiens	IC50	nM	4219.0
	2030603	CHEMBL886373	Inhibition of CDK2 by IMAP technology	B	CCNC(=O)N1CCC(Nc2ncc(Cl)c(-n3ccc4ccccc43)n2)CC1		CHEMBL245925	=	IC50	nM	4443.0	CHEMBL301	Homo sapiens	IC50	nM	4443.0
	2030604	CHEMBL886373	Inhibition of CDK2 by IMAP technology	B	CCNC(=O)N1CCC(Nc2ncc(Cl)c(-c3cnc4ccccn34)n2)CC1		CHEMBL397531	=	IC50	nM	605.0	CHEMBL301	Homo sapiens	IC50	nM	605.0
	2030605	CHEMBL886373	Inhibition of CDK2 by IMAP technology	B	CCNC(=O)N1CCC(Nc2nccc(-c3c[nH]c4ccccc34)n2)CC1		CHEMBL245725	=	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
Not Active	2030606	CHEMBL886373	Inhibition of CDK2 by IMAP technology	B	CCNC(=O)N1CCC(Nc2ncc(C)c(-c3c[nH]c4ccccc34)n2)CC1		CHEMBL245724		Activity			CHEMBL301	Homo sapiens	Activity		
	2030607	CHEMBL886373	Inhibition of CDK2 by IMAP technology	B	CCNC(=O)N1CCC(Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)CC1		CHEMBL248176	=	IC50	nM	1517.0	CHEMBL301	Homo sapiens	IC50	nM	1517.0
	2051576	CHEMBL942717	Inhibition of CDK2	B	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	=	Ki	nM	3088.0	CHEMBL301	Homo sapiens	Ki	uM	3.088
	2073734	CHEMBL928873	Inhibition of CDK2	B	CC(=O)N1CCN(C(=O)c2cc(Sc3cnc(Nc4cccc(Br)n4)s3)ccc2C)CC1		CHEMBL254050	=	IC50	nM	490.0	CHEMBL301	Homo sapiens	IC50	uM	0.49
	2073738	CHEMBL928873	Inhibition of CDK2	B	Cc1ccc(Sc2cnc(Nc3cccc(Br)n3)s2)cc1C(=O)N1CCN(C(=O)[C@@H](C)N)CC1		CHEMBL251796	=	IC50	nM	230.0	CHEMBL301	Homo sapiens	IC50	uM	0.23
	2073739	CHEMBL928873	Inhibition of CDK2	B	Cc1ccc(Sc2cnc(Nc3cccc(Br)n3)s2)cc1C(=O)N1CCN(C(=O)[C@H](C)N)CC1		CHEMBL251795	=	IC50	nM	520.0	CHEMBL301	Homo sapiens	IC50	uM	0.52
	2073740	CHEMBL928873	Inhibition of CDK2	B	Cc1ccc(Sc2cnc(Nc3cccc(Br)n3)s2)cc1C(=O)N1CCN(C(=O)CN)CC1		CHEMBL254895	=	IC50	nM	540.0	CHEMBL301	Homo sapiens	IC50	uM	0.54
	2073741	CHEMBL928873	Inhibition of CDK2	B	CNCCN(C)C(=O)c1cc(Sc2cnc(Nc3cccc(Br)n3)s2)ccc1C		CHEMBL254269	=	IC50	nM	180.0	CHEMBL301	Homo sapiens	IC50	uM	0.18
Active	2074303	CHEMBL928948	Binding affinity to human CDK2	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2c(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)cc(O)c12		CHEMBL402915		Activity			CHEMBL301	Homo sapiens	Activity		
	2080206	CHEMBL928477	Inhibition of CDK2	B	CCN(CC)CCOc1ccc(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)cc1		CHEMBL253292	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	2081374	CHEMBL928649	Inhibition of CDK2	B	NC1CCN(Cc2ccn3ncnc(Oc4ccc(NC(=O)NC(=O)Cc5ccc(F)cc5)cc4F)c23)CC1		CHEMBL253881	>	IC50	nM	5000.0	CHEMBL301	Homo sapiens	IC50	uM	5.0
	2082441	CHEMBL929003	Inhibition of CDK2	B	O=C(Cc1ccccc1)Nc1n[nH]c2ccc([N+](=O)[O-])cc12		CHEMBL257624	=	IC50	nM	2000.0	CHEMBL301	Homo sapiens	IC50	uM	2.0
	2082442	CHEMBL929003	Inhibition of CDK2	B	O=C(Cc1ccc(-c2ccncc2)cc1)Nc1n[nH]c2ccc(N3CCCS3(=O)=O)cc12		CHEMBL254171	=	IC50	nM	30.0	CHEMBL301	Homo sapiens	IC50	uM	0.03
	2082443	CHEMBL929003	Inhibition of CDK2	B	O=C(Cc1ccc(-c2ccccc2)cc1)Nc1n[nH]c2ccc(N3CCCS3(=O)=O)cc12		CHEMBL402759	=	IC50	nM	14.0	CHEMBL301	Homo sapiens	IC50	uM	0.014
	2082444	CHEMBL929003	Inhibition of CDK2	B	O=C(Cc1ccc2ccccc2c1)Nc1n[nH]c2ccc(N3CCCS3(=O)=O)cc12		CHEMBL254979	=	IC50	nM	9.0	CHEMBL301	Homo sapiens	IC50	uM	0.009
	2082445	CHEMBL929003	Inhibition of CDK2	B	O=C(Cc1cccc2ccccc12)Nc1n[nH]c2ccc(N3CCCS3(=O)=O)cc12		CHEMBL254367	=	IC50	nM	20.0	CHEMBL301	Homo sapiens	IC50	uM	0.02
	2082446	CHEMBL929003	Inhibition of CDK2	B	CS(=O)(=O)c1ccc(CC(=O)Nc2n[nH]c3ccc(N4CCCS4(=O)=O)cc23)cc1		CHEMBL254170	=	IC50	nM	22.0	CHEMBL301	Homo sapiens	IC50	uM	0.022
	2082447	CHEMBL929003	Inhibition of CDK2	B	CSc1ccc(CC(=O)Nc2n[nH]c3ccc(N4CCCS4(=O)=O)cc23)cc1		CHEMBL415789	=	IC50	nM	10.0	CHEMBL301	Homo sapiens	IC50	uM	0.01
	2082448	CHEMBL929003	Inhibition of CDK2	B	O=C(Cc1ccc(N2CCCCC2)cc1)Nc1n[nH]c2ccc(N3CCCS3(=O)=O)cc12		CHEMBL258040	=	IC50	nM	30.0	CHEMBL301	Homo sapiens	IC50	uM	0.03
	2082449	CHEMBL929003	Inhibition of CDK2	B	CCN(CC)c1ccc(CC(=O)Nc2n[nH]c3ccc(N4CCCS4(=O)=O)cc23)cc1		CHEMBL258039	=	IC50	nM	40.0	CHEMBL301	Homo sapiens	IC50	uM	0.04
	2082450	CHEMBL929003	Inhibition of CDK2	B	CN(C)c1ccc(CC(=O)Nc2n[nH]c3ccc(N4CCCS4(=O)=O)cc23)cc1		CHEMBL257831	=	IC50	nM	10.0	CHEMBL301	Homo sapiens	IC50	uM	0.01
	2082451	CHEMBL929003	Inhibition of CDK2	B	Nc1ccc(CC(=O)Nc2n[nH]c3ccc(N4CCCS4(=O)=O)cc23)cc1		CHEMBL255932	=	IC50	nM	16.0	CHEMBL301	Homo sapiens	IC50	uM	0.016
	2082452	CHEMBL929003	Inhibition of CDK2	B	O=C(Cc1ccc(O)cc1)Nc1n[nH]c2ccc(N3CCCS3(=O)=O)cc12		CHEMBL255718	=	IC50	nM	9.0	CHEMBL301	Homo sapiens	IC50	uM	0.009
	2082453	CHEMBL929003	Inhibition of CDK2	B	Cc1ccc(CC(=O)Nc2n[nH]c3ccc(N4CCCS4(=O)=O)cc23)cc1		CHEMBL256558	=	IC50	nM	7.0	CHEMBL301	Homo sapiens	IC50	uM	0.007
	2082454	CHEMBL929003	Inhibition of CDK2	B	Cc1cccc(CC(=O)Nc2n[nH]c3ccc(N4CCCS4(=O)=O)cc23)c1		CHEMBL403605	=	IC50	nM	10.0	CHEMBL301	Homo sapiens	IC50	uM	0.01
	2082455	CHEMBL929003	Inhibition of CDK2	B	O=C(Cc1ccc(Br)cc1)Nc1n[nH]c2ccc(N3CCCS3(=O)=O)cc12		CHEMBL402370	=	IC50	nM	7.0	CHEMBL301	Homo sapiens	IC50	uM	0.007
	2082456	CHEMBL929003	Inhibition of CDK2	B	O=C(Cc1cccc(Br)c1)Nc1n[nH]c2ccc(N3CCCS3(=O)=O)cc12		CHEMBL402158	=	IC50	nM	7.0	CHEMBL301	Homo sapiens	IC50	uM	0.007
	2082457	CHEMBL929003	Inhibition of CDK2	B	O=C(Cc1ccc(Cl)cc1)Nc1n[nH]c2ccc(N3CCCS3(=O)=O)cc12		CHEMBL402157	=	IC50	nM	10.0	CHEMBL301	Homo sapiens	IC50	uM	0.01
	2082458	CHEMBL929003	Inhibition of CDK2	B	O=C(Cc1cccc(Cl)c1)Nc1n[nH]c2ccc(N3CCCS3(=O)=O)cc12		CHEMBL404504	=	IC50	nM	10.0	CHEMBL301	Homo sapiens	IC50	uM	0.01
	2082459	CHEMBL929003	Inhibition of CDK2	B	O=C(Cc1ccccc1Cl)Nc1n[nH]c2ccc(N3CCCS3(=O)=O)cc12		CHEMBL255463	=	IC50	nM	24.0	CHEMBL301	Homo sapiens	IC50	uM	0.024
	2082460	CHEMBL929003	Inhibition of CDK2	B	O=C(Cc1ccc(F)cc1)Nc1n[nH]c2ccc(N3CCCS3(=O)=O)cc12		CHEMBL255263	=	IC50	nM	20.0	CHEMBL301	Homo sapiens	IC50	uM	0.02
	2082461	CHEMBL929003	Inhibition of CDK2	B	O=C(Cc1cccc(F)c1)Nc1n[nH]c2ccc(N3CCCS3(=O)=O)cc12		CHEMBL255262	=	IC50	nM	10.0	CHEMBL301	Homo sapiens	IC50	uM	0.01
	2082462	CHEMBL929003	Inhibition of CDK2	B	O=C(Cc1ccccc1)Nc1n[nH]c2ccc(N3CCCS3(=O)=O)cc12		CHEMBL255255	=	IC50	nM	36.0	CHEMBL301	Homo sapiens	IC50	uM	0.036
	2082463	CHEMBL929003	Inhibition of CDK2	B	O=C(Cc1ccccc1)Nc1n[nH]c2ccc(N3C(=O)CNC3=O)cc12		CHEMBL258404	=	IC50	nM	2000.0	CHEMBL301	Homo sapiens	IC50	uM	2.0
	2082464	CHEMBL929003	Inhibition of CDK2	B	O=C(Cc1ccccc1)Nc1n[nH]c2ccc(N3CCCCC3=O)cc12		CHEMBL414949	=	IC50	nM	7100.0	CHEMBL301	Homo sapiens	IC50	uM	7.1
	2082465	CHEMBL929003	Inhibition of CDK2	B	O=C(Cc1ccccc1)Nc1n[nH]c2ccc(N3CCCC3=O)cc12		CHEMBL404747	=	IC50	nM	170.0	CHEMBL301	Homo sapiens	IC50	uM	0.17
	2082466	CHEMBL929003	Inhibition of CDK2	B	CCCCN(CCCC)c1ccc2[nH]nc(NC(=O)Cc3ccccc3)c2c1		CHEMBL258391	>	IC50	nM	100000.0	CHEMBL301	Homo sapiens	IC50	uM	100.0
	2082467	CHEMBL929003	Inhibition of CDK2	B	CCCN(CCC)c1ccc2[nH]nc(NC(=O)Cc3ccccc3)c2c1		CHEMBL401603	=	IC50	nM	1800.0	CHEMBL301	Homo sapiens	IC50	uM	1.8
	2082468	CHEMBL929003	Inhibition of CDK2	B	CCN(CC)c1ccc2[nH]nc(NC(=O)Cc3ccccc3)c2c1		CHEMBL402910	=	IC50	nM	200.0	CHEMBL301	Homo sapiens	IC50	uM	0.2
	2082469	CHEMBL929003	Inhibition of CDK2	B	CCNc1ccc2[nH]nc(NC(=O)Cc3ccccc3)c2c1		CHEMBL257625	=	IC50	nM	500.0	CHEMBL301	Homo sapiens	IC50	uM	0.5
	2086302	CHEMBL946928	Inhibition of CDK2	B	COc1cccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)c1		CHEMBL271271	<	IC50	nM	16000.0	CHEMBL301	Homo sapiens	IC50	uM	16.0
	2110631	CHEMBL952109	Inhibition of CDK2	B	NC(=O)c1c(NC(=O)CN2C(=O)CCC2=O)sc2c1CCC2		CHEMBL272171	<	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	2110638	CHEMBL952112	Inhibition of CDK2 by FRET assay	B	NC(=O)c1c(NC(=O)CN2C(=O)CCC2=O)sc2c1CCC2		CHEMBL272171	=	IC50	nM	7500.0	CHEMBL301	Homo sapiens	IC50	uM	7.5
	2110757	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Br)cc32)cc1		CHEMBL411491	=	IC50	nM	60.0	CHEMBL301	Homo sapiens	IC50	nM	60.0
	2110758	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL445945	=	IC50	nM	1.5	CHEMBL301	Homo sapiens	IC50	nM	1.5
	2110759	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	IC50	nM	1.6	CHEMBL301	Homo sapiens	IC50	nM	1.6
	2110760	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	IC50	nM	2.8	CHEMBL301	Homo sapiens	IC50	nM	2.8
	2110761	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL407709	=	IC50	nM	7.1	CHEMBL301	Homo sapiens	IC50	nM	7.1
	2110762	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4[nH]nnc4c32)cc1		CHEMBL271952	=	IC50	nM	9.5	CHEMBL301	Homo sapiens	IC50	nM	9.5
	2110763	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4[nH]nc(Cl)c4c32)cc1		CHEMBL269882	=	IC50	nM	2.2	CHEMBL301	Homo sapiens	IC50	nM	2.2
	2110764	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4[nH]ncc4c32)cc1		CHEMBL272833	=	IC50	nM	13.0	CHEMBL301	Homo sapiens	IC50	nM	13.0
	2110765	CHEMBL952109	Inhibition of CDK2	B	Cc1c([N+](=O)[O-])ccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272667	=	IC50	nM	4.6	CHEMBL301	Homo sapiens	IC50	nM	4.6
	2110766	CHEMBL952109	Inhibition of CDK2	B	COc1ccc2c(c1Cl)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271822	=	IC50	nM	54.0	CHEMBL301	Homo sapiens	IC50	nM	54.0
	2110767	CHEMBL952109	Inhibition of CDK2	B	Cc1ccc2c(c1Cl)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL411490	=	IC50	nM	13.0	CHEMBL301	Homo sapiens	IC50	nM	13.0
	2110768	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3cc(CO)ccc32)cc1		CHEMBL410293	=	IC50	nM	61.0	CHEMBL301	Homo sapiens	IC50	nM	61.0
	2110769	CHEMBL952109	Inhibition of CDK2	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	IC50	nM	75.0	CHEMBL301	Homo sapiens	IC50	nM	75.0
	2110770	CHEMBL952109	Inhibition of CDK2	B	CCc1ccc2c(c1)NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271182	=	IC50	nM	21.0	CHEMBL301	Homo sapiens	IC50	nM	21.0
	2110771	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cc(Br)ccc32)cc1		CHEMBL271183	=	IC50	nM	43.0	CHEMBL301	Homo sapiens	IC50	nM	43.0
	2110772	CHEMBL952109	Inhibition of CDK2	B	COc1cccc(OC)c1CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271136	=	IC50	nM	1.7	CHEMBL301	Homo sapiens	IC50	nM	1.7
	2110773	CHEMBL952109	Inhibition of CDK2	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	IC50	nM	6.8	CHEMBL301	Homo sapiens	IC50	nM	6.8
	2110774	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4cccnc4)cc32)cc1		CHEMBL271953	=	IC50	nM	2.1	CHEMBL301	Homo sapiens	IC50	nM	2.1
	2110775	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	IC50	nM	8.9	CHEMBL301	Homo sapiens	IC50	nM	8.9
	2110776	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	IC50	nM	25.0	CHEMBL301	Homo sapiens	IC50	nM	25.0
	2110777	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	IC50	nM	12.0	CHEMBL301	Homo sapiens	IC50	nM	12.0
	2110778	CHEMBL952109	Inhibition of CDK2	B	CN(C)C(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL409868	=	IC50	nM	17.0	CHEMBL301	Homo sapiens	IC50	nM	17.0
	2110779	CHEMBL952109	Inhibition of CDK2	B	NC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410883	=	IC50	nM	4.5	CHEMBL301	Homo sapiens	IC50	nM	4.5
	2110780	CHEMBL952109	Inhibition of CDK2	B	CC(C)CC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL429142	=	IC50	nM	1.9	CHEMBL301	Homo sapiens	IC50	nM	1.9
	2110781	CHEMBL952109	Inhibition of CDK2	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	nM	3.0
	2110782	CHEMBL952109	Inhibition of CDK2	B	COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL409731	=	IC50	nM	2.1	CHEMBL301	Homo sapiens	IC50	nM	2.1
	2110783	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc(C(=O)O)cc32)cc1		CHEMBL272668	=	IC50	nM	28.0	CHEMBL301	Homo sapiens	IC50	nM	28.0
	2110784	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(S(=O)(=O)O)cc32)cc1		CHEMBL412091	=	IC50	nM	15.0	CHEMBL301	Homo sapiens	IC50	nM	15.0
	2110785	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)cc1		CHEMBL272387	=	IC50	nM	43.0	CHEMBL301	Homo sapiens	IC50	nM	43.0
	2110786	CHEMBL952109	Inhibition of CDK2	B	CS(=O)(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272389	=	IC50	nM	16.0	CHEMBL301	Homo sapiens	IC50	nM	16.0
	2110787	CHEMBL952109	Inhibition of CDK2	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	IC50	nM	310.0	CHEMBL301	Homo sapiens	IC50	nM	310.0
	2110788	CHEMBL952109	Inhibition of CDK2	B	Nc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271842	=	IC50	nM	74.0	CHEMBL301	Homo sapiens	IC50	nM	74.0
	2110789	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc([N+](=O)[O-])cc32)cc1		CHEMBL411886	=	IC50	nM	15.0	CHEMBL301	Homo sapiens	IC50	nM	15.0
	2110790	CHEMBL952109	Inhibition of CDK2	B	COc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL260103	=	IC50	nM	12.0	CHEMBL301	Homo sapiens	IC50	nM	12.0
	2110791	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(O)cc32)cc1		CHEMBL409690	=	IC50	nM	10.0	CHEMBL301	Homo sapiens	IC50	nM	10.0
	2110792	CHEMBL952109	Inhibition of CDK2	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	IC50	nM	46.0	CHEMBL301	Homo sapiens	IC50	nM	46.0
	2110793	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(I)cc32)cc1		CHEMBL273060	=	IC50	nM	11.0	CHEMBL301	Homo sapiens	IC50	nM	11.0
	2110794	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(F)cc32)cc1		CHEMBL273061	=	IC50	nM	34.0	CHEMBL301	Homo sapiens	IC50	nM	34.0
	2110795	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc([N+](=O)[O-])c32)cc1		CHEMBL409619	=	IC50	nM	2400.0	CHEMBL301	Homo sapiens	IC50	nM	2400.0
	2110796	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3cccc(CO)c32)cc1		CHEMBL271137	=	IC50	nM	54.0	CHEMBL301	Homo sapiens	IC50	nM	54.0
	2110797	CHEMBL952109	Inhibition of CDK2	B	CCOC(=O)c1cccc2c1/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL408210	=	IC50	nM	8.9	CHEMBL301	Homo sapiens	IC50	nM	8.9
	2110798	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(-c4cc[nH]n4)c32)cc1		CHEMBL272684	=	IC50	nM	19.0	CHEMBL301	Homo sapiens	IC50	nM	19.0
	2110799	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccc(O)cc4)c32)cc1		CHEMBL411865	=	IC50	nM	12.0	CHEMBL301	Homo sapiens	IC50	nM	12.0
	2110800	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(/C=C/c4ccc(O)cc4)c32)cc1		CHEMBL272380	=	IC50	nM	9.3	CHEMBL301	Homo sapiens	IC50	nM	9.3
	2110801	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(OCCc4ccncc4)c32)cc1		CHEMBL272217	=	IC50	nM	21.0	CHEMBL301	Homo sapiens	IC50	nM	21.0
	2110802	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(Oc4ccccc4)c32)cc1		CHEMBL409104	=	IC50	nM	13.0	CHEMBL301	Homo sapiens	IC50	nM	13.0
	2110803	CHEMBL952109	Inhibition of CDK2	B	CC(C)Oc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271160	=	IC50	nM	3.4	CHEMBL301	Homo sapiens	IC50	nM	3.4
	2110804	CHEMBL952109	Inhibition of CDK2	B	CCOc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL411696	=	IC50	nM	93.0	CHEMBL301	Homo sapiens	IC50	nM	93.0
	2110805	CHEMBL952109	Inhibition of CDK2	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	IC50	nM	1.5	CHEMBL301	Homo sapiens	IC50	nM	1.5
	2110806	CHEMBL952109	Inhibition of CDK2	B	CC(C)Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL411224	=	IC50	nM	1.2	CHEMBL301	Homo sapiens	IC50	nM	1.2
	2110807	CHEMBL952109	Inhibition of CDK2	B	CC(C)c1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL411426	=	IC50	nM	2.5	CHEMBL301	Homo sapiens	IC50	nM	2.5
	2110808	CHEMBL952109	Inhibition of CDK2	B	CCc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL411425	=	IC50	nM	7.9	CHEMBL301	Homo sapiens	IC50	nM	7.9
	2110809	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(/N=N/c2c(O)[nH]c3cccc(I)c23)cc1		CHEMBL314397	=	IC50	nM	4.6	CHEMBL301	Homo sapiens	IC50	nM	4.6
	2110810	CHEMBL952109	Inhibition of CDK2	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccc(-c3cnco3)cc21		CHEMBL411887	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	IC50	nM	2.0
	2110811	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL270132	=	IC50	nM	2.5	CHEMBL301	Homo sapiens	IC50	nM	2.5
	2110812	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	IC50	nM	2.3	CHEMBL301	Homo sapiens	IC50	nM	2.3
	2110813	CHEMBL952109	Inhibition of CDK2	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccc(Cl)cc21		CHEMBL412097	=	IC50	nM	22.0	CHEMBL301	Homo sapiens	IC50	nM	22.0
	2110814	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	IC50	nM	43.0	CHEMBL301	Homo sapiens	IC50	nM	43.0
	2110815	CHEMBL952109	Inhibition of CDK2	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	IC50	nM	360.0	CHEMBL301	Homo sapiens	IC50	nM	360.0
	2110816	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL269850	=	IC50	nM	690.0	CHEMBL301	Homo sapiens	IC50	nM	690.0
	2110817	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccccc32)cc1		CHEMBL438721	=	IC50	nM	120.0	CHEMBL301	Homo sapiens	IC50	nM	120.0
	2110884	CHEMBL952109	Inhibition of CDK2	B	NC(=O)c1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271778	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	2110885	CHEMBL952109	Inhibition of CDK2	B	Cc1cc(Cl)cc2c1NC(=O)/C2=C\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL410517	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	2110886	CHEMBL952109	Inhibition of CDK2	B	Cc1cc(C)c2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269846	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	2110887	CHEMBL952109	Inhibition of CDK2	B	Cc1cccc2c1NC(=O)/C2=C\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL408131	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	2110888	CHEMBL952109	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cc(Oc4ccccc4)ccc32)cc1		CHEMBL272885	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	2110889	CHEMBL952109	Inhibition of CDK2	B	CC(C)(C)c1ccc2c(c1)NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271777	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	2112569	CHEMBL951022	Inhibition of CDK2 at 10 uM	B	Nc1ncnc2oc(-c3cccnc3)c(-c3ccc(NS(=O)(=O)c4ccccc4)cc3)c12		CHEMBL258081	=	Inhibition	%	27.0	CHEMBL301	Homo sapiens	Inhibition	%	27.0
	2136810	CHEMBL937647	Inhibition of Cdk2	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	>	IC50	nM	100000.0	CHEMBL301	Homo sapiens	IC50	nM	100000.0
	2137024	CHEMBL937647	Inhibition of Cdk2	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	2137179	CHEMBL937647	Inhibition of Cdk2	B	CC(C)n1cnc2c(NCc3ccccc3O)nc(NCCCO)nc21		CHEMBL419931	=	IC50	nM	80.0	CHEMBL301	Homo sapiens	IC50	nM	80.0
	2137212	CHEMBL937647	Inhibition of Cdk2	B	COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL127907	=	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
Not Evaluated	2149595	CHEMBL931292	Inhibition of human CDK2	B	NC(=O)c1c(NC(=O)C2CC2)sc2c1CCCC2		CHEMBL379367		Activity			CHEMBL301	Homo sapiens	Activity		
	2153735	CHEMBL924593	Inhibition of CDK2 at 20 uM	B	CN(C)CCOc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL409525	<	Inhibition	%	50.0	CHEMBL301	Homo sapiens	Inhibition	%	50.0
	2153770	CHEMBL924593	Inhibition of CDK2 at 20 uM	B	c1ccc(-c2nn3c(c2-c2ccnc4cc(OCCN5CCOCC5)ccc24)CCC3)nc1		CHEMBL260015	<	Inhibition	%	50.0	CHEMBL301	Homo sapiens	Inhibition	%	50.0
	2158764	CHEMBL922527	Inhibition of Cdk2	B	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	2167620	CHEMBL932340	Inhibition of CDK2	B	CS(=O)(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL445162	=	IC50	nM	17600.0	CHEMBL301	Homo sapiens	IC50	uM	17.6
	2182412	CHEMBL941311	Inhibition of human CDK2/cyclinA at 1 uM	B	CS(=O)(=O)c1cccc(CNc2nc(Nc3ccc4c(c3)CCC(=O)N4)ncc2C(F)(F)F)c1		CHEMBL514554	=	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	2182413	CHEMBL941312	Inhibition of human CDK2/cyclinE at 1 uM	B	CS(=O)(=O)c1cccc(CNc2nc(Nc3ccc4c(c3)CCC(=O)N4)ncc2C(F)(F)F)c1		CHEMBL514554	=	Inhibition	%	44.0	CHEMBL301	Homo sapiens	INH	%	44.0
	2211748	CHEMBL986935	Inhibition of Cdk2/cyclin A	B	OCCn1cnc2c(NCc3ccccc3)nc(NCc3ccc(Br)cc3)nc21		CHEMBL513336	=	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	2228669	CHEMBL1003092	Binding affinity to CDK2	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	IC50	nM	100.0	CHEMBL301	Homo sapiens	IC50	uM	0.1
	2228673	CHEMBL1003092	Binding affinity to CDK2	B	O=C(/C=C/c1ccc(O)c(O)c1)c1ccc(O)cc1O		CHEMBL128000	=	Kd	nM	100000.0	CHEMBL301	Homo sapiens	Kd	uM	100.0
	2234585	CHEMBL1003894	Inhibition of CDK2/cyclin E	B	O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL509101	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	2234721	CHEMBL997786	Inhibition of CDK2	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(-c3ccccc3)cc12)C1CC1		CHEMBL427909	=	IC50	nM	5.0	CHEMBL301	Homo sapiens	IC50	nM	5.0
	2234722	CHEMBL997786	Inhibition of CDK2	B	O=C(Nc1n[nH]c2nc(-c3cccs3)c(Br)cc12)C1CC1		CHEMBL260231	=	IC50	nM	639.0	CHEMBL301	Homo sapiens	IC50	nM	639.0
	2234723	CHEMBL997786	Inhibition of CDK2	B	O=C(Nc1n[nH]c2cc(-c3ccsc3)ccc12)C1CC1		CHEMBL260928	=	IC50	nM	484.0	CHEMBL301	Homo sapiens	IC50	nM	484.0
	2234724	CHEMBL997786	Inhibition of CDK2	B	O=C(Nc1n[nH]c2cc(-c3cccs3)ccc12)C1CC1		CHEMBL318522	=	IC50	nM	341.0	CHEMBL301	Homo sapiens	IC50	nM	341.0
	2234725	CHEMBL997786	Inhibition of CDK2	B	O=C(Nc1n[nH]c2cc(-c3ccco3)ccc12)C1CC1		CHEMBL421207	=	IC50	nM	631.0	CHEMBL301	Homo sapiens	IC50	nM	631.0
	2234726	CHEMBL997786	Inhibition of CDK2	B	O=C(Nc1n[nH]c2cc(-c3ccc[nH]3)ccc12)C1CC1		CHEMBL260929	=	IC50	nM	497.0	CHEMBL301	Homo sapiens	IC50	nM	497.0
	2234727	CHEMBL997786	Inhibition of CDK2	B	O=C(NC1=NNC2=CC=CC21)C1CC1		CHEMBL500804	=	IC50	nM	5.0	CHEMBL301	Homo sapiens	IC50	nM	5.0
	2234728	CHEMBL997786	Inhibition of CDK2	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)c(Br)c3)ccc12)C1CC1		CHEMBL260416	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	IC50	nM	2.0
	2234729	CHEMBL997786	Inhibition of CDK2	B	CCN1CCN(CCCC(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL407981	=	IC50	nM	60.0	CHEMBL301	Homo sapiens	IC50	nM	60.0
	2234730	CHEMBL997786	Inhibition of CDK2	B	O=C(Nc1n[nH]c2nc(-c3ccccc3)c(Br)cc12)C1CC1		CHEMBL259270	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	2234731	CHEMBL997786	Inhibition of CDK2	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	IC50	nM	5.0	CHEMBL301	Homo sapiens	IC50	nM	5.0
	2234732	CHEMBL997786	Inhibition of CDK2	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CCN(Cc2ccccc2)C1		CHEMBL317657	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	2234733	CHEMBL997786	Inhibition of CDK2	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1		CHEMBL101747	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	2234734	CHEMBL997786	Inhibition of CDK2	B	O=C(Nc1n[nH]c2nc(-c3nccs3)c(Br)cc12)C1CCCC1		CHEMBL406644	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	2234735	CHEMBL997786	Inhibition of CDK2	B	O=C(Nc1n[nH]c2nc(-c3nccs3)c(Br)cc12)C1CC1		CHEMBL261690	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	2234736	CHEMBL997786	Inhibition of CDK2	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	2234737	CHEMBL997786	Inhibition of CDK2	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	2234738	CHEMBL997786	Inhibition of CDK2	B	O=C(Nc1n[nH]c2nc(-c3cccs3)c(Br)cc12)C1CCCC1		CHEMBL407980	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	2234739	CHEMBL997786	Inhibition of CDK2	B	O=C(Nc1n[nH]c2cc(-c3ccoc3)ccc12)C1CC1		CHEMBL260243	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	2234740	CHEMBL997786	Inhibition of CDK2	B	O=C(Nc1n[nH]c2cc(-c3cccc(F)c3)ccc12)C1CC1		CHEMBL261660	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	2234741	CHEMBL997786	Inhibition of CDK2	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	2234742	CHEMBL997786	Inhibition of CDK2	B	O=C(Nc1n[nH]c2cc(-c3ccc4[nH]ccc4c3)ccc12)C1CC1		CHEMBL261659	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	2234743	CHEMBL997786	Inhibition of CDK2	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	2238321	CHEMBL976288	Inhibition of CDK2/CyclinA	B	Cc1cccc(C)c1/C=C/n1cnc2c(Nc3ccc(P(C)(C)=O)cc3)ncnc21		CHEMBL488840	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	2239381	CHEMBL980070	Inhibition of CDK2/cyclinA assessed as residual enzyme activity at 1 uM	B	Cc1ncc(NC(=O)c2cc(NC(=O)c3cccc(C(F)(F)F)c3)ccc2Cl)s1		CHEMBL462132	=	Activity	%	95.0	CHEMBL301	Homo sapiens	Activity	%	95.0
	2239730	CHEMBL996959	Inhibition of CDK2/cyclin A at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)ccc2n1CCCc1nnn[nH]1		CHEMBL471329	=	Inhibition	%	27.0	CHEMBL301	Homo sapiens	INH	%	27.0
	2239758	CHEMBL996959	Inhibition of CDK2/cyclin A at 10 uM	B	CS(=O)(=O)NC(=O)CCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL460940	=	Inhibition	%	54.0	CHEMBL301	Homo sapiens	INH	%	54.0
	2239786	CHEMBL996959	Inhibition of CDK2/cyclin A at 10 uM	B	CN(C)CCNC(=O)CCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL462011	=	Inhibition	%	48.0	CHEMBL301	Homo sapiens	INH	%	48.0
	2239814	CHEMBL996959	Inhibition of CDK2/cyclin A at 10 uM	B	CNCCCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL508541	=	Inhibition	%	10.0	CHEMBL301	Homo sapiens	INH	%	10.0
	2239842	CHEMBL996959	Inhibition of CDK2/cyclin A at 10 uM	B	CNCCCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4)cc21)C(=O)NC3=O		CHEMBL455192	=	Inhibition	%	14.0	CHEMBL301	Homo sapiens	INH	%	14.0
	2239870	CHEMBL996959	Inhibition of CDK2/cyclin A at 10 uM	B	O=C1NC(=O)c2c1c(-c1c(Cl)cccc1Cl)cc1c2c2cc(O)ccc2n1CCCO		CHEMBL471163	=	Inhibition	%	4.0	CHEMBL301	Homo sapiens	INH	%	4.0
	2239897	CHEMBL996959	Inhibition of CDK2/cyclin A at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)ccc2n1CCCO		CHEMBL411662	=	Inhibition	%	38.0	CHEMBL301	Homo sapiens	INH	%	38.0
	2239925	CHEMBL996959	Inhibition of CDK2/cyclin A at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	=	Inhibition	%	38.0	CHEMBL301	Homo sapiens	INH	%	38.0
Not Active	2240595	CHEMBL972658	Inhibition of CDK2 at 30 uM	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(C(F)(F)F)cc3)c2)n1		CHEMBL523411		Activity			CHEMBL301	Homo sapiens	Activity		
	2248192	CHEMBL1012675	Inhibition of CDK2 at 5 uM	B	O=C1NC(=O)/C(=C/c2cccc(C(F)(F)F)c2)S1		CHEMBL183906	=	Inhibition	%	0.0	CHEMBL301	Homo sapiens	INH	%	0.0
	2248222	CHEMBL1012675	Inhibition of CDK2 at 5 uM	B	CCCOc1ccc(/C=C2\SC(=O)NC2=O)cc1		CHEMBL84558	=	Inhibition	%	-2.0	CHEMBL301	Homo sapiens	INH	%	-2.0
	2250919	CHEMBL1022463	Inhibition of Cdk2A	B	Nc1nccc(-c2cc3c([nH]2)[C@@H](CCF)CNC3=O)n1		CHEMBL524266	=	IC50	nM	138.0	CHEMBL301	Homo sapiens	IC50	uM	0.138
	2251264	CHEMBL1009883	Inhibition of CDK2/Cyclin A	B	c1ccc2[nH]c(-c3cc[nH]n3)nc2c1		CHEMBL495758	=	IC50	nM	28000.0	CHEMBL301	Homo sapiens	IC50	uM	28.0
	2251265	CHEMBL1009883	Inhibition of CDK2/Cyclin A	B	CC(=O)Nc1c[nH]nc1-c1nc2ccccc2[nH]1		CHEMBL504155	=	IC50	nM	990.0	CHEMBL301	Homo sapiens	IC50	uM	0.99
	2251266	CHEMBL1009883	Inhibition of CDK2/Cyclin A	B	O=C(Nc1c[nH]nc1-c1nc2ccccc2[nH]1)c1ccccc1		CHEMBL522891	=	IC50	nM	52.0	CHEMBL301	Homo sapiens	IC50	uM	0.052
	2251267	CHEMBL1009883	Inhibition of CDK2/Cyclin A	B	O=C(Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1)c1ccccc1		CHEMBL496569	=	IC50	nM	140.0	CHEMBL301	Homo sapiens	IC50	uM	0.14
	2251268	CHEMBL1009883	Inhibition of CDK2/Cyclin A	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1ccc(F)cc1		CHEMBL522563	=	IC50	nM	530.0	CHEMBL301	Homo sapiens	IC50	uM	0.53
Not Determined	2251269	CHEMBL1009883	Inhibition of CDK2/Cyclin A	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		IC50			CHEMBL301	Homo sapiens	IC50		
	2251270	CHEMBL1009883	Inhibition of CDK2/Cyclin A	B	O=C(Nc1ccccc1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1		CHEMBL458420	=	IC50	nM	1800.0	CHEMBL301	Homo sapiens	IC50	uM	1.8
	2251271	CHEMBL1009883	Inhibition of CDK2/Cyclin A	B	O=C(Nc1ccccc1F)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1		CHEMBL516003	=	IC50	nM	230.0	CHEMBL301	Homo sapiens	IC50	uM	0.23
	2251272	CHEMBL1009883	Inhibition of CDK2/Cyclin A	B	O=C(Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1)Nc1c(F)cccc1F		CHEMBL458421	=	IC50	nM	160.0	CHEMBL301	Homo sapiens	IC50	uM	0.16
	2251273	CHEMBL1009883	Inhibition of CDK2/Cyclin A	B	O=C(Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1)NC1CCCCC1		CHEMBL496754	=	IC50	nM	1200.0	CHEMBL301	Homo sapiens	IC50	uM	1.2
	2251274	CHEMBL1009883	Inhibition of CDK2/Cyclin A	B	O=C(Nc1cccnc1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1		CHEMBL523923	=	IC50	nM	160.0	CHEMBL301	Homo sapiens	IC50	uM	0.16
Not Determined	2251275	CHEMBL1009883	Inhibition of CDK2/Cyclin A	B	O=C(Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1)NC1CCOCC1		CHEMBL522214		IC50			CHEMBL301	Homo sapiens	IC50		
	2251505	CHEMBL998564	Inhibition of CDK2	B	Cc1nnc(-c2ccc(-c3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)c(C)c2)o1		CHEMBL497350	>	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	2251514	CHEMBL998564	Inhibition of CDK2	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1-c1ccc2ccncc2c1		CHEMBL521887	>	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	2251523	CHEMBL998564	Inhibition of CDK2	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1-c1ccc2c(N)noc2c1		CHEMBL497353	>	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	2251532	CHEMBL998564	Inhibition of CDK2	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1-c1ccc(-c2csc(N)n2)cc1		CHEMBL496129	>	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	2254056	CHEMBL1002021	Inhibition of human CDK2 by HTRF assay	B	c1cnn2ncc(-c3ccnc(NC4CC4)n3)c2c1		CHEMBL525194	=	IC50	nM	120.0	CHEMBL301	Homo sapiens	IC50	uM	0.12
	2254057	CHEMBL1002021	Inhibition of human CDK2 by HTRF assay	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	uM	1.0
	2254058	CHEMBL1002021	Inhibition of human CDK2 by HTRF assay	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	uM	1.0
	2254059	CHEMBL1002021	Inhibition of human CDK2 by HTRF assay	B	c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359554	=	IC50	nM	8.0	CHEMBL301	Homo sapiens	IC50	uM	0.008
	2254060	CHEMBL1002021	Inhibition of human CDK2 by HTRF assay	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	IC50	nM	4.0	CHEMBL301	Homo sapiens	IC50	uM	0.004
	2254061	CHEMBL1002021	Inhibition of human CDK2 by HTRF assay	B	CCN(CC)Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL513354	=	IC50	nM	50.0	CHEMBL301	Homo sapiens	IC50	uM	0.05
	2254062	CHEMBL1002021	Inhibition of human CDK2 by HTRF assay	B	O=[N+]([O-])c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL188938	=	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	uM	0.003
	2254063	CHEMBL1002021	Inhibition of human CDK2 by HTRF assay	B	O=[N+]([O-])c1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL526110	=	IC50	nM	0.3	CHEMBL301	Homo sapiens	IC50	uM	0.0003
	2254064	CHEMBL1002021	Inhibition of human CDK2 by HTRF assay	B	N#Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359794	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	IC50	uM	0.002
	2254065	CHEMBL1002021	Inhibition of human CDK2 by HTRF assay	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	IC50	uM	0.002
	2254066	CHEMBL1002021	Inhibition of human CDK2 by HTRF assay	B	c1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(-c2cocn2)c1		CHEMBL497564	=	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	uM	0.003
	2254067	CHEMBL1002021	Inhibition of human CDK2 by HTRF assay	B	NC(=O)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL523735	=	IC50	nM	16.0	CHEMBL301	Homo sapiens	IC50	uM	0.016
	2254068	CHEMBL1002021	Inhibition of human CDK2 by HTRF assay	B	O=C(O)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL524059	=	IC50	nM	40.0	CHEMBL301	Homo sapiens	IC50	uM	0.04
	2254069	CHEMBL1002021	Inhibition of human CDK2 by HTRF assay	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	IC50	nM	40.0	CHEMBL301	Homo sapiens	IC50	uM	0.04
	2254070	CHEMBL1002021	Inhibition of human CDK2 by HTRF assay	B	CCN(CC)CCNC(=O)c1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495751	=	IC50	nM	40.0	CHEMBL301	Homo sapiens	IC50	uM	0.04
	2254071	CHEMBL1002021	Inhibition of human CDK2 by HTRF assay	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5nc(-c6ccc(F)cc6)ccc45)n3)cc2)CC1		CHEMBL522718	>	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	2254072	CHEMBL1002021	Inhibition of human CDK2 by HTRF assay	B	CC(C)Oc1ccc2c(-c3ccnc(Nc4ccc(N5CCN(C)CC5)cc4)n3)cnn2n1		CHEMBL496162	=	IC50	nM	230.0	CHEMBL301	Homo sapiens	IC50	uM	0.23
	2254073	CHEMBL1002021	Inhibition of human CDK2 by HTRF assay	B	CN(C)CC(O)COc1ccc(Nc2nccc(-c3cnn4nc(N5CCOCC5)ccc34)n2)cc1		CHEMBL521871	=	IC50	nM	450.0	CHEMBL301	Homo sapiens	IC50	uM	0.45
	2254075	CHEMBL1002021	Inhibition of human CDK2 by HTRF assay	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2)CC1		CHEMBL495545	=	IC50	nM	100.0	CHEMBL301	Homo sapiens	IC50	uM	0.1
	2254177	CHEMBL1002041	Inhibition of CDK2/cyclin A by IMAP florescence polarization assay	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	IC50	nM	38.0	CHEMBL301	Homo sapiens	IC50	uM	0.038
	2254178	CHEMBL1002041	Inhibition of CDK2/cyclin A by IMAP florescence polarization assay	B	CC(C)(C)c1cnc(CSc2cnc(NCC3CCNCC3)s2)o1		CHEMBL524629	=	IC50	nM	229.0	CHEMBL301	Homo sapiens	IC50	uM	0.229
	2254179	CHEMBL1002041	Inhibition of CDK2/cyclin A by IMAP florescence polarization assay	B	CC(C)(C)c1cnc(CSc2cnc(NCC3CCCCC3)s2)o1		CHEMBL495754	=	IC50	nM	168.0	CHEMBL301	Homo sapiens	IC50	uM	0.168
	2254180	CHEMBL1002041	Inhibition of CDK2/cyclin A by IMAP florescence polarization assay	B	CC(C)(C)c1cnc(CSc2cnc(N[C@H]3CC[C@H](N)CC3)s2)o1		CHEMBL496567	=	IC50	nM	20.0	CHEMBL301	Homo sapiens	IC50	uM	0.02
	2254181	CHEMBL1002041	Inhibition of CDK2/cyclin A by IMAP florescence polarization assay	B	CC(C)(C)c1cnc(CSc2cnc(N[C@H]3CC[C@@H](N)CC3)s2)o1		CHEMBL496568	=	IC50	nM	503.0	CHEMBL301	Homo sapiens	IC50	uM	0.503
	2254182	CHEMBL1002041	Inhibition of CDK2/cyclin A by IMAP florescence polarization assay	B	CC(C)(C)c1cnc(CSc2cnc(N[C@H]3CC[C@H](O)CC3)s2)o1		CHEMBL495557	=	IC50	nM	7.0	CHEMBL301	Homo sapiens	IC50	uM	0.007
	2254183	CHEMBL1002041	Inhibition of CDK2/cyclin A by IMAP florescence polarization assay	B	CC(C)(C)c1cnc(CSc2cnc(NC3CCCC(N)C3)s2)o1		CHEMBL505474	=	IC50	nM	158.0	CHEMBL301	Homo sapiens	IC50	uM	0.158
	2254184	CHEMBL1002041	Inhibition of CDK2/cyclin A by IMAP florescence polarization assay	B	CC(C)(C)c1cnc(CSc2cnc(NC3CCCC(O)C3)s2)o1		CHEMBL495558	=	IC50	nM	28.0	CHEMBL301	Homo sapiens	IC50	uM	0.028
	2254185	CHEMBL1002041	Inhibition of CDK2/cyclin A by IMAP florescence polarization assay	B	CC(C)(C)c1cnc(CSc2cnc(NC3CCCCC3)s2)o1		CHEMBL496785	=	IC50	nM	9.0	CHEMBL301	Homo sapiens	IC50	uM	0.009
	2254186	CHEMBL1002041	Inhibition of CDK2/cyclin A by IMAP florescence polarization assay	B	CC(C)(C)c1cnc(CSc2cnc(NC3CCNCC3)s2)o1		CHEMBL509772	=	IC50	nM	538.0	CHEMBL301	Homo sapiens	IC50	uM	0.538
	2254187	CHEMBL1002041	Inhibition of CDK2/cyclin A by IMAP florescence polarization assay	B	CC(C)(C)c1cnc(CSc2cnc(N)s2)o1		CHEMBL507536	=	IC50	nM	690.0	CHEMBL301	Homo sapiens	IC50	uM	0.69
	2256995	CHEMBL1001228	Inhibition of CDK2/CyclinA	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	2261798	CHEMBL998564	Inhibition of CDK2	B	Cc1ccc(C(=O)Nc2cccc(N3CCOCC3)c2)cc1-c1ccc2c(C3CCNCC3)noc2c1		CHEMBL485285	>	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	2261808	CHEMBL998564	Inhibition of CDK2	B	Cc1nnc(-c2ccc(-c3cc(C(=O)Nc4cccc(N5CCOCC5)c4)ccc3C)c(C)c2)o1		CHEMBL523559	>	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	2261818	CHEMBL998564	Inhibition of CDK2	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc2c(C3CCNCC3)noc2c1		CHEMBL485286	>	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	2261830	CHEMBL998564	Inhibition of CDK2	B	Cc1nnc(-c2ccc(-c3cc(NC(=O)c4ccnc(N5CCCC5)c4)ccc3C)c(C)c2)o1		CHEMBL495729	>	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	2261842	CHEMBL998564	Inhibition of CDK2	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(C3CCNCC3)noc2c1		CHEMBL497563	>	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	2261854	CHEMBL998564	Inhibition of CDK2	B	Cc1nnc(-c2ccc(-c3cc(C(=O)NC4CC4)ccc3C)c(C)c2)o1		CHEMBL522579	>	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	2261865	CHEMBL998564	Inhibition of CDK2	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(=O)n(CC3CC3)nnc2c1		CHEMBL521734	>	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	2261876	CHEMBL998564	Inhibition of CDK2	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2ccncc2c1		CHEMBL526639	>	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	2261888	CHEMBL998564	Inhibition of CDK2	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649	>	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	2268425	CHEMBL960829	Inhibition of Cdk2 at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL522629	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2268769	CHEMBL960829	Inhibition of Cdk2 at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3c[nH]cn3)nn2)c1		CHEMBL464619	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2268770	CHEMBL960829	Inhibition of Cdk2 at 10 uM	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccnc4ccccc34)nn2)c1		CHEMBL517021	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2268771	CHEMBL960829	Inhibition of Cdk2 at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3ccnc4ccccc34)nn2)c1		CHEMBL516635	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2268772	CHEMBL960829	Inhibition of Cdk2 at 10 uM	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccc4c(c3)OCO4)nn2)c1		CHEMBL460959	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2268773	CHEMBL960829	Inhibition of Cdk2 at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3ccc4c(c3)OCO4)nn2)c1		CHEMBL460958	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2268774	CHEMBL960829	Inhibition of Cdk2 at 10 uM	B	Fc1ccc(CNc2ccccc2-c2cn(-c3cccc(Cl)c3)nn2)cc1F		CHEMBL460751	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2268775	CHEMBL960829	Inhibition of Cdk2 at 10 uM	B	Cc1cc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)ccc1C(F)(F)F		CHEMBL454403	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2268776	CHEMBL960829	Inhibition of Cdk2 at 10 uM	B	Cc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1C(F)(F)F		CHEMBL523320	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2268777	CHEMBL960829	Inhibition of Cdk2 at 10 uM	B	Clc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1Cl		CHEMBL491872	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2268778	CHEMBL960829	Inhibition of Cdk2 at 10 uM	B	FC(F)(F)c1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1Cl		CHEMBL491871	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2268779	CHEMBL960829	Inhibition of Cdk2 at 10 uM	B	FC(F)(F)c1cc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)ccc1Cl		CHEMBL522133	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2268780	CHEMBL960829	Inhibition of Cdk2 at 10 uM	B	c1ccc(-c2cn(-c3ccc4[nH]ncc4c3)nn2)c(NCc2ccncc2)c1		CHEMBL516645	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2268781	CHEMBL960829	Inhibition of Cdk2 at 10 uM	B	c1ccc(-c2cn(-c3ccc4ccccc4n3)nn2)c(NCc2ccncc2)c1		CHEMBL461605	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2268782	CHEMBL960829	Inhibition of Cdk2 at 10 uM	B	CC(C)(C)c1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1		CHEMBL461392	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2268783	CHEMBL960829	Inhibition of Cdk2 at 10 uM	B	CC(C)(C)c1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL461391	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2268784	CHEMBL960829	Inhibition of Cdk2 at 10 uM	B	CC(C)c1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL518652	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2268785	CHEMBL960829	Inhibition of Cdk2 at 10 uM	B	FC(F)(F)Oc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1		CHEMBL491681	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2268786	CHEMBL960829	Inhibition of Cdk2 at 10 uM	B	FC(F)(F)c1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1		CHEMBL522304	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2268787	CHEMBL960829	Inhibition of Cdk2 at 10 uM	B	Clc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1		CHEMBL491680	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2268788	CHEMBL960829	Inhibition of Cdk2 at 10 uM	B	FC(F)(F)Oc1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL491502	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2268789	CHEMBL960829	Inhibition of Cdk2 at 10 uM	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccccn3)nn2)c1		CHEMBL523133	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2268790	CHEMBL960829	Inhibition of Cdk2 at 10 uM	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3cccnc3)nn2)c1		CHEMBL490969	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2268791	CHEMBL960829	Inhibition of Cdk2 at 10 uM	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL490968	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2268792	CHEMBL960829	Inhibition of Cdk2 at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3ccccn3)nn2)c1		CHEMBL523301	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2268793	CHEMBL960829	Inhibition of Cdk2 at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3cccnc3)nn2)c1		CHEMBL489329	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2270554	CHEMBL964944	Inhibition of CDK2 by virtual HTS assay	B	O=C(NC(=S)Nc1ccc(O)c(-c2nc3ccccc3s2)c1)c1ccc([N+](=O)[O-])cc1		CHEMBL460746	=	IC50	nM	700.0	CHEMBL301	Homo sapiens	IC50	uM	0.7
	2279724	CHEMBL960138	Inhibition of CDK2 at 10 uM	B	CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1		CHEMBL493937	>	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	2280924	CHEMBL960930	Inhibition of Cdk2	B	CNc1nc2oc(-c3ccccc3)nc2c2c1ncn2C		CHEMBL493940	=	IC50	nM	16000.0	CHEMBL301	Homo sapiens	IC50	uM	16.0
	2280925	CHEMBL960930	Inhibition of Cdk2	B	CNc1nc2c(nc(-c3ccccc3)n2C)c2c1ncn2C		CHEMBL522011	=	IC50	nM	23000.0	CHEMBL301	Homo sapiens	IC50	uM	23.0
	2280926	CHEMBL960930	Inhibition of Cdk2	B	CNc1nc2sc(-c3cccc(CNC(C)=O)c3)nc2c2c1ncn2C		CHEMBL454973	=	IC50	nM	31000.0	CHEMBL301	Homo sapiens	IC50	uM	31.0
	2296611	CHEMBL1034204	Inhibition of Cdk2/cyclinA	B	O=C1N=C(NCc2ccccc2)S/C1=C\c1c[nH]c2ncccc12		CHEMBL484990	<	IC50	nM	50.0	CHEMBL301	Homo sapiens	IC50	nM	50.0
Not Active	2301927	CHEMBL949874	Inhibition of CDK2/cyclin A up to 100 uM	B	CN(C)c1ncnc2c1ncn2CC(=O)c1c[nH]c2ccccc12		CHEMBL519977		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	2301950	CHEMBL949874	Inhibition of CDK2/cyclin A up to 100 uM	B	COc1ncnc2ncn(CC(=O)c3ccccc3)c12		CHEMBL483271		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	2301974	CHEMBL949874	Inhibition of CDK2/cyclin A up to 100 uM	B	COc1ncnc2c1ncn2CC(=O)c1ccccc1		CHEMBL519976		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	2301998	CHEMBL949874	Inhibition of CDK2/cyclin A up to 100 uM	B	Nc1ncnc2c1ncn2CC(=O)c1cccnc1		CHEMBL501256		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	2302022	CHEMBL949874	Inhibition of CDK2/cyclin A up to 100 uM	B	Nc1ncnc2c1ncn2CC(=O)c1ccccn1		CHEMBL504135		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	2302046	CHEMBL949874	Inhibition of CDK2/cyclin A up to 100 uM	B	Nc1ncnc2ncn(CC(=O)c3ccccc3)c12		CHEMBL485444		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	2302070	CHEMBL949874	Inhibition of CDK2/cyclin A up to 100 uM	B	Nc1ncnc2c1ncn2CC(=O)c1ccccc1		CHEMBL520515		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	2302094	CHEMBL949874	Inhibition of CDK2/cyclin A up to 100 uM	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	2302118	CHEMBL949874	Inhibition of CDK2/cyclin A up to 100 uM	B	Nc1ncnc2c1ncn2CC(=O)c1c[nH]c2ccccc12		CHEMBL521155		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	2302170	CHEMBL950839	Inhibition of CDK2/cyclin A at 10 uM	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	2341420	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(N3CCN(C(=O)Cc4c[nH]c5ccccc45)CC3)ncn2)c1		CHEMBL524898	=	Inhibition	%	10.0	CHEMBL301	Homo sapiens	INH	%	10.0
	2341460	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL501459	=	Inhibition	%	24.0	CHEMBL301	Homo sapiens	INH	%	24.0
	2341501	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	Nc1nc(N2CCOCC2)cc(N2CCC(C(=O)NCCc3ccc(O)cc3)CC2)n1		CHEMBL501728	=	Inhibition	%	5.0	CHEMBL301	Homo sapiens	INH	%	5.0
	2341542	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	O=C(NCCc1ccc(O)cc1)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL499617	=	Inhibition	%	8.0	CHEMBL301	Homo sapiens	INH	%	8.0
	2341583	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2cc(Nc3cccc(Br)c3)ncn2)CC1		CHEMBL501200	=	Inhibition	%	5.0	CHEMBL301	Homo sapiens	INH	%	5.0
	2341624	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)N[C@@H](CO)c2ccccc2)n1		CHEMBL525070	=	Inhibition	%	1.0	CHEMBL301	Homo sapiens	INH	%	1.0
	2341665	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)NCCc2cccc(I)c2)n1		CHEMBL501463	=	Inhibition	%	5.0	CHEMBL301	Homo sapiens	INH	%	5.0
	2341706	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	O=C(NC1Cc2ccccc2C1)c1cccc(Nc2ccnc(N3CCN(c4ccccc4)CC3)n2)c1		CHEMBL499624	=	Inhibition	%	2.0	CHEMBL301	Homo sapiens	INH	%	2.0
	2341747	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)ncn2)c1		CHEMBL502826	=	Inhibition	%	1.0	CHEMBL301	Homo sapiens	INH	%	1.0
	2341788	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3ccc(CC(=O)Nc4ccc5ncsc5c4)cc3)ncn2)c1		CHEMBL502827	=	Inhibition	%	4.0	CHEMBL301	Homo sapiens	INH	%	4.0
	2341829	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	COc1ccc(NC(=O)Cc2ccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)cc2)cn1		CHEMBL526914	=	Inhibition	%	6.0	CHEMBL301	Homo sapiens	INH	%	6.0
	2341870	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)n2)c1		CHEMBL501471	=	Inhibition	%	1.0	CHEMBL301	Homo sapiens	INH	%	1.0
	2341911	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	O=C(NCc1cccnc1)c1cccc(-c2ccc(Nc3ccc4ncsc4c3)nn2)c1		CHEMBL501182	=	Inhibition	%	0.0	CHEMBL301	Homo sapiens	INH	%	0.0
	2341952	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N4CCCC5CCCCC54)c3)ncn2)c1		CHEMBL499606	=	Inhibition	%	4.0	CHEMBL301	Homo sapiens	INH	%	4.0
	2341993	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)nc(N)n2)c1		CHEMBL499865	=	Inhibition	%	1.0	CHEMBL301	Homo sapiens	INH	%	1.0
	2342034	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)n2)c1		CHEMBL499866	=	Inhibition	%	28.0	CHEMBL301	Homo sapiens	INH	%	28.0
	2342075	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	O=C(CN1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1)Nc1cc(F)ccc1F		CHEMBL520451	=	Inhibition	%	9.0	CHEMBL301	Homo sapiens	INH	%	9.0
	2342116	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	O=C(NCc1ccncc1)c1cccc(Nc2cc(Nc3cccc(Br)c3)ncn2)c1		CHEMBL482513	=	Inhibition	%	15.0	CHEMBL301	Homo sapiens	INH	%	15.0
	2342157	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2cc(Nc3cccc(C(=O)N(CC(C)O)CC(C)O)c3)ncn2)c1		CHEMBL483318	=	Inhibition	%	3.0	CHEMBL301	Homo sapiens	INH	%	3.0
	2342198	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCCCn4ccnc4)c3)ncn2)c1		CHEMBL520971	=	Inhibition	%	12.0	CHEMBL301	Homo sapiens	INH	%	12.0
	2342239	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)ncn2)c1		CHEMBL521469	=	Inhibition	%	21.0	CHEMBL301	Homo sapiens	INH	%	21.0
	2342280	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	CC(=O)N1CCN(C(=O)c2cccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)c2)CC1		CHEMBL521478	=	Inhibition	%	9.0	CHEMBL301	Homo sapiens	INH	%	9.0
	2342321	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCc4ccncc4)c3)ncn2)c1		CHEMBL483506	=	Inhibition	%	20.0	CHEMBL301	Homo sapiens	INH	%	20.0
	2342362	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	CN(CCc1ccccn1)C(=O)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL483507	=	Inhibition	%	12.0	CHEMBL301	Homo sapiens	INH	%	12.0
	2342403	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(C(=O)NCCCn4ccnc4)c3)nc(N)n2)c1		CHEMBL520980	=	Inhibition	%	2.0	CHEMBL301	Homo sapiens	INH	%	2.0
	2342444	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)[C@@H]1CCCN1c1cc(Nc2cccc(OC)c2)nc(N)n1		CHEMBL519962	=	Inhibition	%	7.0	CHEMBL301	Homo sapiens	INH	%	7.0
	2342485	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCN3CCCCC3)nc(N)n2)c1		CHEMBL526526	=	Inhibition	%	12.0	CHEMBL301	Homo sapiens	INH	%	12.0
	2342526	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	O=C(COc1ccccc1)N1CCN(c2nccc(Nc3ccc4ncsc4c3)n2)CC1		CHEMBL482488	=	Inhibition	%	8.0	CHEMBL301	Homo sapiens	INH	%	8.0
	2342799	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	O=C(NC[C@@H]1CCCO1)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL500661	=	Inhibition	%	38.0	CHEMBL301	Homo sapiens	INH	%	38.0
	2342832	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	Clc1ccc2sc(CN3CCN(c4ncnc5c4CN(Cc4ccccc4)CC5)CC3)cc2c1		CHEMBL483710	=	Inhibition	%	16.0	CHEMBL301	Homo sapiens	INH	%	16.0
	2343107	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccccc2)cc(N2CCC(C(=O)NCCc3ccccn3)CC2)n1		CHEMBL521002	=	Inhibition	%	17.0	CHEMBL301	Homo sapiens	INH	%	17.0
	2343131	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	CC(=O)CCCCC(=O)N1CCN(c2nccc(Oc3cccc(C)c3)n2)CC1		CHEMBL484713	=	Inhibition	%	10.0	CHEMBL301	Homo sapiens	INH	%	10.0
	2343153	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	COc1ccc(-c2noc(CN3CCN(c4cc(Nc5cccc(O)c5)ncn4)CC3)n2)cc1		CHEMBL483715	=	Inhibition	%	6.0	CHEMBL301	Homo sapiens	INH	%	6.0
	2343177	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCN(CC(=O)Nc4cccc5c4CCCC5)CC3)n2)c1		CHEMBL520512	=	Inhibition	%	4.0	CHEMBL301	Homo sapiens	INH	%	4.0
	2343201	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(N3CCN(CC(=O)Nc4nc(-c5ccccc5)cs4)CC3)ncn2)c1		CHEMBL519534	=	Inhibition	%	2.0	CHEMBL301	Homo sapiens	INH	%	2.0
	2343225	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc(C(=O)NCCc3ccncc3)cc2)cc(N2CCOCC2)n1		CHEMBL485524	=	Inhibition	%	2.0	CHEMBL301	Homo sapiens	INH	%	2.0
	2343249	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc3c2CN(C(=O)c2cc(C)n(C)c2C)CC3)c1		CHEMBL519146	=	Inhibition	%	8.0	CHEMBL301	Homo sapiens	INH	%	8.0
	2343273	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	Cc1cc(C(=O)N2CCN(c3ncnc4c3CN(Cc3ccccc3)CC4)CC2)c(C)n1C		CHEMBL482710	=	Inhibition	%	3.0	CHEMBL301	Homo sapiens	INH	%	3.0
	2343634	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	Nc1nc(N2CCOCC2)cc(N2CCC(C(=O)NCc3cccs3)CC2)n1		CHEMBL482910	=	Inhibition	%	14.0	CHEMBL301	Homo sapiens	INH	%	14.0
	2343695	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCc3ccc(O)cc3)nc(N)n2)c1		CHEMBL483518	=	Inhibition	%	3.0	CHEMBL301	Homo sapiens	INH	%	3.0
	2343716	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCC[C@H]3C(=O)NCc3cccnc3)n2)c1		CHEMBL482717	=	Inhibition	%	8.0	CHEMBL301	Homo sapiens	INH	%	8.0
	2343738	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	COC(=O)C(CO)NC(=O)[C@@H]1CCCN1c1nccc(Oc2cccc(C)c2)n1		CHEMBL519310	=	Inhibition	%	6.0	CHEMBL301	Homo sapiens	INH	%	6.0
	2343760	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCN(C(=O)c4c(C)noc4C)CC3)n2)c1		CHEMBL482721	=	Inhibition	%	2.0	CHEMBL301	Homo sapiens	INH	%	2.0
	2343782	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)C1CCN(c2cc(N3CCOCC3)nc(N)n2)CC1		CHEMBL519311	=	Inhibition	%	8.0	CHEMBL301	Homo sapiens	INH	%	8.0
	2343804	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCC[C@H]3C(=O)NCCCn3ccnc3)n2)c1		CHEMBL482722	=	Inhibition	%	3.0	CHEMBL301	Homo sapiens	INH	%	3.0
	2343825	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1		CHEMBL446637	=	Inhibition	%	0.0	CHEMBL301	Homo sapiens	INH	%	0.0
	2343847	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	CN(C)c1ccc(C(=O)N2CCN(c3ncnc4c3CN(Cc3ccccc3)CC4)CC2)c2ccccc12		CHEMBL520331	=	Inhibition	%	5.0	CHEMBL301	Homo sapiens	INH	%	5.0
	2343869	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2ncnc3c2CN(C(=O)c2ccc(N(C)C)c4ccccc24)CC3)c1		CHEMBL484324	=	Inhibition	%	24.0	CHEMBL301	Homo sapiens	INH	%	24.0
	2343888	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)C1CCCN1c1cc(Nc2cccc(Br)c2)ncn1		CHEMBL484521	=	Inhibition	%	4.0	CHEMBL301	Homo sapiens	INH	%	4.0
	2343913	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL519349	=	Inhibition	%	0.0	CHEMBL301	Homo sapiens	INH	%	0.0
	2343935	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL521000	=	Inhibition	%	9.0	CHEMBL301	Homo sapiens	INH	%	9.0
	2343956	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	O=C(C1CCN(c2nccc(Nc3ccccc3)n2)CC1)N1CC[C@@H](O)C1		CHEMBL484706	=	Inhibition	%	5.0	CHEMBL301	Homo sapiens	INH	%	5.0
	2343978	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(CC(C)C)CC(C)C)c3)ncn2)c1		CHEMBL484707	=	Inhibition	%	6.0	CHEMBL301	Homo sapiens	INH	%	6.0
	2344000	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	CN(CCc1ccccn1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL521479	=	Inhibition	%	5.0	CHEMBL301	Homo sapiens	INH	%	5.0
	2344023	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	CN(CCCn1ccnc1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL519658	=	Inhibition	%	24.0	CHEMBL301	Homo sapiens	INH	%	24.0
	2344731	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(CN2CCN(c3cc(N(C)c4cccc(C)c4)ncn3)CC2)c1		CHEMBL446087	=	Inhibition	%	0.0	CHEMBL301	Homo sapiens	INH	%	0.0
	2344753	CHEMBL953380	Inhibition of CDK2 at 10 uM by HTRF assay relative to control	B	Cc1ccc(CN2CCN(c3nccc(C(C#N)c4ccccn4)n3)CC2)cc1		CHEMBL521145	=	Inhibition	%	7.0	CHEMBL301	Homo sapiens	INH	%	7.0
	2350840	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	CN1CCN(c2ccc(N/C=C3\C(=O)NC(=O)c4ccccc43)cc2)CC1		CHEMBL482678	>	IC50	nM	28000.0	CHEMBL301	Homo sapiens	IC50	uM	28.0
	2350841	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	CN1CCN(c2ccc(N/C=C3\C(=O)NC(=O)c4ccc(C#Cc5ccccc5)cc43)cc2)CC1		CHEMBL487737	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350842	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	CN1CCN(c2ccc(N/C=C3\C(=O)NC(=O)c4ccc(-c5ccc(C=O)cc5)cc43)cc2)CC1		CHEMBL487531	=	IC50	nM	7700.0	CHEMBL301	Homo sapiens	IC50	uM	7.7
	2350843	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	CN1CCN(c2ccc(N/C=C3\C(=O)NC(=O)c4ccc(-c5ccsc5)cc43)cc2)CC1		CHEMBL486091	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350844	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	CN1CCN(c2ccc(N/C=C3\C(=O)NC(=O)c4ccc(-c5ccoc5)cc43)cc2)CC1		CHEMBL487328	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350845	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	CN1CCN(c2ccc(N/C=C3\C(=O)NC(=O)c4ccc(-c5ccco5)cc43)cc2)CC1		CHEMBL487327	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350846	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	CN1CCN(c2ccc(N/C=C3\C(=O)NC(=O)c4ccc(-c5ccccc5)cc43)cc2)CC1		CHEMBL487326	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350847	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	CN1CCN(c2ccc(N/C=C3\C(=O)NC(=O)c4ccc(N5CCCCC5)cc43)cc2)CC1		CHEMBL485892	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350848	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	CC(=O)Nc1ccc2c(c1)/C(=C/Nc1ccc(N3CCN(C)CC3)cc1)C(=O)NC2=O		CHEMBL487731	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350849	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	CN1CCN(c2ccc(N/C=C3\C(=O)NC(=O)c4ccc(-n5cccc5)cc43)cc2)CC1		CHEMBL487730	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350850	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	CN1CCN(c2ccc(N/C=C3\C(=O)NC(=O)c4ccc(C(=O)N(C)C)cc43)cc2)CC1		CHEMBL487526	=	IC50	nM	47000.0	CHEMBL301	Homo sapiens	IC50	uM	47.0
	2350851	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	CN1CCN(c2ccc(N/C=C3\C(=O)NC(=O)c4ccc(I)cc43)cc2)CC1		CHEMBL488955	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350852	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	CN1CCN(c2ccc(N/C=C3\C(=O)NC(=O)c4ccc([N+](=O)[O-])cc43)cc2)CC1		CHEMBL488342	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350853	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	CN1CCN(c2ccc(N/C=C3\C(=O)NC(=O)c4ccc(Br)cc43)cc2)CC1		CHEMBL486286	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350854	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	CN1CCN(c2ccc(N/C=C3\C(=O)NC(=O)c4cc(Br)ccc43)cc2)CC1		CHEMBL486285	=	IC50	nM	47000.0	CHEMBL301	Homo sapiens	IC50	uM	47.0
	2350855	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccccc2/C1=C/Nc1ccc(CN2CCCCC2)cc1		CHEMBL486284	=	IC50	nM	19600.0	CHEMBL301	Homo sapiens	IC50	uM	19.6
	2350856	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccccc2/C1=C/Nc1ccc(CN2CCOCC2)cc1		CHEMBL482883	=	IC50	nM	21000.0	CHEMBL301	Homo sapiens	IC50	uM	21.0
	2350857	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccccc2/C1=C/Nc1ccc(N2CCOCC2)cc1		CHEMBL482679	>	IC50	nM	29000.0	CHEMBL301	Homo sapiens	IC50	uM	29.0
	2350858	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccc(Br)cc2/C1=C/Nc1ccc(CN2CCCCC2)cc1		CHEMBL407095	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350859	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	CN1CCN(c2cnc(N/C=C3\C(=O)NC(=O)c4ccc(-c5ccoc5)cc43)cn2)CC1		CHEMBL521459	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350860	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	CN1CCN(c2ncc(N/C=C3\C(=O)NC(=O)c4ccc(-c5ccoc5)cc43)cn2)CC1		CHEMBL483081	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350861	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	CN1CCN(c2ccc(N/C=C3\C(=O)NC(=O)c4ccc(-c5ccoc5)cc43)cc2F)CC1		CHEMBL488562	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350862	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	CN1CCN(c2ccc(N/C=C3\C(=O)NC(=O)c4ccc(-c5ccoc5)cc43)nn2)CC1		CHEMBL530335	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350863	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	CN1CCN(c2ccc(N/C=C3\C(=O)NC(=O)c4ccc(-c5ccoc5)cc43)cn2)CC1		CHEMBL486497	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350864	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	CN1CCN(c2ccc(N/C=C3\C(=O)NC(=O)c4ccc(-c5ccoc5)cc43)nc2)CC1		CHEMBL515949	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350865	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	C[C@H]1CN(C)[C@H](C)CN1c1ccc(N/C=C2\C(=O)NC(=O)c3ccc(I)cc32)cc1		CHEMBL477077	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350866	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	CC1CN(c2ccc(N/C=C3\C(=O)NC(=O)c4ccc(I)cc43)cc2)CCN1C		CHEMBL476907	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350867	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	C[C@H]1CN(c2ccc(N/C=C3\C(=O)NC(=O)c4ccc(I)cc43)cc2)C[C@@H](C)N1C		CHEMBL477073	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350868	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	C[C@H]1CN(c2ccc(N/C=C3\C(=O)NC(=O)c4ccc(I)cc43)cc2)C[C@@H](C)N1		CHEMBL483728	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350869	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	CN1CC2CC1CN2c1ccc(N/C=C2\C(=O)NC(=O)c3ccc(I)cc32)cc1		CHEMBL488128	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350870	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	N#Cc1ccc2c(c1)/C(=C/Nc1ccc(CN3CCCCC3)cc1)C(=O)NC2=O		CHEMBL483535	=	IC50	nM	26500.0	CHEMBL301	Homo sapiens	IC50	uM	26.5
	2350871	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccc(-c3ccc(Oc4ccccc4)cc3)cc2/C1=C\Nc1ccc(CN2CCCCC2)cc1		CHEMBL489655	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350872	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	COc1ccc(-c2ccc3c(c2)/C(=C/Nc2ccc(CN4CCCCC4)cc2)C(=O)NC3=O)cc1		CHEMBL483530	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350873	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	COc1cccc(-c2ccc3c(c2)/C(=C/Nc2ccc(CN4CCCCC4)cc2)C(=O)NC3=O)c1		CHEMBL482919	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350874	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccc(-c3ccc(O)cc3)cc2/C1=C/Nc1ccc(CN2CCCCC2)cc1		CHEMBL482918	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350875	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccc(-c3cccc(O)c3)cc2/C1=C/Nc1ccc(CN2CCCCC2)cc1		CHEMBL520458	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350876	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccc(-c3ccc(Cl)cc3)cc2/C1=C/Nc1ccc(CN2CCCCC2)cc1		CHEMBL483514	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350877	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccc(-c3ccc(F)cc3)cc2/C1=C/Nc1ccc(CN2CCCCC2)cc1		CHEMBL486712	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350878	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccc(-c3ccsc3)cc2/C1=C/Nc1ccc(CN2CCCCC2)cc1		CHEMBL486711	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350879	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccc(-c3cccnc3)cc2/C1=C/Nc1ccc(CN2CCCCC2)cc1		CHEMBL488349	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350880	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccc(-c3ccoc3)cc2/C1=C/Nc1ccc(CN2CCCCC2)cc1		CHEMBL260864	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350881	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccc(-c3ccccc3)cc2/C1=C/Nc1ccc(CN2CCCCC2)cc1		CHEMBL487521	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350882	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccc(Nc3ccccc3)cc2/C1=C/Nc1ccc(CN2CCCCC2)cc1		CHEMBL409861	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350883	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	CN1CCN(c2ccc3c(c2)/C(=C/Nc2ccc(CN4CCCCC4)cc2)C(=O)NC3=O)CC1		CHEMBL485878	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350884	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccc(N3CCOCC3)cc2/C1=C/Nc1ccc(CN2CCCCC2)cc1		CHEMBL485877	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350885	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccc(N3CCCCC3)cc2/C1=C/Nc1ccc(CN2CCCCC2)cc1		CHEMBL488549	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350886	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	CC(=O)Nc1ccc2c(c1)/C(=C/Nc1ccc(CN3CCCCC3)cc1)C(=O)NC2=O		CHEMBL488548	=	IC50	nM	8100.0	CHEMBL301	Homo sapiens	IC50	uM	8.1
	2350887	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccc(-n3cccc3)cc2/C1=C/Nc1ccc(CN2CCCCC2)cc1		CHEMBL529661	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350888	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	CN(C)C(=O)c1ccc2c(c1)/C(=C/Nc1ccc(CN3CCCCC3)cc1)C(=O)NC2=O		CHEMBL486487	=	IC50	nM	39800.0	CHEMBL301	Homo sapiens	IC50	uM	39.8
	2350889	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccc(I)cc2/C1=C/Nc1ccc(CN2CCCCC2)cc1		CHEMBL486302	=	IC50	nM	20400.0	CHEMBL301	Homo sapiens	IC50	uM	20.4
	2350890	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccc([N+](=O)[O-])cc2/C1=C/Nc1ccc(CN2CCCCC2)cc1		CHEMBL520864	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350891	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	COc1ccc2c(c1)/C(=C/Nc1ccc(CN3CCCCC3)cc1)C(=O)NC2=O		CHEMBL484288	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2350892	CHEMBL964737	Inhibition of CDK2/cyclin E expressed in Sf9 cells-baculovirus system assessed as retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccc(Cl)cc2/C1=C/Nc1ccc(CN2CCCCC2)cc1		CHEMBL486301	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2356961	CHEMBL958258	Inhibition of CDK2 at 1 uM relative to control	B	Cc1ccn(-c2cccc(C(F)(F)F)c2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL504805	=	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	2396065	CHEMBL1006304	Inhibition of CDK2/Cyclin A at 1 uM relative to control	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)Nc2cccc(NC(C)=O)c2)cc1		CHEMBL515560	=	Inhibition	%	48.0	CHEMBL301	Homo sapiens	INH	%	48.0
	2396792	CHEMBL945310	Inhibition of CDK2	B	Cc1cc(C)cc(Nc2nccc(-c3nc(C)c(C(=O)N[C@H](C)CO)s3)n2)c1		CHEMBL473229	>	Ki	nM	3330.0	CHEMBL301	Homo sapiens	Ki	uM	3.33
	2396793	CHEMBL945310	Inhibition of CDK2	B	Cc1cc(C)cc(Nc2nccc(-c3nc(C)c(C(=O)N[C@@H](C)CO)s3)n2)c1		CHEMBL512172	>	Ki	nM	3330.0	CHEMBL301	Homo sapiens	Ki	uM	3.33
	2396794	CHEMBL945310	Inhibition of CDK2	B	OCCCOc1cc(Nc2nccc(-c3nccs3)n2)cc(C(F)(F)F)c1		CHEMBL475254	>	Ki	nM	5000.0	CHEMBL301	Homo sapiens	Ki	uM	5.0
	2396795	CHEMBL945310	Inhibition of CDK2	B	Oc1cc(Nc2nccc(-c3nccs3)n2)cc(C(F)(F)F)c1		CHEMBL470175	=	Ki	nM	1652.0	CHEMBL301	Homo sapiens	Ki	uM	1.652
	2396796	CHEMBL945310	Inhibition of CDK2	B	Cc1cc(Nc2nccc(-c3nc(CO)cs3)n2)cc(C(F)(F)F)c1		CHEMBL485731	=	Ki	nM	1500.0	CHEMBL301	Homo sapiens	Ki	uM	1.5
	2396797	CHEMBL945310	Inhibition of CDK2	B	COc1cc(Nc2nccc(-c3ncc(C)s3)n2)cc(C(F)(F)F)c1		CHEMBL451450	>	Ki	nM	2500.0	CHEMBL301	Homo sapiens	Ki	uM	2.5
	2396798	CHEMBL945310	Inhibition of CDK2	B	OCc1csc(-c2ccnc(Nc3cc(O)cc(C(F)(F)F)c3)n2)n1		CHEMBL485730	=	Ki	nM	1500.0	CHEMBL301	Homo sapiens	Ki	uM	1.5
	2396799	CHEMBL945310	Inhibition of CDK2	B	COc1cc(Nc2nccc(-c3nc(CO)cs3)n2)cc(C(F)(F)F)c1		CHEMBL486751	>	Ki	nM	2500.0	CHEMBL301	Homo sapiens	Ki	uM	2.5
	2396800	CHEMBL945310	Inhibition of CDK2	B	Cc1cc(Nc2nccc(-c3nc(C)c(CCO)s3)n2)cc(C(F)(F)F)c1		CHEMBL475249	>	Ki	nM	2500.0	CHEMBL301	Homo sapiens	Ki	uM	2.5
	2396801	CHEMBL945310	Inhibition of CDK2	B	Cc1cc(C)cc(Nc2nccc(-c3nc(C)c(CCO)s3)n2)c1		CHEMBL471727	>	Ki	nM	2270.0	CHEMBL301	Homo sapiens	Ki	uM	2.27
	2396802	CHEMBL945310	Inhibition of CDK2	B	Cc1cc(C)cc(Nc2nccc(-c3nc(CO)cs3)n2)c1		CHEMBL511811	=	Ki	nM	2400.0	CHEMBL301	Homo sapiens	Ki	uM	2.4
	2396803	CHEMBL945310	Inhibition of CDK2	B	Cc1cc(C)cc(Nc2nccc(-c3ncc(CO)s3)n2)c1		CHEMBL511670	>	Ki	nM	2500.0	CHEMBL301	Homo sapiens	Ki	uM	2.5
	2396804	CHEMBL945310	Inhibition of CDK2	B	Cc1cc(C)cc(Nc2nccc(-c3nc(C)cs3)n2)c1		CHEMBL453217	=	Ki	nM	100.0	CHEMBL301	Homo sapiens	Ki	uM	0.1
	2396805	CHEMBL945310	Inhibition of CDK2	B	Cc1cc(C)cc(Nc2nccc(-c3ncc(C)s3)n2)c1		CHEMBL470780	=	Ki	nM	1100.0	CHEMBL301	Homo sapiens	Ki	uM	1.1
	2396806	CHEMBL945310	Inhibition of CDK2	B	Cc1ccc(C)c(Nc2nccc(-c3nccs3)n2)c1		CHEMBL475570	>	Ki	nM	5000.0	CHEMBL301	Homo sapiens	Ki	uM	5.0
	2396807	CHEMBL945310	Inhibition of CDK2	B	Cc1cccc(Nc2nccc(-c3nccs3)n2)c1		CHEMBL471819	=	Ki	nM	2452.0	CHEMBL301	Homo sapiens	Ki	uM	2.452
	2396808	CHEMBL945310	Inhibition of CDK2	B	COc1cc(Nc2nccc(-c3nccs3)n2)cc(OC)c1		CHEMBL472478	>	Ki	nM	5000.0	CHEMBL301	Homo sapiens	Ki	uM	5.0
	2396809	CHEMBL945310	Inhibition of CDK2	B	Cc1cc(Nc2nccc(-c3nccs3)n2)cc(C(F)(F)F)c1		CHEMBL471776	>	Ki	nM	5000.0	CHEMBL301	Homo sapiens	Ki	uM	5.0
	2396810	CHEMBL945310	Inhibition of CDK2	B	COc1cc(Nc2nccc(-c3nccs3)n2)cc(C(F)(F)F)c1		CHEMBL512319	>	Ki	nM	5000.0	CHEMBL301	Homo sapiens	Ki	uM	5.0
	2396811	CHEMBL945310	Inhibition of CDK2	B	Cc1cc(C)cc(Nc2nccc(-c3nccs3)n2)c1		CHEMBL509161	>	Ki	nM	5000.0	CHEMBL301	Homo sapiens	Ki	uM	5.0
	2400769	CHEMBL942204	Inhibition of CDK2/cyclin A	B	COc1cc(Nc2ncc3c(C)nc(-c4ccccc4)n3n2)cc(OC)c1OC		CHEMBL519715	=	IC50	nM	230.0	CHEMBL301	Homo sapiens	IC50	uM	0.23
	2401986	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccc(I)cc2/C1=C/NCc1ccn(-c2ccoc2)c(=O)c1		CHEMBL490451	=	IC50	nM	2600.0	CHEMBL301	Homo sapiens	IC50	uM	2.6
	2401989	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccc(I)cc2/C1=C/NCc1ccn(-c2ccccc2)c(=O)c1		CHEMBL490251	=	IC50	nM	41500.0	CHEMBL301	Homo sapiens	IC50	uM	41.5
	2401992	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccc(Br)cc2/C1=C/NCc1cc[nH]c(=O)c1		CHEMBL449818	=	IC50	nM	2700.0	CHEMBL301	Homo sapiens	IC50	uM	2.7
	2401995	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	COc1coc(CN/C=C2\C(=O)NC(=O)c3ccc(Br)cc32)cc1=O		CHEMBL489030	=	IC50	nM	16900.0	CHEMBL301	Homo sapiens	IC50	uM	16.9
	2401998	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	COc1cc(CN/C=C2\C(=O)NC(=O)c3ccc(Br)cc32)ccn1		CHEMBL490241	=	IC50	nM	6100.0	CHEMBL301	Homo sapiens	IC50	uM	6.1
	2402003	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccc(C3CCCC3)cc2/C1=C/NCc1cc(O)c(-c2ccoc2)cn1		CHEMBL490240	=	IC50	nM	1300.0	CHEMBL301	Homo sapiens	IC50	uM	1.3
	2402008	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	CC(C)(C)c1ccc2c(c1)/C(=C/NCc1cc(O)c(-c3ccoc3)cn1)C(=O)NC2=O		CHEMBL489629	=	IC50	nM	1900.0	CHEMBL301	Homo sapiens	IC50	uM	1.9
	2402013	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccc(I)cc2/C1=C/NCc1cc(O)c(-c2ccoc2)cn1		CHEMBL521922	=	IC50	nM	2300.0	CHEMBL301	Homo sapiens	IC50	uM	2.3
	2402018	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	CC(C)(C)c1ccc2c(c1)/C(=C/NCc1cc(O)c(-c3ccccc3)cn1)C(=O)NC2=O		CHEMBL514678	=	IC50	nM	2600.0	CHEMBL301	Homo sapiens	IC50	uM	2.6
	2402023	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	CCCOc1cnc(CN/C=C2\C(=O)NC(=O)c3ccc(C4CCCC4)cc32)cc1O		CHEMBL477259	=	IC50	nM	1200.0	CHEMBL301	Homo sapiens	IC50	uM	1.2
	2402028	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	CCCOc1cnc(CN/C=C2\C(=O)NC(=O)c3ccc(C(C)(C)C)cc32)cc1O		CHEMBL515631	=	IC50	nM	960.0	CHEMBL301	Homo sapiens	IC50	uM	0.96
	2402033	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	CCCOc1cnc(CN/C=C2\C(=O)NC(=O)c3ccc(I)cc32)cc1O		CHEMBL477064	=	IC50	nM	1600.0	CHEMBL301	Homo sapiens	IC50	uM	1.6
	2402038	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	COc1cnc(CN/C=C2\C(=O)NC(=O)c3ccc(I)cc32)cc1O		CHEMBL477063	=	IC50	nM	500.0	CHEMBL301	Homo sapiens	IC50	uM	0.5
	2402043	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	CCCOc1ccc(CN/C=C2\C(=O)NC(=O)c3ccc(I)cc32)nc1O		CHEMBL477863	=	IC50	nM	700.0	CHEMBL301	Homo sapiens	IC50	uM	0.7
	2402048	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	COc1cnc(CN/C=C2\C(=O)NC(=O)c3ccc(I)cc32)nc1O		CHEMBL477862	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2402053	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	CCCOc1ccc(CN/C=C2\C(=O)NC(=O)c3ccc(I)cc32)cc1O		CHEMBL477861	=	IC50	nM	2600.0	CHEMBL301	Homo sapiens	IC50	uM	2.6
	2402058	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccc(I)cc2/C1=C/NCc1ccc(-c2ccncc2)c(O)c1		CHEMBL477860	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2402063	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccc(I)cc2/C1=C/NCc1ccc(-c2cccnc2)c(O)c1		CHEMBL452447	=	IC50	nM	3600.0	CHEMBL301	Homo sapiens	IC50	uM	3.6
	2402068	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccc(I)cc2/C1=C/NCc1ccc(-c2ccccn2)c(O)c1		CHEMBL451298	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2402073	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccc(I)cc2/C1=C/NCc1ccc(-c2ccoc2)c(O)c1		CHEMBL504547	=	IC50	nM	4700.0	CHEMBL301	Homo sapiens	IC50	uM	4.7
	2402078	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccc(I)cc2/C1=C/NCc1ccc(-c2ccco2)c(O)c1		CHEMBL477877	=	IC50	nM	8400.0	CHEMBL301	Homo sapiens	IC50	uM	8.4
	2402083	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccc(I)cc2/C1=C/NCc1ccc(-c2ccccc2)c(O)c1		CHEMBL478488	=	IC50	nM	15100.0	CHEMBL301	Homo sapiens	IC50	uM	15.1
	2402088	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	Cc1ccc(CN/C=C2\C(=O)NC(=O)c3ccc(I)cc32)cc1O		CHEMBL478487	=	IC50	nM	13600.0	CHEMBL301	Homo sapiens	IC50	uM	13.6
	2402091	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	Nc1ccc(CN/C=C2\C(=O)NC(=O)c3ccc(Br)cc32)cc1O		CHEMBL502651	=	IC50	nM	6700.0	CHEMBL301	Homo sapiens	IC50	uM	6.7
	2402094	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	COc1cc(CN/C=C2\C(=O)NC(=O)c3ccc(Br)cc32)cc(O)c1OC		CHEMBL484477	<	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2402097	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	CCOc1ccc(CN/C=C2\C(=O)NC(=O)c3ccc(Br)cc32)cc1O		CHEMBL484274	=	IC50	nM	45500.0	CHEMBL301	Homo sapiens	IC50	uM	45.5
	2402100	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	COCCOc1ccc(CN/C=C2\C(=O)NC(=O)c3ccc(Br)cc32)cc1O		CHEMBL485503	<	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2402103	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	CCCOc1ccc(CN/C=C2\C(=O)NC(=O)c3ccc(Br)cc32)cc1O		CHEMBL485502	<	IC50	nM	34500.0	CHEMBL301	Homo sapiens	IC50	uM	34.5
	2402106	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccc(Br)cc2/C1=C/NCc1ccc(O)c(O)c1		CHEMBL520020	<	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2402109	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	COc1ccc(CN(C)/C=C2\C(=O)NC(=O)c3ccc(Br)cc32)cc1O		CHEMBL490053	=	IC50	nM	44400.0	CHEMBL301	Homo sapiens	IC50	uM	44.4
	2402112	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	COc1ccc(C(C)N/C=C2\C(=O)NC(=O)c3ccc(Br)cc32)cc1O		CHEMBL489854	<	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2402115	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	COc1ccc(CN/C=C2\C(=O)NC(=O)c3ccc(-c4ccccc4)cc32)cc1O		CHEMBL523780	<	IC50	nM	25900.0	CHEMBL301	Homo sapiens	IC50	uM	25.9
	2402118	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	COc1ccc(CN/C=C2\C(=O)NC(=O)c3ccc(-c4ccoc4)cc32)cc1O		CHEMBL489853	=	IC50	nM	1100.0	CHEMBL301	Homo sapiens	IC50	uM	1.1
	2402121	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	COc1ccc(CN/C=C2\C(=O)NC(=O)c3ccc(-c4ccsc4)cc32)cc1O		CHEMBL489646	=	IC50	nM	18300.0	CHEMBL301	Homo sapiens	IC50	uM	18.3
	2402124	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	COc1ccc(CN/C=C2\C(=O)NC(=O)c3ccc(-n4cccc4)cc32)cc1O		CHEMBL489445	=	IC50	nM	3100.0	CHEMBL301	Homo sapiens	IC50	uM	3.1
	2402127	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	COc1ccc2c(c1)/C(=C/NCc1ccc(OC)c(O)c1)C(=O)NC2=O		CHEMBL489246	=	IC50	nM	2900.0	CHEMBL301	Homo sapiens	IC50	uM	2.9
	2402132	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	COc1ccc(CN/C=C2\C(=O)NC(=O)c3ccc(I)cc32)cc1O		CHEMBL489245	=	IC50	nM	870.0	CHEMBL301	Homo sapiens	IC50	uM	0.87
	2402135	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	COc1ccc(CN/C=C2\C(=O)NC(=O)c3ccc(Br)cc32)cc1O		CHEMBL489244	<	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2402138	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	COc1ccc(CN/C=C2\C(=O)NC(=O)c3cccc(Br)c32)cc1O		CHEMBL489039	=	IC50	nM	3100.0	CHEMBL301	Homo sapiens	IC50	uM	3.1
	2402141	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	COc1ccc(CN/C=C2\C(=O)NC(=O)c3ccc(Cl)cc32)cc1O		CHEMBL489631	<	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2402144	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	COc1ccc(CN/C=C2\C(=O)NC(=O)c3ccc(F)cc32)cc1O		CHEMBL489432	=	IC50	nM	6600.0	CHEMBL301	Homo sapiens	IC50	uM	6.6
	2402148	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	COc1ccc(CN/C=C2\C(=O)NC(=O)c3ccccc32)cc1O		CHEMBL489430	=	IC50	nM	6900.0	CHEMBL301	Homo sapiens	IC50	uM	6.9
	2402151	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccccc2/C1=C/NCc1cccc(O)c1		CHEMBL447758	=	IC50	nM	16900.0	CHEMBL301	Homo sapiens	IC50	uM	16.9
	2402154	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccccc2/C1=C/NCc1ccc(O)cc1		CHEMBL489627	=	IC50	nM	17300.0	CHEMBL301	Homo sapiens	IC50	uM	17.3
	2402157	CHEMBL981028	Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation	B	O=C1NC(=O)c2ccccc2/C1=C/NCc1ccc(O)c(O)c1		CHEMBL450383	=	IC50	nM	12500.0	CHEMBL301	Homo sapiens	IC50	uM	12.5
	2402873	CHEMBL963375	Inhibition of CDK2/Cyclin E	B	Cn1cc(C2=C(c3coc4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL301138	=	IC50	nM	1410.0	CHEMBL301	Homo sapiens	IC50	nM	1410.0
	2402874	CHEMBL963375	Inhibition of CDK2/Cyclin E	B	Cn1cc(C2=C(c3coc4cc(CO)ccc34)C(=O)NC2=O)c2cc(F)ccc21		CHEMBL477038	=	IC50	nM	237.0	CHEMBL301	Homo sapiens	IC50	nM	237.0
	2402875	CHEMBL963375	Inhibition of CDK2/Cyclin E	B	Cn1cc(C2=C(c3coc4cc(CO)ccc34)C(=O)NC2=O)c2cc(F)c(Cl)cc21		CHEMBL522590	=	IC50	nM	11700.0	CHEMBL301	Homo sapiens	IC50	nM	11700.0
	2402876	CHEMBL963375	Inhibition of CDK2/Cyclin E	B	COc1cccc2c(C3=C(c4cn(C)c5cc(Cl)c(F)cc45)C(=O)NC3=O)coc12		CHEMBL522760	=	IC50	nM	99000.0	CHEMBL301	Homo sapiens	IC50	nM	99000.0
	2402877	CHEMBL963375	Inhibition of CDK2/Cyclin E	B	COc1cccc2c(C3=C(c4cn(C)c5ccc(Br)cc45)C(=O)NC3=O)coc12		CHEMBL505673	=	IC50	nM	1160.0	CHEMBL301	Homo sapiens	IC50	nM	1160.0
	2402878	CHEMBL963375	Inhibition of CDK2/Cyclin E	B	Cn1cc(C2=C(c3coc4cc(CO)ccc34)C(=O)NC2=O)c2cc(Br)ccc21		CHEMBL489833	=	IC50	nM	337.0	CHEMBL301	Homo sapiens	IC50	nM	337.0
	2402879	CHEMBL963375	Inhibition of CDK2/Cyclin E	B	Cn1cc(C2=C(c3coc4ccc(F)cc34)C(=O)NC2=O)c2cc(Cl)ccc21		CHEMBL523113	=	IC50	nM	1840.0	CHEMBL301	Homo sapiens	IC50	nM	1840.0
	2402880	CHEMBL963375	Inhibition of CDK2/Cyclin E	B	Cn1cc(C2=C(c3coc4ccccc34)C(=O)NC2=O)c2cc(I)ccc21		CHEMBL522751	=	IC50	nM	1070.0	CHEMBL301	Homo sapiens	IC50	nM	1070.0
	2402881	CHEMBL963375	Inhibition of CDK2/Cyclin E	B	Cn1cc(C2=C(c3coc4ccccc34)C(=O)NC2=O)c2cc(C3CC3)ccc21		CHEMBL491064	=	IC50	nM	32000.0	CHEMBL301	Homo sapiens	IC50	nM	32000.0
	2402882	CHEMBL963375	Inhibition of CDK2/Cyclin E	B	Cn1cc(C2=C(c3coc4ccccc34)C(=O)NC2=O)c2cccc(CO)c21		CHEMBL522464	=	IC50	nM	149.0	CHEMBL301	Homo sapiens	IC50	nM	149.0
	2402883	CHEMBL963375	Inhibition of CDK2/Cyclin E	B	Cn1cc(C2=C(c3coc4cc(CO)ccc34)C(=O)NC2=O)c2cccc(CO)c21		CHEMBL491447	=	IC50	nM	27.0	CHEMBL301	Homo sapiens	IC50	nM	27.0
	2402884	CHEMBL963375	Inhibition of CDK2/Cyclin E	B	COCc1cccc2c(C3=C(c4coc5ccccc45)C(=O)NC3=O)cn(C)c12		CHEMBL491647	=	IC50	nM	3880.0	CHEMBL301	Homo sapiens	IC50	nM	3880.0
	2402885	CHEMBL963375	Inhibition of CDK2/Cyclin E	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	3.8	CHEMBL301	Homo sapiens	IC50	nM	3.8
	2418049	CHEMBL1019607	Inhibition of CDK2/cyclin A at 1 uM	B	C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1c(ccc([C@H]3C[C@@H](N(C)C)[C@H](O)[C@@H](C)O3)c1O)C2=O		CHEMBL2216825	=	Inhibition	%	0.0	CHEMBL301	Homo sapiens	INH	%	0.0
	2418836	CHEMBL963378	Inhibition of CDK2/Cyclin A	B	Cn1cc(C2=C(c3coc4cc(CO)ccc34)C(=O)NC2=O)c2cc(F)c(Cl)cc21		CHEMBL522590	=	IC50	nM	10600.0	CHEMBL301	Homo sapiens	IC50	uM	10.6
	2418852	CHEMBL963378	Inhibition of CDK2/Cyclin A	B	COc1cccc2c(C3=C(c4cn(C)c5cc(Cl)c(F)cc45)C(=O)NC3=O)coc12		CHEMBL522760	=	IC50	nM	27200.0	CHEMBL301	Homo sapiens	IC50	uM	27.2
	2418868	CHEMBL963378	Inhibition of CDK2/Cyclin A	B	Cn1cc(C2=C(c3coc4cc(CO)ccc34)C(=O)NC2=O)c2cc(Br)ccc21		CHEMBL489833	=	IC50	nM	550.0	CHEMBL301	Homo sapiens	IC50	uM	0.55
	2418884	CHEMBL963378	Inhibition of CDK2/Cyclin A	B	COCc1cccc2c(C3=C(c4coc5ccccc45)C(=O)NC3=O)cn(C)c12		CHEMBL491647	=	IC50	nM	4090.0	CHEMBL301	Homo sapiens	IC50	uM	4.09
	2418900	CHEMBL963378	Inhibition of CDK2/Cyclin A	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.4	CHEMBL301	Homo sapiens	IC50	uM	0.0014
	2418917	CHEMBL963378	Inhibition of CDK2/Cyclin A	B	COc1cccc2c(C3=C(c4cn(C)c5cc(I)c(F)cc45)C(=O)NC3=O)coc12		CHEMBL523435	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	nM	50000.0
	2418918	CHEMBL963375	Inhibition of CDK2/Cyclin E	B	COc1cccc2c(C3=C(c4cn(C)c5cc(I)c(F)cc45)C(=O)NC3=O)coc12		CHEMBL523435	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	nM	50000.0
	2420215	CHEMBL994306	Inhibition of human cdk2/cyclin A	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	IC50	nM	70.0	CHEMBL301	Homo sapiens	IC50	nM	70.0
	2420216	CHEMBL994307	Inhibition of human cdk2/cyclin E	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	IC50	nM	35.0	CHEMBL301	Homo sapiens	IC50	nM	35.0
	2420232	CHEMBL994306	Inhibition of human cdk2/cyclin A	B	CC(C)[C@H](CO)Nc1nc(Nc2ccc(C(=O)O)c(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23254	=	IC50	nM	6.0	CHEMBL301	Homo sapiens	IC50	nM	6.0
	2420233	CHEMBL994307	Inhibition of human cdk2/cyclin E	B	CC(C)[C@H](CO)Nc1nc(Nc2ccc(C(=O)O)c(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23254	=	IC50	nM	9.0	CHEMBL301	Homo sapiens	IC50	nM	9.0
	2460280	CHEMBL958731	Inhibition of CDK2	B	Nc1cncc(Cl)n1		CHEMBL191632	=	IC50	nM	350000.0	CHEMBL301	Homo sapiens	IC50	uM	350.0
	2460281	CHEMBL958731	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(Nc2cncc(Cl)n2)cc1		CHEMBL487738	=	IC50	nM	9100.0	CHEMBL301	Homo sapiens	IC50	uM	9.1
	2461679	CHEMBL966179	Inhibition of recombinant CDK2/CycA	B	Cc1cc(O)cc2oc(=O)c3c(O)cc(O)cc3c12		CHEMBL519982	=	IC50	ug.mL-1	3.3	CHEMBL301	Homo sapiens	IC50	10'-6g/ml	3.3
	2461729	CHEMBL966179	Inhibition of recombinant CDK2/CycA	B	COc1cc(O)c2c(=O)oc3c(O)c(O)cc(C)c3c2c1		CHEMBL520144	=	IC50	ug.mL-1	2.4	CHEMBL301	Homo sapiens	IC50	10'-6g/ml	2.4
	2461730	CHEMBL966179	Inhibition of recombinant CDK2/CycA	B	COc1cc(O)c2c(=O)oc3cc(O)cc(C)c3c2c1		CHEMBL483526	=	IC50	ug.mL-1	3.6	CHEMBL301	Homo sapiens	IC50	10'-6g/ml	3.6
	2461731	CHEMBL966179	Inhibition of recombinant CDK2/CycA	B	Cc1cc(O)cc2oc(=O)c3c(O)cc(OS(=O)(=O)O)cc3c12		CHEMBL483525	=	IC50	ug.mL-1	0.84	CHEMBL301	Homo sapiens	IC50	10'-7g/ml	8.4
	2461770	CHEMBL966179	Inhibition of recombinant CDK2/CycA	B	COc1cc(O)c(C(=O)O)c(-c2cc(O)c(O)cc2C)c1		CHEMBL483531	>	IC50	ug.mL-1	10.0	CHEMBL301	Homo sapiens	IC50	10'-5g/ml	1.0
	2461771	CHEMBL966179	Inhibition of recombinant CDK2/CycA	B	O=C1C[C@H](O)[C@@H]2c3c(ccc(O)c31)-c1ccc(O)c3c1[C@@]2(O)CCC3=O		CHEMBL521470	>	IC50	ug.mL-1	10.0	CHEMBL301	Homo sapiens	IC50	10'-5g/ml	1.0
	2461772	CHEMBL966179	Inhibition of recombinant CDK2/CycA	B	COc1cc(O)c(C(=O)O)c(C2=C(C)C[C@@H](O)C2=O)c1		CHEMBL519395	>	IC50	ug.mL-1	10.0	CHEMBL301	Homo sapiens	IC50	10'-5g/ml	1.0
	2461773	CHEMBL966179	Inhibition of recombinant CDK2/CycA	B	COc1cc(O)c2c(c1)C1(OC2=O)C(C)=CC(=O)C1O		CHEMBL408995	>	IC50	ug.mL-1	10.0	CHEMBL301	Homo sapiens	IC50	10'-5g/ml	1.0
	2461774	CHEMBL966179	Inhibition of recombinant CDK2/CycA	B	COc1cc(O)c2c(c1)-c1cc(O)c(O)cc1COC2=O		CHEMBL507058	>	IC50	ug.mL-1	10.0	CHEMBL301	Homo sapiens	IC50	10'-5g/ml	1.0
	2461775	CHEMBL966179	Inhibition of recombinant CDK2/CycA	B	Cc1cc(O)c(O)cc1-c1cc(O)cc(O)c1C(=O)O		CHEMBL483532	>	IC50	ug.mL-1	10.0	CHEMBL301	Homo sapiens	IC50	10'-5g/ml	1.0
	2464993	CHEMBL957969	Inhibition of human recombinant CDK2/cyclin A	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201511	=	IC50	nM	6900.0	CHEMBL301	Homo sapiens	IC50	uM	6.9
	2465031	CHEMBL957969	Inhibition of human recombinant CDK2/cyclin A	B	COc1cc(C2=C(c3cn(C)c4ccccc34)C(=O)NC2)cc(OC)c1OC		CHEMBL509435	=	IC50	nM	42000.0	CHEMBL301	Homo sapiens	IC50	uM	42.0
	2465032	CHEMBL957969	Inhibition of human recombinant CDK2/cyclin A	B	COc1cc(C2=C(c3cn(COc4ccccc4)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL488811	=	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	2465033	CHEMBL957969	Inhibition of human recombinant CDK2/cyclin A	B	COc1cc(C2=C(c3cn(COC(C)(C)C)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL488646	=	IC50	nM	23000.0	CHEMBL301	Homo sapiens	IC50	uM	23.0
	2466798	CHEMBL992478	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(Nc2nccc(-c3cnc4ccccn34)n2)cc1		CHEMBL73303	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	IC50	uM	0.002
	2466799	CHEMBL992478	Inhibition of CDK2	B	COCCNS(=O)(=O)c1ccc(Nc2nccc(-c3cnc4ccccn34)n2)cc1		CHEMBL309573	<	IC50	nM	12.0	CHEMBL301	Homo sapiens	IC50	uM	0.012
	2466800	CHEMBL992478	Inhibition of CDK2	B	CNS(=O)(=O)c1ccc(Nc2nccc(-c3cnc4cccnn34)n2)cc1		CHEMBL520003	<	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	uM	0.003
	2466801	CHEMBL992478	Inhibition of CDK2	B	CN(C)CCNS(=O)(=O)c1ccc(Nc2nccc(-c3cnc4cccnn34)n2)cc1		CHEMBL484571	=	IC50	nM	8.0	CHEMBL301	Homo sapiens	IC50	uM	0.008
	2466802	CHEMBL992478	Inhibition of CDK2	B	Cc1ncc(-c2ccnc(Nc3ccc(S(N)(=O)=O)cc3)n2)n1C		CHEMBL484738	=	IC50	nM	11.0	CHEMBL301	Homo sapiens	IC50	uM	0.011
	2466803	CHEMBL992478	Inhibition of CDK2	B	CNS(=O)(=O)c1ccc(Nc2nccc(-c3cnc(C)n3C)n2)cc1		CHEMBL485425	<	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	uM	0.003
	2466804	CHEMBL992478	Inhibition of CDK2	B	COCCNS(=O)(=O)c1ccc(Nc2nccc(-c3cnc(C)n3C)n2)cc1		CHEMBL520187	=	IC50	nM	8.0	CHEMBL301	Homo sapiens	IC50	uM	0.008
	2466805	CHEMBL992478	Inhibition of CDK2	B	Cc1ncc(-c2ccnc(Nc3ccc(S(=O)(=O)NCCCOC(C)C)cc3)n2)n1C		CHEMBL520353	=	IC50	nM	6.0	CHEMBL301	Homo sapiens	IC50	uM	0.006
	2466806	CHEMBL992478	Inhibition of CDK2	B	Cc1ncc(-c2ccnc(Nc3ccc(S(=O)(=O)NCCN(C)C)cc3)n2)n1C		CHEMBL485431	=	IC50	nM	25.0	CHEMBL301	Homo sapiens	IC50	uM	0.025
	2466807	CHEMBL992478	Inhibition of CDK2	B	COCCN(C)S(=O)(=O)c1ccc(Nc2nccc(-c3cnc(C)n3C)n2)cc1		CHEMBL485602	=	IC50	nM	400.0	CHEMBL301	Homo sapiens	IC50	uM	0.4
	2466808	CHEMBL992478	Inhibition of CDK2	B	CCn1c(-c2ccnc(Nc3ccc(S(=O)(=O)NCCOC)cc3)n2)cnc1C		CHEMBL485618	=	IC50	nM	4.0	CHEMBL301	Homo sapiens	IC50	uM	0.004
	2466809	CHEMBL992478	Inhibition of CDK2	B	COCCNS(=O)(=O)c1ccc(Nc2nccc(-c3cnc(C)n3C(C)C)n2)cc1		CHEMBL478409	=	IC50	nM	1.0	CHEMBL301	Homo sapiens	IC50	uM	0.001
	2466810	CHEMBL992478	Inhibition of CDK2	B	COCCNS(=O)(=O)c1ccc(Nc2nccc(-c3cnc(C)n3C3CCCC3)n2)cc1		CHEMBL484555	<	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	uM	0.003
	2466811	CHEMBL992478	Inhibition of CDK2	B	COCCNS(=O)(=O)c1ccc(Nc2nccc(-c3cnc(C)n3CC(C)C)n2)cc1		CHEMBL485619	=	IC50	nM	15.0	CHEMBL301	Homo sapiens	IC50	uM	0.015
	2466812	CHEMBL992478	Inhibition of CDK2	B	COCCN(C)S(=O)(=O)c1ccc(Nc2nccc(-c3cnc(C)n3C3CC3)n2)cc1		CHEMBL483590	=	IC50	nM	83.0	CHEMBL301	Homo sapiens	IC50	uM	0.083
	2466813	CHEMBL992478	Inhibition of CDK2	B	COCCNS(=O)(=O)c1ccc(Nc2nccc(-c3c(C)nc(C)n3C)n2)cc1		CHEMBL458547	=	IC50	nM	68.0	CHEMBL301	Homo sapiens	IC50	uM	0.068
	2466814	CHEMBL992478	Inhibition of CDK2	B	Cc1ncc(-c2ccnc(Nc3ccc(S(=O)(=O)CCCN(C)C)cc3)n2)n1C		CHEMBL458548	=	IC50	nM	295.0	CHEMBL301	Homo sapiens	IC50	uM	0.295
	2466815	CHEMBL992478	Inhibition of CDK2	B	CCn1c(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)cnc1C		CHEMBL514913	=	IC50	nM	23.0	CHEMBL301	Homo sapiens	IC50	uM	0.023
	2466816	CHEMBL992478	Inhibition of CDK2	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	=	IC50	nM	6.0	CHEMBL301	Homo sapiens	IC50	uM	0.006
	2466817	CHEMBL992478	Inhibition of CDK2	B	CCCS(=O)(=O)c1ccc(Nc2nccc(-c3cnc(C)n3C(C)C)n2)cc1		CHEMBL485240	=	IC50	nM	8.0	CHEMBL301	Homo sapiens	IC50	uM	0.008
	2466818	CHEMBL992478	Inhibition of CDK2	B	Cc1ncc(-c2ccnc(Nc3ccc(S(=O)(=O)Cc4ccccc4)cc3)n2)n1C(C)C		CHEMBL457979	=	IC50	nM	19.0	CHEMBL301	Homo sapiens	IC50	uM	0.019
	2466819	CHEMBL992478	Inhibition of CDK2	B	COCCS(=O)(=O)c1ccc(Nc2nccc(-c3cnc(C)n3C(C)C)n2)cc1		CHEMBL515854	=	IC50	nM	14.0	CHEMBL301	Homo sapiens	IC50	uM	0.014
	2466820	CHEMBL992478	Inhibition of CDK2	B	Cc1ncc(-c2ccnc(Nc3ccc(S(=O)(=O)CC4CCCO4)cc3)n2)n1C(C)C		CHEMBL515839	=	IC50	nM	13.0	CHEMBL301	Homo sapiens	IC50	uM	0.013
	2466821	CHEMBL992478	Inhibition of CDK2	B	Cc1ncc(-c2ccnc(Nc3ccc(S(=O)(=O)CCCN(C)C)cc3)n2)n1C(C)C		CHEMBL457887	=	IC50	nM	36.0	CHEMBL301	Homo sapiens	IC50	uM	0.036
	2466822	CHEMBL992478	Inhibition of CDK2	B	Cc1ncc(-c2ccnc(Nc3ccc(S(=O)(=O)CCCN4CCOCC4)cc3)n2)n1C(C)C		CHEMBL457888	=	IC50	nM	33.0	CHEMBL301	Homo sapiens	IC50	uM	0.033
	2470088	CHEMBL1032230	Inhibition of CDK2 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL301	Homo sapiens	INH	%	10.0
Not Evaluated	2476744	CHEMBL982772	Binding affinity to human CDK2 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL301	Homo sapiens	Activity		
Not Evaluated	2478583	CHEMBL982772	Binding affinity to human CDK2 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL301	Homo sapiens	Activity		
	2478786	CHEMBL982772	Binding affinity to human CDK2 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	Activity	%	26.2	CHEMBL301	Homo sapiens	Activity	%	26.2
	2479641	CHEMBL982772	Binding affinity to human CDK2 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Activity	%	0.9	CHEMBL301	Homo sapiens	Activity	%	0.9
Not Evaluated	2479844	CHEMBL982772	Binding affinity to human CDK2 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167		Activity			CHEMBL301	Homo sapiens	Activity		
	2480641	CHEMBL982772	Binding affinity to human CDK2 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	28.3	CHEMBL301	Homo sapiens	Activity	%	28.3
Not Evaluated	2480843	CHEMBL982772	Binding affinity to human CDK2 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL301	Homo sapiens	Activity		
	2486589	CHEMBL994195	Inhibition of Cdk2	B	CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL523823	>	Ki	nM	8570.0	CHEMBL301	Homo sapiens	Ki	uM	8.57
	2496328	CHEMBL993951	Inhibition of human recombinant CDK2/cyclin A expressed in baculovirus-infected insect cells	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)n2ncc(C(C)C)c2n1		CHEMBL482193	=	IC50	nM	40.0	CHEMBL301	Homo sapiens	IC50	uM	0.04
	2496329	CHEMBL993951	Inhibition of human recombinant CDK2/cyclin A expressed in baculovirus-infected insect cells	B	CC(C)c1cnn2c(NCc3ccc(Cl)cc3)nc(N[C@@H](CO)C(C)C)nc12		CHEMBL480442	=	IC50	nM	60.0	CHEMBL301	Homo sapiens	IC50	uM	0.06
	2496330	CHEMBL993951	Inhibition of human recombinant CDK2/cyclin A expressed in baculovirus-infected insect cells	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	IC50	nM	70.0	CHEMBL301	Homo sapiens	IC50	uM	0.07
	2496331	CHEMBL993951	Inhibition of human recombinant CDK2/cyclin A expressed in baculovirus-infected insect cells	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	IC50	nM	220.0	CHEMBL301	Homo sapiens	IC50	uM	0.22
	2496332	CHEMBL993951	Inhibition of human recombinant CDK2/cyclin A expressed in baculovirus-infected insect cells	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncc(C(C)C)n2n1		CHEMBL482211	=	IC50	nM	220.0	CHEMBL301	Homo sapiens	IC50	uM	0.22
Not Determined	2496333	CHEMBL993951	Inhibition of human recombinant CDK2/cyclin A expressed in baculovirus-infected insect cells	B	CC[C@@H](CO)Nc1nc(NCc2ccccc2)n2ncc(C(C)C)c2n1		CHEMBL521274		IC50			CHEMBL301	Homo sapiens	IC50		
	2503649	CHEMBL960393	Inhibition of CDK2/Cyclin B	B	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21		CHEMBL280074	=	IC50	nM	7000.0	CHEMBL301	Homo sapiens	IC50	uM	7.0
	2503650	CHEMBL960394	Inhibition of CDK2/Cyclin E	B	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21		CHEMBL280074	=	IC50	nM	7000.0	CHEMBL301	Homo sapiens	IC50	uM	7.0
Not Active	2504252	CHEMBL939807	Inhibition of CDK2 in human HeLa cells by immunoprecipitation kinase assay	B	C=CC1CC2(O)CC3(O)CCC=CC3C2(O)C1(O)CCC		CHEMBL475046		Activity			CHEMBL301	Homo sapiens	Activity		
	2504595	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	Cc1cc(NC(=O)c2ccccc2)n[nH]1		CHEMBL115125	=	IC50	nM	1500.0	CHEMBL301	Homo sapiens	IC50	nM	1500.0
	2504596	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	CCCC(=O)Nc1cc(C)[nH]n1		CHEMBL115177	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	2504597	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	CCCC(=O)Nc1cc(C2CC2)[nH]n1		CHEMBL112442	=	IC50	nM	224.0	CHEMBL301	Homo sapiens	IC50	nM	224.0
	2504598	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Nc1cc(C2CC2)n[nH]1)c1ccccc1		CHEMBL324942	=	IC50	nM	290.0	CHEMBL301	Homo sapiens	IC50	nM	290.0
	2504599	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Nc1cc(C2CC2)[nH]n1)c1ccc(Br)cc1		CHEMBL115319	=	IC50	nM	34.0	CHEMBL301	Homo sapiens	IC50	nM	34.0
	2504600	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Nc1cc(C2CC2)[nH]n1)c1ccc(Cl)cc1		CHEMBL115264	=	IC50	nM	85.0	CHEMBL301	Homo sapiens	IC50	nM	85.0
	2504601	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	COc1ccc(C(=O)Nc2cc(C3CC3)[nH]n2)cc1		CHEMBL111897	=	IC50	nM	705.0	CHEMBL301	Homo sapiens	IC50	nM	705.0
	2504602	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(O)c1ccc(C(=O)Nc2cc(C3CC3)[nH]n2)cc1		CHEMBL324186	=	IC50	nM	165.0	CHEMBL301	Homo sapiens	IC50	nM	165.0
	2504603	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	NC(=O)c1ccc(C(=O)Nc2cc(C3CC3)[nH]n2)cc1		CHEMBL325606	=	IC50	nM	68.0	CHEMBL301	Homo sapiens	IC50	nM	68.0
	2504604	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Nc1cc(C2CC2)[nH]n1)c1cccc(Br)c1		CHEMBL114577	=	IC50	nM	990.0	CHEMBL301	Homo sapiens	IC50	nM	990.0
	2504605	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Nc1cc(C2CC2)[nH]n1)c1cccc(Cl)c1		CHEMBL326310	=	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	2504606	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	COc1cccc(C(=O)Nc2cc(C3CC3)[nH]n2)c1		CHEMBL420135	=	IC50	nM	600.0	CHEMBL301	Homo sapiens	IC50	nM	600.0
	2504607	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Nc1cc(C2CC2)[nH]n1)c1cccc(C(F)(F)F)c1		CHEMBL333605	=	IC50	nM	500.0	CHEMBL301	Homo sapiens	IC50	nM	500.0
	2504608	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Nc1cc(C2CC2)[nH]n1)c1ccccc1Br		CHEMBL116047	=	IC50	nM	1500.0	CHEMBL301	Homo sapiens	IC50	nM	1500.0
	2504609	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Nc1cc(C2CC2)[nH]n1)c1ccccc1Cl		CHEMBL115446	=	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	2504610	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	COc1ccccc1C(=O)Nc1cc(C2CC2)[nH]n1		CHEMBL323417	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	2504611	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Nc1cc(C2CC2)[nH]n1)c1c(Cl)cccc1Cl		CHEMBL327017	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	2504612	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Nc1cc(C2CC2)[nH]n1)c1ccc(Cl)c(Cl)c1		CHEMBL323392	=	IC50	nM	83.0	CHEMBL301	Homo sapiens	IC50	nM	83.0
	2504613	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Nc1cc(C2CCC2)[nH]n1)c1ccc(Br)cc1		CHEMBL112136	=	IC50	nM	90.0	CHEMBL301	Homo sapiens	IC50	nM	90.0
	2504614	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Nc1cc(C2CCCC2)[nH]n1)c1ccc(Br)cc1		CHEMBL419753	=	IC50	nM	50.0	CHEMBL301	Homo sapiens	IC50	nM	50.0
	2504615	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Nc1cc(C2CCCCC2)[nH]n1)c1ccc(Br)cc1		CHEMBL333382	=	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	2504616	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	Cc1cc(NC(=O)c2ccc(Br)cc2)n[nH]1		CHEMBL323594	=	IC50	nM	6000.0	CHEMBL301	Homo sapiens	IC50	nM	6000.0
	2504617	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	CCc1cc(NC(=O)c2ccc(Br)cc2)n[nH]1		CHEMBL115047	=	IC50	nM	630.0	CHEMBL301	Homo sapiens	IC50	nM	630.0
	2504618	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	CCCc1cc(NC(=O)c2ccc(Br)cc2)n[nH]1		CHEMBL114432	=	IC50	nM	650.0	CHEMBL301	Homo sapiens	IC50	nM	650.0
	2504619	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	CC(C)c1cc(NC(=O)c2ccc(Br)cc2)n[nH]1		CHEMBL430703	=	IC50	nM	200.0	CHEMBL301	Homo sapiens	IC50	nM	200.0
	2504620	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	CC(C)(C)c1cc(NC(=O)c2ccc(Br)cc2)n[nH]1		CHEMBL324360	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	2504621	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Nc1cc(-c2ccccc2)[nH]n1)c1ccc(Br)cc1		CHEMBL114247	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	2504622	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Nc1cc(Cc2ccccc2)[nH]n1)c1ccc(Br)cc1		CHEMBL420677	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	2504623	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Cc1ccccc1)Nc1cc(C2CC2)[nH]n1		CHEMBL114851	=	IC50	nM	48.0	CHEMBL301	Homo sapiens	IC50	nM	48.0
	2504624	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	NC(=O)c1ccc(CC(=O)Nc2cc(C3CC3)[nH]n2)cc1		CHEMBL324577	=	IC50	nM	74.0	CHEMBL301	Homo sapiens	IC50	nM	74.0
	2504625	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	COc1cccc(CC(=O)Nc2cc(C3CC3)[nH]n2)c1		CHEMBL114917	=	IC50	nM	29.0	CHEMBL301	Homo sapiens	IC50	nM	29.0
	2504626	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Cc1ccc(OC(F)(F)F)cc1)Nc1cc(C2CC2)[nH]n1		CHEMBL115994	=	IC50	nM	67.0	CHEMBL301	Homo sapiens	IC50	nM	67.0
	2504627	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Cc1ccc(-c2ccccc2)cc1)Nc1cc(C2CC2)[nH]n1		CHEMBL115933	=	IC50	nM	56.0	CHEMBL301	Homo sapiens	IC50	nM	56.0
	2504628	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Cc1ccc(-c2ccccc2)c(F)c1)Nc1cc(C2CC2)[nH]n1		CHEMBL489477	=	IC50	nM	4.0	CHEMBL301	Homo sapiens	IC50	nM	4.0
	2504629	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	Cc1cc(CC(=O)Nc2cc(C3CC3)[nH]n2)ccc1-c1ccccc1		CHEMBL490480	=	IC50	nM	9.0	CHEMBL301	Homo sapiens	IC50	nM	9.0
	2504630	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Cc1ccc(Cc2cccs2)cc1)Nc1cc(C2CC2)[nH]n1		CHEMBL490481	=	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	nM	3.0
	2504631	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	CO[C@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccccc1		CHEMBL190154	=	IC50	nM	2000.0	CHEMBL301	Homo sapiens	IC50	nM	2000.0
	2504632	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	CO[C@@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccccc1		CHEMBL370036	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	2504633	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	N[C@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccccc1		CHEMBL193287	=	IC50	nM	960.0	CHEMBL301	Homo sapiens	IC50	nM	960.0
	2504634	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Nc1cc(C2CC2)[nH]n1)C(=O)c1ccccc1		CHEMBL190178	=	IC50	nM	2600.0	CHEMBL301	Homo sapiens	IC50	nM	2600.0
	2504635	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	C[C@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccccc1		CHEMBL366230	=	IC50	nM	84.0	CHEMBL301	Homo sapiens	IC50	nM	84.0
	2504636	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	C[C@@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccccc1		CHEMBL365988	=	IC50	nM	6000.0	CHEMBL301	Homo sapiens	IC50	nM	6000.0
	2504637	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	C[C@@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(N2CCCC2=O)cc1		CHEMBL192471	=	IC50	nM	2500.0	CHEMBL301	Homo sapiens	IC50	nM	2500.0
	2504638	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	C[C@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(N2CCCC2=O)cc1		CHEMBL191144	=	IC50	nM	37.0	CHEMBL301	Homo sapiens	IC50	nM	37.0
	2504639	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	C[C@@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(N2Cc3ccccc3C2=O)cc1		CHEMBL192126	=	IC50	nM	170.0	CHEMBL301	Homo sapiens	IC50	nM	170.0
	2504640	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	C[C@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(N2Cc3ccccc3C2=O)cc1		CHEMBL190446	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	IC50	nM	2.0
	2504641	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	C[C@@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(N2CCNC2=O)cc1		CHEMBL189047	=	IC50	nM	455.0	CHEMBL301	Homo sapiens	IC50	nM	455.0
	2504642	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	C[C@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(N2CCNC2=O)cc1		CHEMBL192602	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	IC50	nM	2.0
	2504643	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	C[C@@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(N2CCN(C)C2=O)cc1		CHEMBL365355	=	IC50	nM	8500.0	CHEMBL301	Homo sapiens	IC50	nM	8500.0
	2504644	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	C[C@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(N2CCN(C)C2=O)cc1		CHEMBL192042	=	IC50	nM	17.0	CHEMBL301	Homo sapiens	IC50	nM	17.0
	2504645	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	C[C@@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(N2CCOC2=O)cc1		CHEMBL192179	=	IC50	nM	2500.0	CHEMBL301	Homo sapiens	IC50	nM	2500.0
	2504646	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	C[C@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(N2CCOC2=O)cc1		CHEMBL191834	=	IC50	nM	20.0	CHEMBL301	Homo sapiens	IC50	nM	20.0
	2504647	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	C[C@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(N2CCCC2)cc1		CHEMBL365341	=	IC50	nM	80.0	CHEMBL301	Homo sapiens	IC50	nM	80.0
	2504648	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	Cc1cc(NC(=O)c2ccccc2)n[nH]1		CHEMBL115125	=	IC50	nM	1499.68	CHEMBL301	Homo sapiens	pIC50		5.824
	2504649	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	CCCC(=O)Nc1cc(C2CC2)[nH]n1		CHEMBL112442	=	IC50	nM	223.87	CHEMBL301	Homo sapiens	pIC50		6.65
	2504650	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Nc1cc(C2CC2)n[nH]1)c1ccccc1		CHEMBL324942	=	IC50	nM	289.73	CHEMBL301	Homo sapiens	pIC50		6.538
	2504651	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Nc1cc(C2CC2)[nH]n1)c1ccc(Br)cc1		CHEMBL115319	=	IC50	nM	33.96	CHEMBL301	Homo sapiens	pIC50		7.469
	2504652	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Nc1cc(C2CC2)[nH]n1)c1ccc(Cl)cc1		CHEMBL115264	=	IC50	nM	84.92	CHEMBL301	Homo sapiens	pIC50		7.071
	2504653	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	COc1ccc(C(=O)Nc2cc(C3CC3)[nH]n2)cc1		CHEMBL111897	=	IC50	nM	704.69	CHEMBL301	Homo sapiens	pIC50		6.152
	2504654	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(O)c1ccc(C(=O)Nc2cc(C3CC3)[nH]n2)cc1		CHEMBL324186	=	IC50	nM	164.82	CHEMBL301	Homo sapiens	pIC50		6.783
	2504655	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	NC(=O)c1ccc(C(=O)Nc2cc(C3CC3)[nH]n2)cc1		CHEMBL325606	=	IC50	nM	68.08	CHEMBL301	Homo sapiens	pIC50		7.167
	2504656	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Nc1cc(C2CC2)[nH]n1)c1cccc(Br)c1		CHEMBL114577	=	IC50	nM	990.83	CHEMBL301	Homo sapiens	pIC50		6.004
	2504657	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Nc1cc(C2CC2)[nH]n1)c1cccc(Cl)c1		CHEMBL326310	=	IC50	nM	1000.0	CHEMBL301	Homo sapiens	pIC50		6.0
	2504658	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	COc1cccc(C(=O)Nc2cc(C3CC3)[nH]n2)c1		CHEMBL420135	=	IC50	nM	599.79	CHEMBL301	Homo sapiens	pIC50		6.222
	2504659	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Nc1cc(C2CC2)[nH]n1)c1cccc(C(F)(F)F)c1		CHEMBL333605	=	IC50	nM	500.03	CHEMBL301	Homo sapiens	pIC50		6.301
	2504660	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Nc1cc(C2CC2)[nH]n1)c1ccccc1Br		CHEMBL116047	=	IC50	nM	1499.68	CHEMBL301	Homo sapiens	pIC50		5.824
	2504661	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Nc1cc(C2CC2)[nH]n1)c1ccccc1Cl		CHEMBL115446	=	IC50	nM	1000.0	CHEMBL301	Homo sapiens	pIC50		6.0
	2504662	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Nc1cc(C2CC2)[nH]n1)c1ccc(Cl)c(Cl)c1		CHEMBL323392	=	IC50	nM	82.99	CHEMBL301	Homo sapiens	pIC50		7.081
	2504663	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Nc1cc(C2CCC2)[nH]n1)c1ccc(Br)cc1		CHEMBL112136	=	IC50	nM	89.95	CHEMBL301	Homo sapiens	pIC50		7.046
	2504664	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Nc1cc(C2CCCC2)[nH]n1)c1ccc(Br)cc1		CHEMBL419753	=	IC50	nM	50.0	CHEMBL301	Homo sapiens	pIC50		7.301
	2504665	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Nc1cc(C2CCCCC2)[nH]n1)c1ccc(Br)cc1		CHEMBL333382	=	IC50	nM	1000.0	CHEMBL301	Homo sapiens	pIC50		6.0
	2504666	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	Cc1cc(NC(=O)c2ccc(Br)cc2)n[nH]1		CHEMBL323594	=	IC50	nM	5997.91	CHEMBL301	Homo sapiens	pIC50		5.222
	2504667	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	CCc1cc(NC(=O)c2ccc(Br)cc2)n[nH]1		CHEMBL115047	=	IC50	nM	629.51	CHEMBL301	Homo sapiens	pIC50		6.201
	2504668	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	CCCc1cc(NC(=O)c2ccc(Br)cc2)n[nH]1		CHEMBL114432	=	IC50	nM	650.13	CHEMBL301	Homo sapiens	pIC50		6.187
	2504669	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	CC(C)c1cc(NC(=O)c2ccc(Br)cc2)n[nH]1		CHEMBL430703	=	IC50	nM	199.99	CHEMBL301	Homo sapiens	pIC50		6.699
	2504670	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Cc1ccccc1)Nc1cc(C2CC2)[nH]n1		CHEMBL114851	=	IC50	nM	47.97	CHEMBL301	Homo sapiens	pIC50		7.319
	2504671	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	NC(=O)c1ccc(CC(=O)Nc2cc(C3CC3)[nH]n2)cc1		CHEMBL324577	=	IC50	nM	73.96	CHEMBL301	Homo sapiens	pIC50		7.131
	2504672	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	COc1cccc(CC(=O)Nc2cc(C3CC3)[nH]n2)c1		CHEMBL114917	=	IC50	nM	28.97	CHEMBL301	Homo sapiens	pIC50		7.538
	2504673	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Cc1ccc(OC(F)(F)F)cc1)Nc1cc(C2CC2)[nH]n1		CHEMBL115994	=	IC50	nM	66.99	CHEMBL301	Homo sapiens	pIC50		7.174
	2504674	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Cc1ccc(-c2ccccc2)cc1)Nc1cc(C2CC2)[nH]n1		CHEMBL115933	=	IC50	nM	55.98	CHEMBL301	Homo sapiens	pIC50		7.252
	2504675	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Cc1ccc(-c2ccccc2)c(F)c1)Nc1cc(C2CC2)[nH]n1		CHEMBL489477	=	IC50	nM	3.999	CHEMBL301	Homo sapiens	pIC50		8.398
	2504676	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	Cc1cc(CC(=O)Nc2cc(C3CC3)[nH]n2)ccc1-c1ccccc1		CHEMBL490480	=	IC50	nM	8.995	CHEMBL301	Homo sapiens	pIC50		8.046
	2504677	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Cc1ccc(Cc2cccs2)cc1)Nc1cc(C2CC2)[nH]n1		CHEMBL490481	=	IC50	nM	2.999	CHEMBL301	Homo sapiens	pIC50		8.523
	2504678	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	CO[C@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccccc1		CHEMBL190154	=	IC50	nM	1999.86	CHEMBL301	Homo sapiens	pIC50		5.699
	2504679	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	N[C@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccccc1		CHEMBL193287	=	IC50	nM	959.4	CHEMBL301	Homo sapiens	pIC50		6.018
	2504680	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	O=C(Nc1cc(C2CC2)[nH]n1)C(=O)c1ccccc1		CHEMBL190178	=	IC50	nM	2600.16	CHEMBL301	Homo sapiens	pIC50		5.585
	2504681	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	C[C@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccccc1		CHEMBL366230	=	IC50	nM	83.95	CHEMBL301	Homo sapiens	pIC50		7.076
	2504682	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	C[C@@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccccc1		CHEMBL365988	=	IC50	nM	5997.91	CHEMBL301	Homo sapiens	pIC50		5.222
	2504683	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	C[C@@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(N2CCCC2=O)cc1		CHEMBL192471	=	IC50	nM	2500.35	CHEMBL301	Homo sapiens	pIC50		5.602
	2504684	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	C[C@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(N2CCCC2=O)cc1		CHEMBL191144	=	IC50	nM	36.98	CHEMBL301	Homo sapiens	pIC50		7.432
	2504685	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	C[C@@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(N2Cc3ccccc3C2=O)cc1		CHEMBL192126	=	IC50	nM	169.82	CHEMBL301	Homo sapiens	pIC50		6.77
	2504686	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	C[C@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(N2Cc3ccccc3C2=O)cc1		CHEMBL190446	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	pIC50		8.699
	2504687	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	C[C@@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(N2CCNC2=O)cc1		CHEMBL189047	=	IC50	nM	454.99	CHEMBL301	Homo sapiens	pIC50		6.342
	2504688	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	C[C@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(N2CCNC2=O)cc1		CHEMBL192602	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	pIC50		8.699
	2504689	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	C[C@@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(N2CCN(C)C2=O)cc1		CHEMBL365355	=	IC50	nM	8491.8	CHEMBL301	Homo sapiens	pIC50		5.071
	2504690	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	C[C@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(N2CCN(C)C2=O)cc1		CHEMBL192042	=	IC50	nM	16.98	CHEMBL301	Homo sapiens	pIC50		7.77
	2504691	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	C[C@@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(N2CCOC2=O)cc1		CHEMBL192179	=	IC50	nM	2500.35	CHEMBL301	Homo sapiens	pIC50		5.602
	2504692	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	C[C@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(N2CCOC2=O)cc1		CHEMBL191834	=	IC50	nM	20.0	CHEMBL301	Homo sapiens	pIC50		7.699
	2504693	CHEMBL951804	Inhibition of CDK2/Cyclin A	B	C[C@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccc(N2CCCC2)cc1		CHEMBL365341	=	IC50	nM	79.98	CHEMBL301	Homo sapiens	pIC50		7.097
	2506867	CHEMBL942590	Inhibition of human CDK2	B	COc1cc(O)ccc1-c1ccc2c(-c3nc4c(N5CCN(C)CC5)cccc4[nH]3)n[nH]c2c1		CHEMBL474619	=	IC50	nM	102.0	CHEMBL301	Homo sapiens	IC50	nM	102.0
	2506868	CHEMBL942590	Inhibition of human CDK2	B	COc1cc(-c2ccc3c(-c4nc5c(N6CCN(C)CC6)cccc5[nH]4)n[nH]c3c2)ccc1O		CHEMBL514197	=	IC50	nM	4.1	CHEMBL301	Homo sapiens	IC50	nM	4.1
	2506869	CHEMBL942590	Inhibition of human CDK2	B	CN1CCN(c2cccc3[nH]c(-c4n[nH]c5cc(-c6ccc(O)cc6)ccc45)nc23)CC1		CHEMBL473631	=	IC50	nM	13.3	CHEMBL301	Homo sapiens	IC50	nM	13.3
	2506870	CHEMBL942590	Inhibition of human CDK2	B	CN1CCN(c2cccc3[nH]c(-c4n[nH]c5cc(-c6ccc(CO)cc6)ccc45)nc23)CC1		CHEMBL474807	=	IC50	nM	21500.0	CHEMBL301	Homo sapiens	IC50	nM	21500.0
	2506871	CHEMBL942590	Inhibition of human CDK2	B	COc1ccc(-c2ccc3c(-c4nc5c(N6CCN(C)CC6)cccc5[nH]4)n[nH]c3c2)c(OC)c1		CHEMBL475640	=	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	2506872	CHEMBL942590	Inhibition of human CDK2	B	COc1ccccc1-c1ccc2c(-c3nc4c(N5CCN(C)CC5)cccc4[nH]3)n[nH]c2c1		CHEMBL516244	=	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	2506873	CHEMBL942590	Inhibition of human CDK2	B	COc1cc(F)ccc1-c1ccc2c(-c3nc4c(N5CCN(C)CC5)cccc4[nH]3)n[nH]c2c1		CHEMBL482350	=	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	2506874	CHEMBL942590	Inhibition of human CDK2	B	CN1CCN(c2cccc3nc(-c4n[nH]c5cc(-c6ccc(N)cc6)ccc45)[nH]c23)CC1		CHEMBL480391	=	IC50	nM	1040.0	CHEMBL301	Homo sapiens	IC50	nM	1040.0
	2506875	CHEMBL942590	Inhibition of human CDK2	B	CN1CCN(c2cccc3[nH]c(-c4n[nH]c5cc(-c6cccc(N)c6)ccc45)nc23)CC1		CHEMBL480392	=	IC50	nM	6100.0	CHEMBL301	Homo sapiens	IC50	nM	6100.0
	2506876	CHEMBL942590	Inhibition of human CDK2	B	CN1CCN(c2cccc3[nH]c(-c4n[nH]c5cc(-c6ccc(N)c(F)c6)ccc45)nc23)CC1		CHEMBL519795	=	IC50	nM	1730.0	CHEMBL301	Homo sapiens	IC50	nM	1730.0
	2506877	CHEMBL942590	Inhibition of human CDK2	B	COc1cc(-c2ccc3c(-c4nc5c(N6CCN(C)CC6)cccc5[nH]4)n[nH]c3c2)ccc1N		CHEMBL482368	=	IC50	nM	247.0	CHEMBL301	Homo sapiens	IC50	nM	247.0
	2506878	CHEMBL942590	Inhibition of human CDK2	B	CN1CCN(c2cccc3[nH]c(-c4n[nH]c5cc(-c6ccc(CN)cc6)ccc45)nc23)CC1		CHEMBL474433	=	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	2506879	CHEMBL942590	Inhibition of human CDK2	B	CC(=O)Nc1ccc(-c2ccc3c(-c4nc5c(N6CCN(C)CC6)cccc5[nH]4)n[nH]c3c2)cc1		CHEMBL474600	=	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	2506880	CHEMBL942590	Inhibition of human CDK2	B	CNc1ccc(-c2ccc3c(-c4nc5c(N6CCN(C)CC6)cccc5[nH]4)n[nH]c3c2)cc1	Outside typical range	CHEMBL474441	=	IC50	nM	109000.0	CHEMBL301	Homo sapiens	IC50	nM	109000.0
	2506881	CHEMBL942590	Inhibition of human CDK2	B	COc1cc(N)ccc1-c1ccc2c(-c3nc4c(N5CCN(C)CC5)cccc4[nH]3)n[nH]c2c1		CHEMBL471790	=	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	2506882	CHEMBL942590	Inhibition of human CDK2	B	CN1CCN(c2cccc3[nH]c(-c4n[nH]c5cc(-c6ccc(C(=O)O)cc6)ccc45)nc23)CC1		CHEMBL471791	=	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	2506883	CHEMBL942590	Inhibition of human CDK2	B	CC(=O)c1ccc(-c2ccc3c(-c4nc5c(N6CCN(C)CC6)cccc5[nH]4)n[nH]c3c2)cc1		CHEMBL472148	=	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	2506884	CHEMBL942590	Inhibition of human CDK2	B	CN1CCN(c2cccc3[nH]c(-c4n[nH]c5cc(-c6ccc7[nH]ccc7c6)ccc45)nc23)CC1		CHEMBL520911	=	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	2506885	CHEMBL942590	Inhibition of human CDK2	B	CN1CCN(c2cccc3[nH]c(-c4n[nH]c5cc(C6=CC7=CC=CNC7C=C6)ccc45)nc23)CC1		CHEMBL480384	=	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	2506886	CHEMBL942590	Inhibition of human CDK2	B	O=C(NC1CC1)c1n[nH]c2cc(-c3ccc(O)cc3)c(Br)cc12		CHEMBL481562	=	IC50	nM	5.0	CHEMBL301	Homo sapiens	IC50	nM	5.0
	2507168	CHEMBL947786	Inhibition of Cdk2	B	Nc1ncc(NC(=O)c2cc(NC(=O)c3cccc(C(F)(F)F)c3)ccc2Cl)cc1Cl		CHEMBL475817	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	2511568	CHEMBL972527	Inhibition of CDK2/cyclinA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.36	CHEMBL301	Homo sapiens	IC50	uM	0.00036
	2511614	CHEMBL972527	Inhibition of CDK2/cyclinA	B	COc1ccc(NC(=S)N/N=C2\C(=O)Nc3ccccc32)cc1		CHEMBL504574	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2511963	CHEMBL969668	Inhibition of human CDK2/cyclin E at 1 uM assessed as residual enzyme activity	B	O=C(Nc1ccccc1Cl)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL521949	=	Activity	%	44.0	CHEMBL301	Homo sapiens	Activity	%	44.0
	2512021	CHEMBL970574	Inhibition of CDK2/cyclin A at 1 uM	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	Inhibition	%	15.0	CHEMBL301	Homo sapiens	INH	%	15.0
	2512071	CHEMBL969660	Inhibition of CDK2/cyclin A	B	O=C(Nc1ccccc1Cl)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL521949	=	IC50	nM	3200.0	CHEMBL301	Homo sapiens	IC50	uM	3.2
	2512072	CHEMBL969660	Inhibition of CDK2/cyclin A	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	>	IC50	nM	16000.0	CHEMBL301	Homo sapiens	IC50	uM	16.0
	2512073	CHEMBL969660	Inhibition of CDK2/cyclin A	B	CCN1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL502124	>	IC50	nM	16000.0	CHEMBL301	Homo sapiens	IC50	uM	16.0
Not Determined	2512127	CHEMBL969660	Inhibition of CDK2/cyclin A	B	O=C(NC1CC1)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL507170		IC50			CHEMBL301	Homo sapiens	IC50		
Not Determined	2512128	CHEMBL969660	Inhibition of CDK2/cyclin A	B	O=C(Nc1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1)c1ccccc1Cl		CHEMBL523991		IC50			CHEMBL301	Homo sapiens	IC50		
Not Determined	2512129	CHEMBL969660	Inhibition of CDK2/cyclin A	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084		IC50			CHEMBL301	Homo sapiens	IC50		
	2528299	CHEMBL986816	Inhibition of human Thr160-phospho CDK2/CyclinA	B	Oc1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL340813	=	IC50	nM	2300.0	CHEMBL301	Homo sapiens	IC50	uM	2.3
	2528300	CHEMBL986816	Inhibition of human Thr160-phospho CDK2/CyclinA	B	c1ccc(Nc2nc(OCC3CCCCC3)c3[nH]cnc3n2)cc1		CHEMBL122264	=	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	uM	1.0
	2528943	CHEMBL985011	Inhibition of CDK2/cyclinA	B	O[C@H]1CC[C@H](c2n[nH]cc2-c2ccnc(NC3CCCC3)n2)CC1		CHEMBL507249	=	IC50	nM	590.0	CHEMBL301	Homo sapiens	IC50	uM	0.59
	2560951	CHEMBL984724	Inhibition of CDK2/Cyclin E	B	Cc1ncc(-c2ccnc(Nc3ccc(C#N)cc3)n2)n1C(C)C		CHEMBL444194	<	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	uM	0.003
	2560954	CHEMBL984724	Inhibition of CDK2/Cyclin E	B	CC(=O)N1CCN(c2ccc(Nc3nccc(-c4cnc(C)n4C(C)C)n3)cc2)CC1		CHEMBL477568	<	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	uM	0.003
	2560955	CHEMBL984724	Inhibition of CDK2/Cyclin E	B	Cc1ncc(-c2ccnc(Nc3ccc(N4CCN(S(C)(=O)=O)CC4)cc3)n2)n1C(C)C		CHEMBL477567	<	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	uM	0.003
	2560956	CHEMBL984724	Inhibition of CDK2/Cyclin E	B	COCCNS(=O)(=O)c1ccc(Nc2nccc(-c3cnc(C)n3C(C)C)n2)cc1		CHEMBL478409	<	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	uM	0.003
	2560957	CHEMBL984724	Inhibition of CDK2/Cyclin E	B	Cc1ncc(-c2ccnc(Nc3ccc(Cl)cc3)n2)n1C(C)C		CHEMBL478408	<	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	uM	0.003
	2560958	CHEMBL984724	Inhibition of CDK2/Cyclin E	B	Cc1ncc(-c2ccnc(Nc3ccc(F)cc3)n2)n1C(C)C		CHEMBL478407	=	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	uM	0.003
	2560959	CHEMBL984724	Inhibition of CDK2/Cyclin E	B	COc1ccc(Nc2nccc(-c3cnc(C)n3C(C)C)n2)cc1		CHEMBL478828	=	IC50	nM	8.0	CHEMBL301	Homo sapiens	IC50	uM	0.008
	2560960	CHEMBL984724	Inhibition of CDK2/Cyclin E	B	Cc1ncc(-c2ccnc(Nc3ccc(N(C)C)cc3)n2)n1C(C)C		CHEMBL476518	=	IC50	nM	24.0	CHEMBL301	Homo sapiens	IC50	uM	0.024
	2560969	CHEMBL984724	Inhibition of CDK2/Cyclin E	B	Cc1ncc(-c2nc(Nc3ccc(N4CCC[C@H]4C(=O)N(C)C)cc3)ncc2F)n1C(C)C		CHEMBL475948	=	IC50	nM	46.0	CHEMBL301	Homo sapiens	IC50	uM	0.046
	2560970	CHEMBL984724	Inhibition of CDK2/Cyclin E	B	CC(=O)N[C@@H]1CCN(c2ccc(Nc3ncc(F)c(-c4cnc(C)n4C(C)C)n3)cc2)C1		CHEMBL476578	>	IC50	nM	0.3	CHEMBL301	Homo sapiens	IC50	uM	0.0003
	2560971	CHEMBL984724	Inhibition of CDK2/Cyclin E	B	CC(=O)NC1CN(c2ccc(Nc3ncc(F)c(-c4cnc(C)n4C(C)C)n3)cc2)C1		CHEMBL476577	=	IC50	nM	0.5	CHEMBL301	Homo sapiens	IC50	uM	0.0005
	2560972	CHEMBL984724	Inhibition of CDK2/Cyclin E	B	Cc1ncc(-c2nc(Nc3ccc(N4CCOCC4)cc3)ncc2F)n1C(C)C		CHEMBL515001	=	IC50	nM	8.0	CHEMBL301	Homo sapiens	IC50	uM	0.008
	2560973	CHEMBL984724	Inhibition of CDK2/Cyclin E	B	Cc1ncc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)n1C(C)C		CHEMBL514690	=	IC50	nM	9.0	CHEMBL301	Homo sapiens	IC50	uM	0.009
	2560974	CHEMBL984724	Inhibition of CDK2/Cyclin E	B	Cc1ncc(-c2nc(Nc3ccc(N4CCN(C(=O)CO)CC4)cc3)ncc2F)n1C(C)C		CHEMBL476993	=	IC50	nM	6.0	CHEMBL301	Homo sapiens	IC50	uM	0.006
	2560975	CHEMBL984724	Inhibition of CDK2/Cyclin E	B	Cc1ncc(-c2ccnc(Nc3ccc(N4CCN(C(=O)CN(C)C)CC4)cc3)n2)n1C(C)C		CHEMBL478241	=	IC50	nM	16.0	CHEMBL301	Homo sapiens	IC50	uM	0.016
	2560976	CHEMBL984724	Inhibition of CDK2/Cyclin E	B	Cc1ncc(-c2ccnc(Nc3ccc(N4CCN(C(=O)[C@H](C)O)CC4)cc3)n2)n1C(C)C		CHEMBL515311	=	IC50	nM	17.0	CHEMBL301	Homo sapiens	IC50	uM	0.017
	2560977	CHEMBL984724	Inhibition of CDK2/Cyclin E	B	Cc1ncc(-c2ccnc(Nc3ccc(N4CCN(C(=O)CO)CC4)cc3)n2)n1C(C)C		CHEMBL477786	=	IC50	nM	17.0	CHEMBL301	Homo sapiens	IC50	uM	0.017
	2560978	CHEMBL984724	Inhibition of CDK2/Cyclin E	B	COCCS(=O)(=O)N1CCN(c2ccc(Nc3nccc(-c4cnc(C)n4C(C)C)n3)cc2)CC1		CHEMBL514384	<	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	uM	0.003
	2560979	CHEMBL984724	Inhibition of CDK2/Cyclin E	B	Cc1ncc(-c2ccnc(Nc3ccc(N4CCN(S(=O)(=O)CCN(C)C)CC4)cc3)n2)n1C(C)C		CHEMBL477785	=	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	uM	0.003
	2561738	CHEMBL1003979	Inhibition of CDK2	B	Cc1cc(CNc2ncc(Br)c(Nc3cc(C4CC4)[nH]n3)n2)on1		CHEMBL497854	=	IC50	nM	110.0	CHEMBL301	Homo sapiens	IC50	uM	0.11
	2562877	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21.[Cl-]	Outside typical range	CHEMBL258765	=	IC50	nM	500000.0	CHEMBL301	Homo sapiens	IC50	uM	500.0
	2562879	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	Cc1cccc(-c2ccccc2C(=O)N2CCc3c([nH]c4ccccc34)C2)c1	Outside typical range	CHEMBL515356	=	IC50	nM	386000.0	CHEMBL301	Homo sapiens	IC50	uM	386.0
	2562880	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	O=C(c1ccccc1-c1cccnc1)N1CCc2c([nH]c3ccccc23)C1	Outside typical range	CHEMBL457390	=	IC50	nM	312000.0	CHEMBL301	Homo sapiens	IC50	uM	312.0
	2562881	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	O=C(c1ccccc1-c1ccncc1)N1CCc2c([nH]c3ccccc23)C1	Outside typical range	CHEMBL457180	=	IC50	nM	354000.0	CHEMBL301	Homo sapiens	IC50	uM	354.0
	2562882	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	O=C(NCCc1c[nH]c2ccccc12)c1cccc(-c2cccnc2)c1	Outside typical range	CHEMBL515051	=	IC50	nM	150000.0	CHEMBL301	Homo sapiens	IC50	uM	150.0
	2562883	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	CN(CCc1c[nH]c2ccccc12)C(=O)c1ccc(-c2ccncc2)cc1		CHEMBL457179	=	IC50	nM	92000.0	CHEMBL301	Homo sapiens	IC50	uM	92.0
	2562884	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	COc1ccccc1-c1ccc(C(=O)N2CCc3c([nH]c4ccccc34)C2)cc1	Outside typical range	CHEMBL456113	=	IC50	nM	321000.0	CHEMBL301	Homo sapiens	IC50	uM	321.0
	2562885	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	COc1cccc(-c2ccc(C(=O)N3CCc4c([nH]c5ccccc45)C3)cc2)c1	Outside typical range	CHEMBL456112	=	IC50	nM	424000.0	CHEMBL301	Homo sapiens	IC50	uM	424.0
	2562886	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	Cc1ccccc1-c1ccc(C(=O)N2CCc3c([nH]c4ccccc34)C2)cc1	Outside typical range	CHEMBL517154	=	IC50	nM	340000.0	CHEMBL301	Homo sapiens	IC50	uM	340.0
	2562887	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	Cc1cccc(-c2ccc(C(=O)N3CCc4c([nH]c5ccccc45)C3)cc2)c1	Outside typical range	CHEMBL463384	=	IC50	nM	405000.0	CHEMBL301	Homo sapiens	IC50	uM	405.0
	2562888	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	Cc1ccc(-c2ccc(C(=O)N3CCc4c([nH]c5ccccc45)C3)cc2)cc1	Outside typical range	CHEMBL463383	=	IC50	nM	736000.0	CHEMBL301	Homo sapiens	IC50	uM	736.0
	2562889	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	O=C(c1ccc(-c2ccccc2F)cc1)N1CCc2c([nH]c3ccccc23)C1	Outside typical range	CHEMBL456584	=	IC50	nM	310000.0	CHEMBL301	Homo sapiens	IC50	uM	310.0
	2562890	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	O=C(c1ccc(-c2cccc(F)c2)cc1)N1CCc2c([nH]c3ccccc23)C1	Outside typical range	CHEMBL456378	=	IC50	nM	296000.0	CHEMBL301	Homo sapiens	IC50	uM	296.0
	2562891	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	O=C(c1ccc(-c2ccc(F)cc2)cc1)N1CCc2c([nH]c3ccccc23)C1	Outside typical range	CHEMBL456995	=	IC50	nM	438000.0	CHEMBL301	Homo sapiens	IC50	uM	438.0
	2562892	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	COc1ccccc1-c1cccc(C(=O)N2CCc3c([nH]c4ccccc34)C2)c1	Outside typical range	CHEMBL456797	=	IC50	nM	1109000.0	CHEMBL301	Homo sapiens	IC50	uM	1109.0
	2562893	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	COc1cccc(-c2cccc(C(=O)N3CCc4c([nH]c5ccccc45)C3)c2)c1	Outside typical range	CHEMBL456796	=	IC50	nM	362000.0	CHEMBL301	Homo sapiens	IC50	uM	362.0
	2562894	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	Cc1ccccc1-c1cccc(C(=O)N2CCc3c([nH]c4ccccc34)C2)c1	Outside typical range	CHEMBL458076	=	IC50	nM	665000.0	CHEMBL301	Homo sapiens	IC50	uM	665.0
	2562895	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	Cc1cccc(-c2cccc(C(=O)N3CCc4c([nH]c5ccccc45)C3)c2)c1	Outside typical range	CHEMBL458075	=	IC50	nM	465000.0	CHEMBL301	Homo sapiens	IC50	uM	465.0
	2562896	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	Cc1ccc(-c2cccc(C(=O)N3CCc4c([nH]c5ccccc45)C3)c2)cc1	Outside typical range	CHEMBL456143	=	IC50	nM	466000.0	CHEMBL301	Homo sapiens	IC50	uM	466.0
	2562897	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	O=C(c1cccc(-c2ccccc2F)c1)N1CCc2c([nH]c3ccccc23)C1	Outside typical range	CHEMBL455931	=	IC50	nM	335000.0	CHEMBL301	Homo sapiens	IC50	uM	335.0
	2562898	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	O=C(c1cccc(-c2cccc(F)c2)c1)N1CCc2c([nH]c3ccccc23)C1	Outside typical range	CHEMBL509499	=	IC50	nM	611000.0	CHEMBL301	Homo sapiens	IC50	uM	611.0
	2562899	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	O=C(c1cccc(-c2ccc(F)cc2)c1)N1CCc2c([nH]c3ccccc23)C1	Outside typical range	CHEMBL457191	=	IC50	nM	318000.0	CHEMBL301	Homo sapiens	IC50	uM	318.0
	2562900	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	O=C(c1ccccc1-c1ccccc1F)N1CCc2c([nH]c3ccccc23)C1	Outside typical range	CHEMBL457190	=	IC50	nM	434000.0	CHEMBL301	Homo sapiens	IC50	uM	434.0
	2562901	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	O=C(c1ccccc1-c1cccc(F)c1)N1CCc2c([nH]c3ccccc23)C1	Outside typical range	CHEMBL515674	=	IC50	nM	480000.0	CHEMBL301	Homo sapiens	IC50	uM	480.0
	2562902	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	O=C(c1ccccc1-c1ccc(F)cc1)N1CCc2c([nH]c3ccccc23)C1	Outside typical range	CHEMBL457401	=	IC50	nM	357000.0	CHEMBL301	Homo sapiens	IC50	uM	357.0
	2562903	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	Cc1cccc(-c2ccccc2C(=O)NCCc2c[nH]c3ccccc23)c1	Outside typical range	CHEMBL456121	=	IC50	nM	406000.0	CHEMBL301	Homo sapiens	IC50	uM	406.0
	2562904	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	O=C(NCCc1c[nH]c2ccccc12)c1ccccc1-c1cccc(F)c1	Outside typical range	CHEMBL456964	=	IC50	nM	417000.0	CHEMBL301	Homo sapiens	IC50	uM	417.0
	2562905	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	COc1ccccc1-c1ccccc1C(=O)NCCc1c[nH]c2ccccc12	Outside typical range	CHEMBL456760	=	IC50	nM	375000.0	CHEMBL301	Homo sapiens	IC50	uM	375.0
	2562906	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	COc1cccc(-c2ccccc2C(=O)NCCc2c[nH]c3ccccc23)c1	Outside typical range	CHEMBL456759	=	IC50	nM	926000.0	CHEMBL301	Homo sapiens	IC50	uM	926.0
	2562907	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	COc1ccc(-c2ccccc2C(=O)NCCc2c[nH]c3ccccc23)cc1	Outside typical range	CHEMBL456965	=	IC50	nM	921000.0	CHEMBL301	Homo sapiens	IC50	uM	921.0
	2562908	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	CC(C)(C)c1ccc(-c2ccccc2C(=O)NCCc2c[nH]c3ccccc23)cc1	Outside typical range	CHEMBL525530	=	IC50	nM	262000.0	CHEMBL301	Homo sapiens	IC50	uM	262.0
	2562909	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	O=C(NCCc1c[nH]c2ccccc12)c1ccccc1-c1ccc(F)cc1	Outside typical range	CHEMBL497454	=	IC50	nM	1216000.0	CHEMBL301	Homo sapiens	IC50	uM	1216.0
	2562910	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	O=C(NCCc1c[nH]c2ccccc12)c1cccc(-c2ccccc2)c1	Outside typical range	CHEMBL498130	=	IC50	nM	1002000.0	CHEMBL301	Homo sapiens	IC50	uM	1002.0
	2562911	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	COc1ccc(-c2ccc(C(=O)NCCc3c[nH]c4ccccc34)cc2)cc1	Outside typical range	CHEMBL527039	=	IC50	nM	1085000.0	CHEMBL301	Homo sapiens	IC50	uM	1085.0
	2562912	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	CC(C)(C)c1ccc(-c2ccc(C(=O)NCCc3c[nH]c4ccccc34)cc2)cc1	Outside typical range	CHEMBL498710	=	IC50	nM	790000.0	CHEMBL301	Homo sapiens	IC50	uM	790.0
	2562913	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	Cc1ccc(-c2ccc(C(=O)NCCc3c[nH]c4ccccc34)cc2)cc1	Outside typical range	CHEMBL496482	=	IC50	nM	816000.0	CHEMBL301	Homo sapiens	IC50	uM	816.0
	2562914	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	O=C(NCCc1c[nH]c2ccccc12)c1ccc(-c2ccc(F)cc2)cc1	Outside typical range	CHEMBL496481	=	IC50	nM	764000.0	CHEMBL301	Homo sapiens	IC50	uM	764.0
	2562915	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	O=C(NCCc1c[nH]c2ccccc12)c1ccc(-c2ccccc2)cc1	Outside typical range	CHEMBL521733	=	IC50	nM	855000.0	CHEMBL301	Homo sapiens	IC50	uM	855.0
	2562916	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	CN(CCc1c[nH]c2ccccc12)C(=O)c1ccc(-c2ccc(-c3ccccc3)cc2)cc1		CHEMBL498705	=	IC50	nM	91000.0	CHEMBL301	Homo sapiens	IC50	uM	91.0
	2562917	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	COc1ccc(-c2ccc(C(=O)N(C)CCc3c[nH]c4ccccc34)cc2)cc1	Outside typical range	CHEMBL525538	=	IC50	nM	289000.0	CHEMBL301	Homo sapiens	IC50	uM	289.0
	2562918	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	CN(CCc1c[nH]c2ccccc12)C(=O)c1ccc(-c2ccc(C(C)(C)C)cc2)cc1	Outside typical range	CHEMBL498521	=	IC50	nM	745000.0	CHEMBL301	Homo sapiens	IC50	uM	745.0
	2562919	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	Cc1ccc(-c2ccc(C(=O)N(C)CCc3c[nH]c4ccccc34)cc2)cc1		CHEMBL525921	=	IC50	nM	70000.0	CHEMBL301	Homo sapiens	IC50	uM	70.0
	2562920	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	CN(CCc1c[nH]c2ccccc12)C(=O)c1ccc(-c2ccc(F)cc2)cc1	Outside typical range	CHEMBL498520	=	IC50	nM	875000.0	CHEMBL301	Homo sapiens	IC50	uM	875.0
	2562921	CHEMBL974551	Inhibition of human CDK2/GST-cyclin A expressed in Sf9 cells assessed as histone phosphorylation	B	CN(CCc1c[nH]c2ccccc12)C(=O)c1ccc(-c2ccccc2)cc1	Outside typical range	CHEMBL213805	=	IC50	nM	521000.0	CHEMBL301	Homo sapiens	IC50	uM	521.0
	2565230	CHEMBL967074	Inhibition of CDK2	B	CCCCOc1c(C(=O)c2ccccc2)cnc2[nH]ncc12		CHEMBL14619	=	IC50	nM	110.0	CHEMBL301	Homo sapiens	IC50	uM	0.11
	2567171	CHEMBL970777	Inhibition of CDK2/CyclinA	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	uM	15.0
	2568856	CHEMBL971698	Inhibition of CDK2/Cyclin A by radiometric assay	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	IC50	nM	370.0	CHEMBL301	Homo sapiens	IC50	uM	0.37
	2568857	CHEMBL971698	Inhibition of CDK2/Cyclin A by radiometric assay	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	=	IC50	nM	47.0	CHEMBL301	Homo sapiens	IC50	uM	0.047
	2568858	CHEMBL971698	Inhibition of CDK2/Cyclin A by radiometric assay	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(F)cccc1Cl		CHEMBL497477	=	IC50	nM	110.0	CHEMBL301	Homo sapiens	IC50	uM	0.11
	2568859	CHEMBL971698	Inhibition of CDK2/Cyclin A by radiometric assay	B	COc1cccc(F)c1C(=O)Nc1c[nH]nc1C(=O)NC1CCNCC1		CHEMBL497306	=	IC50	nM	350.0	CHEMBL301	Homo sapiens	IC50	uM	0.35
	2568860	CHEMBL971698	Inhibition of CDK2/Cyclin A by radiometric assay	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(F)cc(F)cc1F		CHEMBL448316	=	IC50	nM	750.0	CHEMBL301	Homo sapiens	IC50	uM	0.75
	2568861	CHEMBL971698	Inhibition of CDK2/Cyclin A by radiometric assay	B	Cl.O=C(N[C@H]1CCCNC1)c1n[nH]cc1NC(=O)c1c(F)cccc1F		CHEMBL498659	=	IC50	nM	44.0	CHEMBL301	Homo sapiens	IC50	uM	0.044
	2568862	CHEMBL971698	Inhibition of CDK2/Cyclin A by radiometric assay	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(F)cccc1F		CHEMBL457388	=	IC50	nM	140.0	CHEMBL301	Homo sapiens	IC50	uM	0.14
	2568863	CHEMBL971698	Inhibition of CDK2/Cyclin A by radiometric assay	B	N[C@H]1CC[C@H](NC(=O)c2n[nH]cc2NC(=O)c2c(F)cccc2F)CC1		CHEMBL507167	=	IC50	nM	38.0	CHEMBL301	Homo sapiens	IC50	uM	0.038
	2568864	CHEMBL971698	Inhibition of CDK2/Cyclin A by radiometric assay	B	O=C(N[C@H]1CC[C@H](O)CC1)c1n[nH]cc1NC(=O)c1c(F)cccc1F		CHEMBL457177	=	IC50	nM	19.0	CHEMBL301	Homo sapiens	IC50	uM	0.019
	2568865	CHEMBL971698	Inhibition of CDK2/Cyclin A by radiometric assay	B	O=C(NC1CCCCC1)c1n[nH]cc1NC(=O)c1c(F)cccc1F		CHEMBL456963	=	IC50	nM	12.0	CHEMBL301	Homo sapiens	IC50	uM	0.012
	2568866	CHEMBL971698	Inhibition of CDK2/Cyclin A by radiometric assay	B	O=C(NCC1CC1)c1n[nH]cc1NC(=O)c1c(F)cccc1F		CHEMBL510578	=	IC50	nM	25.0	CHEMBL301	Homo sapiens	IC50	uM	0.025
	2568867	CHEMBL971698	Inhibition of CDK2/Cyclin A by radiometric assay	B	O=C(Nc1ccc(F)cc1)c1n[nH]cc1NC(=O)c1c(F)cccc1F		CHEMBL518383	=	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	uM	0.003
	2568868	CHEMBL971698	Inhibition of CDK2/Cyclin A by radiometric assay	B	O=C(Nc1c[nH]nc1C(=O)Nc1ccc(F)cc1)c1ccccc1		CHEMBL463580	=	IC50	nM	140.0	CHEMBL301	Homo sapiens	IC50	uM	0.14
	2568869	CHEMBL971698	Inhibition of CDK2/Cyclin A by radiometric assay	B	O=C(Nc1ccc(F)cc1)c1n[nH]cc1NC(=O)C1CCCCC1		CHEMBL463579	=	IC50	nM	90.0	CHEMBL301	Homo sapiens	IC50	uM	0.09
	2568870	CHEMBL971698	Inhibition of CDK2/Cyclin A by radiometric assay	B	O=C(Cc1ccccc1)Nc1c[nH]nc1C(=O)Nc1ccc(F)cc1		CHEMBL457208	=	IC50	nM	1600.0	CHEMBL301	Homo sapiens	IC50	uM	1.6
	2568871	CHEMBL971698	Inhibition of CDK2/Cyclin A by radiometric assay	B	O=C(CO)Nc1c[nH]nc1C(=O)Nc1ccc(F)cc1		CHEMBL443198	=	IC50	nM	730.0	CHEMBL301	Homo sapiens	IC50	uM	0.73
	2568872	CHEMBL971698	Inhibition of CDK2/Cyclin A by radiometric assay	B	CC(=O)Nc1c[nH]nc1C(=O)Nc1ccc(F)cc1		CHEMBL456163	=	IC50	nM	850.0	CHEMBL301	Homo sapiens	IC50	uM	0.85
	2568873	CHEMBL971698	Inhibition of CDK2/Cyclin A by radiometric assay	B	Nc1c[nH]nc1C(=O)Nc1ccc(F)cc1		CHEMBL499521	=	IC50	nM	85000.0	CHEMBL301	Homo sapiens	IC50	uM	85.0
	2568874	CHEMBL971698	Inhibition of CDK2/Cyclin A by radiometric assay	B	c1ccc2[nH]c(-c3cc[nH]n3)nc2c1		CHEMBL495758	=	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	2568875	CHEMBL971698	Inhibition of CDK2/Cyclin A by radiometric assay	B	O=C(Nc1ccccc1)c1cc[nH]n1		CHEMBL445420	=	IC50	nM	97000.0	CHEMBL301	Homo sapiens	IC50	uM	97.0
	2568876	CHEMBL971698	Inhibition of CDK2/Cyclin A by radiometric assay	B	NS(=O)(=O)c1ccc(NC(=O)c2n[nH]c3ccccc23)cc1		CHEMBL455946	=	IC50	nM	660.0	CHEMBL301	Homo sapiens	IC50	uM	0.66
	2568877	CHEMBL971698	Inhibition of CDK2/Cyclin A by radiometric assay	B	O=C(Nc1ccccc1)c1n[nH]c2ccccc12		CHEMBL508964	=	IC50	nM	3000.0	CHEMBL301	Homo sapiens	IC50	uM	3.0
	2568878	CHEMBL971698	Inhibition of CDK2/Cyclin A by radiometric assay	B	CC(C)Nc1cc(N[C@H]2CC[C@H](N)CC2)nc2c(C#N)cnn12		CHEMBL509730	=	IC50	nM	30.0	CHEMBL301	Homo sapiens	IC50	uM	0.03
	2568879	CHEMBL971698	Inhibition of CDK2/Cyclin A by radiometric assay	B	CC(C)Nc1cc(Cl)nc2c(C#N)cnn12		CHEMBL458926	=	IC50	nM	1500.0	CHEMBL301	Homo sapiens	IC50	uM	1.5
	2568880	CHEMBL971698	Inhibition of CDK2/Cyclin A by radiometric assay	B	NS(=O)(=O)c1ccc(Nc2cncc(Cl)n2)cc1		CHEMBL487738	=	IC50	nM	1900.0	CHEMBL301	Homo sapiens	IC50	uM	1.9
	2568881	CHEMBL971698	Inhibition of CDK2/Cyclin A by radiometric assay	B	Clc1cncc(Nc2ccccc2)n1		CHEMBL448853	=	IC50	nM	7000.0	CHEMBL301	Homo sapiens	IC50	uM	7.0
	2568882	CHEMBL971698	Inhibition of CDK2/Cyclin A by radiometric assay	B	N#Cc1cnn2cccnc12		CHEMBL503917	=	IC50	nM	370.0	CHEMBL301	Homo sapiens	IC50	uM	0.37
	2568883	CHEMBL971698	Inhibition of CDK2/Cyclin A by radiometric assay	B	NS(=O)(=O)c1cccc2c(O)cccc12		CHEMBL457047	=	IC50	nM	120000.0	CHEMBL301	Homo sapiens	IC50	uM	120.0
	2568884	CHEMBL971698	Inhibition of CDK2/Cyclin A by radiometric assay	B	c1ccc2[nH]ncc2c1		CHEMBL86795	=	IC50	nM	185000.0	CHEMBL301	Homo sapiens	IC50	uM	185.0
	2568885	CHEMBL971699	Inhibition of CDK2/Cyclin A at 1 mM by radiometric assay	B	N#Cc1cnn2cccnc12		CHEMBL503917	=	Inhibition	%	54.0	CHEMBL301	Homo sapiens	INH	%	54.0
	2568886	CHEMBL971699	Inhibition of CDK2/Cyclin A at 1 mM by radiometric assay	B	Nc1cncc(Cl)n1		CHEMBL191632	=	Inhibition	%	64.0	CHEMBL301	Homo sapiens	INH	%	64.0
Active	2568947	CHEMBL975509	Inhibition of CDK2 in human HCT116 cells assessed as Rb(Thr321) phosphorylation	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813		Activity			CHEMBL301	Homo sapiens	Activity		
Active	2568948	CHEMBL975510	Inhibition of CDK2 in human HCT116 cells assessed as NPM(Thr199) phosphorylation	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813		Activity			CHEMBL301	Homo sapiens	Activity		
	2577262	CHEMBL982772	Binding affinity to human CDK2 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901	=	Activity	%	4.7	CHEMBL301	Homo sapiens	Activity	%	4.7
	2577465	CHEMBL982772	Binding affinity to human CDK2 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337	=	Activity	%	2.8	CHEMBL301	Homo sapiens	Activity	%	2.8
	2582000	CHEMBL962977	Inhibition of human CDK2/Cyc2	B	N=C(N)SCCCN1C(=O)C2=C(C1=O)n1ccc3cccc(c31)C1Cc3ccccc3N21		CHEMBL514316	=	IC50	nM	4300.0	CHEMBL301	Homo sapiens	IC50	uM	4.3
	2582002	CHEMBL962235	Inhibition of human CDK2/CycA	B	CNC(=N)SCCCN1C(=O)C2=C(C1=O)n1ccc3cccc(c31)C1Cc3ccccc3N21		CHEMBL447317	=	IC50	nM	5300.0	CHEMBL301	Homo sapiens	IC50	uM	5.3
	2582006	CHEMBL962235	Inhibition of human CDK2/CycA	B	CCNC(=N)SCCCN1C(=O)C2=C(C1=O)n1ccc3cccc(c31)C1Cc3ccccc3N21		CHEMBL474724	=	IC50	nM	6800.0	CHEMBL301	Homo sapiens	IC50	uM	6.8
	2582008	CHEMBL962235	Inhibition of human CDK2/CycA	B	O=C1C2=C(C(=O)N1CCCSC1=NCCN1)n1ccc3cccc(c31)C1Cc3ccccc3N21		CHEMBL488270	=	IC50	nM	7700.0	CHEMBL301	Homo sapiens	IC50	uM	7.7
	2582009	CHEMBL962235	Inhibition of human CDK2/CycA	B	N=C(Nc1ccccc1)SCCCN1C(=O)C2=C(C1=O)n1ccc3cccc(c31)C1Cc3ccccc3N21		CHEMBL487254	=	IC50	nM	5100.0	CHEMBL301	Homo sapiens	IC50	uM	5.1
	2582018	CHEMBL962235	Inhibition of human CDK2/CycA	B	N=C(N)SCCCn1c(=O)c2c(c1=O)n1c3ccccc3cc1c1cccc3ccn2c31		CHEMBL489083	=	IC50	nM	3600.0	CHEMBL301	Homo sapiens	IC50	uM	3.6
	2582035	CHEMBL962235	Inhibition of human CDK2/CycA	B	CNC(=N)SCCCn1c(=O)c2c(c1=O)n1c3ccccc3cc1c1cccc3ccn2c31		CHEMBL488271	=	IC50	nM	6300.0	CHEMBL301	Homo sapiens	IC50	uM	6.3
	2583145	CHEMBL1022591	Inhibition of CDK2	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	<	IC50	nM	6.0	CHEMBL301	Homo sapiens	IC50	uM	0.006
	2583146	CHEMBL1022591	Inhibition of CDK2	B	Cc1ncc(-c2ccnc(Nc3ccc(C(N)=O)cc3)n2)n1C(C)C		CHEMBL488084	=	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	uM	0.003
	2583147	CHEMBL1022591	Inhibition of CDK2	B	CNC(=O)c1ccc(Nc2nccc(-c3cnc(C)n3C(C)C)n2)cc1		CHEMBL508129	=	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	uM	0.003
	2583148	CHEMBL1022591	Inhibition of CDK2	B	Cc1ncc(-c2ccnc(Nc3ccc(C(=O)N(C)C)cc3)n2)n1C(C)C		CHEMBL488085	=	IC50	nM	8.0	CHEMBL301	Homo sapiens	IC50	uM	0.008
	2583149	CHEMBL1022591	Inhibition of CDK2	B	Cc1ncc(-c2ccnc(Nc3ccc(C(=O)NC4CC4)cc3)n2)n1C(C)C		CHEMBL487066	=	IC50	nM	17.0	CHEMBL301	Homo sapiens	IC50	uM	0.017
	2583150	CHEMBL1022591	Inhibition of CDK2	B	Cc1ncc(-c2ccnc(Nc3ccc(C(=O)NCCO)cc3)n2)n1C(C)C		CHEMBL487067	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	IC50	uM	0.002
	2583151	CHEMBL1022591	Inhibition of CDK2	B	CCn1c(-c2ccnc(Nc3ccc(C(=O)NC)cc3)n2)cnc1C		CHEMBL519422	=	IC50	nM	56.0	CHEMBL301	Homo sapiens	IC50	uM	0.056
	2583152	CHEMBL1022591	Inhibition of CDK2	B	CNC(=O)c1ccc(Nc2nccc(-c3cnc(C)n3CC3CC3)n2)cc1		CHEMBL488256	=	IC50	nM	42.0	CHEMBL301	Homo sapiens	IC50	uM	0.042
	2583153	CHEMBL1022591	Inhibition of CDK2	B	CNC(=O)c1ccc(Nc2nccc(-c3cnc(C)n3C3CCCC3)n2)cc1		CHEMBL488257	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	IC50	uM	0.002
	2583154	CHEMBL1022591	Inhibition of CDK2	B	CNC(=O)c1ccc(Nc2nccc(-c3cnc(C4CC4)n3C(C)C)n2)cc1		CHEMBL507142	=	IC50	nM	81.0	CHEMBL301	Homo sapiens	IC50	uM	0.081
	2583155	CHEMBL1022591	Inhibition of CDK2	B	CNC(=O)c1ccc(Nc2nccc(-c3cnc(COC)n3C(C)C)n2)cc1		CHEMBL453651	=	IC50	nM	62.0	CHEMBL301	Homo sapiens	IC50	uM	0.062
	2583156	CHEMBL1022591	Inhibition of CDK2	B	Cc1ncc(-c2nc(Nc3ccc(C(N)=O)cc3)ncc2F)n1C(C)C		CHEMBL509881	<	IC50	nM	1.0	CHEMBL301	Homo sapiens	IC50	uM	0.001
	2583157	CHEMBL1022591	Inhibition of CDK2	B	CNC(=O)c1ccc(Nc2ncc(F)c(-c3cnc(C)n3C(C)C)n2)cc1		CHEMBL453655	=	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	uM	0.003
	2583158	CHEMBL1022591	Inhibition of CDK2	B	Cc1ncc(-c2nc(Nc3ccc(C(=O)N(C)C)cc3)ncc2F)n1C(C)C		CHEMBL453862	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	IC50	uM	0.002
	2583159	CHEMBL1022591	Inhibition of CDK2	B	Cc1ncc(-c2ccnc(Nc3ccc(C(N)=O)c(F)c3)n2)n1C(C)C		CHEMBL455427	<	IC50	nM	1.0	CHEMBL301	Homo sapiens	IC50	uM	0.001
	2583160	CHEMBL1022591	Inhibition of CDK2	B	CNC(=O)c1ccc(Nc2nccc(-c3cnc(C)n3C(C)C)n2)cc1F		CHEMBL455428	<	IC50	nM	1.0	CHEMBL301	Homo sapiens	IC50	uM	0.001
	2583161	CHEMBL1022591	Inhibition of CDK2	B	Cc1ncc(-c2ccnc(Nc3ccc(C(=O)N(C)C)c(F)c3)n2)n1C(C)C		CHEMBL510436	=	IC50	nM	6.0	CHEMBL301	Homo sapiens	IC50	uM	0.006
	2583162	CHEMBL1022591	Inhibition of CDK2	B	Cc1ncc(-c2nc(Nc3ccc(C(N)=O)c(F)c3)ncc2F)n1C(C)C		CHEMBL455429	<	IC50	nM	1.0	CHEMBL301	Homo sapiens	IC50	uM	0.001
	2583163	CHEMBL1022591	Inhibition of CDK2	B	CNC(=O)c1ccc(Nc2ncc(F)c(-c3cnc(C)n3C(C)C)n2)cc1F		CHEMBL455651	<	IC50	nM	1.0	CHEMBL301	Homo sapiens	IC50	uM	0.001
	2583164	CHEMBL1022591	Inhibition of CDK2	B	Cc1ncc(-c2nc(Nc3ccc(C(=O)N(C)C)c(F)c3)ncc2F)n1C(C)C		CHEMBL454648	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	IC50	uM	0.002
	2583165	CHEMBL1022591	Inhibition of CDK2	B	Cc1cc(Nc2ncc(F)c(-c3cnc(C)n3C(C)C)n2)ccc1C(=O)N(C)C		CHEMBL508739	=	IC50	nM	9.0	CHEMBL301	Homo sapiens	IC50	uM	0.009
	2584870	CHEMBL955780	Inhibition of CDK2	B	O=c1[nH]cnc2[nH]c(-c3ccnc(/C=C/c4ccc(CN5CCOCC5)cc4)c3)cc12		CHEMBL461139	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	2584898	CHEMBL955780	Inhibition of CDK2	B	CN(C)CCOc1ccc(/C=C/c2cc(-c3cc4c(=O)[nH]cnc4[nH]3)ccn2)cc1		CHEMBL461140	=	IC50	nM	8200.0	CHEMBL301	Homo sapiens	IC50	uM	8.2
	2586190	CHEMBL1018123	Inhibition of CDK2	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	=	IC50	nM	6.0	CHEMBL301	Homo sapiens	IC50	uM	0.006
	2586191	CHEMBL1018123	Inhibition of CDK2	B	Cc1ncc(-c2ccnc(Nc3ccc(C(=O)N4CCN(C)CC4)cc3)n2)n1C(C)C		CHEMBL455467	=	IC50	nM	9.0	CHEMBL301	Homo sapiens	IC50	uM	0.009
	2586192	CHEMBL1018123	Inhibition of CDK2	B	Cc1ncc(-c2nc(Nc3ccc(C(=O)N4CCN(C)CC4)cc3)ncc2F)n1C(C)C		CHEMBL451462	=	IC50	nM	18.0	CHEMBL301	Homo sapiens	IC50	uM	0.018
	2586193	CHEMBL1018123	Inhibition of CDK2	B	Cc1ncc(-c2ccnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3)n2)n1C(C)C		CHEMBL455468	=	IC50	nM	37.0	CHEMBL301	Homo sapiens	IC50	uM	0.037
	2586194	CHEMBL1018123	Inhibition of CDK2	B	Cc1ncc(-c2nc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3)ncc2F)n1C(C)C		CHEMBL507722	=	IC50	nM	36.0	CHEMBL301	Homo sapiens	IC50	uM	0.036
	2586195	CHEMBL1018123	Inhibition of CDK2	B	Cc1ncc(-c2ccnc(Nc3ccc(C(=O)NC4CCN(C)CC4)c(F)c3)n2)n1C(C)C		CHEMBL453895	=	IC50	nM	11.0	CHEMBL301	Homo sapiens	IC50	uM	0.011
	2586196	CHEMBL1018123	Inhibition of CDK2	B	Cc1ncc(-c2nc(Nc3ccc(C(=O)NC4CCN(C)CC4)c(F)c3)ncc2F)n1C(C)C		CHEMBL509406	=	IC50	nM	1.0	CHEMBL301	Homo sapiens	IC50	uM	0.001
	2586197	CHEMBL1018123	Inhibition of CDK2	B	Cc1ncc(-c2ccnc(Nc3ccc(C(=O)NCCN(C)C)c(F)c3)n2)n1C(C)C		CHEMBL453629	=	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	uM	0.003
	2586198	CHEMBL1018123	Inhibition of CDK2	B	Cc1ncc(-c2nc(Nc3ccc(C(=O)NCCN(C)C)c(F)c3)ncc2F)n1C(C)C		CHEMBL462385	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	IC50	uM	0.002
	2586199	CHEMBL1018123	Inhibition of CDK2	B	Cc1ncc(-c2nc(Nc3ccc(C(=O)N4CC[C@H](N(C)C)C4)cc3)ncc2F)n1C(C)C		CHEMBL460102	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	IC50	uM	0.002
	2586200	CHEMBL1018123	Inhibition of CDK2	B	Cc1ncc(-c2nc(Nc3ccc(C(=O)N4CC[C@@H](N(C)C)C4)cc3)ncc2F)n1C(C)C		CHEMBL460103	=	IC50	nM	6.0	CHEMBL301	Homo sapiens	IC50	uM	0.006
	2586201	CHEMBL1018123	Inhibition of CDK2	B	Cc1ncc(-c2nc(Nc3ccc(C(=O)N4CCCN(C)CC4)cc3)ncc2F)n1C(C)C		CHEMBL462192	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	IC50	uM	0.002
	2586202	CHEMBL1018123	Inhibition of CDK2	B	CCCN(C)[C@H]1CCN(C(=O)c2ccc(Nc3nccc(-c4cnc(C)n4C(C)C)n3)cc2)C1		CHEMBL518826	=	IC50	nM	4.0	CHEMBL301	Homo sapiens	IC50	uM	0.004
	2586203	CHEMBL1018123	Inhibition of CDK2	B	Cc1ncc(-c2ccnc(Nc3ccc(C(=O)N4CC[C@H](NC5CC5)C4)cc3)n2)n1C(C)C		CHEMBL460086	<	IC50	nM	1.0	CHEMBL301	Homo sapiens	IC50	uM	0.001
	2586204	CHEMBL1018123	Inhibition of CDK2	B	CN[C@H]1CCN(C(=O)c2ccc(Nc3nccc(-c4cnc(C)n4C(C)C)n3)cc2)C1		CHEMBL460087	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	IC50	uM	0.002
	2586205	CHEMBL1018123	Inhibition of CDK2	B	CN[C@H]1CCN(C(=O)c2ccc(Nc3ncc(F)c(-c4cnc(C)n4C(C)C)n3)cc2)C1		CHEMBL455657	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	IC50	uM	0.002
	2592886	CHEMBL965585	Inhibition of CDK2/Cyclin A by fluorescence polarization assay	B	C[C@@H]1CNC[C@@H](C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)C1		CHEMBL510566	=	IC50	nM	200.0	CHEMBL301	Homo sapiens	IC50	uM	0.2
	2592887	CHEMBL965585	Inhibition of CDK2/Cyclin A by fluorescence polarization assay	B	C[C@@H]1CNC[C@H](C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)C1		CHEMBL452602	=	IC50	nM	20.0	CHEMBL301	Homo sapiens	IC50	uM	0.02
	2592888	CHEMBL965585	Inhibition of CDK2/Cyclin A by fluorescence polarization assay	B	C[C@H]1CNC[C@H](C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)C1		CHEMBL452601	=	IC50	nM	5.0	CHEMBL301	Homo sapiens	IC50	uM	0.005
	2592889	CHEMBL965585	Inhibition of CDK2/Cyclin A by fluorescence polarization assay	B	C[C@H]1CNC[C@@H](C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)C1		CHEMBL455450	=	IC50	nM	36.0	CHEMBL301	Homo sapiens	IC50	uM	0.036
	2592890	CHEMBL965585	Inhibition of CDK2/Cyclin A by fluorescence polarization assay	B	CC1CNCC(C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)C1		CHEMBL454646	=	IC50	nM	140.0	CHEMBL301	Homo sapiens	IC50	uM	0.14
	2592891	CHEMBL965585	Inhibition of CDK2/Cyclin A by fluorescence polarization assay	B	CC1CCC(C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)CN1		CHEMBL454645	=	IC50	nM	14.0	CHEMBL301	Homo sapiens	IC50	uM	0.014
	2592892	CHEMBL965585	Inhibition of CDK2/Cyclin A by fluorescence polarization assay	B	CC1NCCCC1C(=O)Nc1ncc(SCc2ncc(C(C)(C)C)o2)s1		CHEMBL508506	=	IC50	nM	95.0	CHEMBL301	Homo sapiens	IC50	uM	0.095
	2592893	CHEMBL965585	Inhibition of CDK2/Cyclin A by fluorescence polarization assay	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCCNC3)s2)o1		CHEMBL297570	=	IC50	nM	20.0	CHEMBL301	Homo sapiens	IC50	uM	0.02
	2592894	CHEMBL965585	Inhibition of CDK2/Cyclin A by fluorescence polarization assay	B	CC(C)C1CC(C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)CCN1		CHEMBL509012	=	IC50	nM	17.0	CHEMBL301	Homo sapiens	IC50	uM	0.017
	2592895	CHEMBL965585	Inhibition of CDK2/Cyclin A by fluorescence polarization assay	B	CCC1CC(C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)CCN1		CHEMBL455195	=	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	uM	0.003
	2592896	CHEMBL965585	Inhibition of CDK2/Cyclin A by fluorescence polarization assay	B	CC1CC(C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)CCN1		CHEMBL455194	=	IC50	nM	15.0	CHEMBL301	Homo sapiens	IC50	uM	0.015
	2592897	CHEMBL965585	Inhibition of CDK2/Cyclin A by fluorescence polarization assay	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	IC50	nM	46.0	CHEMBL301	Homo sapiens	IC50	uM	0.046
Not Evaluated	2593670	CHEMBL982772	Binding affinity to human CDK2 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL301	Homo sapiens	Activity		
Not Evaluated	2593936	CHEMBL982772	Binding affinity to human CDK2 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL301	Homo sapiens	Activity		
Not Evaluated	2594139	CHEMBL982772	Binding affinity to human CDK2 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL301	Homo sapiens	Activity		
Not Evaluated	2594879	CHEMBL982772	Binding affinity to human CDK2 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL301	Homo sapiens	Activity		
Not Evaluated	2595082	CHEMBL982772	Binding affinity to human CDK2 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL301	Homo sapiens	Activity		
Not Evaluated	2596279	CHEMBL982772	Binding affinity to human CDK2 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL301	Homo sapiens	Activity		
	2596482	CHEMBL982772	Binding affinity to human CDK2 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019	=	Activity	%	0.5	CHEMBL301	Homo sapiens	Activity	%	0.5
Not Evaluated	2597751	CHEMBL982772	Binding affinity to human CDK2 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL301	Homo sapiens	Activity		
	2600724	CHEMBL1029074	Inhibition of CDK2-mediated retinoblastoma protein phosphorylation by dose-response curve analysis	B	CCc1cc2c(N/N=C\c3cccs3)ncnc2s1		CHEMBL470439	=	IC50	ug.mL-1	1.1	CHEMBL301	Homo sapiens	IC50	ug ml-1	1.1
	2600725	CHEMBL1029074	Inhibition of CDK2-mediated retinoblastoma protein phosphorylation by dose-response curve analysis	B	Cc1cc2c(N/N=C\c3cccs3)ncnc2s1		CHEMBL475294	=	IC50	ug.mL-1	1.7	CHEMBL301	Homo sapiens	IC50	ug ml-1	1.7
	2600726	CHEMBL1029074	Inhibition of CDK2-mediated retinoblastoma protein phosphorylation by dose-response curve analysis	B	CC(C)c1cc2c(N/N=C\c3cccs3)ncnc2s1		CHEMBL475295	=	IC50	ug.mL-1	0.35	CHEMBL301	Homo sapiens	IC50	ug ml-1	0.35
	2600727	CHEMBL1029074	Inhibition of CDK2-mediated retinoblastoma protein phosphorylation by dose-response curve analysis	B	CC(C)(C)c1cc2c(N/N=C\c3cccs3)ncnc2s1		CHEMBL514342	=	IC50	ug.mL-1	0.56	CHEMBL301	Homo sapiens	IC50	ug ml-1	0.56
	2600728	CHEMBL1029074	Inhibition of CDK2-mediated retinoblastoma protein phosphorylation by dose-response curve analysis	B	C(=N\Nc1ncnc2sc(Cc3ccccc3)cc12)\c1cccs1		CHEMBL475296	=	IC50	ug.mL-1	6.5	CHEMBL301	Homo sapiens	IC50	ug ml-1	6.5
	2600729	CHEMBL1029074	Inhibition of CDK2-mediated retinoblastoma protein phosphorylation by dose-response curve analysis	B	CCc1c(C)sc2ncnc(N/N=C\c3cccs3)c12		CHEMBL473887	=	IC50	ug.mL-1	12.0	CHEMBL301	Homo sapiens	IC50	ug ml-1	12.0
	2600730	CHEMBL1029074	Inhibition of CDK2-mediated retinoblastoma protein phosphorylation by dose-response curve analysis	B	C(=N\Nc1ncnc2sc3c(c12)CCCC3)\c1cccs1		CHEMBL473888	>	IC50	ug.mL-1	20.0	CHEMBL301	Homo sapiens	IC50	ug ml-1	20.0
	2600731	CHEMBL1029074	Inhibition of CDK2-mediated retinoblastoma protein phosphorylation by dose-response curve analysis	B	Cc1csc2ncnc(N/N=C\c3cccs3)c12		CHEMBL472667	>	IC50	ug.mL-1	20.0	CHEMBL301	Homo sapiens	IC50	ug ml-1	20.0
	2600732	CHEMBL1029074	Inhibition of CDK2-mediated retinoblastoma protein phosphorylation by dose-response curve analysis	B	CCc1cc2c(N/N=C\c3cccs3)nc(C)nc2s1		CHEMBL504102	>	IC50	ug.mL-1	20.0	CHEMBL301	Homo sapiens	IC50	ug ml-1	20.0
	2600733	CHEMBL1029074	Inhibition of CDK2-mediated retinoblastoma protein phosphorylation by dose-response curve analysis	B	CCc1cc2c(N/N=C\c3cccs3)nc(-c3ccccc3)nc2s1		CHEMBL472668	>	IC50	ug.mL-1	20.0	CHEMBL301	Homo sapiens	IC50	ug ml-1	20.0
	2600734	CHEMBL1029074	Inhibition of CDK2-mediated retinoblastoma protein phosphorylation by dose-response curve analysis	B	C/C(=N/Nc1ncnc2sc(C(C)C)cc12)c1cccs1		CHEMBL472865	=	IC50	ug.mL-1	8.9	CHEMBL301	Homo sapiens	IC50	ug ml-1	8.9
	2600735	CHEMBL1029074	Inhibition of CDK2-mediated retinoblastoma protein phosphorylation by dose-response curve analysis	B	CC(C)c1cc2c(-n3ccc(-c4cccs4)n3)ncnc2s1		CHEMBL460426	>	IC50	ug.mL-1	20.0	CHEMBL301	Homo sapiens	IC50	ug ml-1	20.0
	2600736	CHEMBL1029074	Inhibition of CDK2-mediated retinoblastoma protein phosphorylation by dose-response curve analysis	B	CCc1cc2c(N/N=C\C(C)(C)C)ncnc2s1		CHEMBL511520	=	IC50	ug.mL-1	3.8	CHEMBL301	Homo sapiens	IC50	ug ml-1	3.8
	2600737	CHEMBL1029074	Inhibition of CDK2-mediated retinoblastoma protein phosphorylation by dose-response curve analysis	B	CCc1cc2c(N/N=C\C3CC3)ncnc2s1		CHEMBL460642	=	IC50	ug.mL-1	4.1	CHEMBL301	Homo sapiens	IC50	ug ml-1	4.1
	2600738	CHEMBL1029074	Inhibition of CDK2-mediated retinoblastoma protein phosphorylation by dose-response curve analysis	B	CC(C)c1cc2c(N/N=C\c3ccccn3)ncnc2s1		CHEMBL512389	=	IC50	ug.mL-1	3.1	CHEMBL301	Homo sapiens	IC50	ug ml-1	3.1
	2600739	CHEMBL1029074	Inhibition of CDK2-mediated retinoblastoma protein phosphorylation by dose-response curve analysis	B	CC(C)c1cc2c(N/N=C\c3cccnc3)ncnc2s1		CHEMBL460640	=	IC50	ug.mL-1	0.7	CHEMBL301	Homo sapiens	IC50	ug ml-1	0.7
	2600740	CHEMBL1029074	Inhibition of CDK2-mediated retinoblastoma protein phosphorylation by dose-response curve analysis	B	CC(C)c1cc2c(N/N=C\c3ccncc3)ncnc2s1		CHEMBL512390	=	IC50	ug.mL-1	0.33	CHEMBL301	Homo sapiens	IC50	ug ml-1	0.33
	2600741	CHEMBL1029074	Inhibition of CDK2-mediated retinoblastoma protein phosphorylation by dose-response curve analysis	B	CC(C)c1cc2c(N/N=C\c3ccccc3)ncnc2s1		CHEMBL460641	=	IC50	ug.mL-1	0.88	CHEMBL301	Homo sapiens	IC50	ug ml-1	0.88
	2600742	CHEMBL1029074	Inhibition of CDK2-mediated retinoblastoma protein phosphorylation by dose-response curve analysis	B	CC(C)c1cc2c(N/N=C\c3ccco3)ncnc2s1		CHEMBL460017	=	IC50	ug.mL-1	0.55	CHEMBL301	Homo sapiens	IC50	ug ml-1	0.55
	2600743	CHEMBL1029074	Inhibition of CDK2-mediated retinoblastoma protein phosphorylation by dose-response curve analysis	B	CC(C)(C)c1cc2c(N/N=C\c3ccccn3)ncnc2s1		CHEMBL461684	=	IC50	ug.mL-1	2.8	CHEMBL301	Homo sapiens	IC50	ug ml-1	2.8
	2600744	CHEMBL1029074	Inhibition of CDK2-mediated retinoblastoma protein phosphorylation by dose-response curve analysis	B	CC(C)(C)c1cc2c(N/N=C\c3cccnc3)ncnc2s1		CHEMBL461685	=	IC50	ug.mL-1	0.56	CHEMBL301	Homo sapiens	IC50	ug ml-1	0.56
	2600745	CHEMBL1029074	Inhibition of CDK2-mediated retinoblastoma protein phosphorylation by dose-response curve analysis	B	Cc1ccc(/C=N\Nc2ncnc3sc(C(C)(C)C)cc23)nc1		CHEMBL511357	=	IC50	ug.mL-1	12.0	CHEMBL301	Homo sapiens	IC50	ug ml-1	12.0
	2600746	CHEMBL1029074	Inhibition of CDK2-mediated retinoblastoma protein phosphorylation by dose-response curve analysis	B	Cc1cccc(/C=N\Nc2ncnc3sc(C(C)(C)C)cc23)n1		CHEMBL460401	=	IC50	ug.mL-1	6.9	CHEMBL301	Homo sapiens	IC50	ug ml-1	6.9
	2600747	CHEMBL1029074	Inhibition of CDK2-mediated retinoblastoma protein phosphorylation by dose-response curve analysis	B	CC(C)(C)c1cc2c(N/N=C\c3cccc(CN)n3)ncnc2s1		CHEMBL450370	=	IC50	ug.mL-1	3.6	CHEMBL301	Homo sapiens	IC50	ug ml-1	3.6
	2600748	CHEMBL1029074	Inhibition of CDK2-mediated retinoblastoma protein phosphorylation by dose-response curve analysis	B	CNCc1cccc(/C=N\Nc2ncnc3sc(C(C)(C)C)cc23)n1		CHEMBL518023	=	IC50	ug.mL-1	7.1	CHEMBL301	Homo sapiens	IC50	ug ml-1	7.1
	2600749	CHEMBL1029074	Inhibition of CDK2-mediated retinoblastoma protein phosphorylation by dose-response curve analysis	B	CN(C)Cc1cccc(/C=N\Nc2ncnc3sc(C(C)(C)C)cc23)n1		CHEMBL459363	=	IC50	ug.mL-1	1.4	CHEMBL301	Homo sapiens	IC50	ug ml-1	1.4
	2600750	CHEMBL1029074	Inhibition of CDK2-mediated retinoblastoma protein phosphorylation by dose-response curve analysis	B	CC(C)(C)c1cc2c(N/N=C\c3cccc(CN4CCOCC4)n3)ncnc2s1		CHEMBL459364	=	IC50	ug.mL-1	5.5	CHEMBL301	Homo sapiens	IC50	ug ml-1	5.5
	2600751	CHEMBL1029074	Inhibition of CDK2-mediated retinoblastoma protein phosphorylation by dose-response curve analysis	B	CC(C)(C)c1cc2c(N/N=C\c3cccc(CO)n3)ncnc2s1		CHEMBL459365	=	IC50	ug.mL-1	2.1	CHEMBL301	Homo sapiens	IC50	ug ml-1	2.1
Not Active	2600834	CHEMBL1029076	Inhibition of CDK2-mediated retinoblastoma protein phosphorylation up to 20 ug/mL by dose-response curve analysis	B	C(=N\Nc1ncnc2sc(Cc3ccccc3)cc12)\c1cccs1		CHEMBL475296		Activity			CHEMBL301	Homo sapiens	Activity		
	2602484	CHEMBL1034906	Inhibition of CDK2 at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccncc1		CHEMBL515880	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2602838	CHEMBL1034906	Inhibition of CDK2 at 10 uM by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCc1ccc2ccccc2n1		CHEMBL458532	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2602839	CHEMBL1034906	Inhibition of CDK2 at 10 uM by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCc1cnoc1		CHEMBL512380	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2602840	CHEMBL1034906	Inhibition of CDK2 at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccnc2ccccc12		CHEMBL458531	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2602841	CHEMBL1034906	Inhibition of CDK2 at 10 uM by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCc1ccnc2ccccc12		CHEMBL517399	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2602842	CHEMBL1034906	Inhibition of CDK2 at 10 uM by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCCc1ccc2c(c1)OCO2		CHEMBL462528	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2602843	CHEMBL1034906	Inhibition of CDK2 at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCCc1ccc2c(c1)OCO2		CHEMBL462527	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2602844	CHEMBL1034906	Inhibition of CDK2 at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccc(F)c(F)c1		CHEMBL518204	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2602845	CHEMBL1034906	Inhibition of CDK2 at 10 uM by HTRF assay	B	O=C(NCc1ccc2c(c1)OCO2)c1nscc1NCc1ccncc1		CHEMBL462315	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2602846	CHEMBL1034906	Inhibition of CDK2 at 10 uM by HTRF assay	B	Cc1ccc(NC(=O)c2nscc2NCc2ccncc2)c(F)c1		CHEMBL460191	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2602847	CHEMBL1034906	Inhibition of CDK2 at 10 uM by HTRF assay	B	Cc1cc(NC(=O)c2nscc2NCc2ccncc2)ccc1C(F)(F)F		CHEMBL512863	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2602848	CHEMBL1034906	Inhibition of CDK2 at 10 uM by HTRF assay	B	Cc1ccc(NC(=O)c2nscc2NCc2ccncc2)cc1C(F)(F)F		CHEMBL470441	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2602849	CHEMBL1034906	Inhibition of CDK2 at 10 uM by HTRF assay	B	O=C(Nc1ccc(Cl)c(Cl)c1)c1nscc1NCc1ccncc1		CHEMBL470440	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2602850	CHEMBL1034906	Inhibition of CDK2 at 10 uM by HTRF assay	B	O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1nscc1NCc1ccncc1		CHEMBL512862	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2602851	CHEMBL1034906	Inhibition of CDK2 at 10 uM by HTRF assay	B	O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)c1nscc1NCc1ccncc1		CHEMBL473268	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2602852	CHEMBL1034906	Inhibition of CDK2 at 10 uM by HTRF assay	B	O=C(NC1=CC2C=NNC2C=C1)c1nscc1NCc1ccncc1		CHEMBL443921	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2602853	CHEMBL1034906	Inhibition of CDK2 at 10 uM by HTRF assay	B	O=C(Nc1ccc2ccccc2n1)c1nscc1NCc1ccncc1		CHEMBL474709	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2602854	CHEMBL1034906	Inhibition of CDK2 at 10 uM by HTRF assay	B	O=C(Nc1ccccc1Br)c1nscc1NCc1ccncc1		CHEMBL509737	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2602855	CHEMBL1034906	Inhibition of CDK2 at 10 uM by HTRF assay	B	O=C(Nc1ccc(Br)cc1)c1nscc1NCc1ccncc1		CHEMBL473288	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2602856	CHEMBL1034906	Inhibition of CDK2 at 10 uM by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCc1ccncc1		CHEMBL473287	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2602857	CHEMBL1034906	Inhibition of CDK2 at 10 uM by HTRF assay	B	O=C(Nc1ccc(Cl)cc1)c1nscc1NCc1ccncc1		CHEMBL475709	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2602858	CHEMBL1034906	Inhibition of CDK2 at 10 uM by HTRF assay	B	CC(C)(C)c1ccc(NC(=O)c2nscc2NCc2ccncc2)cc1		CHEMBL475708	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2602859	CHEMBL1034906	Inhibition of CDK2 at 10 uM by HTRF assay	B	CC(C)(C)c1cccc(NC(=O)c2nscc2NCc2ccncc2)c1		CHEMBL475510	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2602860	CHEMBL1034906	Inhibition of CDK2 at 10 uM by HTRF assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1nscc1NCc1ccncc1		CHEMBL516243	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2602861	CHEMBL1034906	Inhibition of CDK2 at 10 uM by HTRF assay	B	O=C(Nc1cccc(OC(F)(F)F)c1)c1nscc1NCc1ccncc1		CHEMBL475509	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2602862	CHEMBL1034906	Inhibition of CDK2 at 10 uM by HTRF assay	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1nscc1NCc1ccccn1		CHEMBL474494	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2602863	CHEMBL1034906	Inhibition of CDK2 at 10 uM by HTRF assay	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1nscc1NCc1cccnc1		CHEMBL474293	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2602864	CHEMBL1034906	Inhibition of CDK2 at 10 uM by HTRF assay	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1nscc1NCc1ccncc1		CHEMBL475704	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2602865	CHEMBL1034906	Inhibition of CDK2 at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccccn1		CHEMBL475703	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2602866	CHEMBL1034906	Inhibition of CDK2 at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1cccnc1		CHEMBL514986	<	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	2613322	CHEMBL1016949	Inhibition of Cdk2	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	2613346	CHEMBL1015232	Inhibition of CDK2/cyclin A	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	2613490	CHEMBL1031532	Inhibition of CDK2	B	COc1ccc(-n2cnc3ccc(-c4nnc(SCc5cccc(C#N)c5)o4)cc32)cc1		CHEMBL516640	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	2618063	CHEMBL1016031	Inhibition of CDK2/Cyclin A	B	Cl.N[C@@H](CCCN/C=C1\C(=O)Nc2ccc(Br)cc21)C(=O)O		CHEMBL503236	=	IC50	nM	6600.0	CHEMBL301	Homo sapiens	IC50	uM	6.6
	2618064	CHEMBL1016031	Inhibition of CDK2/Cyclin A	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	IC50	nM	700.0	CHEMBL301	Homo sapiens	IC50	uM	0.7
	2619049	CHEMBL1035820	Inhibition of human CDK2/Cyclin E by IMAP assay	B	C=CCc1c(C)nc2sc3c(N)ncnc3c2c1C		CHEMBL463119	>	Ki	nM	5000.0	CHEMBL301	Homo sapiens	Ki	nM	5000.0
	2635910	CHEMBL1003340	Inhibition of CDK2/cyclin A at 1 uM relative to control	B	CSc1cc(Oc2ccnc3[nH]c(=O)[nH]c23)ccc1NC(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL496009	=	Residual_activity	%	100.0	CHEMBL301	Homo sapiens	Residual_activity	%	100.0
	2635978	CHEMBL1003340	Inhibition of CDK2/cyclin A at 1 uM relative to control	B	O=C(Nc1cc(C(F)(F)F)ccc1F)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)c2ccccc12		CHEMBL498112	=	Residual_activity	%	100.0	CHEMBL301	Homo sapiens	Residual_activity	%	100.0
	2636046	CHEMBL1003340	Inhibition of CDK2/cyclin A at 1 uM relative to control	B	CC(C)(C)c1cccc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)c1		CHEMBL496073	=	Residual_activity	%	100.0	CHEMBL301	Homo sapiens	Residual_activity	%	100.0
	2639191	CHEMBL1022928	Inhibition of CDK2	B	O[C@H]1CC[C@H](Nc2ccc3nnc(-c4cccc(C(F)(F)F)c4)n3n2)CC1		CHEMBL494221	=	Ki	nM	3100.0	CHEMBL301	Homo sapiens	Ki	nM	3100.0
	2639192	CHEMBL1022928	Inhibition of CDK2	B	FC(F)(F)c1cccc(-c2nnc3ccc(NC4CCNCC4)nn23)c1		CHEMBL493169	>	Ki	nM	4000.0	CHEMBL301	Homo sapiens	Ki	nM	4000.0
	2651600	CHEMBL1030223	Inhibition of CDK2 at 10 uM	B	Cc1cccc(-c2nc(Nc3ccncc3)c3ccccc3n2)n1		CHEMBL570533	=	Inhibition	%	2.0	CHEMBL301	Homo sapiens	INH	%	2.0
	2661253	CHEMBL1063936	Inhibition of CDK2/Cyclin A	B	CN1CCN(c2cccc(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3C)CC4)c2)CC1		CHEMBL559513	=	IC50	nM	1.0	CHEMBL301	Homo sapiens	IC50	uM	0.001
	2661254	CHEMBL1063936	Inhibition of CDK2/Cyclin A	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3)ncc1CC2		CHEMBL559845	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	IC50	uM	0.002
	2661255	CHEMBL1063936	Inhibition of CDK2/Cyclin A	B	CN1CCN(c2ccc(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3C)CC4)cc2)CC1		CHEMBL560817	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	IC50	uM	0.002
	2661256	CHEMBL1063936	Inhibition of CDK2/Cyclin A	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccc(N4CCOCC4)cc3)ncc1CC2		CHEMBL556881	=	IC50	nM	14.0	CHEMBL301	Homo sapiens	IC50	uM	0.014
	2661257	CHEMBL1063936	Inhibition of CDK2/Cyclin A	B	CN1CCN(c2ccc(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3C)C(C)(C)C4)cc2)CC1		CHEMBL563641	=	IC50	nM	17.0	CHEMBL301	Homo sapiens	IC50	uM	0.017
	2661258	CHEMBL1063936	Inhibition of CDK2/Cyclin A	B	CNC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccccc3)nc1-2		CHEMBL562104	=	IC50	nM	19.0	CHEMBL301	Homo sapiens	IC50	uM	0.019
	2661259	CHEMBL1063936	Inhibition of CDK2/Cyclin A	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3)ncc1CC2(C)C		CHEMBL560818	=	IC50	nM	24.0	CHEMBL301	Homo sapiens	IC50	uM	0.024
	2661260	CHEMBL1063936	Inhibition of CDK2/Cyclin A	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(OC4CCN(C)CC4)cc3)nc1-2		CHEMBL565137	=	IC50	nM	29.0	CHEMBL301	Homo sapiens	IC50	uM	0.029
	2661264	CHEMBL1063936	Inhibition of CDK2/Cyclin A	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3cccc(N4CCN(C)CC4)c3)nc1-2		CHEMBL564884	=	IC50	nM	31.0	CHEMBL301	Homo sapiens	IC50	uM	0.031
	2661265	CHEMBL1063936	Inhibition of CDK2/Cyclin A	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(CN(C)C)cc3)nc1-2		CHEMBL561440	=	IC50	nM	35.0	CHEMBL301	Homo sapiens	IC50	uM	0.035
	2661266	CHEMBL1063936	Inhibition of CDK2/Cyclin A	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(CN4CCOCC4)cc3)nc1-2		CHEMBL550959	=	IC50	nM	36.0	CHEMBL301	Homo sapiens	IC50	uM	0.036
	2661267	CHEMBL1063936	Inhibition of CDK2/Cyclin A	B	CNC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL559844	=	IC50	nM	45.0	CHEMBL301	Homo sapiens	IC50	uM	0.045
	2661268	CHEMBL1063936	Inhibition of CDK2/Cyclin A	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	IC50	nM	45.0	CHEMBL301	Homo sapiens	IC50	uM	0.045
	2661269	CHEMBL1063936	Inhibition of CDK2/Cyclin A	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3cccc(OC4CCN(C)CC4)c3)nc1-2		CHEMBL560102	=	IC50	nM	47.0	CHEMBL301	Homo sapiens	IC50	uM	0.047
	2661275	CHEMBL1063936	Inhibition of CDK2/Cyclin A	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(CN4CCN(C)CC4)cc3)nc1-2		CHEMBL549675	=	IC50	nM	55.0	CHEMBL301	Homo sapiens	IC50	uM	0.055
	2661276	CHEMBL1063936	Inhibition of CDK2/Cyclin A	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3cccc(CN4CCN(C)CC4)c3)nc1-2		CHEMBL564470	=	IC50	nM	59.0	CHEMBL301	Homo sapiens	IC50	uM	0.059
	2661277	CHEMBL1063936	Inhibition of CDK2/Cyclin A	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N(C)C)cc3)nc1-2		CHEMBL560301	=	IC50	nM	59.0	CHEMBL301	Homo sapiens	IC50	uM	0.059
	2661278	CHEMBL1063936	Inhibition of CDK2/Cyclin A	B	Cn1nc(C(=O)NCCO)c2c1-c1nc(Nc3ccccc3)ncc1CC2		CHEMBL538195	=	IC50	nM	74.0	CHEMBL301	Homo sapiens	IC50	uM	0.074
	2661279	CHEMBL1063936	Inhibition of CDK2/Cyclin A	B	Cn1nc(C(=O)NC2CC2)c2c1-c1nc(Nc3ccccc3)ncc1CC2		CHEMBL559639	=	IC50	nM	81.0	CHEMBL301	Homo sapiens	IC50	uM	0.081
	2661280	CHEMBL1063936	Inhibition of CDK2/Cyclin A	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3cccc(CN(C)C)c3)nc1-2		CHEMBL550964	=	IC50	nM	83.0	CHEMBL301	Homo sapiens	IC50	uM	0.083
	2661283	CHEMBL1063936	Inhibition of CDK2/Cyclin A	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCOCC4)cc3)nc1-2		CHEMBL565211	=	IC50	nM	137.0	CHEMBL301	Homo sapiens	IC50	uM	0.137
	2661285	CHEMBL1063936	Inhibition of CDK2/Cyclin A	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3cccc(CN4CCOCC4)c3)nc1-2		CHEMBL565160	=	IC50	nM	160.0	CHEMBL301	Homo sapiens	IC50	uM	0.16
	2661293	CHEMBL1063936	Inhibition of CDK2/Cyclin A	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3cccc(N(C)C)c3)nc1-2		CHEMBL563366	=	IC50	nM	220.0	CHEMBL301	Homo sapiens	IC50	uM	0.22
	2661295	CHEMBL1063936	Inhibition of CDK2/Cyclin A	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3cccc(N4CCOCC4)c3)nc1-2		CHEMBL560839	=	IC50	nM	248.0	CHEMBL301	Homo sapiens	IC50	uM	0.248
	2661299	CHEMBL1054635	Inhibition of CDK2/Cyclin E	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	IC50	nM	363.0	CHEMBL301	Homo sapiens	IC50	uM	0.363
	2661311	CHEMBL1063936	Inhibition of CDK2/Cyclin A	B	Cn1nc(C(=O)Nc2ccccc2)c2c1-c1nc(Nc3ccccc3)ncc1CC2		CHEMBL563150	=	IC50	nM	574.0	CHEMBL301	Homo sapiens	IC50	uM	0.574
	2661322	CHEMBL1063936	Inhibition of CDK2/Cyclin A	B	Cn1nc(C(=O)NCc2ccccc2)c2c1-c1nc(Nc3ccccc3)ncc1CC2		CHEMBL562030	=	IC50	nM	1053.0	CHEMBL301	Homo sapiens	IC50	uM	1.053
	2661333	CHEMBL1063936	Inhibition of CDK2/Cyclin A	B	Cn1nc(C(=O)NC2CCCC2)c2c1-c1nc(Nc3ccccc3)ncc1CC2		CHEMBL563028	=	IC50	nM	3900.0	CHEMBL301	Homo sapiens	IC50	uM	3.9
Active	2661390	CHEMBL1058595	Inhibition of CDK2 in human A2780 cells assessed as reduction of hyperphosphorylated form of retinoblastoma protein at 3 uM relative to control	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829		Activity			CHEMBL301	Homo sapiens	Activity		
Active	2661391	CHEMBL1058596	Inhibition of CDK2 in human A2780 cells assessed as accumulation of hypophosphorylated form of retinoblastoma protein at 1 uM relative to control	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829		Activity			CHEMBL301	Homo sapiens	Activity		
Active	2661392	CHEMBL1058597	Inhibition of CDK2 in human A2780 cells assessed as accumulation of hypophosphorylated form of retinoblastoma protein at 3 uM relative to control	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829		Activity			CHEMBL301	Homo sapiens	Activity		
Active	2661430	CHEMBL1058594	Inhibition of CDK2 in human A2780 cells assessed as reduction of hyperphosphorylated form of retinoblastoma protein at 1 uM relative to control	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829		Activity			CHEMBL301	Homo sapiens	Activity		
	2661581	CHEMBL1060445	Inhibition of CDK2/cyclinA after 1 hr by mobility shift electrophoresis assay	B	COC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(C(=O)OC)CC4)c3n2)cc1		CHEMBL561708	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	2671899	CHEMBL1026223	Inhibition of recombinant CDK2/CycA	B	COc1cc(O)c2c(c1)C(=O)C1=C(C2=O)[C@H](O)[C@@H](O)[C@@](C)(O)[C@@H]1O		CHEMBL512054	>	IC50	ug.mL-1	10.0	CHEMBL301	Homo sapiens	IC50	ug ml-1	10.0
	2671900	CHEMBL1026223	Inhibition of recombinant CDK2/CycA	B	COc1cc(O)c2c(c1)C(=O)c1cc(C)c(O)cc1C2=O		CHEMBL463054	>	IC50	ug.mL-1	10.0	CHEMBL301	Homo sapiens	IC50	ug ml-1	10.0
	2671901	CHEMBL1026223	Inhibition of recombinant CDK2/CycA	B	COc1cc(O)c2c(c1)C(=O)c1cc(C)c(O)c(O)c1C2=O		CHEMBL556684	>	IC50	ug.mL-1	10.0	CHEMBL301	Homo sapiens	IC50	ug ml-1	10.0
	2672310	CHEMBL1026223	Inhibition of recombinant CDK2/CycA	B	COc1cc2c(c(O)c1-c1c(OC)cc(O)c3c1C(=O)C1=C(C3=O)[C@H](O)[C@@H](O)[C@@](C)(O)[C@@H]1O)C(=O)c1cc(O)c(C)cc1C2=O		CHEMBL554993	>	IC50	ug.mL-1	10.0	CHEMBL301	Homo sapiens	IC50	ug ml-1	10.0
	2679763	CHEMBL1061363	Inhibition of CDK2/Cyclin A	B	CCSc1nn2c(COc3ccc(Cl)cc3)nnc2s1		CHEMBL557238	=	IC50	nM	24000.0	CHEMBL301	Homo sapiens	IC50	uM	24.0
	2679764	CHEMBL1061363	Inhibition of CDK2/Cyclin A	B	CCSc1nn2c(Cc3ccccc3)nnc2s1		CHEMBL557237	=	IC50	nM	24000.0	CHEMBL301	Homo sapiens	IC50	uM	24.0
	2679765	CHEMBL1061363	Inhibition of CDK2/Cyclin A	B	S=c1[nH]c(=S)c2c(Cc3nn4c(Cc5ccccc5)nnc4s3)n[nH]c2[nH]1		CHEMBL563674	=	IC50	nM	24000.0	CHEMBL301	Homo sapiens	IC50	uM	24.0
	2679766	CHEMBL1061363	Inhibition of CDK2/Cyclin A	B	Cc1nnc2sc(Cc3n[nH]c4[nH]c(=S)[nH]c(=S)c34)nn12		CHEMBL550855	=	IC50	nM	24000.0	CHEMBL301	Homo sapiens	IC50	uM	24.0
	2679767	CHEMBL1061363	Inhibition of CDK2/Cyclin A	B	Cc1nnc2sc(SSc3nn4c(C)nnc4s3)nn12		CHEMBL551318	=	IC50	nM	23000.0	CHEMBL301	Homo sapiens	IC50	uM	23.0
	2679768	CHEMBL1061363	Inhibition of CDK2/Cyclin A	B	Sc1nn2c(Cc3ccccc3)nnc2s1		CHEMBL550856	=	IC50	nM	23000.0	CHEMBL301	Homo sapiens	IC50	uM	23.0
	2679773	CHEMBL1061363	Inhibition of CDK2/Cyclin A	B	Cc1nnc2sc(SCc3ccccc3)nn12		CHEMBL561985	=	IC50	nM	16000.0	CHEMBL301	Homo sapiens	IC50	uM	16.0
	2679774	CHEMBL1061363	Inhibition of CDK2/Cyclin A	B	NNc1nn2c(COc3ccc(Cl)cc3)nnc2s1		CHEMBL570313	=	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	uM	15.0
	2679775	CHEMBL1061363	Inhibition of CDK2/Cyclin A	B	c1ccc(Cc2nnc3sc(SSc4nn5c(Cc6ccccc6)nnc5s4)nn23)cc1		CHEMBL556836	=	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	uM	15.0
	2679778	CHEMBL1061363	Inhibition of CDK2/Cyclin A	B	Nc1nc(O)c(Cc2nn3c(Cc4ccccc4)nnc3s2)s1		CHEMBL550712	=	IC50	nM	14000.0	CHEMBL301	Homo sapiens	IC50	uM	14.0
	2679782	CHEMBL1061363	Inhibition of CDK2/Cyclin A	B	Cc1nnc2sc(NN)nn12		CHEMBL551722	=	IC50	nM	11000.0	CHEMBL301	Homo sapiens	IC50	uM	11.0
	2679783	CHEMBL1061363	Inhibition of CDK2/Cyclin A	B	CCSc1nn2c(C)nnc2s1		CHEMBL542013	=	IC50	nM	11000.0	CHEMBL301	Homo sapiens	IC50	uM	11.0
	2679789	CHEMBL1061363	Inhibition of CDK2/Cyclin A	B	Cc1nnc2sc(S)nn12		CHEMBL540752	=	IC50	nM	6800.0	CHEMBL301	Homo sapiens	IC50	uM	6.8
	2679796	CHEMBL1061363	Inhibition of CDK2/Cyclin A	B	Clc1ccc(OCc2nnc3sc(SSc4nn5c(COc6ccc(Cl)cc6)nnc5s4)nn23)cc1		CHEMBL551258	=	IC50	nM	820.0	CHEMBL301	Homo sapiens	IC50	uM	0.82
	2679797	CHEMBL1061363	Inhibition of CDK2/Cyclin A	B	Cc1nnc2sc(-c3ccc(N)cc3)nn12		CHEMBL553906	=	IC50	nM	570.0	CHEMBL301	Homo sapiens	IC50	uM	0.57
	2679799	CHEMBL1061363	Inhibition of CDK2/Cyclin A	B	Sc1nn2c(COc3ccc(Cl)cc3)nnc2s1		CHEMBL555229	=	IC50	nM	400.0	CHEMBL301	Homo sapiens	IC50	uM	0.4
	2679800	CHEMBL1061363	Inhibition of CDK2/Cyclin A	B	Nc1ccc(-c2nn3c(COc4ccc(Cl)cc4)nnc3s2)cc1		CHEMBL561179	=	IC50	nM	330.0	CHEMBL301	Homo sapiens	IC50	uM	0.33
	2679801	CHEMBL1061363	Inhibition of CDK2/Cyclin A	B	Cc1nnc2sc(Cc3sc(N)nc3O)nn12		CHEMBL556214	=	IC50	nM	250.0	CHEMBL301	Homo sapiens	IC50	uM	0.25
	2679802	CHEMBL1061363	Inhibition of CDK2/Cyclin A	B	Nc1nc(O)c(Cc2nn3c(COc4ccc(Cl)cc4)nnc3s2)s1		CHEMBL559301	=	IC50	nM	180.0	CHEMBL301	Homo sapiens	IC50	uM	0.18
	2680324	CHEMBL1061363	Inhibition of CDK2/Cyclin A	B	S=c1[nH]c(=S)c2c(Cc3nn4c(COc5ccc(Cl)cc5)nnc4s3)n[nH]c2[nH]1		CHEMBL563733	=	IC50	nM	37000.0	CHEMBL301	Homo sapiens	IC50	uM	37.0
	2680339	CHEMBL1061363	Inhibition of CDK2/Cyclin A	B	Nc1ccc(-c2nn3c(Cc4ccccc4)nnc3s2)cc1		CHEMBL562319	>	IC50	nM	28000.0	CHEMBL301	Homo sapiens	IC50	uM	28.0
	2680340	CHEMBL1061363	Inhibition of CDK2/Cyclin A	B	c1ccc(CSc2nn3c(Cc4ccccc4)nnc3s2)cc1		CHEMBL551663	>	IC50	nM	28000.0	CHEMBL301	Homo sapiens	IC50	uM	28.0
	2680341	CHEMBL1061363	Inhibition of CDK2/Cyclin A	B	Clc1ccc(OCc2nnc3sc(SCc4ccccc4)nn23)cc1		CHEMBL551664	>	IC50	nM	28000.0	CHEMBL301	Homo sapiens	IC50	uM	28.0
	2680342	CHEMBL1061363	Inhibition of CDK2/Cyclin A	B	NNc1nn2c(Cc3ccccc3)nnc2s1		CHEMBL539917	>	IC50	nM	28000.0	CHEMBL301	Homo sapiens	IC50	uM	28.0
	2702933	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	O=C(C(=O)N1CCc2ccccc21)c1c[nH]c2ccccc12	Outside typical range	CHEMBL556712	=	IC50	nM	760000.0	CHEMBL301	Homo sapiens	IC50	uM	760.0
	2702934	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	O=C(C(=O)N1CCc2ccccc21)c1c[nH]c2ccc(F)cc12	Outside typical range	CHEMBL551612	=	IC50	nM	1160000.0	CHEMBL301	Homo sapiens	IC50	uM	1160.0
	2702935	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	O=C(C(=O)N1CCc2ccccc21)c1c[nH]c2ccc(Cl)cc12	Outside typical range	CHEMBL551936	=	IC50	nM	985000.0	CHEMBL301	Homo sapiens	IC50	uM	985.0
	2702936	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	Cc1ccc2[nH]cc(C(=O)C(=O)N3CCc4ccccc43)c2c1	Outside typical range	CHEMBL562198	=	IC50	nM	951000.0	CHEMBL301	Homo sapiens	IC50	uM	951.0
	2702937	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	O=C(C(=O)N1CCc2cc(F)ccc21)c1c[nH]c2ccccc12	Outside typical range	CHEMBL540971	=	IC50	nM	790000.0	CHEMBL301	Homo sapiens	IC50	uM	790.0
	2702938	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	O=C(C(=O)N1CCc2cc(Cl)ccc21)c1c[nH]c2ccccc12	Outside typical range	CHEMBL558601	=	IC50	nM	1030000.0	CHEMBL301	Homo sapiens	IC50	uM	1030.0
	2702939	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	Cc1ccc2c(c1)CCN2C(=O)C(=O)c1c[nH]c2ccccc12	Outside typical range	CHEMBL561136	=	IC50	nM	910000.0	CHEMBL301	Homo sapiens	IC50	uM	910.0
	2702940	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	O=C(C(=O)N1CCc2cc(F)ccc21)c1c[nH]c2ccc(F)cc12	Outside typical range	CHEMBL559683	=	IC50	nM	816000.0	CHEMBL301	Homo sapiens	IC50	uM	816.0
	2702941	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	O=C(C(=O)N1CCc2cc(Cl)ccc21)c1c[nH]c2ccc(Cl)cc12	Outside typical range	CHEMBL552136	=	IC50	nM	915000.0	CHEMBL301	Homo sapiens	IC50	uM	915.0
	2702942	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	Cc1ccc2c(c1)CCN2C(=O)C(=O)c1c[nH]c2ccc(C)cc12	Outside typical range	CHEMBL559882	=	IC50	nM	710000.0	CHEMBL301	Homo sapiens	IC50	uM	710.0
	2702943	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	c1ccc2c(c1)ccn2CCc1c[nH]c2ccccc12	Outside typical range	CHEMBL552214	>	IC50	nM	500000.0	CHEMBL301	Homo sapiens	IC50	uM	500.0
	2702944	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	Fc1ccc2[nH]cc(CCn3ccc4ccccc43)c2c1	Outside typical range	CHEMBL557321	=	IC50	nM	200000.0	CHEMBL301	Homo sapiens	IC50	uM	200.0
	2702945	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	Clc1ccc2[nH]cc(CCn3ccc4ccccc43)c2c1	Outside typical range	CHEMBL563159	>	IC50	nM	500000.0	CHEMBL301	Homo sapiens	IC50	uM	500.0
	2702946	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	Cc1ccc2[nH]cc(CCn3ccc4ccccc43)c2c1	Outside typical range	CHEMBL569847	=	IC50	nM	400000.0	CHEMBL301	Homo sapiens	IC50	uM	400.0
	2702947	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	Fc1ccc2c(ccn2CCc2c[nH]c3ccccc23)c1	Outside typical range	CHEMBL557525	>	IC50	nM	500000.0	CHEMBL301	Homo sapiens	IC50	uM	500.0
	2702948	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	Clc1ccc2c(ccn2CCc2c[nH]c3ccccc23)c1	Outside typical range	CHEMBL557049	=	IC50	nM	430000.0	CHEMBL301	Homo sapiens	IC50	uM	430.0
	2702949	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	Cc1ccc2c(ccn2CCc2c[nH]c3ccccc23)c1	Outside typical range	CHEMBL556095	=	IC50	nM	500000.0	CHEMBL301	Homo sapiens	IC50	uM	500.0
	2702950	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	Clc1ccc2c(ccn2CCc2c[nH]c3ccc(Cl)cc23)c1	Outside typical range	CHEMBL549303	=	IC50	nM	862000.0	CHEMBL301	Homo sapiens	IC50	uM	862.0
	2702951	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	Cc1ccc2c(ccn2CCc2c[nH]c3ccc(C)cc23)c1	Outside typical range	CHEMBL560278	=	IC50	nM	960000.0	CHEMBL301	Homo sapiens	IC50	uM	960.0
	2702952	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	c1ccc2c(c1)CCN2CCN1CCc2ccccc21	Outside typical range	CHEMBL557050	=	IC50	nM	1230000.0	CHEMBL301	Homo sapiens	IC50	uM	1230.0
ND(Insoluble)	2702953	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	c1ccc2c(c1)CCN2CCCN1CCc2ccccc21		CHEMBL549715		IC50			CHEMBL301	Homo sapiens	IC50		
ND(Insoluble)	2702954	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	c1ccc2c(c1)CCN2CCCCN1CCc2ccccc21		CHEMBL563333		IC50			CHEMBL301	Homo sapiens	IC50		
ND(Insoluble)	2702955	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	c1ccc2c(c1)CCN2CCCCCN1CCc2ccccc21		CHEMBL564333		IC50			CHEMBL301	Homo sapiens	IC50		
ND(Insoluble)	2702956	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	c1ccc2c(c1)CCN2CCCCCCN1CCc2ccccc21		CHEMBL549716		IC50			CHEMBL301	Homo sapiens	IC50		
	2702957	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	c1ccc2c(c1)ccn2CCn1ccc2ccccc21	Outside typical range	CHEMBL549792	=	IC50	nM	940000.0	CHEMBL301	Homo sapiens	IC50	uM	940.0
	2702958	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	c1ccc2c(c1)ccn2CCCn1ccc2ccccc21	Outside typical range	CHEMBL557456	=	IC50	nM	1070000.0	CHEMBL301	Homo sapiens	IC50	uM	1070.0
	2702959	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	c1ccc2c(c1)ccn2CCCCn1ccc2ccccc21	Outside typical range	CHEMBL558849	=	IC50	nM	1026000.0	CHEMBL301	Homo sapiens	IC50	uM	1026.0
	2702960	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	c1ccc2c(c1)ccn2CCCCCn1ccc2ccccc21	Outside typical range	CHEMBL560393	=	IC50	nM	950000.0	CHEMBL301	Homo sapiens	IC50	uM	950.0
	2702961	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	c1ccc2c(c1)ccn2CCCCCCn1ccc2ccccc21	Outside typical range	CHEMBL549850	=	IC50	nM	1210000.0	CHEMBL301	Homo sapiens	IC50	uM	1210.0
	2702962	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	Fc1ccc2c(ccn2CCc2c[nH]c3ccc(F)cc23)c1	Outside typical range	CHEMBL563948	=	IC50	nM	895000.0	CHEMBL301	Homo sapiens	IC50	uM	895.0
	2702964	CHEMBL1051861	Inhibition of human CDK2/ Cyclin A catalytic subunit expressed in Sf9 insect cells assessed as histone H1 phosphorylation-associated depletion in ATP level by luminescence assay	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21.[Cl-]	Outside typical range	CHEMBL258765	=	IC50	nM	500000.0	CHEMBL301	Homo sapiens	IC50	uM	500.0
	2721565	CHEMBL1060973	Inhibition of CDK2/cyclin A at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	2721566	CHEMBL1060974	Inhibition of CDK2/cyclin E at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	2722269	CHEMBL1063585	Inhibition of CDK2	B	Cc1ccc2c(c1)N(Cc1cc(F)cc3c1OCOC3)C(=O)/C2=N\O		CHEMBL551140	>	Ki	nM	30000.0	CHEMBL301	Homo sapiens	Ki	uM	30.0
Active	2727706	CHEMBL1056635	Effect on wild type recombinant CDK2/cyclin E1 assessed as p27kip1 phosphorylation after 1 hr by immunoblot analysis	B	C#CCNP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL557670		Activity			CHEMBL301	Homo sapiens	Activity		
Active	2727707	CHEMBL1056635	Effect on wild type recombinant CDK2/cyclin E1 assessed as p27kip1 phosphorylation after 1 hr by immunoblot analysis	B	[N-]=[N+]=Nc1ccc(NP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@H](O)[C@@H]2O)cc1		CHEMBL558335		Activity			CHEMBL301	Homo sapiens	Activity		
Active	2727708	CHEMBL1056635	Effect on wild type recombinant CDK2/cyclin E1 assessed as p27kip1 phosphorylation after 1 hr by immunoblot analysis	B	[N-]=[N+]=NCCOP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL564435		Activity			CHEMBL301	Homo sapiens	Activity		
Active	2727709	CHEMBL1056635	Effect on wild type recombinant CDK2/cyclin E1 assessed as p27kip1 phosphorylation after 1 hr by immunoblot analysis	B	[N-]=[N+]=NCCOCCOCCOCCNP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL553675		Activity			CHEMBL301	Homo sapiens	Activity		
Active	2727710	CHEMBL1056635	Effect on wild type recombinant CDK2/cyclin E1 assessed as p27kip1 phosphorylation after 1 hr by immunoblot analysis	B	[N-]=[N+]=NCCCCCCNP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL550942		Activity			CHEMBL301	Homo sapiens	Activity		
Active	2727711	CHEMBL1056635	Effect on wild type recombinant CDK2/cyclin E1 assessed as p27kip1 phosphorylation after 1 hr by immunoblot analysis	B	C=CCNP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL560604		Activity			CHEMBL301	Homo sapiens	Activity		
Active	2727712	CHEMBL1056635	Effect on wild type recombinant CDK2/cyclin E1 assessed as p27kip1 phosphorylation after 1 hr by immunoblot analysis	B	C#CCCCOP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL564508		Activity			CHEMBL301	Homo sapiens	Activity		
Active	2727713	CHEMBL1056635	Effect on wild type recombinant CDK2/cyclin E1 assessed as p27kip1 phosphorylation after 1 hr by immunoblot analysis	B	C#CCCCNP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL560883		Activity			CHEMBL301	Homo sapiens	Activity		
Active	2727714	CHEMBL1056635	Effect on wild type recombinant CDK2/cyclin E1 assessed as p27kip1 phosphorylation after 1 hr by immunoblot analysis	B	C#CCCNP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL551481		Activity			CHEMBL301	Homo sapiens	Activity		
	2892450	CHEMBL1061986	Selectivity for CDK2 as proportion of 290 kinases in screen with similar potency; non-selective = 1 highly selective = 0	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Selectivity		0.0588	CHEMBL301	Homo sapiens	Selectivity		0.0588
	2892451	CHEMBL1061986	Selectivity for CDK2 as proportion of 290 kinases in screen with similar potency; non-selective = 1 highly selective = 0	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Selectivity		0.1696	CHEMBL301	Homo sapiens	Selectivity		0.1696
	2892452	CHEMBL1061986	Selectivity for CDK2 as proportion of 290 kinases in screen with similar potency; non-selective = 1 highly selective = 0	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Selectivity		0.0833	CHEMBL301	Homo sapiens	Selectivity		0.0833
	2892453	CHEMBL1061986	Selectivity for CDK2 as proportion of 290 kinases in screen with similar potency; non-selective = 1 highly selective = 0	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Selectivity		0.0313	CHEMBL301	Homo sapiens	Selectivity		0.0313
	2897204	CHEMBL1063693	Percent residual CDK2-cyclinA activity in the presence of 10uM inhibitor	B	O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12		CHEMBL92361	=	Activity	%	91.0	CHEMBL301	Homo sapiens	Activity	%	91.0
	2897205	CHEMBL1063693	Percent residual CDK2-cyclinA activity in the presence of 10uM inhibitor	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Activity	%	18.0	CHEMBL301	Homo sapiens	Activity	%	18.0
	2897206	CHEMBL1063693	Percent residual CDK2-cyclinA activity in the presence of 10uM inhibitor	B	Cc1cc(O)c2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL289277	=	Activity	%	75.0	CHEMBL301	Homo sapiens	Activity	%	75.0
	2903695	CHEMBL1061138	Binding constant for full-length CDK2	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903696	CHEMBL1061138	Binding constant for full-length CDK2	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903697	CHEMBL1061138	Binding constant for full-length CDK2	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	760.0	CHEMBL301	Homo sapiens	Kd	nM	760.0
	2903698	CHEMBL1061138	Binding constant for full-length CDK2	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903699	CHEMBL1061138	Binding constant for full-length CDK2	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903700	CHEMBL1061138	Binding constant for full-length CDK2	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	69.0	CHEMBL301	Homo sapiens	Kd	nM	69.0
	2903701	CHEMBL1061138	Binding constant for full-length CDK2	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903702	CHEMBL1061138	Binding constant for full-length CDK2	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903703	CHEMBL1061138	Binding constant for full-length CDK2	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903704	CHEMBL1061138	Binding constant for full-length CDK2	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903705	CHEMBL1061138	Binding constant for full-length CDK2	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903706	CHEMBL1061138	Binding constant for full-length CDK2	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903707	CHEMBL1061138	Binding constant for full-length CDK2	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903708	CHEMBL1061138	Binding constant for full-length CDK2	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903709	CHEMBL1061138	Binding constant for full-length CDK2	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	550.0	CHEMBL301	Homo sapiens	Kd	nM	550.0
	2903710	CHEMBL1061138	Binding constant for full-length CDK2	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903711	CHEMBL1061138	Binding constant for full-length CDK2	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903712	CHEMBL1061138	Binding constant for full-length CDK2	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903713	CHEMBL1061138	Binding constant for full-length CDK2	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903714	CHEMBL1061138	Binding constant for full-length CDK2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	23.0	CHEMBL301	Homo sapiens	Kd	nM	23.0
	2903715	CHEMBL1061138	Binding constant for full-length CDK2	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903716	CHEMBL1061138	Binding constant for full-length CDK2	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903717	CHEMBL1061138	Binding constant for full-length CDK2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903718	CHEMBL1061138	Binding constant for full-length CDK2	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903719	CHEMBL1061138	Binding constant for full-length CDK2	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903720	CHEMBL1061138	Binding constant for full-length CDK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903721	CHEMBL1061138	Binding constant for full-length CDK2	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903722	CHEMBL1061138	Binding constant for full-length CDK2	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Kd	nM	3400.0	CHEMBL301	Homo sapiens	Kd	nM	3400.0
	2903723	CHEMBL1061138	Binding constant for full-length CDK2	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903724	CHEMBL1061138	Binding constant for full-length CDK2	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903725	CHEMBL1061138	Binding constant for full-length CDK2	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903726	CHEMBL1061138	Binding constant for full-length CDK2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903727	CHEMBL1061138	Binding constant for full-length CDK2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	7.0	CHEMBL301	Homo sapiens	Kd	nM	7.0
	2903728	CHEMBL1061138	Binding constant for full-length CDK2	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903729	CHEMBL1061138	Binding constant for full-length CDK2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903730	CHEMBL1061138	Binding constant for full-length CDK2	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903731	CHEMBL1061138	Binding constant for full-length CDK2	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2903732	CHEMBL1061138	Binding constant for full-length CDK2	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	2921408	CHEMBL1052884	Inhibition of CDK2 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL301	Homo sapiens	Activity	%	100.0
	2924032	CHEMBL1038775	Inhibition of C-terminal 6xHis-tagged CDK2 by [gamma-33-P]ATP based assay	B	Cc1ccc(-c2ccc3occ(-c4ccc([S@+](C)[O-])cc4)c3c2)o1		CHEMBL574588	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	2924033	CHEMBL1038775	Inhibition of C-terminal 6xHis-tagged CDK2 by [gamma-33-P]ATP based assay	B	CC[S@+]([O-])c1ccc(-c2coc3ccc(-c4ccc(C)o4)cc23)cc1		CHEMBL574613	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	2926222	CHEMBL1050234	Inhibition of CDK2 assessed as remaining enzyme activity at 3 uM relative to DMSO	B	COc1ccccc1-n1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL574236	=	Activity	%	97.0	CHEMBL301	Homo sapiens	Activity	%	97.0
	2928408	CHEMBL1060306	Inhibition of CDK2 assessed as remaining enzyme activity at 1 uM relative to DMSO	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	90.0	CHEMBL301	Homo sapiens	Activity	%	90.0
	2938296	CHEMBL1044905	Inhibition of CDK2	B	COc1cccc(Nc2ncc(C)c(-c3c[nH]c(C(=O)N[C@H](CO)c4cccc(Cl)c4)c3)n2)c1OC		CHEMBL569181	>	Ki	nM	2500.0	CHEMBL301	Homo sapiens	Ki	nM	2500.0
	2938297	CHEMBL1044905	Inhibition of CDK2	B	Cc1cnc(Nc2cccc3c2OCCO3)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL571722	=	Ki	nM	138.0	CHEMBL301	Homo sapiens	Ki	nM	138.0
	2938298	CHEMBL1044905	Inhibition of CDK2	B	Cc1cnc(Nc2cccc3c2OC(F)(F)O3)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL576683	=	Ki	nM	170.0	CHEMBL301	Homo sapiens	Ki	nM	170.0
	2938299	CHEMBL1044905	Inhibition of CDK2	B	Cc1cnc(Nc2cccc3c2OCO3)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL571484	=	Ki	nM	209.0	CHEMBL301	Homo sapiens	Ki	nM	209.0
	2938300	CHEMBL1044905	Inhibition of CDK2	B	Cc1cnc(Nc2cccc3c2CCCC3)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL570111	=	Ki	nM	250.0	CHEMBL301	Homo sapiens	Ki	nM	250.0
	2938301	CHEMBL1044905	Inhibition of CDK2	B	Cc1cnc(Nc2cccc3c2CCC3)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL568937	=	Ki	nM	642.0	CHEMBL301	Homo sapiens	Ki	nM	642.0
	2938302	CHEMBL1044905	Inhibition of CDK2	B	CCc1ccccc1Nc1ncc(C)c(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)n1		CHEMBL571056	=	Ki	nM	450.0	CHEMBL301	Homo sapiens	Ki	nM	450.0
	2938303	CHEMBL1044905	Inhibition of CDK2	B	Cc1cnc(Nc2ccc(Cl)cc2F)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL576048	=	Ki	nM	316.0	CHEMBL301	Homo sapiens	Ki	nM	316.0
	2938304	CHEMBL1044905	Inhibition of CDK2	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Ki	nM	852.0	CHEMBL301	Homo sapiens	Ki	nM	852.0
	2938305	CHEMBL1044905	Inhibition of CDK2	B	Cc1cc(Cl)ccc1Nc1ncc(C)c(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)n1		CHEMBL568483	=	Ki	nM	76.0	CHEMBL301	Homo sapiens	Ki	nM	76.0
	2938306	CHEMBL1044905	Inhibition of CDK2	B	Cc1cnc(Nc2cccc(F)c2C)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL582829	=	Ki	nM	150.0	CHEMBL301	Homo sapiens	Ki	nM	150.0
	2938307	CHEMBL1044905	Inhibition of CDK2	B	Cc1cnc(Nc2cccc(C)c2C)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL572157	=	Ki	nM	41.0	CHEMBL301	Homo sapiens	Ki	nM	41.0
	2938308	CHEMBL1044905	Inhibition of CDK2	B	Cc1cccc([C@@H](CO)NC(=O)c2cc(-c3nc(Nc4ccccc4)ncc3C)c[nH]2)c1		CHEMBL565460	=	Ki	nM	69.0	CHEMBL301	Homo sapiens	Ki	nM	69.0
	2938309	CHEMBL1044905	Inhibition of CDK2	B	Cc1cnc(Nc2ccccc2)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL577193	=	Ki	nM	290.0	CHEMBL301	Homo sapiens	Ki	nM	290.0
	2938310	CHEMBL1044905	Inhibition of CDK2	B	Cc1cnc(Nc2ccccc2)nc1-c1c[nH]c(C(=O)N[C@@H](CO)c2ccccc2)c1		CHEMBL570367	=	Ki	nM	1100.0	CHEMBL301	Homo sapiens	Ki	nM	1100.0
	2938311	CHEMBL1044905	Inhibition of CDK2	B	Cc1cnc(Nc2ccccc2O)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2ccccc2)c1		CHEMBL570366	<	Ki	nM	100.0	CHEMBL301	Homo sapiens	Ki	nM	100.0
	2938312	CHEMBL1044905	Inhibition of CDK2	B	Cc1cnc(Nc2ccccc2C(F)(F)F)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2ccccc2)c1		CHEMBL571030	>	Ki	nM	4000.0	CHEMBL301	Homo sapiens	Ki	nM	4000.0
	2938313	CHEMBL1044905	Inhibition of CDK2	B	Cc1cnc(Nc2ccccc2F)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2ccccc2)c1		CHEMBL572162	=	Ki	nM	57.0	CHEMBL301	Homo sapiens	Ki	nM	57.0
	2938314	CHEMBL1044905	Inhibition of CDK2	B	CCc1ccccc1Nc1ncc(C)c(-c2c[nH]c(C(=O)N[C@H](CO)c3ccccc3)c2)n1		CHEMBL572361	=	Ki	nM	210.0	CHEMBL301	Homo sapiens	Ki	nM	210.0
	2938315	CHEMBL1044905	Inhibition of CDK2	B	Cc1ccccc1Nc1ncc(C)c(-c2c[nH]c(C(=O)N[C@H](CO)c3ccccc3)c2)n1		CHEMBL584754	=	Ki	nM	140.0	CHEMBL301	Homo sapiens	Ki	nM	140.0
	2938316	CHEMBL1044905	Inhibition of CDK2	B	Cc1cnc(Nc2ccccc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2ccccc2)c1		CHEMBL571038	=	Ki	nM	240.0	CHEMBL301	Homo sapiens	Ki	nM	240.0
	2938317	CHEMBL1044905	Inhibition of CDK2	B	Cc1cnc(Nc2ccccc2)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2ccccc2)c1		CHEMBL565459	=	Ki	nM	16.0	CHEMBL301	Homo sapiens	Ki	nM	16.0
Not Active	2938615	CHEMBL1041485	Inhibition of CDK2 at 10 uM	B	O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL565286		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Determined	2939236	CHEMBL1044905	Inhibition of CDK2	B	Cc1cnc(Nc2ccccc2)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(F)c2)c1		CHEMBL569869		Ki			CHEMBL301	Homo sapiens	Ki		
Not Determined	2939237	CHEMBL1044905	Inhibition of CDK2	B	Cc1ccccc1Nc1ncc(C)c(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)n1		CHEMBL571031		Ki			CHEMBL301	Homo sapiens	Ki		
	2942578	CHEMBL1060308	Inhibition of CDK2 by HTRF assay	B	O=c1[nH]c(CN2CC[C@H](O)C2)nc2c1sc1ccc(-c3ccc(O)cc3)cc12		CHEMBL583187	>	Ki	nM	1000.0	CHEMBL301	Homo sapiens	Ki	microM	1.0
	2942579	CHEMBL1060308	Inhibition of CDK2 by HTRF assay	B	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	>	Ki	nM	1000.0	CHEMBL301	Homo sapiens	Ki	microM	1.0
	2943700	CHEMBL1044079	Inhibition of CDK2	B	C=CC(=O)N1CCC[C@H]1C(=O)Nc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OCCOC		CHEMBL571040	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	microM	10.0
	2943712	CHEMBL1044079	Inhibition of CDK2	B	C=CC(=O)N1CCC[C@H]1C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3F)ncnc2cc1OCCOC		CHEMBL569880	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	microM	10.0
	2943958	CHEMBL1039604	Inhibition of CDK2	B	Cc1c(I)c(=O)n(C2CCCC2)c2nc(Nc3ccc(N4CCNCC4)cc3)ncc12		CHEMBL190460	>	IC50	nM	360.0	CHEMBL301	Homo sapiens	IC50	nM	360.0
	2946001	CHEMBL1054426	Inhibition of CDK2 at 2 uM	B	c1ccc2c(c1)CC(Nc1nc(Nc3ccncc3)nc(N3CCNCC3)n1)C2		CHEMBL575741	<	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	2981340	CHEMBL1043448	Inhibition of CDK2	B	Cc1cc(Nc2cnc(C#N)c(N[C@@H](C)c3ncc(F)cn3)n2)n[nH]1		CHEMBL570002	=	IC50	nM	50.0	CHEMBL301	Homo sapiens	IC50	uM	0.05
	2981341	CHEMBL1043448	Inhibition of CDK2	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)c(C#N)nc2C)n[nH]1		CHEMBL569720	=	IC50	nM	410.0	CHEMBL301	Homo sapiens	IC50	uM	0.41
	2981342	CHEMBL1043448	Inhibition of CDK2	B	Cc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)c(C#N)nc2C)n[nH]1		CHEMBL578201	=	IC50	nM	460.0	CHEMBL301	Homo sapiens	IC50	uM	0.46
	2981343	CHEMBL1043448	Inhibition of CDK2	B	Cc1cc(Nc2cnc(C#N)c(N[C@@H](C)c3ccc(F)cn3)n2)n[nH]1		CHEMBL576257	=	IC50	nM	30.0	CHEMBL301	Homo sapiens	IC50	uM	0.03
	3062449	CHEMBL1048642	Binding affinity to human CDK2 at 200 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595545	=	Activity	%	100.0	CHEMBL301	Homo sapiens	Activity	%	100.0
	3063584	CHEMBL1045170	Binding affinity to human CDK2 at 500 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Activity	%	69.0	CHEMBL301	Homo sapiens	Activity	%	69.0
	3063674	CHEMBL1038885	Binding affinity to human CDK2 at 50 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL609010	=	Activity	%	100.0	CHEMBL301	Homo sapiens	Activity	%	100.0
	3063751	CHEMBL1048619	Ratio of compound to staurosporine binding affinity to human CDK2 in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Selectivity ratio		50.0	CHEMBL301	Homo sapiens	Selectivity ratio		50.0
	3065854	CHEMBL1069284	Inhibition of CDK2 at 10 uM	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Inhibition	%	4.0	CHEMBL301	Homo sapiens	INH	%	4.0
	3066920	CHEMBL1069284	Inhibition of CDK2 at 10 uM	B	O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21		CHEMBL607196	=	Inhibition	%	0.0	CHEMBL301	Homo sapiens	INH	%	0.0
	3084381	CHEMBL1072660	Inhibition of CDK2	B	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	IC50	nM	140.0	CHEMBL301	Homo sapiens	IC50	uM	0.14
	3089494	CHEMBL1067351	Inhibition of CDK2	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC[C@@H](N)C2)ccc2[nH]ccc12		CHEMBL606245	=	IC50	nM	17000.0	CHEMBL301	Homo sapiens	IC50	nM	17000.0
	3091504	CHEMBL1067148	Inhibition of CDK2	B	O=C(O)c1cc2c(c3c1c([N+](=O)[O-])cc1ccccc13)OCO2		CHEMBL602280	>	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	3091505	CHEMBL1067148	Inhibition of CDK2	B	COc1cccc2c1cc([N+](=O)[O-])c1c(C(=O)O)cc3c(c12)OCO3		CHEMBL93353	>	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	3091506	CHEMBL1067148	Inhibition of CDK2	B	COc1cccc2c1c(OC)c([N+](=O)[O-])c1c(C(=O)O)cc3c(c12)OCO3		CHEMBL601663	>	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	3091507	CHEMBL1067148	Inhibition of CDK2	B	COc1cc(OC)c2cc([N+](=O)[O-])c3c(C(=O)O)cc4c(c3c2c1)OCO4		CHEMBL465004	>	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	3091508	CHEMBL1067148	Inhibition of CDK2	B	O=C(O)c1cc2c(c3c1c([N+](=O)[O-])cc1ccc(O)cc13)OCO2		CHEMBL603494	=	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	3091509	CHEMBL1067148	Inhibition of CDK2	B	COc1c(O)ccc2c1cc([N+](=O)[O-])c1c(C(=O)O)cc3c(c12)OCO3		CHEMBL600828	=	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	3091510	CHEMBL1067148	Inhibition of CDK2	B	COc1cc(O)cc2c1cc([N+](=O)[O-])c1c(C(=O)O)cc3c(c12)OCO3		CHEMBL604748	=	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	3091511	CHEMBL1067148	Inhibition of CDK2	B	O=C(O)c1cc2c(c3c1c([N+](=O)[O-])cc1c(O)cccc13)OCO2		CHEMBL601026	=	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	uM	15.0
	3091512	CHEMBL1067148	Inhibition of CDK2	B	COc1ccc2cc([N+](=O)[O-])c3c(C(=O)O)cc4c(c3c2c1)OCO4		CHEMBL601027	>	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	3091513	CHEMBL1067148	Inhibition of CDK2	B	O=C(O)c1cc(O)c(O)c2c1c([N+](=O)[O-])cc1ccccc12		CHEMBL600386	=	IC50	nM	13400.0	CHEMBL301	Homo sapiens	IC50	uM	13.4
	3091514	CHEMBL1067148	Inhibition of CDK2	B	O=C(O)c1cc(O)c(O)c2c1c([N+](=O)[O-])c(Cl)c1ccccc12		CHEMBL600387	=	IC50	nM	18000.0	CHEMBL301	Homo sapiens	IC50	uM	18.0
	3091515	CHEMBL1067148	Inhibition of CDK2	B	COc1cccc2c1cc([N+](=O)[O-])c1c(C(=O)O)cc(O)c(O)c12		CHEMBL599986	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	3091516	CHEMBL1067148	Inhibition of CDK2	B	O=C(O)c1cc(O)c(O)c2c1c([N+](=O)[O-])cc1c(O)cccc12		CHEMBL599987	=	IC50	nM	5700.0	CHEMBL301	Homo sapiens	IC50	uM	5.7
	3091517	CHEMBL1067148	Inhibition of CDK2	B	COc1cccc2c1c(Cl)c([N+](=O)[O-])c1c(C(=O)O)cc(O)c(O)c12		CHEMBL606426	=	IC50	nM	16500.0	CHEMBL301	Homo sapiens	IC50	uM	16.5
	3091518	CHEMBL1067148	Inhibition of CDK2	B	O=C1Nc2cc3ccccc3c3c4c(cc1c23)OCO4		CHEMBL603073	=	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	uM	15.0
	3091519	CHEMBL1067148	Inhibition of CDK2	B	COc1cccc2c1cc1c3c(cc4c(c32)OCO4)C(=O)N1		CHEMBL479127	=	IC50	nM	1200.0	CHEMBL301	Homo sapiens	IC50	uM	1.2
	3091520	CHEMBL1067148	Inhibition of CDK2	B	COc1ccc2c(cc3c4c(cc5c(c42)OCO5)C(=O)N3)c1OC		CHEMBL605632	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	uM	15.0
	3091521	CHEMBL1067148	Inhibition of CDK2	B	COc1cc(OC)c2cc3c4c(cc5c(c4c2c1)OCO5)C(=O)N3		CHEMBL598535	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	uM	15.0
	3091522	CHEMBL1067148	Inhibition of CDK2	B	COc1c(O)ccc2c1cc1c3c(cc4c(c32)OCO4)C(=O)N1		CHEMBL598724	=	IC50	nM	2900.0	CHEMBL301	Homo sapiens	IC50	uM	2.9
	3091523	CHEMBL1067148	Inhibition of CDK2	B	COc1cc(O)cc2c1cc1c3c(cc4c(c32)OCO4)C(=O)N1		CHEMBL602733	>	IC50	nM	35000.0	CHEMBL301	Homo sapiens	IC50	uM	35.0
	3091524	CHEMBL1067148	Inhibition of CDK2	B	O=C1Nc2cc3c(O)cccc3c3c4c(cc1c23)OCO4		CHEMBL609040	=	IC50	nM	35.0	CHEMBL301	Homo sapiens	IC50	uM	0.035
	3091525	CHEMBL1067148	Inhibition of CDK2	B	O=C1Nc2cc3c(O)c(O)ccc3c3c4c(cc1c23)OCO4		CHEMBL611081	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	3091526	CHEMBL1067148	Inhibition of CDK2	B	O=C1Nc2cc3c(O)cc(O)cc3c3c4c(cc1c23)OCO4		CHEMBL599312	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	3091527	CHEMBL1067148	Inhibition of CDK2	B	O=C1Nc2cc3ccc(O)cc3c3c4c(cc1c23)OCO4		CHEMBL607579	=	IC50	nM	2150.0	CHEMBL301	Homo sapiens	IC50	uM	2.15
	3091528	CHEMBL1067148	Inhibition of CDK2	B	COc1cccc2c1cc1c3c(cc4c(c32)OCO4)C(=O)N1C		CHEMBL599313	>	IC50	nM	35000.0	CHEMBL301	Homo sapiens	IC50	uM	35.0
	3091529	CHEMBL1067148	Inhibition of CDK2	B	CN1C(=O)c2cc3c(c4c2c1cc1c(O)cccc14)OCO3		CHEMBL599330	>	IC50	nM	35000.0	CHEMBL301	Homo sapiens	IC50	uM	35.0
	3091530	CHEMBL1067148	Inhibition of CDK2	B	O=C1Nc2cc3ccccc3c3c(O)c(O)cc1c23		CHEMBL604806	>	IC50	nM	35000.0	CHEMBL301	Homo sapiens	IC50	uM	35.0
	3091531	CHEMBL1067148	Inhibition of CDK2	B	O=C1Nc2c(Cl)c3ccccc3c3c(O)c(O)cc1c23		CHEMBL600402	>	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	3091532	CHEMBL1067148	Inhibition of CDK2	B	COc1cccc2c1cc1c3c(cc(O)c(O)c32)C(=O)N1		CHEMBL605577	>	IC50	nM	35000.0	CHEMBL301	Homo sapiens	IC50	uM	35.0
	3091533	CHEMBL1067148	Inhibition of CDK2	B	O=C1Nc2cc3c(O)cccc3c3c(O)c(O)cc1c23		CHEMBL600403	>	IC50	nM	35000.0	CHEMBL301	Homo sapiens	IC50	uM	35.0
	3091534	CHEMBL1067148	Inhibition of CDK2	B	COc1cccc2c1c(Cl)c1c3c(cc(O)c(O)c32)C(=O)N1		CHEMBL602679	=	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	3091535	CHEMBL1067148	Inhibition of CDK2	B	COc1cc2c(cc1OC)-c1c3c(cc4c1[C@H](C2)N(C)CC4)OCO3		CHEMBL464748	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	3091536	CHEMBL1067148	Inhibition of CDK2	B	COc1ccc2c(c1OC)CC1c3c(cc4c(c3-2)OCO4)CCN1C		CHEMBL604339	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	3091537	CHEMBL1067148	Inhibition of CDK2	B	Br.CN1CCc2cc3c(c4c2[C@H]1Cc1ccccc1-4)OCO3		CHEMBL602275	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	3091538	CHEMBL1067148	Inhibition of CDK2	B	COc1ccc2c(c1O)-c1c(OC)c(OC)cc3c1[C@H](C2)N(C)CC3		CHEMBL489525	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	3091539	CHEMBL1067148	Inhibition of CDK2	B	COc1cc2c3c(c1O)-c1c(ccc(OC)c1OC)C[C@@H]3N(C)CC2		CHEMBL489524	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	3091540	CHEMBL1067148	Inhibition of CDK2	B	COc1ccc2c(c1O)-c1c(O)c(OC)cc3c1[C@H](C2)N(C)CC3		CHEMBL227965	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	3091541	CHEMBL1067148	Inhibition of CDK2	B	COC1=C[C@]23CCN(C)[C@H](Cc4ccc(OC)c(O)c42)C3=CC1=O		CHEMBL404097	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	3091542	CHEMBL1067148	Inhibition of CDK2	B	COC1=C[C@@H]2[C@@H]3Cc4ccc(OC)c(O)c4[C@]2(CCN3C)CC1=O		CHEMBL248095	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	3091543	CHEMBL1067148	Inhibition of CDK2	B	COc1cccc2c1C[C@@H]1c3c(cc4c(c3-2)OCO4)CCN1C		CHEMBL601020	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	3091544	CHEMBL1067148	Inhibition of CDK2	B	COc1ccc2c(c1OC)CN1CCc3cc4c(cc3C1C2)OCO4		CHEMBL275097	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	3091545	CHEMBL1067148	Inhibition of CDK2	B	COc1c(O)cc2c3c(cc4ccc(O)cc4c13)NC2=O		CHEMBL388956	=	IC50	nM	140.0	CHEMBL301	Homo sapiens	IC50	uM	0.14
	3091546	CHEMBL1067148	Inhibition of CDK2	B	COc1ccc2nc3[nH]nc(C)c3c(OC)c2c1		CHEMBL603097	=	IC50	nM	20.0	CHEMBL301	Homo sapiens	IC50	uM	0.02
Not Active	3091564	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	O=C(O)c1cc2c(c3c1c([N+](=O)[O-])cc1ccccc13)OCO2		CHEMBL602280		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3091565	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	COc1cccc2c1cc([N+](=O)[O-])c1c(C(=O)O)cc3c(c12)OCO3		CHEMBL93353		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3091566	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	COc1cccc2c1c(OC)c([N+](=O)[O-])c1c(C(=O)O)cc3c(c12)OCO3		CHEMBL601663		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3091567	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	COc1cc(OC)c2cc([N+](=O)[O-])c3c(C(=O)O)cc4c(c3c2c1)OCO4		CHEMBL465004		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3091568	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	O=C(O)c1cc2c(c3c1c([N+](=O)[O-])cc1ccc(O)cc13)OCO2		CHEMBL603494		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3091569	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	COc1c(O)ccc2c1cc([N+](=O)[O-])c1c(C(=O)O)cc3c(c12)OCO3		CHEMBL600828		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3091570	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	COc1cc(O)cc2c1cc([N+](=O)[O-])c1c(C(=O)O)cc3c(c12)OCO3		CHEMBL604748		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3091571	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	O=C(O)c1cc2c(c3c1c([N+](=O)[O-])cc1c(O)cccc13)OCO2		CHEMBL601026		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3091572	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	COc1ccc2cc([N+](=O)[O-])c3c(C(=O)O)cc4c(c3c2c1)OCO4		CHEMBL601027		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3091573	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	O=C(O)c1cc(O)c(O)c2c1c([N+](=O)[O-])cc1ccccc12		CHEMBL600386		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3091574	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	O=C(O)c1cc(O)c(O)c2c1c([N+](=O)[O-])c(Cl)c1ccccc12		CHEMBL600387		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3091575	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	COc1cccc2c1cc([N+](=O)[O-])c1c(C(=O)O)cc(O)c(O)c12		CHEMBL599986		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3091576	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	O=C(O)c1cc(O)c(O)c2c1c([N+](=O)[O-])cc1c(O)cccc12		CHEMBL599987		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3091577	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	COc1cccc2c1c(Cl)c([N+](=O)[O-])c1c(C(=O)O)cc(O)c(O)c12		CHEMBL606426		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3091578	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	O=C1Nc2cc3ccccc3c3c4c(cc1c23)OCO4		CHEMBL603073		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3091579	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	COc1cccc2c1cc1c3c(cc4c(c32)OCO4)C(=O)N1		CHEMBL479127		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3091580	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	COc1ccc2c(cc3c4c(cc5c(c42)OCO5)C(=O)N3)c1OC		CHEMBL605632		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3091581	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	COc1cc(OC)c2cc3c4c(cc5c(c4c2c1)OCO5)C(=O)N3		CHEMBL598535		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3091582	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	COc1c(O)ccc2c1cc1c3c(cc4c(c32)OCO4)C(=O)N1		CHEMBL598724		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3091583	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	COc1cc(O)cc2c1cc1c3c(cc4c(c32)OCO4)C(=O)N1		CHEMBL602733		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3091584	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	O=C1Nc2cc3c(O)cccc3c3c4c(cc1c23)OCO4		CHEMBL609040		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3091585	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	O=C1Nc2cc3c(O)c(O)ccc3c3c4c(cc1c23)OCO4		CHEMBL611081		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3091586	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	O=C1Nc2cc3c(O)cc(O)cc3c3c4c(cc1c23)OCO4		CHEMBL599312		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3091587	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	O=C1Nc2cc3ccc(O)cc3c3c4c(cc1c23)OCO4		CHEMBL607579		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3091588	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	COc1cccc2c1cc1c3c(cc4c(c32)OCO4)C(=O)N1C		CHEMBL599313		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3091589	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	CN1C(=O)c2cc3c(c4c2c1cc1c(O)cccc14)OCO3		CHEMBL599330		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3091590	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	O=C1Nc2cc3ccccc3c3c(O)c(O)cc1c23		CHEMBL604806		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3091591	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	O=C1Nc2c(Cl)c3ccccc3c3c(O)c(O)cc1c23		CHEMBL600402		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3091592	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	COc1cccc2c1cc1c3c(cc(O)c(O)c32)C(=O)N1		CHEMBL605577		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3091593	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	O=C1Nc2cc3c(O)cccc3c3c(O)c(O)cc1c23		CHEMBL600403		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3091594	CHEMBL1067154	Inhibition of CDK2 at 50 uM	B	COc1cccc2c1c(Cl)c1c3c(cc(O)c(O)c32)C(=O)N1		CHEMBL602679		Activity			CHEMBL301	Homo sapiens	Activity		
	3094273	CHEMBL1073144	Inhibition of CDK2	B	COc1c(O)cc2c3c(cc4ccc(O)cc4c13)NC2=O		CHEMBL388956	=	IC50	nM	140.0	CHEMBL301	Homo sapiens	IC50	nM	140.0
	3094278	CHEMBL1073144	Inhibition of CDK2	B	O=C1Nc2cc3c(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cccc3c3c4c(cc1c23)OCO4		CHEMBL601640	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	3104129	CHEMBL1068932	Inhibition of recombinant CDK2 by IMAP assay	B	C[C@@H](Oc1ccc2ncccc2c1)c1c(Cl)ccc(F)c1Cl		CHEMBL600795	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	3104156	CHEMBL1068932	Inhibition of recombinant CDK2 by IMAP assay	B	C[C@@H](Oc1ccc2ncc(C3CC3C(N)=O)cc2c1)c1c(Cl)ccc(F)c1Cl		CHEMBL602472	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	3104235	CHEMBL1068932	Inhibition of recombinant CDK2 by IMAP assay	B	C[C@@H](Oc1ccc2ncc(/C=C/C(N)=O)cc2c1)c1c(Cl)ccc(F)c1Cl		CHEMBL602471	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	3110868	CHEMBL1071097	Inhibition of CDK2	B	Nc1nn(-c2cccc(-c3ccc4cc[nH]c4c3)c2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL597839	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
Active	3118087	CHEMBL1072241	Inhibition of CDK2 in human A2780 cells assessed as reduction in hyperphosphorylated pRb level at 1 to 3 uM after 24 hrs by immunoblot	B	CNC(=O)c1nn(C)c2c1CCc1cnc(NC3CCN(C(=O)C4CCN(S(C)(=O)=O)CC4)CC3)nc1-2		CHEMBL597754		Activity			CHEMBL301	Homo sapiens	Activity		
	3130830	CHEMBL1066173	Inhibition of CDK2 at 3 to 6 uM relative to control	B	COc1ccc(C(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1OC		CHEMBL604087	>	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	3131745	CHEMBL1065750	Inhibition of CDK2 at 3 uM relative to control	B	NC(=O)c1ccc(NC(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1		CHEMBL600852	>	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	3186452	CHEMBL1113277	Inhibition of Cdk2 at 20 uM	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccccc3)cc12		CHEMBL1095040	=	Inhibition	%	93.0	CHEMBL301	Homo sapiens	INH	%	93.0
	3186460	CHEMBL1113302	Inhibition of Cdk2	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccccc3)cc12		CHEMBL1095040	=	IC50	nM	2500.0	CHEMBL301	Homo sapiens	IC50	nM	2500.0
	3186461	CHEMBL1113302	Inhibition of Cdk2	B	CCCC(=O)Nc1n[nH]c2c(F)c(Cl)c(-c3ccccc3)cc12		CHEMBL1086427	=	IC50	nM	3160.0	CHEMBL301	Homo sapiens	IC50	nM	3160.0
	3186462	CHEMBL1113302	Inhibition of Cdk2	B	CCCC(=O)Nc1n[nH]c2c(Cl)c(Cl)c(-c3ccccc3)cc12		CHEMBL1097003	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	3192023	CHEMBL1104220	Inhibition of CDK2	B	Cc1n[nH]c2ccc(-c3nnc(NC[C@@H](N)Cc4ccccc4)s3)cc12		CHEMBL1087281	=	IC50	nM	72.0	CHEMBL301	Homo sapiens	IC50	nM	72.0
Not Determined	3192026	CHEMBL1104220	Inhibition of CDK2	B	Cc1n[nH]c2ccc(-c3nnc(NC[C@H](N)Cc4ccccc4)s3)cc12		CHEMBL1088612		IC50			CHEMBL301	Homo sapiens	IC50		
	3192029	CHEMBL1104220	Inhibition of CDK2	B	Cc1n[nH]c2ccc(-c3nnc(NC[C@@H](N)Cc4ccccc4F)s3)cc12		CHEMBL1088613	=	IC50	nM	104.0	CHEMBL301	Homo sapiens	IC50	nM	104.0
	3192032	CHEMBL1104220	Inhibition of CDK2	B	Cc1n[nH]c2ccc(-c3nnc(NC[C@@H](N)Cc4ccccc4Cl)s3)cc12		CHEMBL1080891	=	IC50	nM	57.0	CHEMBL301	Homo sapiens	IC50	nM	57.0
	3192035	CHEMBL1104220	Inhibition of CDK2	B	Cc1n[nH]c2ccc(-c3nnc(NC[C@@H](N)Cc4ccccc4C(F)(F)F)s3)cc12		CHEMBL1080892	=	IC50	nM	198.0	CHEMBL301	Homo sapiens	IC50	nM	198.0
Not Determined	3192038	CHEMBL1104220	Inhibition of CDK2	B	Cc1n[nH]c2ccc(-c3nnc(NC[C@@H](N)Cc4cccc(F)c4)s3)cc12		CHEMBL1076553		IC50			CHEMBL301	Homo sapiens	IC50		
	3192041	CHEMBL1104220	Inhibition of CDK2	B	Cc1n[nH]c2ccc(-c3nnc(NC[C@@H](N)Cc4cccc(Cl)c4)s3)cc12		CHEMBL1080893	=	IC50	nM	17.0	CHEMBL301	Homo sapiens	IC50	nM	17.0
	3193160	CHEMBL1104220	Inhibition of CDK2	B	Cc1n[nH]c2ccc(-c3nnc(NC[C@@H](N)Cc4cccc(C(F)(F)F)c4)s3)cc12		CHEMBL1080561	=	IC50	nM	35.0	CHEMBL301	Homo sapiens	IC50	nM	35.0
	3193163	CHEMBL1104220	Inhibition of CDK2	B	Cc1n[nH]c2ccc(-c3nnc(NC[C@@H](N)Cc4ccc(Cl)cc4)s3)cc12		CHEMBL1080740	=	IC50	nM	72.0	CHEMBL301	Homo sapiens	IC50	nM	72.0
	3193166	CHEMBL1104220	Inhibition of CDK2	B	Cc1n[nH]c2ccc(-c3nnc(NC[C@@H](N)Cc4ccc(C(F)(F)F)cc4)s3)cc12		CHEMBL1080911	=	IC50	nM	17.0	CHEMBL301	Homo sapiens	IC50	nM	17.0
	3193169	CHEMBL1104220	Inhibition of CDK2	B	Cc1n[nH]c2ccc(-c3nnc(NC[C@@H](N)Cc4ccc(Cl)cc4Cl)s3)cc12		CHEMBL1080912	=	IC50	nM	70.0	CHEMBL301	Homo sapiens	IC50	nM	70.0
	3193172	CHEMBL1104220	Inhibition of CDK2	B	Cc1n[nH]c2ccc(-c3nnc(NC[C@@H](N)Cc4ccc(F)c(F)c4)s3)cc12		CHEMBL1080913	=	IC50	nM	19.0	CHEMBL301	Homo sapiens	IC50	nM	19.0
Not Determined	3193175	CHEMBL1104220	Inhibition of CDK2	B	CCc1n[nH]c2ccc(-c3nnc(NC[C@@H](N)Cc4ccccc4)s3)cc12		CHEMBL1081426		IC50			CHEMBL301	Homo sapiens	IC50		
	3193178	CHEMBL1104220	Inhibition of CDK2	B	N[C@H](CNc1nnc(-c2ccc3[nH]nc(C4CC4)c3c2)s1)Cc1ccc(C(F)(F)F)cc1		CHEMBL1081437	=	IC50	nM	135.0	CHEMBL301	Homo sapiens	IC50	nM	135.0
	3193181	CHEMBL1104220	Inhibition of CDK2	B	N[C@H](CNc1nnc(-c2ccc3[nH]nc(-c4ccccc4)c3c2)s1)Cc1cccc(C(F)(F)F)c1		CHEMBL1081438	=	IC50	nM	79.0	CHEMBL301	Homo sapiens	IC50	nM	79.0
Not Determined	3193184	CHEMBL1104220	Inhibition of CDK2	B	N[C@H](CNc1nnc(-c2ccc3[nH]ncc3c2)s1)Cc1cccc(C(F)(F)F)c1		CHEMBL1076565		IC50			CHEMBL301	Homo sapiens	IC50		
	3193187	CHEMBL1104220	Inhibition of CDK2	B	N[C@H](CNc1nnc(-c2ccc3[nH]ncc3c2)s1)Cc1ccc(F)cc1		CHEMBL1081439	=	IC50	nM	74.0	CHEMBL301	Homo sapiens	IC50	nM	74.0
	3193190	CHEMBL1104220	Inhibition of CDK2	B	N[C@H](CNc1nnc(-c2ccc3[nH]ncc3c2)s1)Cc1ccc(Cl)cc1		CHEMBL1081451	=	IC50	nM	41.0	CHEMBL301	Homo sapiens	IC50	nM	41.0
	3193193	CHEMBL1104220	Inhibition of CDK2	B	N[C@H](CNc1nnc(-c2ccc3[nH]ncc3c2)s1)Cc1ccc(C(F)(F)F)cc1		CHEMBL1081628	=	IC50	nM	24.0	CHEMBL301	Homo sapiens	IC50	nM	24.0
	3193196	CHEMBL1104220	Inhibition of CDK2	B	N[C@H](CNc1nnc(-c2ccc3[nH]ncc3c2)s1)Cc1ccc(Cl)cc1Cl		CHEMBL1076581	=	IC50	nM	323.0	CHEMBL301	Homo sapiens	IC50	nM	323.0
	3193202	CHEMBL1104220	Inhibition of CDK2	B	N[C@H](CNc1nnc(-c2ccc3cnccc3c2)s1)Cc1ccc(C(F)(F)F)cc1		CHEMBL1080569	=	IC50	nM	53.0	CHEMBL301	Homo sapiens	IC50	nM	53.0
	3193205	CHEMBL1104220	Inhibition of CDK2	B	Cc1cc2cc(-c3nnc(NC[C@@H](N)Cc4ccc(C(F)(F)F)cc4)s3)ccc2cn1		CHEMBL1081629	=	IC50	nM	607.0	CHEMBL301	Homo sapiens	IC50	nM	607.0
	3196138	CHEMBL1102923	Inhibition of CDK2	B	N[C@H](CNc1nnc(-c2ccc3cnccc3c2)s1)Cc1ccc(C(F)(F)F)cc1		CHEMBL1080569	=	IC50	nM	53.0	CHEMBL301	Homo sapiens	IC50	nM	53.0
	3196142	CHEMBL1102923	Inhibition of CDK2	B	N[C@H](CNc1ncc(-c2ccc3cnccc3c2)s1)Cc1ccc(C(F)(F)F)cc1		CHEMBL1081263	=	IC50	nM	12.4	CHEMBL301	Homo sapiens	IC50	nM	12.4
	3196146	CHEMBL1102923	Inhibition of CDK2	B	N[C@H](CNc1cnc(-c2ccc3cnccc3c2)s1)Cc1ccc(C(F)(F)F)cc1		CHEMBL1081425	=	IC50	nM	1070.0	CHEMBL301	Homo sapiens	IC50	nM	1070.0
	3196150	CHEMBL1102923	Inhibition of CDK2	B	N[C@H](CNc1cc(-c2ccc3cnccc3c2)no1)Cc1ccc(C(F)(F)F)cc1		CHEMBL1081104	=	IC50	nM	93.0	CHEMBL301	Homo sapiens	IC50	nM	93.0
	3196154	CHEMBL1102923	Inhibition of CDK2	B	N[C@H](CCc1cc(-c2ccc3cnccc3c2)no1)Cc1ccc(C(F)(F)F)cc1		CHEMBL1081105	=	IC50	nM	117.0	CHEMBL301	Homo sapiens	IC50	nM	117.0
	3196158	CHEMBL1102923	Inhibition of CDK2	B	N[C@H](CCc1nc(-c2ccc3cnccc3c2)no1)Cc1ccc(C(F)(F)F)cc1		CHEMBL1081118	=	IC50	nM	4630.0	CHEMBL301	Homo sapiens	IC50	nM	4630.0
	3196162	CHEMBL1102923	Inhibition of CDK2	B	N[C@H](CNc1nnc(-c2ccc3cnccc3c2)o1)Cc1ccc(C(F)(F)F)cc1		CHEMBL1081119	=	IC50	nM	348.0	CHEMBL301	Homo sapiens	IC50	nM	348.0
	3196166	CHEMBL1102923	Inhibition of CDK2	B	Nc1cc2cc(-c3cnc(NC[C@@H](N)Cc4ccc(C(F)(F)F)cc4)s3)ccc2cn1		CHEMBL1081295	=	IC50	nM	15.4	CHEMBL301	Homo sapiens	IC50	nM	15.4
	3196170	CHEMBL1102923	Inhibition of CDK2	B	N[C@H](CNc1ncc(-c2ccc3cncnc3c2)s1)Cc1ccc(C(F)(F)F)cc1		CHEMBL1081296	=	IC50	nM	136.0	CHEMBL301	Homo sapiens	IC50	nM	136.0
	3196174	CHEMBL1102923	Inhibition of CDK2	B	N[C@H](CNc1ncc(-c2ccc3nnccc3c2)s1)Cc1ccc(C(F)(F)F)cc1		CHEMBL1081974	>	IC50	nM	2000.0	CHEMBL301	Homo sapiens	IC50	nM	2000.0
	3196178	CHEMBL1102923	Inhibition of CDK2	B	N[C@H](CNc1ncc(-c2ccc3cn[nH]c3c2)s1)Cc1ccc(C(F)(F)F)cc1		CHEMBL1079625	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
Not Determined	3196182	CHEMBL1102923	Inhibition of CDK2	B	Cn1ncc2ccc(-c3cnc(NC[C@@H](N)Cc4ccc(C(F)(F)F)cc4)s3)cc21		CHEMBL1079626		IC50			CHEMBL301	Homo sapiens	IC50		
	3196186	CHEMBL1102923	Inhibition of CDK2	B	Cn1nc(N)c2ccc(-c3cnc(NC[C@@H](N)Cc4ccc(C(F)(F)F)cc4)s3)cc21		CHEMBL1079627	>	IC50	nM	2000.0	CHEMBL301	Homo sapiens	IC50	nM	2000.0
	3196190	CHEMBL1102923	Inhibition of CDK2	B	Nc1noc2ccc(-c3cnc(NC[C@@H](N)Cc4ccc(C(F)(F)F)cc4)s3)cc12		CHEMBL1081660	>	IC50	nM	2000.0	CHEMBL301	Homo sapiens	IC50	nM	2000.0
Not Determined	3196194	CHEMBL1102923	Inhibition of CDK2	B	N[C@H](CNc1ncc(-c2ccc3[nH]ncc3c2)s1)Cc1ccc(C(F)(F)F)cc1		CHEMBL1081829		IC50			CHEMBL301	Homo sapiens	IC50		
	3196198	CHEMBL1102923	Inhibition of CDK2	B	N[C@H](CNc1ncc(-c2ccc3nnn(N)c3c2)s1)Cc1ccc(C(F)(F)F)cc1		CHEMBL1081830	=	IC50	nM	55.3	CHEMBL301	Homo sapiens	IC50	nM	55.3
	3196202	CHEMBL1102923	Inhibition of CDK2	B	N[C@H](CNc1ncc(-c2ccc3c(c2)CC(=O)N3)s1)Cc1ccc(C(F)(F)F)cc1		CHEMBL1081831	=	IC50	nM	185.0	CHEMBL301	Homo sapiens	IC50	nM	185.0
	3196206	CHEMBL1102923	Inhibition of CDK2	B	N[C@H](CNc1ncc(-c2ccc3[nH]c(=O)oc3c2)s1)Cc1ccc(C(F)(F)F)cc1		CHEMBL1081852	=	IC50	nM	138.0	CHEMBL301	Homo sapiens	IC50	nM	138.0
	3196210	CHEMBL1102923	Inhibition of CDK2	B	N[C@H](CNc1ncc(-c2ccc3[nH]c(=O)sc3c2)s1)Cc1ccc(C(F)(F)F)cc1		CHEMBL1081853	=	IC50	nM	285.0	CHEMBL301	Homo sapiens	IC50	nM	285.0
	3196214	CHEMBL1102923	Inhibition of CDK2	B	Cn1c(=O)[nH]c2ccc(-c3cnc(NC[C@@H](N)Cc4ccc(C(F)(F)F)cc4)s3)cc21		CHEMBL1082016	=	IC50	nM	276.0	CHEMBL301	Homo sapiens	IC50	nM	276.0
	3196218	CHEMBL1102923	Inhibition of CDK2	B	N[C@H](CNc1ncc(-c2ccc3c(c2)CCC(=O)N3)s1)Cc1ccc(C(F)(F)F)cc1		CHEMBL1082017	>	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	nM	25000.0
	3196222	CHEMBL1102923	Inhibition of CDK2	B	N[C@H](CNc1ncc(-c2ccc3cn[nH]c(=O)c3c2)s1)Cc1ccc(C(F)(F)F)cc1		CHEMBL1082030	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	3196226	CHEMBL1102923	Inhibition of CDK2	B	NC(=O)c1ccc(-c2cnc(NC[C@@H](N)Cc3ccc(C(F)(F)F)cc3)s2)cc1		CHEMBL1081028	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	3196230	CHEMBL1102923	Inhibition of CDK2	B	N[C@H](CNc1ncc(-c2ccc3c(c2)CNC3=O)s1)Cc1ccc(C(F)(F)F)cc1		CHEMBL1081029	>	IC50	nM	9000.0	CHEMBL301	Homo sapiens	IC50	nM	9000.0
	3200303	CHEMBL1102103	Inhibition of CDK2	B	COc1ccc(C2=NNC(=O)/C2=N\Nc2cccc(OC)c2)cc1		CHEMBL1080902	=	Ki	nM	95.0	CHEMBL301	Homo sapiens	Ki	nM	95.0
	3200329	CHEMBL1102103	Inhibition of CDK2	B	COc1ccc(C2=NNC(=O)/C2=N\Nc2cccnc2)cc1		CHEMBL1076721	=	Ki	nM	62.0	CHEMBL301	Homo sapiens	Ki	nM	62.0
	3200355	CHEMBL1102103	Inhibition of CDK2	B	COc1ccncc1C1=NNC(=O)/C1=N\Nc1ccccc1		CHEMBL1086736	=	Ki	nM	76.0	CHEMBL301	Homo sapiens	Ki	nM	76.0
	3203245	CHEMBL1102999	Inhibition of CDK2	B	Cn1cc(C2=C(c3cccc(NCC(O)CO)c3)C(=O)NC2=O)c2cc(F)ccc21		CHEMBL1082152	=	Kd	nM	150.0	CHEMBL301	Homo sapiens	Kd	uM	0.15
	3213891	CHEMBL1114039	Inhibition of CDK2 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	-1.0	CHEMBL301	Homo sapiens	INH	%	-1.0
	3219999	CHEMBL1115848	Inhibition of CDK2	B	CN1C[C@@H]2C[C@H]1CN2c1ccc(-c2ccnc3c(-c4cccc(O)c4)c(-c4ccncc4)nn23)cc1		CHEMBL1087650	=	IC50	nM	26400.0	CHEMBL301	Homo sapiens	IC50	uM	26.4
	3228110	CHEMBL1114822	Inhibition of CDK2	B	CN(C)Cc1ccc(-c2cnn3c(-c4cccc(NC(=O)c5cccc(C(F)(F)F)c5)c4)ccnc23)cc1		CHEMBL1087397	>	IC50	nM	2000.0	CHEMBL301	Homo sapiens	IC50	uM	2.0
	3229265	CHEMBL1108485	Inhibition of CDK2	B	COc1cc2c(cc1Cl)C(c1ccc(Cl)c(Cl)c1)=NCC2		CHEMBL1087421	<	IC50	nM	10000.0	CHEMBL301	Homo sapiens	pIC50		5.0
	3229278	CHEMBL1108485	Inhibition of CDK2	B	COc1cc2c(cc1Cl)C(c1cccc(Cl)c1)=NCC2		CHEMBL1088633	<	IC50	nM	10000.0	CHEMBL301	Homo sapiens	pIC50		5.0
	3251253	CHEMBL1107908	Inhibition of CDK2	B	Cn1cc(/C=C2\Oc3cccc(O)c3C2=O)c2c(-c3ccc(C(=O)NCCO)cc3)ccnc21		CHEMBL1092754	=	IC50	nM	35.5	CHEMBL301	Homo sapiens	IC50	nM	35.5
	3253943	CHEMBL1111588	Inhibition of CDK2 at 10 uM	B	O=C(Nc1ccccc1)Nc1n[nH]c2cc(Cl)c(-c3ccccc3)cc12		CHEMBL1092134	<	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	3260503	CHEMBL1109838	Inhibition of CDK2	B	O=C(Nc1cccc(-c2ccnc3cc(-c4ccncc4)nn23)c1)c1cccc(C(F)(F)F)c1		CHEMBL1089082	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	3262017	CHEMBL1114552	Inhibition of CDK2	B	CP(C)(=O)c1ccc(Nc2nc(C3CCCC3)nc3c2ncn3CCc2cccc(O)c2)cc1		CHEMBL1089405	=	IC50	nM	20900.0	CHEMBL301	Homo sapiens	IC50	uM	20.9
	3262026	CHEMBL1114552	Inhibition of CDK2	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	IC50	nM	70.0	CHEMBL301	Homo sapiens	IC50	nM	70.0
	3264367	CHEMBL1104636	Inhibition of CDK2	B	CC(C)(C)OC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(N)cc4)nc32)CC1		CHEMBL1095627	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	3271030	CHEMBL1104636	Inhibition of CDK2	B	COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(N)cc4)nc32)CC1		CHEMBL1095626	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
Not Active	3271796	CHEMBL1112903	Inhibition of CDK2	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	3271797	CHEMBL1112903	Inhibition of CDK2	B	COc1ccccc1/C=C1/C(=O)Nc2ccccc21		CHEMBL444673		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	3271798	CHEMBL1112903	Inhibition of CDK2	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1F		CHEMBL1088391		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	3271799	CHEMBL1112903	Inhibition of CDK2	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1[N+](=O)[O-]		CHEMBL1088392		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	3271800	CHEMBL1112903	Inhibition of CDK2	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1S(=O)(=O)O		CHEMBL1088529		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	3271801	CHEMBL1112903	Inhibition of CDK2	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccc2c(c1)OCO2		CHEMBL1086669		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	3271802	CHEMBL1112903	Inhibition of CDK2	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1cc(F)cc(F)c1		CHEMBL1086670		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	3271803	CHEMBL1112903	Inhibition of CDK2	B	NC(=O)Cc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL1086795		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	3271804	CHEMBL1112903	Inhibition of CDK2	B	COc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1OC		CHEMBL1086796		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	3271805	CHEMBL1112903	Inhibition of CDK2	B	COc1cc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc(OC)c1OC		CHEMBL383871		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	3271806	CHEMBL1112903	Inhibition of CDK2	B	COc1cc(OC)c(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1		CHEMBL1086939	<	Inhibition	%	20.0	CHEMBL301	Homo sapiens	INH	%	20.0
Not Active	3271807	CHEMBL1112903	Inhibition of CDK2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	3304985	CHEMBL1119481	Inhibition of CDK2	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	390.0	CHEMBL301	Homo sapiens	Ki	nM	390.0
	3304986	CHEMBL1119481	Inhibition of CDK2	B	Cc1nc(C)c(-c2ccnc(Nc3ccc(N4CCN(S(C)(=O)=O)CC4)cc3)n2)s1		CHEMBL1083484	=	Ki	nM	3967.0	CHEMBL301	Homo sapiens	Ki	nM	3967.0
	3304987	CHEMBL1119481	Inhibition of CDK2	B	CC(=O)N1CCN(c2ccc(Nc3nccc(-c4sc(C)nc4C)n3)cc2)CC1		CHEMBL1083786	=	Ki	nM	432.0	CHEMBL301	Homo sapiens	Ki	nM	432.0
	3304988	CHEMBL1119481	Inhibition of CDK2	B	CNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)n2)s1		CHEMBL1083785	=	Ki	nM	297.0	CHEMBL301	Homo sapiens	Ki	nM	297.0
	3304989	CHEMBL1119481	Inhibition of CDK2	B	CC(=O)N1CCN(c2ccc(Nc3nccc(-c4sc(N)nc4C)n3)cc2)CC1		CHEMBL1084969	=	Ki	nM	522.0	CHEMBL301	Homo sapiens	Ki	nM	522.0
	3304990	CHEMBL1119481	Inhibition of CDK2	B	CCNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)s1		CHEMBL1084630	=	Ki	nM	151.0	CHEMBL301	Homo sapiens	Ki	nM	151.0
	3304991	CHEMBL1119481	Inhibition of CDK2	B	CNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)s1		CHEMBL1084629	=	Ki	nM	156.0	CHEMBL301	Homo sapiens	Ki	nM	156.0
	3304992	CHEMBL1119481	Inhibition of CDK2	B	Cc1nc(C)c(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)s1		CHEMBL1085626	=	Ki	nM	1039.0	CHEMBL301	Homo sapiens	Ki	nM	1039.0
	3304993	CHEMBL1119481	Inhibition of CDK2	B	CCNc1nc(C)c(-c2ccnc(Nc3ccc(CNC(C)=O)cc3)n2)s1		CHEMBL1084715	=	Ki	nM	32.0	CHEMBL301	Homo sapiens	Ki	nM	32.0
	3304994	CHEMBL1119481	Inhibition of CDK2	B	CCNc1nc(C)c(-c2ccnc(Nc3cc(OC)c(OC)c(OC)c3)n2)s1		CHEMBL1086088	=	Ki	nM	463.0	CHEMBL301	Homo sapiens	Ki	nM	463.0
	3304995	CHEMBL1119481	Inhibition of CDK2	B	CNc1nc(C)c(-c2ccnc(Nc3cc(OC)c(OC)c(OC)c3)n2)s1		CHEMBL1083152	=	Ki	nM	256.0	CHEMBL301	Homo sapiens	Ki	nM	256.0
	3304996	CHEMBL1119481	Inhibition of CDK2	B	COc1cc(Nc2nccc(-c3sc(C)nc3C)n2)cc(OC)c1OC		CHEMBL1083151	=	Ki	nM	239.0	CHEMBL301	Homo sapiens	Ki	nM	239.0
	3304997	CHEMBL1119481	Inhibition of CDK2	B	Cc1nc(C)c(-c2ccnc(Nc3ccc(N)cc3)n2)s1		CHEMBL1084454	=	Ki	nM	168.0	CHEMBL301	Homo sapiens	Ki	nM	168.0
	3304998	CHEMBL1119481	Inhibition of CDK2	B	CNc1ccc(Nc2nccc(-c3sc(C)nc3C)n2)cc1		CHEMBL1083150	=	Ki	nM	286.0	CHEMBL301	Homo sapiens	Ki	nM	286.0
	3304999	CHEMBL1119481	Inhibition of CDK2	B	Cc1nc(C)c(-c2ccnc(Nc3ccc(N(C)C)cc3)n2)s1		CHEMBL46817	=	Ki	nM	251.0	CHEMBL301	Homo sapiens	Ki	nM	251.0
	3305000	CHEMBL1119481	Inhibition of CDK2	B	Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL298445	=	Ki	nM	2.0	CHEMBL301	Homo sapiens	Ki	nM	2.0
	3331861	CHEMBL1168820	Inhibition of CDK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	3333276	CHEMBL1168820	Inhibition of CDK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	3334681	CHEMBL1168820	Inhibition of CDK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	3336101	CHEMBL1168820	Inhibition of CDK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	3337478	CHEMBL1168820	Inhibition of CDK2 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	3337726	CHEMBL1168820	Inhibition of CDK2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	3339058	CHEMBL1168820	Inhibition of CDK2 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	3340360	CHEMBL1168820	Inhibition of CDK2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	3340629	CHEMBL1168820	Inhibition of CDK2 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	3342045	CHEMBL1168820	Inhibition of CDK2 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	3352625	CHEMBL1175614	Inhibition of CDK2	B	NC(=O)Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3)ncc1CC2		CHEMBL1171948	=	IC50	nM	10.0	CHEMBL301	Homo sapiens	IC50	nM	10.0
	3352638	CHEMBL1175614	Inhibition of CDK2	B	NC(=O)c1nn(CC2CCNCC2)c2c1CCc1cnc(Nc3ccccc3)nc1-2		CHEMBL1171949	=	IC50	nM	12.0	CHEMBL301	Homo sapiens	IC50	nM	12.0
	3352643	CHEMBL1175614	Inhibition of CDK2	B	NCCCn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3)ncc1CC2		CHEMBL1171950	=	IC50	nM	1.0	CHEMBL301	Homo sapiens	IC50	nM	1.0
	3352645	CHEMBL1175614	Inhibition of CDK2	B	Cc1cc(CNC(=O)c2nn(C)c3c2CCc2cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc2-3)ccn1		CHEMBL1169805	=	IC50	nM	319.0	CHEMBL301	Homo sapiens	IC50	nM	319.0
	3352647	CHEMBL1175614	Inhibition of CDK2	B	Cc1cc(CNC(=O)c2nn(CCCN)c3c2CCc2cnc(Nc4cccc(CC(=O)N(C)C)c4)nc2-3)ccn1		CHEMBL1172241	=	IC50	nM	500.0	CHEMBL301	Homo sapiens	IC50	nM	500.0
	3358490	CHEMBL1174104	Inhibition of CDK2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	10.0	CHEMBL301	Homo sapiens	INH	%	10.0
	3358932	CHEMBL1174104	Inhibition of CDK2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	13.0	CHEMBL301	Homo sapiens	INH	%	13.0
	3410568	CHEMBL1228245	Inhibition of recombinant CDK2 after 15 mins	B	CN(C)CCNC(=O)c1ccc(-c2cnc3ccc(NCc4ccc(Cl)c(Cl)c4)nn23)cc1		CHEMBL588573	>	IC50	nM	100000.0	CHEMBL301	Homo sapiens	IC50	uM	100.0
	3410569	CHEMBL1228245	Inhibition of recombinant CDK2 after 15 mins	B	O=C(NCCN1CCCC1)c1ccc(-c2cnc3ccc(NCc4ccc(Cl)c(Cl)c4)nn23)cc1		CHEMBL1222474	>	IC50	nM	100000.0	CHEMBL301	Homo sapiens	IC50	uM	100.0
	3410570	CHEMBL1228245	Inhibition of recombinant CDK2 after 15 mins	B	O=C(NC[C@@H]1CCCN1)c1ccc(-c2cnc3ccc(NCc4ccc(Cl)c(Cl)c4)nn23)cc1		CHEMBL1222565	=	IC50	nM	95000.0	CHEMBL301	Homo sapiens	IC50	uM	95.0
	3410571	CHEMBL1228245	Inhibition of recombinant CDK2 after 15 mins	B	O=C(NC[C@@H]1CCCN1)c1ccc(-c2cnc3ccc(NCC4CC4)nn23)cc1		CHEMBL1222990	>	IC50	nM	100000.0	CHEMBL301	Homo sapiens	IC50	uM	100.0
	3410572	CHEMBL1228245	Inhibition of recombinant CDK2 after 15 mins	B	O=C(NC[C@@H]1CCCN1)c1ccc(-c2cnc3ccc(NCc4cccc(Cl)c4)nn23)cc1		CHEMBL1222992	>	IC50	nM	100000.0	CHEMBL301	Homo sapiens	IC50	uM	100.0
	3410573	CHEMBL1228245	Inhibition of recombinant CDK2 after 15 mins	B	CN(C)CCNC(=O)c1ccc(-c2cnc3ccc(NCC4CC4)nn23)cc1		CHEMBL1223203	>	IC50	nM	100000.0	CHEMBL301	Homo sapiens	IC50	uM	100.0
Not Determined	3410574	CHEMBL1228245	Inhibition of recombinant CDK2 after 15 mins	B	CCN(CC)CCNC(=O)c1ccc(-c2cnc3ccc(NCC4CC4)nn23)cc1		CHEMBL1223204		IC50			CHEMBL301	Homo sapiens	IC50		
Not Determined	3410575	CHEMBL1228245	Inhibition of recombinant CDK2 after 15 mins	B	CC(CN(C)C)NC(=O)c1ccc(-c2cnc3ccc(NCC4CC4)nn23)cc1		CHEMBL1223207		IC50			CHEMBL301	Homo sapiens	IC50		
Not Active	3418827	CHEMBL1226708	Inhibition of CDK2-mediated p53 phosphorylation	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	3419694	CHEMBL1226386	Induction of CDK2 in HEK293T cells transfected with FLAG-tagged p27 at 200 nM by autoradiography	B	CC(=O)O[C@@H](C)/C=C\C(=O)N[C@@H]1C[C@H](C)[C@H](C/C=C(C)/C=C/[C@H]2O[C@](C)(O)C[C@@]3(CO3)[C@@H]2O)O[C@@H]1C		CHEMBL494107		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3419695	CHEMBL1226387	Induction of CDK2 in HEK293T cells transfected with FLAG-tagged truncated p27 at 200 nM by autoradiography	B	CC(=O)O[C@@H](C)/C=C\C(=O)N[C@@H]1C[C@H](C)[C@H](C/C=C(C)/C=C/[C@H]2O[C@](C)(O)C[C@@]3(CO3)[C@@H]2O)O[C@@H]1C		CHEMBL494107		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3419696	CHEMBL1226388	Induction of CDK2 in HEK293T cells transfected with FLAG-tagged p27 at 20 nM by Western blot analysis	B	CC(=O)O[C@@H](C)/C=C\C(=O)N[C@@H]1C[C@H](C)[C@H](C/C=C(C)/C=C/[C@H]2O[C@](C)(O)C[C@@]3(CO3)[C@@H]2O)O[C@@H]1C		CHEMBL494107		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3419697	CHEMBL1226389	Induction of CDK2 in HEK293T cells transfected with FLAG-tagged truncated p27 at 20 nM by Western blot analysis	B	CC(=O)O[C@@H](C)/C=C\C(=O)N[C@@H]1C[C@H](C)[C@H](C/C=C(C)/C=C/[C@H]2O[C@](C)(O)C[C@@]3(CO3)[C@@H]2O)O[C@@H]1C		CHEMBL494107		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3419698	CHEMBL1226395	Induction of CDK2 in HEK293T cells transfected with FLAG-tagged p27 at 190 nM by Western blot analysis	B	CO[C@]1(C)C[C@@]2(CO2)[C@H](O)[C@@H](/C=C/C(C)=C/C[C@@H]2O[C@H](C)[C@H](NC(=O)/C=C\[C@H](C)OC(C)=O)C[C@@H]2C)O1		CHEMBL1221942		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	3419699	CHEMBL1226394	Induction of CDK2 in HEK293T cells transfected with FLAG-tagged truncated p27 at 190 nM by Western blot analysis	B	CO[C@]1(C)C[C@@]2(CO2)[C@H](O)[C@@H](/C=C/C(C)=C/C[C@@H]2O[C@H](C)[C@H](NC(=O)/C=C\[C@H](C)OC(C)=O)C[C@@H]2C)O1		CHEMBL1221942		Activity			CHEMBL301	Homo sapiens	Activity		
	3420188	CHEMBL1226913	Inhibition of cdk2	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	IC50	nM	40.0	CHEMBL301	Homo sapiens	IC50	nM	40.0
	3420219	CHEMBL1226913	Inhibition of cdk2	B	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	=	IC50	nM	240.0	CHEMBL301	Homo sapiens	IC50	nM	240.0
	3439149	CHEMBL1247982	Inhibition of CDK2 by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3ccccc3Nc3ccccc3)cc2)n1		CHEMBL1243200	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	3441510	CHEMBL1244093	Inhibition of human CDK2	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nmol/L	10000.0
	3445057	CHEMBL1244758	Binding affinity to CDK2	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	20.0	CHEMBL301	Homo sapiens	Kd	nM	20.0
	3446948	CHEMBL1250281	Inhibition of CDK2	B	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21		CHEMBL280074	=	IC50	nM	7000.0	CHEMBL301	Homo sapiens	IC50	uM	7.0
	3446949	CHEMBL1250281	Inhibition of CDK2	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	IC50	nM	700.0	CHEMBL301	Homo sapiens	IC50	uM	0.7
	3446950	CHEMBL1250281	Inhibition of CDK2	B	CCNc1cc(N[C@H]2CC[C@@H](O)CC2)nc(Nc2ccc3c(ccn3Cc3ccccc3)c2)n1		CHEMBL1242367	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	3446951	CHEMBL1250281	Inhibition of CDK2	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	IC50	nM	170.0	CHEMBL301	Homo sapiens	IC50	uM	0.17
	3446952	CHEMBL1250281	Inhibition of CDK2	B	CCCCOc1c(C(=O)c2c(F)cc(F)cc2F)c[nH]c2nncc1-2		CHEMBL79049	=	IC50	nM	50.0	CHEMBL301	Homo sapiens	IC50	uM	0.05
	3446953	CHEMBL1250281	Inhibition of CDK2	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	IC50	nM	35.0	CHEMBL301	Homo sapiens	IC50	uM	0.035
	3446954	CHEMBL1250281	Inhibition of CDK2	B	O=C1C(c2c(O)[nH]c3ccc(S(=O)(=O)O)cc23)=Nc2ccccc21		CHEMBL1207227	=	IC50	nM	22.0	CHEMBL301	Homo sapiens	IC50	uM	0.022
	3446955	CHEMBL1250281	Inhibition of CDK2	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	IC50	nM	15.0	CHEMBL301	Homo sapiens	IC50	uM	0.015
	3446956	CHEMBL1250281	Inhibition of CDK2	B	O=C(Nc1cc(CN[C@H]2Cc3ccc(Cl)cc3C2)n[nH]1)Nc1cccc2c1[C@@H]1CCCN1C2=O		CHEMBL336242	=	IC50	nM	78.0	CHEMBL301	Homo sapiens	IC50	uM	0.078
	3446957	CHEMBL1250281	Inhibition of CDK2	B	O=C(Nc1ccccn1)Nc1cccc2c1[C@H]1CCCN1C2=O		CHEMBL141247	=	IC50	nM	440.0	CHEMBL301	Homo sapiens	IC50	uM	0.44
	3446958	CHEMBL1250281	Inhibition of CDK2	B	COC(=O)[C@@]1(Cc2ccc(O)c(CC=C(C)C)c2)OC(=O)C(O)=C1c1ccc(O)cc1		CHEMBL1242973	=	IC50	nM	1500.0	CHEMBL301	Homo sapiens	IC50	uM	1.5
	3446959	CHEMBL1250281	Inhibition of CDK2	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(Oc4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL133498	=	IC50	nM	2110.0	CHEMBL301	Homo sapiens	IC50	uM	2.11
	3446960	CHEMBL1250281	Inhibition of CDK2	B	NC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(=O)(=O)NCCOCCO)cc1)C(=O)N2		CHEMBL1242832	=	IC50	nM	4500.0	CHEMBL301	Homo sapiens	IC50	uM	4.5
	3446961	CHEMBL1250281	Inhibition of CDK2	B	CC(C)(C)Nc1nc(C(F)(F)F)nc2ccc(Nc3ccccc3)cc12		CHEMBL1242833	=	IC50	nM	600.0	CHEMBL301	Homo sapiens	IC50	uM	0.6
	3446962	CHEMBL1250281	Inhibition of CDK2	B	CC(C)(C)Nc1nc(C(F)(F)F)nc2ccc(-c3cccnc3)cc12		CHEMBL16484	=	IC50	nM	1200.0	CHEMBL301	Homo sapiens	IC50	uM	1.2
	3446963	CHEMBL1250281	Inhibition of CDK2	B	c1ccc2c(c1)Cc1c-2n[nH]c1-c1ccncc1		CHEMBL1234009	=	IC50	nM	1300.0	CHEMBL301	Homo sapiens	IC50	uM	1.3
	3446964	CHEMBL1250281	Inhibition of CDK2	B	Cc1nc2ccccn2c1-c1ccnc(Nc2ccc(OCC(O)CN(C)C)cc2)n1		CHEMBL102926	=	IC50	nM	1.0	CHEMBL301	Homo sapiens	IC50	uM	0.001
	3446965	CHEMBL1250281	Inhibition of CDK2	B	Cc1ccc(F)c(Nc2nccc(-c3ccc(S(N)(=O)=O)cc3)n2)c1		CHEMBL1241566	=	IC50	nM	32.0	CHEMBL301	Homo sapiens	IC50	uM	0.032
	3446966	CHEMBL1250281	Inhibition of CDK2	B	CCCCOc1c(C(=O)c2c(F)cc(C)cc2F)ccc2[nH]ncc12		CHEMBL1241567	=	IC50	nM	6.0	CHEMBL301	Homo sapiens	IC50	uM	0.006
	3446967	CHEMBL1250281	Inhibition of CDK2	B	Nc1nc(N)c(N=O)c(=O)[nH]1		CHEMBL291324	=	IC50	nM	9.0	CHEMBL301	Homo sapiens	IC50	uM	0.009
	3446968	CHEMBL1250281	Inhibition of CDK2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nc(OCc2ccccc2)c1N=O		CHEMBL1241661	=	IC50	nM	2200.0	CHEMBL301	Homo sapiens	IC50	uM	2.2
	3446969	CHEMBL1250281	Inhibition of CDK2	B	Nc1nc2ccc(C(=O)c3c(F)cccc3Cl)cc2n1Cc1c(F)cccc1F		CHEMBL1241662	=	IC50	nM	33.0	CHEMBL301	Homo sapiens	IC50	uM	0.033
	3446970	CHEMBL1250281	Inhibition of CDK2	B	COc1ccc(-c2[nH]nc3c2C(=O)c2c(NC(=O)NNC(=O)c4ccc(O)cc4)cccc2-3)cc1		CHEMBL362560	=	IC50	nM	9.0	CHEMBL301	Homo sapiens	IC50	uM	0.009
	3446971	CHEMBL1250281	Inhibition of CDK2	B	CN(C)CCNS(=O)(=O)c1ccc(Nc2cccc(-c3cnc4ccccn34)c2)cc1		CHEMBL1241849	=	IC50	nM	5.0	CHEMBL301	Homo sapiens	IC50	uM	0.005
	3446972	CHEMBL1250281	Inhibition of CDK2	B	O=C(Cc1ccc2ccccc2c1)Nc1cc(C2CC2)n[nH]1		CHEMBL115220	=	IC50	nM	37.0	CHEMBL301	Homo sapiens	IC50	uM	0.037
	3446973	CHEMBL1250281	Inhibition of CDK2	B	FC(F)(F)c1cnc(Nc2ccc3[nH]cnc3c2)nc1Nc1ccccc1Cl		CHEMBL194721	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	IC50	uM	0.002
	3447619	CHEMBL1249834	Inhibition of CDK2 at 10 mM	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	IC50	nM	100000.0	CHEMBL301	Homo sapiens	IC50	uM	100.0
	3447800	CHEMBL1250106	Inhibition of wild type CDK2	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	IC50	nM	18000.0	CHEMBL301	Homo sapiens	IC50	uM	18.0
	3447805	CHEMBL1250111	Inhibition of CDK2 F80G mutant	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	IC50	nM	15.0	CHEMBL301	Homo sapiens	IC50	uM	0.015
	3447810	CHEMBL1250106	Inhibition of wild type CDK2	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	IC50	nM	29000.0	CHEMBL301	Homo sapiens	IC50	uM	29.0
	3447815	CHEMBL1250111	Inhibition of CDK2 F80G mutant	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	IC50	nM	5.0	CHEMBL301	Homo sapiens	IC50	uM	0.005
	3448370	CHEMBL1244758	Binding affinity to CDK2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	3448707	CHEMBL1244758	Binding affinity to CDK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	3449594	CHEMBL1244758	Binding affinity to CDK2	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	3450021	CHEMBL1244758	Binding affinity to CDK2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	3450302	CHEMBL1244758	Binding affinity to CDK2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	3450935	CHEMBL1244758	Binding affinity to CDK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
Not Active	3499120	CHEMBL1259864	Inhibition of CDK2 at 10 uM relative to control	B	CCNC(=O)NCc1ccccc1-c1cc(-c2cnc(NC(C)C)s2)nc(NCCN(C)C)n1		CHEMBL1230171		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	3521253	CHEMBL1272511	Inhibition of CDK2	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc([C@@H](C)N3C[C@H](C)O[C@H](C)C3)ns2)n1		CHEMBL1270399	>	IC50	nM	10.0	CHEMBL301	Homo sapiens	IC50	nM	10.0
	3601412	CHEMBL1292324	Inhibition of CDK2	B	COc1ccc(NC(=O)c2n[nH]c3ccccc23)cc1		CHEMBL1288651	=	IC50	nM	3000.0	CHEMBL301	Homo sapiens	IC50	uM	3.0
	3601414	CHEMBL1292324	Inhibition of CDK2	B	COc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1		CHEMBL1288582	=	IC50	nM	4000.0	CHEMBL301	Homo sapiens	IC50	uM	4.0
	5112261	CHEMBL1640699	Inhibition of CDK2 by flash plate based radioactive enzyme assay	B	O=C(/C=C/c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)NO		CHEMBL1630107	=	IC50	nM	440.0	CHEMBL301	Homo sapiens	IC50	uM	0.44
	5112262	CHEMBL1640699	Inhibition of CDK2 by flash plate based radioactive enzyme assay	B	O=C(/C=C/c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)s1)NO		CHEMBL1630108	=	IC50	nM	440.0	CHEMBL301	Homo sapiens	IC50	uM	0.44
	5112263	CHEMBL1640699	Inhibition of CDK2 by flash plate based radioactive enzyme assay	B	O=C(/C=C/c1cccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)c1)NO		CHEMBL1630109	=	IC50	nM	920.0	CHEMBL301	Homo sapiens	IC50	uM	0.92
	5112264	CHEMBL1640699	Inhibition of CDK2 by flash plate based radioactive enzyme assay	B	O=C(/C=C/c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)cc1)NO		CHEMBL1630110	=	IC50	nM	850.0	CHEMBL301	Homo sapiens	IC50	uM	0.85
	5112265	CHEMBL1640699	Inhibition of CDK2 by flash plate based radioactive enzyme assay	B	Nc1ccccc1NC(=O)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL1630111	=	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	uM	15.0
	5112266	CHEMBL1640699	Inhibition of CDK2 by flash plate based radioactive enzyme assay	B	Nc1ccccc1NC(=O)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)s1		CHEMBL1630112	=	IC50	nM	2100.0	CHEMBL301	Homo sapiens	IC50	uM	2.1
	5112267	CHEMBL1640699	Inhibition of CDK2 by flash plate based radioactive enzyme assay	B	Nc1ccccc1NC(=O)/C=C/c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL1630113	=	IC50	nM	1900.0	CHEMBL301	Homo sapiens	IC50	uM	1.9
	5112268	CHEMBL1640699	Inhibition of CDK2 by flash plate based radioactive enzyme assay	B	Nc1ccccc1NC(=O)/C=C/c1cccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)c1		CHEMBL1630114	=	IC50	nM	850.0	CHEMBL301	Homo sapiens	IC50	uM	0.85
	5112269	CHEMBL1640699	Inhibition of CDK2 by flash plate based radioactive enzyme assay	B	Nc1ccccc1NC(=O)/C=C/c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)cc1		CHEMBL1630115	=	IC50	nM	1200.0	CHEMBL301	Homo sapiens	IC50	uM	1.2
	5112270	CHEMBL1640699	Inhibition of CDK2 by flash plate based radioactive enzyme assay	B	Nc1ccccc1NC(=O)CCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)cc1		CHEMBL1630116	=	IC50	nM	1400.0	CHEMBL301	Homo sapiens	IC50	uM	1.4
	5112271	CHEMBL1640699	Inhibition of CDK2 by flash plate based radioactive enzyme assay	B	O=C(NO)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL1630117	=	IC50	nM	460.0	CHEMBL301	Homo sapiens	IC50	uM	0.46
	5112272	CHEMBL1640699	Inhibition of CDK2 by flash plate based radioactive enzyme assay	B	O=C(NO)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)s1		CHEMBL1630118	=	IC50	nM	200.0	CHEMBL301	Homo sapiens	IC50	uM	0.2
	5112273	CHEMBL1640699	Inhibition of CDK2 by flash plate based radioactive enzyme assay	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	=	IC50	nM	11000.0	CHEMBL301	Homo sapiens	IC50	uM	11.0
Not Determined	5116539	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	O=C1NC(=O)/C(=C/c2ccc(OCc3ccccc3)c(OCc3ccccc3)c2)N1		CHEMBL1630431		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Determined	5116540	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	COc1ccc2nc3c(=O)[nH]c(=O)nc-3n(C[C@@H](O)[C@@H](O)[C@@H](O)CO)c2c1		CHEMBL1630432		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Determined	5116541	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	COC(=O)C(=O)c1c(C(=O)OC)nc2n[nH]c(=N)n2c1-c1cccc([N+](=O)[O-])c1		CHEMBL1630433		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	5116542	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	Oc1ccc(Nc2ncnc3[nH]cnc23)cc1CN(CCCl)CCCl		CHEMBL1630434	=	Inhibition	%	98.0	CHEMBL301	Homo sapiens	INH	%	98.0
Not Determined	5116543	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	COc1ccc([C@H]2c3cc4c(cc3OC(O)(CO)[C@H]2C(=O)O)OCO4)c(OC)c1		CHEMBL1630435		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Determined	5116544	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	CSc1nc(N[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(Cl)c(=O)[nH]1		CHEMBL1630436		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Determined	5116545	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	COC(=O)c1cc(-c2ccc(N)cc2)c2c(=O)n(-c3ccccc3)[nH]c2c1		CHEMBL1630437		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Determined	5116546	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	COc1ccc(-c2c3c(nc4nc(SCCc5ccccc5)nc(N)c24)CCCC3)cc1OC		CHEMBL1630438		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Determined	5116547	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	COc1nc(N[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(Cl)c(=O)[nH]1		CHEMBL1630439		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Determined	5116548	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	CN1C=NC([N+](=O)[O-])C1NCCN1CCNC1=O		CHEMBL1630440		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Determined	5116549	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	Nc1n[nH]c(Sc2ncccc2[N+](=O)[O-])n1		CHEMBL1486850		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Determined	5116550	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	N=C(N)NCCC[C@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC1=O		CHEMBL1630441		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	5116551	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	COc1cc(/C=C2/NC(=O)NC2=O)cc(OC)c1OC		CHEMBL1630442	=	Inhibition	%	84.0	CHEMBL301	Homo sapiens	INH	%	84.0
Not Determined	5116552	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	COc1cc(/C=C2\CCNC2=O)ccc1Oc1ccccc1		CHEMBL1630443		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Determined	5116553	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	COc1cc2c(cc1Cl)nc1c(=O)[nH]c(=O)nc-1n2CCN1CCCC1		CHEMBL1630444		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	5116554	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	O=C(O)CCN(CCC(=O)O)c1ccc(/C=C2\SC(=S)NC2=O)cc1		CHEMBL1630445	=	Inhibition	%	27.0	CHEMBL301	Homo sapiens	INH	%	27.0
	5116555	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	COc1cc(-c2cc(-c3cc(C)cc(Cl)c3O)nc3ncnc(N)c23)ccc1O		CHEMBL1630446	=	Inhibition	%	91.0	CHEMBL301	Homo sapiens	INH	%	91.0
Not Determined	5116556	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	COc1ccc(-c2c3c(nc4nc(SCC(=O)c5ccc(Br)cc5)nc(N)c24)CCCC3)cc1OC		CHEMBL1630447		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Determined	5116557	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	COc1ccc(/C=C2\SC(=O)NC2=O)cc1S(=O)(=O)O		CHEMBL1630448		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Determined	5116558	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	CNc1nnc(Sc2ncccc2[N+](=O)[O-])s1		CHEMBL1589102		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Determined	5116559	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	COC(=O)C(=O)c1c(C(=O)OC)nc2n[nH]c(=N)n2c1-c1ccc(O)c(OC)c1		CHEMBL1630449		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Determined	5116560	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	O=C1NC(N2CCC[C@H](CO)C2)=N/C1=C\c1ccccc1		CHEMBL1630450		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	5116561	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	COc1ccc(-c2cc(-c3ccc(F)cc3)[nH]c(=O)c2O)cc1		CHEMBL1630451	=	Inhibition	%	94.0	CHEMBL301	Homo sapiens	INH	%	94.0
	5116562	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	Cc1ccc(Nc2nnc(-c3ccc([N+](=O)[O-])cc3)o2)cc1Cl		CHEMBL1630452	=	Inhibition	%	22.0	CHEMBL301	Homo sapiens	INH	%	22.0
Not Determined	5116563	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL1643		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Determined	5116564	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	COc1cc(/C=C2\NC(=O)NC2=O)ccc1OCC(=O)c1ccccc1		CHEMBL1290815		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Determined	5116565	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	COc1cc(/C=C2\NC(=O)NC2=O)ccc1OCC(=O)C1CCOCC1		CHEMBL1630453		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	5116566	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	O=C1NC(=O)/C(=C/c2cccc3c2OCO3)N1		CHEMBL1288549	=	Inhibition	%	27.0	CHEMBL301	Homo sapiens	INH	%	27.0
Not Determined	5116567	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)CN(CCO)CO3)N1		CHEMBL1630454		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Determined	5116568	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	COc1ccc(CCN2COc3c([C@@H](C)CCC=C(C)C)ccc(C)c3C2)cc1OC		CHEMBL1630455		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Determined	5116569	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	CC(C)=CCC[C@H](C)c1ccc(C)c2c1OCN(CCCCCO)C2		CHEMBL1630456		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Determined	5116570	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	O=C1NC(=O)/C(=C/c2ccc(N(CCO)CCO)cc2)N1		CHEMBL1630457		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Determined	5116571	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	O=C1NC(=O)/C(=C/c2ccc(/C=C3/NC(=O)NC3=O)cc2)N1		CHEMBL1630458		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Determined	5116572	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	CCCCOc1ccc(/C=C2\NC(=O)NC2=O)cc1[N+](=O)[O-]		CHEMBL1630459		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Determined	5116573	CHEMBL1640852	Inhibition of recombinant CDK2 at 10 uM by Z'-LYTE kinase assay kit method	B	O[C@]12C=C(c3[nH]ccc4c5ccccc5nc3-4)[C@@H]3CCN(CCCC/C=C\CC1)C[C@@]31C[C@@H]3/C=C\CCCCN3[C@@H]21		CHEMBL326531		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	5140486	CHEMBL1646801	Inhibition of CDK2 at 10 uM	B	CC(C)(C)c1cc(C(=O)O)c(NC(=O)Nc2ccc3[nH]ncc3c2)s1		CHEMBL1641799	=	Inhibition	%	10.0	CHEMBL301	Homo sapiens	INH	%	10.0
	5140529	CHEMBL1646065	Inhibition of CDK2 at 1 uM	B	CC(C)(C)c1cc(C(=O)O)c(NC(=O)Nc2ccc3[nH]ncc3c2)s1		CHEMBL1641799	=	Inhibition	%	10.0	CHEMBL301	Homo sapiens	INH	%	10.0
	5143838	CHEMBL1656198	Inhibition of CDK2	B	CCN(Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)C(C)(C)CO.Cl		CHEMBL1650533	>	IC50	nM	100.0	CHEMBL301	Homo sapiens	IC50	nM	100.0
	5143855	CHEMBL1656198	Inhibition of CDK2	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCC(F)(F)C3)ns2)n1.Cl		CHEMBL1650545	>	IC50	nM	100.0	CHEMBL301	Homo sapiens	IC50	nM	100.0
	5143872	CHEMBL1656198	Inhibition of CDK2	B	Cl.[2H]C([2H])(c1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)N1CCC(F)(F)C1		CHEMBL1650551	>	IC50	nM	100.0	CHEMBL301	Homo sapiens	IC50	nM	100.0
	5152475	CHEMBL1656387	Inhibition of CDK2A by Caliper mobility shift assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL2012519	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	5152500	CHEMBL1656387	Inhibition of CDK2A by Caliper mobility shift assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)CC(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1651521	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	5293778	CHEMBL1696300	Inhibition of CDK2	B	Nc1nccc(-c2ccc3c(N)n[nH]c3c2)n1		CHEMBL1688215	=	IC50	nM	280.0	CHEMBL301	Homo sapiens	IC50	uM	0.28
Not Active	6150860	CHEMBL1764770	Inhibition of Cdk2	B	C[C@H]1C(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C(=O)N1Cc1ccnc2ccccc12		CHEMBL1738841		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	6153358	CHEMBL1763546	Inhibition of CDK2 in presence of 60 uM ATP	B	Nc1nc(Nc2cccnc2)sc1C(=O)c1ccccc1F		CHEMBL1761791	=	IC50	nM	25.0	CHEMBL301	Homo sapiens	IC50	nM	25.0
	6157880	CHEMBL1764780	Inhibition of CDK2	B	COc1cc(Nc2nccc(Nc3cnc4ccccc4c3)n2)cc(OC)c1OC		CHEMBL1760035	=	IC50	nM	711.0	CHEMBL301	Homo sapiens	IC50	uM	0.711
	6157881	CHEMBL1764780	Inhibition of CDK2	B	c1ccc2ncc(Nc3ccnc(Nc4ccc(OCCCN5CCCCC5)cc4)n3)cc2c1		CHEMBL1760057	=	IC50	nM	19500.0	CHEMBL301	Homo sapiens	IC50	uM	19.5
Not Active	6230334	CHEMBL1785281	Inhibition of human CDK2	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	6231472	CHEMBL1787306	Inhibition of CDK2	B	O=C(c1ccco1)N1N=C(c2cccnc2)CC1c1ccccc1O		CHEMBL1779593	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	6262751	CHEMBL1798620	Inhibition of CDK2	B	Cc1ccc(C(=O)NCCO)cc1-n1cnc(OCc2ccc(F)cc2F)c(Cl)c1=O		CHEMBL1738710	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	6264916	CHEMBL1799799	Inhibition of CDK2 at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796254	<	Inhibition	%	65.0	CHEMBL301	Homo sapiens	INH	%	65.0
	6265640	CHEMBL1799799	Inhibition of CDK2 at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4N(C)S(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796257	<	Inhibition	%	65.0	CHEMBL301	Homo sapiens	INH	%	65.0
	6267493	CHEMBL1799019	Inhibition of CDK2 at 10 uM	B	O=c1c(Cl)c(OCc2ccc(F)cc2F)cc(CO)n1-c1c(F)cccc1F		CHEMBL1797211	<	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	6267494	CHEMBL1799019	Inhibition of CDK2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cccc(C(N)=O)c1		CHEMBL1797224	<	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	6268158	CHEMBL1805341	Inhibition of Cdk2	B	CSc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C)ns2)n1		CHEMBL1270795	=	IC50	nM	2273.0	CHEMBL301	Homo sapiens	IC50	nM	2273.0
	6271700	CHEMBL1804641	Binding affinity to human Cdk2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
Active	6274448	CHEMBL1805637	Inhibition of CDK2 in human HCT116 cells assessed as decrease in protein level at 30 to 40 umol/L after 24 hrs by immunoblotting analysis	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	6274457	CHEMBL1805523	Inhibition of CDK2-mediated phosphorylation of RB at Ser780 in human HCT116 cells after 4 hrs by immunoblotting analysis	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	6274458	CHEMBL1805543	Inhibition of CDK2-mediated phosphorylation of RB at Ser780 in human HCT116 cells after 24 hrs by immunoblotting analysis	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	6274459	CHEMBL1805544	Inhibition of CDK2-mediated phosphorylation of RB at Ser795 in human HCT116 cells after 4 hrs by immunoblotting analysis	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	6274460	CHEMBL1805545	Inhibition of CDK2-mediated phosphorylation of RB at Ser795 in human HCT116 cells after 24 hrs by immunoblotting analysis	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	6274461	CHEMBL1805546	Inhibition of CDK2-mediated phosphorylation of RB at Ser801 in human HCT116 cells after 4 hrs by immunoblotting analysis	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	6274462	CHEMBL1805547	Inhibition of CDK2-mediated phosphorylation of RB at Ser801 in human HCT116 cells after 24 hrs by immunoblotting analysis	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	6274463	CHEMBL1805548	Inhibition of CDK2-mediated phosphorylation of RB at Ser807/811 in human HCT116 cells after 4 hrs by immunoblotting analysis	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	6274464	CHEMBL1805549	Inhibition of CDK2-mediated phosphorylation of RB at Ser807/811 in human HCT116 cells after 24 hrs by immunoblotting analysis	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	6274465	CHEMBL1805550	Inhibition of CDK2-mediated phosphorylation of RB at Thr821 in human HCT116 cells after 4 hrs by immunoblotting analysis	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	6274466	CHEMBL1805551	Inhibition of CDK2-mediated phosphorylation of RB at Thr821 in human HCT116 cells after 24 hrs by immunoblotting analysis	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	6274472	CHEMBL1805557	Inhibition of phospho-CDK2-mediated phosphorylation of RB protein in human HCT116 cells after 4 hrs by immunoblotting analysis	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	6274473	CHEMBL1805558	Inhibition of CDK2-mediated phosphorylation of RB protein in human HCT116 cells after 4 hrs by immunoblotting analysis	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	6274483	CHEMBL1805620	Inhibition of phospho-CDK2-mediated phosphorylation of RNA pol3 in human HCT116 cells after 4 hrs by immunoblotting analysis	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	6274484	CHEMBL1805621	Inhibition of CDK2-mediated phosphorylation of RNA pol3 in human HCT116 cells after 4 hrs by immunoblotting analysis	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	6274496	CHEMBL1805636	Inhibition of CDK2 in human HCT116 cells assessed as decrease in protein level at 1 umol/L after 24 hrs by immunoblotting analysis	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	6274497	CHEMBL1805638	Inhibition of CDK2 phosphorylation at Thr170 in human HCT116 cells after 24 hrs by immunoblotting analysis	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	6282054	CHEMBL1804256	Inhibition of CDK2 in presence of 100 uM ATP	B	Nc1nc(NC2CCCC2)cc(-c2cc(N3C[C@H](O)[C@@H](O)C3)ccc2O)n1		CHEMBL1800464	=	IC50	nM	15.0	CHEMBL301	Homo sapiens	IC50	uM	0.015
	6282058	CHEMBL1804256	Inhibition of CDK2 in presence of 100 uM ATP	B	Nc1nccc(-c2cc(N3C[C@H](O)[C@@H](O)C3)ccc2O)n1		CHEMBL1800449	=	IC50	nM	21.0	CHEMBL301	Homo sapiens	IC50	uM	0.021
	6282062	CHEMBL1804256	Inhibition of CDK2 in presence of 100 uM ATP	B	Cc1cc(-c2cc(N3C[C@H](O)[C@@H](O)C3)ccc2O)nc(N)n1		CHEMBL1800450	=	IC50	nM	42.0	CHEMBL301	Homo sapiens	IC50	uM	0.042
	6282063	CHEMBL1804256	Inhibition of CDK2 in presence of 100 uM ATP	B	Nc1nc(-c2cc(N3C[C@H](O)[C@@H](O)C3)ccc2O)cc(C2CCCC2)n1		CHEMBL1800455	=	IC50	nM	42.0	CHEMBL301	Homo sapiens	IC50	uM	0.042
	6282065	CHEMBL1804256	Inhibition of CDK2 in presence of 100 uM ATP	B	CCc1cc(-c2cc(N3C[C@H](O)[C@@H](O)C3)ccc2O)nc(N)n1		CHEMBL1800451	=	IC50	nM	50.0	CHEMBL301	Homo sapiens	IC50	uM	0.05
	6282066	CHEMBL1804256	Inhibition of CDK2 in presence of 100 uM ATP	B	Nc1nc(-c2cc(N3C[C@H](O)[C@@H](O)C3)ccc2O)cc(C2CCCCC2)n1		CHEMBL1800456	=	IC50	nM	52.0	CHEMBL301	Homo sapiens	IC50	uM	0.052
	6282067	CHEMBL1804256	Inhibition of CDK2 in presence of 100 uM ATP	B	Nc1nc(NC2CCCCC2)cc(-c2cc(N3C[C@H](O)[C@@H](O)C3)ccc2O)n1		CHEMBL1800465	=	IC50	nM	60.0	CHEMBL301	Homo sapiens	IC50	uM	0.06
	6282068	CHEMBL1804256	Inhibition of CDK2 in presence of 100 uM ATP	B	CC(C)c1cc(-c2cc(N3C[C@H](O)[C@@H](O)C3)ccc2O)nc(N)n1		CHEMBL1800452	=	IC50	nM	68.0	CHEMBL301	Homo sapiens	IC50	uM	0.068
	6282069	CHEMBL1804256	Inhibition of CDK2 in presence of 100 uM ATP	B	Nc1nc(-c2cc(N3C[C@H](O)[C@@H](O)C3)ccc2O)cc(C2CCCCCC2)n1		CHEMBL1800457	=	IC50	nM	90.0	CHEMBL301	Homo sapiens	IC50	uM	0.09
	6282071	CHEMBL1804256	Inhibition of CDK2 in presence of 100 uM ATP	B	Nc1nc(-c2cc(N3C[C@H](O)[C@@H](O)C3)ccc2O)cc(C2CCNCC2)n1		CHEMBL1800459	=	IC50	nM	200.0	CHEMBL301	Homo sapiens	IC50	uM	0.2
	6282073	CHEMBL1804256	Inhibition of CDK2 in presence of 100 uM ATP	B	CN(C)c1cc(-c2cc(N3C[C@H](O)[C@@H](O)C3)ccc2O)nc(N)n1		CHEMBL1800460	=	IC50	nM	250.0	CHEMBL301	Homo sapiens	IC50	uM	0.25
	6282076	CHEMBL1804256	Inhibition of CDK2 in presence of 100 uM ATP	B	CN1CCN(c2cc(-c3cc(N4C[C@H](O)[C@@H](O)C4)ccc3O)nc(N)n2)CC1		CHEMBL1800462	=	IC50	nM	300.0	CHEMBL301	Homo sapiens	IC50	uM	0.3
	6282079	CHEMBL1804256	Inhibition of CDK2 in presence of 100 uM ATP	B	Nc1nc(-c2cc(N3C[C@H](O)[C@@H](O)C3)ccc2O)cc(C2CCCNC2)n1		CHEMBL1800458	=	IC50	nM	360.0	CHEMBL301	Homo sapiens	IC50	uM	0.36
	6282083	CHEMBL1804256	Inhibition of CDK2 in presence of 100 uM ATP	B	CCCCCCc1cc(-c2cc(N3C[C@H](O)[C@@H](O)C3)ccc2O)nc(N)n1		CHEMBL1800453	=	IC50	nM	450.0	CHEMBL301	Homo sapiens	IC50	uM	0.45
	6282084	CHEMBL1804256	Inhibition of CDK2 in presence of 100 uM ATP	B	Nc1nc(NCCN2CCOCC2)cc(-c2cc(N3C[C@H](O)[C@@H](O)C3)ccc2O)n1		CHEMBL1800463	=	IC50	nM	450.0	CHEMBL301	Homo sapiens	IC50	uM	0.45
	6282090	CHEMBL1804256	Inhibition of CDK2 in presence of 100 uM ATP	B	Nc1nccc(-c2cc(N3CCOCC3)ccc2O)n1		CHEMBL1800218	=	IC50	nM	790.0	CHEMBL301	Homo sapiens	IC50	uM	0.79
	6282097	CHEMBL1804256	Inhibition of CDK2 in presence of 100 uM ATP	B	Nc1nc(-c2cc(N3C[C@H](O)[C@@H](O)C3)ccc2O)cc(N2CCOCC2)n1		CHEMBL1800461	=	IC50	nM	940.0	CHEMBL301	Homo sapiens	IC50	uM	0.94
	6282109	CHEMBL1804256	Inhibition of CDK2 in presence of 100 uM ATP	B	Nc1nccc(-c2cc(N3CCC(O)C3)ccc2O)n1		CHEMBL1800448	=	IC50	nM	2110.0	CHEMBL301	Homo sapiens	IC50	uM	2.11
	6282115	CHEMBL1804256	Inhibition of CDK2 in presence of 100 uM ATP	B	Nc1nccc(-c2cc(N3CCC(O)CC3)ccc2O)n1		CHEMBL1800447	=	IC50	nM	3760.0	CHEMBL301	Homo sapiens	IC50	uM	3.76
	6282116	CHEMBL1804256	Inhibition of CDK2 in presence of 100 uM ATP	B	Nc1nccc(-c2cc(N3CCS(=O)(=O)CC3)ccc2O)n1		CHEMBL1800219	=	IC50	nM	3980.0	CHEMBL301	Homo sapiens	IC50	uM	3.98
	6282133	CHEMBL1804256	Inhibition of CDK2 in presence of 100 uM ATP	B	Nc1nccc(-c2cc(N3CCCCC3)ccc2O)n1		CHEMBL1800216	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	6282134	CHEMBL1804256	Inhibition of CDK2 in presence of 100 uM ATP	B	CCC1CCN(c2ccc(O)c(-c3ccnc(N)n3)c2)CC1		CHEMBL1800217	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	6282135	CHEMBL1804256	Inhibition of CDK2 in presence of 100 uM ATP	B	Nc1nccc(-c2cc(N3CCC(=O)CC3)ccc2O)n1		CHEMBL1800446	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	6282136	CHEMBL1804256	Inhibition of CDK2 in presence of 100 uM ATP	B	Nc1nc(-c2cc(N3C[C@H](O)[C@@H](O)C3)ccc2O)cc(C2CC2)n1		CHEMBL1800454	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	6295141	CHEMBL1810766	Inhibition of recombinant CDK2 expressed in baculovirus using [gamma-32P]-ATP by 33-P leadseeker assay	B	O=c1[nH]cc(-c2ccc(N3CCOCC3)cc2)c2sc(-c3ccncc3)cc12		CHEMBL1809107	=	IC50	nM	15848.93	CHEMBL301	Homo sapiens	pIC50		4.8
Not Determined	6295142	CHEMBL1810766	Inhibition of recombinant CDK2 expressed in baculovirus using [gamma-32P]-ATP by 33-P leadseeker assay	B	Cc1cc(-c2cc3c(=O)[nH]cc(-c4cccc(NS(C)(=O)=O)c4)c3s2)ccn1		CHEMBL1809108		pIC50			CHEMBL301	Homo sapiens	pIC50		
	6295143	CHEMBL1810766	Inhibition of recombinant CDK2 expressed in baculovirus using [gamma-32P]-ATP by 33-P leadseeker assay	B	CS(=O)(=O)Nc1cccc(-c2c[nH]c(=O)c3cc(-c4ccnc5[nH]ccc45)sc23)c1		CHEMBL1809109	=	IC50	nM	3162.28	CHEMBL301	Homo sapiens	pIC50		5.5
	6295144	CHEMBL1810766	Inhibition of recombinant CDK2 expressed in baculovirus using [gamma-32P]-ATP by 33-P leadseeker assay	B	O=c1[nH]cc(-c2ccc(N3CCOCC3)cc2)c2sc(-c3cn[nH]c3)cc12		CHEMBL1809110	=	IC50	nM	251.19	CHEMBL301	Homo sapiens	pIC50		6.6
	6295145	CHEMBL1810766	Inhibition of recombinant CDK2 expressed in baculovirus using [gamma-32P]-ATP by 33-P leadseeker assay	B	Cn1cc(-c2ccc(N3CCOCC3)cc2)c2sc(-c3ccncc3)cc2c1=O		CHEMBL1809111	<	IC50	nM	15848.93	CHEMBL301	Homo sapiens	pIC50		4.8
	6295146	CHEMBL1810766	Inhibition of recombinant CDK2 expressed in baculovirus using [gamma-32P]-ATP by 33-P leadseeker assay	B	COc1ncc(-c2ccc(N3CCOCC3)cc2)c2sc(-c3ccncc3)cc12		CHEMBL1809112	<	IC50	nM	15848.93	CHEMBL301	Homo sapiens	pIC50		4.8
	6295147	CHEMBL1810766	Inhibition of recombinant CDK2 expressed in baculovirus using [gamma-32P]-ATP by 33-P leadseeker assay	B	N#Cc1ccc(F)c(-c2c[nH]c(=O)c3cc(-c4ccncc4)sc23)c1		CHEMBL1809113	=	IC50	nM	199.53	CHEMBL301	Homo sapiens	pIC50		6.7
	6295148	CHEMBL1810766	Inhibition of recombinant CDK2 expressed in baculovirus using [gamma-32P]-ATP by 33-P leadseeker assay	B	O=c1[nH]cc(-c2ccc3c(c2)OCCO3)c2sc(-c3ccncc3)cc12		CHEMBL1809114	=	IC50	nM	1584.89	CHEMBL301	Homo sapiens	pIC50		5.8
	6295149	CHEMBL1810766	Inhibition of recombinant CDK2 expressed in baculovirus using [gamma-32P]-ATP by 33-P leadseeker assay	B	N#CCc1cccc(-c2c[nH]c(=O)c3cc(-c4ccncc4)sc23)c1		CHEMBL1809115	=	IC50	nM	3981.07	CHEMBL301	Homo sapiens	pIC50		5.4
	6295150	CHEMBL1810766	Inhibition of recombinant CDK2 expressed in baculovirus using [gamma-32P]-ATP by 33-P leadseeker assay	B	O=c1[nH]cc(-c2cccc(Cl)n2)c2sc(-c3ccncc3)cc12		CHEMBL1809116	<	IC50	nM	15848.93	CHEMBL301	Homo sapiens	pIC50		4.8
	6295151	CHEMBL1810766	Inhibition of recombinant CDK2 expressed in baculovirus using [gamma-32P]-ATP by 33-P leadseeker assay	B	N#Cc1cscc1-c1c[nH]c(=O)c2cc(-c3ccncc3)sc12		CHEMBL1809117	=	IC50	nM	158.49	CHEMBL301	Homo sapiens	pIC50		6.8
	6295152	CHEMBL1810766	Inhibition of recombinant CDK2 expressed in baculovirus using [gamma-32P]-ATP by 33-P leadseeker assay	B	COCc1ccccc1-c1c[nH]c(=O)c2cc(-c3ccncc3)sc12		CHEMBL1809118	=	IC50	nM	5011.87	CHEMBL301	Homo sapiens	pIC50		5.3
	6295153	CHEMBL1810766	Inhibition of recombinant CDK2 expressed in baculovirus using [gamma-32P]-ATP by 33-P leadseeker assay	B	CCOc1ccc(-c2c[nH]c(=O)c3cc(-c4ccncc4)sc23)cn1		CHEMBL1809119	=	IC50	nM	6309.57	CHEMBL301	Homo sapiens	pIC50		5.2
	6295154	CHEMBL1810766	Inhibition of recombinant CDK2 expressed in baculovirus using [gamma-32P]-ATP by 33-P leadseeker assay	B	COc1cc(F)ccc1-c1c[nH]c(=O)c2cc(-c3ccncc3)sc12		CHEMBL1809120	=	IC50	nM	5011.87	CHEMBL301	Homo sapiens	pIC50		5.3
	6295155	CHEMBL1810766	Inhibition of recombinant CDK2 expressed in baculovirus using [gamma-32P]-ATP by 33-P leadseeker assay	B	CN(C)C(=O)c1ccccc1-c1c[nH]c(=O)c2cc(-c3ccncc3)sc12		CHEMBL1809121	<	IC50	nM	15848.93	CHEMBL301	Homo sapiens	pIC50		4.8
	6295156	CHEMBL1810766	Inhibition of recombinant CDK2 expressed in baculovirus using [gamma-32P]-ATP by 33-P leadseeker assay	B	O=c1[nH]cc(-c2cccc3cccnc23)c2sc(-c3ccncc3)cc12		CHEMBL1809122	=	IC50	nM	12589.25	CHEMBL301	Homo sapiens	pIC50		4.9
	6296126	CHEMBL1811056	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(Nc2nccc(-c3cnc4ccccn34)n2)cc1		CHEMBL73303	=	IC50	nM	1.0	CHEMBL301	Homo sapiens	IC50	uM	0.001
	6296127	CHEMBL1811056	Inhibition of CDK2	B	CC(=O)N1CCN(c2ccc(Nc3nccc(-c4cnc5ccccn45)n3)cc2)CC1		CHEMBL1809191	=	IC50	nM	78.0	CHEMBL301	Homo sapiens	IC50	uM	0.078
	6296128	CHEMBL1811056	Inhibition of CDK2	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1nccc(-c2cnc3ccccn23)n1		CHEMBL1809192	>	IC50	nM	100000.0	CHEMBL301	Homo sapiens	IC50	uM	100.0
	6296129	CHEMBL1811056	Inhibition of CDK2	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(F)c(-c2cnc3ccccn23)n1		CHEMBL1809193	=	IC50	nM	2700.0	CHEMBL301	Homo sapiens	IC50	uM	2.7
	6296130	CHEMBL1811056	Inhibition of CDK2	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1		CHEMBL1809044	=	IC50	nM	1100.0	CHEMBL301	Homo sapiens	IC50	uM	1.1
	6296131	CHEMBL1811056	Inhibition of CDK2	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Br)c(-c2cnc3ccccn23)n1		CHEMBL1809194	=	IC50	nM	1100.0	CHEMBL301	Homo sapiens	IC50	uM	1.1
	6296132	CHEMBL1811056	Inhibition of CDK2	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(C)c(-c2cnc3ccccn23)n1		CHEMBL1809195	=	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	6296133	CHEMBL1811056	Inhibition of CDK2	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(C(F)(F)F)c(-c2cnc3ccccn23)n1		CHEMBL1809196	=	IC50	nM	16000.0	CHEMBL301	Homo sapiens	IC50	uM	16.0
	6296134	CHEMBL1811056	Inhibition of CDK2	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(OC)c(-c2cnc3ccccn23)n1		CHEMBL1809197	=	IC50	nM	53000.0	CHEMBL301	Homo sapiens	IC50	uM	53.0
	6296135	CHEMBL1811056	Inhibition of CDK2	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(C#N)c(-c2cnc3ccccn23)n1		CHEMBL1806525	=	IC50	nM	27000.0	CHEMBL301	Homo sapiens	IC50	uM	27.0
	6299676	CHEMBL1811573	Inhibition of CDK2	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1ncnn2cc(C(=O)c3ccccc3)c(C)c12		CHEMBL1807446	>	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	6325426	CHEMBL1819980	Inhibition of CDK2	B	c1ccc2[nH]ncc2c1		CHEMBL86795	=	IC50	nM	185000.0	CHEMBL301	Homo sapiens	IC50	uM	185.0
	6340007	CHEMBL1827245	Activity of CDK2 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	87.0	CHEMBL301	Homo sapiens	Activity	%	87.0
	6340539	CHEMBL1825377	Inhibition of CDK2	B	N[C@H](CNc1nnc(-c2ccc3cnccc3c2)s1)Cc1ccc(C(F)(F)F)cc1		CHEMBL1080569	=	IC50	nM	50.0	CHEMBL301	Homo sapiens	IC50	uM	0.05
	6340540	CHEMBL1825377	Inhibition of CDK2	B	N[C@H](CNc1nnc(-c2ccc3c(c2)CC(=O)N3)s1)Cc1ccc(C(F)(F)F)cc1		CHEMBL1823630	=	IC50	nM	190.0	CHEMBL301	Homo sapiens	IC50	uM	0.19
	6340541	CHEMBL1825377	Inhibition of CDK2	B	N[C@H](CNC(=O)c1ccc2cnccc2c1)Cc1ccc(C(F)(F)F)cc1		CHEMBL1823631	>	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	6340542	CHEMBL1825377	Inhibition of CDK2	B	O=C(NC(c1ccccc1)C1CCNCC1)c1ccc2cnccc2c1		CHEMBL1823632	=	IC50	nM	19700.0	CHEMBL301	Homo sapiens	IC50	uM	19.7
	6340543	CHEMBL1825377	Inhibition of CDK2	B	O=C(NC(c1ccc2ccccc2c1)C1CCNCC1)c1ccc2cnccc2c1		CHEMBL1823633	>	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	6340544	CHEMBL1825377	Inhibition of CDK2	B	O=C(NC(c1nccs1)C1CCNCC1)c1ccc2cnccc2c1		CHEMBL1823634	>	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	6340545	CHEMBL1825377	Inhibition of CDK2	B	COc1ccc(C(NC(=O)c2ccc3cnccc3c2)C2CCNCC2)cc1F		CHEMBL1823635	>	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	6340546	CHEMBL1825377	Inhibition of CDK2	B	O=C(NC(c1ccc(F)c(F)c1)C1CCNCC1)c1ccc2cnccc2c1		CHEMBL1823636	>	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	6340547	CHEMBL1825377	Inhibition of CDK2	B	O=C(NC(c1ccc(Cl)c(-c2ccccc2)c1)C1CCNCC1)c1ccc2cnccc2c1		CHEMBL1823637	>	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	6340548	CHEMBL1825377	Inhibition of CDK2	B	N#Cc1cc(C(NC(=O)c2ccc3cnccc3c2)C2CCNCC2)ccc1Cl		CHEMBL1823638	>	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	6340549	CHEMBL1825377	Inhibition of CDK2	B	O=C(NC(c1cccc(Cl)c1)C1CCNCC1)c1ccc2cnccc2c1		CHEMBL1823639	>	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	6340550	CHEMBL1825377	Inhibition of CDK2	B	O=C(NC(c1ccc(Cl)cc1)C1CCNCC1)c1ccc2cnccc2c1		CHEMBL1823640	>	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	6340551	CHEMBL1825377	Inhibition of CDK2	B	O=C(NC(c1ccc(Cl)c(F)c1)C1CCNCC1)c1ccc2cnccc2c1		CHEMBL1823641	>	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	6340552	CHEMBL1825377	Inhibition of CDK2	B	O=C(NC(c1cccc(Cl)c1Cl)C1CCNCC1)c1ccc2cnccc2c1		CHEMBL1823642	>	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	6340553	CHEMBL1825377	Inhibition of CDK2	B	O=C(NC(c1ccc(Cl)c(Cl)c1)C1CCNCC1)c1ccc2cnccc2c1		CHEMBL1823643	>	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	6340554	CHEMBL1825377	Inhibition of CDK2	B	O=C(NC(c1cnc(Cl)c(Cl)c1)C1CCNCC1)c1ccc2cnccc2c1		CHEMBL1823644	>	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	6340555	CHEMBL1825377	Inhibition of CDK2	B	O=C(NC(c1ccc(Cl)c(Cl)c1)C1CCNCC1)c1ccc2cnc(F)cc2c1		CHEMBL1823651	>	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	6340556	CHEMBL1825377	Inhibition of CDK2	B	O=C(NC(c1ccc(Cl)c(Cl)c1)C1CCCNC1)c1ccc2cnccc2c1		CHEMBL1823653	=	IC50	nM	21000.0	CHEMBL301	Homo sapiens	IC50	uM	21.0
	6340557	CHEMBL1825377	Inhibition of CDK2	B	O=C(NC(c1ccc(Cl)c(Cl)c1)C1CCNC1)c1ccc2cnccc2c1		CHEMBL1823654	>	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	6340558	CHEMBL1825377	Inhibition of CDK2	B	O=C(N[C@@H](c1ccc(Cl)c(Cl)c1)C1CNC1)c1ccc2cnccc2c1		CHEMBL1823655	=	IC50	nM	680.0	CHEMBL301	Homo sapiens	IC50	uM	0.68
	6340559	CHEMBL1825377	Inhibition of CDK2	B	O=C(N[C@H](c1ccc(Cl)c(Cl)c1)C1CNC1)c1ccc2cnccc2c1		CHEMBL1823656	=	IC50	nM	9800.0	CHEMBL301	Homo sapiens	IC50	uM	9.8
	6340560	CHEMBL1825377	Inhibition of CDK2	B	O=C(NC(c1ccc(Cl)c(Cl)c1)C1CCCCC1)c1ccc2cnccc2c1		CHEMBL1823657	>	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	6340561	CHEMBL1825377	Inhibition of CDK2	B	O=C(NC(c1cncnc1)c1ccc(Cl)c(Cl)c1)c1ccc2cnccc2c1		CHEMBL1823658	>	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	6340562	CHEMBL1825377	Inhibition of CDK2	B	O=C(NC(c1ccncc1)c1ccc(Cl)c(Cl)c1)c1ccc2cnccc2c1		CHEMBL1823659	>	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	6340563	CHEMBL1825377	Inhibition of CDK2	B	CC(C)CN1CCC([C@@H](NC(=O)c2ccc3cnccc3c2)c2ccc(Cl)c(Cl)c2)CC1		CHEMBL1823660	>	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	6340564	CHEMBL1825377	Inhibition of CDK2	B	O=C(N[C@@H](c1ccc(Cl)c(Cl)c1)C1CCN(Cc2ccccc2)CC1)c1ccc2cnccc2c1		CHEMBL1823661	>	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	6340565	CHEMBL1825377	Inhibition of CDK2	B	O=C(N[C@@H](c1ccc(Cl)c(Cl)c1)C1CCN(Cc2ccc(C(F)(F)F)cc2)CC1)c1ccc2cnccc2c1		CHEMBL1823662	>	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	6340566	CHEMBL1825377	Inhibition of CDK2	B	CN1CC([C@@H](NC(=O)c2ccc3cnccc3c2)c2ccc(Cl)c(Cl)c2)C1		CHEMBL1823663	=	IC50	nM	360.0	CHEMBL301	Homo sapiens	IC50	uM	0.36
	6384489	CHEMBL1837576	Inhibition of human CDK2 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834114	<	Inhibition	%	35.0	CHEMBL301	Homo sapiens	INH	%	35.0
	6384490	CHEMBL1837576	Inhibition of human CDK2 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CCCC1		CHEMBL1834318	<	Inhibition	%	35.0	CHEMBL301	Homo sapiens	INH	%	35.0
	6384491	CHEMBL1837576	Inhibition of human CDK2 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834323	<	Inhibition	%	35.0	CHEMBL301	Homo sapiens	INH	%	35.0
	6384492	CHEMBL1837576	Inhibition of human CDK2 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	CC(C)[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834324	<	Inhibition	%	35.0	CHEMBL301	Homo sapiens	INH	%	35.0
	6384493	CHEMBL1837576	Inhibition of human CDK2 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2		CHEMBL1834330	<	Inhibition	%	35.0	CHEMBL301	Homo sapiens	INH	%	35.0
	6386352	CHEMBL1839863	Inhibition of recombinant CDK2	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
active	7457361	CHEMBL1794381	PUBCHEM_BIOASSAY: MLPCN Dyrk1A - CDK2 selectivity Assay Measured in Biochemical System Using Plate Reader - 2124-06_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504442]	B	COc1ccc2nc(C(F)(F)Cl)c(C#N)c(N)c2c1		CHEMBL1533622	=	AC50	nM	5220.0	CHEMBL301	Homo sapiens	AC50	uM	5.22
active	7457362	CHEMBL1794381	PUBCHEM_BIOASSAY: MLPCN Dyrk1A - CDK2 selectivity Assay Measured in Biochemical System Using Plate Reader - 2124-06_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504442]	B	CC(C)[C@H](CO)Nc1nc(NCc2ccc(S(N)(=O)=O)cc2)c2ncn(C(C)C)c2n1		CHEMBL1459203	=	AC50	nM	1200.0	CHEMBL301	Homo sapiens	AC50	uM	1.2
active	7457363	CHEMBL1794381	PUBCHEM_BIOASSAY: MLPCN Dyrk1A - CDK2 selectivity Assay Measured in Biochemical System Using Plate Reader - 2124-06_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504442]	B	c1cncc(CNc2nccc(-c3ccc4cn[nH]c4c3)n2)c1		CHEMBL1894742	=	AC50	nM	13820.0	CHEMBL301	Homo sapiens	AC50	uM	13.82
active	7457364	CHEMBL1794381	PUBCHEM_BIOASSAY: MLPCN Dyrk1A - CDK2 selectivity Assay Measured in Biochemical System Using Plate Reader - 2124-06_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504442]	B	c1cncc(CNc2nccc(-c3ccc4c(c3)OCO4)n2)c1		CHEMBL1877990	=	AC50	nM	14290.0	CHEMBL301	Homo sapiens	AC50	uM	14.29
active	7457365	CHEMBL1794381	PUBCHEM_BIOASSAY: MLPCN Dyrk1A - CDK2 selectivity Assay Measured in Biochemical System Using Plate Reader - 2124-06_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504442]	B	Cc1c(-c2ccnc(NCc3cccnc3)n2)sc(=O)n1C		CHEMBL1901114	=	AC50	nM	15120.0	CHEMBL301	Homo sapiens	AC50	uM	15.12
active	7457366	CHEMBL1794381	PUBCHEM_BIOASSAY: MLPCN Dyrk1A - CDK2 selectivity Assay Measured in Biochemical System Using Plate Reader - 2124-06_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504442]	B	Cc1ccsc1CN(C)c1ncnc2ccc(-c3ccoc3)cc12		CHEMBL1612677	=	AC50	nM	7770.0	CHEMBL301	Homo sapiens	AC50	uM	7.77
active	7457367	CHEMBL1794381	PUBCHEM_BIOASSAY: MLPCN Dyrk1A - CDK2 selectivity Assay Measured in Biochemical System Using Plate Reader - 2124-06_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504442]	B	c1cncc(CNc2nccc(-c3ccc4[nH]ncc4c3)n2)c1		CHEMBL1902528	=	AC50	nM	3520.0	CHEMBL301	Homo sapiens	AC50	uM	3.52
active	7457368	CHEMBL1794381	PUBCHEM_BIOASSAY: MLPCN Dyrk1A - CDK2 selectivity Assay Measured in Biochemical System Using Plate Reader - 2124-06_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504442]	B	Cc1ccc(CN(C)c2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)o1		CHEMBL1592223	=	AC50	nM	11280.0	CHEMBL301	Homo sapiens	AC50	uM	11.28
	7567239	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7567698	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7568169	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7568627	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7569212	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7569672	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7570144	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7570165	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7570592	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7571188	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7571645	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7572142	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7572558	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	5200.0	CHEMBL301	Homo sapiens	Kd	nM	5200.0
	7573169	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	1400.0	CHEMBL301	Homo sapiens	Kd	nM	1400.0
	7573660	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7574129	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7574537	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7575147	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7575166	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7575637	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7576102	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7576510	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7577138	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7577616	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7578086	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7578491	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7578687	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7579061	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7579511	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	550.0	CHEMBL301	Homo sapiens	Kd	nM	550.0
	7579985	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7580454	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7580857	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7581045	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7581430	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7581875	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7582346	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	=	Kd	nM	5000.0	CHEMBL301	Homo sapiens	Kd	nM	5000.0
	7582810	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7583391	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7583788	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	69.0	CHEMBL301	Homo sapiens	Kd	nM	69.0
	7584233	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7584704	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7585128	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7585721	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7586129	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7586575	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7587058	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	=	Kd	nM	0.53	CHEMBL301	Homo sapiens	Kd	nM	0.53
	7587682	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7588101	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	20.0	CHEMBL301	Homo sapiens	Kd	nM	20.0
	7588554	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7588583	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7589034	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7589647	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7590071	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7590570	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7591021	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7591620	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	450.0	CHEMBL301	Homo sapiens	Kd	nM	450.0
	7592072	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7592545	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7592998	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7593580	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7594052	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7594525	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7594977	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	8700.0	CHEMBL301	Homo sapiens	Kd	nM	8700.0
	7595113	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	=	Kd	nM	30.0	CHEMBL301	Homo sapiens	Kd	nM	30.0
	7595557	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7596031	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7596502	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7596949	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	7.0	CHEMBL301	Homo sapiens	Kd	nM	7.0
	7597085	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7597538	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7598011	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7598481	CHEMBL1908541	Binding constant for CDK2 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	nM	10000.0
	7849681	CHEMBL1912414	Inhibition of CDK2	B	Nc1nc(N)c(N=O)c(OCC2CCCCC2)n1		CHEMBL303958	=	Ki	nM	1300.0	CHEMBL301	Homo sapiens	Ki	uM	1.3
Not Active	7950648	CHEMBL1926134	Inhibition of CDK2	B	CC[C@H](Nc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1)[C@H](C)O		CHEMBL1922221		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	7950649	CHEMBL1926134	Inhibition of CDK2	B	CC[C@@H](Nc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1)[C@@H](C)O		CHEMBL1922222		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	7970417	CHEMBL1930200	Inhibition of CDK2 at 10 uM	B	NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL1929247	=	Inhibition	%	-2.0	CHEMBL301	Homo sapiens	INH	%	-2.0
	7986266	CHEMBL1937384	Inhibition of CDK2	B	Cc1cnc2nc1-c1cccc(c1)OCC/C=C/CN(C)Cc1cccc(c1)N2		CHEMBL1933343	=	IC50	nM	150.0	CHEMBL301	Homo sapiens	IC50	uM	0.15
	7986267	CHEMBL1937384	Inhibition of CDK2	B	CN1C/C=C/CCOc2cccc(c2)-c2nc(nc3[nH]cnc23)Nc2cccc(c2)C1		CHEMBL1933344	=	IC50	nM	4100.0	CHEMBL301	Homo sapiens	IC50	uM	4.1
	7986268	CHEMBL1937384	Inhibition of CDK2	B	Oc1ccc(-c2nc(Nc3cccc(Cl)c3)nc3[nH]cnc23)cc1		CHEMBL1933345	=	IC50	nM	7000.0	CHEMBL301	Homo sapiens	IC50	uM	7.0
	7986269	CHEMBL1937384	Inhibition of CDK2	B	COc1ccc(-c2nc(Nc3cccc(NC(=O)CN)c3)nc3[nH]cnc23)cc1OC		CHEMBL1933346	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	7986270	CHEMBL1937384	Inhibition of CDK2	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	IC50	nM	1500.0	CHEMBL301	Homo sapiens	IC50	uM	1.5
	7987116	CHEMBL1936069	Inhibition of Cdk2	B	O=C(c1cc2cc(F)ccc2[nH]1)N1C[C@]2(CCN(C3CCCNC3)C2)c2ccccc21		CHEMBL1933538	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	7987138	CHEMBL1936069	Inhibition of Cdk2	B	O=C(c1cc2ccc(F)cc2[nH]1)N1C[C@]2(CCN(C3CCNC3)C2)c2ccccc21		CHEMBL1933550	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	7987160	CHEMBL1936069	Inhibition of Cdk2	B	C[C@@H]1CCC(N2CC[C@]3(CN(C(=O)c4cc5ccccc5[nH]4)c4ccccc43)C2)CN1		CHEMBL1933551	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	7987192	CHEMBL1936069	Inhibition of Cdk2	B	C[C@@H]1CCC(N2CC[C@]3(CN(C(=O)c4cc5ccc(F)cc5[nH]4)c4ccccc43)C2)CN1		CHEMBL1933552	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	8003424	CHEMBL1944417	Inhibition of human CDK2 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940980	<	Inhibition	%	35.0	CHEMBL301	Homo sapiens	INH	%	35.0
	8003425	CHEMBL1944417	Inhibition of human CDK2 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940981	<	Inhibition	%	35.0	CHEMBL301	Homo sapiens	INH	%	35.0
	8003426	CHEMBL1944417	Inhibition of human CDK2 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940987	<	Inhibition	%	35.0	CHEMBL301	Homo sapiens	INH	%	35.0
	8003427	CHEMBL1944417	Inhibition of human CDK2 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940990	<	Inhibition	%	35.0	CHEMBL301	Homo sapiens	INH	%	35.0
	8013054	CHEMBL1947841	Inhibition of CDK2 using ATP as substrate	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
Active	8014821	CHEMBL1948610	Inhibition of CDK2 in human HCT116 cells assessed as Rb phosphorylation at 40 nM after 24 hrs by Western blot analysis	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	8014822	CHEMBL1948609	Inhibition of CDK2 in human MV411 cells assessed as Rb phosphorylation after 24 hrs by Western blot analysis	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	=	IC50	nM	130.0	CHEMBL301	Homo sapiens	IC50	uM	0.13
Active	8014823	CHEMBL1948608	Inhibition of CDK2 in human MV411 cells assessed as Stat5 phosphorylation after 24 hrs by Western blot analysis	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	8014824	CHEMBL1948607	Inhibition of CDK2 in human MV411 cells assessed as FLT3 phosphorylation after 24 hrs by Western blot analysis	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	8014854	CHEMBL1947385	Inhibition of CDK2 in human HCT116 cells assessed as Rb phosphorylation at 200 nM after 24 hrs by Western blot analysis	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	8017848	CHEMBL1948816	Inhibition of CDK2 assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CC1CCOCC1		CHEMBL1945953	=	Activity	%	90.0	CHEMBL301	Homo sapiens	Activity	%	90.0
	8017849	CHEMBL1948816	Inhibition of CDK2 assessed as activity remaining at 10 uM	B	CC(C)(O)c1ccc(-c2cnc3[nH]c(=O)n(CC4CCCCC4)c3n2)cc1		CHEMBL1945950	=	Activity	%	81.0	CHEMBL301	Homo sapiens	Activity	%	81.0
	8017850	CHEMBL1948816	Inhibition of CDK2 assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc4[nH]cnc4c3)nc2n1CC1CCCCC1		CHEMBL1946262	=	Activity	%	81.0	CHEMBL301	Homo sapiens	Activity	%	81.0
	8040211	CHEMBL1953285	Inhibition of CDK2	B	COc1ccc(C(=O)NC[C@@H](O)CO)cc1/C=C/c1ccc(Cl)cc1		CHEMBL1949788	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	8040212	CHEMBL1953285	Inhibition of CDK2	B	COc1ccc(C(=O)NC[C@H](O)CO)cc1/C=C/c1ccc(Cl)cc1		CHEMBL1949789	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	8042227	CHEMBL1954969	Binding affinity to human Cdk2 by fluorescence spectroscopy	B	O=S(=O)(O)c1cccc2cccc(Nc3ccccc3)c12		CHEMBL285527	=	Kd	nM	37000.0	CHEMBL301	Homo sapiens	Kd	uM	37.0
	8046178	CHEMBL1960392	Inhibition of CDK2	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)cc1		CHEMBL1957085	=	IC50	nM	794.33	CHEMBL301	Homo sapiens	pIC50		6.1
	8046219	CHEMBL1960395	Inhibition of CDK2 by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)cc1		CHEMBL1957085	=	IC50	nM	501.19	CHEMBL301	Homo sapiens	pIC50		6.3
	8046220	CHEMBL1960395	Inhibition of CDK2 by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)cc1Cl		CHEMBL1957091	=	IC50	nM	501.19	CHEMBL301	Homo sapiens	pIC50		6.3
	8046221	CHEMBL1960395	Inhibition of CDK2 by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)cc1F		CHEMBL1957092	=	IC50	nM	501.19	CHEMBL301	Homo sapiens	pIC50		6.3
	8046222	CHEMBL1960395	Inhibition of CDK2 by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)c(F)c1		CHEMBL1957093	=	IC50	nM	5011.87	CHEMBL301	Homo sapiens	pIC50		5.3
	8046223	CHEMBL1960395	Inhibition of CDK2 by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)c(C)c1		CHEMBL1957094	<	IC50	nM	15848.93	CHEMBL301	Homo sapiens	pIC50		4.8
	8046224	CHEMBL1960395	Inhibition of CDK2 by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)cc1-c1ccncc1		CHEMBL1957095	<	IC50	nM	15848.93	CHEMBL301	Homo sapiens	pIC50		4.8
	8046225	CHEMBL1960395	Inhibition of CDK2 by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)cc1N1CCOCC1		CHEMBL1957096	<	IC50	nM	15848.93	CHEMBL301	Homo sapiens	pIC50		4.8
	8046226	CHEMBL1960395	Inhibition of CDK2 by AlphaLISA assay	B	O=C(NCc1ccncc1)c1ncoc1-c1ccc(Oc2ccccc2)c(Cl)c1		CHEMBL1957097	<	IC50	nM	15848.93	CHEMBL301	Homo sapiens	pIC50		4.8
	8046227	CHEMBL1960395	Inhibition of CDK2 by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)cn1		CHEMBL1957098	=	IC50	nM	5011.87	CHEMBL301	Homo sapiens	pIC50		5.3
	8046228	CHEMBL1960395	Inhibition of CDK2 by AlphaLISA assay	B	COc1ncc(-c2ocnc2C(=O)NCc2ccncc2)cc1Cl		CHEMBL1957099	=	IC50	nM	5011.87	CHEMBL301	Homo sapiens	pIC50		5.3
	8046229	CHEMBL1960395	Inhibition of CDK2 by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)nc1Cl		CHEMBL1957100	<	IC50	nM	15848.93	CHEMBL301	Homo sapiens	pIC50		4.8
	8046230	CHEMBL1960395	Inhibition of CDK2 by AlphaLISA assay	B	COc1cnc(-c2ocnc2C(=O)NCc2ccncc2)cc1Cl		CHEMBL1957101	<	IC50	nM	15848.93	CHEMBL301	Homo sapiens	pIC50		4.8
	8046231	CHEMBL1960395	Inhibition of CDK2 by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccnc(Cl)c2)cc1Cl		CHEMBL1957102	=	IC50	nM	630.96	CHEMBL301	Homo sapiens	pIC50		6.2
	8046232	CHEMBL1960395	Inhibition of CDK2 by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccnc(C)c2)cc1Cl		CHEMBL1957225	=	IC50	nM	1258.93	CHEMBL301	Homo sapiens	pIC50		5.9
	8046233	CHEMBL1960395	Inhibition of CDK2 by AlphaLISA assay	B	COc1cc(CNC(=O)c2ncoc2-c2ccc(OC)c(Cl)c2)ccn1		CHEMBL1957226	=	IC50	nM	630.96	CHEMBL301	Homo sapiens	pIC50		6.2
	8046234	CHEMBL1960395	Inhibition of CDK2 by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccnc(C(F)(F)F)c2)cc1Cl		CHEMBL1957227	=	IC50	nM	1995.26	CHEMBL301	Homo sapiens	pIC50		5.7
	8046235	CHEMBL1960395	Inhibition of CDK2 by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccnnc2)cc1Cl		CHEMBL1957228	=	IC50	nM	501.19	CHEMBL301	Homo sapiens	pIC50		6.3
	8046236	CHEMBL1960395	Inhibition of CDK2 by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccnc(C)n2)cc1Cl		CHEMBL1957229	=	IC50	nM	3162.28	CHEMBL301	Homo sapiens	pIC50		5.5
	8046237	CHEMBL1960395	Inhibition of CDK2 by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCCc2ccncc2)cc1Cl		CHEMBL1957230	=	IC50	nM	3162.28	CHEMBL301	Homo sapiens	pIC50		5.5
	8046238	CHEMBL1960395	Inhibition of CDK2 by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccn3ccnc3c2)cc1Cl		CHEMBL1957231	=	IC50	nM	501.19	CHEMBL301	Homo sapiens	pIC50		6.3
	8047313	CHEMBL1960794	Inhibition of CDK2	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	=	IC50	nM	3500.0	CHEMBL301	Homo sapiens	IC50	nM	3500.0
	8047314	CHEMBL1960794	Inhibition of CDK2	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21		CHEMBL1956071	=	IC50	nM	7000.0	CHEMBL301	Homo sapiens	IC50	nM	7000.0
	8061291	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	1.79	CHEMBL301	Homo sapiens	Inhibition	%	1.79
	8061292	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	1.58	CHEMBL301	Homo sapiens	Inhibition	%	1.58
	8061468	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	0.3	CHEMBL301	Homo sapiens	Inhibition	%	0.3
	8061469	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	6.08	CHEMBL301	Homo sapiens	Inhibition	%	6.08
	8061799	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	-0.3	CHEMBL301	Homo sapiens	Inhibition	%	-0.3
	8061800	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	2.14	CHEMBL301	Homo sapiens	Inhibition	%	2.14
	8061990	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	2.66	CHEMBL301	Homo sapiens	Inhibition	%	2.66
	8061991	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	7.44	CHEMBL301	Homo sapiens	Inhibition	%	7.44
	8062330	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.01	CHEMBL301	Homo sapiens	Inhibition	%	2.01
	8062331	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	3.69	CHEMBL301	Homo sapiens	Inhibition	%	3.69
	8062492	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	63.14	CHEMBL301	Homo sapiens	Inhibition	%	63.14
	8062493	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	38.84	CHEMBL301	Homo sapiens	Inhibition	%	38.84
	8062716	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	2.39	CHEMBL301	Homo sapiens	Inhibition	%	2.39
	8062717	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	6.28	CHEMBL301	Homo sapiens	Inhibition	%	6.28
	8062814	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	4.47	CHEMBL301	Homo sapiens	Inhibition	%	4.47
	8062815	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	4.8	CHEMBL301	Homo sapiens	Inhibition	%	4.8
	8063170	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	0.56	CHEMBL301	Homo sapiens	Inhibition	%	0.56
	8063171	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	2.98	CHEMBL301	Homo sapiens	Inhibition	%	2.98
	8063337	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.46	CHEMBL301	Homo sapiens	Inhibition	%	1.46
	8063338	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.44	CHEMBL301	Homo sapiens	Inhibition	%	1.44
	8063561	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	-2.2	CHEMBL301	Homo sapiens	Inhibition	%	-2.2
	8063562	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.76	CHEMBL301	Homo sapiens	Inhibition	%	1.76
	8063669	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	0.87	CHEMBL301	Homo sapiens	Inhibition	%	0.87
	8063670	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.37	CHEMBL301	Homo sapiens	Inhibition	%	1.37
	8063851	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	3.89	CHEMBL301	Homo sapiens	Inhibition	%	3.89
	8063852	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	8.9	CHEMBL301	Homo sapiens	Inhibition	%	8.9
	8064075	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	1.29	CHEMBL301	Homo sapiens	Inhibition	%	1.29
	8064076	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	4.14	CHEMBL301	Homo sapiens	Inhibition	%	4.14
	8064190	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	11.24	CHEMBL301	Homo sapiens	Inhibition	%	11.24
	8064191	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	11.64	CHEMBL301	Homo sapiens	Inhibition	%	11.64
	8064400	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.82	CHEMBL301	Homo sapiens	Inhibition	%	0.82
	8064401	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.72	CHEMBL301	Homo sapiens	Inhibition	%	0.72
	8064624	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	7.43	CHEMBL301	Homo sapiens	Inhibition	%	7.43
	8064625	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.06	CHEMBL301	Homo sapiens	Inhibition	%	1.06
	8064762	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	8.91	CHEMBL301	Homo sapiens	Inhibition	%	8.91
	8064763	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	7.2	CHEMBL301	Homo sapiens	Inhibition	%	7.2
	8065152	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.61	CHEMBL301	Homo sapiens	Inhibition	%	1.61
	8065153	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.4	CHEMBL301	Homo sapiens	Inhibition	%	1.4
	8065268	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	4.48	CHEMBL301	Homo sapiens	Inhibition	%	4.48
	8065269	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	2.56	CHEMBL301	Homo sapiens	Inhibition	%	2.56
	8065667	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	0.77	CHEMBL301	Homo sapiens	Inhibition	%	0.77
	8065668	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	4.5	CHEMBL301	Homo sapiens	Inhibition	%	4.5
	8065782	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.74	CHEMBL301	Homo sapiens	Inhibition	%	1.74
	8065783	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.65	CHEMBL301	Homo sapiens	Inhibition	%	1.65
	8066006	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	8.52	CHEMBL301	Homo sapiens	Inhibition	%	8.52
	8066007	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	2.7	CHEMBL301	Homo sapiens	Inhibition	%	2.7
	8066216	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	2.75	CHEMBL301	Homo sapiens	Inhibition	%	2.75
	8066217	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.55	CHEMBL301	Homo sapiens	Inhibition	%	1.55
	8066352	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	31.55	CHEMBL301	Homo sapiens	Inhibition	%	31.55
	8066353	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	27.61	CHEMBL301	Homo sapiens	Inhibition	%	27.61
	8066576	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	54.49	CHEMBL301	Homo sapiens	Inhibition	%	54.49
	8066577	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	63.59	CHEMBL301	Homo sapiens	Inhibition	%	63.59
	8066742	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	10.65	CHEMBL301	Homo sapiens	Inhibition	%	10.65
	8066743	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	4.59	CHEMBL301	Homo sapiens	Inhibition	%	4.59
	8066866	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	3.2	CHEMBL301	Homo sapiens	Inhibition	%	3.2
	8066867	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.48	CHEMBL301	Homo sapiens	Inhibition	%	1.48
	8067090	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	-0.87	CHEMBL301	Homo sapiens	Inhibition	%	-0.87
	8067091	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	2.15	CHEMBL301	Homo sapiens	Inhibition	%	2.15
	8067265	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	1.37	CHEMBL301	Homo sapiens	Inhibition	%	1.37
	8067266	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	3.44	CHEMBL301	Homo sapiens	Inhibition	%	3.44
	8067610	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	2.05	CHEMBL301	Homo sapiens	Inhibition	%	2.05
	8067611	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.19	CHEMBL301	Homo sapiens	Inhibition	%	1.19
	8067820	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	4.67	CHEMBL301	Homo sapiens	Inhibition	%	4.67
	8067821	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	3.62	CHEMBL301	Homo sapiens	Inhibition	%	3.62
	8068179	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	109.74	CHEMBL301	Homo sapiens	Inhibition	%	109.74
	8068180	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	90.05	CHEMBL301	Homo sapiens	Inhibition	%	90.05
	8068343	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	6.59	CHEMBL301	Homo sapiens	Inhibition	%	6.59
	8068344	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	7.57	CHEMBL301	Homo sapiens	Inhibition	%	7.57
	8068692	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.4	CHEMBL301	Homo sapiens	Inhibition	%	0.4
	8068693	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.42	CHEMBL301	Homo sapiens	Inhibition	%	0.42
	8068866	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	4.57	CHEMBL301	Homo sapiens	Inhibition	%	4.57
	8068867	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	3.85	CHEMBL301	Homo sapiens	Inhibition	%	3.85
	8069215	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	2.06	CHEMBL301	Homo sapiens	Inhibition	%	2.06
	8069216	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	2.02	CHEMBL301	Homo sapiens	Inhibition	%	2.02
	8069510	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	72.45	CHEMBL301	Homo sapiens	Inhibition	%	72.45
	8069511	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	78.77	CHEMBL301	Homo sapiens	Inhibition	%	78.77
	8069671	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	44.43	CHEMBL301	Homo sapiens	Inhibition	%	44.43
	8069672	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	40.1	CHEMBL301	Homo sapiens	Inhibition	%	40.1
	8070021	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-1.07	CHEMBL301	Homo sapiens	Inhibition	%	-1.07
	8070022	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.03	CHEMBL301	Homo sapiens	Inhibition	%	1.03
	8070193	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	1.21	CHEMBL301	Homo sapiens	Inhibition	%	1.21
	8070194	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	3.23	CHEMBL301	Homo sapiens	Inhibition	%	3.23
	8070417	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	1.86	CHEMBL301	Homo sapiens	Inhibition	%	1.86
	8070418	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	3.44	CHEMBL301	Homo sapiens	Inhibition	%	3.44
	8070542	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.87	CHEMBL301	Homo sapiens	Inhibition	%	1.87
	8070543	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.12	CHEMBL301	Homo sapiens	Inhibition	%	1.12
	8070840	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	92.67	CHEMBL301	Homo sapiens	Inhibition	%	92.67
	8070841	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	95.01	CHEMBL301	Homo sapiens	Inhibition	%	95.01
	8070997	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.27	CHEMBL301	Homo sapiens	Inhibition	%	1.27
	8070998	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.42	CHEMBL301	Homo sapiens	Inhibition	%	1.42
	8071221	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.22	CHEMBL301	Homo sapiens	Inhibition	%	2.22
	8071222	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	4.71	CHEMBL301	Homo sapiens	Inhibition	%	4.71
	8071347	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.57	CHEMBL301	Homo sapiens	Inhibition	%	0.57
	8071348	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.23	CHEMBL301	Homo sapiens	Inhibition	%	0.23
	8071744	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	3.87	CHEMBL301	Homo sapiens	Inhibition	%	3.87
	8071745	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	3.75	CHEMBL301	Homo sapiens	Inhibition	%	3.75
	8071869	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-0.02	CHEMBL301	Homo sapiens	Inhibition	%	-0.02
	8071870	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.4	CHEMBL301	Homo sapiens	Inhibition	%	1.4
	8072093	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	1.75	CHEMBL301	Homo sapiens	Inhibition	%	1.75
	8072094	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	1.36	CHEMBL301	Homo sapiens	Inhibition	%	1.36
	8072183	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.37	CHEMBL301	Homo sapiens	Inhibition	%	0.37
	8072184	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.62	CHEMBL301	Homo sapiens	Inhibition	%	0.62
	8072564	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.21	CHEMBL301	Homo sapiens	Inhibition	%	1.21
	8072565	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.69	CHEMBL301	Homo sapiens	Inhibition	%	1.69
	8072689	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-1.61	CHEMBL301	Homo sapiens	Inhibition	%	-1.61
	8072690	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.63	CHEMBL301	Homo sapiens	Inhibition	%	0.63
	8072913	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	1.29	CHEMBL301	Homo sapiens	Inhibition	%	1.29
	8072914	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-0.22	CHEMBL301	Homo sapiens	Inhibition	%	-0.22
	8073080	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	28.39	CHEMBL301	Homo sapiens	Inhibition	%	28.39
	8073081	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	9.11	CHEMBL301	Homo sapiens	Inhibition	%	9.11
	8073429	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	3.03	CHEMBL301	Homo sapiens	Inhibition	%	3.03
	8073430	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	2.74	CHEMBL301	Homo sapiens	Inhibition	%	2.74
	8073548	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	27.0	CHEMBL301	Homo sapiens	Inhibition	%	27.0
	8073549	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	34.99	CHEMBL301	Homo sapiens	Inhibition	%	34.99
	8073781	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-0.89	CHEMBL301	Homo sapiens	Inhibition	%	-0.89
	8073782	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.21	CHEMBL301	Homo sapiens	Inhibition	%	1.21
	8074005	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	2.04	CHEMBL301	Homo sapiens	Inhibition	%	2.04
	8074006	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.5	CHEMBL301	Homo sapiens	Inhibition	%	0.5
	8074157	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	0.35	CHEMBL301	Homo sapiens	Inhibition	%	0.35
	8074158	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	3.15	CHEMBL301	Homo sapiens	Inhibition	%	3.15
	8074511	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-0.21	CHEMBL301	Homo sapiens	Inhibition	%	-0.21
	8074512	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.54	CHEMBL301	Homo sapiens	Inhibition	%	0.54
	8074668	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.15	CHEMBL301	Homo sapiens	Inhibition	%	1.15
	8074669	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.82	CHEMBL301	Homo sapiens	Inhibition	%	1.82
	8075019	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	1.96	CHEMBL301	Homo sapiens	Inhibition	%	1.96
	8075020	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	2.69	CHEMBL301	Homo sapiens	Inhibition	%	2.69
	8075130	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	69.57	CHEMBL301	Homo sapiens	Inhibition	%	69.57
	8075131	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	74.2	CHEMBL301	Homo sapiens	Inhibition	%	74.2
	8075354	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	1.19	CHEMBL301	Homo sapiens	Inhibition	%	1.19
	8075355	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	2.29	CHEMBL301	Homo sapiens	Inhibition	%	2.29
	8075591	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-0.71	CHEMBL301	Homo sapiens	Inhibition	%	-0.71
	8075592	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	1.53	CHEMBL301	Homo sapiens	Inhibition	%	1.53
	8075732	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	2.0	CHEMBL301	Homo sapiens	Inhibition	%	2.0
	8075733	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	1.73	CHEMBL301	Homo sapiens	Inhibition	%	1.73
	8076098	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	1.04	CHEMBL301	Homo sapiens	Inhibition	%	1.04
	8076099	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.81	CHEMBL301	Homo sapiens	Inhibition	%	-0.81
	8076246	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	2.0	CHEMBL301	Homo sapiens	Inhibition	%	2.0
	8076247	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	2.1	CHEMBL301	Homo sapiens	Inhibition	%	2.1
	8076470	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	0.55	CHEMBL301	Homo sapiens	Inhibition	%	0.55
	8076471	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.3	CHEMBL301	Homo sapiens	Inhibition	%	2.3
	8076604	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	3.44	CHEMBL301	Homo sapiens	Inhibition	%	3.44
	8076605	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	4.49	CHEMBL301	Homo sapiens	Inhibition	%	4.49
	8076930	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.72	CHEMBL301	Homo sapiens	Inhibition	%	0.72
	8076931	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	5.92	CHEMBL301	Homo sapiens	Inhibition	%	5.92
	8077177	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	2.07	CHEMBL301	Homo sapiens	Inhibition	%	2.07
	8077178	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	2.92	CHEMBL301	Homo sapiens	Inhibition	%	2.92
	8077305	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	9.11	CHEMBL301	Homo sapiens	Inhibition	%	9.11
	8077306	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	1.86	CHEMBL301	Homo sapiens	Inhibition	%	1.86
	8077529	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.13	CHEMBL301	Homo sapiens	Inhibition	%	1.13
	8077530	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.82	CHEMBL301	Homo sapiens	Inhibition	%	1.82
	8077680	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.96	CHEMBL301	Homo sapiens	Inhibition	%	0.96
	8077681	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	1.48	CHEMBL301	Homo sapiens	Inhibition	%	1.48
	8078047	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	3.19	CHEMBL301	Homo sapiens	Inhibition	%	3.19
	8078048	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	5.22	CHEMBL301	Homo sapiens	Inhibition	%	5.22
	8078186	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	53.29	CHEMBL301	Homo sapiens	Inhibition	%	53.29
	8078187	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	59.85	CHEMBL301	Homo sapiens	Inhibition	%	59.85
	8078512	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.63	CHEMBL301	Homo sapiens	Inhibition	%	0.63
	8078513	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	1.2	CHEMBL301	Homo sapiens	Inhibition	%	1.2
	8078762	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	4.12	CHEMBL301	Homo sapiens	Inhibition	%	4.12
	8078763	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	4.27	CHEMBL301	Homo sapiens	Inhibition	%	4.27
	8079102	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	0.6	CHEMBL301	Homo sapiens	Inhibition	%	0.6
	8079103	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	2.15	CHEMBL301	Homo sapiens	Inhibition	%	2.15
	8079260	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	1.64	CHEMBL301	Homo sapiens	Inhibition	%	1.64
	8079261	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-2.32	CHEMBL301	Homo sapiens	Inhibition	%	-2.32
	8079626	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	1.07	CHEMBL301	Homo sapiens	Inhibition	%	1.07
	8079627	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	1.88	CHEMBL301	Homo sapiens	Inhibition	%	1.88
	8079765	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	78.91	CHEMBL301	Homo sapiens	Inhibition	%	78.91
	8079766	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	86.86	CHEMBL301	Homo sapiens	Inhibition	%	86.86
	8079989	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	1.78	CHEMBL301	Homo sapiens	Inhibition	%	1.78
	8079990	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	7.06	CHEMBL301	Homo sapiens	Inhibition	%	7.06
	8080094	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-0.53	CHEMBL301	Homo sapiens	Inhibition	%	-0.53
	8080095	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	2.51	CHEMBL301	Homo sapiens	Inhibition	%	2.51
	8080346	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	81.98	CHEMBL301	Homo sapiens	Inhibition	%	81.98
	8080347	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	66.24	CHEMBL301	Homo sapiens	Inhibition	%	66.24
	8080685	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.36	CHEMBL301	Homo sapiens	Inhibition	%	1.36
	8080686	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.4	CHEMBL301	Homo sapiens	Inhibition	%	0.4
	8080849	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	2.63	CHEMBL301	Homo sapiens	Inhibition	%	2.63
	8080850	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	3.99	CHEMBL301	Homo sapiens	Inhibition	%	3.99
	8081073	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	4.08	CHEMBL301	Homo sapiens	Inhibition	%	4.08
	8081074	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-1.76	CHEMBL301	Homo sapiens	Inhibition	%	-1.76
	8081208	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	-1.12	CHEMBL301	Homo sapiens	Inhibition	%	-1.12
	8081209	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	2.86	CHEMBL301	Homo sapiens	Inhibition	%	2.86
	8081576	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	0.94	CHEMBL301	Homo sapiens	Inhibition	%	0.94
	8081577	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	11.79	CHEMBL301	Homo sapiens	Inhibition	%	11.79
	8081679	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.84	CHEMBL301	Homo sapiens	Inhibition	%	1.84
	8081680	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	2.79	CHEMBL301	Homo sapiens	Inhibition	%	2.79
	8081903	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	6.86	CHEMBL301	Homo sapiens	Inhibition	%	6.86
	8081904	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	10.55	CHEMBL301	Homo sapiens	Inhibition	%	10.55
	8081931	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	86.61	CHEMBL301	Homo sapiens	Inhibition	%	86.61
	8081932	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	82.73	CHEMBL301	Homo sapiens	Inhibition	%	82.73
	8082155	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	7.81	CHEMBL301	Homo sapiens	Inhibition	%	7.81
	8082156	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	8.62	CHEMBL301	Homo sapiens	Inhibition	%	8.62
	8082268	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	-4.84	CHEMBL301	Homo sapiens	Inhibition	%	-4.84
	8082269	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.13	CHEMBL301	Homo sapiens	Inhibition	%	1.13
	8082665	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-7.29	CHEMBL301	Homo sapiens	Inhibition	%	-7.29
	8082666	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.76	CHEMBL301	Homo sapiens	Inhibition	%	-0.76
	8082788	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.38	CHEMBL301	Homo sapiens	Inhibition	%	2.38
	8082789	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.25	CHEMBL301	Homo sapiens	Inhibition	%	2.25
	8083168	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	97.39	CHEMBL301	Homo sapiens	Inhibition	%	97.39
	8083169	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	64.96	CHEMBL301	Homo sapiens	Inhibition	%	64.96
	8083491	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.58	CHEMBL301	Homo sapiens	Inhibition	%	1.58
	8083492	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.31	CHEMBL301	Homo sapiens	Inhibition	%	1.31
	8083745	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	44.61	CHEMBL301	Homo sapiens	Inhibition	%	44.61
	8083746	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	41.48	CHEMBL301	Homo sapiens	Inhibition	%	41.48
	8083855	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	0.76	CHEMBL301	Homo sapiens	Inhibition	%	0.76
	8083856	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.45	CHEMBL301	Homo sapiens	Inhibition	%	1.45
	8084079	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.07	CHEMBL301	Homo sapiens	Inhibition	%	1.07
	8084080	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	2.89	CHEMBL301	Homo sapiens	Inhibition	%	2.89
	8084264	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	93.38	CHEMBL301	Homo sapiens	Inhibition	%	93.38
	8084265	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	83.06	CHEMBL301	Homo sapiens	Inhibition	%	83.06
	8084382	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.45	CHEMBL301	Homo sapiens	Inhibition	%	0.45
	8084383	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	3.3	CHEMBL301	Homo sapiens	Inhibition	%	3.3
	8084606	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	1.76	CHEMBL301	Homo sapiens	Inhibition	%	1.76
	8084607	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.18	CHEMBL301	Homo sapiens	Inhibition	%	2.18
	8084767	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	97.9	CHEMBL301	Homo sapiens	Inhibition	%	97.9
	8084768	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	82.39	CHEMBL301	Homo sapiens	Inhibition	%	82.39
	8085089	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	6.73	CHEMBL301	Homo sapiens	Inhibition	%	6.73
	8085090	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	4.6	CHEMBL301	Homo sapiens	Inhibition	%	4.6
	8085345	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	0.83	CHEMBL301	Homo sapiens	Inhibition	%	0.83
	8085346	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-0.38	CHEMBL301	Homo sapiens	Inhibition	%	-0.38
	8085677	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	0.89	CHEMBL301	Homo sapiens	Inhibition	%	0.89
	8085678	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	1.14	CHEMBL301	Homo sapiens	Inhibition	%	1.14
	8085866	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	86.59	CHEMBL301	Homo sapiens	Inhibition	%	86.59
	8085867	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	84.26	CHEMBL301	Homo sapiens	Inhibition	%	84.26
	8086205	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	4.21	CHEMBL301	Homo sapiens	Inhibition	%	4.21
	8086206	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	3.51	CHEMBL301	Homo sapiens	Inhibition	%	3.51
	8086367	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	16.25	CHEMBL301	Homo sapiens	Inhibition	%	16.25
	8086368	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	9.58	CHEMBL301	Homo sapiens	Inhibition	%	9.58
	8086690	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.3	CHEMBL301	Homo sapiens	Inhibition	%	1.3
	8086691	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.11	CHEMBL301	Homo sapiens	Inhibition	%	1.11
	8086901	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	0.92	CHEMBL301	Homo sapiens	Inhibition	%	0.92
	8086902	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	-0.41	CHEMBL301	Homo sapiens	Inhibition	%	-0.41
	8087125	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	-0.22	CHEMBL301	Homo sapiens	Inhibition	%	-0.22
	8087126	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	3.85	CHEMBL301	Homo sapiens	Inhibition	%	3.85
	8087283	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	3.84	CHEMBL301	Homo sapiens	Inhibition	%	3.84
	8087284	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	3.5	CHEMBL301	Homo sapiens	Inhibition	%	3.5
	8087621	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	2.24	CHEMBL301	Homo sapiens	Inhibition	%	2.24
	8087622	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	1.7	CHEMBL301	Homo sapiens	Inhibition	%	1.7
	8087759	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	5.88	CHEMBL301	Homo sapiens	Inhibition	%	5.88
	8087760	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.99	CHEMBL301	Homo sapiens	Inhibition	%	4.99
	8088125	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	2.62	CHEMBL301	Homo sapiens	Inhibition	%	2.62
	8088126	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	3.23	CHEMBL301	Homo sapiens	Inhibition	%	3.23
	8088273	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.21	CHEMBL301	Homo sapiens	Inhibition	%	0.21
	8088274	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.2	CHEMBL301	Homo sapiens	Inhibition	%	0.2
	8088625	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	1.36	CHEMBL301	Homo sapiens	Inhibition	%	1.36
	8088626	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	3.93	CHEMBL301	Homo sapiens	Inhibition	%	3.93
	8088942	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.17	CHEMBL301	Homo sapiens	Inhibition	%	2.17
	8088943	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	4.31	CHEMBL301	Homo sapiens	Inhibition	%	4.31
	8089070	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	1.48	CHEMBL301	Homo sapiens	Inhibition	%	1.48
	8089071	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-0.16	CHEMBL301	Homo sapiens	Inhibition	%	-0.16
	8089294	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	5.95	CHEMBL301	Homo sapiens	Inhibition	%	5.95
	8089295	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.71	CHEMBL301	Homo sapiens	Inhibition	%	0.71
	8089442	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	102.93	CHEMBL301	Homo sapiens	Inhibition	%	102.93
	8089443	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	74.11	CHEMBL301	Homo sapiens	Inhibition	%	74.11
	8089786	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.49	CHEMBL301	Homo sapiens	Inhibition	%	0.49
	8089787	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	-0.35	CHEMBL301	Homo sapiens	Inhibition	%	-0.35
	8089966	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-2.27	CHEMBL301	Homo sapiens	Inhibition	%	-2.27
	8089967	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.2	CHEMBL301	Homo sapiens	Inhibition	%	0.2
	8090355	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	1.57	CHEMBL301	Homo sapiens	Inhibition	%	1.57
	8090356	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	0.45	CHEMBL301	Homo sapiens	Inhibition	%	0.45
	8090522	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.24	CHEMBL301	Homo sapiens	Inhibition	%	2.24
	8090523	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.24	CHEMBL301	Homo sapiens	Inhibition	%	2.24
	8090885	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	0.55	CHEMBL301	Homo sapiens	Inhibition	%	0.55
	8090886	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	1.2	CHEMBL301	Homo sapiens	Inhibition	%	1.2
	8091090	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	1.6	CHEMBL301	Homo sapiens	Inhibition	%	1.6
	8091091	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.45	CHEMBL301	Homo sapiens	Inhibition	%	2.45
	8091451	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	5.19	CHEMBL301	Homo sapiens	Inhibition	%	5.19
	8091452	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	3.79	CHEMBL301	Homo sapiens	Inhibition	%	3.79
	8091606	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	3.06	CHEMBL301	Homo sapiens	Inhibition	%	3.06
	8091607	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	4.47	CHEMBL301	Homo sapiens	Inhibition	%	4.47
	8091946	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	3.34	CHEMBL301	Homo sapiens	Inhibition	%	3.34
	8091947	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	4.15	CHEMBL301	Homo sapiens	Inhibition	%	4.15
	8092083	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-3.24	CHEMBL301	Homo sapiens	Inhibition	%	-3.24
	8092084	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-2.35	CHEMBL301	Homo sapiens	Inhibition	%	-2.35
	8092307	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-1.87	CHEMBL301	Homo sapiens	Inhibition	%	-1.87
	8092308	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-0.94	CHEMBL301	Homo sapiens	Inhibition	%	-0.94
	8092458	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	3.05	CHEMBL301	Homo sapiens	Inhibition	%	3.05
	8092459	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	1.9	CHEMBL301	Homo sapiens	Inhibition	%	1.9
	8092606	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.06	CHEMBL301	Homo sapiens	Inhibition	%	1.06
	8092607	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.37	CHEMBL301	Homo sapiens	Inhibition	%	1.37
	8092830	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-0.17	CHEMBL301	Homo sapiens	Inhibition	%	-0.17
	8092831	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	3.98	CHEMBL301	Homo sapiens	Inhibition	%	3.98
	8092959	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	5.88	CHEMBL301	Homo sapiens	Inhibition	%	5.88
	8092960	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	7.11	CHEMBL301	Homo sapiens	Inhibition	%	7.11
	8093271	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	0.91	CHEMBL301	Homo sapiens	Inhibition	%	0.91
	8093272	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	0.52	CHEMBL301	Homo sapiens	Inhibition	%	0.52
	8093635	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	0.3	CHEMBL301	Homo sapiens	Inhibition	%	0.3
	8093636	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-0.8	CHEMBL301	Homo sapiens	Inhibition	%	-0.8
	8093774	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	92.43	CHEMBL301	Homo sapiens	Inhibition	%	92.43
	8093775	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	79.35	CHEMBL301	Homo sapiens	Inhibition	%	79.35
	8094118	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	3.52	CHEMBL301	Homo sapiens	Inhibition	%	3.52
	8094119	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.49	CHEMBL301	Homo sapiens	Inhibition	%	1.49
	8094298	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.49	CHEMBL301	Homo sapiens	Inhibition	%	0.49
	8094299	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.38	CHEMBL301	Homo sapiens	Inhibition	%	0.38
	8094697	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	2.71	CHEMBL301	Homo sapiens	Inhibition	%	2.71
	8094698	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	0.79	CHEMBL301	Homo sapiens	Inhibition	%	0.79
	8094853	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.48	CHEMBL301	Homo sapiens	Inhibition	%	2.48
	8094854	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	4.68	CHEMBL301	Homo sapiens	Inhibition	%	4.68
	8095217	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	14.37	CHEMBL301	Homo sapiens	Inhibition	%	14.37
	8095218	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	7.47	CHEMBL301	Homo sapiens	Inhibition	%	7.47
	8095420	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.53	CHEMBL301	Homo sapiens	Inhibition	%	2.53
	8095421	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.9	CHEMBL301	Homo sapiens	Inhibition	%	3.9
	8095785	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	22.52	CHEMBL301	Homo sapiens	Inhibition	%	22.52
	8095786	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	28.26	CHEMBL301	Homo sapiens	Inhibition	%	28.26
	8095933	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	4.41	CHEMBL301	Homo sapiens	Inhibition	%	4.41
	8095934	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	6.35	CHEMBL301	Homo sapiens	Inhibition	%	6.35
	8096157	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	2.68	CHEMBL301	Homo sapiens	Inhibition	%	2.68
	8096158	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	7.13	CHEMBL301	Homo sapiens	Inhibition	%	7.13
	8096274	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	3.4	CHEMBL301	Homo sapiens	Inhibition	%	3.4
	8096275	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	2.94	CHEMBL301	Homo sapiens	Inhibition	%	2.94
	8096637	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	2.81	CHEMBL301	Homo sapiens	Inhibition	%	2.81
	8096638	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.43	CHEMBL301	Homo sapiens	Inhibition	%	0.43
	8096793	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	1.47	CHEMBL301	Homo sapiens	Inhibition	%	1.47
	8096794	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	4.94	CHEMBL301	Homo sapiens	Inhibition	%	4.94
	8097164	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.85	CHEMBL301	Homo sapiens	Inhibition	%	1.85
	8097165	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	2.92	CHEMBL301	Homo sapiens	Inhibition	%	2.92
	8097471	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	-3.65	CHEMBL301	Homo sapiens	Inhibition	%	-3.65
	8097472	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	3.87	CHEMBL301	Homo sapiens	Inhibition	%	3.87
	8097845	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	5.96	CHEMBL301	Homo sapiens	Inhibition	%	5.96
	8097846	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	1.32	CHEMBL301	Homo sapiens	Inhibition	%	1.32
	8097978	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-1.03	CHEMBL301	Homo sapiens	Inhibition	%	-1.03
	8097979	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	1.71	CHEMBL301	Homo sapiens	Inhibition	%	1.71
	8098202	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	4.44	CHEMBL301	Homo sapiens	Inhibition	%	4.44
	8098203	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	1.67	CHEMBL301	Homo sapiens	Inhibition	%	1.67
	8098322	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.15	CHEMBL301	Homo sapiens	Inhibition	%	0.15
	8098323	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.91	CHEMBL301	Homo sapiens	Inhibition	%	-0.91
	8098502	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.75	CHEMBL301	Homo sapiens	Inhibition	%	1.75
	8098503	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	2.54	CHEMBL301	Homo sapiens	Inhibition	%	2.54
	8098726	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.69	CHEMBL301	Homo sapiens	Inhibition	%	1.69
	8098727	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.66	CHEMBL301	Homo sapiens	Inhibition	%	0.66
	8098911	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	0.03	CHEMBL301	Homo sapiens	Inhibition	%	0.03
	8098912	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	0.42	CHEMBL301	Homo sapiens	Inhibition	%	0.42
	8099055	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.91	CHEMBL301	Homo sapiens	Inhibition	%	2.91
	8099056	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	1.53	CHEMBL301	Homo sapiens	Inhibition	%	1.53
	8099279	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.02	CHEMBL301	Homo sapiens	Inhibition	%	2.02
	8099280	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.24	CHEMBL301	Homo sapiens	Inhibition	%	3.24
	8099421	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	0.94	CHEMBL301	Homo sapiens	Inhibition	%	0.94
	8099422	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	2.2	CHEMBL301	Homo sapiens	Inhibition	%	2.2
	8099615	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.26	CHEMBL301	Homo sapiens	Inhibition	%	1.26
	8099616	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.0	CHEMBL301	Homo sapiens	Inhibition	%	1.0
	8099839	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.36	CHEMBL301	Homo sapiens	Inhibition	%	0.36
	8099840	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.3	CHEMBL301	Homo sapiens	Inhibition	%	0.3
	8099986	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	5.82	CHEMBL301	Homo sapiens	Inhibition	%	5.82
	8099987	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	2.46	CHEMBL301	Homo sapiens	Inhibition	%	2.46
	8100356	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	85.8	CHEMBL301	Homo sapiens	Inhibition	%	85.8
	8100357	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	67.25	CHEMBL301	Homo sapiens	Inhibition	%	67.25
	8100472	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	2.91	CHEMBL301	Homo sapiens	Inhibition	%	2.91
	8100473	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	3.74	CHEMBL301	Homo sapiens	Inhibition	%	3.74
	8100836	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	2.09	CHEMBL301	Homo sapiens	Inhibition	%	2.09
	8100837	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.73	CHEMBL301	Homo sapiens	Inhibition	%	1.73
	8100996	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	3.39	CHEMBL301	Homo sapiens	Inhibition	%	3.39
	8100997	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	3.05	CHEMBL301	Homo sapiens	Inhibition	%	3.05
	8101220	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	2.68	CHEMBL301	Homo sapiens	Inhibition	%	2.68
	8101221	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	4.66	CHEMBL301	Homo sapiens	Inhibition	%	4.66
	8101362	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	0.56	CHEMBL301	Homo sapiens	Inhibition	%	0.56
	8101363	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	0.79	CHEMBL301	Homo sapiens	Inhibition	%	0.79
	8101547	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-2.63	CHEMBL301	Homo sapiens	Inhibition	%	-2.63
	8101548	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-1.28	CHEMBL301	Homo sapiens	Inhibition	%	-1.28
	8101771	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-1.27	CHEMBL301	Homo sapiens	Inhibition	%	-1.27
	8101772	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	1.93	CHEMBL301	Homo sapiens	Inhibition	%	1.93
	8101800	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	30.35	CHEMBL301	Homo sapiens	Inhibition	%	30.35
	8101801	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	9.46	CHEMBL301	Homo sapiens	Inhibition	%	9.46
	8102024	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	73.74	CHEMBL301	Homo sapiens	Inhibition	%	73.74
	8102025	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	45.49	CHEMBL301	Homo sapiens	Inhibition	%	45.49
	8102179	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	10.27	CHEMBL301	Homo sapiens	Inhibition	%	10.27
	8102180	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	3.38	CHEMBL301	Homo sapiens	Inhibition	%	3.38
	8102534	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	2.02	CHEMBL301	Homo sapiens	Inhibition	%	2.02
	8102535	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	3.09	CHEMBL301	Homo sapiens	Inhibition	%	3.09
	8102654	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.04	CHEMBL301	Homo sapiens	Inhibition	%	-0.04
	8102655	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.85	CHEMBL301	Homo sapiens	Inhibition	%	-0.85
	8102878	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.95	CHEMBL301	Homo sapiens	Inhibition	%	-0.95
	8102879	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.54	CHEMBL301	Homo sapiens	Inhibition	%	-0.54
	8103056	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.48	CHEMBL301	Homo sapiens	Inhibition	%	1.48
	8103057	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.25	CHEMBL301	Homo sapiens	Inhibition	%	2.25
	8103252	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	3.52	CHEMBL301	Homo sapiens	Inhibition	%	3.52
	8103253	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	0.77	CHEMBL301	Homo sapiens	Inhibition	%	0.77
	8103614	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	2.07	CHEMBL301	Homo sapiens	Inhibition	%	2.07
	8103615	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.92	CHEMBL301	Homo sapiens	Inhibition	%	0.92
	8103764	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	2.63	CHEMBL301	Homo sapiens	Inhibition	%	2.63
	8103765	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	3.96	CHEMBL301	Homo sapiens	Inhibition	%	3.96
	8104173	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-0.3	CHEMBL301	Homo sapiens	Inhibition	%	-0.3
	8104174	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	1.4	CHEMBL301	Homo sapiens	Inhibition	%	1.4
	8104321	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	10.96	CHEMBL301	Homo sapiens	Inhibition	%	10.96
	8104322	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	7.81	CHEMBL301	Homo sapiens	Inhibition	%	7.81
	8104691	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	94.41	CHEMBL301	Homo sapiens	Inhibition	%	94.41
	8104692	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	74.67	CHEMBL301	Homo sapiens	Inhibition	%	74.67
	8104805	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	0.77	CHEMBL301	Homo sapiens	Inhibition	%	0.77
	8104806	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	1.81	CHEMBL301	Homo sapiens	Inhibition	%	1.81
	8105029	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	1.99	CHEMBL301	Homo sapiens	Inhibition	%	1.99
	8105030	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	2.89	CHEMBL301	Homo sapiens	Inhibition	%	2.89
	8105169	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	2.1	CHEMBL301	Homo sapiens	Inhibition	%	2.1
	8105170	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.29	CHEMBL301	Homo sapiens	Inhibition	%	-0.29
	8105559	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-1.38	CHEMBL301	Homo sapiens	Inhibition	%	-1.38
	8105560	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-0.63	CHEMBL301	Homo sapiens	Inhibition	%	-0.63
	8105697	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	9.21	CHEMBL301	Homo sapiens	Inhibition	%	9.21
	8105698	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	6.45	CHEMBL301	Homo sapiens	Inhibition	%	6.45
	8105977	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	0.72	CHEMBL301	Homo sapiens	Inhibition	%	0.72
	8105978	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	2.0	CHEMBL301	Homo sapiens	Inhibition	%	2.0
	8106366	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-2.76	CHEMBL301	Homo sapiens	Inhibition	%	-2.76
	8106367	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-2.39	CHEMBL301	Homo sapiens	Inhibition	%	-2.39
	8106522	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	59.93	CHEMBL301	Homo sapiens	Inhibition	%	59.93
	8106523	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	34.23	CHEMBL301	Homo sapiens	Inhibition	%	34.23
	8106875	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	5.22	CHEMBL301	Homo sapiens	Inhibition	%	5.22
	8106876	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	3.61	CHEMBL301	Homo sapiens	Inhibition	%	3.61
	8107220	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-1.61	CHEMBL301	Homo sapiens	Inhibition	%	-1.61
	8107221	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-2.22	CHEMBL301	Homo sapiens	Inhibition	%	-2.22
	8107392	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	0.47	CHEMBL301	Homo sapiens	Inhibition	%	0.47
	8107393	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	0.99	CHEMBL301	Homo sapiens	Inhibition	%	0.99
	8107593	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	4.36	CHEMBL301	Homo sapiens	Inhibition	%	4.36
	8107594	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	2.97	CHEMBL301	Homo sapiens	Inhibition	%	2.97
	8107817	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	4.32	CHEMBL301	Homo sapiens	Inhibition	%	4.32
	8107818	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	1.61	CHEMBL301	Homo sapiens	Inhibition	%	1.61
	8107952	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	4.6	CHEMBL301	Homo sapiens	Inhibition	%	4.6
	8107953	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	5.16	CHEMBL301	Homo sapiens	Inhibition	%	5.16
	8108110	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	0.22	CHEMBL301	Homo sapiens	Inhibition	%	0.22
	8108111	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	2.17	CHEMBL301	Homo sapiens	Inhibition	%	2.17
	8108334	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	1.77	CHEMBL301	Homo sapiens	Inhibition	%	1.77
	8108335	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	3.8	CHEMBL301	Homo sapiens	Inhibition	%	3.8
	8108509	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-1.22	CHEMBL301	Homo sapiens	Inhibition	%	-1.22
	8108510	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.48	CHEMBL301	Homo sapiens	Inhibition	%	0.48
	8108656	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	3.1	CHEMBL301	Homo sapiens	Inhibition	%	3.1
	8108657	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	2.66	CHEMBL301	Homo sapiens	Inhibition	%	2.66
	8108880	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	4.03	CHEMBL301	Homo sapiens	Inhibition	%	4.03
	8108881	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	5.46	CHEMBL301	Homo sapiens	Inhibition	%	5.46
	8109022	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	2.29	CHEMBL301	Homo sapiens	Inhibition	%	2.29
	8109023	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	4.07	CHEMBL301	Homo sapiens	Inhibition	%	4.07
	8109360	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	4.39	CHEMBL301	Homo sapiens	Inhibition	%	4.39
	8109361	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	4.46	CHEMBL301	Homo sapiens	Inhibition	%	4.46
	8109490	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.92	CHEMBL301	Homo sapiens	Inhibition	%	1.92
	8109491	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.19	CHEMBL301	Homo sapiens	Inhibition	%	1.19
	8109714	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	2.44	CHEMBL301	Homo sapiens	Inhibition	%	2.44
	8109715	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	1.61	CHEMBL301	Homo sapiens	Inhibition	%	1.61
	8109885	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-0.94	CHEMBL301	Homo sapiens	Inhibition	%	-0.94
	8109886	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	2.09	CHEMBL301	Homo sapiens	Inhibition	%	2.09
	8110017	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	1.87	CHEMBL301	Homo sapiens	Inhibition	%	1.87
	8110018	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	3.39	CHEMBL301	Homo sapiens	Inhibition	%	3.39
	8110241	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	12.69	CHEMBL301	Homo sapiens	Inhibition	%	12.69
	8110242	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	15.09	CHEMBL301	Homo sapiens	Inhibition	%	15.09
	8110296	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.81	CHEMBL301	Homo sapiens	Inhibition	%	1.81
	8110297	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	0.87	CHEMBL301	Homo sapiens	Inhibition	%	0.87
	8110520	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	0.88	CHEMBL301	Homo sapiens	Inhibition	%	0.88
	8110521	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.63	CHEMBL301	Homo sapiens	Inhibition	%	2.63
	8110686	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	3.18	CHEMBL301	Homo sapiens	Inhibition	%	3.18
	8110687	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	1.3	CHEMBL301	Homo sapiens	Inhibition	%	1.3
	8110844	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	0.26	CHEMBL301	Homo sapiens	Inhibition	%	0.26
	8110845	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	2.03	CHEMBL301	Homo sapiens	Inhibition	%	2.03
	8111068	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	0.59	CHEMBL301	Homo sapiens	Inhibition	%	0.59
	8111069	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	2.69	CHEMBL301	Homo sapiens	Inhibition	%	2.69
	8111191	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	0.71	CHEMBL301	Homo sapiens	Inhibition	%	0.71
	8111192	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	3.03	CHEMBL301	Homo sapiens	Inhibition	%	3.03
	8111542	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-1.52	CHEMBL301	Homo sapiens	Inhibition	%	-1.52
	8111543	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-0.64	CHEMBL301	Homo sapiens	Inhibition	%	-0.64
	8111708	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.92	CHEMBL301	Homo sapiens	Inhibition	%	2.92
	8111709	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	3.19	CHEMBL301	Homo sapiens	Inhibition	%	3.19
	8112137	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	8.62	CHEMBL301	Homo sapiens	Inhibition	%	8.62
	8112138	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	9.01	CHEMBL301	Homo sapiens	Inhibition	%	9.01
	8112274	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	1.78	CHEMBL301	Homo sapiens	Inhibition	%	1.78
	8112275	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	1.09	CHEMBL301	Homo sapiens	Inhibition	%	1.09
	8112666	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	1.79	CHEMBL301	Homo sapiens	Inhibition	%	1.79
	8112667	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	2.68	CHEMBL301	Homo sapiens	Inhibition	%	2.68
	8112838	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.48	CHEMBL301	Homo sapiens	Inhibition	%	1.48
	8112839	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.98	CHEMBL301	Homo sapiens	Inhibition	%	1.98
	8113214	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.96	CHEMBL301	Homo sapiens	Inhibition	%	3.96
	8113215	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	2.75	CHEMBL301	Homo sapiens	Inhibition	%	2.75
	8113350	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	2.76	CHEMBL301	Homo sapiens	Inhibition	%	2.76
	8113351	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	6.29	CHEMBL301	Homo sapiens	Inhibition	%	6.29
	8113698	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	6.7	CHEMBL301	Homo sapiens	Inhibition	%	6.7
	8113699	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	6.04	CHEMBL301	Homo sapiens	Inhibition	%	6.04
	8114038	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.11	CHEMBL301	Homo sapiens	Inhibition	%	0.11
	8114039	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.62	CHEMBL301	Homo sapiens	Inhibition	%	0.62
	8114214	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	2.27	CHEMBL301	Homo sapiens	Inhibition	%	2.27
	8114215	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	2.01	CHEMBL301	Homo sapiens	Inhibition	%	2.01
	8114570	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	2.79	CHEMBL301	Homo sapiens	Inhibition	%	2.79
	8114571	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	3.66	CHEMBL301	Homo sapiens	Inhibition	%	3.66
	8114846	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	7.52	CHEMBL301	Homo sapiens	Inhibition	%	7.52
	8114847	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	3.98	CHEMBL301	Homo sapiens	Inhibition	%	3.98
	8115012	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	2.5	CHEMBL301	Homo sapiens	Inhibition	%	2.5
	8115013	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	2.09	CHEMBL301	Homo sapiens	Inhibition	%	2.09
	8115401	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-1.04	CHEMBL301	Homo sapiens	Inhibition	%	-1.04
	8115402	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-1.65	CHEMBL301	Homo sapiens	Inhibition	%	-1.65
	8115521	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	1.95	CHEMBL301	Homo sapiens	Inhibition	%	1.95
	8115522	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	-0.35	CHEMBL301	Homo sapiens	Inhibition	%	-0.35
	8115745	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	0.75	CHEMBL301	Homo sapiens	Inhibition	%	0.75
	8115746	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	0.06	CHEMBL301	Homo sapiens	Inhibition	%	0.06
	8115878	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-0.07	CHEMBL301	Homo sapiens	Inhibition	%	-0.07
	8115879	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-0.07	CHEMBL301	Homo sapiens	Inhibition	%	-0.07
	8116037	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	87.31	CHEMBL301	Homo sapiens	Inhibition	%	87.31
	8116038	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	68.37	CHEMBL301	Homo sapiens	Inhibition	%	68.37
	8116261	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	93.61	CHEMBL301	Homo sapiens	Inhibition	%	93.61
	8116262	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	81.19	CHEMBL301	Homo sapiens	Inhibition	%	81.19
	8116464	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	3.56	CHEMBL301	Homo sapiens	Inhibition	%	3.56
	8116465	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	1.95	CHEMBL301	Homo sapiens	Inhibition	%	1.95
	8116598	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	7.56	CHEMBL301	Homo sapiens	Inhibition	%	7.56
	8116599	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	2.33	CHEMBL301	Homo sapiens	Inhibition	%	2.33
	8116822	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	5.99	CHEMBL301	Homo sapiens	Inhibition	%	5.99
	8116823	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	3.16	CHEMBL301	Homo sapiens	Inhibition	%	3.16
	8116994	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	2.91	CHEMBL301	Homo sapiens	Inhibition	%	2.91
	8116995	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	5.08	CHEMBL301	Homo sapiens	Inhibition	%	5.08
	8117165	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	3.32	CHEMBL301	Homo sapiens	Inhibition	%	3.32
	8117166	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	3.45	CHEMBL301	Homo sapiens	Inhibition	%	3.45
	8117389	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	51.44	CHEMBL301	Homo sapiens	Inhibition	%	51.44
	8117390	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	53.47	CHEMBL301	Homo sapiens	Inhibition	%	53.47
	8117547	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.53	CHEMBL301	Homo sapiens	Inhibition	%	3.53
	8117548	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	5.28	CHEMBL301	Homo sapiens	Inhibition	%	5.28
	8117677	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	2.6	CHEMBL301	Homo sapiens	Inhibition	%	2.6
	8117678	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	3.64	CHEMBL301	Homo sapiens	Inhibition	%	3.64
	8117901	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	3.73	CHEMBL301	Homo sapiens	Inhibition	%	3.73
	8117902	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	4.5	CHEMBL301	Homo sapiens	Inhibition	%	4.5
	8118039	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-1.17	CHEMBL301	Homo sapiens	Inhibition	%	-1.17
	8118040	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	3.33	CHEMBL301	Homo sapiens	Inhibition	%	3.33
	8118379	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	3.12	CHEMBL301	Homo sapiens	Inhibition	%	3.12
	8118380	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	2.17	CHEMBL301	Homo sapiens	Inhibition	%	2.17
	8118551	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	1.87	CHEMBL301	Homo sapiens	Inhibition	%	1.87
	8118552	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	3.44	CHEMBL301	Homo sapiens	Inhibition	%	3.44
	8118911	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	2.68	CHEMBL301	Homo sapiens	Inhibition	%	2.68
	8118912	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	6.69	CHEMBL301	Homo sapiens	Inhibition	%	6.69
	8119182	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	0.1	CHEMBL301	Homo sapiens	Inhibition	%	0.1
	8119183	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	-0.26	CHEMBL301	Homo sapiens	Inhibition	%	-0.26
	8119341	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	13.47	CHEMBL301	Homo sapiens	Inhibition	%	13.47
	8119342	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	15.46	CHEMBL301	Homo sapiens	Inhibition	%	15.46
	8119565	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	6.03	CHEMBL301	Homo sapiens	Inhibition	%	6.03
	8119566	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	2.88	CHEMBL301	Homo sapiens	Inhibition	%	2.88
	8119732	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.26	CHEMBL301	Homo sapiens	Inhibition	%	-0.26
	8119733	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.18	CHEMBL301	Homo sapiens	Inhibition	%	-0.18
	8120075	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	9.99	CHEMBL301	Homo sapiens	Inhibition	%	9.99
	8120076	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.32	CHEMBL301	Homo sapiens	Inhibition	%	1.32
	8120214	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-0.16	CHEMBL301	Homo sapiens	Inhibition	%	-0.16
	8120215	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.31	CHEMBL301	Homo sapiens	Inhibition	%	0.31
	8120598	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.92	CHEMBL301	Homo sapiens	Inhibition	%	0.92
	8120599	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	3.48	CHEMBL301	Homo sapiens	Inhibition	%	3.48
	8120799	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	1.76	CHEMBL301	Homo sapiens	Inhibition	%	1.76
	8120800	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	3.09	CHEMBL301	Homo sapiens	Inhibition	%	3.09
	8121151	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	28.88	CHEMBL301	Homo sapiens	Inhibition	%	28.88
	8121152	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	18.95	CHEMBL301	Homo sapiens	Inhibition	%	18.95
	8121323	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	0.69	CHEMBL301	Homo sapiens	Inhibition	%	0.69
	8121324	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.15	CHEMBL301	Homo sapiens	Inhibition	%	1.15
	8121714	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	71.58	CHEMBL301	Homo sapiens	Inhibition	%	71.58
	8121715	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	67.68	CHEMBL301	Homo sapiens	Inhibition	%	67.68
	8121877	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	7.43	CHEMBL301	Homo sapiens	Inhibition	%	7.43
	8121878	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	4.88	CHEMBL301	Homo sapiens	Inhibition	%	4.88
	8122222	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	0.72	CHEMBL301	Homo sapiens	Inhibition	%	0.72
	8122223	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	0.45	CHEMBL301	Homo sapiens	Inhibition	%	0.45
	8122360	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-0.54	CHEMBL301	Homo sapiens	Inhibition	%	-0.54
	8122361	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	6.4	CHEMBL301	Homo sapiens	Inhibition	%	6.4
	8122584	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	82.66	CHEMBL301	Homo sapiens	Inhibition	%	82.66
	8122585	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	70.85	CHEMBL301	Homo sapiens	Inhibition	%	70.85
	8122704	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	3.62	CHEMBL301	Homo sapiens	Inhibition	%	3.62
	8122705	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	3.13	CHEMBL301	Homo sapiens	Inhibition	%	3.13
	8122871	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	2.74	CHEMBL301	Homo sapiens	Inhibition	%	2.74
	8122872	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	2.65	CHEMBL301	Homo sapiens	Inhibition	%	2.65
	8123095	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	1.69	CHEMBL301	Homo sapiens	Inhibition	%	1.69
	8123096	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	5.6	CHEMBL301	Homo sapiens	Inhibition	%	5.6
	8123237	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	-2.45	CHEMBL301	Homo sapiens	Inhibition	%	-2.45
	8123238	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	0.41	CHEMBL301	Homo sapiens	Inhibition	%	0.41
	8123515	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	-9.04	CHEMBL301	Homo sapiens	Inhibition	%	-9.04
	8123516	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	0.04	CHEMBL301	Homo sapiens	Inhibition	%	0.04
	8123889	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	42.14	CHEMBL301	Homo sapiens	Inhibition	%	42.14
	8123890	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	13.71	CHEMBL301	Homo sapiens	Inhibition	%	13.71
	8124056	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-3.99	CHEMBL301	Homo sapiens	Inhibition	%	-3.99
	8124057	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-3.22	CHEMBL301	Homo sapiens	Inhibition	%	-3.22
	8124399	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	72.78	CHEMBL301	Homo sapiens	Inhibition	%	72.78
	8124400	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	64.67	CHEMBL301	Homo sapiens	Inhibition	%	64.67
	8124538	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	2.09	CHEMBL301	Homo sapiens	Inhibition	%	2.09
	8124539	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.68	CHEMBL301	Homo sapiens	Inhibition	%	1.68
	8124762	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.41	CHEMBL301	Homo sapiens	Inhibition	%	0.41
	8124763	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.63	CHEMBL301	Homo sapiens	Inhibition	%	0.63
	8124927	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-1.09	CHEMBL301	Homo sapiens	Inhibition	%	-1.09
	8124928	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	2.34	CHEMBL301	Homo sapiens	Inhibition	%	2.34
	8125128	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.63	CHEMBL301	Homo sapiens	Inhibition	%	3.63
	8125129	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	2.03	CHEMBL301	Homo sapiens	Inhibition	%	2.03
	8125482	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	65.5	CHEMBL301	Homo sapiens	Inhibition	%	65.5
	8125483	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	38.94	CHEMBL301	Homo sapiens	Inhibition	%	38.94
	8125650	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	0.19	CHEMBL301	Homo sapiens	Inhibition	%	0.19
	8125651	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.72	CHEMBL301	Homo sapiens	Inhibition	%	1.72
	8126038	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	3.86	CHEMBL301	Homo sapiens	Inhibition	%	3.86
	8126039	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	3.75	CHEMBL301	Homo sapiens	Inhibition	%	3.75
	8126202	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	5.68	CHEMBL301	Homo sapiens	Inhibition	%	5.68
	8126203	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	8.08	CHEMBL301	Homo sapiens	Inhibition	%	8.08
	8126541	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	5.32	CHEMBL301	Homo sapiens	Inhibition	%	5.32
	8126542	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	5.95	CHEMBL301	Homo sapiens	Inhibition	%	5.95
	8126901	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	94.4	CHEMBL301	Homo sapiens	Inhibition	%	94.4
	8126902	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	75.02	CHEMBL301	Homo sapiens	Inhibition	%	75.02
	8127023	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	3.49	CHEMBL301	Homo sapiens	Inhibition	%	3.49
	8127024	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.95	CHEMBL301	Homo sapiens	Inhibition	%	2.95
	8127414	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	3.74	CHEMBL301	Homo sapiens	Inhibition	%	3.74
	8127415	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	4.05	CHEMBL301	Homo sapiens	Inhibition	%	4.05
	8127556	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	1.5	CHEMBL301	Homo sapiens	Inhibition	%	1.5
	8127557	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	4.83	CHEMBL301	Homo sapiens	Inhibition	%	4.83
	8127780	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	2.4	CHEMBL301	Homo sapiens	Inhibition	%	2.4
	8127781	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	4.68	CHEMBL301	Homo sapiens	Inhibition	%	4.68
	8127844	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	2.04	CHEMBL301	Homo sapiens	Inhibition	%	2.04
	8127845	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.75	CHEMBL301	Homo sapiens	Inhibition	%	0.75
	8128220	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	2.51	CHEMBL301	Homo sapiens	Inhibition	%	2.51
	8128221	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.36	CHEMBL301	Homo sapiens	Inhibition	%	1.36
	8128387	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	8.02	CHEMBL301	Homo sapiens	Inhibition	%	8.02
	8128388	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-2.32	CHEMBL301	Homo sapiens	Inhibition	%	-2.32
	8128611	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.6	CHEMBL301	Homo sapiens	Inhibition	%	0.6
	8128612	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-0.47	CHEMBL301	Homo sapiens	Inhibition	%	-0.47
	8128730	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	105.02	CHEMBL301	Homo sapiens	Inhibition	%	105.02
	8128731	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	78.64	CHEMBL301	Homo sapiens	Inhibition	%	78.64
	8129091	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	4.41	CHEMBL301	Homo sapiens	Inhibition	%	4.41
	8129092	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	3.66	CHEMBL301	Homo sapiens	Inhibition	%	3.66
	8129262	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.07	CHEMBL301	Homo sapiens	Inhibition	%	-0.07
	8129263	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.38	CHEMBL301	Homo sapiens	Inhibition	%	-0.38
	8129451	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	2.75	CHEMBL301	Homo sapiens	Inhibition	%	2.75
	8129452	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	2.75	CHEMBL301	Homo sapiens	Inhibition	%	2.75
	8129675	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	4.51	CHEMBL301	Homo sapiens	Inhibition	%	4.51
	8129676	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	0.96	CHEMBL301	Homo sapiens	Inhibition	%	0.96
	8129814	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	91.17	CHEMBL301	Homo sapiens	Inhibition	%	91.17
	8129815	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	75.35	CHEMBL301	Homo sapiens	Inhibition	%	75.35
	8129975	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.79	CHEMBL301	Homo sapiens	Inhibition	%	1.79
	8129976	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	4.11	CHEMBL301	Homo sapiens	Inhibition	%	4.11
	8130199	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	14.05	CHEMBL301	Homo sapiens	Inhibition	%	14.05
	8130200	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	16.44	CHEMBL301	Homo sapiens	Inhibition	%	16.44
	8130371	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	20.36	CHEMBL301	Homo sapiens	Inhibition	%	20.36
	8130372	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	12.36	CHEMBL301	Homo sapiens	Inhibition	%	12.36
	8130531	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	39.51	CHEMBL301	Homo sapiens	Inhibition	%	39.51
	8130532	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	40.35	CHEMBL301	Homo sapiens	Inhibition	%	40.35
	8130755	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	82.47	CHEMBL301	Homo sapiens	Inhibition	%	82.47
	8130756	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	70.08	CHEMBL301	Homo sapiens	Inhibition	%	70.08
	8130871	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	0.67	CHEMBL301	Homo sapiens	Inhibition	%	0.67
	8130872	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	0.53	CHEMBL301	Homo sapiens	Inhibition	%	0.53
	8131234	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	3.78	CHEMBL301	Homo sapiens	Inhibition	%	3.78
	8131235	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	6.32	CHEMBL301	Homo sapiens	Inhibition	%	6.32
	8131354	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	4.28	CHEMBL301	Homo sapiens	Inhibition	%	4.28
	8131355	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	4.3	CHEMBL301	Homo sapiens	Inhibition	%	4.3
	8131578	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-0.09	CHEMBL301	Homo sapiens	Inhibition	%	-0.09
	8131579	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-0.76	CHEMBL301	Homo sapiens	Inhibition	%	-0.76
	8131745	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	4.31	CHEMBL301	Homo sapiens	Inhibition	%	4.31
	8131746	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	5.69	CHEMBL301	Homo sapiens	Inhibition	%	5.69
	8132110	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	8.86	CHEMBL301	Homo sapiens	Inhibition	%	8.86
	8132111	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	10.77	CHEMBL301	Homo sapiens	Inhibition	%	10.77
	8132172	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	2.37	CHEMBL301	Homo sapiens	Inhibition	%	2.37
	8132173	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	3.13	CHEMBL301	Homo sapiens	Inhibition	%	3.13
	8132396	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-3.41	CHEMBL301	Homo sapiens	Inhibition	%	-3.41
	8132397	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-2.41	CHEMBL301	Homo sapiens	Inhibition	%	-2.41
	8132543	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	0.67	CHEMBL301	Homo sapiens	Inhibition	%	0.67
	8132544	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	4.91	CHEMBL301	Homo sapiens	Inhibition	%	4.91
	8132935	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-0.73	CHEMBL301	Homo sapiens	Inhibition	%	-0.73
	8132936	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.52	CHEMBL301	Homo sapiens	Inhibition	%	0.52
	8133056	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	4.06	CHEMBL301	Homo sapiens	Inhibition	%	4.06
	8133057	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	4.31	CHEMBL301	Homo sapiens	Inhibition	%	4.31
	8133418	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.71	CHEMBL301	Homo sapiens	Inhibition	%	2.71
	8133419	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.12	CHEMBL301	Homo sapiens	Inhibition	%	1.12
	8133590	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.53	CHEMBL301	Homo sapiens	Inhibition	%	0.53
	8133591	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.33	CHEMBL301	Homo sapiens	Inhibition	%	0.33
	8133994	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	10.82	CHEMBL301	Homo sapiens	Inhibition	%	10.82
	8133995	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	5.93	CHEMBL301	Homo sapiens	Inhibition	%	5.93
	8134142	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	1.51	CHEMBL301	Homo sapiens	Inhibition	%	1.51
	8134143	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	1.72	CHEMBL301	Homo sapiens	Inhibition	%	1.72
	8134526	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	-0.08	CHEMBL301	Homo sapiens	Inhibition	%	-0.08
	8134527	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.91	CHEMBL301	Homo sapiens	Inhibition	%	0.91
	8134710	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	1.42	CHEMBL301	Homo sapiens	Inhibition	%	1.42
	8134711	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	2.53	CHEMBL301	Homo sapiens	Inhibition	%	2.53
	8135094	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	2.14	CHEMBL301	Homo sapiens	Inhibition	%	2.14
	8135095	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	3.02	CHEMBL301	Homo sapiens	Inhibition	%	3.02
	8135209	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.67	CHEMBL301	Homo sapiens	Inhibition	%	1.67
	8135210	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.85	CHEMBL301	Homo sapiens	Inhibition	%	1.85
	8135433	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	6.22	CHEMBL301	Homo sapiens	Inhibition	%	6.22
	8135434	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	2.59	CHEMBL301	Homo sapiens	Inhibition	%	2.59
	8135574	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	4.53	CHEMBL301	Homo sapiens	Inhibition	%	4.53
	8135575	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	8.92	CHEMBL301	Homo sapiens	Inhibition	%	8.92
	8135919	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-1.09	CHEMBL301	Homo sapiens	Inhibition	%	-1.09
	8135920	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	0.82	CHEMBL301	Homo sapiens	Inhibition	%	0.82
	8136087	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	1.78	CHEMBL301	Homo sapiens	Inhibition	%	1.78
	8136088	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.49	CHEMBL301	Homo sapiens	Inhibition	%	2.49
	8136455	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	1.83	CHEMBL301	Homo sapiens	Inhibition	%	1.83
	8136456	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	3.24	CHEMBL301	Homo sapiens	Inhibition	%	3.24
	8136745	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	1.23	CHEMBL301	Homo sapiens	Inhibition	%	1.23
	8136746	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-2.88	CHEMBL301	Homo sapiens	Inhibition	%	-2.88
	8136880	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	0.45	CHEMBL301	Homo sapiens	Inhibition	%	0.45
	8136881	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	-0.59	CHEMBL301	Homo sapiens	Inhibition	%	-0.59
	8137267	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	7.1	CHEMBL301	Homo sapiens	Inhibition	%	7.1
	8137268	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	1.17	CHEMBL301	Homo sapiens	Inhibition	%	1.17
	8137387	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	17.62	CHEMBL301	Homo sapiens	Inhibition	%	17.62
	8137388	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	21.54	CHEMBL301	Homo sapiens	Inhibition	%	21.54
	8137611	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-3.98	CHEMBL301	Homo sapiens	Inhibition	%	-3.98
	8137612	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-1.1	CHEMBL301	Homo sapiens	Inhibition	%	-1.1
	8137759	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	13.8	CHEMBL301	Homo sapiens	Inhibition	%	13.8
	8137760	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	7.61	CHEMBL301	Homo sapiens	Inhibition	%	7.61
	8137925	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.45	CHEMBL301	Homo sapiens	Inhibition	%	-0.45
	8137926	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-2.16	CHEMBL301	Homo sapiens	Inhibition	%	-2.16
	8138149	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	0.88	CHEMBL301	Homo sapiens	Inhibition	%	0.88
	8138150	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.2	CHEMBL301	Homo sapiens	Inhibition	%	-0.2
	8138328	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.96	CHEMBL301	Homo sapiens	Inhibition	%	1.96
	8138329	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.42	CHEMBL301	Homo sapiens	Inhibition	%	1.42
	8138476	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	2.69	CHEMBL301	Homo sapiens	Inhibition	%	2.69
	8138477	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	5.09	CHEMBL301	Homo sapiens	Inhibition	%	5.09
	8138700	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	0.33	CHEMBL301	Homo sapiens	Inhibition	%	0.33
	8138701	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-0.92	CHEMBL301	Homo sapiens	Inhibition	%	-0.92
	8138858	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	1.04	CHEMBL301	Homo sapiens	Inhibition	%	1.04
	8138859	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	3.1	CHEMBL301	Homo sapiens	Inhibition	%	3.1
	8139043	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	18.12	CHEMBL301	Homo sapiens	Inhibition	%	18.12
	8139044	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	21.97	CHEMBL301	Homo sapiens	Inhibition	%	21.97
	8139267	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	4.61	CHEMBL301	Homo sapiens	Inhibition	%	4.61
	8139268	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	1.77	CHEMBL301	Homo sapiens	Inhibition	%	1.77
	8139426	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	2.77	CHEMBL301	Homo sapiens	Inhibition	%	2.77
	8139427	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	7.32	CHEMBL301	Homo sapiens	Inhibition	%	7.32
	8139764	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	8.37	CHEMBL301	Homo sapiens	Inhibition	%	8.37
	8139765	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	4.6	CHEMBL301	Homo sapiens	Inhibition	%	4.6
	8139905	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	3.62	CHEMBL301	Homo sapiens	Inhibition	%	3.62
	8139906	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	5.35	CHEMBL301	Homo sapiens	Inhibition	%	5.35
	8140252	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	3.34	CHEMBL301	Homo sapiens	Inhibition	%	3.34
	8140253	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	1.44	CHEMBL301	Homo sapiens	Inhibition	%	1.44
	8140411	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	5.08	CHEMBL301	Homo sapiens	Inhibition	%	5.08
	8140412	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	3.83	CHEMBL301	Homo sapiens	Inhibition	%	3.83
	8140635	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.0	CHEMBL301	Homo sapiens	Inhibition	%	1.0
	8140636	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.41	CHEMBL301	Homo sapiens	Inhibition	%	2.41
	8140778	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	3.44	CHEMBL301	Homo sapiens	Inhibition	%	3.44
	8140779	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	6.04	CHEMBL301	Homo sapiens	Inhibition	%	6.04
	8141080	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.42	CHEMBL301	Homo sapiens	Inhibition	%	0.42
	8141081	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.6	CHEMBL301	Homo sapiens	Inhibition	%	1.6
	8141210	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	4.04	CHEMBL301	Homo sapiens	Inhibition	%	4.04
	8141211	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	3.25	CHEMBL301	Homo sapiens	Inhibition	%	3.25
	8141434	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	3.24	CHEMBL301	Homo sapiens	Inhibition	%	3.24
	8141435	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	-0.16	CHEMBL301	Homo sapiens	Inhibition	%	-0.16
	8141594	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	42.14	CHEMBL301	Homo sapiens	Inhibition	%	42.14
	8141595	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	9.16	CHEMBL301	Homo sapiens	Inhibition	%	9.16
	8141937	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	4.82	CHEMBL301	Homo sapiens	Inhibition	%	4.82
	8141938	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-2.25	CHEMBL301	Homo sapiens	Inhibition	%	-2.25
	8142098	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.22	CHEMBL301	Homo sapiens	Inhibition	%	0.22
	8142099	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-0.84	CHEMBL301	Homo sapiens	Inhibition	%	-0.84
	8142490	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-0.78	CHEMBL301	Homo sapiens	Inhibition	%	-0.78
	8142491	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-0.93	CHEMBL301	Homo sapiens	Inhibition	%	-0.93
	8142666	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	-0.45	CHEMBL301	Homo sapiens	Inhibition	%	-0.45
	8142667	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	0.41	CHEMBL301	Homo sapiens	Inhibition	%	0.41
	8143039	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-0.04	CHEMBL301	Homo sapiens	Inhibition	%	-0.04
	8143040	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	0.52	CHEMBL301	Homo sapiens	Inhibition	%	0.52
	8143194	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.4	CHEMBL301	Homo sapiens	Inhibition	%	1.4
	8143195	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	2.14	CHEMBL301	Homo sapiens	Inhibition	%	2.14
	8143605	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	3.86	CHEMBL301	Homo sapiens	Inhibition	%	3.86
	8143606	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	3.35	CHEMBL301	Homo sapiens	Inhibition	%	3.35
	8143764	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	4.09	CHEMBL301	Homo sapiens	Inhibition	%	4.09
	8143765	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	2.95	CHEMBL301	Homo sapiens	Inhibition	%	2.95
	8144102	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-2.31	CHEMBL301	Homo sapiens	Inhibition	%	-2.31
	8144103	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-1.96	CHEMBL301	Homo sapiens	Inhibition	%	-1.96
	8144241	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	4.32	CHEMBL301	Homo sapiens	Inhibition	%	4.32
	8144242	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	6.57	CHEMBL301	Homo sapiens	Inhibition	%	6.57
	8144465	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	2.76	CHEMBL301	Homo sapiens	Inhibition	%	2.76
	8144466	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	4.72	CHEMBL301	Homo sapiens	Inhibition	%	4.72
	8144595	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	3.24	CHEMBL301	Homo sapiens	Inhibition	%	3.24
	8144596	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	2.97	CHEMBL301	Homo sapiens	Inhibition	%	2.97
	8144972	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.91	CHEMBL301	Homo sapiens	Inhibition	%	1.91
	8144973	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	3.39	CHEMBL301	Homo sapiens	Inhibition	%	3.39
	8145109	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	2.32	CHEMBL301	Homo sapiens	Inhibition	%	2.32
	8145110	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	3.6	CHEMBL301	Homo sapiens	Inhibition	%	3.6
	8145422	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	-1.8	CHEMBL301	Homo sapiens	Inhibition	%	-1.8
	8145423	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.6	CHEMBL301	Homo sapiens	Inhibition	%	1.6
	8145770	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	6.79	CHEMBL301	Homo sapiens	Inhibition	%	6.79
	8145771	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	3.89	CHEMBL301	Homo sapiens	Inhibition	%	3.89
	8145931	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	3.62	CHEMBL301	Homo sapiens	Inhibition	%	3.62
	8145932	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	-0.54	CHEMBL301	Homo sapiens	Inhibition	%	-0.54
	8146275	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	-0.08	CHEMBL301	Homo sapiens	Inhibition	%	-0.08
	8146276	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.48	CHEMBL301	Homo sapiens	Inhibition	%	0.48
	8146435	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.43	CHEMBL301	Homo sapiens	Inhibition	%	0.43
	8146436	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-0.22	CHEMBL301	Homo sapiens	Inhibition	%	-0.22
	8146659	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	4.39	CHEMBL301	Homo sapiens	Inhibition	%	4.39
	8146660	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	0.86	CHEMBL301	Homo sapiens	Inhibition	%	0.86
	8146826	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	2.52	CHEMBL301	Homo sapiens	Inhibition	%	2.52
	8146827	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	0.83	CHEMBL301	Homo sapiens	Inhibition	%	0.83
	8146995	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	18.56	CHEMBL301	Homo sapiens	Inhibition	%	18.56
	8146996	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	5.38	CHEMBL301	Homo sapiens	Inhibition	%	5.38
	8147219	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	63.19	CHEMBL301	Homo sapiens	Inhibition	%	63.19
	8147220	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	32.53	CHEMBL301	Homo sapiens	Inhibition	%	32.53
	8147361	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.41	CHEMBL301	Homo sapiens	Inhibition	%	1.41
	8147362	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	3.41	CHEMBL301	Homo sapiens	Inhibition	%	3.41
	8147514	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.57	CHEMBL301	Homo sapiens	Inhibition	%	1.57
	8147515	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.31	CHEMBL301	Homo sapiens	Inhibition	%	3.31
	8147738	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	0.03	CHEMBL301	Homo sapiens	Inhibition	%	0.03
	8147739	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.35	CHEMBL301	Homo sapiens	Inhibition	%	2.35
	8147925	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	8.07	CHEMBL301	Homo sapiens	Inhibition	%	8.07
	8147926	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	2.47	CHEMBL301	Homo sapiens	Inhibition	%	2.47
	8148083	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	3.14	CHEMBL301	Homo sapiens	Inhibition	%	3.14
	8148084	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	7.4	CHEMBL301	Homo sapiens	Inhibition	%	7.4
	8148307	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	3.79	CHEMBL301	Homo sapiens	Inhibition	%	3.79
	8148308	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	3.46	CHEMBL301	Homo sapiens	Inhibition	%	3.46
	8148421	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-1.03	CHEMBL301	Homo sapiens	Inhibition	%	-1.03
	8148422	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-0.05	CHEMBL301	Homo sapiens	Inhibition	%	-0.05
	8148784	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	2.67	CHEMBL301	Homo sapiens	Inhibition	%	2.67
	8148785	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	7.13	CHEMBL301	Homo sapiens	Inhibition	%	7.13
	8148922	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	3.34	CHEMBL301	Homo sapiens	Inhibition	%	3.34
	8148923	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	3.03	CHEMBL301	Homo sapiens	Inhibition	%	3.03
	8149146	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	3.6	CHEMBL301	Homo sapiens	Inhibition	%	3.6
	8149147	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	4.26	CHEMBL301	Homo sapiens	Inhibition	%	4.26
	8149305	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-1.63	CHEMBL301	Homo sapiens	Inhibition	%	-1.63
	8149306	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-2.44	CHEMBL301	Homo sapiens	Inhibition	%	-2.44
	8149439	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	2.63	CHEMBL301	Homo sapiens	Inhibition	%	2.63
	8149440	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	5.45	CHEMBL301	Homo sapiens	Inhibition	%	5.45
	8149663	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	0.58	CHEMBL301	Homo sapiens	Inhibition	%	0.58
	8149664	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	2.89	CHEMBL301	Homo sapiens	Inhibition	%	2.89
	8149761	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	0.63	CHEMBL301	Homo sapiens	Inhibition	%	0.63
	8149762	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	1.5	CHEMBL301	Homo sapiens	Inhibition	%	1.5
	8150110	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-3.1	CHEMBL301	Homo sapiens	Inhibition	%	-3.1
	8150111	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-4.34	CHEMBL301	Homo sapiens	Inhibition	%	-4.34
	8150270	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	12.15	CHEMBL301	Homo sapiens	Inhibition	%	12.15
	8150271	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	2.62	CHEMBL301	Homo sapiens	Inhibition	%	2.62
	8150494	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-0.2	CHEMBL301	Homo sapiens	Inhibition	%	-0.2
	8150495	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	4.58	CHEMBL301	Homo sapiens	Inhibition	%	4.58
	8150614	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	6.71	CHEMBL301	Homo sapiens	Inhibition	%	6.71
	8150615	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.81	CHEMBL301	Homo sapiens	Inhibition	%	0.81
	8151003	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	6.12	CHEMBL301	Homo sapiens	Inhibition	%	6.12
	8151004	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-1.41	CHEMBL301	Homo sapiens	Inhibition	%	-1.41
	8151166	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	0.12	CHEMBL301	Homo sapiens	Inhibition	%	0.12
	8151167	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-1.68	CHEMBL301	Homo sapiens	Inhibition	%	-1.68
	8151567	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	3.24	CHEMBL301	Homo sapiens	Inhibition	%	3.24
	8151568	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	2.25	CHEMBL301	Homo sapiens	Inhibition	%	2.25
	8151705	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	13.52	CHEMBL301	Homo sapiens	Inhibition	%	13.52
	8151706	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	26.43	CHEMBL301	Homo sapiens	Inhibition	%	26.43
	8152083	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.83	CHEMBL301	Homo sapiens	Inhibition	%	1.83
	8152084	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	4.1	CHEMBL301	Homo sapiens	Inhibition	%	4.1
	8152271	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	7.32	CHEMBL301	Homo sapiens	Inhibition	%	7.32
	8152272	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	4.31	CHEMBL301	Homo sapiens	Inhibition	%	4.31
	8152653	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	10.53	CHEMBL301	Homo sapiens	Inhibition	%	10.53
	8152654	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	12.34	CHEMBL301	Homo sapiens	Inhibition	%	12.34
	8152767	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	1.59	CHEMBL301	Homo sapiens	Inhibition	%	1.59
	8152768	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	2.45	CHEMBL301	Homo sapiens	Inhibition	%	2.45
	8152991	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	3.06	CHEMBL301	Homo sapiens	Inhibition	%	3.06
	8152992	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	3.56	CHEMBL301	Homo sapiens	Inhibition	%	3.56
	8153130	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.79	CHEMBL301	Homo sapiens	Inhibition	%	2.79
	8153131	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.41	CHEMBL301	Homo sapiens	Inhibition	%	3.41
	8153491	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	3.94	CHEMBL301	Homo sapiens	Inhibition	%	3.94
	8153492	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	3.71	CHEMBL301	Homo sapiens	Inhibition	%	3.71
	8153648	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-2.87	CHEMBL301	Homo sapiens	Inhibition	%	-2.87
	8153649	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-4.09	CHEMBL301	Homo sapiens	Inhibition	%	-4.09
	8154005	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	3.6	CHEMBL301	Homo sapiens	Inhibition	%	3.6
	8154006	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	5.11	CHEMBL301	Homo sapiens	Inhibition	%	5.11
	8154102	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	-1.72	CHEMBL301	Homo sapiens	Inhibition	%	-1.72
	8154103	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	0.5	CHEMBL301	Homo sapiens	Inhibition	%	0.5
	8154326	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	1.31	CHEMBL301	Homo sapiens	Inhibition	%	1.31
	8154327	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	1.38	CHEMBL301	Homo sapiens	Inhibition	%	1.38
	8154452	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	3.18	CHEMBL301	Homo sapiens	Inhibition	%	3.18
	8154453	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-4.0	CHEMBL301	Homo sapiens	Inhibition	%	-4.0
	8154835	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	6.57	CHEMBL301	Homo sapiens	Inhibition	%	6.57
	8154836	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	4.27	CHEMBL301	Homo sapiens	Inhibition	%	4.27
	8154955	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.78	CHEMBL301	Homo sapiens	Inhibition	%	0.78
	8154956	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.17	CHEMBL301	Homo sapiens	Inhibition	%	0.17
	8155179	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	5.75	CHEMBL301	Homo sapiens	Inhibition	%	5.75
	8155180	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-0.76	CHEMBL301	Homo sapiens	Inhibition	%	-0.76
	8155355	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.36	CHEMBL301	Homo sapiens	Inhibition	%	-0.36
	8155356	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.77	CHEMBL301	Homo sapiens	Inhibition	%	-0.77
	8155516	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	4.69	CHEMBL301	Homo sapiens	Inhibition	%	4.69
	8155517	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	0.18	CHEMBL301	Homo sapiens	Inhibition	%	0.18
	8155740	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	3.46	CHEMBL301	Homo sapiens	Inhibition	%	3.46
	8155741	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	0.67	CHEMBL301	Homo sapiens	Inhibition	%	0.67
	8155918	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	10.36	CHEMBL301	Homo sapiens	Inhibition	%	10.36
	8155919	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	9.7	CHEMBL301	Homo sapiens	Inhibition	%	9.7
	8156056	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	1.78	CHEMBL301	Homo sapiens	Inhibition	%	1.78
	8156057	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	3.35	CHEMBL301	Homo sapiens	Inhibition	%	3.35
	8156280	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	8.89	CHEMBL301	Homo sapiens	Inhibition	%	8.89
	8156281	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	14.14	CHEMBL301	Homo sapiens	Inhibition	%	14.14
	8156492	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	1.63	CHEMBL301	Homo sapiens	Inhibition	%	1.63
	8156493	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	4.69	CHEMBL301	Homo sapiens	Inhibition	%	4.69
	8156642	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	6.76	CHEMBL301	Homo sapiens	Inhibition	%	6.76
	8156643	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	8.73	CHEMBL301	Homo sapiens	Inhibition	%	8.73
	8157009	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	108.84	CHEMBL301	Homo sapiens	Inhibition	%	108.84
	8157010	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	86.79	CHEMBL301	Homo sapiens	Inhibition	%	86.79
	8157129	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	2.54	CHEMBL301	Homo sapiens	Inhibition	%	2.54
	8157130	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	2.66	CHEMBL301	Homo sapiens	Inhibition	%	2.66
	8157353	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	6.05	CHEMBL301	Homo sapiens	Inhibition	%	6.05
	8157354	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	6.67	CHEMBL301	Homo sapiens	Inhibition	%	6.67
	8157494	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	3.13	CHEMBL301	Homo sapiens	Inhibition	%	3.13
	8157495	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	6.0	CHEMBL301	Homo sapiens	Inhibition	%	6.0
	8157848	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	3.35	CHEMBL301	Homo sapiens	Inhibition	%	3.35
	8157849	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	5.24	CHEMBL301	Homo sapiens	Inhibition	%	5.24
	8158009	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-1.17	CHEMBL301	Homo sapiens	Inhibition	%	-1.17
	8158010	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	2.3	CHEMBL301	Homo sapiens	Inhibition	%	2.3
	8158259	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	-7.25	CHEMBL301	Homo sapiens	Inhibition	%	-7.25
	8158260	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	2.47	CHEMBL301	Homo sapiens	Inhibition	%	2.47
	8158483	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	2.14	CHEMBL301	Homo sapiens	Inhibition	%	2.14
	8158484	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	2.3	CHEMBL301	Homo sapiens	Inhibition	%	2.3
	8158641	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	2.88	CHEMBL301	Homo sapiens	Inhibition	%	2.88
	8158642	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	6.44	CHEMBL301	Homo sapiens	Inhibition	%	6.44
	8158810	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.01	CHEMBL301	Homo sapiens	Inhibition	%	2.01
	8158811	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.48	CHEMBL301	Homo sapiens	Inhibition	%	2.48
	8159034	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	17.33	CHEMBL301	Homo sapiens	Inhibition	%	17.33
	8159035	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	11.56	CHEMBL301	Homo sapiens	Inhibition	%	11.56
	8159169	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	1.57	CHEMBL301	Homo sapiens	Inhibition	%	1.57
	8159170	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	4.21	CHEMBL301	Homo sapiens	Inhibition	%	4.21
	8159513	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-1.82	CHEMBL301	Homo sapiens	Inhibition	%	-1.82
	8159514	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-1.42	CHEMBL301	Homo sapiens	Inhibition	%	-1.42
	8159644	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	78.14	CHEMBL301	Homo sapiens	Inhibition	%	78.14
	8159645	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	56.04	CHEMBL301	Homo sapiens	Inhibition	%	56.04
	8159868	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	2.13	CHEMBL301	Homo sapiens	Inhibition	%	2.13
	8159869	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	3.57	CHEMBL301	Homo sapiens	Inhibition	%	3.57
	8160009	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	-5.6	CHEMBL301	Homo sapiens	Inhibition	%	-5.6
	8160010	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	3.84	CHEMBL301	Homo sapiens	Inhibition	%	3.84
	8160146	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	3.4	CHEMBL301	Homo sapiens	Inhibition	%	3.4
	8160147	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	6.96	CHEMBL301	Homo sapiens	Inhibition	%	6.96
	8160370	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	4.28	CHEMBL301	Homo sapiens	Inhibition	%	4.28
	8160371	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	8.06	CHEMBL301	Homo sapiens	Inhibition	%	8.06
	8160520	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-0.46	CHEMBL301	Homo sapiens	Inhibition	%	-0.46
	8160521	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	0.06	CHEMBL301	Homo sapiens	Inhibition	%	0.06
	8160814	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	0.2	CHEMBL301	Homo sapiens	Inhibition	%	0.2
	8160815	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	6.42	CHEMBL301	Homo sapiens	Inhibition	%	6.42
	8160964	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	1.15	CHEMBL301	Homo sapiens	Inhibition	%	1.15
	8160965	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	3.19	CHEMBL301	Homo sapiens	Inhibition	%	3.19
	8161188	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	11.27	CHEMBL301	Homo sapiens	Inhibition	%	11.27
	8161189	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	4.7	CHEMBL301	Homo sapiens	Inhibition	%	4.7
	8161331	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	65.46	CHEMBL301	Homo sapiens	Inhibition	%	65.46
	8161332	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	73.62	CHEMBL301	Homo sapiens	Inhibition	%	73.62
	8161680	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	3.51	CHEMBL301	Homo sapiens	Inhibition	%	3.51
	8161681	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	3.32	CHEMBL301	Homo sapiens	Inhibition	%	3.32
	8161818	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	20.84	CHEMBL301	Homo sapiens	Inhibition	%	20.84
	8161819	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	28.82	CHEMBL301	Homo sapiens	Inhibition	%	28.82
	8162042	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	2.32	CHEMBL301	Homo sapiens	Inhibition	%	2.32
	8162043	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	7.11	CHEMBL301	Homo sapiens	Inhibition	%	7.11
	8162172	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	25.88	CHEMBL301	Homo sapiens	Inhibition	%	25.88
	8162173	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	19.74	CHEMBL301	Homo sapiens	Inhibition	%	19.74
	8162332	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-3.51	CHEMBL301	Homo sapiens	Inhibition	%	-3.51
	8162333	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-2.32	CHEMBL301	Homo sapiens	Inhibition	%	-2.32
	8162556	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	5.29	CHEMBL301	Homo sapiens	Inhibition	%	5.29
	8162557	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-2.03	CHEMBL301	Homo sapiens	Inhibition	%	-2.03
	8162809	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	-1.11	CHEMBL301	Homo sapiens	Inhibition	%	-1.11
	8162810	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	5.5	CHEMBL301	Homo sapiens	Inhibition	%	5.5
	8162957	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	89.09	CHEMBL301	Homo sapiens	Inhibition	%	89.09
	8162958	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	74.27	CHEMBL301	Homo sapiens	Inhibition	%	74.27
	8163350	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	4.98	CHEMBL301	Homo sapiens	Inhibition	%	4.98
	8163351	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	5.24	CHEMBL301	Homo sapiens	Inhibition	%	5.24
	8163484	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	-1.38	CHEMBL301	Homo sapiens	Inhibition	%	-1.38
	8163485	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	2.99	CHEMBL301	Homo sapiens	Inhibition	%	2.99
	8163831	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-3.21	CHEMBL301	Homo sapiens	Inhibition	%	-3.21
	8163832	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	0.06	CHEMBL301	Homo sapiens	Inhibition	%	0.06
	8164189	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	10.79	CHEMBL301	Homo sapiens	Inhibition	%	10.79
	8164190	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	8.67	CHEMBL301	Homo sapiens	Inhibition	%	8.67
	8164329	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.22	CHEMBL301	Homo sapiens	Inhibition	%	1.22
	8164330	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.34	CHEMBL301	Homo sapiens	Inhibition	%	1.34
	8164708	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	89.85	CHEMBL301	Homo sapiens	Inhibition	%	89.85
	8164709	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	82.31	CHEMBL301	Homo sapiens	Inhibition	%	82.31
	8164852	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-4.73	CHEMBL301	Homo sapiens	Inhibition	%	-4.73
	8164853	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	1.24	CHEMBL301	Homo sapiens	Inhibition	%	1.24
	8165146	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	2.38	CHEMBL301	Homo sapiens	Inhibition	%	2.38
	8165147	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	7.73	CHEMBL301	Homo sapiens	Inhibition	%	7.73
	8165511	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	1.75	CHEMBL301	Homo sapiens	Inhibition	%	1.75
	8165512	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	3.39	CHEMBL301	Homo sapiens	Inhibition	%	3.39
	8165654	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	86.14	CHEMBL301	Homo sapiens	Inhibition	%	86.14
	8165655	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	93.99	CHEMBL301	Homo sapiens	Inhibition	%	93.99
	8166004	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	20.61	CHEMBL301	Homo sapiens	Inhibition	%	20.61
	8166005	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	18.67	CHEMBL301	Homo sapiens	Inhibition	%	18.67
	8166366	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	11.13	CHEMBL301	Homo sapiens	Inhibition	%	11.13
	8166367	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	28.39	CHEMBL301	Homo sapiens	Inhibition	%	28.39
	8166496	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	1.15	CHEMBL301	Homo sapiens	Inhibition	%	1.15
	8166497	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	5.08	CHEMBL301	Homo sapiens	Inhibition	%	5.08
	8166821	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	3.22	CHEMBL301	Homo sapiens	Inhibition	%	3.22
	8166822	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	6.07	CHEMBL301	Homo sapiens	Inhibition	%	6.07
	8167133	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	2.58	CHEMBL301	Homo sapiens	Inhibition	%	2.58
	8167134	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	2.65	CHEMBL301	Homo sapiens	Inhibition	%	2.65
	8167274	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	108.79	CHEMBL301	Homo sapiens	Inhibition	%	108.79
	8167275	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	76.72	CHEMBL301	Homo sapiens	Inhibition	%	76.72
	8167498	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	3.04	CHEMBL301	Homo sapiens	Inhibition	%	3.04
	8167499	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	8.82	CHEMBL301	Homo sapiens	Inhibition	%	8.82
	8167662	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	0.97	CHEMBL301	Homo sapiens	Inhibition	%	0.97
	8167663	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	6.76	CHEMBL301	Homo sapiens	Inhibition	%	6.76
	8167795	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	1.3	CHEMBL301	Homo sapiens	Inhibition	%	1.3
	8167796	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	3.91	CHEMBL301	Homo sapiens	Inhibition	%	3.91
	8168019	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	7.59	CHEMBL301	Homo sapiens	Inhibition	%	7.59
	8168020	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	5.8	CHEMBL301	Homo sapiens	Inhibition	%	5.8
	8168143	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	3.84	CHEMBL301	Homo sapiens	Inhibition	%	3.84
	8168144	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	2.47	CHEMBL301	Homo sapiens	Inhibition	%	2.47
	8168508	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	-0.03	CHEMBL301	Homo sapiens	Inhibition	%	-0.03
	8168509	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	3.22	CHEMBL301	Homo sapiens	Inhibition	%	3.22
	8168644	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.26	CHEMBL301	Homo sapiens	Inhibition	%	0.26
	8168645	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.26	CHEMBL301	Homo sapiens	Inhibition	%	0.26
	8168868	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	0.27	CHEMBL301	Homo sapiens	Inhibition	%	0.27
	8168869	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	0.15	CHEMBL301	Homo sapiens	Inhibition	%	0.15
	8169032	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	121.14	CHEMBL301	Homo sapiens	Inhibition	%	121.14
	8169033	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	87.24	CHEMBL301	Homo sapiens	Inhibition	%	87.24
	8169174	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	2.2	CHEMBL301	Homo sapiens	Inhibition	%	2.2
	8169175	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	2.71	CHEMBL301	Homo sapiens	Inhibition	%	2.71
	8169398	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	6.28	CHEMBL301	Homo sapiens	Inhibition	%	6.28
	8169399	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	5.01	CHEMBL301	Homo sapiens	Inhibition	%	5.01
	8169478	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	9.91	CHEMBL301	Homo sapiens	Inhibition	%	9.91
	8169479	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	9.82	CHEMBL301	Homo sapiens	Inhibition	%	9.82
	8169836	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	4.91	CHEMBL301	Homo sapiens	Inhibition	%	4.91
	8169837	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	6.65	CHEMBL301	Homo sapiens	Inhibition	%	6.65
	8169981	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	0.86	CHEMBL301	Homo sapiens	Inhibition	%	0.86
	8169982	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	1.68	CHEMBL301	Homo sapiens	Inhibition	%	1.68
	8170205	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	2.88	CHEMBL301	Homo sapiens	Inhibition	%	2.88
	8170206	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	3.96	CHEMBL301	Homo sapiens	Inhibition	%	3.96
	8170330	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.45	CHEMBL301	Homo sapiens	Inhibition	%	1.45
	8170331	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.45	CHEMBL301	Homo sapiens	Inhibition	%	2.45
	8170694	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-0.3	CHEMBL301	Homo sapiens	Inhibition	%	-0.3
	8170695	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	6.49	CHEMBL301	Homo sapiens	Inhibition	%	6.49
	8170829	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	-1.31	CHEMBL301	Homo sapiens	Inhibition	%	-1.31
	8170830	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	6.33	CHEMBL301	Homo sapiens	Inhibition	%	6.33
	8171053	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	19.78	CHEMBL301	Homo sapiens	Inhibition	%	19.78
	8171054	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	22.78	CHEMBL301	Homo sapiens	Inhibition	%	22.78
	8171250	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	0.73	CHEMBL301	Homo sapiens	Inhibition	%	0.73
	8171251	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	2.32	CHEMBL301	Homo sapiens	Inhibition	%	2.32
	8171467	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	7.1	CHEMBL301	Homo sapiens	Inhibition	%	7.1
	8171468	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	5.1	CHEMBL301	Homo sapiens	Inhibition	%	5.1
	8171832	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	-0.79	CHEMBL301	Homo sapiens	Inhibition	%	-0.79
	8171833	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	10.19	CHEMBL301	Homo sapiens	Inhibition	%	10.19
	8171985	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	3.77	CHEMBL301	Homo sapiens	Inhibition	%	3.77
	8171986	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	0.9	CHEMBL301	Homo sapiens	Inhibition	%	0.9
	8172341	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	2.91	CHEMBL301	Homo sapiens	Inhibition	%	2.91
	8172342	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	3.74	CHEMBL301	Homo sapiens	Inhibition	%	3.74
	8172469	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	7.76	CHEMBL301	Homo sapiens	Inhibition	%	7.76
	8172470	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	9.24	CHEMBL301	Homo sapiens	Inhibition	%	9.24
	8172693	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	1.03	CHEMBL301	Homo sapiens	Inhibition	%	1.03
	8172694	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	2.23	CHEMBL301	Homo sapiens	Inhibition	%	2.23
	8172835	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	1.7	CHEMBL301	Homo sapiens	Inhibition	%	1.7
	8172836	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	4.45	CHEMBL301	Homo sapiens	Inhibition	%	4.45
	8173195	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-6.96	CHEMBL301	Homo sapiens	Inhibition	%	-6.96
	8173196	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	3.36	CHEMBL301	Homo sapiens	Inhibition	%	3.36
	8173360	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	47.04	CHEMBL301	Homo sapiens	Inhibition	%	47.04
	8173361	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	24.65	CHEMBL301	Homo sapiens	Inhibition	%	24.65
	8173725	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	2.18	CHEMBL301	Homo sapiens	Inhibition	%	2.18
	8173726	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	3.46	CHEMBL301	Homo sapiens	Inhibition	%	3.46
	8173812	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	79.07	CHEMBL301	Homo sapiens	Inhibition	%	79.07
	8173813	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	76.7	CHEMBL301	Homo sapiens	Inhibition	%	76.7
	8174036	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	88.77	CHEMBL301	Homo sapiens	Inhibition	%	88.77
	8174037	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	90.38	CHEMBL301	Homo sapiens	Inhibition	%	90.38
	8174168	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.61	CHEMBL301	Homo sapiens	Inhibition	%	2.61
	8174169	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	3.33	CHEMBL301	Homo sapiens	Inhibition	%	3.33
	8174540	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.17	CHEMBL301	Homo sapiens	Inhibition	%	1.17
	8174541	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.3	CHEMBL301	Homo sapiens	Inhibition	%	2.3
	8174662	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.8	CHEMBL301	Homo sapiens	Inhibition	%	3.8
	8174663	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.99	CHEMBL301	Homo sapiens	Inhibition	%	3.99
	8174886	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.63	CHEMBL301	Homo sapiens	Inhibition	%	2.63
	8174887	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.61	CHEMBL301	Homo sapiens	Inhibition	%	2.61
	8175029	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	4.17	CHEMBL301	Homo sapiens	Inhibition	%	4.17
	8175030	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	9.55	CHEMBL301	Homo sapiens	Inhibition	%	9.55
	8175389	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	78.68	CHEMBL301	Homo sapiens	Inhibition	%	78.68
	8175390	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	64.55	CHEMBL301	Homo sapiens	Inhibition	%	64.55
	8175645	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	13.35	CHEMBL301	Homo sapiens	Inhibition	%	13.35
	8175646	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	22.17	CHEMBL301	Homo sapiens	Inhibition	%	22.17
	8175808	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	-0.61	CHEMBL301	Homo sapiens	Inhibition	%	-0.61
	8175809	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	2.2	CHEMBL301	Homo sapiens	Inhibition	%	2.2
	8176185	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	5.13	CHEMBL301	Homo sapiens	Inhibition	%	5.13
	8176186	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	10.11	CHEMBL301	Homo sapiens	Inhibition	%	10.11
	8176334	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	39.15	CHEMBL301	Homo sapiens	Inhibition	%	39.15
	8176335	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	13.03	CHEMBL301	Homo sapiens	Inhibition	%	13.03
	8176558	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	21.75	CHEMBL301	Homo sapiens	Inhibition	%	21.75
	8176559	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	16.26	CHEMBL301	Homo sapiens	Inhibition	%	16.26
	8176690	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	7.88	CHEMBL301	Homo sapiens	Inhibition	%	7.88
	8176691	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	12.81	CHEMBL301	Homo sapiens	Inhibition	%	12.81
	8177044	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-8.72	CHEMBL301	Homo sapiens	Inhibition	%	-8.72
	8177045	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	5.64	CHEMBL301	Homo sapiens	Inhibition	%	5.64
	8177186	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	-1.42	CHEMBL301	Homo sapiens	Inhibition	%	-1.42
	8177187	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	0.42	CHEMBL301	Homo sapiens	Inhibition	%	0.42
	8177548	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	1.85	CHEMBL301	Homo sapiens	Inhibition	%	1.85
	8177549	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	3.64	CHEMBL301	Homo sapiens	Inhibition	%	3.64
	8177712	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	76.82	CHEMBL301	Homo sapiens	Inhibition	%	76.82
	8177713	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	65.23	CHEMBL301	Homo sapiens	Inhibition	%	65.23
	8177936	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	3.61	CHEMBL301	Homo sapiens	Inhibition	%	3.61
	8177937	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	6.09	CHEMBL301	Homo sapiens	Inhibition	%	6.09
	8178076	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	1.15	CHEMBL301	Homo sapiens	Inhibition	%	1.15
	8178077	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	5.04	CHEMBL301	Homo sapiens	Inhibition	%	5.04
	8178388	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.13	CHEMBL301	Homo sapiens	Inhibition	%	1.13
	8178389	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	3.08	CHEMBL301	Homo sapiens	Inhibition	%	3.08
	8178515	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	4.42	CHEMBL301	Homo sapiens	Inhibition	%	4.42
	8178516	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	5.75	CHEMBL301	Homo sapiens	Inhibition	%	5.75
	8178739	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	10.11	CHEMBL301	Homo sapiens	Inhibition	%	10.11
	8178740	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	5.86	CHEMBL301	Homo sapiens	Inhibition	%	5.86
	8178888	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	9.03	CHEMBL301	Homo sapiens	Inhibition	%	9.03
	8178889	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.72	CHEMBL301	Homo sapiens	Inhibition	%	2.72
	8179235	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	-0.72	CHEMBL301	Homo sapiens	Inhibition	%	-0.72
	8179236	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	3.62	CHEMBL301	Homo sapiens	Inhibition	%	3.62
	8179379	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	84.9	CHEMBL301	Homo sapiens	Inhibition	%	84.9
	8179380	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	77.98	CHEMBL301	Homo sapiens	Inhibition	%	77.98
	8179740	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	0.78	CHEMBL301	Homo sapiens	Inhibition	%	0.78
	8179741	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.97	CHEMBL301	Homo sapiens	Inhibition	%	1.97
	8179997	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	1.83	CHEMBL301	Homo sapiens	Inhibition	%	1.83
	8179998	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	5.55	CHEMBL301	Homo sapiens	Inhibition	%	5.55
	8180151	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	2.33	CHEMBL301	Homo sapiens	Inhibition	%	2.33
	8180152	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	8.5	CHEMBL301	Homo sapiens	Inhibition	%	8.5
	8180375	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-1.97	CHEMBL301	Homo sapiens	Inhibition	%	-1.97
	8180376	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-0.46	CHEMBL301	Homo sapiens	Inhibition	%	-0.46
	8180531	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	30.37	CHEMBL301	Homo sapiens	Inhibition	%	30.37
	8180532	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	31.43	CHEMBL301	Homo sapiens	Inhibition	%	31.43
	8180903	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	82.58	CHEMBL301	Homo sapiens	Inhibition	%	82.58
	8180904	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	53.97	CHEMBL301	Homo sapiens	Inhibition	%	53.97
	8181036	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	2.82	CHEMBL301	Homo sapiens	Inhibition	%	2.82
	8181037	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	4.22	CHEMBL301	Homo sapiens	Inhibition	%	4.22
	8181391	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	7.75	CHEMBL301	Homo sapiens	Inhibition	%	7.75
	8181392	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	8.8	CHEMBL301	Homo sapiens	Inhibition	%	8.8
	8181531	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	2.36	CHEMBL301	Homo sapiens	Inhibition	%	2.36
	8181532	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	0.7	CHEMBL301	Homo sapiens	Inhibition	%	0.7
	8181755	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	3.52	CHEMBL301	Homo sapiens	Inhibition	%	3.52
	8181756	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	4.57	CHEMBL301	Homo sapiens	Inhibition	%	4.57
	8181894	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	3.0	CHEMBL301	Homo sapiens	Inhibition	%	3.0
	8181895	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	4.91	CHEMBL301	Homo sapiens	Inhibition	%	4.91
	8182281	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	0.25	CHEMBL301	Homo sapiens	Inhibition	%	0.25
	8182282	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	10.65	CHEMBL301	Homo sapiens	Inhibition	%	10.65
	8182421	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.15	CHEMBL301	Homo sapiens	Inhibition	%	1.15
	8182422	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.94	CHEMBL301	Homo sapiens	Inhibition	%	3.94
	8182737	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.7	CHEMBL301	Homo sapiens	Inhibition	%	1.7
	8182738	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	3.18	CHEMBL301	Homo sapiens	Inhibition	%	3.18
	8183083	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	48.52	CHEMBL301	Homo sapiens	Inhibition	%	48.52
	8183084	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	15.47	CHEMBL301	Homo sapiens	Inhibition	%	15.47
	8183232	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	1.38	CHEMBL301	Homo sapiens	Inhibition	%	1.38
	8183233	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	2.62	CHEMBL301	Homo sapiens	Inhibition	%	2.62
	8183585	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	1.49	CHEMBL301	Homo sapiens	Inhibition	%	1.49
	8183586	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	5.4	CHEMBL301	Homo sapiens	Inhibition	%	5.4
	8183727	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	110.38	CHEMBL301	Homo sapiens	Inhibition	%	110.38
	8183728	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	86.16	CHEMBL301	Homo sapiens	Inhibition	%	86.16
	8183951	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	46.73	CHEMBL301	Homo sapiens	Inhibition	%	46.73
	8183952	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	58.46	CHEMBL301	Homo sapiens	Inhibition	%	58.46
	8184087	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	-1.6	CHEMBL301	Homo sapiens	Inhibition	%	-1.6
	8184088	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	7.0	CHEMBL301	Homo sapiens	Inhibition	%	7.0
	8184353	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	5.99	CHEMBL301	Homo sapiens	Inhibition	%	5.99
	8184354	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	7.79	CHEMBL301	Homo sapiens	Inhibition	%	7.79
	8184724	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-1.57	CHEMBL301	Homo sapiens	Inhibition	%	-1.57
	8184725	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	2.07	CHEMBL301	Homo sapiens	Inhibition	%	2.07
	8184881	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	1.25	CHEMBL301	Homo sapiens	Inhibition	%	1.25
	8184882	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	2.71	CHEMBL301	Homo sapiens	Inhibition	%	2.71
	8185254	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.01	CHEMBL301	Homo sapiens	Inhibition	%	1.01
	8185255	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.24	CHEMBL301	Homo sapiens	Inhibition	%	1.24
	8185385	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	4.49	CHEMBL301	Homo sapiens	Inhibition	%	4.49
	8185386	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	4.92	CHEMBL301	Homo sapiens	Inhibition	%	4.92
	8185609	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	-1.15	CHEMBL301	Homo sapiens	Inhibition	%	-1.15
	8185610	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	0.97	CHEMBL301	Homo sapiens	Inhibition	%	0.97
	8185740	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	56.02	CHEMBL301	Homo sapiens	Inhibition	%	56.02
	8185741	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	48.11	CHEMBL301	Homo sapiens	Inhibition	%	48.11
	8186103	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	11.2	CHEMBL301	Homo sapiens	Inhibition	%	11.2
	8186104	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	8.54	CHEMBL301	Homo sapiens	Inhibition	%	8.54
	8186244	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	0.74	CHEMBL301	Homo sapiens	Inhibition	%	0.74
	8186245	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	3.63	CHEMBL301	Homo sapiens	Inhibition	%	3.63
	8186632	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	3.48	CHEMBL301	Homo sapiens	Inhibition	%	3.48
	8186633	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	4.49	CHEMBL301	Homo sapiens	Inhibition	%	4.49
	8186771	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	-0.44	CHEMBL301	Homo sapiens	Inhibition	%	-0.44
	8186772	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.93	CHEMBL301	Homo sapiens	Inhibition	%	3.93
	8186995	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	1.03	CHEMBL301	Homo sapiens	Inhibition	%	1.03
	8186996	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	3.93	CHEMBL301	Homo sapiens	Inhibition	%	3.93
	8187093	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.56	CHEMBL301	Homo sapiens	Inhibition	%	1.56
	8187094	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	2.51	CHEMBL301	Homo sapiens	Inhibition	%	2.51
	8187441	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	11.09	CHEMBL301	Homo sapiens	Inhibition	%	11.09
	8187442	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	14.8	CHEMBL301	Homo sapiens	Inhibition	%	14.8
	8187589	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	5.48	CHEMBL301	Homo sapiens	Inhibition	%	5.48
	8187590	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	7.35	CHEMBL301	Homo sapiens	Inhibition	%	7.35
	8187813	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.26	CHEMBL301	Homo sapiens	Inhibition	%	1.26
	8187814	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.79	CHEMBL301	Homo sapiens	Inhibition	%	2.79
	8187942	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	-1.87	CHEMBL301	Homo sapiens	Inhibition	%	-1.87
	8187943	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	5.36	CHEMBL301	Homo sapiens	Inhibition	%	5.36
	8188309	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	102.5	CHEMBL301	Homo sapiens	Inhibition	%	102.5
	8188310	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	80.49	CHEMBL301	Homo sapiens	Inhibition	%	80.49
	8188444	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	32.1	CHEMBL301	Homo sapiens	Inhibition	%	32.1
	8188445	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	7.18	CHEMBL301	Homo sapiens	Inhibition	%	7.18
	8188668	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	68.0	CHEMBL301	Homo sapiens	Inhibition	%	68.0
	8188669	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	41.56	CHEMBL301	Homo sapiens	Inhibition	%	41.56
	8188718	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	0.8	CHEMBL301	Homo sapiens	Inhibition	%	0.8
	8188719	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.54	CHEMBL301	Homo sapiens	Inhibition	%	3.54
	8188942	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	5.34	CHEMBL301	Homo sapiens	Inhibition	%	5.34
	8188943	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	6.73	CHEMBL301	Homo sapiens	Inhibition	%	6.73
	8189090	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	7.48	CHEMBL301	Homo sapiens	Inhibition	%	7.48
	8189091	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	6.02	CHEMBL301	Homo sapiens	Inhibition	%	6.02
	8189246	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	3.7	CHEMBL301	Homo sapiens	Inhibition	%	3.7
	8189247	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	2.76	CHEMBL301	Homo sapiens	Inhibition	%	2.76
	8189470	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	4.87	CHEMBL301	Homo sapiens	Inhibition	%	4.87
	8189471	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	5.07	CHEMBL301	Homo sapiens	Inhibition	%	5.07
	8189619	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-3.16	CHEMBL301	Homo sapiens	Inhibition	%	-3.16
	8189620	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	3.29	CHEMBL301	Homo sapiens	Inhibition	%	3.29
	8189975	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	-0.68	CHEMBL301	Homo sapiens	Inhibition	%	-0.68
	8189976	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	1.11	CHEMBL301	Homo sapiens	Inhibition	%	1.11
	8190107	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	2.84	CHEMBL301	Homo sapiens	Inhibition	%	2.84
	8190108	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	7.89	CHEMBL301	Homo sapiens	Inhibition	%	7.89
	8190471	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	2.79	CHEMBL301	Homo sapiens	Inhibition	%	2.79
	8190472	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	4.07	CHEMBL301	Homo sapiens	Inhibition	%	4.07
	8190608	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	3.93	CHEMBL301	Homo sapiens	Inhibition	%	3.93
	8190609	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	3.97	CHEMBL301	Homo sapiens	Inhibition	%	3.97
	8190832	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	1.69	CHEMBL301	Homo sapiens	Inhibition	%	1.69
	8190833	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	4.05	CHEMBL301	Homo sapiens	Inhibition	%	4.05
	8190996	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	3.47	CHEMBL301	Homo sapiens	Inhibition	%	3.47
	8190997	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	6.31	CHEMBL301	Homo sapiens	Inhibition	%	6.31
	8191358	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	0.46	CHEMBL301	Homo sapiens	Inhibition	%	0.46
	8191359	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	5.24	CHEMBL301	Homo sapiens	Inhibition	%	5.24
	8191454	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.98	CHEMBL301	Homo sapiens	Inhibition	%	1.98
	8191455	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	3.29	CHEMBL301	Homo sapiens	Inhibition	%	3.29
	8191678	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.22	CHEMBL301	Homo sapiens	Inhibition	%	2.22
	8191679	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.03	CHEMBL301	Homo sapiens	Inhibition	%	2.03
	8191800	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	60.09	CHEMBL301	Homo sapiens	Inhibition	%	60.09
	8191801	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	57.01	CHEMBL301	Homo sapiens	Inhibition	%	57.01
	8192173	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	3.61	CHEMBL301	Homo sapiens	Inhibition	%	3.61
	8192174	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	4.02	CHEMBL301	Homo sapiens	Inhibition	%	4.02
	8192302	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	-2.09	CHEMBL301	Homo sapiens	Inhibition	%	-2.09
	8192303	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	1.68	CHEMBL301	Homo sapiens	Inhibition	%	1.68
	8192526	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	-1.7	CHEMBL301	Homo sapiens	Inhibition	%	-1.7
	8192527	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	3.08	CHEMBL301	Homo sapiens	Inhibition	%	3.08
	8192670	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	1.87	CHEMBL301	Homo sapiens	Inhibition	%	1.87
	8192671	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	11.96	CHEMBL301	Homo sapiens	Inhibition	%	11.96
	8193030	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	2.24	CHEMBL301	Homo sapiens	Inhibition	%	2.24
	8193031	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	1.37	CHEMBL301	Homo sapiens	Inhibition	%	1.37
	8193302	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	2.41	CHEMBL301	Homo sapiens	Inhibition	%	2.41
	8193303	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	2.49	CHEMBL301	Homo sapiens	Inhibition	%	2.49
	8193447	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	46.53	CHEMBL301	Homo sapiens	Inhibition	%	46.53
	8193448	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	32.42	CHEMBL301	Homo sapiens	Inhibition	%	32.42
	8193828	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	8.39	CHEMBL301	Homo sapiens	Inhibition	%	8.39
	8193829	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	16.02	CHEMBL301	Homo sapiens	Inhibition	%	16.02
	8193977	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	1.0	CHEMBL301	Homo sapiens	Inhibition	%	1.0
	8193978	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	0.81	CHEMBL301	Homo sapiens	Inhibition	%	0.81
	8194332	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	1.34	CHEMBL301	Homo sapiens	Inhibition	%	1.34
	8194333	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	4.69	CHEMBL301	Homo sapiens	Inhibition	%	4.69
	8194463	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	-1.47	CHEMBL301	Homo sapiens	Inhibition	%	-1.47
	8194464	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	9.34	CHEMBL301	Homo sapiens	Inhibition	%	9.34
	8194687	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	-1.05	CHEMBL301	Homo sapiens	Inhibition	%	-1.05
	8194688	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	5.31	CHEMBL301	Homo sapiens	Inhibition	%	5.31
	8194830	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	5.38	CHEMBL301	Homo sapiens	Inhibition	%	5.38
	8194831	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	3.97	CHEMBL301	Homo sapiens	Inhibition	%	3.97
	8195187	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	-0.92	CHEMBL301	Homo sapiens	Inhibition	%	-0.92
	8195188	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	4.55	CHEMBL301	Homo sapiens	Inhibition	%	4.55
	8195351	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	2.59	CHEMBL301	Homo sapiens	Inhibition	%	2.59
	8195352	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	4.71	CHEMBL301	Homo sapiens	Inhibition	%	4.71
	8195714	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	1.49	CHEMBL301	Homo sapiens	Inhibition	%	1.49
	8195715	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	3.56	CHEMBL301	Homo sapiens	Inhibition	%	3.56
	8196036	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	3.53	CHEMBL301	Homo sapiens	Inhibition	%	3.53
	8196037	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	3.67	CHEMBL301	Homo sapiens	Inhibition	%	3.67
	8196153	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.89	CHEMBL301	Homo sapiens	Inhibition	%	2.89
	8196154	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	6.18	CHEMBL301	Homo sapiens	Inhibition	%	6.18
	8196377	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	7.78	CHEMBL301	Homo sapiens	Inhibition	%	7.78
	8196378	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	8.1	CHEMBL301	Homo sapiens	Inhibition	%	8.1
	8196527	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	2.27	CHEMBL301	Homo sapiens	Inhibition	%	2.27
	8196528	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	2.35	CHEMBL301	Homo sapiens	Inhibition	%	2.35
	8196879	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-2.8	CHEMBL301	Homo sapiens	Inhibition	%	-2.8
	8196880	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-0.55	CHEMBL301	Homo sapiens	Inhibition	%	-0.55
	8197020	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	10.98	CHEMBL301	Homo sapiens	Inhibition	%	10.98
	8197021	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	16.42	CHEMBL301	Homo sapiens	Inhibition	%	16.42
	8197381	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	12.49	CHEMBL301	Homo sapiens	Inhibition	%	12.49
	8197382	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	11.94	CHEMBL301	Homo sapiens	Inhibition	%	11.94
	8197656	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	-6.47	CHEMBL301	Homo sapiens	Inhibition	%	-6.47
	8197657	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	2.14	CHEMBL301	Homo sapiens	Inhibition	%	2.14
	8197796	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	1.7	CHEMBL301	Homo sapiens	Inhibition	%	1.7
	8197797	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	2.24	CHEMBL301	Homo sapiens	Inhibition	%	2.24
	8198020	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	6.39	CHEMBL301	Homo sapiens	Inhibition	%	6.39
	8198021	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	5.06	CHEMBL301	Homo sapiens	Inhibition	%	5.06
	8198177	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-1.04	CHEMBL301	Homo sapiens	Inhibition	%	-1.04
	8198178	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	0.41	CHEMBL301	Homo sapiens	Inhibition	%	0.41
	8198315	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21	Outside typical range	CHEMBL187985	=	Inhibition	%	-11.03	CHEMBL301	Homo sapiens	Inhibition	%	-11.03
	8198316	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	5.24	CHEMBL301	Homo sapiens	Inhibition	%	5.24
	8198539	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	2.51	CHEMBL301	Homo sapiens	Inhibition	%	2.51
	8198540	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	2.72	CHEMBL301	Homo sapiens	Inhibition	%	2.72
	8198669	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	1.09	CHEMBL301	Homo sapiens	Inhibition	%	1.09
	8198670	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	6.24	CHEMBL301	Homo sapiens	Inhibition	%	6.24
	8199024	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	0.31	CHEMBL301	Homo sapiens	Inhibition	%	0.31
	8199025	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	6.11	CHEMBL301	Homo sapiens	Inhibition	%	6.11
	8199172	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	2.83	CHEMBL301	Homo sapiens	Inhibition	%	2.83
	8199173	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	4.49	CHEMBL301	Homo sapiens	Inhibition	%	4.49
	8199396	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	6.58	CHEMBL301	Homo sapiens	Inhibition	%	6.58
	8199397	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	5.71	CHEMBL301	Homo sapiens	Inhibition	%	5.71
	8199530	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	1.7	CHEMBL301	Homo sapiens	Inhibition	%	1.7
	8199531	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.38	CHEMBL301	Homo sapiens	Inhibition	%	4.38
	8199693	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	19.34	CHEMBL301	Homo sapiens	Inhibition	%	19.34
	8199694	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	15.7	CHEMBL301	Homo sapiens	Inhibition	%	15.7
	8199917	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.03	CHEMBL301	Homo sapiens	Inhibition	%	1.03
	8199918	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	2.66	CHEMBL301	Homo sapiens	Inhibition	%	2.66
	8200055	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	-2.92	CHEMBL301	Homo sapiens	Inhibition	%	-2.92
	8200056	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.52	CHEMBL301	Homo sapiens	Inhibition	%	4.52
	8200383	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	1.43	CHEMBL301	Homo sapiens	Inhibition	%	1.43
	8200384	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	1.3	CHEMBL301	Homo sapiens	Inhibition	%	1.3
	8200722	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	3.26	CHEMBL301	Homo sapiens	Inhibition	%	3.26
	8200723	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	4.7	CHEMBL301	Homo sapiens	Inhibition	%	4.7
	8200872	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	0.79	CHEMBL301	Homo sapiens	Inhibition	%	0.79
	8200873	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	5.57	CHEMBL301	Homo sapiens	Inhibition	%	5.57
	8201226	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	6.63	CHEMBL301	Homo sapiens	Inhibition	%	6.63
	8201227	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	4.77	CHEMBL301	Homo sapiens	Inhibition	%	4.77
	8201361	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	1.51	CHEMBL301	Homo sapiens	Inhibition	%	1.51
	8201362	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	1.41	CHEMBL301	Homo sapiens	Inhibition	%	1.41
	8201585	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.11	CHEMBL301	Homo sapiens	Inhibition	%	2.11
	8201586	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	1.57	CHEMBL301	Homo sapiens	Inhibition	%	1.57
	8201718	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	0.63	CHEMBL301	Homo sapiens	Inhibition	%	0.63
	8201719	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	1.09	CHEMBL301	Homo sapiens	Inhibition	%	1.09
	8201997	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	5.89	CHEMBL301	Homo sapiens	Inhibition	%	5.89
	8201998	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	1.93	CHEMBL301	Homo sapiens	Inhibition	%	1.93
	8202361	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	1.38	CHEMBL301	Homo sapiens	Inhibition	%	1.38
	8202362	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-0.42	CHEMBL301	Homo sapiens	Inhibition	%	-0.42
	8202528	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	1.08	CHEMBL301	Homo sapiens	Inhibition	%	1.08
	8202529	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	0.29	CHEMBL301	Homo sapiens	Inhibition	%	0.29
	8202877	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	5.92	CHEMBL301	Homo sapiens	Inhibition	%	5.92
	8202878	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	3.29	CHEMBL301	Homo sapiens	Inhibition	%	3.29
	8203007	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	3.16	CHEMBL301	Homo sapiens	Inhibition	%	3.16
	8203008	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	7.06	CHEMBL301	Homo sapiens	Inhibition	%	7.06
	8203231	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	13.18	CHEMBL301	Homo sapiens	Inhibition	%	13.18
	8203232	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	11.84	CHEMBL301	Homo sapiens	Inhibition	%	11.84
	8203362	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	-1.06	CHEMBL301	Homo sapiens	Inhibition	%	-1.06
	8203363	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	2.08	CHEMBL301	Homo sapiens	Inhibition	%	2.08
	8203732	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	1.1	CHEMBL301	Homo sapiens	Inhibition	%	1.1
	8203733	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	5.32	CHEMBL301	Homo sapiens	Inhibition	%	5.32
	8203866	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	5.5	CHEMBL301	Homo sapiens	Inhibition	%	5.5
	8203867	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.99	CHEMBL301	Homo sapiens	Inhibition	%	4.99
	8204256	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	0.25	CHEMBL301	Homo sapiens	Inhibition	%	0.25
	8204257	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	6.74	CHEMBL301	Homo sapiens	Inhibition	%	6.74
	8204393	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	0.84	CHEMBL301	Homo sapiens	Inhibition	%	0.84
	8204394	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	3.98	CHEMBL301	Homo sapiens	Inhibition	%	3.98
	8204617	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	6.62	CHEMBL301	Homo sapiens	Inhibition	%	6.62
	8204618	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	4.84	CHEMBL301	Homo sapiens	Inhibition	%	4.84
	8204722	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	3.91	CHEMBL301	Homo sapiens	Inhibition	%	3.91
	8204723	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	2.48	CHEMBL301	Homo sapiens	Inhibition	%	2.48
	8205061	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	28.28	CHEMBL301	Homo sapiens	Inhibition	%	28.28
	8205062	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	13.87	CHEMBL301	Homo sapiens	Inhibition	%	13.87
	8205210	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	6.45	CHEMBL301	Homo sapiens	Inhibition	%	6.45
	8205211	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	9.31	CHEMBL301	Homo sapiens	Inhibition	%	9.31
	8205434	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	50.67	CHEMBL301	Homo sapiens	Inhibition	%	50.67
	8205435	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	43.16	CHEMBL301	Homo sapiens	Inhibition	%	43.16
	8205570	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	0.81	CHEMBL301	Homo sapiens	Inhibition	%	0.81
	8205571	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	2.66	CHEMBL301	Homo sapiens	Inhibition	%	2.66
	8205933	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	-1.15	CHEMBL301	Homo sapiens	Inhibition	%	-1.15
	8205934	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	1.18	CHEMBL301	Homo sapiens	Inhibition	%	1.18
	8206065	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-1.45	CHEMBL301	Homo sapiens	Inhibition	%	-1.45
	8206066	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	1.29	CHEMBL301	Homo sapiens	Inhibition	%	1.29
	8206341	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	-0.79	CHEMBL301	Homo sapiens	Inhibition	%	-0.79
	8206342	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	3.21	CHEMBL301	Homo sapiens	Inhibition	%	3.21
	8206708	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-0.83	CHEMBL301	Homo sapiens	Inhibition	%	-0.83
	8206709	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	2.91	CHEMBL301	Homo sapiens	Inhibition	%	2.91
	8206888	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.53	CHEMBL301	Homo sapiens	Inhibition	%	2.53
	8206889	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	4.53	CHEMBL301	Homo sapiens	Inhibition	%	4.53
	8207238	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	1.23	CHEMBL301	Homo sapiens	Inhibition	%	1.23
	8207239	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	3.69	CHEMBL301	Homo sapiens	Inhibition	%	3.69
	8207592	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	63.12	CHEMBL301	Homo sapiens	Inhibition	%	63.12
	8207593	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	36.52	CHEMBL301	Homo sapiens	Inhibition	%	36.52
	8207724	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	4.54	CHEMBL301	Homo sapiens	Inhibition	%	4.54
	8207725	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	4.14	CHEMBL301	Homo sapiens	Inhibition	%	4.14
	8208093	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	5.75	CHEMBL301	Homo sapiens	Inhibition	%	5.75
	8208094	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	5.99	CHEMBL301	Homo sapiens	Inhibition	%	5.99
	8208225	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	1.84	CHEMBL301	Homo sapiens	Inhibition	%	1.84
	8208226	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	4.73	CHEMBL301	Homo sapiens	Inhibition	%	4.73
	8208449	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	7.74	CHEMBL301	Homo sapiens	Inhibition	%	7.74
	8208450	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	5.82	CHEMBL301	Homo sapiens	Inhibition	%	5.82
	8208615	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	2.98	CHEMBL301	Homo sapiens	Inhibition	%	2.98
	8208616	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	3.36	CHEMBL301	Homo sapiens	Inhibition	%	3.36
	8208972	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	5.0	CHEMBL301	Homo sapiens	Inhibition	%	5.0
	8208973	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	5.56	CHEMBL301	Homo sapiens	Inhibition	%	5.56
	8209077	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	1.76	CHEMBL301	Homo sapiens	Inhibition	%	1.76
	8209078	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	0.27	CHEMBL301	Homo sapiens	Inhibition	%	0.27
	8209301	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	7.78	CHEMBL301	Homo sapiens	Inhibition	%	7.78
	8209302	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	3.78	CHEMBL301	Homo sapiens	Inhibition	%	3.78
	8209417	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	1.62	CHEMBL301	Homo sapiens	Inhibition	%	1.62
	8209418	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	4.08	CHEMBL301	Homo sapiens	Inhibition	%	4.08
	8209791	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	2.91	CHEMBL301	Homo sapiens	Inhibition	%	2.91
	8209792	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	2.18	CHEMBL301	Homo sapiens	Inhibition	%	2.18
	8209927	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	2.63	CHEMBL301	Homo sapiens	Inhibition	%	2.63
	8209928	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	5.12	CHEMBL301	Homo sapiens	Inhibition	%	5.12
	8210292	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	-1.13	CHEMBL301	Homo sapiens	Inhibition	%	-1.13
	8210293	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.92	CHEMBL301	Homo sapiens	Inhibition	%	2.92
	8210428	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	0.61	CHEMBL301	Homo sapiens	Inhibition	%	0.61
	8210429	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-0.6	CHEMBL301	Homo sapiens	Inhibition	%	-0.6
	8210652	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	6.41	CHEMBL301	Homo sapiens	Inhibition	%	6.41
	8210653	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	5.24	CHEMBL301	Homo sapiens	Inhibition	%	5.24
	8210687	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-1.4	CHEMBL301	Homo sapiens	Inhibition	%	-1.4
	8210688	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	0.91	CHEMBL301	Homo sapiens	Inhibition	%	0.91
	8210911	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-2.99	CHEMBL301	Homo sapiens	Inhibition	%	-2.99
	8210912	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	0.03	CHEMBL301	Homo sapiens	Inhibition	%	0.03
	8211055	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	1.51	CHEMBL301	Homo sapiens	Inhibition	%	1.51
	8211056	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	4.73	CHEMBL301	Homo sapiens	Inhibition	%	4.73
	8211225	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	-3.59	CHEMBL301	Homo sapiens	Inhibition	%	-3.59
	8211226	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	6.13	CHEMBL301	Homo sapiens	Inhibition	%	6.13
	8211449	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	1.56	CHEMBL301	Homo sapiens	Inhibition	%	1.56
	8211450	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	3.67	CHEMBL301	Homo sapiens	Inhibition	%	3.67
	8211572	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	0.95	CHEMBL301	Homo sapiens	Inhibition	%	0.95
	8211573	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	4.47	CHEMBL301	Homo sapiens	Inhibition	%	4.47
	8211925	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	107.8	CHEMBL301	Homo sapiens	Inhibition	%	107.8
	8211926	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	72.95	CHEMBL301	Homo sapiens	Inhibition	%	72.95
	8212057	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	1.1	CHEMBL301	Homo sapiens	Inhibition	%	1.1
	8212058	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	5.88	CHEMBL301	Homo sapiens	Inhibition	%	5.88
	8212281	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	3.16	CHEMBL301	Homo sapiens	Inhibition	%	3.16
	8212282	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	6.78	CHEMBL301	Homo sapiens	Inhibition	%	6.78
	8212422	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	-0.94	CHEMBL301	Homo sapiens	Inhibition	%	-0.94
	8212423	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	2.56	CHEMBL301	Homo sapiens	Inhibition	%	2.56
	8212779	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	2.01	CHEMBL301	Homo sapiens	Inhibition	%	2.01
	8212780	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	4.78	CHEMBL301	Homo sapiens	Inhibition	%	4.78
	8212949	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	9.64	CHEMBL301	Homo sapiens	Inhibition	%	9.64
	8212950	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	14.24	CHEMBL301	Homo sapiens	Inhibition	%	14.24
	8213302	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	27.98	CHEMBL301	Homo sapiens	Inhibition	%	27.98
	8213303	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	23.67	CHEMBL301	Homo sapiens	Inhibition	%	23.67
	8213630	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.04	CHEMBL301	Homo sapiens	Inhibition	%	-1.04
	8213631	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.37	CHEMBL301	Homo sapiens	Inhibition	%	-0.37
	8213743	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	1.29	CHEMBL301	Homo sapiens	Inhibition	%	1.29
	8213744	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	5.96	CHEMBL301	Homo sapiens	Inhibition	%	5.96
	8214114	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	13.43	CHEMBL301	Homo sapiens	Inhibition	%	13.43
	8214115	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	5.85	CHEMBL301	Homo sapiens	Inhibition	%	5.85
	8214251	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	2.81	CHEMBL301	Homo sapiens	Inhibition	%	2.81
	8214252	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	4.41	CHEMBL301	Homo sapiens	Inhibition	%	4.41
	8214475	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	14.66	CHEMBL301	Homo sapiens	Inhibition	%	14.66
	8214476	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	14.32	CHEMBL301	Homo sapiens	Inhibition	%	14.32
	8214609	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	-0.93	CHEMBL301	Homo sapiens	Inhibition	%	-0.93
	8214610	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	-0.2	CHEMBL301	Homo sapiens	Inhibition	%	-0.2
	8214985	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	0.41	CHEMBL301	Homo sapiens	Inhibition	%	0.41
	8214986	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	4.78	CHEMBL301	Homo sapiens	Inhibition	%	4.78
	8215236	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	1.82	CHEMBL301	Homo sapiens	Inhibition	%	1.82
	8215237	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	2.73	CHEMBL301	Homo sapiens	Inhibition	%	2.73
	8215389	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	3.81	CHEMBL301	Homo sapiens	Inhibition	%	3.81
	8215390	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	8.33	CHEMBL301	Homo sapiens	Inhibition	%	8.33
	8215777	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	4.93	CHEMBL301	Homo sapiens	Inhibition	%	4.93
	8215778	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	2.07	CHEMBL301	Homo sapiens	Inhibition	%	2.07
	8215896	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	-1.75	CHEMBL301	Homo sapiens	Inhibition	%	-1.75
	8215897	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	0.16	CHEMBL301	Homo sapiens	Inhibition	%	0.16
	8216120	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	4.45	CHEMBL301	Homo sapiens	Inhibition	%	4.45
	8216121	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	0.53	CHEMBL301	Homo sapiens	Inhibition	%	0.53
	8216239	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	1.25	CHEMBL301	Homo sapiens	Inhibition	%	1.25
	8216240	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	1.94	CHEMBL301	Homo sapiens	Inhibition	%	1.94
	8216599	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	3.01	CHEMBL301	Homo sapiens	Inhibition	%	3.01
	8216600	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	5.72	CHEMBL301	Homo sapiens	Inhibition	%	5.72
	8216737	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	5.81	CHEMBL301	Homo sapiens	Inhibition	%	5.81
	8216738	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	6.81	CHEMBL301	Homo sapiens	Inhibition	%	6.81
	8217095	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	13.52	CHEMBL301	Homo sapiens	Inhibition	%	13.52
	8217096	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	4.88	CHEMBL301	Homo sapiens	Inhibition	%	4.88
	8217269	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.43	CHEMBL301	Homo sapiens	Inhibition	%	0.43
	8217270	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.94	CHEMBL301	Homo sapiens	Inhibition	%	0.94
	8217493	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.24	CHEMBL301	Homo sapiens	Inhibition	%	1.24
	8217494	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	3.16	CHEMBL301	Homo sapiens	Inhibition	%	3.16
	8217624	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	2.46	CHEMBL301	Homo sapiens	Inhibition	%	2.46
	8217625	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	4.39	CHEMBL301	Homo sapiens	Inhibition	%	4.39
	8217949	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-8.99	CHEMBL301	Homo sapiens	Inhibition	%	-8.99
	8217950	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	0.53	CHEMBL301	Homo sapiens	Inhibition	%	0.53
	8218064	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	1.86	CHEMBL301	Homo sapiens	Inhibition	%	1.86
	8218065	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	6.01	CHEMBL301	Homo sapiens	Inhibition	%	6.01
	8218288	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	11.12	CHEMBL301	Homo sapiens	Inhibition	%	11.12
	8218289	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	7.95	CHEMBL301	Homo sapiens	Inhibition	%	7.95
	8218415	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	36.14	CHEMBL301	Homo sapiens	Inhibition	%	36.14
	8218416	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	13.37	CHEMBL301	Homo sapiens	Inhibition	%	13.37
	8218782	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	1.73	CHEMBL301	Homo sapiens	Inhibition	%	1.73
	8218783	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	4.28	CHEMBL301	Homo sapiens	Inhibition	%	4.28
	8218913	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	16.11	CHEMBL301	Homo sapiens	Inhibition	%	16.11
	8218914	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	7.62	CHEMBL301	Homo sapiens	Inhibition	%	7.62
	8219297	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	0.03	CHEMBL301	Homo sapiens	Inhibition	%	0.03
	8219298	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	4.73	CHEMBL301	Homo sapiens	Inhibition	%	4.73
	8219547	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	-4.06	CHEMBL301	Homo sapiens	Inhibition	%	-4.06
	8219548	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	2.71	CHEMBL301	Homo sapiens	Inhibition	%	2.71
	8219708	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	2.89	CHEMBL301	Homo sapiens	Inhibition	%	2.89
	8219709	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	6.07	CHEMBL301	Homo sapiens	Inhibition	%	6.07
	8219932	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	0.12	CHEMBL301	Homo sapiens	Inhibition	%	0.12
	8219933	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	7.82	CHEMBL301	Homo sapiens	Inhibition	%	7.82
	8220101	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	2.69	CHEMBL301	Homo sapiens	Inhibition	%	2.69
	8220102	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	5.61	CHEMBL301	Homo sapiens	Inhibition	%	5.61
	8220454	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	2.27	CHEMBL301	Homo sapiens	Inhibition	%	2.27
	8220455	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	3.76	CHEMBL301	Homo sapiens	Inhibition	%	3.76
	8220568	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	1.52	CHEMBL301	Homo sapiens	Inhibition	%	1.52
	8220569	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	3.25	CHEMBL301	Homo sapiens	Inhibition	%	3.25
	8220930	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	5.49	CHEMBL301	Homo sapiens	Inhibition	%	5.49
	8220931	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	10.57	CHEMBL301	Homo sapiens	Inhibition	%	10.57
	8221066	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.12	CHEMBL301	Homo sapiens	Inhibition	%	1.12
	8221067	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.64	CHEMBL301	Homo sapiens	Inhibition	%	1.64
	8221290	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	29.54	CHEMBL301	Homo sapiens	Inhibition	%	29.54
	8221291	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	19.05	CHEMBL301	Homo sapiens	Inhibition	%	19.05
	8221423	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	1.99	CHEMBL301	Homo sapiens	Inhibition	%	1.99
	8221424	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	4.11	CHEMBL301	Homo sapiens	Inhibition	%	4.11
	8221812	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.21	CHEMBL301	Homo sapiens	Inhibition	%	1.21
	8221813	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.82	CHEMBL301	Homo sapiens	Inhibition	%	0.82
	8221943	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	5.28	CHEMBL301	Homo sapiens	Inhibition	%	5.28
	8221944	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	5.94	CHEMBL301	Homo sapiens	Inhibition	%	5.94
	8222265	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	1.87	CHEMBL301	Homo sapiens	Inhibition	%	1.87
	8222266	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	3.84	CHEMBL301	Homo sapiens	Inhibition	%	3.84
	8222623	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	48.19	CHEMBL301	Homo sapiens	Inhibition	%	48.19
	8222624	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	56.22	CHEMBL301	Homo sapiens	Inhibition	%	56.22
	8222741	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	89.92	CHEMBL301	Homo sapiens	Inhibition	%	89.92
	8222742	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	48.38	CHEMBL301	Homo sapiens	Inhibition	%	48.38
	8223109	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	28.08	CHEMBL301	Homo sapiens	Inhibition	%	28.08
	8223110	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	28.76	CHEMBL301	Homo sapiens	Inhibition	%	28.76
	8223238	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	0.68	CHEMBL301	Homo sapiens	Inhibition	%	0.68
	8223239	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	2.28	CHEMBL301	Homo sapiens	Inhibition	%	2.28
	8223462	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	4.24	CHEMBL301	Homo sapiens	Inhibition	%	4.24
	8223463	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	4.67	CHEMBL301	Homo sapiens	Inhibition	%	4.67
	8223623	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.44	CHEMBL301	Homo sapiens	Inhibition	%	0.44
	8223624	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	1.63	CHEMBL301	Homo sapiens	Inhibition	%	1.63
	8223873	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	2.79	CHEMBL301	Homo sapiens	Inhibition	%	2.79
	8223874	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	3.25	CHEMBL301	Homo sapiens	Inhibition	%	3.25
	8224259	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	-0.92	CHEMBL301	Homo sapiens	Inhibition	%	-0.92
	8224260	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	6.57	CHEMBL301	Homo sapiens	Inhibition	%	6.57
	8224429	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	-0.48	CHEMBL301	Homo sapiens	Inhibition	%	-0.48
	8224430	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	5.92	CHEMBL301	Homo sapiens	Inhibition	%	5.92
	8224788	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	2.28	CHEMBL301	Homo sapiens	Inhibition	%	2.28
	8224789	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	4.05	CHEMBL301	Homo sapiens	Inhibition	%	4.05
	8224902	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	-0.94	CHEMBL301	Homo sapiens	Inhibition	%	-0.94
	8224903	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	2.4	CHEMBL301	Homo sapiens	Inhibition	%	2.4
	8225126	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	9.38	CHEMBL301	Homo sapiens	Inhibition	%	9.38
	8225127	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	7.57	CHEMBL301	Homo sapiens	Inhibition	%	7.57
	8225260	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	16.69	CHEMBL301	Homo sapiens	Inhibition	%	16.69
	8225261	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	16.52	CHEMBL301	Homo sapiens	Inhibition	%	16.52
	8225622	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.58	CHEMBL301	Homo sapiens	Inhibition	%	1.58
	8225623	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	2.41	CHEMBL301	Homo sapiens	Inhibition	%	2.41
	8225757	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	5.79	CHEMBL301	Homo sapiens	Inhibition	%	5.79
	8225758	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	4.66	CHEMBL301	Homo sapiens	Inhibition	%	4.66
	8226139	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	6.19	CHEMBL301	Homo sapiens	Inhibition	%	6.19
	8226140	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.53	CHEMBL301	Homo sapiens	Inhibition	%	1.53
	8226264	CHEMBL1962020	GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	1.73	CHEMBL301	Homo sapiens	Inhibition	%	1.73
	8226265	CHEMBL1962022	GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	3.74	CHEMBL301	Homo sapiens	Inhibition	%	3.74
	8226488	CHEMBL1962021	GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	1.37	CHEMBL301	Homo sapiens	Inhibition	%	1.37
	8226489	CHEMBL1962023	GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	5.25	CHEMBL301	Homo sapiens	Inhibition	%	5.25
active	9578301	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	=	Ki	nM	501.19	CHEMBL301	Homo sapiens	pKi		6.3
inactive	9578302	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)c(OC)c1		CHEMBL2003768	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578303	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9578304	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1ccc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)c1		CHEMBL1982880	=	Ki	nM	5011.87	CHEMBL301	Homo sapiens	pKi		5.3
inactive	9578305	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9578306	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	7.943	CHEMBL301	Homo sapiens	pKi		8.1
inactive	9578307	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9578308	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)c1		CHEMBL1980435	=	Ki	nM	39.81	CHEMBL301	Homo sapiens	pKi		7.4
active	9578309	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C1Nc2ccccc2Nc2cc(-c3ccncc3F)ccc21		CHEMBL1989293	=	Ki	nM	398.11	CHEMBL301	Homo sapiens	pKi		6.4
inactive	9578310	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9578311	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1		CHEMBL578061	=	Ki	nM	5011.87	CHEMBL301	Homo sapiens	pKi		5.3
active	9578312	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	=	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
inactive	9578313	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9578314	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682345	=	Ki	nM	251.19	CHEMBL301	Homo sapiens	pKi		6.6
active	9578315	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	=	Ki	nM	1995.26	CHEMBL301	Homo sapiens	pKi		5.7
inactive	9578316	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578317	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9578318	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	=	Ki	nM	100.0	CHEMBL301	Homo sapiens	pKi		7.0
inactive	9578319	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9578320	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	=	Ki	nM	12.59	CHEMBL301	Homo sapiens	pKi		7.9
inactive	9578321	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1c(C)n(Cc2ccccc2)c2ccc(C(=O)Nc3nc[nH]n3)cc12		CHEMBL1979718	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578322	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9578323	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	c1ccc(Cn2cc(-c3ccc4[nH]nc(-c5cn(Cc6ccccc6)nn5)c4c3)nn2)cc1		CHEMBL1964288	=	Ki	nM	5.012	CHEMBL301	Homo sapiens	pKi		8.3
inactive	9578324	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL523823	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9578325	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC1(C)CC2=Nc3cc(Cl)ccc3SC2=C(O)C1		CHEMBL1562756	=	Ki	nM	6309.57	CHEMBL301	Homo sapiens	pKi		5.2
active	9578326	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	=	Ki	nM	50.12	CHEMBL301	Homo sapiens	pKi		7.3
active	9578327	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	=	Ki	nM	251.19	CHEMBL301	Homo sapiens	pKi		6.6
inactive	9578328	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578329	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578330	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1ccccc1		CHEMBL1993413	<	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
inactive	9578331	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1990583	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9578332	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	12.59	CHEMBL301	Homo sapiens	pKi		7.9
active	9578333	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	=	Ki	nM	5011.87	CHEMBL301	Homo sapiens	pKi		5.3
active	9578334	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN(C)CCCOc1cc(-c2ccncc2)cc2[nH]nc(N)c12		CHEMBL1988662	=	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
inactive	9578335	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9578336	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	=	Ki	nM	19.95	CHEMBL301	Homo sapiens	pKi		7.7
active	9578337	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	=	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
active	9578338	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Ki	nM	794.33	CHEMBL301	Homo sapiens	pKi		6.1
active	9578339	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)(CNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)CNS(C)(=O)=O		CHEMBL1971172	=	Ki	nM	199.53	CHEMBL301	Homo sapiens	pKi		6.7
active	9578340	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	=	Ki	nM	251.19	CHEMBL301	Homo sapiens	pKi		6.6
inactive	9578341	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9578342	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1ccccc1C(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1997643	=	Ki	nM	251.19	CHEMBL301	Homo sapiens	pKi		6.6
active	9578343	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	=	Ki	nM	2511.89	CHEMBL301	Homo sapiens	pKi		5.6
inactive	9578344	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9578345	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	=	Ki	nM	5011.87	CHEMBL301	Homo sapiens	pKi		5.3
inactive	9578346	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578347	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9578348	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	=	Ki	nM	125.89	CHEMBL301	Homo sapiens	pKi		6.9
inactive	9578349	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9578350	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	=	Ki	nM	25.12	CHEMBL301	Homo sapiens	pKi		7.6
active	9578351	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cc(O)ccc1-n1c2cc(Cl)ccc2c(=O)c2c(N)nc(N)nc21		CHEMBL1995592	=	Ki	nM	794.33	CHEMBL301	Homo sapiens	pKi		6.1
inactive	9578352	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578353	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1ccc(OC)c(CNC(=O)c2cc(N)c(C#N)c(OC(C)C)n2)c1		CHEMBL1982541	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578354	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Clc1cc2nn[nH]c2cc1Cl		CHEMBL1996923	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578355	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578356	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578357	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9578358	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCc1nc2c(c3cc(OC)c(OC)cc13)C(=O)NC2=O		CHEMBL2003524	=	Ki	nM	398.11	CHEMBL301	Homo sapiens	pKi		6.4
active	9578359	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	=	Ki	nM	50.12	CHEMBL301	Homo sapiens	pKi		7.3
active	9578360	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1983589	=	Ki	nM	398.11	CHEMBL301	Homo sapiens	pKi		6.4
active	9578361	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCCn1c(C2CCNCC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CCCCC2)n1		CHEMBL437747	=	Ki	nM	630.96	CHEMBL301	Homo sapiens	pKi		6.2
active	9578362	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CS(=O)(=O)NCCNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL2005718	=	Ki	nM	251.19	CHEMBL301	Homo sapiens	pKi		6.6
inactive	9578363	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578364	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL507936	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578365	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL1987756	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578366	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9578367	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	=	Ki	nM	1584.89	CHEMBL301	Homo sapiens	pKi		5.8
active	9578368	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	=	Ki	nM	25.12	CHEMBL301	Homo sapiens	pKi		7.6
inactive	9578369	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(=O)c1cc(Cl)cc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1984788	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578370	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	FC(F)(F)c1ccc(-c2nnc3ccc(NC4CC4)nn23)cc1		CHEMBL451964	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9578371	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL1964307	=	Ki	nM	2511.89	CHEMBL301	Homo sapiens	pKi		5.6
inactive	9578372	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578373	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578374	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578375	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578376	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1F		CHEMBL1994361	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578377	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578378	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9578379	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(COc1cncc(-c2cc3cnccc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1972840	=	Ki	nM	3981.07	CHEMBL301	Homo sapiens	pKi		5.4
inactive	9578380	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578381	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=c1cc(-c2ccc(F)cc2)[nH]c2c(-c3ccc(F)cc3)cnn12		CHEMBL2004443	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578382	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578383	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578384	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578385	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=c1[nH]cc(I)c2nc(-c3ccccc3)cn12		CHEMBL2001668	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578386	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1n[nH]c2c1C(c1ccccc1I)C(C#N)=C(N)O2		CHEMBL1979318	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578387	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578388	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578389	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578390	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9578391	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	=	Ki	nM	1995.26	CHEMBL301	Homo sapiens	pKi		5.7
active	9578392	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)(CN)CNc1cc(-c2c[nH]c3ncccc23)cc(F)n1		CHEMBL1987261	=	Ki	nM	316.23	CHEMBL301	Homo sapiens	pKi		6.5
active	9578393	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCCCNc1cc(-c2c[nH]c3ncccc23)ncn1		CHEMBL1968459	=	Ki	nM	199.53	CHEMBL301	Homo sapiens	pKi		6.7
active	9578394	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	=	Ki	nM	25.12	CHEMBL301	Homo sapiens	pKi		7.6
inactive	9578395	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(=O)C1CCCN(C(=O)c2cc(-c3ccc4[nH]ncc4c3)on2)C1		CHEMBL1970369	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578396	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578397	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9578398	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cc(C)c2c(n1)sc1c(N)ncnc12		CHEMBL504950	=	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9578399	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN(C)CCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1966425	=	Ki	nM	1258.93	CHEMBL301	Homo sapiens	pKi		5.9
active	9578400	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	=	Ki	nM	3981.07	CHEMBL301	Homo sapiens	pKi		5.4
active	9578401	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	=	Ki	nM	100.0	CHEMBL301	Homo sapiens	pKi		7.0
active	9578402	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COC(=O)c1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)c2c(N)ncnn2c1C		CHEMBL1977041	=	Ki	nM	6309.57	CHEMBL301	Homo sapiens	pKi		5.2
active	9578403	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(=O)c1cccc2c1Nc1nnc(Cl)cc1C(=O)N2		CHEMBL1968070	=	Ki	nM	630.96	CHEMBL301	Homo sapiens	pKi		6.2
active	9578404	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	=	Ki	nM	1258.93	CHEMBL301	Homo sapiens	pKi		5.9
inactive	9578405	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578406	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9578407	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)(CN)CNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1985723	=	Ki	nM	501.19	CHEMBL301	Homo sapiens	pKi		6.3
active	9578408	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL178737	=	Ki	nM	316.23	CHEMBL301	Homo sapiens	pKi		6.5
active	9578409	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	=	Ki	nM	10.0	CHEMBL301	Homo sapiens	pKi		8.0
inactive	9578410	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578411	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9578412	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	=	Ki	nM	2511.89	CHEMBL301	Homo sapiens	pKi		5.6
inactive	9578413	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9578414	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	N#Cc1cccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)c1		CHEMBL1977128	=	Ki	nM	31.62	CHEMBL301	Homo sapiens	pKi		7.5
inactive	9578415	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cccc(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1997759	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578416	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9578417	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9578418	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=c1[nH]c2cc(Cl)cc(Cl)c2c(-c2cc(Cl)ccc2O)c1O		CHEMBL1974803	=	Ki	nM	5011.87	CHEMBL301	Homo sapiens	pKi		5.3
active	9578419	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	=	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9578420	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN(C)C1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1965702	=	Ki	nM	1258.93	CHEMBL301	Homo sapiens	pKi		5.9
inactive	9578421	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
active	9578422	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	=	Ki	nM	630.96	CHEMBL301	Homo sapiens	pKi		6.2
active	9578423	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)(C)Oc1cc(-c2ccncc2)cc2[nH]nc(N)c12		CHEMBL2002456	=	Ki	nM	125.89	CHEMBL301	Homo sapiens	pKi		6.9
inactive	9581996	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC1=NN(c2cccc(Br)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2005112	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9581997	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	=	Ki	nM	251.19	CHEMBL301	Homo sapiens	pKi		6.6
inactive	9581998	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCN(CC)CCOc1ccc(-c2nc3c(C(N)=O)cccc3[nH]2)cc1		CHEMBL1984044	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9581999	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	=	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582000	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	=	Ki	nM	50.12	CHEMBL301	Homo sapiens	pKi		7.3
inactive	9582001	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582002	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	=	Ki	nM	1000.0	CHEMBL301	Homo sapiens	pKi		6.0
inactive	9582003	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582004	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCCOn1c2ccc(Cl)cc2c(=O)c2c(C)nn(C)c21		CHEMBL207253	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582005	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(=NNC(=O)c1nnn(-c2nonc2N)c1-c1ccccc1)c1ccco1		CHEMBL1890036	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582006	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582007	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C1CC(c2ccc(Cl)cc2Cl)Cc2nc3cc(Cl)ccc3c(O)c21		CHEMBL326282	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582008	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(Cl)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)NCCOCCOCCN)[nH]c12		CHEMBL2002682	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582009	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCOc1ccccc1C=NNC(=O)c1nnn(-c2nonc2N)c1N1CCCC1		CHEMBL1992732	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582010	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582011	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	=	Ki	nM	398.11	CHEMBL301	Homo sapiens	pKi		6.4
active	9582012	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)CNC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL2006456	=	Ki	nM	251.19	CHEMBL301	Homo sapiens	pKi		6.6
inactive	9582013	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582014	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582015	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582016	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CCC(N2CCCC2)CC1		CHEMBL2007151	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582017	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COCCNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1964340	=	Ki	nM	251.19	CHEMBL301	Homo sapiens	pKi		6.6
inactive	9582018	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582019	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Nc1ccc2[nH]ncc2c1)c1cccc(F)c1		CHEMBL1461728	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582020	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582021	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	=	Ki	nM	1258.93	CHEMBL301	Homo sapiens	pKi		5.9
active	9582022	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	=	Ki	nM	1995.26	CHEMBL301	Homo sapiens	pKi		5.7
inactive	9582023	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NCCOc1cccc(Nc2ccnc(N)n2)c1		CHEMBL1995448	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582024	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	=	Ki	nM	50.12	CHEMBL301	Homo sapiens	pKi		7.3
active	9582025	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1974457	=	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
active	9582026	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)(CO)CCCNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1967662	=	Ki	nM	100.0	CHEMBL301	Homo sapiens	pKi		7.0
inactive	9582027	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	6309.57	CHEMBL301	Homo sapiens	pKi		5.2
inactive	9582028	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Oc1ccc(Nc2ncnc3scc(Cl)c23)cc1		CHEMBL2006580	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582029	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1999414	<	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
active	9582030	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21		CHEMBL280074	=	Ki	nM	3981.07	CHEMBL301	Homo sapiens	pKi		5.4
inactive	9582031	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1Cl		CHEMBL2006581	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582032	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCCC1		CHEMBL2006481	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582033	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582034	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582035	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582036	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCNc1nc2cc(Cl)c(OC)cc2nc1NCC		CHEMBL1995927	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582037	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL2006450	<	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
inactive	9582038	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582039	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	=	Ki	nM	100.0	CHEMBL301	Homo sapiens	pKi		7.0
active	9582040	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	=	Ki	nM	1995.26	CHEMBL301	Homo sapiens	pKi		5.7
active	9582041	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccc(Nc2nccc(Nc3ccccc3C(=O)O)n2)cc1F		CHEMBL243518	=	Ki	nM	398.11	CHEMBL301	Homo sapiens	pKi		6.4
active	9582042	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	=	Ki	nM	100.0	CHEMBL301	Homo sapiens	pKi		7.0
active	9582043	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	=	Ki	nM	2511.89	CHEMBL301	Homo sapiens	pKi		5.6
inactive	9582044	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582045	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	=	Ki	nM	3981.07	CHEMBL301	Homo sapiens	pKi		5.4
active	9582046	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	=	Ki	nM	398.11	CHEMBL301	Homo sapiens	pKi		6.4
active	9582047	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(=O)c1cc2c(-c3ccc(Br)c(F)c3F)cncc2s1		CHEMBL1999918	=	Ki	nM	316.23	CHEMBL301	Homo sapiens	pKi		6.5
inactive	9582048	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582049	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	=	Ki	nM	1995.26	CHEMBL301	Homo sapiens	pKi		5.7
active	9582050	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	=	Ki	nM	3981.07	CHEMBL301	Homo sapiens	pKi		5.4
active	9582051	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	=	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582052	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccc3ccccc3c2)n1		CHEMBL2002240	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582053	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582054	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccc(-n2nc(C)c3c(=O)c4cc(Cl)ccc4n(O)c32)cc1		CHEMBL1991143	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582055	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582056	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(=O)NC1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1980178	=	Ki	nM	501.19	CHEMBL301	Homo sapiens	pKi		6.3
active	9582057	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	=	Ki	nM	501.19	CHEMBL301	Homo sapiens	pKi		6.3
inactive	9582058	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O		CHEMBL485556	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582059	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582060	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582061	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	=	Ki	nM	63.1	CHEMBL301	Homo sapiens	pKi		7.2
inactive	9582062	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582063	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cc(-c2ccc3c(c2)Nc2ccccc2NC3=O)ccn1		CHEMBL1981511	=	Ki	nM	501.19	CHEMBL301	Homo sapiens	pKi		6.3
inactive	9582064	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582065	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	=	Ki	nM	3981.07	CHEMBL301	Homo sapiens	pKi		5.4
inactive	9582066	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1997025	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582067	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	=	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582068	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)csc12		CHEMBL1982476	=	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582069	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C1C(=NNc2cccc3c(=O)[nH][nH]c(=O)c23)C(c2ccccc2)=NN1c1ccccc1		CHEMBL1984274	=	Ki	nM	1000.0	CHEMBL301	Homo sapiens	pKi		6.0
inactive	9582070	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582071	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582072	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)c(Cl)ccc12		CHEMBL2006010	=	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
inactive	9582073	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582074	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582075	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CS(=O)(=O)Nc1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O		CHEMBL1975937	=	Ki	nM	6309.57	CHEMBL301	Homo sapiens	pKi		5.2
active	9582076	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COCC(C)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1998068	=	Ki	nM	158.49	CHEMBL301	Homo sapiens	pKi		6.8
inactive	9582077	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1n[nH]c2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc12		CHEMBL1997623	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582078	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582079	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1c(NC2CCC(N)CC2)nc2ccnn2c1Nc1ccc(F)c(Cl)c1		CHEMBL1980371	=	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582080	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCCn1c(=O)c2[nH]c(-c3cnn(Cc4cccc(C(F)(F)F)c4)c3)nc2n(CC)c1=O		CHEMBL260933	=	Ki	nM	5011.87	CHEMBL301	Homo sapiens	pKi		5.3
active	9582081	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCN(C)CCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1993166	=	Ki	nM	1000.0	CHEMBL301	Homo sapiens	pKi		6.0
inactive	9582082	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582083	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL1966035	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582084	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582085	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	c1ccc(-c2n[nH]cc2-c2ccncc2)cc1		CHEMBL1992644	=	Ki	nM	12589.25	CHEMBL301	Homo sapiens	pKi		4.9
inactive	9582086	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(NS(=O)(=O)c1ccc(NCCSc2ccc(O)cc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1		CHEMBL1992645	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582087	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCOC(=O)c1c[nH]n2c(=O)cc(-c3ccncc3)nc12		CHEMBL1990708	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582088	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582089	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582090	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	=	Ki	nM	398.11	CHEMBL301	Homo sapiens	pKi		6.4
inactive	9582091	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCN(CC)CCCNc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)n1		CHEMBL1972276	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582092	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582093	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	=	Ki	nM	501.19	CHEMBL301	Homo sapiens	pKi		6.3
inactive	9582094	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582095	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2OCC(C)C		CHEMBL1977814	=	Ki	nM	1000.0	CHEMBL301	Homo sapiens	pKi		6.0
active	9582096	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1nc2ccccn2c1-c1csc(Nc2ccc(O)cc2)n1		CHEMBL513846	=	Ki	nM	794.33	CHEMBL301	Homo sapiens	pKi		6.1
inactive	9582097	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582098	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	63.1	CHEMBL301	Homo sapiens	pKi		7.2
inactive	9582099	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582100	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NCCNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1972290	=	Ki	nM	398.11	CHEMBL301	Homo sapiens	pKi		6.4
inactive	9582101	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582102	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582103	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(=O)NC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2F)C1		CHEMBL1975208	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582104	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	794.33	CHEMBL301	Homo sapiens	pKi		6.1
inactive	9582105	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582106	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(=O)c1cc2c(Oc3cccc(F)c3)cncc2s1		CHEMBL1964777	=	Ki	nM	1000.0	CHEMBL301	Homo sapiens	pKi		6.0
inactive	9582107	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582108	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582109	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Cc1ccccc1Cl)Nc1ccc2cn[nH]c2c1		CHEMBL1987533	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582110	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582111	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cn1cc(Nc2ncc(Cl)c(Nc3ccccc3C(N)=O)n2)cn1		CHEMBL1984548	=	Ki	nM	1.259	CHEMBL301	Homo sapiens	pKi		8.9
active	9582112	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	=	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
active	9582113	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	=	Ki	nM	6309.57	CHEMBL301	Homo sapiens	pKi		5.2
active	9582114	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	=	Ki	nM	398.11	CHEMBL301	Homo sapiens	pKi		6.4
inactive	9582115	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	<	Ki	nM	5011.87	CHEMBL301	Homo sapiens	pKi		5.3
inactive	9582116	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582117	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	=	Ki	nM	6309.57	CHEMBL301	Homo sapiens	pKi		5.2
active	9582118	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	=	Ki	nM	15.85	CHEMBL301	Homo sapiens	pKi		7.8
inactive	9582119	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582120	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	=	Ki	nM	630.96	CHEMBL301	Homo sapiens	pKi		6.2
inactive	9582121	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1nsc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL2002553	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582122	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582123	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	=	Ki	nM	1584.89	CHEMBL301	Homo sapiens	pKi		5.8
inactive	9582124	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582125	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	=	Ki	nM	5011.87	CHEMBL301	Homo sapiens	pKi		5.3
active	9582126	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	=	Ki	nM	251.19	CHEMBL301	Homo sapiens	pKi		6.6
inactive	9582127	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCCC2)C1		CHEMBL1988370	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582128	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	=	Ki	nM	3981.07	CHEMBL301	Homo sapiens	pKi		5.4
inactive	9582129	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582130	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	=	Ki	nM	5011.87	CHEMBL301	Homo sapiens	pKi		5.3
active	9582131	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	=	Ki	nM	1258.93	CHEMBL301	Homo sapiens	pKi		5.9
inactive	9582132	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(COc1cncc(-c2ccc(F)cc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1996543	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582133	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	=	Ki	nM	1584.89	CHEMBL301	Homo sapiens	pKi		5.8
inactive	9582134	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582135	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582136	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1ccc(C(=O)Nc2nc3ccc(Cl)cc3s2)c(OC)c1		CHEMBL1983309	=	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
active	9582137	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	=	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
inactive	9582138	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC1=NN(c2ccccc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1999126	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582139	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)Oc1ccc(-c2noc(-c3ccc(NC4CCC(C(=O)O)C4)cc3)n2)cc1Cl		CHEMBL1997503	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582140	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1972339	=	Ki	nM	158.49	CHEMBL301	Homo sapiens	pKi		6.8
active	9582141	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	=	Ki	nM	1000.0	CHEMBL301	Homo sapiens	pKi		6.0
inactive	9582142	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cc(C)c(C)c(OCCCc2c(C(=O)O)[nH]c3c(-c4ccccc4C)cccc23)c1		CHEMBL1990821	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582143	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582144	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582145	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582146	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582147	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582148	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(CNc2cc(-c3c[nH]c4ncccc34)ncn2)c1		CHEMBL1995932	=	Ki	nM	39.81	CHEMBL301	Homo sapiens	pKi		7.4
active	9582149	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	=	Ki	nM	158.49	CHEMBL301	Homo sapiens	pKi		6.8
active	9582150	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1n[nH]c2ccc(-c3cncc(OCCNS(C)(=O)=O)c3)cc12		CHEMBL1967704	=	Ki	nM	316.23	CHEMBL301	Homo sapiens	pKi		6.5
inactive	9582151	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582152	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582153	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582154	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	=	Ki	nM	2511.89	CHEMBL301	Homo sapiens	pKi		5.6
active	9582155	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(Cl)c1		CHEMBL1983595	=	Ki	nM	79.43	CHEMBL301	Homo sapiens	pKi		7.1
active	9582156	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	=	Ki	nM	630.96	CHEMBL301	Homo sapiens	pKi		6.2
inactive	9582157	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4snc(N)c34)cc2)c1		CHEMBL1976328	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582158	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582159	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1ccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)cc1OC		CHEMBL1964399	=	Ki	nM	630.96	CHEMBL301	Homo sapiens	pKi		6.2
inactive	9582160	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582161	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582162	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCOCC2)n1		CHEMBL1980253	=	Ki	nM	63.1	CHEMBL301	Homo sapiens	pKi		7.2
active	9582163	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	=	Ki	nM	2511.89	CHEMBL301	Homo sapiens	pKi		5.6
active	9582164	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN(C)c1ccc(-c2c(-c3ccc4[nH]nc(N)c4c3)nnn2Cc2ccccc2)cc1		CHEMBL1969221	=	Ki	nM	125.89	CHEMBL301	Homo sapiens	pKi		6.9
active	9582165	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	=	Ki	nM	39.81	CHEMBL301	Homo sapiens	pKi		7.4
active	9582166	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	=	Ki	nM	251.19	CHEMBL301	Homo sapiens	pKi		6.6
active	9582167	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	c1ccc(Cc2cc(-c3ccc4[nH]ncc4c3)on2)cc1		CHEMBL1682357	=	Ki	nM	794.33	CHEMBL301	Homo sapiens	pKi		6.1
active	9582168	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	=	Ki	nM	316.23	CHEMBL301	Homo sapiens	pKi		6.5
inactive	9582169	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCOc1nc(C(=O)NCc2cccnc2)cc(N)c1C#N		CHEMBL209534	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582170	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582171	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582172	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN(C)S(=O)(=O)c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O		CHEMBL2006631	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582173	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582174	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582175	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Nc1n[nH]c2nc3ccccc3cc12)c1ccncc1		CHEMBL1990415	=	Ki	nM	501.19	CHEMBL301	Homo sapiens	pKi		6.3
inactive	9582176	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	C(=Cc1cncc(OC2CCNC2)c1)c1ccncc1		CHEMBL1966087	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582177	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cn1cc(-c2ccccc2)c2nc(-c3ccncc3)cc(=O)n21		CHEMBL1986767	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582178	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582179	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582180	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582181	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582182	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1998470	=	Ki	nM	1258.93	CHEMBL301	Homo sapiens	pKi		5.9
active	9582183	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CNCC(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1996980	=	Ki	nM	19.95	CHEMBL301	Homo sapiens	pKi		7.7
active	9582184	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C)c1		CHEMBL1984432	=	Ki	nM	5011.87	CHEMBL301	Homo sapiens	pKi		5.3
inactive	9582185	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL1970735	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582186	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL219722	=	Ki	nM	6309.57	CHEMBL301	Homo sapiens	pKi		5.2
active	9582187	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN(Cc1ccccc1)c1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1969920	=	Ki	nM	31.62	CHEMBL301	Homo sapiens	pKi		7.5
active	9582188	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cn1cc(Nc2ncc(Br)c(Nc3ccccc3C(N)=O)n2)cn1		CHEMBL1994669	=	Ki	nM	1.585	CHEMBL301	Homo sapiens	pKi		8.8
inactive	9582189	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582190	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCOC(=O)C1=C(N)n2c(sc(=Cc3cccs3)c2=O)=C(C(N)=O)C1c1cccs1		CHEMBL2004365	=	Ki	nM	5011.87	CHEMBL301	Homo sapiens	pKi		5.3
inactive	9582191	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582192	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	100.0	CHEMBL301	Homo sapiens	pKi		7.0
inactive	9582193	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582194	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582195	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C1NCCc2[nH]c(-c3ccnc(Cl)c3)cc21		CHEMBL226232	=	Ki	nM	1995.26	CHEMBL301	Homo sapiens	pKi		5.7
inactive	9582196	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582197	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	Ki	nM	1995.26	CHEMBL301	Homo sapiens	pKi		5.7
inactive	9582198	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582199	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	=	Ki	nM	39.81	CHEMBL301	Homo sapiens	pKi		7.4
active	9582200	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	=	Ki	nM	5011.87	CHEMBL301	Homo sapiens	pKi		5.3
active	9582201	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	=	Ki	nM	501.19	CHEMBL301	Homo sapiens	pKi		6.3
active	9582202	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	=	Ki	nM	100.0	CHEMBL301	Homo sapiens	pKi		7.0
inactive	9582203	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582204	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	=	Ki	nM	316.23	CHEMBL301	Homo sapiens	pKi		6.5
active	9582205	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Ki	nM	79.43	CHEMBL301	Homo sapiens	pKi		7.1
active	9582206	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	c1ccc(CNc2cc(-c3c[nH]c4ncccc34)ncn2)cc1		CHEMBL2002346	=	Ki	nM	15.85	CHEMBL301	Homo sapiens	pKi		7.8
active	9582207	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	=	Ki	nM	1258.93	CHEMBL301	Homo sapiens	pKi		5.9
inactive	9582208	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582209	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2006836	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582210	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#Cc5cccnc5)cnc(N)c34)cc2)c1		CHEMBL1971947	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582211	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	Ki	nM	1584.89	CHEMBL301	Homo sapiens	pKi		5.8
inactive	9582212	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582213	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC1CCCCC1Nc1nccc(Nc2ccccc2C(=O)O)n1		CHEMBL1985153	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582214	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582215	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	=	Ki	nM	794.33	CHEMBL301	Homo sapiens	pKi		6.1
inactive	9582216	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582217	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	<	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
inactive	9582218	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582219	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(O)c1ccccc1Nc1ncnc(Nc2ccc(F)cc2)n1		CHEMBL1992231	=	Ki	nM	1000.0	CHEMBL301	Homo sapiens	pKi		6.0
active	9582220	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	15.85	CHEMBL301	Homo sapiens	pKi		7.8
inactive	9582221	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582222	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(NCc1ccc(Cl)cc1)Nc1cccc2[nH]ncc12		CHEMBL1977713	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582223	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	=	Ki	nM	1584.89	CHEMBL301	Homo sapiens	pKi		5.8
active	9582224	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	=	Ki	nM	794.33	CHEMBL301	Homo sapiens	pKi		6.1
inactive	9582225	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=S(=O)(O)c1ccc(NCc2ccc3c(c2)OCO3)c2c(O)cccc12		CHEMBL2004544	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582226	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCCCNc1cc(-c2ccncc2)cc2[nH]nc(N)c12		CHEMBL1983157	=	Ki	nM	199.53	CHEMBL301	Homo sapiens	pKi		6.7
inactive	9582227	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582228	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	FC(F)(F)c1cccc(CNc2cc(-c3c[nH]c4ncccc34)ncn2)c1		CHEMBL1966040	=	Ki	nM	630.96	CHEMBL301	Homo sapiens	pKi		6.2
inactive	9582229	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582230	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CSc1cnc2c(ccc3cnccc32)c1O		CHEMBL2006933	=	Ki	nM	125.89	CHEMBL301	Homo sapiens	pKi		6.9
inactive	9582231	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9582232	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582233	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	12.59	CHEMBL301	Homo sapiens	pKi		7.9
inactive	9582234	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9582235	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(=NNC(=N)N)c1cc(NC(=O)c2cccc(C(=O)Nc3cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c3)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL2000685	=	Ki	nM	125.89	CHEMBL301	Homo sapiens	pKi		6.9
active	9585797	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	Ki	nM	125.89	CHEMBL301	Homo sapiens	pKi		6.9
active	9585798	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC1CCCCC1Nc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL1994438	=	Ki	nM	125.89	CHEMBL301	Homo sapiens	pKi		6.9
active	9585799	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(CO)ccc4F)cc3)c12		CHEMBL1985311	=	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
active	9585800	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	=	Ki	nM	100.0	CHEMBL301	Homo sapiens	pKi		7.0
inactive	9585801	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)cc3n21		CHEMBL1989265	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585802	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	63.1	CHEMBL301	Homo sapiens	pKi		7.2
inactive	9585803	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CNC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2Br)C1		CHEMBL2004647	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585804	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	=	Ki	nM	630.96	CHEMBL301	Homo sapiens	pKi		6.2
inactive	9585805	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CCC(N2CCCC2)CC1		CHEMBL1965910	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585806	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCCCOc1cc(-c2ccncc2)cc2[nH]nc(N)c12		CHEMBL1996447	=	Ki	nM	1000.0	CHEMBL301	Homo sapiens	pKi		6.0
active	9585807	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	=	Ki	nM	251.19	CHEMBL301	Homo sapiens	pKi		6.6
inactive	9585808	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585809	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585810	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585811	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(CN)Cc4ccccc4)c3)cc12		CHEMBL2000271	=	Ki	nM	158.49	CHEMBL301	Homo sapiens	pKi		6.8
active	9585812	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	=	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
active	9585813	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2004692	=	Ki	nM	3981.07	CHEMBL301	Homo sapiens	pKi		5.4
inactive	9585814	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585815	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585816	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	=	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585817	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	=	Ki	nM	6309.57	CHEMBL301	Homo sapiens	pKi		5.2
active	9585818	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	=	Ki	nM	39.81	CHEMBL301	Homo sapiens	pKi		7.4
inactive	9585819	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	<	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
active	9585820	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	=	Ki	nM	251.19	CHEMBL301	Homo sapiens	pKi		6.6
active	9585821	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN(C)C1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1969151	=	Ki	nM	25.12	CHEMBL301	Homo sapiens	pKi		7.6
inactive	9585822	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585823	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	=	Ki	nM	398.11	CHEMBL301	Homo sapiens	pKi		6.4
active	9585824	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	=	Ki	nM	251.19	CHEMBL301	Homo sapiens	pKi		6.6
inactive	9585825	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585826	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585827	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cn1ncc2c1CCCC2=O		CHEMBL1981107	<	Ki	nM	19952.62	CHEMBL301	Homo sapiens	pKi		4.7
inactive	9585828	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585829	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	=	Ki	nM	630.96	CHEMBL301	Homo sapiens	pKi		6.2
active	9585830	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	=	Ki	nM	12.59	CHEMBL301	Homo sapiens	pKi		7.9
active	9585831	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	=	Ki	nM	630.96	CHEMBL301	Homo sapiens	pKi		6.2
inactive	9585832	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585833	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585834	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc(OC)cc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)c1		CHEMBL2002613	=	Ki	nM	251.19	CHEMBL301	Homo sapiens	pKi		6.6
inactive	9585835	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585836	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	=	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
inactive	9585837	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585838	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(NCc1ccccc1)c1c[nH]n2c(=O)cc(-c3ccncc3)nc12		CHEMBL1974250	=	Ki	nM	158.49	CHEMBL301	Homo sapiens	pKi		6.8
active	9585839	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	=	Ki	nM	1000.0	CHEMBL301	Homo sapiens	pKi		6.0
inactive	9585840	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCN(CC)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1983195	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585841	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	=	Ki	nM	1995.26	CHEMBL301	Homo sapiens	pKi		5.7
active	9585842	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	=	Ki	nM	79.43	CHEMBL301	Homo sapiens	pKi		7.1
inactive	9585843	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	OCCNc1cc2cc(-c3ccccc3)ccc2cn1		CHEMBL1989957	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585844	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585845	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585846	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585847	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN(C)c1cc(-c2ccncc2)cc2[nH]nc(N)c12		CHEMBL2003229	=	Ki	nM	630.96	CHEMBL301	Homo sapiens	pKi		6.2
inactive	9585848	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	<	Ki	nM	5011.87	CHEMBL301	Homo sapiens	pKi		5.3
inactive	9585849	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585850	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(CNc2cc(-c3c[nH]c4ncccc34)cc(Cl)n2)c1C		CHEMBL1988331	=	Ki	nM	199.53	CHEMBL301	Homo sapiens	pKi		6.7
active	9585851	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1998432	=	Ki	nM	158.49	CHEMBL301	Homo sapiens	pKi		6.8
active	9585852	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	=	Ki	nM	398.11	CHEMBL301	Homo sapiens	pKi		6.4
active	9585853	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCO)nc21		CHEMBL86066	=	Ki	nM	1584.89	CHEMBL301	Homo sapiens	pKi		5.8
inactive	9585854	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585855	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1n[nH]c2ccc(-c3cncc(OCCN(C)S(C)(=O)=O)c3)cc12		CHEMBL1998826	=	Ki	nM	501.19	CHEMBL301	Homo sapiens	pKi		6.3
active	9585856	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	c1cc2[nH]ncc2cc1-c1cc(CN2CCCCC2)no1		CHEMBL1682360	=	Ki	nM	1000.0	CHEMBL301	Homo sapiens	pKi		6.0
inactive	9585857	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585858	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	=	Ki	nM	1000.0	CHEMBL301	Homo sapiens	pKi		6.0
inactive	9585859	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585860	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585861	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	794.33	CHEMBL301	Homo sapiens	pKi		6.1
active	9585862	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	=	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
active	9585863	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	c1cnc2[nH]cc(-c3ccnc(NCC4CCCCC4)n3)c2c1		CHEMBL213207	=	Ki	nM	3.981	CHEMBL301	Homo sapiens	pKi		8.4
inactive	9585864	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585865	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	=	Ki	nM	316.23	CHEMBL301	Homo sapiens	pKi		6.5
active	9585866	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1n[nH]c2cccc(-c3ccc(Br)cc3)c12		CHEMBL1990346	=	Ki	nM	3981.07	CHEMBL301	Homo sapiens	pKi		5.4
active	9585867	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	=	Ki	nM	1258.93	CHEMBL301	Homo sapiens	pKi		5.9
inactive	9585868	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1c(F)cccc1F		CHEMBL1991410	<	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
inactive	9585869	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585870	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	=	Ki	nM	251.19	CHEMBL301	Homo sapiens	pKi		6.6
active	9585871	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	=	Ki	nM	251.19	CHEMBL301	Homo sapiens	pKi		6.6
active	9585872	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	=	Ki	nM	5011.87	CHEMBL301	Homo sapiens	pKi		5.3
active	9585873	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	=	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585874	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)c(F)c3n21		CHEMBL1977604	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585875	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Fc1cccc(-c2c[nH]c3ncccc23)c1		CHEMBL1993648	=	Ki	nM	1258.93	CHEMBL301	Homo sapiens	pKi		5.9
active	9585876	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	79.43	CHEMBL301	Homo sapiens	pKi		7.1
inactive	9585877	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585878	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	100.0	CHEMBL301	Homo sapiens	pKi		7.0
active	9585879	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	125.89	CHEMBL301	Homo sapiens	pKi		6.9
active	9585880	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(F)c2)n1		CHEMBL243298	=	Ki	nM	316.23	CHEMBL301	Homo sapiens	pKi		6.5
inactive	9585881	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585882	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(=O)c1ccc(-c2ccnc(N)n2)cc1N1CCCCC1		CHEMBL1971951	=	Ki	nM	1258.93	CHEMBL301	Homo sapiens	pKi		5.9
inactive	9585883	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585884	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585885	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585886	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(NN=Cc1ccc(Sc2nc3ccccc3[nH]2)o1)c1cccc([N+](=O)[O-])c1		CHEMBL1992555	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585887	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	=	Ki	nM	501.19	CHEMBL301	Homo sapiens	pKi		6.3
active	9585888	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Fc1ccc2c(c1)-c1n[nH]cc1CS2		CHEMBL1989069	=	Ki	nM	19952.62	CHEMBL301	Homo sapiens	pKi		4.7
active	9585889	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	=	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
active	9585890	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=c1cc(-c2ccncc2)nc(NCc2cc(F)cc(F)c2)[nH]1		CHEMBL2003682	=	Ki	nM	794.33	CHEMBL301	Homo sapiens	pKi		6.1
active	9585891	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	=	Ki	nM	316.23	CHEMBL301	Homo sapiens	pKi		6.5
inactive	9585892	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	C(=NNc1nc2ccccc2[nH]1)c1c[nH]c2ccccc12		CHEMBL535331	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585893	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	=	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585894	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccc(F)cc1		CHEMBL1966204	=	Ki	nM	12.59	CHEMBL301	Homo sapiens	pKi		7.9
inactive	9585895	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585896	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)=C(C)c1cccc2c(CCCOc3cccc(Cl)c3Cl)c(C(=O)O)[nH]c12		CHEMBL1982980	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585897	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585898	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	=	Ki	nM	794.33	CHEMBL301	Homo sapiens	pKi		6.1
active	9585899	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	=	Ki	nM	3981.07	CHEMBL301	Homo sapiens	pKi		5.4
active	9585900	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	FC(F)(F)c1ccccc1CNc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1999153	=	Ki	nM	5.012	CHEMBL301	Homo sapiens	pKi		8.3
active	9585901	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	c1ccc(Cn2nnc(-c3ccc4[nH]ncc4c3)c2-c2ccccc2)cc1		CHEMBL1969473	=	Ki	nM	63.1	CHEMBL301	Homo sapiens	pKi		7.2
inactive	9585902	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585903	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585904	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(=O)c1cc2c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cncc2s1		CHEMBL2002322	=	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
active	9585905	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COCCN(CCOC)c1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1985654	=	Ki	nM	1995.26	CHEMBL301	Homo sapiens	pKi		5.7
inactive	9585906	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccc(F)c(-c2ccc3nnc(N)n3c2)c1		CHEMBL2002323	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585907	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	=	Ki	nM	15.85	CHEMBL301	Homo sapiens	pKi		7.8
inactive	9585908	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585909	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COC(=O)c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O		CHEMBL2004513	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585910	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NCCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1972258	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585911	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CNCCOc1cncc(-c2ccc3[nH]nc(C)c3c2)c1		CHEMBL1983855	=	Ki	nM	501.19	CHEMBL301	Homo sapiens	pKi		6.3
inactive	9585912	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	<	Ki	nM	6309.57	CHEMBL301	Homo sapiens	pKi		5.2
inactive	9585913	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(Cl)cc4Cl)c(=O)c3=O)ccc21		CHEMBL2005548	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585914	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccccc1-c1c(C(=O)O)n(CCCOc2cccc3ccccc23)c2ccccc12		CHEMBL1987793	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585915	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585916	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	=	Ki	nM	1000.0	CHEMBL301	Homo sapiens	pKi		6.0
inactive	9585917	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	OCCCn1cnc(-c2ccccc2)c1-c1ccncc1		CHEMBL2002373	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585918	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585919	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	=	Ki	nM	6309.57	CHEMBL301	Homo sapiens	pKi		5.2
inactive	9585920	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585921	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	=	Ki	nM	316.23	CHEMBL301	Homo sapiens	pKi		6.5
active	9585922	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	=	Ki	nM	100.0	CHEMBL301	Homo sapiens	pKi		7.0
active	9585923	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3C3CC3)cc12		CHEMBL2004631	=	Ki	nM	79.43	CHEMBL301	Homo sapiens	pKi		7.1
inactive	9585924	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCOC(=O)c1cccc2[nH]c(-c3ccc(N4CCC(N)C4)cc3)nc12		CHEMBL1995736	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585925	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585926	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	=	Ki	nM	50.12	CHEMBL301	Homo sapiens	pKi		7.3
inactive	9585927	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585928	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	=	Ki	nM	398.11	CHEMBL301	Homo sapiens	pKi		6.4
inactive	9585929	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)(O)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1998551	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585930	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1977374	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585931	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COCc1nnn(-c2nonc2N)c1C(=O)NN=C(C)c1ccc(O)cc1O		CHEMBL1991180	=	Ki	nM	1995.26	CHEMBL301	Homo sapiens	pKi		5.7
inactive	9585932	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585933	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	=	Ki	nM	1258.93	CHEMBL301	Homo sapiens	pKi		5.9
active	9585934	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccccc1-c1c(-c2ccc3[nH]nc(C)c3c2)nnn1Cc1ccccc1		CHEMBL1983315	=	Ki	nM	3.981	CHEMBL301	Homo sapiens	pKi		8.4
inactive	9585935	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1c(O)cccc1NC(=O)c1cnn2c(-c3ccccc3)ccnc12		CHEMBL1978656	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585936	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	=	Ki	nM	251.19	CHEMBL301	Homo sapiens	pKi		6.6
active	9585937	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCO)c(Cl)cc1NC(=O)N2		CHEMBL413779	=	Ki	nM	1995.26	CHEMBL301	Homo sapiens	pKi		5.7
inactive	9585938	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585939	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	=	Ki	nM	3981.07	CHEMBL301	Homo sapiens	pKi		5.4
inactive	9585940	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585941	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL1973961	<	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
active	9585942	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	=	Ki	nM	630.96	CHEMBL301	Homo sapiens	pKi		6.2
active	9585943	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN(c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O)S(C)(=O)=O		CHEMBL1980497	=	Ki	nM	1995.26	CHEMBL301	Homo sapiens	pKi		5.7
active	9585944	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	=	Ki	nM	1995.26	CHEMBL301	Homo sapiens	pKi		5.7
inactive	9585945	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585946	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585947	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccc(Cl)cc1		CHEMBL1987073	=	Ki	nM	19.95	CHEMBL301	Homo sapiens	pKi		7.7
active	9585948	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN(C)CC(=O)NC1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1995712	=	Ki	nM	1995.26	CHEMBL301	Homo sapiens	pKi		5.7
active	9585949	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	=	Ki	nM	316.23	CHEMBL301	Homo sapiens	pKi		6.5
inactive	9585950	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2003657	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585951	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585952	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585953	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(=O)c1ccc(Nc2ncnc3[nH]cc(-c4ccccc4)c23)cc1		CHEMBL1975440	=	Ki	nM	501.19	CHEMBL301	Homo sapiens	pKi		6.3
inactive	9585954	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	OCCNc1cc2cc(-c3ccncc3)ccc2cn1		CHEMBL1998435	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585955	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	=	Ki	nM	199.53	CHEMBL301	Homo sapiens	pKi		6.7
active	9585956	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)N(C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1)C(C)C		CHEMBL2006156	=	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
inactive	9585957	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585958	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	<	Ki	nM	6309.57	CHEMBL301	Homo sapiens	pKi		5.2
active	9585959	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Ki	nM	125.89	CHEMBL301	Homo sapiens	pKi		6.9
active	9585960	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	=	Ki	nM	251.19	CHEMBL301	Homo sapiens	pKi		6.6
active	9585961	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	=	Ki	nM	501.19	CHEMBL301	Homo sapiens	pKi		6.3
inactive	9585962	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	FC(F)(F)Oc1ccc(-c2ccc3[nH]cc(C4=CCNCC4)c3c2)cc1		CHEMBL1987982	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585963	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585964	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1		CHEMBL1969102	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585965	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1682346	=	Ki	nM	501.19	CHEMBL301	Homo sapiens	pKi		6.3
active	9585966	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	=	Ki	nM	6309.57	CHEMBL301	Homo sapiens	pKi		5.2
inactive	9585967	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CNC(=O)N1CCN(CCCOc2ccc3c(c2)-c2[nH]nc(-c4ccc(C#N)nc4)c2C3)CC1		CHEMBL2001998	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585968	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	=	Ki	nM	1000.0	CHEMBL301	Homo sapiens	pKi		6.0
inactive	9585969	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585970	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585971	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Ki	nM	31.62	CHEMBL301	Homo sapiens	pKi		7.5
active	9585972	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	=	Ki	nM	199.53	CHEMBL301	Homo sapiens	pKi		6.7
inactive	9585973	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585974	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]ncc34)cc2)c1		CHEMBL375284	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585975	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CS(=O)(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1980562	=	Ki	nM	100.0	CHEMBL301	Homo sapiens	pKi		7.0
inactive	9585976	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585977	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=c1cc(-c2cccc(F)c2)[nH]c2c(-c3ccc(F)cc3)cnn12		CHEMBL2004156	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585978	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585979	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	c1ccc(CSc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL1968926	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585980	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCNC(=O)c1n[nH]c(-c2cc(Cl)c(O)cc2O)c1-c1ccc(OC)cc1		CHEMBL365617	=	Ki	nM	6309.57	CHEMBL301	Homo sapiens	pKi		5.2
inactive	9585981	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCOc1nc(C(=O)NCc2ccncc2)cc(N)c1C#N		CHEMBL1984206	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585982	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	=	Ki	nM	5011.87	CHEMBL301	Homo sapiens	pKi		5.3
inactive	9585983	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C1CCCCC1		CHEMBL1991577	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585984	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(O)c1ccccc1Nc1ncnc(Nc2cccc(F)c2)n1		CHEMBL1979933	=	Ki	nM	630.96	CHEMBL301	Homo sapiens	pKi		6.2
inactive	9585985	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585986	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585987	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	OC1CCCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1976936	=	Ki	nM	630.96	CHEMBL301	Homo sapiens	pKi		6.2
inactive	9585988	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585989	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)(O)CNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL2005387	=	Ki	nM	251.19	CHEMBL301	Homo sapiens	pKi		6.6
active	9585990	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	=	Ki	nM	2511.89	CHEMBL301	Homo sapiens	pKi		5.6
inactive	9585991	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9585992	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL1972362	=	Ki	nM	1000.0	CHEMBL301	Homo sapiens	pKi		6.0
active	9585993	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	c1ccc(Cn2cc(-c3ccc4[nH]nc(-c5ccccc5)c4c3)nn2)cc1		CHEMBL1982400	=	Ki	nM	100.0	CHEMBL301	Homo sapiens	pKi		7.0
inactive	9585994	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585995	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	6309.57	CHEMBL301	Homo sapiens	pKi		5.2
inactive	9585996	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Clc1cc(-c2c[nH]c3ncccc23)ncn1		CHEMBL1972988	<	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
active	9585997	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	=	Ki	nM	316.23	CHEMBL301	Homo sapiens	pKi		6.5
inactive	9585998	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CNc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2007372	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9585999	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1ccc(OC)c(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1982167	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9586000	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1971017	=	Ki	nM	158.49	CHEMBL301	Homo sapiens	pKi		6.8
inactive	9586001	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9586002	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	=	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9586003	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9586004	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9586005	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL2000104	=	Ki	nM	1584.89	CHEMBL301	Homo sapiens	pKi		5.8
inactive	9586006	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9586007	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1987448	=	Ki	nM	39.81	CHEMBL301	Homo sapiens	pKi		7.4
inactive	9586008	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9586009	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9586010	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC1=NN(c2ccc(Cl)c(Cl)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1997349	=	Ki	nM	1584.89	CHEMBL301	Homo sapiens	pKi		5.8
inactive	9586011	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9586012	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9586013	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	=	Ki	nM	6309.57	CHEMBL301	Homo sapiens	pKi		5.2
inactive	9586014	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9586015	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9586016	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9586017	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9586018	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(=O)c1ccc(-c2ccncc2)cc1NCc1cccc(F)c1		CHEMBL1982982	=	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
active	9586019	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CS(=O)(=O)NC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL2005216	=	Ki	nM	398.11	CHEMBL301	Homo sapiens	pKi		6.4
inactive	9586020	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9586021	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	=	Ki	nM	1584.89	CHEMBL301	Homo sapiens	pKi		5.8
inactive	9586022	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9586023	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	Ki	nM	125.89	CHEMBL301	Homo sapiens	pKi		6.9
inactive	9586024	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1970879	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9586025	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1c(C=O)c(O)n2c(nc3ccccc32)c1C#N		CHEMBL1989856	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9586026	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9586027	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	=	Ki	nM	1258.93	CHEMBL301	Homo sapiens	pKi		5.9
active	9586028	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Ki	nM	5011.87	CHEMBL301	Homo sapiens	pKi		5.3
inactive	9586029	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cncc(C=Cc2ccncc2)c1		CHEMBL1972568	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9586030	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN1CCC1COc1cncc(CCc2ccncc2)c1		CHEMBL1996155	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9586031	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2F)c1		CHEMBL1986851	<	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
active	9586032	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C1Nc2ccccc2Nc2cc(-c3ccncc3Cl)ccc21		CHEMBL1987745	=	Ki	nM	501.19	CHEMBL301	Homo sapiens	pKi		6.3
active	9586033	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	=	Ki	nM	25.12	CHEMBL301	Homo sapiens	pKi		7.6
inactive	9586034	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9586035	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1682359	=	Ki	nM	630.96	CHEMBL301	Homo sapiens	pKi		6.2
active	9586036	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	=	Ki	nM	50.12	CHEMBL301	Homo sapiens	pKi		7.3
inactive	9589602	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1ccccc1		CHEMBL1991846	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589603	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	31.62	CHEMBL301	Homo sapiens	pKi		7.5
active	9589604	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	=	Ki	nM	316.23	CHEMBL301	Homo sapiens	pKi		6.5
inactive	9589605	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1988995	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589606	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc(C=O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL207995	=	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
inactive	9589607	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589608	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	=	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589609	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	=	Ki	nM	398.11	CHEMBL301	Homo sapiens	pKi		6.4
inactive	9589610	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589611	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C1CN=C(c2cccc(Cl)c2)c2c(sc3c2CCCC3)N1		CHEMBL2002470	=	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589612	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589613	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1OCC(O)CO		CHEMBL1981045	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589614	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589615	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	c1ccc(Cn2nnc(-c3ccc4[nH]ncc4c3)c2C2CC2)cc1		CHEMBL1975418	=	Ki	nM	31.62	CHEMBL301	Homo sapiens	pKi		7.5
inactive	9589616	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=c1[nH]c2ccc(Cl)cc2c(-c2ccccc2)c1C1=NNC(c2ccccc2)C1		CHEMBL1992796	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589617	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
inactive	9589618	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCC(O)CO)c(Cl)cc1NC(=O)N2		CHEMBL223257	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589619	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	=	Ki	nM	3981.07	CHEMBL301	Homo sapiens	pKi		5.4
inactive	9589620	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589621	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589622	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589623	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1n[nH]c2ccc(-c3cc(Cc4ccccc4)no3)cc12		CHEMBL1682358	=	Ki	nM	199.53	CHEMBL301	Homo sapiens	pKi		6.7
inactive	9589624	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589625	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	=	Ki	nM	125.89	CHEMBL301	Homo sapiens	pKi		6.9
inactive	9589626	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589627	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589628	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1c(Cl)c(N2CCC(CN)C2)nc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL1999774	=	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589629	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589630	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	OC1CCN(c2ncnc3[nH]cc(-c4ccccc4)c23)CC1		CHEMBL1973395	=	Ki	nM	251.19	CHEMBL301	Homo sapiens	pKi		6.6
inactive	9589631	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589632	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	=	Ki	nM	1995.26	CHEMBL301	Homo sapiens	pKi		5.7
active	9589633	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C1Nc2ccccc2Nc2nnccc21		CHEMBL1971801	=	Ki	nM	2511.89	CHEMBL301	Homo sapiens	pKi		5.6
active	9589634	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C1Nc2ccccc2Nc2nnc(Cl)cc21		CHEMBL1968850	=	Ki	nM	316.23	CHEMBL301	Homo sapiens	pKi		6.5
active	9589635	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	=	Ki	nM	5011.87	CHEMBL301	Homo sapiens	pKi		5.3
active	9589636	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	31.62	CHEMBL301	Homo sapiens	pKi		7.5
inactive	9589637	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589638	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	=	Ki	nM	1995.26	CHEMBL301	Homo sapiens	pKi		5.7
active	9589639	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	=	Ki	nM	794.33	CHEMBL301	Homo sapiens	pKi		6.1
inactive	9589640	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589641	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589642	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	=	Ki	nM	19.95	CHEMBL301	Homo sapiens	pKi		7.7
inactive	9589643	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589644	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	501.19	CHEMBL301	Homo sapiens	pKi		6.3
active	9589645	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)cc1Cl		CHEMBL1990212	=	Ki	nM	6309.57	CHEMBL301	Homo sapiens	pKi		5.2
inactive	9589646	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589647	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	=	Ki	nM	199.53	CHEMBL301	Homo sapiens	pKi		6.7
inactive	9589648	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589649	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	c1ccc(Cc2cn(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682341	=	Ki	nM	630.96	CHEMBL301	Homo sapiens	pKi		6.2
active	9589650	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	=	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589651	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	=	Ki	nM	125.89	CHEMBL301	Homo sapiens	pKi		6.9
inactive	9589652	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589653	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	C#Cc1cc2c(cc1OC)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL1972250	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589654	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	=	Ki	nM	158.49	CHEMBL301	Homo sapiens	pKi		6.8
inactive	9589655	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL2004072	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589656	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(=O)c1ccc(-c2ccncc2)cc1NCc1ccccc1		CHEMBL2001477	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589657	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589658	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	=	Ki	nM	251.19	CHEMBL301	Homo sapiens	pKi		6.6
inactive	9589659	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589660	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCNNc1cc(C)c(C#N)c2nc3ccccc3n12		CHEMBL2000433	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589661	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	N#CC(=Cc1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL1974157	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589662	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589663	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589664	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589665	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	=	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
inactive	9589666	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589667	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	=	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
active	9589668	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN(C)c1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1		CHEMBL1992363	=	Ki	nM	50.12	CHEMBL301	Homo sapiens	pKi		7.3
inactive	9589669	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL260092	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589670	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589671	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589672	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1n[nH]c2ncc(C#N)c(-c3ccccc3)c12		CHEMBL1965495	=	Ki	nM	1584.89	CHEMBL301	Homo sapiens	pKi		5.8
active	9589673	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	=	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589674	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	=	Ki	nM	2511.89	CHEMBL301	Homo sapiens	pKi		5.6
inactive	9589675	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589676	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1		CHEMBL1173055	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589677	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	=	Ki	nM	5011.87	CHEMBL301	Homo sapiens	pKi		5.3
inactive	9589678	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589679	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN(C)CC(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1982271	=	Ki	nM	39.81	CHEMBL301	Homo sapiens	pKi		7.4
active	9589680	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	=	Ki	nM	794.33	CHEMBL301	Homo sapiens	pKi		6.1
inactive	9589681	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589682	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C1NC(=O)C(Nc2ccccc2)=C1Cl		CHEMBL2007138	<	Ki	nM	19952.62	CHEMBL301	Homo sapiens	pKi		4.7
active	9589683	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	=	Ki	nM	79.43	CHEMBL301	Homo sapiens	pKi		7.1
inactive	9589684	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589685	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589686	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(C=NNc2cc(N3CCOCC3)nc(OCCc3ccccn3)n2)c1		CHEMBL1965351	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589687	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589688	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589689	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc(Nc2ncnc3ccc(-c4ccc(CN5CC6C(CO)C6C5)cc4)cc23)ccc1Oc1ccccc1		CHEMBL1999749	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589690	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589691	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589692	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc(C(=O)O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1983006	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589693	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN1CCCC1COc1cncc(CCc2ccccc2)c1		CHEMBL1972183	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589694	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	=	Ki	nM	100.0	CHEMBL301	Homo sapiens	pKi		7.0
inactive	9589695	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)Nc1n[nH]c2ccc(N)cc12		CHEMBL1995391	<	Ki	nM	19952.62	CHEMBL301	Homo sapiens	pKi		4.7
inactive	9589696	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589697	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1sc2[nH]c(=O)n3nc(-c4ccncc4)nc3c2c1C		CHEMBL1980592	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589698	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589699	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	=	Ki	nM	6309.57	CHEMBL301	Homo sapiens	pKi		5.2
active	9589700	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	=	Ki	nM	199.53	CHEMBL301	Homo sapiens	pKi		6.7
inactive	9589701	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589702	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	=	Ki	nM	6309.57	CHEMBL301	Homo sapiens	pKi		5.2
active	9589703	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	=	Ki	nM	199.53	CHEMBL301	Homo sapiens	pKi		6.7
active	9589704	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	=	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
active	9589705	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	=	Ki	nM	1584.89	CHEMBL301	Homo sapiens	pKi		5.8
active	9589706	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Nc1ccccc1)Nc1nccs1		CHEMBL1487428	=	Ki	nM	19952.62	CHEMBL301	Homo sapiens	pKi		4.7
active	9589707	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=[N+]([O-])c1cccc(-c2nnc3ccc(N4CCCCC4)nn23)c1		CHEMBL2003637	=	Ki	nM	630.96	CHEMBL301	Homo sapiens	pKi		6.2
active	9589708	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(O)c1ccccc1Nc1ncnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL1986666	=	Ki	nM	316.23	CHEMBL301	Homo sapiens	pKi		6.5
inactive	9589709	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589710	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	=	Ki	nM	1000.0	CHEMBL301	Homo sapiens	pKi		6.0
active	9589711	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(=O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1999556	=	Ki	nM	501.19	CHEMBL301	Homo sapiens	pKi		6.3
active	9589712	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	=	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589713	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(COc1cc(C=Cc2ccncc2)cnc1Cl)Cc1c[nH]c2ccccc12		CHEMBL1968245	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589714	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589715	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	=	Ki	nM	794.33	CHEMBL301	Homo sapiens	pKi		6.1
inactive	9589716	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589717	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	=	Ki	nM	199.53	CHEMBL301	Homo sapiens	pKi		6.7
active	9589718	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1CC#N		CHEMBL1985566	=	Ki	nM	5011.87	CHEMBL301	Homo sapiens	pKi		5.3
inactive	9589719	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589720	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589721	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	N#Cc1ncc2nc1OCC(O)C(O)COc1ccc(Cl)cc1NC(=O)N2		CHEMBL1980802	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589722	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1996649	<	Ki	nM	3162.28	CHEMBL301	Homo sapiens	pKi		5.5
active	9589723	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	OCCNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1989006	=	Ki	nM	316.23	CHEMBL301	Homo sapiens	pKi		6.5
active	9589724	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	=	Ki	nM	158.49	CHEMBL301	Homo sapiens	pKi		6.8
inactive	9589725	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=c1c(NCc2ccc(Cl)cc2Cl)c(Nc2ccc3[nH]ncc3c2)c1=O		CHEMBL1979554	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589726	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2ccncc2)c1-c1ccccc1		CHEMBL1419458	=	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589727	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCOc1nc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)cc(N)c1C#N		CHEMBL2004355	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589728	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589729	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589730	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589731	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	C=CCNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1996339	=	Ki	nM	100.0	CHEMBL301	Homo sapiens	pKi		7.0
inactive	9589732	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589733	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589734	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589735	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	=	Ki	nM	1258.93	CHEMBL301	Homo sapiens	pKi		5.9
inactive	9589736	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589737	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	=	Ki	nM	1000.0	CHEMBL301	Homo sapiens	pKi		6.0
inactive	9589738	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589739	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589740	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589741	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Ki	nM	1995.26	CHEMBL301	Homo sapiens	pKi		5.7
active	9589742	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	=	Ki	nM	63.1	CHEMBL301	Homo sapiens	pKi		7.2
active	9589743	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1996390	=	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589744	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	N#Cc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1		CHEMBL1990162	=	Ki	nM	12.59	CHEMBL301	Homo sapiens	pKi		7.9
active	9589745	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCNC(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1992220	=	Ki	nM	10.0	CHEMBL301	Homo sapiens	pKi		8.0
active	9589746	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	12.59	CHEMBL301	Homo sapiens	pKi		7.9
inactive	9589747	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589748	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1n[nH]c2sc(C(=O)NCCc3ccc(Cl)cc3)cc12		CHEMBL1998414	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589749	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589750	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	=	Ki	nM	1258.93	CHEMBL301	Homo sapiens	pKi		5.9
inactive	9589751	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589752	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=c1[nH]sc2c1c(=O)c1cc(F)c(NCc3ccccc3)c(F)c1n2C1CC1		CHEMBL1991640	=	Ki	nM	3981.07	CHEMBL301	Homo sapiens	pKi		5.4
inactive	9589753	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589754	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Ki	nM	15.85	CHEMBL301	Homo sapiens	pKi		7.8
inactive	9589755	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589756	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	=	Ki	nM	501.19	CHEMBL301	Homo sapiens	pKi		6.3
active	9589757	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	=	Ki	nM	25.12	CHEMBL301	Homo sapiens	pKi		7.6
active	9589758	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	=	Ki	nM	2511.89	CHEMBL301	Homo sapiens	pKi		5.6
active	9589759	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CS(=O)(=O)NC1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1987948	=	Ki	nM	125.89	CHEMBL301	Homo sapiens	pKi		6.9
inactive	9589760	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589761	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589762	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Clc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1381197	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589763	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	=	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589764	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	=	Ki	nM	79.43	CHEMBL301	Homo sapiens	pKi		7.1
active	9589765	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	=	Ki	nM	1995.26	CHEMBL301	Homo sapiens	pKi		5.7
active	9589766	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1		CHEMBL336961	=	Ki	nM	501.19	CHEMBL301	Homo sapiens	pKi		6.3
active	9589767	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	=	Ki	nM	630.96	CHEMBL301	Homo sapiens	pKi		6.2
inactive	9589768	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(Cl)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1987054	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589769	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1ncc(-c2ccncc2)c2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1970083	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589770	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589771	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12		CHEMBL2005631	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589772	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589773	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	6309.57	CHEMBL301	Homo sapiens	pKi		5.2
active	9589774	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	=	Ki	nM	3.162	CHEMBL301	Homo sapiens	pKi		8.5
inactive	9589775	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589776	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589777	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	<	Ki	nM	1584.89	CHEMBL301	Homo sapiens	pKi		5.8
inactive	9589778	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589779	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCCCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1991728	=	Ki	nM	501.19	CHEMBL301	Homo sapiens	pKi		6.3
active	9589780	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cc(F)ccc1F		CHEMBL1995811	=	Ki	nM	25.12	CHEMBL301	Homo sapiens	pKi		7.6
active	9589781	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(=O)c1cc2c(-c3ccc(F)cc3F)cncc2s1		CHEMBL1975787	=	Ki	nM	251.19	CHEMBL301	Homo sapiens	pKi		6.6
active	9589782	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc(C=C(C#N)c2n[nH]c(N)c2C#N)ccc1O		CHEMBL2002407	=	Ki	nM	1258.93	CHEMBL301	Homo sapiens	pKi		5.9
inactive	9589783	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589784	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	=	Ki	nM	6309.57	CHEMBL301	Homo sapiens	pKi		5.2
active	9589785	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	=	Ki	nM	1258.93	CHEMBL301	Homo sapiens	pKi		5.9
active	9589786	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCOC(=O)c1c(NC(=O)C2C(C)(C)C2(C)C)sc2cnccc12		CHEMBL1990541	=	Ki	nM	1000.0	CHEMBL301	Homo sapiens	pKi		6.0
active	9589787	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)(CN)CNc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL1968930	=	Ki	nM	39.81	CHEMBL301	Homo sapiens	pKi		7.4
active	9589788	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1CC#N		CHEMBL1985566	=	Ki	nM	5011.87	CHEMBL301	Homo sapiens	pKi		5.3
inactive	9589789	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589790	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589791	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589792	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589793	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	=	Ki	nM	63.1	CHEMBL301	Homo sapiens	pKi		7.2
inactive	9589794	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589795	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	6309.57	CHEMBL301	Homo sapiens	pKi		5.2
inactive	9589796	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589797	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(O)c1ccccc1Nc1ccnc(NCc2cccc(O)c2)n1		CHEMBL1970950	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589798	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589799	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589800	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589801	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	=	Ki	nM	1995.26	CHEMBL301	Homo sapiens	pKi		5.7
active	9589802	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	=	Ki	nM	6309.57	CHEMBL301	Homo sapiens	pKi		5.2
inactive	9589803	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589804	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	=	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589805	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1987648	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589806	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCOC(=O)c1cn(-c2ccc(O)cc2C)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL1996780	=	Ki	nM	3981.07	CHEMBL301	Homo sapiens	pKi		5.4
inactive	9589807	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589808	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589809	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCCCCCCCCCCCOc1ccc(NC(=N)N)cc1NC(=N)N		CHEMBL1980715	=	Ki	nM	5011.87	CHEMBL301	Homo sapiens	pKi		5.3
inactive	9589810	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	<	Ki	nM	25.12	CHEMBL301	Homo sapiens	pKi		7.6
active	9589811	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Ki	nM	100.0	CHEMBL301	Homo sapiens	pKi		7.0
inactive	9589812	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589813	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC(COc1cncc(-c2cc3ccncc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1966524	=	Ki	nM	158.49	CHEMBL301	Homo sapiens	pKi		6.8
inactive	9589814	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=c1c2c([nH]c3cc(-c4ccco4)nn13)CSC2		CHEMBL1972152	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589815	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	=	Ki	nM	1995.26	CHEMBL301	Homo sapiens	pKi		5.7
inactive	9589816	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589817	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc(CN2CCCCC2)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL202635	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589818	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589819	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	=	Ki	nM	25.12	CHEMBL301	Homo sapiens	pKi		7.6
inactive	9589820	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589821	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	OCCCCNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1970821	=	Ki	nM	125.89	CHEMBL301	Homo sapiens	pKi		6.9
inactive	9589822	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)(C)NC(=O)c1ccc2nc3[nH]c4ccccc4c3nc2c1		CHEMBL1969264	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589823	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	N#Cc1c(O)[nH]c(=O)c2c(=N)oc3ccc(Cl)cc3c12		CHEMBL1973711	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589824	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589825	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589826	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CNC(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL2005509	=	Ki	nM	15.85	CHEMBL301	Homo sapiens	pKi		7.8
inactive	9589827	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589828	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589829	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589830	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589831	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(O)c1ccc(N2C(=O)c3ccccc3C2=O)cc1O		CHEMBL1972820	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589832	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	=	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589833	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	NNc1cc(N2CCOCC2)nc(OCCc2ccccn2)n1		CHEMBL1996208	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9589834	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589835	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	=	Ki	nM	316.23	CHEMBL301	Homo sapiens	pKi		6.5
inactive	9589836	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589837	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	=	Ki	nM	25.12	CHEMBL301	Homo sapiens	pKi		7.6
inactive	9589838	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9589839	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	=	Ki	nM	199.53	CHEMBL301	Homo sapiens	pKi		6.7
active	9589840	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCCCNc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682554	=	Ki	nM	398.11	CHEMBL301	Homo sapiens	pKi		6.4
inactive	9593410	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9593411	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9593412	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1ccc(CNc2cc(-c3c[nH]c4ncccc34)cc(F)n2)cc1		CHEMBL1986855	=	Ki	nM	7.943	CHEMBL301	Homo sapiens	pKi		8.1
inactive	9593413	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9593414	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9593415	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)(C)OC(=O)n1cc(-c2cncn2C2CCCCC2)c2ccccc21		CHEMBL1975357	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9593416	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9593417	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C1Nc2ccccc2Nc2cc(-c3ccncc3)ccc21		CHEMBL1989136	=	Ki	nM	1000.0	CHEMBL301	Homo sapiens	pKi		6.0
inactive	9593418	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9593419	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9593420	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9593421	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9593422	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9593423	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9593424	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	=	Ki	nM	794.33	CHEMBL301	Homo sapiens	pKi		6.1
inactive	9593425	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9593426	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	c1ccc2c(c1)nnn2Cc1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1966069	=	Ki	nM	1000.0	CHEMBL301	Homo sapiens	pKi		6.0
inactive	9593427	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9593428	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9593429	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9593430	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	316.23	CHEMBL301	Homo sapiens	pKi		6.5
active	9593431	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	=	Ki	nM	3981.07	CHEMBL301	Homo sapiens	pKi		5.4
inactive	9593432	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9593433	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	CSc1nn(-c2ccccn2)c(N)c1C(N)=O		CHEMBL2004615	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
inactive	9593434	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	Cc1nn(C)c(C)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)[nH]c12		CHEMBL1984039	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
active	9593435	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	Ki	nM	158.49	CHEMBL301	Homo sapiens	pKi		6.8
inactive	9593436	CHEMBL1963723	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	<	Ki	nM	7943.28	CHEMBL301	Homo sapiens	pKi		5.1
	10834749	CHEMBL2013356	Inhibition of CDK2	B	COc1ccc(-c2nc3c(NCC4CCNCC4)c(Br)cnc3[nH]2)cc1		CHEMBL2011926	=	IC50	nM	135.0	CHEMBL301	Homo sapiens	IC50	uM	0.135
	10834750	CHEMBL2013356	Inhibition of CDK2	B	COc1ccc(-c2nc3c(OCC4CCNCC4)c(Br)cnc3[nH]2)cc1		CHEMBL2011927	=	IC50	nM	133.0	CHEMBL301	Homo sapiens	IC50	uM	0.133
	10834751	CHEMBL2013356	Inhibition of CDK2	B	COc1ccc(-c2nc3c(NCCCNC(C)=O)c(Br)cnc3[nH]2)cc1		CHEMBL2011928	=	IC50	nM	370.0	CHEMBL301	Homo sapiens	IC50	uM	0.37
	10834752	CHEMBL2013356	Inhibition of CDK2	B	COc1ccc(-c2nc3c(NCCCNC(=O)C(C)C)c(Br)cnc3[nH]2)cc1		CHEMBL2011929	>	IC50	nM	5280.0	CHEMBL301	Homo sapiens	IC50	uM	5.28
	10834753	CHEMBL2013356	Inhibition of CDK2	B	COc1ccc(-c2nc3c(NCCCNC(=O)C(C)(C)C)c(Br)cnc3[nH]2)cc1		CHEMBL2011930	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	10834754	CHEMBL2013356	Inhibition of CDK2	B	COc1ccc(-c2nc3c(NCCCNC(=O)C4CC4)c(Br)cnc3[nH]2)cc1		CHEMBL2011931	=	IC50	nM	1370.0	CHEMBL301	Homo sapiens	IC50	uM	1.37
	10834755	CHEMBL2013356	Inhibition of CDK2	B	COc1ccc(-c2nc3c(NCCCNC(=O)C4(CN)CC4)c(Br)cnc3[nH]2)cc1		CHEMBL2011932	=	IC50	nM	70.0	CHEMBL301	Homo sapiens	IC50	uM	0.07
	10834756	CHEMBL2013356	Inhibition of CDK2	B	COc1ccc(-c2nc3c(NCCCNC(=O)C4CCC4)c(Br)cnc3[nH]2)cc1		CHEMBL2011933	>	IC50	nM	4910.0	CHEMBL301	Homo sapiens	IC50	uM	4.91
	10834757	CHEMBL2013356	Inhibition of CDK2	B	COc1ccc(-c2nc3c(NCCCN(C)C(=O)C4CCC4)c(Br)cnc3[nH]2)cc1		CHEMBL2011934	=	IC50	nM	187.0	CHEMBL301	Homo sapiens	IC50	uM	0.187
	10834758	CHEMBL2013356	Inhibition of CDK2	B	COc1ccc(-c2nc3c(NCCCNC(=O)C4CC(O)C4)c(Br)cnc3[nH]2)cc1		CHEMBL2011935	=	IC50	nM	345.0	CHEMBL301	Homo sapiens	IC50	uM	0.345
	10834759	CHEMBL2013356	Inhibition of CDK2	B	COc1ccc(-c2nc3c(NCCCNC(=O)C4CCCC4)c(Br)cnc3[nH]2)cc1		CHEMBL2011936	=	IC50	nM	2790.0	CHEMBL301	Homo sapiens	IC50	uM	2.79
	10834760	CHEMBL2013356	Inhibition of CDK2	B	COc1ccc(-c2nc3c(NCCCNC(=O)c4ccccc4)c(Br)cnc3[nH]2)cc1		CHEMBL2011937	=	IC50	nM	3970.0	CHEMBL301	Homo sapiens	IC50	uM	3.97
Not Determined	10834761	CHEMBL2013356	Inhibition of CDK2	B	COc1ccc(-c2nc3c(NCCCNC(=O)c4cccnc4)c(Br)cnc3[nH]2)cc1		CHEMBL2011938		IC50			CHEMBL301	Homo sapiens	IC50		
Not Determined	10834762	CHEMBL2013356	Inhibition of CDK2	B	COc1ccc(-c2nc3c(NCCCNC(=O)c4cccs4)c(Br)cnc3[nH]2)cc1		CHEMBL2011939		IC50			CHEMBL301	Homo sapiens	IC50		
	10834763	CHEMBL2013356	Inhibition of CDK2	B	Nc1cccc(-c2nc3c(NCCCNC(=O)C4CCC4)c(Br)cnc3[nH]2)c1		CHEMBL2011940	=	IC50	nM	155.0	CHEMBL301	Homo sapiens	IC50	uM	0.155
	10834764	CHEMBL2013356	Inhibition of CDK2	B	O=C(NCCCNc1c(Br)cnc2[nH]c(-c3ccc(OCCN4CCCCC4)cc3)nc12)C1CCC1		CHEMBL2011941	=	IC50	nM	518.0	CHEMBL301	Homo sapiens	IC50	uM	0.518
	10834765	CHEMBL2013356	Inhibition of CDK2	B	NC(=O)c1cnc2[nH]c(-c3ccc(OCCN4CCCCC4)cc3)nc2c1NCCCNC(=O)C1CCC1		CHEMBL2011942	=	IC50	nM	9410.0	CHEMBL301	Homo sapiens	IC50	uM	9.41
	10834766	CHEMBL2013356	Inhibition of CDK2	B	COc1ccc(-c2nc3c(NCCCNC(=O)C4CCCC4)c(C(N)=O)cnc3[nH]2)cc1		CHEMBL2011943	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	10834767	CHEMBL2013356	Inhibition of CDK2	B	COc1ccccc1-c1nc2c(NCC(O)CNC(=O)C3CCC3)c(Br)cnc2[nH]1		CHEMBL2011944	=	IC50	nM	4650.0	CHEMBL301	Homo sapiens	IC50	uM	4.65
	10834768	CHEMBL2013356	Inhibition of CDK2	B	COc1ccc(F)cc1-c1nc2c(NCCCNC(=O)C3CCC3)c(Br)cnc2[nH]1		CHEMBL2011945	=	IC50	nM	6520.0	CHEMBL301	Homo sapiens	IC50	uM	6.52
	10834769	CHEMBL2013356	Inhibition of CDK2	B	COc1cc(F)ccc1-c1nc2c(NCCCNC(=O)C3CCC3)c(Br)cnc2[nH]1		CHEMBL2010815	=	IC50	nM	2020.0	CHEMBL301	Homo sapiens	IC50	uM	2.02
	10867550	CHEMBL2027480	Inhibition of CDK2 by filter binding assay	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	IC50	nM	5000.0	CHEMBL301	Homo sapiens	IC50	uM	5.0
Not Determined	10871391	CHEMBL2027575	Inhibition of CDK2 using RbING as substrate after 2 hrs by luminescence assay	B	COc1ccc(-c2nc(Nc3cccc(C(=O)NC4CCNC4)c3)nc3[nH]cnc23)cc1OC		CHEMBL2023419		IC50			CHEMBL301	Homo sapiens	IC50		
	10871392	CHEMBL2027575	Inhibition of CDK2 using RbING as substrate after 2 hrs by luminescence assay	B	COc1ccc(-c2nc(Nc3cccc(NC(=O)C4CCNCC4)c3)nc3[nH]cnc23)cc1OC		CHEMBL2023418	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
Not Determined	10871393	CHEMBL2027575	Inhibition of CDK2 using RbING as substrate after 2 hrs by luminescence assay	B	COc1ccc(-c2nc(Nc3cccc(C(=O)NC4CCNCC4)c3)nc3[nH]cnc23)cc1OC		CHEMBL2023417		IC50			CHEMBL301	Homo sapiens	IC50		
Not Determined	10871394	CHEMBL2027575	Inhibition of CDK2 using RbING as substrate after 2 hrs by luminescence assay	B	COc1ccc(-c2nc(Nc3cccc(NC(=O)N4CCCCC4)c3)nc3[nH]cnc23)cc1		CHEMBL2023416		IC50			CHEMBL301	Homo sapiens	IC50		
	10871395	CHEMBL2027575	Inhibition of CDK2 using RbING as substrate after 2 hrs by luminescence assay	B	COc1ccc(-c2nc(Nc3cccc(NC(=O)NCCN4CCOCC4)c3)nc3[nH]cnc23)cc1		CHEMBL2023415	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	10871396	CHEMBL2027575	Inhibition of CDK2 using RbING as substrate after 2 hrs by luminescence assay	B	COc1ccc(-c2nc(Nc3cccc(NC(=O)NCCN4CCOCC4)c3)nc3[nH]cnc23)cc1OC		CHEMBL2023414	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	10871397	CHEMBL2027575	Inhibition of CDK2 using RbING as substrate after 2 hrs by luminescence assay	B	COc1ccc(-c2nc(Nc3cccc(NC(=O)NC4CCNC4)c3)nc3[nH]cnc23)cc1		CHEMBL2023413	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	10871398	CHEMBL2027575	Inhibition of CDK2 using RbING as substrate after 2 hrs by luminescence assay	B	COc1ccc(-c2nc(Nc3cccc(NC(=O)NC4CCNC4)c3)nc3[nH]cnc23)cc1OC		CHEMBL2023201	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	10871399	CHEMBL2027575	Inhibition of CDK2 using RbING as substrate after 2 hrs by luminescence assay	B	COc1cc(-c2nc(Nc3cccc(NC(=O)N4CCCC4)c3)nc3[nH]cnc23)ccc1N		CHEMBL2023200	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	10871400	CHEMBL2027575	Inhibition of CDK2 using RbING as substrate after 2 hrs by luminescence assay	B	O=C(Nc1cccc(Nc2nc(-c3ccc(F)nc3)c3nc[nH]c3n2)c1)N1CCCC1		CHEMBL2023199	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
Not Determined	10871401	CHEMBL2027575	Inhibition of CDK2 using RbING as substrate after 2 hrs by luminescence assay	B	O=C(Nc1cccc(Nc2nc(-c3ccncc3)c3nc[nH]c3n2)c1)N1CCCC1		CHEMBL2023198		IC50			CHEMBL301	Homo sapiens	IC50		
	10871402	CHEMBL2027575	Inhibition of CDK2 using RbING as substrate after 2 hrs by luminescence assay	B	O=C(Nc1cccc(Nc2nc(-c3ccc4c(c3)OCO4)c3nc[nH]c3n2)c1)N1CCCC1		CHEMBL2023197	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	10871403	CHEMBL2027575	Inhibition of CDK2 using RbING as substrate after 2 hrs by luminescence assay	B	COc1ccc(-c2nc(Nc3cccc(NC(=O)N4CCCC4)c3)nc3[nH]cnc23)cc1OC		CHEMBL2023196	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	10871404	CHEMBL2027575	Inhibition of CDK2 using RbING as substrate after 2 hrs by luminescence assay	B	COc1ccc(-c2nc(Nc3cccc(NC(=O)N4CCCC4)c3)nc3[nH]cnc23)cc1		CHEMBL1933347	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	10871405	CHEMBL2027575	Inhibition of CDK2 using RbING as substrate after 2 hrs by luminescence assay	B	CN1CCN(Cc2cccc(-c3nc(Nc4cccc(Cl)c4)nc4[nH]cnc34)c2)CC1		CHEMBL2023195	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	10871406	CHEMBL2027575	Inhibition of CDK2 using RbING as substrate after 2 hrs by luminescence assay	B	Oc1ccc(-c2nc(Nc3cccc(Cl)c3)nc3[nH]cnc23)cc1		CHEMBL1933345	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	10871407	CHEMBL2027575	Inhibition of CDK2 using RbING as substrate after 2 hrs by luminescence assay	B	COc1ccc(-c2nc(Nc3cccc(Cl)c3)nc3[nH]cnc23)cc1OC		CHEMBL2023194	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	10909640	CHEMBL2039967	Inhibition of recombinant CDK2 using RbING as substrate after 2 hrs by luminometric assay	B	CN1C/C=C/COCC2CCCN(C2)c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL2035041	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	10909641	CHEMBL2039967	Inhibition of recombinant CDK2 using RbING as substrate after 2 hrs by luminometric assay	B	CN1C/C=C/CCn2ccc3ccc(cc32)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL2035042	=	IC50	nM	77.0	CHEMBL301	Homo sapiens	IC50	uM	0.077
	10909642	CHEMBL2039967	Inhibition of recombinant CDK2 using RbING as substrate after 2 hrs by luminometric assay	B	C1=C/Cn2ccc3ccc(cc32)-c2ccnc(n2)Nc2cccc(c2)COC/1		CHEMBL2035043	=	IC50	nM	83.0	CHEMBL301	Homo sapiens	IC50	uM	0.083
	10910514	CHEMBL2039967	Inhibition of recombinant CDK2 using RbING as substrate after 2 hrs by luminometric assay	B	CN1C/C=C/CCOc2cc(ccn2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL2035044	=	IC50	nM	22.0	CHEMBL301	Homo sapiens	IC50	uM	0.022
	10910515	CHEMBL2039967	Inhibition of recombinant CDK2 using RbING as substrate after 2 hrs by luminometric assay	B	CN1C/C=C/COCc2cncc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL2035045	=	IC50	nM	420.0	CHEMBL301	Homo sapiens	IC50	uM	0.42
	10910516	CHEMBL2039967	Inhibition of recombinant CDK2 using RbING as substrate after 2 hrs by luminometric assay	B	C1=C/COCc2cncc(c2)-c2ccnc(n2)Nc2cccc(c2)COC/1		CHEMBL2035046	=	IC50	nM	200.0	CHEMBL301	Homo sapiens	IC50	uM	0.2
	10910517	CHEMBL2039967	Inhibition of recombinant CDK2 using RbING as substrate after 2 hrs by luminometric assay	B	CN1C/C=C/COCc2ccc(o2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL2035047	=	IC50	nM	320.0	CHEMBL301	Homo sapiens	IC50	uM	0.32
	10910518	CHEMBL2039967	Inhibition of recombinant CDK2 using RbING as substrate after 2 hrs by luminometric assay	B	C1=C/COCc2ccc(o2)-c2ccnc(n2)Nc2cccc(c2)COC/1		CHEMBL2035048	=	IC50	nM	680.0	CHEMBL301	Homo sapiens	IC50	uM	0.68
	10910519	CHEMBL2039967	Inhibition of recombinant CDK2 using RbING as substrate after 2 hrs by luminometric assay	B	C1=C/Cn2ccc3ccc(cc32)-c2ccnc(n2)Nc2ccc(OCCN3CCCC3)c(c2)COC/1		CHEMBL2035049	=	IC50	nM	230.0	CHEMBL301	Homo sapiens	IC50	uM	0.23
	10910520	CHEMBL2039967	Inhibition of recombinant CDK2 using RbING as substrate after 2 hrs by luminometric assay	B	Cc1cnc2nc1-c1ccc3ccn(c3c1)C/C=C/COCc1cc(ccc1OCCN1CCCC1)N2		CHEMBL2035050	=	IC50	nM	2500.0	CHEMBL301	Homo sapiens	IC50	uM	2.5
	10910521	CHEMBL2039967	Inhibition of recombinant CDK2 using RbING as substrate after 2 hrs by luminometric assay	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cncc(c2)COC/1		CHEMBL2035051	=	IC50	nM	3200.0	CHEMBL301	Homo sapiens	IC50	uM	3.2
	10910522	CHEMBL2039967	Inhibition of recombinant CDK2 using RbING as substrate after 2 hrs by luminometric assay	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2ccnc(c2)OCC/1		CHEMBL2035052	=	IC50	nM	270.0	CHEMBL301	Homo sapiens	IC50	uM	0.27
	10910523	CHEMBL2039967	Inhibition of recombinant CDK2 using RbING as substrate after 2 hrs by luminometric assay	B	Cc1cnc2nc1-c1ccnc(c1)OCC/C=C/COCc1cc(ccc1OCCN1CCCC1)N2		CHEMBL2035053	=	IC50	nM	3900.0	CHEMBL301	Homo sapiens	IC50	uM	3.9
	10910524	CHEMBL2039967	Inhibition of recombinant CDK2 using RbING as substrate after 2 hrs by luminometric assay	B	CN1C/C=C/COCc2ccc(o2)-c2ccnc(n2)Nc2ccc(OCCN3CCCC3)c(c2)C1		CHEMBL2035054	=	IC50	nM	1600.0	CHEMBL301	Homo sapiens	IC50	uM	1.6
	10910525	CHEMBL2039967	Inhibition of recombinant CDK2 using RbING as substrate after 2 hrs by luminometric assay	B	CN1C/C=C/COCc2ccc(s2)-c2ccnc(n2)Nc2ccc(OCCN3CCCC3)c(c2)C1		CHEMBL2035055	=	IC50	nM	710.0	CHEMBL301	Homo sapiens	IC50	uM	0.71
	10910526	CHEMBL2039967	Inhibition of recombinant CDK2 using RbING as substrate after 2 hrs by luminometric assay	B	COCCOc1ccc2cc1CN(C)C/C=C/COCc1ccc(o1)-c1ccnc(n1)N2		CHEMBL2035056	=	IC50	nM	8600.0	CHEMBL301	Homo sapiens	IC50	uM	8.6
	10910527	CHEMBL2039967	Inhibition of recombinant CDK2 using RbING as substrate after 2 hrs by luminometric assay	B	COCCOc1ccc2cc1CN(C)C/C=C/COCc1ccc(s1)-c1ccnc(n1)N2		CHEMBL2035182	=	IC50	nM	330.0	CHEMBL301	Homo sapiens	IC50	uM	0.33
	10910528	CHEMBL2039967	Inhibition of recombinant CDK2 using RbING as substrate after 2 hrs by luminometric assay	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2ccc(s2)COC/1		CHEMBL2035183	=	IC50	nM	2900.0	CHEMBL301	Homo sapiens	IC50	uM	2.9
	10910529	CHEMBL2039967	Inhibition of recombinant CDK2 using RbING as substrate after 2 hrs by luminometric assay	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2csc(c2)COC/1		CHEMBL2035184	=	IC50	nM	6800.0	CHEMBL301	Homo sapiens	IC50	uM	6.8
	10910530	CHEMBL2039967	Inhibition of recombinant CDK2 using RbING as substrate after 2 hrs by luminometric assay	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2ccc(o2)COC/1		CHEMBL2035185	=	IC50	nM	7000.0	CHEMBL301	Homo sapiens	IC50	uM	7.0
	10910531	CHEMBL2039967	Inhibition of recombinant CDK2 using RbING as substrate after 2 hrs by luminometric assay	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2coc(c2)COC/1		CHEMBL2035186	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	10910532	CHEMBL2039967	Inhibition of recombinant CDK2 using RbING as substrate after 2 hrs by luminometric assay	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cc(co2)COC/1		CHEMBL2035181	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	10923009	CHEMBL2044155	Inhibition of CDK2 by caliper method	B	CC(Oc1cc(-c2cc(-c3ccc(CN(C)C)cc3)cnc2N)ccc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL2042031	=	IC50	nM	2740.0	CHEMBL301	Homo sapiens	IC50	uM	2.74
	10923010	CHEMBL2044155	Inhibition of CDK2 by caliper method	B	C[C@@H](/C=C\C(F)(F)F)Oc1cc(-c2cc(-c3cc(CN(C)C)cs3)cnc2N)ccc1C(N)=O		CHEMBL2042042	=	IC50	nM	530.0	CHEMBL301	Homo sapiens	IC50	uM	0.53
	10923011	CHEMBL2044155	Inhibition of CDK2 by caliper method	B	C[C@H](/C=C\C(F)(F)F)Oc1cc(-c2cc(-c3cc(CN(C)C)cs3)cnc2N)ccc1C(N)=O		CHEMBL2042135	=	IC50	nM	4570.0	CHEMBL301	Homo sapiens	IC50	uM	4.57
	10923012	CHEMBL2044155	Inhibition of CDK2 by caliper method	B	C[C@@H](Oc1cc(-c2cc(-c3cc(CN(C)C)cs3)cnc2N)ccc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL2042136	=	IC50	nM	26600.0	CHEMBL301	Homo sapiens	IC50	uM	26.6
	10934978	CHEMBL2051514	Inhibition of CDK2 at 10 uM	B	O=C(Nc1ccc(Oc2ccnc(-c3ncc(C(F)(F)F)[nH]3)c2)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL2047981	=	Inhibition	%	7.8	CHEMBL301	Homo sapiens	INH	%	7.8
Not Active	10936954	CHEMBL2049753	Inhibition of CDK2 at 1 uM	B	N[C@@H]1CCCN(c2c(Br)cccc2/C=C2\SC(=O)NC2=O)C1		CHEMBL2048867		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	10941292	CHEMBL2049860	Inhibition of CDK2	B	CC(C)C[C@H]1CN(c2ccc(C(F)(F)F)c(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046643	>	Ki	nM	4000.0	CHEMBL301	Homo sapiens	Ki	uM	4.0
	10975248	CHEMBL2065462	Inhibition of CDK2	B	CC(=O)Nc1ccc2ccn(-c3cc(NC4CC4)n4ncc(C#N)c4n3)c2c1		CHEMBL2062563	=	IC50	nM	26000.0	CHEMBL301	Homo sapiens	IC50	uM	26.0
	10975249	CHEMBL2065462	Inhibition of CDK2	B	CC(=O)Nc1ccc2cnn(-c3cc(NC4CC4)n4ncc(C#N)c4n3)c2c1		CHEMBL2062564	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	10975250	CHEMBL2065462	Inhibition of CDK2	B	CC(=O)Nc1cnc2ccn(-c3cc(NC4CC4)n4ncc(C#N)c4n3)c2c1		CHEMBL2062565	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	10975251	CHEMBL2065462	Inhibition of CDK2	B	CC(=O)Nc1ccc2ccn(-c3cc(NCCCN(C)C)n4ncc(C#N)c4n3)c2c1		CHEMBL2062575	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	10975252	CHEMBL2065462	Inhibition of CDK2	B	CC(=O)N(C)c1ccc2ccn(-c3cc(NC4CC4)n4ncc(C#N)c4n3)c2c1		CHEMBL2062577	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	10975253	CHEMBL2065462	Inhibition of CDK2	B	CC(=O)Nc1ccc2[nH]cc(-c3cc(NC4CC4)n4ncc(C#N)c4n3)c2c1		CHEMBL2062581	=	IC50	nM	14000.0	CHEMBL301	Homo sapiens	IC50	uM	14.0
	10975254	CHEMBL2065462	Inhibition of CDK2	B	CC(=O)Nc1ccc2c(c1)c(-c1cc(NC3CC3)n3ncc(C#N)c3n1)cn2CCC(=O)O		CHEMBL2062585	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	10978482	CHEMBL2066183	Inhibition of human recombinant CDK2 using ulight CFFKNIVTPRTPPPSQGK-amide as substrate assessed as residual activity at 1 uM after 30 mins by Cerep assay	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2064515	>	Activity	%	80.0	CHEMBL301	Homo sapiens	Activity	%	80.0
	10979935	CHEMBL2067019	Inhibition of CDK2	B	CN(C)C[C@@H](NC(=O)c1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1)c1ccccc1		CHEMBL2064555	=	Ki	nM	3.4	CHEMBL301	Homo sapiens	Ki	uM	0.0034
	10979941	CHEMBL2067020	Inhibition of CDK2 at 1 uM	B	CN1CCN(C(=O)N2Cc3c(NC(=O)c4cccc(Oc5ccccc5)c4)n[nH]c3C2(C)C)[C@@H](Cc2ccccc2)C1		CHEMBL2064557	=	Inhibition	%	20.0	CHEMBL301	Homo sapiens	INH	%	20.0
	10979948	CHEMBL2067019	Inhibition of CDK2	B	CN(C)C[C@@H](NC(=O)N1Cc2c(NC(=O)c3ccccc3)n[nH]c2C1(C)C)c1ccccc1		CHEMBL2064558	=	Ki	nM	1800.0	CHEMBL301	Homo sapiens	Ki	uM	1.8
	10979966	CHEMBL2067019	Inhibition of CDK2	B	CN(C)C[C@@H](OC(=O)N1Cc2c(NC(=O)c3ccccc3)n[nH]c2C1(C)C)c1ccccc1		CHEMBL2064561	=	Ki	nM	2000.0	CHEMBL301	Homo sapiens	Ki	uM	2.0
	10979973	CHEMBL2067019	Inhibition of CDK2	B	CN(C)C[C@@H](OC(=O)N1Cc2c(NC(=O)c3ccc(F)cc3)n[nH]c2C1(C)C)c1ccccc1		CHEMBL2064562	=	Ki	nM	1160.0	CHEMBL301	Homo sapiens	Ki	uM	1.16
	10980005	CHEMBL2067019	Inhibition of CDK2	B	CN(C)C[C@@H](OC(=O)N1Cc2c(NC(=O)C(C)(C)C)n[nH]c2C1(C)C)c1ccccc1		CHEMBL2064628	=	IC50	nM	450.0	CHEMBL301	Homo sapiens	IC50	nM	450.0
	10993499	CHEMBL2073075	Inhibition of CDK2A at 10 uM	B	ClC(Cn1ncc2c(NCc3ccccc3)ncnc21)c1ccccc1		CHEMBL411043	=	Inhibition	%	8.0	CHEMBL301	Homo sapiens	INH	%	8.0
	11015968	CHEMBL2091383	Inhibition of CDK2	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CC(O)CO)c4c21)C(=O)NC3=O		CHEMBL339948	<	IC50	nM	60.0	CHEMBL301	Homo sapiens	IC50	uM	0.06
	11015978	CHEMBL2091383	Inhibition of CDK2	B	Cn1cc(C2=C(c3cn(CC(O)CO)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL341110	=	IC50	nM	1610.0	CHEMBL301	Homo sapiens	IC50	uM	1.61
Not Determined	12075955	CHEMBL2161547	Inhibition of CDK2	B	CNC(=O)Nc1ccc(-c2cc(-c3ccnc(Nc4ccc(C)c(S(N)(=O)=O)c4)n3)ccn2)cc1		CHEMBL2158860		IC50			CHEMBL301	Homo sapiens	IC50		
Not Determined	12075956	CHEMBL2161547	Inhibition of CDK2	B	CN1CCN(c2cc(-c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccn2)CC1		CHEMBL2158856		IC50			CHEMBL301	Homo sapiens	IC50		
Not Determined	12075957	CHEMBL2161547	Inhibition of CDK2	B	c1ccc(Nc2nccc(-c3ccnc(N4CCOCC4)c3)n2)cc1		CHEMBL2158852		IC50			CHEMBL301	Homo sapiens	IC50		
Not Determined	12075958	CHEMBL2161547	Inhibition of CDK2	B	N#Cc1cccc(Nc2nccc(-c3ccnc(N4CCOCC4)c3)n2)c1		CHEMBL2158851		IC50			CHEMBL301	Homo sapiens	IC50		
Not Determined	12075959	CHEMBL2161547	Inhibition of CDK2	B	COc1cccc(Nc2nccc(-c3ccnc(N4CCOCC4)c3)n2)c1		CHEMBL2158850		IC50			CHEMBL301	Homo sapiens	IC50		
Not Determined	12075960	CHEMBL2161547	Inhibition of CDK2	B	FC(F)(F)c1cccc(Nc2nccc(-c3ccnc(N4CCOCC4)c3)n2)c1		CHEMBL2158849		IC50			CHEMBL301	Homo sapiens	IC50		
Not Determined	12075961	CHEMBL2161547	Inhibition of CDK2	B	NS(=O)(=O)c1ccc(Nc2nccc(-c3ccnc(N4CCOCC4)c3)n2)cc1		CHEMBL2158847		IC50			CHEMBL301	Homo sapiens	IC50		
Not Determined	12075962	CHEMBL2161547	Inhibition of CDK2	B	Clc1ccc(Nc2nccc(-c3ccnc(N4CCOCC4)c3)n2)cc1		CHEMBL2158846		IC50			CHEMBL301	Homo sapiens	IC50		
	12075990	CHEMBL2161547	Inhibition of CDK2	B	CCN(CC)c1cc(-c2ccnc(Nc3cccc(S(N)(=O)=O)c3)n2)ccn1		CHEMBL2158853	<	IC50	nM	5.2	CHEMBL301	Homo sapiens	IC50	uM	0.0052
	12075991	CHEMBL2161547	Inhibition of CDK2	B	OCCCNc1cc(-c2ccnc(Nc3cccc(Cl)c3)n2)ccn1		CHEMBL300389	<	IC50	nM	5.2	CHEMBL301	Homo sapiens	IC50	uM	0.0052
	12076687	CHEMBL2161547	Inhibition of CDK2	B	CCN(CC)S(=O)(=O)c1cc(Nc2nccc(-c3ccnc(-c4ccc(NC(=O)NC)cc4)c3)n2)ccc1Cl		CHEMBL2158866	=	IC50	nM	7100.0	CHEMBL301	Homo sapiens	IC50	uM	7.1
	12076694	CHEMBL2161547	Inhibition of CDK2	B	CCN(CC)S(=O)(=O)c1cc(Nc2nccc(-c3ccnc(-c4ccc(NC(=O)NC)cc4)c3)n2)ccc1C		CHEMBL2158863	=	IC50	nM	3000.0	CHEMBL301	Homo sapiens	IC50	uM	3.0
	12076703	CHEMBL2161547	Inhibition of CDK2	B	CCN(CC)S(=O)(=O)c1cccc(Nc2nccc(-c3ccnc(-c4ccc(NC(=O)NC)cc4)c3)n2)c1		CHEMBL2158011	=	IC50	nM	560.0	CHEMBL301	Homo sapiens	IC50	uM	0.56
	12076704	CHEMBL2161547	Inhibition of CDK2	B	CNC(=O)Nc1ccc(-c2cc(-c3ccnc(Nc4ccc(Cl)c(S(=O)(=O)N(C)C)c4)n3)ccn2)cc1		CHEMBL2158865	=	IC50	nM	520.0	CHEMBL301	Homo sapiens	IC50	uM	0.52
	12076705	CHEMBL2161547	Inhibition of CDK2	B	CNC(=O)Nc1ccc(-c2cc(-c3ccnc(Nc4ccc(C)c(S(=O)(=O)N(C)C)c4)n3)ccn2)cc1		CHEMBL2158861	=	IC50	nM	460.0	CHEMBL301	Homo sapiens	IC50	uM	0.46
	12076717	CHEMBL2161547	Inhibition of CDK2	B	CNC(=O)Nc1ccc(-c2cc(-c3ccnc(Nc4ccc(Cl)c(S(=O)(=O)NC)c4)n3)ccn2)cc1		CHEMBL2158864	=	IC50	nM	140.0	CHEMBL301	Homo sapiens	IC50	uM	0.14
	12076720	CHEMBL2161547	Inhibition of CDK2	B	CNC(=O)Nc1ccc(-c2cc(-c3ccnc(Nc4ccc(C)c(S(=O)(=O)NC)c4)n3)ccn2)cc1		CHEMBL2158862	=	IC50	nM	110.0	CHEMBL301	Homo sapiens	IC50	uM	0.11
	12076722	CHEMBL2161547	Inhibition of CDK2	B	CNC(=O)Nc1ccc(-c2cc(-c3ccnc(Nc4cccc(S(=O)(=O)NC)c4)n3)ccn2)cc1		CHEMBL2158859	=	IC50	nM	100.0	CHEMBL301	Homo sapiens	IC50	uM	0.1
	12076743	CHEMBL2161547	Inhibition of CDK2	B	Cc1cccc(Nc2nccc(-c3ccnc(N4CCOCC4)c3)n2)c1		CHEMBL2158848	=	IC50	nM	46.0	CHEMBL301	Homo sapiens	IC50	uM	0.046
	12076750	CHEMBL2161547	Inhibition of CDK2	B	NS(=O)(=O)c1cccc(Nc2nccc(-c3ccnc(N4C5CCC4COC5)c3)n2)c1		CHEMBL2158854	=	IC50	nM	31.0	CHEMBL301	Homo sapiens	IC50	uM	0.031
	12076753	CHEMBL2161547	Inhibition of CDK2	B	CNC(=O)Nc1ccc(-c2cc(-c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccn2)cc1		CHEMBL2158858	=	IC50	nM	23.0	CHEMBL301	Homo sapiens	IC50	uM	0.023
	12076755	CHEMBL2161547	Inhibition of CDK2	B	NS(=O)(=O)c1cccc(Nc2nccc(-c3ccnc(N4CC5CCC(C4)O5)c3)n2)c1		CHEMBL2158855	=	IC50	nM	21.0	CHEMBL301	Homo sapiens	IC50	uM	0.021
	12076756	CHEMBL2161547	Inhibition of CDK2	B	NS(=O)(=O)c1cccc(Nc2nccc(-c3ccnc(N4CCOCC4)c3)n2)c1		CHEMBL2158845	=	IC50	nM	19.0	CHEMBL301	Homo sapiens	IC50	uM	0.019
	12076759	CHEMBL2161547	Inhibition of CDK2	B	NS(=O)(=O)c1cccc(Nc2nccc(-c3ccnc(N4CCCCC4)c3)n2)c1		CHEMBL2158857	=	IC50	nM	16.0	CHEMBL301	Homo sapiens	IC50	uM	0.016
	12076765	CHEMBL2161547	Inhibition of CDK2	B	Clc1cccc(Nc2nccc(-c3ccnc(N4CCOCC4)c3)n2)c1		CHEMBL2158844	=	IC50	nM	8.9	CHEMBL301	Homo sapiens	IC50	uM	0.0089
	12076768	CHEMBL2161547	Inhibition of CDK2	B	NS(=O)(=O)c1cccc(Nc2nccc(-c3ccnc(NCCCO)c3)n2)c1		CHEMBL2158843	=	IC50	nM	6.7	CHEMBL301	Homo sapiens	IC50	uM	0.0067
	12094436	CHEMBL2166172	Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counter	B	CCOc1ccc(Nc2c(C)c(N[C@@H]3CCCNC3)nc3ccnn23)cc1		CHEMBL2163604	>	IC50	nM	100000.0	CHEMBL301	Homo sapiens	IC50	uM	100.0
	12094437	CHEMBL2166172	Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counter	B	CCc1c(N[C@H]2CC[C@H](N)CC2)nc2ccnn2c1Nc1ccccc1Cl	Outside typical range	CHEMBL2163605	>	IC50	nM	300000.0	CHEMBL301	Homo sapiens	IC50	uM	300.0
	12094438	CHEMBL2166172	Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counter	B	Cc1c(N[C@H]2CC[C@H](N)CC2)nc2ccnn2c1Nc1ccccc1Cl		CHEMBL2163606	=	IC50	nM	6400.0	CHEMBL301	Homo sapiens	IC50	uM	6.4
	12094439	CHEMBL2166172	Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counter	B	N[C@H]1CC[C@H](Nc2cc(Nc3ccccc3Cl)n3nccc3n2)CC1		CHEMBL2163607	=	IC50	nM	390.0	CHEMBL301	Homo sapiens	IC50	uM	0.39
	12094440	CHEMBL2166172	Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counter	B	Cc1nc2ccc(Nc3c(C)c(N[C@H]4CCCNC4)nc4ccnn34)cc2s1		CHEMBL2163608	=	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	12094441	CHEMBL2166172	Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counter	B	Cc1c(N[C@H]2CCCNC2)nc2ccnn2c1Nc1ccc2c(cnn2C)c1		CHEMBL2163611	=	IC50	nM	27000.0	CHEMBL301	Homo sapiens	IC50	uM	27.0
	12094442	CHEMBL2166172	Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counter	B	CC(=O)c1ccc(-c2ccc(Nc3c(C)c(N[C@H]4CCCNC4)nc4ccnn34)cc2)s1		CHEMBL2163610	=	IC50	nM	21000.0	CHEMBL301	Homo sapiens	IC50	uM	21.0
	12094443	CHEMBL2166172	Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counter	B	Cc1c(N[C@H]2CCCNC2)nc2ccnn2c1Nc1ccc(C(=O)NC2CCCC2)cc1		CHEMBL2163609	=	IC50	nM	49000.0	CHEMBL301	Homo sapiens	IC50	uM	49.0
	12094444	CHEMBL2166172	Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counter	B	Cc1c(N[C@H]2CCCNC2)nc2ccnn2c1Nc1ccc(OCCN2CCOCC2)cc1		CHEMBL2163612	=	IC50	nM	62000.0	CHEMBL301	Homo sapiens	IC50	uM	62.0
	12094445	CHEMBL2166172	Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counter	B	COCCOc1ccc(Nc2c(C)c(N[C@H]3CCCNC3)nc3ccnn23)cc1		CHEMBL2163616	=	IC50	nM	22000.0	CHEMBL301	Homo sapiens	IC50	uM	22.0
	12094446	CHEMBL2166172	Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counter	B	CCOc1ccc(Nc2c(C)c(N[C@H]3CCCNC3)nc3ccnn23)cc1		CHEMBL1235213	=	IC50	nM	23000.0	CHEMBL301	Homo sapiens	IC50	uM	23.0
	12094447	CHEMBL2166172	Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counter	B	CCc1c(NC2CCCNC2)nc2ccnn2c1Nc1ccc(F)c(Cl)c1		CHEMBL2163623	=	IC50	nM	24000.0	CHEMBL301	Homo sapiens	IC50	uM	24.0
	12094448	CHEMBL2166172	Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counter	B	Cc1c(NC2CCCNC2)nc2ccnn2c1Nc1ccc(F)c(Cl)c1		CHEMBL2163624	=	IC50	nM	33000.0	CHEMBL301	Homo sapiens	IC50	uM	33.0
	12094449	CHEMBL2166172	Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counter	B	Fc1ccc(Nc2cc(NC3CCCNC3)nc3ccnn23)cc1Cl		CHEMBL2163984	=	IC50	nM	700.0	CHEMBL301	Homo sapiens	IC50	uM	0.7
	12094450	CHEMBL2166172	Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counter	B	N[C@H]1CC[C@H](Nc2nc3ccnn3c(Nc3ccc(F)c(Cl)c3)c2-c2ccccc2)CC1		CHEMBL2163991	=	IC50	nM	6000.0	CHEMBL301	Homo sapiens	IC50	uM	6.0
	12094451	CHEMBL2166172	Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counter	B	CCCc1c(N[C@H]2CC[C@H](N)CC2)nc2ccnn2c1Nc1ccc(F)c(Cl)c1		CHEMBL2163992	=	IC50	nM	2100.0	CHEMBL301	Homo sapiens	IC50	uM	2.1
	12094452	CHEMBL2166172	Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counter	B	CCc1c(N[C@H]2CC[C@H](N)CC2)nc2ccnn2c1Nc1ccc(F)c(Cl)c1		CHEMBL2163993	=	IC50	nM	3600.0	CHEMBL301	Homo sapiens	IC50	uM	3.6
	12094453	CHEMBL2166172	Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counter	B	Cc1c(N[C@H]2CC[C@H](N)CC2)nc2ccnn2c1Nc1ccc(F)c(Cl)c1		CHEMBL2163994	=	IC50	nM	11000.0	CHEMBL301	Homo sapiens	IC50	uM	11.0
	12094454	CHEMBL2166172	Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counter	B	N[C@H]1CC[C@H](Nc2cc(Nc3ccc(F)c(Cl)c3)n3ncc(Br)c3n2)CC1		CHEMBL2163995	=	IC50	nM	3.4	CHEMBL301	Homo sapiens	IC50	uM	0.0034
	12094455	CHEMBL2166172	Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counter	B	N[C@H]1CC[C@H](Nc2cc(Nc3ccc(F)c(Cl)c3)n3ncc(Cl)c3n2)CC1		CHEMBL2163996	=	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	uM	0.003
	12094456	CHEMBL2166172	Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counter	B	N#Cc1cnn2c(Nc3ccc(F)c(Cl)c3)cc(N[C@H]3CC[C@H](N)CC3)nc12		CHEMBL2163997	=	IC50	nM	4.0	CHEMBL301	Homo sapiens	IC50	uM	0.004
	12094457	CHEMBL2166172	Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counter	B	N[C@H]1CC[C@H](Nc2cc(Nc3ccc(F)c(Cl)c3)n3nccc3n2)CC1		CHEMBL2163999	=	IC50	nM	55.0	CHEMBL301	Homo sapiens	IC50	uM	0.055
	12100981	CHEMBL2173147	Inhibition of human CDK2	B	O=C(CBr)N(c1ccccc1)S(=O)(=O)c1cc(Cl)sc1Cl		CHEMBL1171238	>	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	uM	20.0
	12150608	CHEMBL2188541	Inhibition of human recombinant CDK2 by radiometric kinase assay	B	CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)n(C5CCCC5)c4n3)cc2)CC1		CHEMBL2178352	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	12166134	CHEMBL2211607	Binding affinity to CDK2 at 1 uM	B	Cc1nc(N)nc(-c2cc(Cl)cnc2Nc2cnc(Cl)c(NS(=O)(=O)N(C)C)c2)n1		CHEMBL2206921	<	Activity	%	50.0	CHEMBL301	Homo sapiens	Activity	%	50.0
	12173701	CHEMBL2209337	Inhibition of CDK2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	53.0	CHEMBL301	Homo sapiens	Activity	%	53.0
	12175183	CHEMBL2210709	Inhibition of CDK2	B	CN(c1ccc(F)c(NC(=O)c2cccc(OC(C)(C)C#N)c2Cl)c1)c1ccc2nc(NC(=O)C3CC3)sc2n1		CHEMBL2204532	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	12183912	CHEMBL2211053	Inhibition of CDK2	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL301	Homo sapiens	pIC50		5.0
	12187784	CHEMBL2208532	Inhibition of CDK2	B	O=S1(=O)NCCCNc2nc(ncc2Br)Nc2cccc1c2		CHEMBL1235529	=	IC50	nM	140.0	CHEMBL301	Homo sapiens	IC50	nM	140.0
	12187785	CHEMBL2208532	Inhibition of CDK2	B	C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2		CHEMBL215803	=	IC50	nM	3.4	CHEMBL301	Homo sapiens	IC50	nM	3.4
	12187788	CHEMBL2208532	Inhibition of CDK2	B	N#CCNc1nc(Nc2ccccc2)ncc1Br		CHEMBL2203628	=	IC50	nM	100.0	CHEMBL301	Homo sapiens	IC50	nM	100.0
	12190842	CHEMBL2213799	Inhibition of CDK2	B	Cn1cc(Nc2ncc(C3CC3)c(NCCCNC(=O)C3CCC3)n2)cn1		CHEMBL2207208	=	IC50	nM	110.0	CHEMBL301	Homo sapiens	IC50	uM	0.11
	12190843	CHEMBL2213799	Inhibition of CDK2	B	O=C(NCCCNc1nc(Nc2ccc(N3CCOCC3)cc2)ncc1C1CC1)C1CCC1		CHEMBL2207198	=	IC50	nM	630.0	CHEMBL301	Homo sapiens	IC50	uM	0.63
	12195904	CHEMBL2216236	Inhibition of CDK2	B	COc1cc(Br)c(C[C@H](C(=O)[O-])[N+](C)(C)C)c(Br)c1		CHEMBL2204075	>	IC50	ug.mL-1	50.0	CHEMBL301	Homo sapiens	IC50	ug ml-1	50.0
	12195905	CHEMBL2216236	Inhibition of CDK2	B	C[N+](C)(C)[C@H](Cc1cc(Br)c(O)c(I)c1)C(=O)[O-]		CHEMBL2204073	>	IC50	ug.mL-1	50.0	CHEMBL301	Homo sapiens	IC50	ug ml-1	50.0
	12195906	CHEMBL2216236	Inhibition of CDK2	B	COc1c(Br)cc(C[C@H](C(=O)[O-])[N+](C)(C)C)cc1I		CHEMBL2204072	>	IC50	ug.mL-1	50.0	CHEMBL301	Homo sapiens	IC50	ug ml-1	50.0
	12195907	CHEMBL2216236	Inhibition of CDK2	B	C[N+](C)(C)[C@H](Cc1cc(I)c(O)c(I)c1)C(=O)[O-]		CHEMBL2204071	>	IC50	ug.mL-1	50.0	CHEMBL301	Homo sapiens	IC50	ug ml-1	50.0
	12195908	CHEMBL2216236	Inhibition of CDK2	B	COc1c(I)cc(C[C@H](C(=O)[O-])[N+](C)(C)C)cc1I		CHEMBL2204070	>	IC50	ug.mL-1	50.0	CHEMBL301	Homo sapiens	IC50	ug ml-1	50.0
	12195909	CHEMBL2216236	Inhibition of CDK2	B	C[N+](C)(C)[C@H](CCOc1c(Br)cc(Br)cc1I)C(=O)[O-]		CHEMBL2204068	>	IC50	ug.mL-1	50.0	CHEMBL301	Homo sapiens	IC50	ug ml-1	50.0
	12195910	CHEMBL2216236	Inhibition of CDK2	B	C[N+](C)(C)[C@H](CCOc1c(Cl)cc(Br)cc1Cl)C(=O)[O-]		CHEMBL2204067	>	IC50	ug.mL-1	50.0	CHEMBL301	Homo sapiens	IC50	ug ml-1	50.0
	12195911	CHEMBL2216236	Inhibition of CDK2	B	C[N+](C)(C)[C@H](CCOc1ccc(Br)cc1Br)C(=O)[O-]		CHEMBL2204066	>	IC50	ug.mL-1	50.0	CHEMBL301	Homo sapiens	IC50	ug ml-1	50.0
	12195912	CHEMBL2216236	Inhibition of CDK2	B	C[N+](C)(C)[C@H](CCOc1c(Br)cc(Br)cc1Br)C(=O)[O-]		CHEMBL2204065	>	IC50	ug.mL-1	50.0	CHEMBL301	Homo sapiens	IC50	ug ml-1	50.0
	12195922	CHEMBL2216236	Inhibition of CDK2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	ug.mL-1	11.76	CHEMBL301	Homo sapiens	IC50	ug ml-1	11.76
	12457542	CHEMBL3056573	Inhibition of CDK2 (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	IC50	nM	30.0	CHEMBL301	Homo sapiens	IC50	uM	0.03
	12457543	CHEMBL3056573	Inhibition of CDK2 (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.1	CHEMBL301	Homo sapiens	IC50	uM	0.0001
Active	12458906	CHEMBL3063323	Destabilization of CDK2 in Homo sapiens (human) IMR32 cells by immunoblot analysis	B	COc1c(-c2cc(-c3ccccc3)n(-c3ccccc3F)n2)ccc2occc12		CHEMBL2263394		Activity			CHEMBL301	Homo sapiens	Activity		
Active	12458907	CHEMBL3063323	Destabilization of CDK2 in Homo sapiens (human) IMR32 cells by immunoblot analysis	B	COc1c(-c2cc(-c3ccccc3)n(-c3cccc(F)c3)n2)ccc2occc12		CHEMBL2263393		Activity			CHEMBL301	Homo sapiens	Activity		
Active	12458908	CHEMBL3063323	Destabilization of CDK2 in Homo sapiens (human) IMR32 cells by immunoblot analysis	B	COc1c(-c2cc(-c3ccccc3)on2)ccc2occc12		CHEMBL2263390		Activity			CHEMBL301	Homo sapiens	Activity		
Active	12458909	CHEMBL3063324	Destabilization of CDK2 in Homo sapiens (human) HeLa cells by immunoblot analysis	B	COc1c(-c2cc(-c3ccccc3)n(-c3ccccc3F)n2)ccc2occc12		CHEMBL2263394		Activity			CHEMBL301	Homo sapiens	Activity		
Active	12458910	CHEMBL3063324	Destabilization of CDK2 in Homo sapiens (human) HeLa cells by immunoblot analysis	B	COc1c(-c2cc(-c3ccccc3)n(-c3cccc(F)c3)n2)ccc2occc12		CHEMBL2263393		Activity			CHEMBL301	Homo sapiens	Activity		
Active	12458911	CHEMBL3063324	Destabilization of CDK2 in Homo sapiens (human) HeLa cells by immunoblot analysis	B	COc1c(-c2cc(-c3ccccc3)on2)ccc2occc12		CHEMBL2263390		Activity			CHEMBL301	Homo sapiens	Activity		
Active	12458912	CHEMBL3063325	Destabilization of CDK2 in Homo sapiens (human) Jurkat cells by immunoblot analysis	B	COc1c(-c2cc(-c3ccccc3)n(-c3ccccc3F)n2)ccc2occc12		CHEMBL2263394		Activity			CHEMBL301	Homo sapiens	Activity		
Active	12458913	CHEMBL3063325	Destabilization of CDK2 in Homo sapiens (human) Jurkat cells by immunoblot analysis	B	COc1c(-c2cc(-c3ccccc3)n(-c3cccc(F)c3)n2)ccc2occc12		CHEMBL2263393		Activity			CHEMBL301	Homo sapiens	Activity		
Active	12458914	CHEMBL3063325	Destabilization of CDK2 in Homo sapiens (human) Jurkat cells by immunoblot analysis	B	COc1c(-c2cc(-c3ccccc3)on2)ccc2occc12		CHEMBL2263390		Activity			CHEMBL301	Homo sapiens	Activity		
	12622855	CHEMBL2321002	Inhibition of human CDK2 after 30 mins by scintillation counting analysis	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Ki	nM	190.0	CHEMBL301	Homo sapiens	Ki	nM	190.0
	12622857	CHEMBL2321002	Inhibition of human CDK2 after 30 mins by scintillation counting analysis	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Ki	nM	38.0	CHEMBL301	Homo sapiens	Ki	nM	38.0
	12622861	CHEMBL2321002	Inhibition of human CDK2 after 30 mins by scintillation counting analysis	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4)oc23)[C@@H]1CO.Cl		CHEMBL4296686	<	Ki	nM	100.0	CHEMBL301	Homo sapiens	Ki	nM	100.0
	12648003	CHEMBL2329202	Inhibition of CDK2 (unknown origin) at 1 uM	B	CC(C)(C)[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325895	=	Inhibition	%	44.0	CHEMBL301	Homo sapiens	INH	%	44.0
	12648004	CHEMBL2329202	Inhibition of CDK2 (unknown origin) at 1 uM	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	Inhibition	%	65.0	CHEMBL301	Homo sapiens	INH	%	65.0
	12648005	CHEMBL2329202	Inhibition of CDK2 (unknown origin) at 1 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C#N		CHEMBL2325906	=	Inhibition	%	81.0	CHEMBL301	Homo sapiens	INH	%	81.0
	12648006	CHEMBL2329202	Inhibition of CDK2 (unknown origin) at 1 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C		CHEMBL2325903	=	Inhibition	%	84.0	CHEMBL301	Homo sapiens	INH	%	84.0
	12649663	CHEMBL2329560	Inhibition of CDK2 (unknown origin) at 10 uM	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	Inhibition	%	96.0	CHEMBL301	Homo sapiens	INH	%	96.0
	12649664	CHEMBL2329560	Inhibition of CDK2 (unknown origin) at 10 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)O		CHEMBL2325904	=	Inhibition	%	95.0	CHEMBL301	Homo sapiens	INH	%	95.0
	12649665	CHEMBL2329560	Inhibition of CDK2 (unknown origin) at 10 uM	B	CC(C)NC(=O)c1c[nH]c2ncc(C3CC3)nc12		CHEMBL2325901	=	Inhibition	%	92.0	CHEMBL301	Homo sapiens	INH	%	92.0
	12656871	CHEMBL2327152	Inhibition of CDK2 (unknown origin)	B	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	IC50	nM	1330.0	CHEMBL301	Homo sapiens	IC50	uM	1.33
	12656872	CHEMBL2327152	Inhibition of CDK2 (unknown origin)	B	Cc1[nH]nc2c1N=C(c1ccccc1Cl)c1cc(N)ccc1N2		CHEMBL2322701	=	IC50	nM	88.0	CHEMBL301	Homo sapiens	IC50	uM	0.088
	12670878	CHEMBL2338942	Inhibition of CDK2 kinase (unknown origin) using [33P]-ATP at 10 uM after 20 to 40 mins by scintillation counting analysis	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc2c(c1)C(Nc1ccc(Cl)cc1Cl)=NS2(=O)=O	Outside typical range	CHEMBL2334805	=	Inhibition	%	-53.0	CHEMBL301	Homo sapiens	INH	%	-53.0
	12675475	CHEMBL2344397	Inhibition of CDK2 (unknown origin)	B	O=C(Nc1ccc(Oc2ncnc3[nH]ncc23)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL2332840	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	12679751	CHEMBL2346291	Inhibition of CDK2 (unknown origin) at 1 uM	B	Cc1ccc(-c2ccc3ncc4c(c3n2)n(C2CCN(C(=O)[C@H](C)O)CC2)c(=O)n4C)cn1		CHEMBL2331664	=	Inhibition	%	0.5	CHEMBL301	Homo sapiens	INH	%	0.5
	12721823	CHEMBL2353808	Inhibition of CDK2 (unknown origin) at 1 uM relative to control	B	CCNC(=O)Nc1nc2ccc(-c3ccccc3OC)cc2s1		CHEMBL2347710	=	Inhibition	%	100.0	CHEMBL301	Homo sapiens	INH	%	100.0
	12722969	CHEMBL2354070	Inhibition of CDK2 (unknown origin) at 1 uM relative to control	B	CN(C)CCC(=O)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@H](CO)c4ccccc4)c23)c1		CHEMBL2347963	=	Inhibition	%	-4.0	CHEMBL301	Homo sapiens	INH	%	-4.0
	12726635	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	N#Cc1ccc2ccn(-c3cc(N)ncn3)c2n1		CHEMBL2348153	>	IC50	nM	83000.0	CHEMBL301	Homo sapiens	IC50	uM	83.0
	12726636	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	Nc1nccc(-n2cc(-c3cccnc3Cl)c3cnc(Cl)cc32)n1		CHEMBL2348152	>	IC50	nM	83000.0	CHEMBL301	Homo sapiens	IC50	uM	83.0
	12726637	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	Nc1nccc(-n2cc(-c3cccnc3Cl)c3cnccc32)n1		CHEMBL2348154	=	IC50	nM	310.0	CHEMBL301	Homo sapiens	IC50	uM	0.31
	12726638	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	Nc1nccc(-n2cc(-c3ccc(Cl)cc3)c3cnccc32)n1		CHEMBL2348155	=	IC50	nM	60.0	CHEMBL301	Homo sapiens	IC50	uM	0.06
	12726639	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	Nc1nccc(-n2cc(-c3cccc(Cl)c3)c3cnccc32)n1		CHEMBL2348157	>	IC50	nM	83000.0	CHEMBL301	Homo sapiens	IC50	uM	83.0
	12726640	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	Nc1nccc(-n2cc(-c3ccccc3Cl)c3cnccc32)n1		CHEMBL2348156	=	IC50	nM	110.0	CHEMBL301	Homo sapiens	IC50	uM	0.11
	12726641	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	Nc1nccc(-n2cc(C3=CCOCC3)c3cnccc32)n1		CHEMBL2348158	=	IC50	nM	160.0	CHEMBL301	Homo sapiens	IC50	uM	0.16
	12726642	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	Nc1nccc(-n2cc(-c3ccoc3)c3cnccc32)n1		CHEMBL2348160	=	IC50	nM	100.0	CHEMBL301	Homo sapiens	IC50	uM	0.1
	12726643	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	Nc1nccc(-n2cc(-c3cc[nH]n3)c3cnccc32)n1		CHEMBL2348159	=	IC50	nM	550.0	CHEMBL301	Homo sapiens	IC50	uM	0.55
	12726644	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	Nc1nccc(-n2cc(-c3ccncc3)c3cnccc32)n1		CHEMBL2348161	=	IC50	nM	160.0	CHEMBL301	Homo sapiens	IC50	uM	0.16
	12726645	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	Nc1nccc(-n2cc(-c3cccnc3)c3cnccc32)n1		CHEMBL2348162	=	IC50	nM	1100.0	CHEMBL301	Homo sapiens	IC50	uM	1.1
	12726646	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	Nc1nccc(-n2cc(-c3ccccc3)c3cnccc32)n1		CHEMBL2348164	=	IC50	nM	310.0	CHEMBL301	Homo sapiens	IC50	uM	0.31
	12726647	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	N#Cc1cnc2ccn(-c3ccnc(N)n3)c2c1		CHEMBL2348163	>	IC50	nM	83000.0	CHEMBL301	Homo sapiens	IC50	uM	83.0
	12726648	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	Nc1nccc(-n2ccc3cnc(Cl)cc32)n1		CHEMBL2346665	=	IC50	nM	38000.0	CHEMBL301	Homo sapiens	IC50	uM	38.0
	12726649	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	N#Cc1cc2c(ccn2-c2ccnc(N)n2)cn1		CHEMBL2348166	>	IC50	nM	44000.0	CHEMBL301	Homo sapiens	IC50	uM	44.0
	12726650	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	Nc1nccc(-n2ccc3ncccc32)n1		CHEMBL2348165	=	IC50	nM	21000.0	CHEMBL301	Homo sapiens	IC50	uM	21.0
	12726651	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	Nc1nccc(-n2ccc3cnccc32)n1		CHEMBL2348168	=	IC50	nM	3700.0	CHEMBL301	Homo sapiens	IC50	uM	3.7
	12726652	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	Nc1nccc(-n2ccc3ccncc32)n1		CHEMBL2348167	=	IC50	nM	45100.0	CHEMBL301	Homo sapiens	IC50	uM	45.1
	12726653	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	Nc1nccc(-n2ccc3cccnc32)n1		CHEMBL2348170	=	IC50	nM	42000.0	CHEMBL301	Homo sapiens	IC50	uM	42.0
	12726654	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	N#Cc1ccc2c(ccn2-c2ccnc(N)n2)c1		CHEMBL2348169	>	IC50	nM	29100.0	CHEMBL301	Homo sapiens	IC50	uM	29.1
	12726655	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	C#Cc1ccc2ccn(-c3ccnc(N)n3)c2c1		CHEMBL2348171	=	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	12726656	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	Nc1nccc(-n2ccc3ccc(O)cc32)n1		CHEMBL2348173	=	IC50	nM	5000.0	CHEMBL301	Homo sapiens	IC50	uM	5.0
	12726657	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	Nc1nccc(-n2ccc3ccc(C(F)(F)F)cc32)n1		CHEMBL2348172	=	IC50	nM	17000.0	CHEMBL301	Homo sapiens	IC50	uM	17.0
	12726658	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	Nc1nccc(-n2ccc3ccc([N+](=O)[O-])cc32)n1		CHEMBL2348174	>	IC50	nM	30600.0	CHEMBL301	Homo sapiens	IC50	uM	30.6
	12726659	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	Nc1nccc(-n2ccc3ccc(Br)cc32)n1		CHEMBL2334965	=	IC50	nM	8200.0	CHEMBL301	Homo sapiens	IC50	uM	8.2
	12726660	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	Nc1nccc(-n2ccc3ccc(Cl)cc32)n1		CHEMBL2334964	=	IC50	nM	3700.0	CHEMBL301	Homo sapiens	IC50	uM	3.7
	12726661	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	Nc1nccc(-n2ccc3ccc(F)cc32)n1		CHEMBL2348175	=	IC50	nM	34000.0	CHEMBL301	Homo sapiens	IC50	uM	34.0
	12726662	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	Nc1nccc(-n2ccc3ccccc32)n1		CHEMBL2348176	=	IC50	nM	28500.0	CHEMBL301	Homo sapiens	IC50	uM	28.5
	12726663	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	N#Cc1ccc2ccn(-c3ccncn3)c2c1		CHEMBL2348177	>	IC50	nM	83000.0	CHEMBL301	Homo sapiens	IC50	uM	83.0
	12726664	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	N#Cc1ccc2ccn(-c3nccc(N)n3)c2c1		CHEMBL2348179	>	IC50	nM	29000.0	CHEMBL301	Homo sapiens	IC50	uM	29.0
	12726665	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	N#Cc1ccc2ccn(-c3cc(N)ncn3)c2c1		CHEMBL2348178	>	IC50	nM	83000.0	CHEMBL301	Homo sapiens	IC50	uM	83.0
	12726666	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	N#Cc1ccc2ccn(-c3ccnc(N)c3)c2c1		CHEMBL2348180	=	IC50	nM	39000.0	CHEMBL301	Homo sapiens	IC50	uM	39.0
	12726667	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	N#Cc1ccc2ccn(-c3cccc(N)n3)c2c1		CHEMBL2348181	=	IC50	nM	45000.0	CHEMBL301	Homo sapiens	IC50	uM	45.0
	12726668	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	CNc1nccc(-n2ccc3ccc(C#N)cc32)n1		CHEMBL2348182	=	IC50	nM	2700.0	CHEMBL301	Homo sapiens	IC50	uM	2.7
	12726669	CHEMBL2353290	Inhibition of CDK2 (unknown origin)	B	N#Cc1ccc2ccn(-c3ccnc(N)n3)c2c1		CHEMBL2334966	=	IC50	nM	16500.0	CHEMBL301	Homo sapiens	IC50	uM	16.5
Active	13279055	CHEMBL2379845	Inhibition of CDK2-mediated Rb phosphorylation at Ser 807/811 in human NCI-H929 cells at 0.005 uM after 24 hrs by immunoblotting analysis	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	13279056	CHEMBL2379846	Inhibition of CDK2-mediated Rb phosphorylation at Ser 807/811 in human NCI-H929 cells at 1.5 uM after 24 hrs by immunoblotting analysis	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)sc1C(=O)c1ccccc1[N+](=O)[O-]		CHEMBL2377825		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	13279062	CHEMBL2379849	Inhibition of CDK2-mediated Rb phosphorylation at Ser 807/811 in human A673 cells at 0.05 uM after 24 hrs by immunoblotting analysis	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	13279063	CHEMBL2379850	Inhibition of CDK2-mediated Rb phosphorylation at Ser 807/811 in human A673 cells at 0.25 uM after 24 hrs by immunoblotting analysis	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)sc1C(=O)c1ccccc1[N+](=O)[O-]		CHEMBL2377825		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	13282408	CHEMBL2378497	Inhibition of CDK2 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3ncn4cc(F)cc(F)c34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376158	=	Inhibition	%	36.0	CHEMBL301	Homo sapiens	INH	%	36.0
	13282409	CHEMBL2378497	Inhibition of CDK2 (unknown origin) at 10 uM relative to control	B	Cn1nc(-c2cnc3[nH]cc(C(=O)N[C@@H](C(=O)N4CC(C#N)C4)C4CC4)c3n2)c2ccc(Cl)cc21		CHEMBL2376154	=	Inhibition	%	32.0	CHEMBL301	Homo sapiens	INH	%	32.0
	13282410	CHEMBL2378497	Inhibition of CDK2 (unknown origin) at 10 uM relative to control	B	CC[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376153	=	Inhibition	%	23.0	CHEMBL301	Homo sapiens	INH	%	23.0
	13282411	CHEMBL2378497	Inhibition of CDK2 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)cc(F)c34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376152	=	Inhibition	%	5.0	CHEMBL301	Homo sapiens	INH	%	5.0
	13282412	CHEMBL2378497	Inhibition of CDK2 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376144	=	Inhibition	%	-4.0	CHEMBL301	Homo sapiens	INH	%	-4.0
	13282413	CHEMBL2378497	Inhibition of CDK2 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3cn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376143	=	Inhibition	%	55.0	CHEMBL301	Homo sapiens	INH	%	55.0
	13311868	CHEMBL2384690	Inhibition of human CDK2	B	COc1ccc2c(c1)C(=O)N(c1nc(C(=O)Nc3cnccc3N3CCNCC3)cs1)C2		CHEMBL2381116	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	nM	30000.0
	13367189	CHEMBL2406345	Inhibition of CDK2 (unknown origin) after 60 mins	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	3970.0	CHEMBL301	Homo sapiens	IC50	uM	3.97
Active	13372554	CHEMBL2405066	Inhibition of CDK2 in human G361 cells sensitized with nocodazole assessed as NPM phosphorylation at Thr199 at 640 nM after 8 hrs by immunoblotting analysis	B	NC1CCC(Nc2nc(NCc3ccc(-c4ccccc4O)nc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL2402946		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	13372555	CHEMBL2405067	Inhibition of CDK2 in human G361 cells sensitized with nocodazole assessed as NPM phosphorylation at Thr199 at 640 nM after 4 hrs by immunoblotting analysis	B	NC1CCC(Nc2nc(NCc3ccc(-c4ccccc4O)nc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL2402946		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	13396875	CHEMBL2410927	Inhibition of CDK2 (unknown origin)	B	CC(=O)Nc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)ccc1C		CHEMBL2409175	=	IC50	nM	7200.0	CHEMBL301	Homo sapiens	IC50	uM	7.2
	13414742	CHEMBL2424036	Inhibition of CDK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420551	<	Inhibition	%	35.0	CHEMBL301	Homo sapiens	INH	%	35.0
	13414743	CHEMBL2424036	Inhibition of CDK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420555	<	Inhibition	%	35.0	CHEMBL301	Homo sapiens	INH	%	35.0
	13414744	CHEMBL2424036	Inhibition of CDK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420573	<	Inhibition	%	35.0	CHEMBL301	Homo sapiens	INH	%	35.0
	13414745	CHEMBL2424036	Inhibition of CDK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420572	<	Inhibition	%	35.0	CHEMBL301	Homo sapiens	INH	%	35.0
	13414746	CHEMBL2424036	Inhibition of CDK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420570	<	Inhibition	%	35.0	CHEMBL301	Homo sapiens	INH	%	35.0
	13414747	CHEMBL2424036	Inhibition of CDK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420565	<	Inhibition	%	35.0	CHEMBL301	Homo sapiens	INH	%	35.0
	13414748	CHEMBL2424036	Inhibition of CDK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420564	<	Inhibition	%	35.0	CHEMBL301	Homo sapiens	INH	%	35.0
	13414749	CHEMBL2424036	Inhibition of CDK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420562	<	Inhibition	%	35.0	CHEMBL301	Homo sapiens	INH	%	35.0
	13414750	CHEMBL2424036	Inhibition of CDK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420560	<	Inhibition	%	35.0	CHEMBL301	Homo sapiens	INH	%	35.0
	13414751	CHEMBL2424036	Inhibition of CDK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420556	<	Inhibition	%	35.0	CHEMBL301	Homo sapiens	INH	%	35.0
	13414752	CHEMBL2424036	Inhibition of CDK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420587	<	Inhibition	%	35.0	CHEMBL301	Homo sapiens	INH	%	35.0
	13414753	CHEMBL2424036	Inhibition of CDK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420585	=	Inhibition	%	59.1	CHEMBL301	Homo sapiens	INH	%	59.1
	13419658	CHEMBL2422092	Inhibition of CDK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	15.0	CHEMBL301	Homo sapiens	INH	%	15.0
	13419659	CHEMBL2422092	Inhibition of CDK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	21.0	CHEMBL301	Homo sapiens	INH	%	21.0
	13419660	CHEMBL2422092	Inhibition of CDK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	19.0	CHEMBL301	Homo sapiens	INH	%	19.0
	13437638	CHEMBL2423635	Inhibition of CDK2 (unknown origin) at 100 nM	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5ccccc5)c4)c3c2)cn1		CHEMBL2418750	=	Inhibition	%	41.0	CHEMBL301	Homo sapiens	INH	%	41.0
	13439716	CHEMBL2428175	Competitive binding affinity to CDK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	100.0	CHEMBL301	Homo sapiens	INH	%	100.0
	13439885	CHEMBL2428175	Competitive binding affinity to CDK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	=	Inhibition	%	90.0	CHEMBL301	Homo sapiens	INH	%	90.0
	13446102	CHEMBL2427325	Inhibition of human N-terminal hexahistidine-tagged CDK2 expressed in baculovirus infected Sf21 cells using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	IC50	nM	500.0	CHEMBL301	Homo sapiens	IC50	uM	0.5
	13446103	CHEMBL2427325	Inhibition of human N-terminal hexahistidine-tagged CDK2 expressed in baculovirus infected Sf21 cells using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP	B	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21		CHEMBL280074	=	IC50	nM	7000.0	CHEMBL301	Homo sapiens	IC50	uM	7.0
	13446104	CHEMBL2427325	Inhibition of human N-terminal hexahistidine-tagged CDK2 expressed in baculovirus infected Sf21 cells using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP	B	COc1ccc(-c2nn(-c3ccccc3)cc2C(=O)NC(=S)Nc2ccc(Cl)cc2)cc1		CHEMBL2426397	=	IC50	nM	30.0	CHEMBL301	Homo sapiens	IC50	uM	0.03
	13446105	CHEMBL2427325	Inhibition of human N-terminal hexahistidine-tagged CDK2 expressed in baculovirus infected Sf21 cells using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP	B	COc1ccc(-c2nn(-c3ccccc3)cc2C(=O)NC(=S)Nc2ccc(F)cc2)cc1		CHEMBL2426396	=	IC50	nM	32.0	CHEMBL301	Homo sapiens	IC50	uM	0.032
	13446106	CHEMBL2427325	Inhibition of human N-terminal hexahistidine-tagged CDK2 expressed in baculovirus infected Sf21 cells using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP	B	COc1ccc(NC(=S)NC(=O)c2cn(-c3ccccc3)nc2-c2ccc(OC)cc2)cc1		CHEMBL2426395	=	IC50	nM	25.0	CHEMBL301	Homo sapiens	IC50	uM	0.025
	13446107	CHEMBL2427325	Inhibition of human N-terminal hexahistidine-tagged CDK2 expressed in baculovirus infected Sf21 cells using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP	B	COc1ccc(-c2nn(-c3ccccc3)cc2C(=O)NC(=S)Nc2ccc(C)cc2)cc1		CHEMBL2426394	=	IC50	nM	29.0	CHEMBL301	Homo sapiens	IC50	uM	0.029
	13446108	CHEMBL2427325	Inhibition of human N-terminal hexahistidine-tagged CDK2 expressed in baculovirus infected Sf21 cells using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP	B	O=C(NC(=S)Nc1ccc(Cl)cc1)c1cn(-c2ccccc2)nc1-c1ccc(F)cc1		CHEMBL2426393	=	IC50	nM	44.0	CHEMBL301	Homo sapiens	IC50	uM	0.044
	13446109	CHEMBL2427325	Inhibition of human N-terminal hexahistidine-tagged CDK2 expressed in baculovirus infected Sf21 cells using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP	B	O=C(NC(=S)Nc1ccc(F)cc1)c1cn(-c2ccccc2)nc1-c1ccc(F)cc1		CHEMBL2426392	=	IC50	nM	49.0	CHEMBL301	Homo sapiens	IC50	uM	0.049
	13446110	CHEMBL2427325	Inhibition of human N-terminal hexahistidine-tagged CDK2 expressed in baculovirus infected Sf21 cells using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP	B	COc1ccc(NC(=S)NC(=O)c2cn(-c3ccccc3)nc2-c2ccc(F)cc2)cc1		CHEMBL2426391	=	IC50	nM	36.0	CHEMBL301	Homo sapiens	IC50	uM	0.036
	13446111	CHEMBL2427325	Inhibition of human N-terminal hexahistidine-tagged CDK2 expressed in baculovirus infected Sf21 cells using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP	B	Cc1ccc(NC(=S)NC(=O)c2cn(-c3ccccc3)nc2-c2ccc(F)cc2)cc1		CHEMBL2426390	=	IC50	nM	43.0	CHEMBL301	Homo sapiens	IC50	uM	0.043
	13446112	CHEMBL2427325	Inhibition of human N-terminal hexahistidine-tagged CDK2 expressed in baculovirus infected Sf21 cells using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP	B	O=C(NC(=S)Nc1ccc(Cl)cc1)c1cn(-c2ccccc2)nc1-c1ccc(Cl)cc1		CHEMBL2426389	=	IC50	nM	58.0	CHEMBL301	Homo sapiens	IC50	uM	0.058
	13446113	CHEMBL2427325	Inhibition of human N-terminal hexahistidine-tagged CDK2 expressed in baculovirus infected Sf21 cells using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP	B	O=C(NC(=S)Nc1ccc(F)cc1)c1cn(-c2ccccc2)nc1-c1ccc(Cl)cc1		CHEMBL2426388	=	IC50	nM	59.0	CHEMBL301	Homo sapiens	IC50	uM	0.059
	13446114	CHEMBL2427325	Inhibition of human N-terminal hexahistidine-tagged CDK2 expressed in baculovirus infected Sf21 cells using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP	B	COc1ccc(NC(=S)NC(=O)c2cn(-c3ccccc3)nc2-c2ccc(Cl)cc2)cc1		CHEMBL2426387	=	IC50	nM	37.0	CHEMBL301	Homo sapiens	IC50	uM	0.037
	13446115	CHEMBL2427325	Inhibition of human N-terminal hexahistidine-tagged CDK2 expressed in baculovirus infected Sf21 cells using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP	B	Cc1ccc(NC(=S)NC(=O)c2cn(-c3ccccc3)nc2-c2ccc(Cl)cc2)cc1		CHEMBL2426386	=	IC50	nM	42.0	CHEMBL301	Homo sapiens	IC50	uM	0.042
	13446116	CHEMBL2427325	Inhibition of human N-terminal hexahistidine-tagged CDK2 expressed in baculovirus infected Sf21 cells using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP	B	Cc1ccc(-c2nn(-c3ccccc3)cc2C(=O)NC(=S)Nc2ccc(Cl)cc2)cc1		CHEMBL2426385	=	IC50	nM	63.0	CHEMBL301	Homo sapiens	IC50	uM	0.063
	13446117	CHEMBL2427325	Inhibition of human N-terminal hexahistidine-tagged CDK2 expressed in baculovirus infected Sf21 cells using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP	B	Cc1ccc(-c2nn(-c3ccccc3)cc2C(=O)NC(=S)Nc2ccc(F)cc2)cc1		CHEMBL2426384	=	IC50	nM	41.0	CHEMBL301	Homo sapiens	IC50	uM	0.041
	13446118	CHEMBL2427325	Inhibition of human N-terminal hexahistidine-tagged CDK2 expressed in baculovirus infected Sf21 cells using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP	B	COc1ccc(NC(=S)NC(=O)c2cn(-c3ccccc3)nc2-c2ccc(C)cc2)cc1		CHEMBL2426383	=	IC50	nM	47.0	CHEMBL301	Homo sapiens	IC50	uM	0.047
	13446119	CHEMBL2427325	Inhibition of human N-terminal hexahistidine-tagged CDK2 expressed in baculovirus infected Sf21 cells using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP	B	Cc1ccc(NC(=S)NC(=O)c2cn(-c3ccccc3)nc2-c2ccc(C)cc2)cc1		CHEMBL2426382	=	IC50	nM	52.0	CHEMBL301	Homo sapiens	IC50	uM	0.052
	13446120	CHEMBL2427325	Inhibition of human N-terminal hexahistidine-tagged CDK2 expressed in baculovirus infected Sf21 cells using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP	B	O=C(NC(=S)Nc1ccc(Cl)cc1)c1cn(-c2ccccc2)nc1-c1ccccc1		CHEMBL2426381	=	IC50	nM	71.0	CHEMBL301	Homo sapiens	IC50	uM	0.071
	13446121	CHEMBL2427325	Inhibition of human N-terminal hexahistidine-tagged CDK2 expressed in baculovirus infected Sf21 cells using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP	B	O=C(NC(=S)Nc1ccc(F)cc1)c1cn(-c2ccccc2)nc1-c1ccccc1		CHEMBL2426380	=	IC50	nM	75.0	CHEMBL301	Homo sapiens	IC50	uM	0.075
	13446122	CHEMBL2427325	Inhibition of human N-terminal hexahistidine-tagged CDK2 expressed in baculovirus infected Sf21 cells using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP	B	COc1ccc(NC(=S)NC(=O)c2cn(-c3ccccc3)nc2-c2ccccc2)cc1		CHEMBL2426399	=	IC50	nM	56.0	CHEMBL301	Homo sapiens	IC50	uM	0.056
	13446123	CHEMBL2427325	Inhibition of human N-terminal hexahistidine-tagged CDK2 expressed in baculovirus infected Sf21 cells using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP	B	Cc1ccc(NC(=S)NC(=O)c2cn(-c3ccccc3)nc2-c2ccccc2)cc1		CHEMBL2426398	=	IC50	nM	69.0	CHEMBL301	Homo sapiens	IC50	uM	0.069
	13448450	CHEMBL2428175	Competitive binding affinity to CDK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	=	Inhibition	%	94.0	CHEMBL301	Homo sapiens	INH	%	94.0
	13451705	CHEMBL2428175	Competitive binding affinity to CDK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	94.0	CHEMBL301	Homo sapiens	INH	%	94.0
	13465480	CHEMBL2434232	Inhibition of human CDK2 assessed as residual activity at 1 uM relative to control	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Activity	%	9.0	CHEMBL301	Homo sapiens	Activity	%	9.0
	13465506	CHEMBL2434781	Inhibition of human CDK2 assessed as residual activity at 10 uM relative to control	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Activity	%	5.0	CHEMBL301	Homo sapiens	Activity	%	5.0
	13465530	CHEMBL2434205	Inhibition of human CDK2 assessed as residual activity at 25 uM relative to control	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	83.0	CHEMBL301	Homo sapiens	Activity	%	83.0
	13466455	CHEMBL2434781	Inhibition of human CDK2 assessed as residual activity at 10 uM relative to control	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	113.0	CHEMBL301	Homo sapiens	Activity	%	113.0
	13466481	CHEMBL2434232	Inhibition of human CDK2 assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	Activity	%	92.2	CHEMBL301	Homo sapiens	Activity	%	92.2
	13466508	CHEMBL2434781	Inhibition of human CDK2 assessed as residual activity at 10 uM relative to control	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	Activity	%	103.84	CHEMBL301	Homo sapiens	Activity	%	103.84
	13466535	CHEMBL2434232	Inhibition of human CDK2 assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	Activity	%	76.71	CHEMBL301	Homo sapiens	Activity	%	76.71
	13466562	CHEMBL2434781	Inhibition of human CDK2 assessed as residual activity at 10 uM relative to control	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	Activity	%	40.33	CHEMBL301	Homo sapiens	Activity	%	40.33
	13475353	CHEMBL2439768	Inhibition of wild type human CDK2 by high throughput ATP-[33P] radiolabeled assay	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1		CHEMBL2436978	=	IC50	nM	1180.0	CHEMBL301	Homo sapiens	IC50	nM	1180.0
	13475364	CHEMBL2439768	Inhibition of wild type human CDK2 by high throughput ATP-[33P] radiolabeled assay	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5cnc6[nH]ccc6c5)c4c3)cc2)CC1		CHEMBL2436977	=	IC50	nM	720.0	CHEMBL301	Homo sapiens	IC50	nM	720.0
	13515623	CHEMBL2446206	Inhibition of CDK2 (unknown origin)	B	Cc1nnc(-c2cccc(-c3cnn4ccc(NCCN)nc34)c2)o1		CHEMBL2442291	=	IC50	nM	580.0	CHEMBL301	Homo sapiens	IC50	nM	580.0
	13515624	CHEMBL2446206	Inhibition of CDK2 (unknown origin)	B	c1cncc(CNc2ccn3ncc(-c4ccc5ccccc5c4)c3n2)c1		CHEMBL2442310	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	nM	50000.0
	13829871	CHEMBL3088384	Inhibition of CDK2 (unknown origin) at 0.1 uM relative to control	B	CN(C)Cc1ccc([C@H]2C[C@@H]2C(=O)Nc2nc3ccc(-c4cn[nH]c4)cc3s2)cc1		CHEMBL3086536	>	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	13836307	CHEMBL3090915	Inhibition of CDK-2 (unknown origin) after 90 mins by TR-FRET/IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1cccc(Cc2c(C)c3cc(Cl)c(OC(=O)N(C)C)cc3oc2=O)c1		CHEMBL3086065	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
Not Active	13859749	CHEMBL3101302	Inhibition of CDK2 (unknown origin)-mediated Rb phosphorylation by cell-based assay	B	COC[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(/C=C/c3ccc(Cl)cc3)ccc2n1		CHEMBL3099753		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	13859750	CHEMBL3101302	Inhibition of CDK2 (unknown origin)-mediated Rb phosphorylation by cell-based assay	B	COC[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099752		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	13859751	CHEMBL3101302	Inhibition of CDK2 (unknown origin)-mediated Rb phosphorylation by cell-based assay	B	CN(C)C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(/C=C/c3ccc(Cl)cc3)ccc2n1		CHEMBL3099751		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	13859752	CHEMBL3101302	Inhibition of CDK2 (unknown origin)-mediated Rb phosphorylation by cell-based assay	B	CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(/C=C/c3ccc(Cl)cc3)ccc2n1		CHEMBL3099750		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	13859753	CHEMBL3101302	Inhibition of CDK2 (unknown origin)-mediated Rb phosphorylation by cell-based assay	B	CCC[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099749		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	13859754	CHEMBL3101302	Inhibition of CDK2 (unknown origin)-mediated Rb phosphorylation by cell-based assay	B	C[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099748		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	13859755	CHEMBL3101302	Inhibition of CDK2 (unknown origin)-mediated Rb phosphorylation by cell-based assay	B	O=C(N[C@@H](Cc1ccc(O)cc1)C(=O)O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099747		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	13859756	CHEMBL3101302	Inhibition of CDK2 (unknown origin)-mediated Rb phosphorylation by cell-based assay	B	O=C(NCCc1ccc(O)cc1)c1cc(C(=O)O)c2cc(-c3cccs3)ccc2n1		CHEMBL3099746		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	13859757	CHEMBL3101302	Inhibition of CDK2 (unknown origin)-mediated Rb phosphorylation by cell-based assay	B	COC(=O)[C@H](Cc1cccc(O)c1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099745		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	13859758	CHEMBL3101302	Inhibition of CDK2 (unknown origin)-mediated Rb phosphorylation by cell-based assay	B	COC(=O)[C@H](Cc1ccc(OC)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099744		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	13859759	CHEMBL3101302	Inhibition of CDK2 (unknown origin)-mediated Rb phosphorylation by cell-based assay	B	COC(=O)[C@H](Cc1ccc(F)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099743		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	13859760	CHEMBL3101302	Inhibition of CDK2 (unknown origin)-mediated Rb phosphorylation by cell-based assay	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)NS(C)(=O)=O)c2cc(-c3cccs3)ccc2n1		CHEMBL3099742		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	13859761	CHEMBL3101302	Inhibition of CDK2 (unknown origin)-mediated Rb phosphorylation by cell-based assay	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(N)=O)c2cc(-c3cccs3)ccc2n1		CHEMBL3099766		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	13859762	CHEMBL3101302	Inhibition of CDK2 (unknown origin)-mediated Rb phosphorylation by cell-based assay	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(CO)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099765		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	13859763	CHEMBL3101302	Inhibition of CDK2 (unknown origin)-mediated Rb phosphorylation by cell-based assay	B	CCCCCCc1ccc2nc(C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)OC)cc(C(=O)O)c2c1		CHEMBL3099764		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	13859764	CHEMBL3101302	Inhibition of CDK2 (unknown origin)-mediated Rb phosphorylation by cell-based assay	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(/C=C/c3ccc(Cl)cc3)ccc2n1		CHEMBL3099763		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	13859765	CHEMBL3101302	Inhibition of CDK2 (unknown origin)-mediated Rb phosphorylation by cell-based assay	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(CCc3ccc(Cl)cc3)ccc2n1		CHEMBL3099762		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	13859766	CHEMBL3101302	Inhibition of CDK2 (unknown origin)-mediated Rb phosphorylation by cell-based assay	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099761		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	13859767	CHEMBL3101302	Inhibition of CDK2 (unknown origin)-mediated Rb phosphorylation by cell-based assay	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(N3CCOCC3)ccc2n1		CHEMBL3099760		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	13859768	CHEMBL3101302	Inhibition of CDK2 (unknown origin)-mediated Rb phosphorylation by cell-based assay	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3ccccc3)ccc2n1		CHEMBL3099759		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	13859769	CHEMBL3101302	Inhibition of CDK2 (unknown origin)-mediated Rb phosphorylation by cell-based assay	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cc(Cl)cc(Cl)c3)ccc2n1		CHEMBL3099758		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	13859770	CHEMBL3101302	Inhibition of CDK2 (unknown origin)-mediated Rb phosphorylation by cell-based assay	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3ccc(Cl)cc3)ccc2n1		CHEMBL3099757		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	13859771	CHEMBL3101302	Inhibition of CDK2 (unknown origin)-mediated Rb phosphorylation by cell-based assay	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3ccccc3Cl)ccc2n1		CHEMBL3099756		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	13859772	CHEMBL3101302	Inhibition of CDK2 (unknown origin)-mediated Rb phosphorylation by cell-based assay	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(Cl)c3)ccc2n1		CHEMBL3099755		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	13859773	CHEMBL3101302	Inhibition of CDK2 (unknown origin)-mediated Rb phosphorylation by cell-based assay	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccs3)ccc2n1		CHEMBL3099754		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	13859774	CHEMBL3101303	Inhibition of CDK2 (unknown origin)-cyclin A interaction preincubated for 30 mins at room temperature followed by incubation at 40 degC for 30 mins by SDS-PAGE analysis	B	COC[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(/C=C/c3ccc(Cl)cc3)ccc2n1		CHEMBL3099753	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	13859775	CHEMBL3101303	Inhibition of CDK2 (unknown origin)-cyclin A interaction preincubated for 30 mins at room temperature followed by incubation at 40 degC for 30 mins by SDS-PAGE analysis	B	COC[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099752	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	13859776	CHEMBL3101303	Inhibition of CDK2 (unknown origin)-cyclin A interaction preincubated for 30 mins at room temperature followed by incubation at 40 degC for 30 mins by SDS-PAGE analysis	B	CN(C)C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(/C=C/c3ccc(Cl)cc3)ccc2n1		CHEMBL3099751	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	13859777	CHEMBL3101303	Inhibition of CDK2 (unknown origin)-cyclin A interaction preincubated for 30 mins at room temperature followed by incubation at 40 degC for 30 mins by SDS-PAGE analysis	B	CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(/C=C/c3ccc(Cl)cc3)ccc2n1		CHEMBL3099750	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	13859778	CHEMBL3101303	Inhibition of CDK2 (unknown origin)-cyclin A interaction preincubated for 30 mins at room temperature followed by incubation at 40 degC for 30 mins by SDS-PAGE analysis	B	CCC[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099749	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	13859779	CHEMBL3101303	Inhibition of CDK2 (unknown origin)-cyclin A interaction preincubated for 30 mins at room temperature followed by incubation at 40 degC for 30 mins by SDS-PAGE analysis	B	C[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099748	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	13859780	CHEMBL3101303	Inhibition of CDK2 (unknown origin)-cyclin A interaction preincubated for 30 mins at room temperature followed by incubation at 40 degC for 30 mins by SDS-PAGE analysis	B	O=C(N[C@@H](Cc1ccc(O)cc1)C(=O)O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099747	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	13859781	CHEMBL3101303	Inhibition of CDK2 (unknown origin)-cyclin A interaction preincubated for 30 mins at room temperature followed by incubation at 40 degC for 30 mins by SDS-PAGE analysis	B	O=C(NCCc1ccc(O)cc1)c1cc(C(=O)O)c2cc(-c3cccs3)ccc2n1		CHEMBL3099746	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	13859782	CHEMBL3101303	Inhibition of CDK2 (unknown origin)-cyclin A interaction preincubated for 30 mins at room temperature followed by incubation at 40 degC for 30 mins by SDS-PAGE analysis	B	COC(=O)[C@H](Cc1cccc(O)c1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099745	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	13859783	CHEMBL3101303	Inhibition of CDK2 (unknown origin)-cyclin A interaction preincubated for 30 mins at room temperature followed by incubation at 40 degC for 30 mins by SDS-PAGE analysis	B	COC(=O)[C@H](Cc1ccc(OC)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099744	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	13859784	CHEMBL3101303	Inhibition of CDK2 (unknown origin)-cyclin A interaction preincubated for 30 mins at room temperature followed by incubation at 40 degC for 30 mins by SDS-PAGE analysis	B	COC(=O)[C@H](Cc1ccc(F)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099743	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	13859785	CHEMBL3101303	Inhibition of CDK2 (unknown origin)-cyclin A interaction preincubated for 30 mins at room temperature followed by incubation at 40 degC for 30 mins by SDS-PAGE analysis	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)NS(C)(=O)=O)c2cc(-c3cccs3)ccc2n1		CHEMBL3099742	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	13859786	CHEMBL3101303	Inhibition of CDK2 (unknown origin)-cyclin A interaction preincubated for 30 mins at room temperature followed by incubation at 40 degC for 30 mins by SDS-PAGE analysis	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(N)=O)c2cc(-c3cccs3)ccc2n1		CHEMBL3099766	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	13859787	CHEMBL3101303	Inhibition of CDK2 (unknown origin)-cyclin A interaction preincubated for 30 mins at room temperature followed by incubation at 40 degC for 30 mins by SDS-PAGE analysis	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(CO)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099765	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	13859788	CHEMBL3101303	Inhibition of CDK2 (unknown origin)-cyclin A interaction preincubated for 30 mins at room temperature followed by incubation at 40 degC for 30 mins by SDS-PAGE analysis	B	CCCCCCc1ccc2nc(C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)OC)cc(C(=O)O)c2c1		CHEMBL3099764	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	13859789	CHEMBL3101303	Inhibition of CDK2 (unknown origin)-cyclin A interaction preincubated for 30 mins at room temperature followed by incubation at 40 degC for 30 mins by SDS-PAGE analysis	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(/C=C/c3ccc(Cl)cc3)ccc2n1		CHEMBL3099763	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	13859790	CHEMBL3101303	Inhibition of CDK2 (unknown origin)-cyclin A interaction preincubated for 30 mins at room temperature followed by incubation at 40 degC for 30 mins by SDS-PAGE analysis	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(CCc3ccc(Cl)cc3)ccc2n1		CHEMBL3099762	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	13859791	CHEMBL3101303	Inhibition of CDK2 (unknown origin)-cyclin A interaction preincubated for 30 mins at room temperature followed by incubation at 40 degC for 30 mins by SDS-PAGE analysis	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099761	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	13859792	CHEMBL3101303	Inhibition of CDK2 (unknown origin)-cyclin A interaction preincubated for 30 mins at room temperature followed by incubation at 40 degC for 30 mins by SDS-PAGE analysis	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(N3CCOCC3)ccc2n1		CHEMBL3099760	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	13859793	CHEMBL3101303	Inhibition of CDK2 (unknown origin)-cyclin A interaction preincubated for 30 mins at room temperature followed by incubation at 40 degC for 30 mins by SDS-PAGE analysis	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3ccccc3)ccc2n1		CHEMBL3099759	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	13859794	CHEMBL3101303	Inhibition of CDK2 (unknown origin)-cyclin A interaction preincubated for 30 mins at room temperature followed by incubation at 40 degC for 30 mins by SDS-PAGE analysis	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cc(Cl)cc(Cl)c3)ccc2n1		CHEMBL3099758	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	13859795	CHEMBL3101303	Inhibition of CDK2 (unknown origin)-cyclin A interaction preincubated for 30 mins at room temperature followed by incubation at 40 degC for 30 mins by SDS-PAGE analysis	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3ccc(Cl)cc3)ccc2n1		CHEMBL3099757	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	13859796	CHEMBL3101303	Inhibition of CDK2 (unknown origin)-cyclin A interaction preincubated for 30 mins at room temperature followed by incubation at 40 degC for 30 mins by SDS-PAGE analysis	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3ccccc3Cl)ccc2n1		CHEMBL3099756	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	13859797	CHEMBL3101303	Inhibition of CDK2 (unknown origin)-cyclin A interaction preincubated for 30 mins at room temperature followed by incubation at 40 degC for 30 mins by SDS-PAGE analysis	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(Cl)c3)ccc2n1		CHEMBL3099755	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	13859798	CHEMBL3101303	Inhibition of CDK2 (unknown origin)-cyclin A interaction preincubated for 30 mins at room temperature followed by incubation at 40 degC for 30 mins by SDS-PAGE analysis	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccs3)ccc2n1		CHEMBL3099754	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
Not Active	13859803	CHEMBL3101309	Inhibition of active state of CDK2 (unknown origin) at 1 uM	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(Cl)c3)ccc2n1		CHEMBL3099755		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	13859806	CHEMBL3101311	Binding affinity to human CDK2 by isothermal titration calorimetric analysis	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(CCc3ccc(Cl)cc3)ccc2n1		CHEMBL3099762	=	Kd	nM	55.0	CHEMBL301	Homo sapiens	Kd	uM	0.055
	13859807	CHEMBL3101311	Binding affinity to human CDK2 by isothermal titration calorimetric analysis	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099761	=	Kd	nM	50.0	CHEMBL301	Homo sapiens	Kd	uM	0.05
	13859808	CHEMBL3101311	Binding affinity to human CDK2 by isothermal titration calorimetric analysis	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(Cl)c3)ccc2n1		CHEMBL3099755	=	Kd	nM	300.0	CHEMBL301	Homo sapiens	Kd	uM	0.3
	13859809	CHEMBL3101311	Binding affinity to human CDK2 by isothermal titration calorimetric analysis	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccs3)ccc2n1		CHEMBL3099754	=	Kd	nM	1000.0	CHEMBL301	Homo sapiens	Kd	uM	1.0
	13859810	CHEMBL3101312	Binding affinity to CDK2 (unknown origin) at 20 to 80 degC by circular dichroism analysis	B	COC[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(/C=C/c3ccc(Cl)cc3)ccc2n1		CHEMBL3099753	=	Kd	nM	25.0	CHEMBL301	Homo sapiens	Kd	uM	0.025
	13859811	CHEMBL3101312	Binding affinity to CDK2 (unknown origin) at 20 to 80 degC by circular dichroism analysis	B	COC[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099752	=	Kd	nM	240.0	CHEMBL301	Homo sapiens	Kd	uM	0.24
	13859812	CHEMBL3101312	Binding affinity to CDK2 (unknown origin) at 20 to 80 degC by circular dichroism analysis	B	CN(C)C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(/C=C/c3ccc(Cl)cc3)ccc2n1		CHEMBL3099751	=	Kd	nM	350.0	CHEMBL301	Homo sapiens	Kd	uM	0.35
	13859813	CHEMBL3101312	Binding affinity to CDK2 (unknown origin) at 20 to 80 degC by circular dichroism analysis	B	CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(/C=C/c3ccc(Cl)cc3)ccc2n1		CHEMBL3099750	=	Kd	nM	300.0	CHEMBL301	Homo sapiens	Kd	uM	0.3
	13859814	CHEMBL3101312	Binding affinity to CDK2 (unknown origin) at 20 to 80 degC by circular dichroism analysis	B	CCC[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099749	=	Kd	nM	400.0	CHEMBL301	Homo sapiens	Kd	uM	0.4
	13859815	CHEMBL3101312	Binding affinity to CDK2 (unknown origin) at 20 to 80 degC by circular dichroism analysis	B	C[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099748	=	Kd	nM	4000.0	CHEMBL301	Homo sapiens	Kd	uM	4.0
	13859816	CHEMBL3101312	Binding affinity to CDK2 (unknown origin) at 20 to 80 degC by circular dichroism analysis	B	O=C(N[C@@H](Cc1ccc(O)cc1)C(=O)O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099747	>	Kd	nM	10000.0	CHEMBL301	Homo sapiens	Kd	uM	10.0
	13859817	CHEMBL3101312	Binding affinity to CDK2 (unknown origin) at 20 to 80 degC by circular dichroism analysis	B	O=C(NCCc1ccc(O)cc1)c1cc(C(=O)O)c2cc(-c3cccs3)ccc2n1		CHEMBL3099746	>	Kd	nM	40000.0	CHEMBL301	Homo sapiens	Kd	uM	40.0
	13859818	CHEMBL3101312	Binding affinity to CDK2 (unknown origin) at 20 to 80 degC by circular dichroism analysis	B	COC(=O)[C@H](Cc1cccc(O)c1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099745	>	Kd	nM	40000.0	CHEMBL301	Homo sapiens	Kd	uM	40.0
	13859819	CHEMBL3101312	Binding affinity to CDK2 (unknown origin) at 20 to 80 degC by circular dichroism analysis	B	COC(=O)[C@H](Cc1ccc(OC)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099744	>	Kd	nM	40000.0	CHEMBL301	Homo sapiens	Kd	uM	40.0
	13859820	CHEMBL3101312	Binding affinity to CDK2 (unknown origin) at 20 to 80 degC by circular dichroism analysis	B	COC(=O)[C@H](Cc1ccc(F)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099743	=	Kd	nM	4000.0	CHEMBL301	Homo sapiens	Kd	uM	4.0
	13859821	CHEMBL3101312	Binding affinity to CDK2 (unknown origin) at 20 to 80 degC by circular dichroism analysis	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)NS(C)(=O)=O)c2cc(-c3cccs3)ccc2n1		CHEMBL3099742	>	Kd	nM	40000.0	CHEMBL301	Homo sapiens	Kd	uM	40.0
	13859822	CHEMBL3101312	Binding affinity to CDK2 (unknown origin) at 20 to 80 degC by circular dichroism analysis	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(N)=O)c2cc(-c3cccs3)ccc2n1		CHEMBL3099766	>	Kd	nM	40000.0	CHEMBL301	Homo sapiens	Kd	uM	40.0
	13859823	CHEMBL3101312	Binding affinity to CDK2 (unknown origin) at 20 to 80 degC by circular dichroism analysis	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(CO)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099765	>	Kd	nM	40000.0	CHEMBL301	Homo sapiens	Kd	uM	40.0
	13859824	CHEMBL3101312	Binding affinity to CDK2 (unknown origin) at 20 to 80 degC by circular dichroism analysis	B	CCCCCCc1ccc2nc(C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)OC)cc(C(=O)O)c2c1		CHEMBL3099764	=	Kd	nM	76.0	CHEMBL301	Homo sapiens	Kd	uM	0.076
	13859825	CHEMBL3101312	Binding affinity to CDK2 (unknown origin) at 20 to 80 degC by circular dichroism analysis	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(/C=C/c3ccc(Cl)cc3)ccc2n1		CHEMBL3099763	=	Kd	nM	5.0	CHEMBL301	Homo sapiens	Kd	uM	0.005
	13859826	CHEMBL3101312	Binding affinity to CDK2 (unknown origin) at 20 to 80 degC by circular dichroism analysis	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(CCc3ccc(Cl)cc3)ccc2n1		CHEMBL3099762	=	Kd	nM	48.0	CHEMBL301	Homo sapiens	Kd	uM	0.048
	13859827	CHEMBL3101312	Binding affinity to CDK2 (unknown origin) at 20 to 80 degC by circular dichroism analysis	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099761	=	Kd	nM	40.0	CHEMBL301	Homo sapiens	Kd	uM	0.04
	13859828	CHEMBL3101312	Binding affinity to CDK2 (unknown origin) at 20 to 80 degC by circular dichroism analysis	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(N3CCOCC3)ccc2n1		CHEMBL3099760	=	Kd	nM	2400.0	CHEMBL301	Homo sapiens	Kd	uM	2.4
	13859829	CHEMBL3101312	Binding affinity to CDK2 (unknown origin) at 20 to 80 degC by circular dichroism analysis	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3ccccc3)ccc2n1		CHEMBL3099759	=	Kd	nM	12000.0	CHEMBL301	Homo sapiens	Kd	uM	12.0
	13859830	CHEMBL3101312	Binding affinity to CDK2 (unknown origin) at 20 to 80 degC by circular dichroism analysis	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cc(Cl)cc(Cl)c3)ccc2n1		CHEMBL3099758	=	Kd	nM	320.0	CHEMBL301	Homo sapiens	Kd	uM	0.32
	13859831	CHEMBL3101312	Binding affinity to CDK2 (unknown origin) at 20 to 80 degC by circular dichroism analysis	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3ccc(Cl)cc3)ccc2n1		CHEMBL3099757	=	Kd	nM	900.0	CHEMBL301	Homo sapiens	Kd	uM	0.9
	13859832	CHEMBL3101312	Binding affinity to CDK2 (unknown origin) at 20 to 80 degC by circular dichroism analysis	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3ccccc3Cl)ccc2n1		CHEMBL3099756	=	Kd	nM	800.0	CHEMBL301	Homo sapiens	Kd	uM	0.8
	13859833	CHEMBL3101312	Binding affinity to CDK2 (unknown origin) at 20 to 80 degC by circular dichroism analysis	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(Cl)c3)ccc2n1		CHEMBL3099755	=	Kd	nM	300.0	CHEMBL301	Homo sapiens	Kd	uM	0.3
	13859834	CHEMBL3101312	Binding affinity to CDK2 (unknown origin) at 20 to 80 degC by circular dichroism analysis	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccs3)ccc2n1		CHEMBL3099754	=	Kd	nM	1100.0	CHEMBL301	Homo sapiens	Kd	uM	1.1
	13859835	CHEMBL3101313	Displacement of B-Alexa-Fluor647 from CDK2 (unknown origin) by fluorescence polarization assay	B	COC[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(/C=C/c3ccc(Cl)cc3)ccc2n1		CHEMBL3099753	<	Ki	nM	100.0	CHEMBL301	Homo sapiens	Ki	uM	0.1
	13859836	CHEMBL3101313	Displacement of B-Alexa-Fluor647 from CDK2 (unknown origin) by fluorescence polarization assay	B	COC[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099752	=	Ki	nM	100.0	CHEMBL301	Homo sapiens	Ki	uM	0.1
	13859837	CHEMBL3101313	Displacement of B-Alexa-Fluor647 from CDK2 (unknown origin) by fluorescence polarization assay	B	CN(C)C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(/C=C/c3ccc(Cl)cc3)ccc2n1		CHEMBL3099751	=	Ki	nM	160.0	CHEMBL301	Homo sapiens	Ki	uM	0.16
	13859838	CHEMBL3101313	Displacement of B-Alexa-Fluor647 from CDK2 (unknown origin) by fluorescence polarization assay	B	CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(/C=C/c3ccc(Cl)cc3)ccc2n1		CHEMBL3099750	=	Ki	nM	100.0	CHEMBL301	Homo sapiens	Ki	uM	0.1
	13859839	CHEMBL3101313	Displacement of B-Alexa-Fluor647 from CDK2 (unknown origin) by fluorescence polarization assay	B	CCC[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099749	=	Ki	nM	300.0	CHEMBL301	Homo sapiens	Ki	uM	0.3
	13859840	CHEMBL3101313	Displacement of B-Alexa-Fluor647 from CDK2 (unknown origin) by fluorescence polarization assay	B	C[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099748	=	Ki	nM	2500.0	CHEMBL301	Homo sapiens	Ki	uM	2.5
	13859841	CHEMBL3101313	Displacement of B-Alexa-Fluor647 from CDK2 (unknown origin) by fluorescence polarization assay	B	O=C(N[C@@H](Cc1ccc(O)cc1)C(=O)O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099747	=	Ki	nM	12000.0	CHEMBL301	Homo sapiens	Ki	uM	12.0
	13859842	CHEMBL3101313	Displacement of B-Alexa-Fluor647 from CDK2 (unknown origin) by fluorescence polarization assay	B	O=C(NCCc1ccc(O)cc1)c1cc(C(=O)O)c2cc(-c3cccs3)ccc2n1		CHEMBL3099746	>	Ki	nM	40000.0	CHEMBL301	Homo sapiens	Ki	uM	40.0
	13859843	CHEMBL3101313	Displacement of B-Alexa-Fluor647 from CDK2 (unknown origin) by fluorescence polarization assay	B	COC(=O)[C@H](Cc1cccc(O)c1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099745	>	Ki	nM	40000.0	CHEMBL301	Homo sapiens	Ki	uM	40.0
	13859844	CHEMBL3101313	Displacement of B-Alexa-Fluor647 from CDK2 (unknown origin) by fluorescence polarization assay	B	COC(=O)[C@H](Cc1ccc(OC)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099744	>	Ki	nM	40000.0	CHEMBL301	Homo sapiens	Ki	uM	40.0
	13859845	CHEMBL3101313	Displacement of B-Alexa-Fluor647 from CDK2 (unknown origin) by fluorescence polarization assay	B	COC(=O)[C@H](Cc1ccc(F)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099743	=	Ki	nM	2500.0	CHEMBL301	Homo sapiens	Ki	uM	2.5
	13859846	CHEMBL3101313	Displacement of B-Alexa-Fluor647 from CDK2 (unknown origin) by fluorescence polarization assay	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)NS(C)(=O)=O)c2cc(-c3cccs3)ccc2n1		CHEMBL3099742	>	Ki	nM	40000.0	CHEMBL301	Homo sapiens	Ki	uM	40.0
	13859847	CHEMBL3101313	Displacement of B-Alexa-Fluor647 from CDK2 (unknown origin) by fluorescence polarization assay	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(N)=O)c2cc(-c3cccs3)ccc2n1		CHEMBL3099766	>	Ki	nM	40000.0	CHEMBL301	Homo sapiens	Ki	uM	40.0
	13859848	CHEMBL3101313	Displacement of B-Alexa-Fluor647 from CDK2 (unknown origin) by fluorescence polarization assay	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(CO)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099765	>	Ki	nM	40000.0	CHEMBL301	Homo sapiens	Ki	uM	40.0
	13859849	CHEMBL3101313	Displacement of B-Alexa-Fluor647 from CDK2 (unknown origin) by fluorescence polarization assay	B	CCCCCCc1ccc2nc(C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)OC)cc(C(=O)O)c2c1		CHEMBL3099764	<	Ki	nM	100.0	CHEMBL301	Homo sapiens	Ki	uM	0.1
	13859850	CHEMBL3101313	Displacement of B-Alexa-Fluor647 from CDK2 (unknown origin) by fluorescence polarization assay	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(/C=C/c3ccc(Cl)cc3)ccc2n1		CHEMBL3099763	<	Ki	nM	100.0	CHEMBL301	Homo sapiens	Ki	uM	0.1
	13859851	CHEMBL3101313	Displacement of B-Alexa-Fluor647 from CDK2 (unknown origin) by fluorescence polarization assay	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(CCc3ccc(Cl)cc3)ccc2n1		CHEMBL3099762	<	Ki	nM	100.0	CHEMBL301	Homo sapiens	Ki	uM	0.1
	13859852	CHEMBL3101313	Displacement of B-Alexa-Fluor647 from CDK2 (unknown origin) by fluorescence polarization assay	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(C(F)(F)F)c3)ccc2n1		CHEMBL3099761	<	Ki	nM	100.0	CHEMBL301	Homo sapiens	Ki	uM	0.1
	13859853	CHEMBL3101313	Displacement of B-Alexa-Fluor647 from CDK2 (unknown origin) by fluorescence polarization assay	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(N3CCOCC3)ccc2n1		CHEMBL3099760	=	Ki	nM	2800.0	CHEMBL301	Homo sapiens	Ki	uM	2.8
	13859854	CHEMBL3101313	Displacement of B-Alexa-Fluor647 from CDK2 (unknown origin) by fluorescence polarization assay	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3ccccc3)ccc2n1		CHEMBL3099759	=	Ki	nM	10000.0	CHEMBL301	Homo sapiens	Ki	uM	10.0
	13859855	CHEMBL3101313	Displacement of B-Alexa-Fluor647 from CDK2 (unknown origin) by fluorescence polarization assay	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cc(Cl)cc(Cl)c3)ccc2n1		CHEMBL3099758	=	Ki	nM	200.0	CHEMBL301	Homo sapiens	Ki	uM	0.2
	13859856	CHEMBL3101313	Displacement of B-Alexa-Fluor647 from CDK2 (unknown origin) by fluorescence polarization assay	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3ccc(Cl)cc3)ccc2n1		CHEMBL3099757	=	Ki	nM	900.0	CHEMBL301	Homo sapiens	Ki	uM	0.9
	13859857	CHEMBL3101313	Displacement of B-Alexa-Fluor647 from CDK2 (unknown origin) by fluorescence polarization assay	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3ccccc3Cl)ccc2n1		CHEMBL3099756	=	Ki	nM	700.0	CHEMBL301	Homo sapiens	Ki	uM	0.7
	13859858	CHEMBL3101313	Displacement of B-Alexa-Fluor647 from CDK2 (unknown origin) by fluorescence polarization assay	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(Cl)c3)ccc2n1		CHEMBL3099755	=	Ki	nM	140.0	CHEMBL301	Homo sapiens	Ki	uM	0.14
	13859859	CHEMBL3101313	Displacement of B-Alexa-Fluor647 from CDK2 (unknown origin) by fluorescence polarization assay	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccs3)ccc2n1		CHEMBL3099754	=	Ki	nM	900.0	CHEMBL301	Homo sapiens	Ki	uM	0.9
Not Active	13863516	CHEMBL3101991	Inhibition of CDK2 (unknown origin) at 1 uM after 1 hr	B	CC1(C)OC(=O)N([C@H]2CC[C@H](c3cnc(N)c(-c4ncccn4)c3)CC2)[C@H]1c1ccccc1		CHEMBL3099716		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	13863517	CHEMBL3101991	Inhibition of CDK2 (unknown origin) at 1 uM after 1 hr	B	CC1(C)OC(=O)N(c2ccc(-c3cnc(N)c(-c4ncccn4)c3)cc2)[C@H]1c1ccccc1		CHEMBL3099720		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	13899606	CHEMBL3112013	Inhibition of human recombinant CDK2 using ATP/Ulight-CFFKNIVTPRTPPPSQGK-amide as substrate after 30 mins by LANCE assay	B	Cc1nn(-c2ccc(Cl)cc2Cl)c2c1c1c(c3cccn32)C(=O)NC1=O		CHEMBL3110144	=	IC50	nM	2800.0	CHEMBL301	Homo sapiens	IC50	uM	2.8
	13914208	CHEMBL3118304	Inhibition of His-6-tagged CDK2 (unknown origin) expressed in baculovirus-infected insect cells using histone H1 as substrate after 1 hr by by liquid scintillation counting in presence of [gamma-33P]ATP	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	IC50	nM	22.0	CHEMBL301	Homo sapiens	IC50	uM	0.022
Not Active	13950885	CHEMBL3129548	Inhibition of human CDK2 at 10 uM	B	C[C@@H]1NC(c2ccc(Br)cc2)=Nc2nc3ccccn3c2C1=O		CHEMBL3125580		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	13953188	CHEMBL3132512	Inhibition of CDK2 (unknown origin)	B	COc1ccc(-c2nc3c(NCCCNC(=O)C4CCC4)c(Br)cnc3[nH]2)cc1		CHEMBL2011933	>	IC50	nM	4910.0	CHEMBL301	Homo sapiens	IC50	uM	4.91
	13953193	CHEMBL3132512	Inhibition of CDK2 (unknown origin)	B	COc1ccc(-c2nc3c(NCCCNC(=O)C4CCCC4)c(-c4nc(C(=O)NCC(C)C)cs4)cnc3[nH]2)cc1		CHEMBL3125720	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	13953194	CHEMBL3132512	Inhibition of CDK2 (unknown origin)	B	COc1ccc(-c2nc3c(NCCCNC(=O)C4CCCC4)c(C(N)=S)cnc3[nH]2)cc1		CHEMBL3125723	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	13953195	CHEMBL3132512	Inhibition of CDK2 (unknown origin)	B	COc1ccc(-c2nc3c(OCCCNC(=O)C4CCCC4)c(-c4csc(C(=O)O)c4)cnc3[nH]2)cc1		CHEMBL3125724	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	13953196	CHEMBL3132512	Inhibition of CDK2 (unknown origin)	B	COc1ccc(-c2nc3c(OCCCNC(=O)C4CCCC4)c(Br)cnc3[nH]2)cc1		CHEMBL3125725	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	13953197	CHEMBL3132512	Inhibition of CDK2 (unknown origin)	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	13953198	CHEMBL3132512	Inhibition of CDK2 (unknown origin)	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	13953199	CHEMBL3132512	Inhibition of CDK2 (unknown origin)	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	13954576	CHEMBL3132512	Inhibition of CDK2 (unknown origin)	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	13954577	CHEMBL3132512	Inhibition of CDK2 (unknown origin)	B	CCC(C)CNC(=O)c1cc(-c2cnc3[nH]c(-c4ccc(OC)cc4)nc3c2)cs1		CHEMBL3125729	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	13954579	CHEMBL3132512	Inhibition of CDK2 (unknown origin)	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)CO)c4)cnc3[nH]2)cc1		CHEMBL3125730	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	13954580	CHEMBL3132512	Inhibition of CDK2 (unknown origin)	B	COCCNC(=O)c1cc(-c2cnc3[nH]c(-c4ccc(OC)cc4)nc3c2)cs1		CHEMBL3125731	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	13954581	CHEMBL3132512	Inhibition of CDK2 (unknown origin)	B	COc1ccc(-c2nc3c(NCCCNC(=O)C4CCCC4)c(-c4nc(C(=O)O)cs4)cnc3[nH]2)cc1		CHEMBL3125722	=	IC50	nM	13600.0	CHEMBL301	Homo sapiens	IC50	uM	13.6
	13954582	CHEMBL3132512	Inhibition of CDK2 (unknown origin)	B	COc1ccc(-c2nc3cc(-c4csc(C(C)=O)c4)cnc3[nH]2)cc1		CHEMBL3125734	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	13954595	CHEMBL3132512	Inhibition of CDK2 (unknown origin)	B	COc1ccc(-c2nc3c(NCCCNC(=O)C4CCCC4)c(Br)cnc3[nH]2)cc1		CHEMBL2011936	=	IC50	nM	2790.0	CHEMBL301	Homo sapiens	IC50	uM	2.79
	13954602	CHEMBL3132512	Inhibition of CDK2 (unknown origin)	B	COc1ccc(-c2nc3c(NCCCNC(=O)C4CCCC4)c(-c4nc(C(N)=O)cs4)cnc3[nH]2)cc1		CHEMBL3125721	=	IC50	nM	1450.0	CHEMBL301	Homo sapiens	IC50	uM	1.45
	13954611	CHEMBL3132512	Inhibition of CDK2 (unknown origin)	B	COc1ccc(-c2nc3cc(-c4csc(C(N)=O)c4)cnc3[nH]2)cc1		CHEMBL3125732	=	IC50	nM	984.0	CHEMBL301	Homo sapiens	IC50	uM	0.984
	13966025	CHEMBL3136513	Inhibition of human full length CDK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	45.5	CHEMBL301	Homo sapiens	INH	%	45.5
	13973091	CHEMBL3136748	Inhibition of CDK2 (unknown origin)	B	COc1cc(Nc2nccc(-c3ccc(Cl)cc3)n2)cc(OC)c1OC		CHEMBL3134612	=	IC50	nM	18782.0	CHEMBL301	Homo sapiens	IC50	uM	18.782
	13973300	CHEMBL3136893	Inhibition of human full length CDK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	1.5	CHEMBL301	Homo sapiens	INH	%	1.5
	13974018	CHEMBL3136482	Inhibition of human full length CDK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	6.0	CHEMBL301	Homo sapiens	INH	%	6.0
	13974109	CHEMBL3135620	Inhibition of human full length CDK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	26.5	CHEMBL301	Homo sapiens	INH	%	26.5
	13974200	CHEMBL3134732	Inhibition of human full length CDK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	53.0	CHEMBL301	Homo sapiens	INH	%	53.0
	13974291	CHEMBL3136843	Inhibition of human full length CDK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	75.0	CHEMBL301	Homo sapiens	INH	%	75.0
	13975029	CHEMBL3135989	Inhibition of human full length CDK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	6.0	CHEMBL301	Homo sapiens	INH	%	6.0
	13975120	CHEMBL3135716	Inhibition of human full length CDK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	1.0	CHEMBL301	Homo sapiens	INH	%	1.0
	13975211	CHEMBL3135800	Inhibition of human full length CDK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	0.0	CHEMBL301	Homo sapiens	INH	%	0.0
	13975854	CHEMBL3135469	Inhibition of human full length CDK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	7.0	CHEMBL301	Homo sapiens	INH	%	7.0
	13975947	CHEMBL3137001	Inhibition of human full length CDK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	7.5	CHEMBL301	Homo sapiens	INH	%	7.5
	13976038	CHEMBL3135394	Inhibition of human full length CDK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	39.5	CHEMBL301	Homo sapiens	INH	%	39.5
	13976129	CHEMBL3136919	Inhibition of human full length CDK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	34.0	CHEMBL301	Homo sapiens	INH	%	34.0
	14543418	CHEMBL3226018	Inhibition of recombinant CDK2 (unknown origin) using poly-Glu-Tyr peptide as substrate	B	Nc1ccccc1NC(=O)c1ccc(COc2ccc3ncnc(Nc4cccc(Br)c4)c3c2)cc1		CHEMBL3217993	=	IC50	nM	22000.0	CHEMBL301	Homo sapiens	IC50	uM	22.0
	14543419	CHEMBL3226018	Inhibition of recombinant CDK2 (unknown origin) using poly-Glu-Tyr peptide as substrate	B	C#Cc1cccc(Nc2ncnc3ccc(OCc4ccc(C(=O)Nc5ccccc5N)cc4)cc23)c1		CHEMBL3218000	=	IC50	nM	13000.0	CHEMBL301	Homo sapiens	IC50	uM	13.0
	14543420	CHEMBL3226018	Inhibition of recombinant CDK2 (unknown origin) using poly-Glu-Tyr peptide as substrate	B	C#Cc1cccc(Nc2ncnc3ccc(S(=O)(=O)n4ccc(/C=C/C(=O)Nc5ccccc5N)c4)cc23)c1		CHEMBL3218001	=	IC50	nM	17000.0	CHEMBL301	Homo sapiens	IC50	uM	17.0
	14543421	CHEMBL3226018	Inhibition of recombinant CDK2 (unknown origin) using poly-Glu-Tyr peptide as substrate	B	C#Cc1cccc(Nc2ncnc3ccc(S(=O)(=O)n4ccc(/C=C/C(=O)NO)c4)cc23)c1		CHEMBL3218002	>	IC50	nM	100000.0	CHEMBL301	Homo sapiens	IC50	uM	100.0
	14543422	CHEMBL3226018	Inhibition of recombinant CDK2 (unknown origin) using poly-Glu-Tyr peptide as substrate	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	IC50	nM	100000.0	CHEMBL301	Homo sapiens	IC50	uM	100.0
	14544038	CHEMBL3226047	Inhibition of CDK2 (unknown origin) at 10 uM	B	CC1(C)C(=O)Nc2cc3nccc(Oc4ccc(NC(=O)Nc5ccc(F)c(C(F)(F)F)c5)cc4Cl)c3cc21		CHEMBL3218350	=	Inhibition	%	7.8	CHEMBL301	Homo sapiens	INH	%	7.8
	14663229	CHEMBL3268852	Inhibition of CDK2 (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	100.0	CHEMBL301	Homo sapiens	INH	%	100.0
	14663230	CHEMBL3268852	Inhibition of CDK2 (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	100.0	CHEMBL301	Homo sapiens	INH	%	100.0
	14663231	CHEMBL3268852	Inhibition of CDK2 (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	84.0	CHEMBL301	Homo sapiens	INH	%	84.0
	14751942	CHEMBL3300811	Inhibition of CDK2 (unknown origin)	B	O=C(CC1CNC(=O)c2cc(-c3cn[nH]c3)cn21)NCc1cccc(F)c1		CHEMBL3298823	=	IC50	nM	60.0	CHEMBL301	Homo sapiens	IC50	uM	0.06
	14976861	CHEMBL3390077	Inhibition of CDK2 (unknown origin) at 0.1 uM	B	O=S(=O)(c1ccccc1)c1cc(Nc2cc(C3CCCC3)[nH]n2)nc(N[C@H]2CC[C@H](O)CC2)c1		CHEMBL3355737	=	Inhibition	%	70.0	CHEMBL301	Homo sapiens	INH	%	70.0
	14980847	CHEMBL3372971	Inhibition of CDK2 (unknown origin) in presence of 1 mM ATP	B	CN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1		CHEMBL3355482	>	IC50	nM	100000.0	CHEMBL301	Homo sapiens	IC50	uM	100.0
	15014024	CHEMBL3364483	Inhibition of Cdk2 (unknown origin)	B	O=C(N[C@H](CO)c1ccc(F)c(Cl)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298414	=	IC50	nM	16.0	CHEMBL301	Homo sapiens	IC50	nM	16.0
	15014025	CHEMBL3364483	Inhibition of Cdk2 (unknown origin)	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	IC50	nM	10.0	CHEMBL301	Homo sapiens	IC50	nM	10.0
	15014026	CHEMBL3364483	Inhibition of Cdk2 (unknown origin)	B	O=C(N[C@H](CO)c1ccc(Cl)c(Cl)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298982	=	IC50	nM	11.0	CHEMBL301	Homo sapiens	IC50	nM	11.0
	15014027	CHEMBL3364483	Inhibition of Cdk2 (unknown origin)	B	C[C@@H](NC(=O)N1CCc2cnc(NC3CCOCC3)nc2C1)c1ccc2cc[nH]c2c1		CHEMBL3298983	=	IC50	nM	69.0	CHEMBL301	Homo sapiens	IC50	nM	69.0
	15014028	CHEMBL3364483	Inhibition of Cdk2 (unknown origin)	B	C[C@@H](NC(=O)N1CCc2cnc(NC3CCOCC3)nc2C1)c1ccc(Cl)c(F)c1		CHEMBL3298984	=	IC50	nM	13.0	CHEMBL301	Homo sapiens	IC50	nM	13.0
	15014029	CHEMBL3364483	Inhibition of Cdk2 (unknown origin)	B	CC[C@@H](NC(=O)N1CCc2cnc(NC3CCOCC3)nc2C1)c1ccc(C#N)c(Cl)c1		CHEMBL3298985	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	IC50	nM	2.0
	15014030	CHEMBL3364483	Inhibition of Cdk2 (unknown origin)	B	C[C@@H](NC(=O)N1CCc2cnc(N[C@H]3CCO[C@@H](CO)C3)nc2C1)c1ccc(Cl)c(Cl)c1		CHEMBL3298199	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	IC50	nM	2.0
	15014031	CHEMBL3364483	Inhibition of Cdk2 (unknown origin)	B	C[C@@H](CO)Nc1ncc2c(n1)CN(C(=O)N[C@H](C)c1ccc(Cl)c(Cl)c1)CC2		CHEMBL3298308	=	IC50	nM	104.0	CHEMBL301	Homo sapiens	IC50	nM	104.0
	15014032	CHEMBL3364483	Inhibition of Cdk2 (unknown origin)	B	CC[C@@H](NC(=O)N1CCc2cnc(N[C@@H](C)CO)nc2C1)c1ccc(F)c(F)c1		CHEMBL3298309	=	IC50	nM	13.0	CHEMBL301	Homo sapiens	IC50	nM	13.0
	15014033	CHEMBL3364483	Inhibition of Cdk2 (unknown origin)	B	CC[C@@H](NC(=O)N1CCc2cnc(N[C@@H](C)CO)nc2C1)c1ccc(Cl)c(Cl)c1		CHEMBL3298310	=	IC50	nM	12.0	CHEMBL301	Homo sapiens	IC50	nM	12.0
	15014034	CHEMBL3364483	Inhibition of Cdk2 (unknown origin)	B	C[C@@H](CO)Nc1ncc2c(n1)CN(C(=O)N[C@H](C)c1ccc(C(F)(F)F)c(F)c1)CC2		CHEMBL3298311	=	IC50	nM	821.0	CHEMBL301	Homo sapiens	IC50	nM	821.0
	15014035	CHEMBL3364483	Inhibition of Cdk2 (unknown origin)	B	CC[C@@H](NC(=O)N1CCc2cnc(N[C@@H](C)CO)nc2C1)c1ccc(OC)c(Cl)c1		CHEMBL3298312	=	IC50	nM	71.0	CHEMBL301	Homo sapiens	IC50	nM	71.0
	15014036	CHEMBL3364483	Inhibition of Cdk2 (unknown origin)	B	Cc1cc(Nc2ncc3c(n2)CN(C(=O)N[C@H](C)c2ccc(Cl)c(Cl)c2)CC3)ccn1		CHEMBL3298418	=	IC50	nM	9.0	CHEMBL301	Homo sapiens	IC50	nM	9.0
	15014037	CHEMBL3364483	Inhibition of Cdk2 (unknown origin)	B	C[C@@H](NC(=O)N1CCc2cnc(Nc3cnn(C)c3)nc2C1)c1ccc(Cl)c(Cl)c1		CHEMBL3357950	=	IC50	nM	4.0	CHEMBL301	Homo sapiens	IC50	nM	4.0
	15014038	CHEMBL3364483	Inhibition of Cdk2 (unknown origin)	B	C[C@@H](NC(=O)N1CCc2cnc(Nc3ccnn3C)nc2C1)c1ccc(Cl)c(Cl)c1		CHEMBL3357951	=	IC50	nM	23.0	CHEMBL301	Homo sapiens	IC50	nM	23.0
	15053963	CHEMBL3369602	Inhibition of CDK2 (unknown origin)	B	Clc1ccc(-c2ccc(-c3nccn3-c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL3314140	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	15091126	CHEMBL3390661	Inhibition of human recombinant CDK2 using Ulight-CFFKNIVTPRTPPPSQGK-amide substrate assessed as remaining enzyme activity at 1 uM after 30 mins relative to control	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Br)c(O)c(Br)c1		CHEMBL2206014	=	Activity	%	95.0	CHEMBL301	Homo sapiens	Activity	%	95.0
	15101451	CHEMBL3380807	Inhibition of human CDK2 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1O		CHEMBL3343033	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	15101452	CHEMBL3380807	Inhibition of human CDK2 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)nc(C)nc2cc1O		CHEMBL3343034	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	15101453	CHEMBL3380807	Inhibition of human CDK2 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCO		CHEMBL3343037	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	15101454	CHEMBL3380807	Inhibition of human CDK2 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCC(=O)O		CHEMBL3343038	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	15101455	CHEMBL3380807	Inhibition of human CDK2 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCC(N)=O		CHEMBL3343039	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	15101456	CHEMBL3380807	Inhibition of human CDK2 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)nc(N)nc2cc1O		CHEMBL3343040	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	15101457	CHEMBL3380807	Inhibition of human CDK2 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)nc(NCCc3ccccn3)nc2cc1O		CHEMBL3343042	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	15101458	CHEMBL3380807	Inhibition of human CDK2 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccn3)cc2)ccc1O		CHEMBL3343044	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	15101459	CHEMBL3380807	Inhibition of human CDK2 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	O=C(Nc1ccc(NC(=O)c2ccccn2)cc1)c1ccc(O)c([N+](=O)[O-])c1		CHEMBL3343045	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	15101460	CHEMBL3380807	Inhibition of human CDK2 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccc3)cc2)ccc1O		CHEMBL3343046	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	15101461	CHEMBL3380807	Inhibition of human CDK2 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccc3)cc2)c(N)cc1O		CHEMBL3343047	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	15101462	CHEMBL3380807	Inhibition of human CDK2 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccc3)cc2)ccc1OCC(=O)O		CHEMBL3343048	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	15101463	CHEMBL3380807	Inhibition of human CDK2 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccn3)cc2)cc(-c2c[nH]c(=O)[nH]c2=O)c1		CHEMBL3341771	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	15101464	CHEMBL3380807	Inhibition of human CDK2 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	O=C(Nc1ccc(NC(=O)c2ccccn2)cc1)c1cccc(-c2c[nH]c(=O)[nH]c2=O)c1		CHEMBL3343051	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	15101465	CHEMBL3380807	Inhibition of human CDK2 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1ccc(C(=O)Nc2ccc(NC(=O)c3ccccn3)cc2)cc1-c1c[nH]c(=O)[nH]c1=O		CHEMBL3343052	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	15101466	CHEMBL3380807	Inhibition of human CDK2 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccn3)cc2)cc(N2CCC(=O)NC2=O)c1		CHEMBL3343055	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	15101467	CHEMBL3380807	Inhibition of human CDK2 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc(C(=O)Nc2ccc(NC(=O)C3CCCCN3)cc2)cc(-c2c[nH]c(=O)[nH]c2=O)c1		CHEMBL3343057	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	15101468	CHEMBL3380807	Inhibition of human CDK2 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	CCNC(=O)Nc1ccc(NC(=O)c2cc(OC)cc(-c3c[nH]c(=O)[nH]c3=O)c2)cc1		CHEMBL3343058	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	uM	30.0
	15112148	CHEMBL3388160	Inhibition of CDK2 (unknown origin)	B	COc1ccc(-c2cccc3nc(NC(=O)C4CC4)nn23)cc1		CHEMBL3360318	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	15116484	CHEMBL3376472	Inhibition of CDK2 (unknown origin)	B	CC(=O)c1ccc(N2CCN(C(=O)CN3CC[C@@H](C(=O)Nc4ccc(O)c(Cl)c4)C3)CC2)cc1		CHEMBL3356117	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	15135640	CHEMBL3375808	Inhibition of CDK2 (unknown origin)	B	COC1CCN(c2nccc(Nc3cc(NC(=O)c4c(Cl)cccc4Cl)ccn3)n2)CC1		CHEMBL3352835	=	IC50	nM	503.0	CHEMBL301	Homo sapiens	IC50	nM	503.0
	15135641	CHEMBL3375808	Inhibition of CDK2 (unknown origin)	B	COC1CCN(c2nccc(Nc3cc4[nH]c(-c5cn[nH]c5)nc4cn3)n2)CC1		CHEMBL3354185	=	IC50	nM	90.0	CHEMBL301	Homo sapiens	IC50	nM	90.0
	15135642	CHEMBL3375808	Inhibition of CDK2 (unknown origin)	B	COC1CCN(c2nccc(Nc3cc4[nH]c(-c5cn[nH]c5)cc4cn3)n2)CC1		CHEMBL3354186	=	IC50	nM	5.0	CHEMBL301	Homo sapiens	IC50	nM	5.0
	15135643	CHEMBL3375808	Inhibition of CDK2 (unknown origin)	B	COC1CCN(c2nccc(Nc3cc4c(cn3)cc(-c3cn[nH]c3)n4C(C)C)n2)CC1		CHEMBL3354187	=	IC50	nM	10.0	CHEMBL301	Homo sapiens	IC50	nM	10.0
	15135644	CHEMBL3375808	Inhibition of CDK2 (unknown origin)	B	COC1CCN(c2nccc(Nc3cc4c(ccn4C(C)C)cn3)n2)CC1		CHEMBL3354188	=	IC50	nM	80.0	CHEMBL301	Homo sapiens	IC50	nM	80.0
	15135645	CHEMBL3375808	Inhibition of CDK2 (unknown origin)	B	COC1CCN(c2nccc(Nc3cc4c(ccn4C4CCCC4)cn3)n2)CC1		CHEMBL3354189	=	IC50	nM	93.0	CHEMBL301	Homo sapiens	IC50	nM	93.0
	15135646	CHEMBL3375808	Inhibition of CDK2 (unknown origin)	B	COC1CCN(c2nccc(Nc3cc4c(cn3)ncn4C(C)C)n2)CC1		CHEMBL3354190	=	IC50	nM	2220.0	CHEMBL301	Homo sapiens	IC50	nM	2220.0
	15135647	CHEMBL3375808	Inhibition of CDK2 (unknown origin)	B	COC1CCN(c2nccc(Nc3cc4c(cn3)c(N)nn4C(C)C)n2)CC1		CHEMBL3354191	=	IC50	nM	530.0	CHEMBL301	Homo sapiens	IC50	nM	530.0
	15135648	CHEMBL3375808	Inhibition of CDK2 (unknown origin)	B	COC1CCN(c2nccc(Nc3cc4c(C(C)C)n[nH]c4cn3)n2)CC1		CHEMBL3354192	=	IC50	nM	476.0	CHEMBL301	Homo sapiens	IC50	nM	476.0
	15137727	CHEMBL3385163	Inhibition of CDK2 (unknown origin) assessed as residual enzyme activity at 10 uM	B	CO[C@H]1CC[C@H](NC(=O)c2n[nH]cc2NC(=O)c2ccccc2)CC1		CHEMBL3335124	=	Activity	%	1.0	CHEMBL301	Homo sapiens	Activity	%	1.0
	15137728	CHEMBL3385163	Inhibition of CDK2 (unknown origin) assessed as residual enzyme activity at 10 uM	B	COc1cccc(OC)c1C(=O)Nc1c[nH]nc1C(=O)N[C@H]1CC[C@H](OC)CC1		CHEMBL3335141	=	Activity	%	9.0	CHEMBL301	Homo sapiens	Activity	%	9.0
	15137729	CHEMBL3385163	Inhibition of CDK2 (unknown origin) assessed as residual enzyme activity at 10 uM	B	CO[C@H]1CC[C@H](NC(=O)c2n[nH]cc2NC(=O)c2ccc(-c3ccccc3)o2)CC1		CHEMBL3335153	=	Activity	%	1.0	CHEMBL301	Homo sapiens	Activity	%	1.0
	15137730	CHEMBL3385163	Inhibition of CDK2 (unknown origin) assessed as residual enzyme activity at 10 uM	B	COc1cccc(OC)c1C(=O)Nc1c[nH]nc1C(=O)NCc1ccccc1		CHEMBL3335161	=	Activity	%	38.0	CHEMBL301	Homo sapiens	Activity	%	38.0
	15146840	CHEMBL3395971	Inhibition of CDK2 (unknown origin) at 1 uM	B	Nc1ncc(-c2ccc3[nH]nc(-c4cnc5ccccc5c4)c3c2)s1		CHEMBL3394059	>	Inhibition	%	90.0	CHEMBL301	Homo sapiens	INH	%	90.0
	15149906	CHEMBL3395793	Inhibition of CDK2 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CCCCC2)ccn1		CHEMBL3394105	<	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	15149907	CHEMBL3395793	Inhibition of CDK2 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	COC(Cn1c(SC2CCC(C(=O)O)CC2O)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1)OC		CHEMBL3394112	<	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	15149915	CHEMBL3395793	Inhibition of CDK2 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CC2)ccn1		CHEMBL3394102	<	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	15149918	CHEMBL3395793	Inhibition of CDK2 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC2CCCO2)ccn1		CHEMBL3394108	<	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	15149937	CHEMBL3395793	Inhibition of CDK2 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(Sc3cccc(I)n3)n2C2CCCCC2)ccn1		CHEMBL3394118	<	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	15169314	CHEMBL3406330	Inhibition of CDK2 (unknown origin) at 1 ug/ml relative to control	B	CN(C(=O)c1ccccc1)c1ccc2[nH]c(-c3n[nH]c4ccccc34)cc2n1		CHEMBL3403010	=	Inhibition	%	28.23	CHEMBL301	Homo sapiens	INH	%	28.23
	15169315	CHEMBL3406330	Inhibition of CDK2 (unknown origin) at 1 ug/ml relative to control	B	CN(C(=O)c1ccc(Cl)cc1)c1ccc2[nH]c(-c3n[nH]c4ccccc34)cc2n1		CHEMBL3403013	=	Inhibition	%	35.47	CHEMBL301	Homo sapiens	INH	%	35.47
	15169316	CHEMBL3406330	Inhibition of CDK2 (unknown origin) at 1 ug/ml relative to control	B	CN(C(=O)Nc1ccccc1)c1ccc2[nH]c(-c3n[nH]c4ccccc34)cc2n1		CHEMBL3403031	=	Inhibition	%	13.77	CHEMBL301	Homo sapiens	INH	%	13.77
	15173770	CHEMBL3405459	Inhibition of CDK2 (unknown origin)	B	Fc1cnc2[nH]cc(-c3ncc(F)c(N[C@H]4C5CCC(CC5)[C@@H]4c4nnn[nH]4)n3)c2c1		CHEMBL3401975	>	Ki	nM	4000.0	CHEMBL301	Homo sapiens	Ki	uM	4.0
	15173771	CHEMBL3405459	Inhibition of CDK2 (unknown origin)	B	O=P(O)(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401976	>	Ki	nM	4000.0	CHEMBL301	Homo sapiens	Ki	uM	4.0
	15173772	CHEMBL3405459	Inhibition of CDK2 (unknown origin)	B	O=P(O)(O)CC[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401977	>	Ki	nM	4000.0	CHEMBL301	Homo sapiens	Ki	uM	4.0
	15173773	CHEMBL3405459	Inhibition of CDK2 (unknown origin)	B	O=c1[nH]c(=O)n(C[C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)o1		CHEMBL3401978	>	Ki	nM	4000.0	CHEMBL301	Homo sapiens	Ki	uM	4.0
	15173774	CHEMBL3405459	Inhibition of CDK2 (unknown origin)	B	Oc1cc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)no1		CHEMBL3401979	>	Ki	nM	4000.0	CHEMBL301	Homo sapiens	Ki	uM	4.0
	15173775	CHEMBL3405459	Inhibition of CDK2 (unknown origin)	B	CC(=O)NS(=O)(=O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401980	>	Ki	nM	4000.0	CHEMBL301	Homo sapiens	Ki	uM	4.0
	15173776	CHEMBL3405459	Inhibition of CDK2 (unknown origin)	B	Oc1cc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)on1		CHEMBL3401981	>	Ki	nM	4000.0	CHEMBL301	Homo sapiens	Ki	uM	4.0
	15173777	CHEMBL3405459	Inhibition of CDK2 (unknown origin)	B	O=c1nc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)[nH]o1		CHEMBL3401982	>	Ki	nM	4000.0	CHEMBL301	Homo sapiens	Ki	uM	4.0
	15173778	CHEMBL3405459	Inhibition of CDK2 (unknown origin)	B	NS(=O)(=O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401983	>	Ki	nM	4000.0	CHEMBL301	Homo sapiens	Ki	uM	4.0
	15173779	CHEMBL3405459	Inhibition of CDK2 (unknown origin)	B	OCC(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401984	>	Ki	nM	4000.0	CHEMBL301	Homo sapiens	Ki	uM	4.0
	15173780	CHEMBL3405459	Inhibition of CDK2 (unknown origin)	B	Oc1cc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)[nH]n1		CHEMBL3401985	>	Ki	nM	4000.0	CHEMBL301	Homo sapiens	Ki	uM	4.0
	15173781	CHEMBL3405459	Inhibition of CDK2 (unknown origin)	B	CNC(=O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401986	>	Ki	nM	4000.0	CHEMBL301	Homo sapiens	Ki	uM	4.0
	15173782	CHEMBL3405459	Inhibition of CDK2 (unknown origin)	B	CC(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401987	=	Ki	nM	1200.0	CHEMBL301	Homo sapiens	Ki	uM	1.2
	15173783	CHEMBL3405459	Inhibition of CDK2 (unknown origin)	B	Cc1noc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)n1		CHEMBL3401988	>	Ki	nM	4000.0	CHEMBL301	Homo sapiens	Ki	uM	4.0
	15173784	CHEMBL3405459	Inhibition of CDK2 (unknown origin)	B	Cc1nnc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)o1		CHEMBL3401989	>	Ki	nM	4000.0	CHEMBL301	Homo sapiens	Ki	uM	4.0
	15173785	CHEMBL3405459	Inhibition of CDK2 (unknown origin)	B	CS(=O)(=O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401990	>	Ki	nM	4000.0	CHEMBL301	Homo sapiens	Ki	uM	4.0
	15235297	CHEMBL3424981	Inhibition of human recombinant full length C-terminal His6-tagged CDK2 expressed in baculovirus infected Sf21 insect cells using fluorescence substrate after 60 mins by caliper off-chip incubation mobility shift assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1cc(-c2c[nH]c3cnccc23)ncn1		CHEMBL3421963	=	IC50	nM	12295.0	CHEMBL301	Homo sapiens	IC50	uM	12.295
	15235298	CHEMBL3424981	Inhibition of human recombinant full length C-terminal His6-tagged CDK2 expressed in baculovirus infected Sf21 insect cells using fluorescence substrate after 60 mins by caliper off-chip incubation mobility shift assay	B	CN1CCN(c2ccc(Nc3cc(-c4c[nH]c5cnccc45)ncn3)cc2)CC1		CHEMBL3421962	=	IC50	nM	577.0	CHEMBL301	Homo sapiens	IC50	uM	0.577
	15235299	CHEMBL3424981	Inhibition of human recombinant full length C-terminal His6-tagged CDK2 expressed in baculovirus infected Sf21 insect cells using fluorescence substrate after 60 mins by caliper off-chip incubation mobility shift assay	B	CN1CCN(c2ccc(Nc3cc(-c4c[nH]c5ccccc45)ncn3)cc2)CC1		CHEMBL3421636	=	IC50	nM	33215.0	CHEMBL301	Homo sapiens	IC50	uM	33.215
	15235342	CHEMBL3424981	Inhibition of human recombinant full length C-terminal His6-tagged CDK2 expressed in baculovirus infected Sf21 insect cells using fluorescence substrate after 60 mins by caliper off-chip incubation mobility shift assay	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1cc(-c2c[nH]c3cnccc23)ncn1		CHEMBL3421964	=	IC50	nM	14060.0	CHEMBL301	Homo sapiens	IC50	uM	14.06
	15235343	CHEMBL3424981	Inhibition of human recombinant full length C-terminal His6-tagged CDK2 expressed in baculovirus infected Sf21 insect cells using fluorescence substrate after 60 mins by caliper off-chip incubation mobility shift assay	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1cc(-c2cn(C)c3cnccc23)ncn1		CHEMBL3421965	=	IC50	nM	14789.0	CHEMBL301	Homo sapiens	IC50	uM	14.789
	15235344	CHEMBL3424981	Inhibition of human recombinant full length C-terminal His6-tagged CDK2 expressed in baculovirus infected Sf21 insect cells using fluorescence substrate after 60 mins by caliper off-chip incubation mobility shift assay	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1nccc(-c2c[nH]c3cnccc23)n1		CHEMBL3421966	=	IC50	nM	1995.0	CHEMBL301	Homo sapiens	IC50	uM	1.995
	15235345	CHEMBL3424981	Inhibition of human recombinant full length C-terminal His6-tagged CDK2 expressed in baculovirus infected Sf21 insect cells using fluorescence substrate after 60 mins by caliper off-chip incubation mobility shift assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1nccc(-c2c[nH]c3cnccc23)n1		CHEMBL3421967	=	IC50	nM	1819.0	CHEMBL301	Homo sapiens	IC50	uM	1.819
	15235346	CHEMBL3424981	Inhibition of human recombinant full length C-terminal His6-tagged CDK2 expressed in baculovirus infected Sf21 insect cells using fluorescence substrate after 60 mins by caliper off-chip incubation mobility shift assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1nccc(-c2cn(C)c3cnccc23)n1		CHEMBL3421968	=	IC50	nM	4473.0	CHEMBL301	Homo sapiens	IC50	uM	4.473
	15235347	CHEMBL3424981	Inhibition of human recombinant full length C-terminal His6-tagged CDK2 expressed in baculovirus infected Sf21 insect cells using fluorescence substrate after 60 mins by caliper off-chip incubation mobility shift assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1nccc(-c2c[nH]c3cnc(C)cc23)n1		CHEMBL3421969	=	IC50	nM	10476.0	CHEMBL301	Homo sapiens	IC50	uM	10.476
	15235348	CHEMBL3424981	Inhibition of human recombinant full length C-terminal His6-tagged CDK2 expressed in baculovirus infected Sf21 insect cells using fluorescence substrate after 60 mins by caliper off-chip incubation mobility shift assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1nccc(-c2c[nH]c3c(C)nccc23)n1		CHEMBL3421970	=	IC50	nM	17368.0	CHEMBL301	Homo sapiens	IC50	uM	17.368
	15235349	CHEMBL3424981	Inhibition of human recombinant full length C-terminal His6-tagged CDK2 expressed in baculovirus infected Sf21 insect cells using fluorescence substrate after 60 mins by caliper off-chip incubation mobility shift assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1nccc(-c2cn(C)c3c(C)nccc23)n1		CHEMBL3421971	=	IC50	nM	13713.0	CHEMBL301	Homo sapiens	IC50	uM	13.713
	15235350	CHEMBL3424981	Inhibition of human recombinant full length C-terminal His6-tagged CDK2 expressed in baculovirus infected Sf21 insect cells using fluorescence substrate after 60 mins by caliper off-chip incubation mobility shift assay	B	CN1CCN(c2ccc(Nc3ncc(Cl)c(-c4c[nH]c5cnccc45)n3)cc2)CC1		CHEMBL3421973	=	IC50	nM	20.0	CHEMBL301	Homo sapiens	IC50	uM	0.02
	15235351	CHEMBL3424981	Inhibition of human recombinant full length C-terminal His6-tagged CDK2 expressed in baculovirus infected Sf21 insect cells using fluorescence substrate after 60 mins by caliper off-chip incubation mobility shift assay	B	O=C(NC1CCCC1)c1ccc(-c2nccc(-c3c[nH]c4cnccc34)n2)cc1		CHEMBL3421974	=	IC50	nM	45885.0	CHEMBL301	Homo sapiens	IC50	uM	45.885
	15235352	CHEMBL3424981	Inhibition of human recombinant full length C-terminal His6-tagged CDK2 expressed in baculovirus infected Sf21 insect cells using fluorescence substrate after 60 mins by caliper off-chip incubation mobility shift assay	B	CS(=O)(=O)c1ccc(-c2nccc(-c3c[nH]c4cnccc34)n2)cc1		CHEMBL3421975	=	IC50	nM	16884.0	CHEMBL301	Homo sapiens	IC50	uM	16.884
	15235353	CHEMBL3424981	Inhibition of human recombinant full length C-terminal His6-tagged CDK2 expressed in baculovirus infected Sf21 insect cells using fluorescence substrate after 60 mins by caliper off-chip incubation mobility shift assay	B	Cn1cc(-c2ccnc(-c3ccc(S(C)(=O)=O)cc3)n2)c2ccncc21		CHEMBL3421976	>	IC50	nM	100000.0	CHEMBL301	Homo sapiens	IC50	uM	100.0
	15235354	CHEMBL3424981	Inhibition of human recombinant full length C-terminal His6-tagged CDK2 expressed in baculovirus infected Sf21 insect cells using fluorescence substrate after 60 mins by caliper off-chip incubation mobility shift assay	B	Cc1nccc2c(-c3ccnc(-c4ccc(S(C)(=O)=O)cc4)n3)c[nH]c12		CHEMBL3421977	>	IC50	nM	100000.0	CHEMBL301	Homo sapiens	IC50	uM	100.0
	15235355	CHEMBL3424981	Inhibition of human recombinant full length C-terminal His6-tagged CDK2 expressed in baculovirus infected Sf21 insect cells using fluorescence substrate after 60 mins by caliper off-chip incubation mobility shift assay	B	C(=C/c1nccc(-c2c[nH]c3cnccc23)n1)\c1ccccc1		CHEMBL3421978	=	IC50	nM	5176.0	CHEMBL301	Homo sapiens	IC50	uM	5.176
	15235356	CHEMBL3424981	Inhibition of human recombinant full length C-terminal His6-tagged CDK2 expressed in baculovirus infected Sf21 insect cells using fluorescence substrate after 60 mins by caliper off-chip incubation mobility shift assay	B	Cc1nccc(-c2c[nH]c3cnccc23)n1		CHEMBL3421979	=	IC50	nM	38379.0	CHEMBL301	Homo sapiens	IC50	uM	38.379
	15235357	CHEMBL3424981	Inhibition of human recombinant full length C-terminal His6-tagged CDK2 expressed in baculovirus infected Sf21 insect cells using fluorescence substrate after 60 mins by caliper off-chip incubation mobility shift assay	B	Cc1nccc(-c2cn(Cc3ccccc3)c3cnccc23)n1		CHEMBL3421980	=	IC50	nM	56703.0	CHEMBL301	Homo sapiens	IC50	uM	56.703
	15235358	CHEMBL3424981	Inhibition of human recombinant full length C-terminal His6-tagged CDK2 expressed in baculovirus infected Sf21 insect cells using fluorescence substrate after 60 mins by caliper off-chip incubation mobility shift assay	B	c1cc2c(-c3ccnc4[nH]ccc34)c[nH]c2cn1		CHEMBL3421981	=	IC50	nM	314.0	CHEMBL301	Homo sapiens	IC50	uM	0.314
	15251906	CHEMBL3430194	Binding affinity to N-terminal His-tagged CDK2 (unknown origin) expressed in Escherichia coli BL21 (DE3) assessed as melting temperature by thermal shift assay (Rvb = 41.5 degC)	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Tm	degrees C	47.7	CHEMBL301	Homo sapiens	Tm	degrees C	47.7
	15253804	CHEMBL3429890	Inhibition of human CDK2	B	CCn1nc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C)c2c(N)ncnc21		CHEMBL3426225	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	15255281	CHEMBL3430194	Binding affinity to N-terminal His-tagged CDK2 (unknown origin) expressed in Escherichia coli BL21 (DE3) assessed as melting temperature by thermal shift assay (Rvb = 41.5 degC)	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Tm	degrees C	43.4	CHEMBL301	Homo sapiens	Tm	degrees C	43.4
	15255486	CHEMBL3430194	Binding affinity to N-terminal His-tagged CDK2 (unknown origin) expressed in Escherichia coli BL21 (DE3) assessed as melting temperature by thermal shift assay (Rvb = 41.5 degC)	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Tm	degrees C	43.9	CHEMBL301	Homo sapiens	Tm	degrees C	43.9
	15258339	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Thermal melting change	degrees C	0.9	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.9
	15258399	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Thermal melting change	degrees C	-0.6	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	-0.6
	15258459	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Thermal melting change	degrees C	0.1	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.1
	15258519	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Thermal melting change	degrees C	3.0	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	3.0
	15258579	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Thermal melting change	degrees C	0.9	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.9
	15258639	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Thermal melting change	degrees C	-0.7	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	-0.7
	15258699	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Thermal melting change	degrees C	0.4	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.4
	15258759	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=C(O)Cc1ccc(O)c([N+](=O)[O-])c1		CHEMBL501822	=	Thermal melting change	degrees C	1.1	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	1.1
	15258819	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	Thermal melting change	degrees C	5.9	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	5.9
	15258879	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Thermal melting change	degrees C	5.2	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	5.2
	15258939	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1642	=	Thermal melting change	degrees C	0.2	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.2
	15258999	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Thermal melting change	degrees C	6.3	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	6.3
	15259059	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Thermal melting change	degrees C	6.6	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	6.6
	15259119	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL216543	=	Thermal melting change	degrees C	9.1	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	9.1
	15259179	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Thermal melting change	degrees C	15.9	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	15.9
	15259239	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Cn1cc(/C=C2/C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL3430785	=	Thermal melting change	degrees C	1.3	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	1.3
	15259299	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B			CHEMBL3430786	=	Thermal melting change	degrees C	0.0	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.0
	15259359	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CCOc1ccc(/C=C2/SC(=O)N(CCN)C2=O)cc1		CHEMBL262615	=	Thermal melting change	degrees C	-0.1	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	-0.1
	15259419	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=c1c(-c2ccc(F)cc2)c(-c2ccncc2)[nH]n1-c1ccc(Cl)cc1		CHEMBL408678	=	Thermal melting change	degrees C	0.2	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.2
	15259479	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Thermal melting change	degrees C	-0.5	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	-0.5
	15259539	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Thermal melting change	degrees C	-0.8	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	-0.8
	15259599	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1		CHEMBL97162	=	Thermal melting change	degrees C	-0.6	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	-0.6
	15259659	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Thermal melting change	degrees C	0.9	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.9
	15259719	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Thermal melting change	degrees C	-0.8	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	-0.8
	15259779	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl		CHEMBL406381	=	Thermal melting change	degrees C	-0.4	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	-0.4
	15259839	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Thermal melting change	degrees C	-0.5	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	-0.5
	15259899	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Thermal melting change	degrees C	-0.4	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	-0.4
	15259959	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Cl.NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL558969	=	Thermal melting change	degrees C	0.1	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.1
	15260019	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1		CHEMBL261641	=	Thermal melting change	degrees C	-0.4	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	-0.4
	15260079	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Thermal melting change	degrees C	0.1	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.1
	15260139	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Thermal melting change	degrees C	0.0	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.0
	15260199	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B			CHEMBL3430787	=	Thermal melting change	degrees C	2.9	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	2.9
	15260259	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Thermal melting change	degrees C	-1.5	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	-1.5
	15260319	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CN(c1cccnc1)c1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cn1		CHEMBL261238	=	Thermal melting change	degrees C	-0.5	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	-0.5
	15260379	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Thermal melting change	degrees C	10.6	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	10.6
	15260439	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Thermal melting change	degrees C	0.2	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.2
	15260499	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL298445	=	Thermal melting change	degrees C	6.1	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	6.1
	15260559	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Thermal melting change	degrees C	0.0	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.0
	15260619	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B			CHEMBL3430788	=	Thermal melting change	degrees C	-0.3	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	-0.3
	15260679	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Thermal melting change	degrees C	3.3	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	3.3
	15260739	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Thermal melting change	degrees C	-0.6	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	-0.6
	15260799	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CN1CCc2[nH]c(=S)c(C#N)c(-c3cccs3)c2C1		CHEMBL261211	=	Thermal melting change	degrees C	0.0	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.0
	15260859	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(O)c1c(F)cccc1F		CHEMBL259605	=	Thermal melting change	degrees C	8.2	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	8.2
	15260919	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Thermal melting change	degrees C	0.2	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.2
	15260979	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Thermal melting change	degrees C	-0.5	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	-0.5
	15261039	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1		CHEMBL258940	=	Thermal melting change	degrees C	0.1	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.1
	15261099	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Thermal melting change	degrees C	0.0	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.0
	15261182	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Thermal melting change	degrees C	1.8	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	1.8
	15261242	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Thermal melting change	degrees C	2.2	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	2.2
	15261302	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Nc1cc2ncnc(Nc3cccc(Br)c3)c2cc1N		CHEMBL328216	=	Thermal melting change	degrees C	1.4	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	1.4
	15261362	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Thermal melting change	degrees C	0.4	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.4
	15261417	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	NC1=N/C(=C2/CCNC(=O)c3[nH]ccc32)C(=O)N1		CHEMBL255465	=	Thermal melting change	degrees C	0.7	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.7
	15261477	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O		CHEMBL435734	=	Thermal melting change	degrees C	0.6	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.6
	15261537	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=C1C=C2C(=Nc3c2c2c(c4c3=NC3=C4CCC=C3)C=NC=2)CC1		CHEMBL408953	=	Thermal melting change	degrees C	4.0	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	4.0
	15261597	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC.[Cl-]		CHEMBL258893	=	Thermal melting change	degrees C	0.2	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.2
	15261670	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC		CHEMBL29197	=	Thermal melting change	degrees C	0.1	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.1
	15261730	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	C[S+]([O-])c1ccc(CSc2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL111456	=	Thermal melting change	degrees C	0.5	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.5
	15261790	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Thermal melting change	degrees C	2.3	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	2.3
	15261850	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12		CHEMBL44	=	Thermal melting change	degrees C	0.7	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.7
	15261906	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Thermal melting change	degrees C	0.4	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.4
	15261966	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CC(C)c1cc(/C=C(\C#N)C(=O)NCCCc2ccccc2)cc(C(C)C)c1O		CHEMBL261508	=	Thermal melting change	degrees C	1.2	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	1.2
	15262026	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Thermal melting change	degrees C	0.3	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.3
	15262086	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B			CHEMBL3430782	=	Thermal melting change	degrees C	1.4	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	1.4
	15262159	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Thermal melting change	degrees C	0.1	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.1
	15262219	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Thermal melting change	degrees C	0.7	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.7
	15262279	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	Thermal melting change	degrees C	2.9	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	2.9
	15262339	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=C(O)c1cc(NCc2cc(O)ccc2O)ccc1O		CHEMBL319620	=	Thermal melting change	degrees C	0.4	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.4
	15262399	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	OC[C@H]1O[C@@H](n2cnc3cc(Cl)c(Cl)cc32)[C@H](O)[C@@H]1O		CHEMBL375530	=	Thermal melting change	degrees C	0.3	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.3
	15262459	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=C(O)c1cc(N(Cc2ccccc2O)Cc2cc(O)ccc2O)ccc1O		CHEMBL103552	=	Thermal melting change	degrees C	1.3	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	1.3
	15262519	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C\c1cc(Br)c(O)c(Br)c1		CHEMBL264949	=	Thermal melting change	degrees C	1.2	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	1.2
	15262579	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Thermal melting change	degrees C	0.9	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.9
	15262639	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CN(C)c1ncnc2nc[nH]c12		CHEMBL407391	=	Thermal melting change	degrees C	0.3	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.3
	15262699	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Cc1ccc2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL405992	=	Thermal melting change	degrees C	3.2	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	3.2
	15262759	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=c1ccc2ccc(O)c(O)c2o1		CHEMBL244948	=	Thermal melting change	degrees C	0.7	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.7
	15262819	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	COc1cc(O)c2c(c1)oc(=O)c1c3cc(O)c(O)cc3oc21		CHEMBL97453	=	Thermal melting change	degrees C	-4.5	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	-4.5
	15262879	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Thermal melting change	degrees C	4.7	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	4.7
	15262939	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Thermal melting change	degrees C	0.2	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.2
	15262999	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Thermal melting change	degrees C	3.6	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	3.6
	15263059	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Thermal melting change	degrees C	4.4	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	4.4
	15263119	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	N#CC(C#N)=Cc1ccc(O)c(O)c1		CHEMBL76904	=	Thermal melting change	degrees C	1.1	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	1.1
	15263179	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Thermal melting change	degrees C	0.9	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.9
	15263239	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)Nc1ccccc1		CHEMBL56731	=	Thermal melting change	degrees C	1.1	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	1.1
	15263299	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CCOc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccccc2)c1O		CHEMBL485070	=	Thermal melting change	degrees C	0.8	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.8
	15263359	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br		CHEMBL228043	=	Thermal melting change	degrees C	1.0	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	1.0
	15263395	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Thermal melting change	degrees C	4.1	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	4.1
	15263455	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Thermal melting change	degrees C	0.5	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.5
	15263510	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=C1c2ccccc2-c2n[nH]c3cccc1c23		CHEMBL7064	=	Thermal melting change	degrees C	2.6	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	2.6
	15263570	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B			CHEMBL3430783	=	Thermal melting change	degrees C	6.1	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	6.1
	15263630	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccccc2)c2ccc(F)cc2)CC1		CHEMBL259388	=	Thermal melting change	degrees C	1.2	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	1.2
	15263690	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Cc1c2ccncc2c(C)c2c1[nH]c1ccccc12		CHEMBL123	=	Thermal melting change	degrees C	1.6	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	1.6
	15263764	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Thermal melting change	degrees C	0.7	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.7
	15263824	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Thermal melting change	degrees C	-3.4	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	-3.4
	15263884	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CN(C)c1ccc(CC2C(=O)Nc3ccccc32)cc1		CHEMBL1373282	=	Thermal melting change	degrees C	1.0	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	1.0
	15263944	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cc2c([nH]1)CCC(Br)C2		CHEMBL408565	=	Thermal melting change	degrees C	0.1	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.1
	15263998	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CCOC(=O)c1cnc2oc3ccc(O)cc3c2c1-c1ccccc1		CHEMBL132904	=	Thermal melting change	degrees C	1.0	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	1.0
	15264058	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21.[Cl-]		CHEMBL258765	=	Thermal melting change	degrees C	0.0	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.0
	15264118	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O		CHEMBL278315	=	Thermal melting change	degrees C	0.5	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.5
	15264178	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Thermal melting change	degrees C	0.3	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.3
	15264251	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cnc[nH]1		CHEMBL261692	=	Thermal melting change	degrees C	6.6	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	6.6
	15264311	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=S(=O)(c1cccc2c(Cl)cccc12)N1CCCNCC1		CHEMBL429298	=	Thermal melting change	degrees C	0.8	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.8
	15264371	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O		CHEMBL116438	=	Thermal melting change	degrees C	1.9	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	1.9
	15264431	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	Thermal melting change	degrees C	1.5	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	1.5
	15264487	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Thermal melting change	degrees C	6.6	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	6.6
	15264547	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	COC(=O)[C@]1(O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL416056	=	Thermal melting change	degrees C	10.3	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	10.3
	15264607	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Thermal melting change	degrees C	0.0	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.0
	15264667	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Cl.NCCNS(=O)(=O)c1cccc2c(Cl)cccc12		CHEMBL1255867	=	Thermal melting change	degrees C	0.1	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.1
	15264739	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Cc1cc(C=C2C(=O)C=CC2=O)cc(C)c1O		CHEMBL437612	=	Thermal melting change	degrees C	1.0	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	1.0
	15264799	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CC(C)(C)c1cc(C=C2C(=O)C=CC2=O)cc(C(C)(C)C)c1O		CHEMBL258726	=	Thermal melting change	degrees C	1.2	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	1.2
	15264859	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Thermal melting change	degrees C	1.2	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	1.2
	15264919	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CC(C)N(CCO)c1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL126254	=	Thermal melting change	degrees C	4.5	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	4.5
	15264975	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	N=C(N)NCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL143054	=	Thermal melting change	degrees C	0.3	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.3
	15265035	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CNC(=O)c1cc(Oc2ccc(Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL3430784	=	Thermal melting change	degrees C	-3.5	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	-3.5
	15265095	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Thermal melting change	degrees C	0.8	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.8
	15265155	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CCn1cnc2c(N)nc(N(c3cccc(Cl)c3)[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL411901	=	Thermal melting change	degrees C	4.7	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	4.7
	15265228	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Thermal melting change	degrees C	1.6	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	1.6
	15265288	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21		CHEMBL280074	=	Thermal melting change	degrees C	0.4	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.4
	15265348	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3O)nc(NCCCO)nc21		CHEMBL419931	=	Thermal melting change	degrees C	1.2	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	1.2
	15265408	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Thermal melting change	degrees C	1.6	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	1.6
	15265464	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Thermal melting change	degrees C	-0.5	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	-0.5
	15265524	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Thermal melting change	degrees C	0.3	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.3
	15265584	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Thermal melting change	degrees C	0.4	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.4
	15265644	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1		CHEMBL414883	=	Thermal melting change	degrees C	0.5	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.5
	15265704	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Thermal melting change	degrees C	2.3	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	2.3
	15265716	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Thermal melting change	degrees C	0.5	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.5
	15265776	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Thermal melting change	degrees C	1.5	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	1.5
	15265836	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=C(O)/C=C/c1cc(CO)ccc1CO		CHEMBL407534	=	Thermal melting change	degrees C	0.9	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.9
	15265896	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Thermal melting change	degrees C	0.3	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.3
	15265956	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=C1CC(=O)c2[nH]c3c4[nH]c5c(c4c4cn(Br)cc4c3c2C1)CCC=C5		CHEMBL264685	=	Thermal melting change	degrees C	3.6	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	3.6
	15266013	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Oc1cc(O)cc(/C=C/c2ccc(O)c(O)c2)c1		CHEMBL69863	=	Thermal melting change	degrees C	1.2	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	1.2
	15266073	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	N#C/C(=C(/N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL261237	=	Thermal melting change	degrees C	0.4	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.4
	15266133	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL411645	=	Thermal melting change	degrees C	6.8	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	6.8
	15266193	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=C1Nc2ccc(S(=O)(=O)O)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL440411	=	Thermal melting change	degrees C	8.1	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	8.1
	15266265	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Thermal melting change	degrees C	-1.1	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	-1.1
	15266325	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Thermal melting change	degrees C	-0.3	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	-0.3
	15266385	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=C1Nc2ccccc2/C1=C\c1ccc[nH]1		CHEMBL101797	=	Thermal melting change	degrees C	3.4	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	3.4
	15266445	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	Thermal melting change	degrees C	5.3	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	5.3
	15266500	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CC(=O)O/N=C1C(=C2/C(=O)Nc3cc(Br)ccc32)/Nc2ccccc2/1		CHEMBL430226	=	Thermal melting change	degrees C	3.2	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	3.2
	15266560	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Thermal melting change	degrees C	1.7	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	1.7
	15266620	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CC(=O)O.Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL3430781	=	Thermal melting change	degrees C	3.0	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	3.0
	15266680	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Thermal melting change	degrees C	1.5	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	1.5
	15266753	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Thermal melting change	degrees C	0.5	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.5
	15266813	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Thermal melting change	degrees C	6.1	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	6.1
	15266873	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Thermal melting change	degrees C	0.9	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.9
	15266933	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Thermal melting change	degrees C	1.3	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	1.3
	15266988	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CS(=O)(=O)O.Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL1591531	=	Thermal melting change	degrees C	8.4	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	8.4
	15267048	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Cl.Cn1cc(C2=C(c3ccc4cc5n(c4c3)CCC(CN)C5)C(=O)NC2=O)c2ccccc21		CHEMBL541401	=	Thermal melting change	degrees C	2.4	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	2.4
	15267108	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CN(C)CC1CCn2c(c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc32)C1		CHEMBL372585	=	Thermal melting change	degrees C	2.5	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	2.5
	15267168	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	CN[C@@H]1CC2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL162	=	Thermal melting change	degrees C	13.8	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	13.8
	15267241	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Thermal melting change	degrees C	0.7	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.7
	15267301	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL127907	=	Thermal melting change	degrees C	0.3	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.3
	15267361	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Thermal melting change	degrees C	0.4	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.4
	15267421	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Thermal melting change	degrees C	-0.1	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	-0.1
	15267476	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	O=c1sn(Cc2ccccc2)c(=S)n1Cc1ccccc1		CHEMBL24338	=	Thermal melting change	degrees C	0.3	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.3
	15267536	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	C=CNC#N		CHEMBL259526	=	Thermal melting change	degrees C	-0.2	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	-0.2
	15267596	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(/N)Sc1ccccc1N		CHEMBL100473	=	Thermal melting change	degrees C	0.7	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.7
	15267656	CHEMBL3430798	Delta TM value showing the stabilisation of CDK2 produced by compound binding	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Thermal melting change	degrees C	0.6	CHEMBL301	Homo sapiens	Thermal melting change	degrees C	0.6
	15642629	CHEMBL3591174	Inhibition of human recombinant CDK2 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis	B	O=C(O)c1nc2ccccc2c2[nH]c3ccccc3c12		CHEMBL3589653	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	15642630	CHEMBL3591174	Inhibition of human recombinant CDK2 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis	B	CC(C)(C)c1ccc2[nH]c3c4ccccc4nc(C(=O)O)c3c2c1		CHEMBL3589654	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	15642631	CHEMBL3591174	Inhibition of human recombinant CDK2 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis	B	O=C(O)c1nc2ccccc2c2[nH]c3ccc(C(F)(F)F)cc3c12		CHEMBL3589655	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	15642632	CHEMBL3591174	Inhibition of human recombinant CDK2 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis	B	O=C(O)c1nc2ccccc2c2[nH]c3ccc([N+](=O)[O-])cc3c12		CHEMBL3589656	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	15642633	CHEMBL3591174	Inhibition of human recombinant CDK2 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis	B	Cc1ccc2[nH]c3c4ccccc4nc(C(=O)O)c3c2c1		CHEMBL3589657	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	15642634	CHEMBL3591174	Inhibition of human recombinant CDK2 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis	B	O=C(O)c1ccc2[nH]c3c4ccccc4nc(C(=O)O)c3c2c1		CHEMBL3589658	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	15642635	CHEMBL3591174	Inhibition of human recombinant CDK2 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis	B	O=C(O)c1nc2ccc(I)cc2c2[nH]c3ccc(Cl)cc3c12		CHEMBL3589659	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	15642636	CHEMBL3591174	Inhibition of human recombinant CDK2 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis	B	O=C(O)c1nc2ccccc2c2[nH]c3c(Cl)cccc3c12		CHEMBL3589660	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	15642637	CHEMBL3591174	Inhibition of human recombinant CDK2 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis	B	O=C(O)c1nc2ccccc2c2[nH]c3c(Br)cccc3c12		CHEMBL3589661	>	IC50	nM	100000.0	CHEMBL301	Homo sapiens	IC50	uM	100.0
	15642638	CHEMBL3591174	Inhibition of human recombinant CDK2 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis	B	O=C(O)c1nc2ccccc2c2[nH]c3c(I)cccc3c12		CHEMBL3589662	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	15642639	CHEMBL3591174	Inhibition of human recombinant CDK2 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis	B	COc1cccc2c1[nH]c1c3ccccc3nc(C(=O)O)c21		CHEMBL3589663	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	15642640	CHEMBL3591174	Inhibition of human recombinant CDK2 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis	B	COc1ccc2c(c1)nc(C(=O)O)c1c3cccc(F)c3[nH]c21		CHEMBL3589664	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	15642641	CHEMBL3591174	Inhibition of human recombinant CDK2 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis	B	COc1ccc2c(c1)nc(C(=O)O)c1c3cccc(Cl)c3[nH]c21		CHEMBL3589665	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	15642642	CHEMBL3591174	Inhibition of human recombinant CDK2 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis	B	COc1ccc2c(c1)nc(C(=O)O)c1c3cccc(Br)c3[nH]c21		CHEMBL3589666	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	15642643	CHEMBL3591174	Inhibition of human recombinant CDK2 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis	B	COc1ccc2c(c1)nc(C(=O)O)c1c3cccc(I)c3[nH]c21		CHEMBL3589667	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	15642644	CHEMBL3591174	Inhibition of human recombinant CDK2 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis	B	O=C(O)c1nc2ccc(I)cc2c2[nH]c3c(F)cccc3c12		CHEMBL3589670	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	15642645	CHEMBL3591174	Inhibition of human recombinant CDK2 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis	B	O=C(O)c1nc2ccc(I)cc2c2[nH]c3c(Cl)cccc3c12		CHEMBL3589671	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	15642646	CHEMBL3591174	Inhibition of human recombinant CDK2 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis	B	O=C(O)c1nc2ccc(I)cc2c2[nH]c3c(Br)cccc3c12		CHEMBL3589672	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	15642647	CHEMBL3591174	Inhibition of human recombinant CDK2 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis	B	COc1ccc2nc(C(=O)O)c3c4cccc(Cl)c4[nH]c3c2c1		CHEMBL3589673	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	15642648	CHEMBL3591174	Inhibition of human recombinant CDK2 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis	B	COc1cccc(-c2ccc3nc(C(=O)O)c4c5cccc(Cl)c5[nH]c4c3c2)c1		CHEMBL3589674	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	15642649	CHEMBL3591174	Inhibition of human recombinant CDK2 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis	B	COc1ccc(-c2ccc3nc(C(=O)O)c4c5cccc(Cl)c5[nH]c4c3c2)cc1		CHEMBL3589675	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	15642650	CHEMBL3591174	Inhibition of human recombinant CDK2 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis	B	O=C(O)c1nc2ccsc2c2[nH]c3c(Cl)cccc3c12		CHEMBL3589774	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	15642651	CHEMBL3591174	Inhibition of human recombinant CDK2 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis	B	O=C(O)c1nc2cccnc2c2[nH]c3c(Br)cccc3c12		CHEMBL3589775	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	15654949	CHEMBL3599523	Inhibition of CDK2 (unknown origin) at 0.5 uM relative to control	B	Nc1nccc(-c2c[nH]c3ccccc23)n1		CHEMBL48082	=	Inhibition	%	0.0	CHEMBL301	Homo sapiens	INH	%	0.0
	15654950	CHEMBL3599523	Inhibition of CDK2 (unknown origin) at 0.5 uM relative to control	B	Nc1nccc(-c2cn(C(=O)N3CCOCC3)c3ccc(Br)cc23)n1		CHEMBL3133762	=	Inhibition	%	0.0	CHEMBL301	Homo sapiens	INH	%	0.0
	15654951	CHEMBL3599523	Inhibition of CDK2 (unknown origin) at 0.5 uM relative to control	B	Cc1noc(C)c1Cn1cc(-c2ccnc(N)n2)c2ccccc21		CHEMBL3133770	=	Inhibition	%	0.0	CHEMBL301	Homo sapiens	INH	%	0.0
	15678939	CHEMBL3606998	Inhibition of CDK2 (unknown origin) using GST-fused pRb (792 to 928) as substrate preincubated for 2 mins followed by [gamma-32P]-ATP addition measured after 15 mins by beta plate counting analysis	B	O=c1c(Br)cc2cnc(Nc3ccc(N4CCNCC4)cc3)nc2n1C1CCCC1		CHEMBL190281	=	IC50	nM	43.0	CHEMBL301	Homo sapiens	IC50	nM	43.0
	15678941	CHEMBL3606998	Inhibition of CDK2 (unknown origin) using GST-fused pRb (792 to 928) as substrate preincubated for 2 mins followed by [gamma-32P]-ATP addition measured after 15 mins by beta plate counting analysis	B	Cc1c(Br)c(=O)n(C2CCCC2)c2nc(Nc3ccc(N4CCNCC4)cc3)ncc12		CHEMBL189937	=	IC50	nM	439.0	CHEMBL301	Homo sapiens	IC50	nM	439.0
	15678943	CHEMBL3606998	Inhibition of CDK2 (unknown origin) using GST-fused pRb (792 to 928) as substrate preincubated for 2 mins followed by [gamma-32P]-ATP addition measured after 15 mins by beta plate counting analysis	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cc3)nc2n(C2CCCC2)c1=O		CHEMBL365847	=	IC50	nM	230.0	CHEMBL301	Homo sapiens	IC50	nM	230.0
	15678946	CHEMBL3606994	Inhibition of CDK2 (unknown origin) expressed in baculovirus infected insect cells using GST-fused pRb (792 to 928) as substrate preincubated for 2 mins followed by [gamma-32P]-ATP addition measured after 15 mins by beta plate counting analysis	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	IC50	nM	5000.0	CHEMBL301	Homo sapiens	IC50	uM	5.0
	15698651	CHEMBL3616090	Inhibition of CDK2 (unknown origin) at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4	Outside typical range	CHEMBL388978	=	Inhibition	%	-100.0	CHEMBL301	Homo sapiens	INH	%	-100.0
	15698652	CHEMBL3616090	Inhibition of CDK2 (unknown origin) at 10 uM	B	Cc1ccc(NC(=O)/C(C#N)=C\Nc2ccc(S(=O)(=O)Nc3cc(C)on3)cc2)cc1		CHEMBL3613685	=	Inhibition	%	0.0	CHEMBL301	Homo sapiens	INH	%	0.0
	15698653	CHEMBL3616090	Inhibition of CDK2 (unknown origin) at 10 uM	B	Cc1cc(NS(=O)(=O)c2ccc(N/C=C(/C#N)C(=O)Nc3ccc(Cl)cc3)cc2)no1		CHEMBL3612084	=	Inhibition	%	-4.0	CHEMBL301	Homo sapiens	INH	%	-4.0
	15698654	CHEMBL3616090	Inhibition of CDK2 (unknown origin) at 10 uM	B	Cc1cc(NS(=O)(=O)c2ccc(N/C=C(/C#N)C(=O)Nc3ccc(Br)cc3)cc2)no1	Outside typical range	CHEMBL3613686	=	Inhibition	%	-12.0	CHEMBL301	Homo sapiens	INH	%	-12.0
	15698655	CHEMBL3616090	Inhibition of CDK2 (unknown origin) at 10 uM	B	Cc1ccc(Nc2c(C(N)=O)cnc3ccc(S(=O)(=O)Nc4cc(C)on4)cc23)cc1	Outside typical range	CHEMBL3613687	=	Inhibition	%	-11.0	CHEMBL301	Homo sapiens	INH	%	-11.0
	15698656	CHEMBL3616090	Inhibition of CDK2 (unknown origin) at 10 uM	B	Cc1cc(NS(=O)(=O)c2ccc3ncc(C(N)=O)c(Nc4ccc(Cl)cc4)c3c2)no1		CHEMBL3613688	=	Inhibition	%	-10.0	CHEMBL301	Homo sapiens	INH	%	-10.0
	15698657	CHEMBL3616090	Inhibition of CDK2 (unknown origin) at 10 uM	B	Cc1cc(NS(=O)(=O)c2ccc3ncc(C(N)=O)c(Nc4ccc(Br)cc4)c3c2)no1		CHEMBL3613689	=	Inhibition	%	-1.0	CHEMBL301	Homo sapiens	INH	%	-1.0
	15698658	CHEMBL3616090	Inhibition of CDK2 (unknown origin) at 10 uM	B	Cc1ccc(Nc2c(C(N)=O)cnc3ccc(C(=O)/C=C/c4ccc(N(C)C)cc4)cc23)cc1		CHEMBL3613690	=	Inhibition	%	-5.0	CHEMBL301	Homo sapiens	INH	%	-5.0
	15698659	CHEMBL3616090	Inhibition of CDK2 (unknown origin) at 10 uM	B	CN(C)c1ccc(/C=C/C(=O)c2ccc3ncc(C(N)=O)c(Nc4ccc(Cl)cc4)c3c2)cc1		CHEMBL3613691	=	Inhibition	%	-1.0	CHEMBL301	Homo sapiens	INH	%	-1.0
	15698660	CHEMBL3616090	Inhibition of CDK2 (unknown origin) at 10 uM	B	CN(C)c1ccc(/C=C/C(=O)c2ccc3ncc(C(N)=O)c(Nc4ccc(Br)cc4)c3c2)cc1		CHEMBL3613692	=	Inhibition	%	-8.0	CHEMBL301	Homo sapiens	INH	%	-8.0
	15698661	CHEMBL3616090	Inhibition of CDK2 (unknown origin) at 10 uM	B	Cc1ccc(Nc2c(C(N)=O)cnc3ccc(C(=O)/C=C/c4ccc(Cl)cc4)cc23)cc1		CHEMBL3613693	=	Inhibition	%	-7.0	CHEMBL301	Homo sapiens	INH	%	-7.0
	15698662	CHEMBL3616090	Inhibition of CDK2 (unknown origin) at 10 uM	B	NC(=O)c1cnc2ccc(C(=O)/C=C/c3ccc(Cl)cc3)cc2c1Nc1ccc(Cl)cc1	Outside typical range	CHEMBL3613694	=	Inhibition	%	-12.0	CHEMBL301	Homo sapiens	INH	%	-12.0
	15698663	CHEMBL3616090	Inhibition of CDK2 (unknown origin) at 10 uM	B	NC(=O)c1cnc2ccc(C(=O)/C=C/c3ccc(Cl)cc3)cc2c1Nc1ccc(Br)cc1		CHEMBL3613695	=	Inhibition	%	-3.0	CHEMBL301	Homo sapiens	INH	%	-3.0
	15698664	CHEMBL3616090	Inhibition of CDK2 (unknown origin) at 10 uM	B	Cc1ccc(Nc2c(C(N)=O)cnc3ccc(-c4csc(N)n4)cc23)cc1		CHEMBL3613696	=	Inhibition	%	-2.0	CHEMBL301	Homo sapiens	INH	%	-2.0
	15698665	CHEMBL3616090	Inhibition of CDK2 (unknown origin) at 10 uM	B	NC(=O)c1cnc2ccc(-c3csc(N)n3)cc2c1Nc1ccc(Cl)cc1		CHEMBL3613697	=	Inhibition	%	-7.0	CHEMBL301	Homo sapiens	INH	%	-7.0
	15698666	CHEMBL3616090	Inhibition of CDK2 (unknown origin) at 10 uM	B	NC(=O)c1cnc2ccc(-c3csc(N)n3)cc2c1Nc1ccc(Br)cc1		CHEMBL3613698	=	Inhibition	%	-9.0	CHEMBL301	Homo sapiens	INH	%	-9.0
	15698667	CHEMBL3616090	Inhibition of CDK2 (unknown origin) at 10 uM	B	Cc1ccc(Nc2c(C(N)=O)cnc3ccc(-c4csc(NC(=S)Nc5ccccc5)n4)cc23)cc1		CHEMBL3613699	=	Inhibition	%	0.0	CHEMBL301	Homo sapiens	INH	%	0.0
	15698668	CHEMBL3616090	Inhibition of CDK2 (unknown origin) at 10 uM	B	NC(=O)c1cnc2ccc(-c3csc(NC(=S)Nc4ccccc4)n3)cc2c1Nc1ccc(Cl)cc1		CHEMBL3613700	=	Inhibition	%	-1.0	CHEMBL301	Homo sapiens	INH	%	-1.0
Not Determined	15698669	CHEMBL3616090	Inhibition of CDK2 (unknown origin) at 10 uM	B	NC(=O)c1cnc2ccc(-c3csc(NC(=S)Nc4ccccc4)n3)cc2c1Nc1ccc(Br)cc1		CHEMBL3613701		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	15722830	CHEMBL3619466	Binding affinity to human CDK2 Y180A mutant expressed in Escherichia coli BL21 assessed as inhibition of interaction with cyclin A3 by measuring HHASPRK phosphorylation by ADP-Glo Max assay	B	CSc1ccc(/C=N/c2cc([N+](=O)[O-])ccc2O)cc1	Outside typical range	CHEMBL3616869	=	IC50	nM	151400.0	CHEMBL301	Homo sapiens	IC50	uM	151.4
	15722831	CHEMBL3619465	Binding affinity to human CDK2 R150A mutant expressed in Escherichia coli BL21 assessed as inhibition of interaction with cyclin A3 by measuring HHASPRK phosphorylation by ADP-Glo Max assay	B	CSc1ccc(/C=N/c2cc([N+](=O)[O-])ccc2O)cc1	Outside typical range	CHEMBL3616869	=	IC50	nM	884700.0	CHEMBL301	Homo sapiens	IC50	uM	884.7
	15722832	CHEMBL3619464	Binding affinity to N-terminal His-tagged recombinant human CDK2 (1 to 298 amino acid residues) expressed in Escherichia coli BL21 assessed as inhibition of interaction with cyclin A3 by measuring 2.5 mM HHASPRK phosphorylation by ADP-Glo Max assay in presence of 75 uM ATP	B	CSc1ccc(/C=N/c2cc([N+](=O)[O-])ccc2O)cc1		CHEMBL3616869	=	IC50	nM	69800.0	CHEMBL301	Homo sapiens	IC50	uM	69.8
	15722833	CHEMBL3619463	Binding affinity to N-terminal His-tagged recombinant human CDK2 (1 to 298 amino acid residues) expressed in Escherichia coli BL21 assessed as inhibition of interaction with cyclin A3 by measuring 1.25 mM HHASPRK phosphorylation by ADP-Glo Max assay in presence of 75 uM ATP	B	CSc1ccc(/C=N/c2cc([N+](=O)[O-])ccc2O)cc1		CHEMBL3616869	=	IC50	nM	58150.0	CHEMBL301	Homo sapiens	IC50	uM	58.15
	15722834	CHEMBL3619462	Binding affinity to N-terminal His-tagged recombinant human CDK2 (1 to 298 amino acid residues) expressed in Escherichia coli BL21 assessed as inhibition of interaction with cyclin A3 by measuring 250 uM HHASPRK phosphorylation by ADP-Glo Max assay in presence of 750 uM ATP	B	CSc1ccc(/C=N/c2cc([N+](=O)[O-])ccc2O)cc1		CHEMBL3616869	=	IC50	nM	55110.0	CHEMBL301	Homo sapiens	IC50	uM	55.11
	15722835	CHEMBL3619461	Binding affinity to N-terminal His-tagged recombinant human CDK2 (1 to 298 amino acid residues) expressed in Escherichia coli BL21 assessed as inhibition of interaction with cyclin A3 by measuring 250 uM HHASPRK phosphorylation by ADP-Glo Max assay in presence of 375 uM ATP	B	CSc1ccc(/C=N/c2cc([N+](=O)[O-])ccc2O)cc1		CHEMBL3616869	=	IC50	nM	78330.0	CHEMBL301	Homo sapiens	IC50	uM	78.33
	15722836	CHEMBL3619460	Binding affinity to N-terminal His-tagged recombinant human CDK2 (1 to 298 amino acid residues) expressed in Escherichia coli BL21 assessed as inhibition of interaction with cyclin A3 by measuring 250 uM HHASPRK phosphorylation by ADP-Glo Max assay in presence of 75 uM ATP	B	CCOc1cc(C(=O)Nc2ccc(S(=O)(=O)Nc3nc(C)cc(C)n3)cc2)cc(OCC)c1OCC	Outside typical range	CHEMBL3616877	=	IC50	nM	105100.0	CHEMBL301	Homo sapiens	IC50	uM	105.1
	15722837	CHEMBL3619460	Binding affinity to N-terminal His-tagged recombinant human CDK2 (1 to 298 amino acid residues) expressed in Escherichia coli BL21 assessed as inhibition of interaction with cyclin A3 by measuring 250 uM HHASPRK phosphorylation by ADP-Glo Max assay in presence of 75 uM ATP	B	CSc1ccc(/C=N/c2cc([N+](=O)[O-])ccc2O)cc1		CHEMBL3616869	=	IC50	nM	52120.0	CHEMBL301	Homo sapiens	IC50	uM	52.12
	15722838	CHEMBL3619459	Binding affinity to N-terminal His-tagged recombinant human CDK2 (1 to 298 amino acid residues) expressed in Escherichia coli BL21 assessed as inhibition of interaction with cyclin A3 by measuring HHASPRK phosphorylation at 100 uM by ADP-Glo Max assay relative to control	B	CCOc1cc(C(=O)Nc2ccc(S(=O)(=O)Nc3nc(C)cc(C)n3)cc2)cc(OCC)c1OCC		CHEMBL3616877	=	Inhibition	%	62.26	CHEMBL301	Homo sapiens	INH	%	62.26
	15722839	CHEMBL3619459	Binding affinity to N-terminal His-tagged recombinant human CDK2 (1 to 298 amino acid residues) expressed in Escherichia coli BL21 assessed as inhibition of interaction with cyclin A3 by measuring HHASPRK phosphorylation at 100 uM by ADP-Glo Max assay relative to control	B	Cc1ccccc1C(=O)N(Cc1ccc(C(F)(F)F)cc1)c1ccc(CC(=O)NCc2ccc(F)cc2)cc1		CHEMBL3616876	=	Inhibition	%	37.53	CHEMBL301	Homo sapiens	INH	%	37.53
	15722840	CHEMBL3619459	Binding affinity to N-terminal His-tagged recombinant human CDK2 (1 to 298 amino acid residues) expressed in Escherichia coli BL21 assessed as inhibition of interaction with cyclin A3 by measuring HHASPRK phosphorylation at 100 uM by ADP-Glo Max assay relative to control	B	CCN(C(=O)CCNC(=O)Cn1cnc2ccccc2c1=O)c1cccc(C(F)(F)F)c1		CHEMBL3616875	=	Inhibition	%	8.39	CHEMBL301	Homo sapiens	INH	%	8.39
	15722841	CHEMBL3619459	Binding affinity to N-terminal His-tagged recombinant human CDK2 (1 to 298 amino acid residues) expressed in Escherichia coli BL21 assessed as inhibition of interaction with cyclin A3 by measuring HHASPRK phosphorylation at 100 uM by ADP-Glo Max assay relative to control	B	CN1C(=O)c2cccc3c(S(=O)(=O)NCCC(=O)O)ccc1c23		CHEMBL3616874	=	Inhibition	%	5.54	CHEMBL301	Homo sapiens	INH	%	5.54
	15722842	CHEMBL3619459	Binding affinity to N-terminal His-tagged recombinant human CDK2 (1 to 298 amino acid residues) expressed in Escherichia coli BL21 assessed as inhibition of interaction with cyclin A3 by measuring HHASPRK phosphorylation at 100 uM by ADP-Glo Max assay relative to control	B	Cc1[nH]c2ccccc2c1/C=N/c1ccccc1C(=O)O		CHEMBL3616873	<	Inhibition	%	5.0	CHEMBL301	Homo sapiens	INH	%	5.0
	15722843	CHEMBL3619459	Binding affinity to N-terminal His-tagged recombinant human CDK2 (1 to 298 amino acid residues) expressed in Escherichia coli BL21 assessed as inhibition of interaction with cyclin A3 by measuring HHASPRK phosphorylation at 100 uM by ADP-Glo Max assay relative to control	B	O=C(CSc1nc2ccc(NC(=O)CSCC(=O)Nc3ccc4ccccc4c3)cc2s1)NCCOc1ccccc1		CHEMBL3616872	<	Inhibition	%	5.0	CHEMBL301	Homo sapiens	INH	%	5.0
	15722844	CHEMBL3619459	Binding affinity to N-terminal His-tagged recombinant human CDK2 (1 to 298 amino acid residues) expressed in Escherichia coli BL21 assessed as inhibition of interaction with cyclin A3 by measuring HHASPRK phosphorylation at 100 uM by ADP-Glo Max assay relative to control	B	COc1ccccc1OCCOc1ccccc1/C=c1\sc2n(c1=O)C(c1ccccc1)C(C(=O)Nc1ccccc1)=C(C)N=2		CHEMBL3616871	<	Inhibition	%	5.0	CHEMBL301	Homo sapiens	INH	%	5.0
	15722845	CHEMBL3619459	Binding affinity to N-terminal His-tagged recombinant human CDK2 (1 to 298 amino acid residues) expressed in Escherichia coli BL21 assessed as inhibition of interaction with cyclin A3 by measuring HHASPRK phosphorylation at 100 uM by ADP-Glo Max assay relative to control	B	Cc1cc(C)nc(NS(=O)(=O)c2ccc(NC(=O)CCCCC(=O)Nc3ccc(S(=O)(=O)Nc4nc(C)cc(C)n4)cc3)cc2)n1		CHEMBL3616870	=	Inhibition	%	38.02	CHEMBL301	Homo sapiens	INH	%	38.02
	15722846	CHEMBL3619459	Binding affinity to N-terminal His-tagged recombinant human CDK2 (1 to 298 amino acid residues) expressed in Escherichia coli BL21 assessed as inhibition of interaction with cyclin A3 by measuring HHASPRK phosphorylation at 100 uM by ADP-Glo Max assay relative to control	B	CSc1ccc(/C=N/c2cc([N+](=O)[O-])ccc2O)cc1		CHEMBL3616869	=	Inhibition	%	65.48	CHEMBL301	Homo sapiens	INH	%	65.48
	15722847	CHEMBL3619459	Binding affinity to N-terminal His-tagged recombinant human CDK2 (1 to 298 amino acid residues) expressed in Escherichia coli BL21 assessed as inhibition of interaction with cyclin A3 by measuring HHASPRK phosphorylation at 100 uM by ADP-Glo Max assay relative to control	B	C/C(Cc1ccccc1)=N\Nc1nnc2c(n1)[nH]c1ccccc12		CHEMBL3616868	=	Inhibition	%	35.17	CHEMBL301	Homo sapiens	INH	%	35.17
	15722848	CHEMBL3619459	Binding affinity to N-terminal His-tagged recombinant human CDK2 (1 to 298 amino acid residues) expressed in Escherichia coli BL21 assessed as inhibition of interaction with cyclin A3 by measuring HHASPRK phosphorylation at 100 uM by ADP-Glo Max assay relative to control	B	OC(CN1CCN(CC(O)Cn2c3ccc(Br)cc3c3cc(Br)cc(Br)c32)CC1)Cn1c2ccccc2c2ccccc21		CHEMBL3616867	=	Inhibition	%	31.03	CHEMBL301	Homo sapiens	INH	%	31.03
	15722849	CHEMBL3619459	Binding affinity to N-terminal His-tagged recombinant human CDK2 (1 to 298 amino acid residues) expressed in Escherichia coli BL21 assessed as inhibition of interaction with cyclin A3 by measuring HHASPRK phosphorylation at 100 uM by ADP-Glo Max assay relative to control	B	Cn1c(=O)[nH]c(=O)c2c1nc(N/N=C1/C(=O)Nc3ccccc31)n2CC(O)COc1ccccc1		CHEMBL3616866	<	Inhibition	%	5.0	CHEMBL301	Homo sapiens	INH	%	5.0
	15722850	CHEMBL3619459	Binding affinity to N-terminal His-tagged recombinant human CDK2 (1 to 298 amino acid residues) expressed in Escherichia coli BL21 assessed as inhibition of interaction with cyclin A3 by measuring HHASPRK phosphorylation at 100 uM by ADP-Glo Max assay relative to control	B	Cc1ccc(S(=O)(=O)Nc2ccc(C(=O)N3N=C(c4c(-c5ccccc5)c5cc(Br)ccc5[nH]c4=O)CC3c3ccccc3)cc2)cc1		CHEMBL3616865	<	Inhibition	%	5.0	CHEMBL301	Homo sapiens	INH	%	5.0
	15722851	CHEMBL3619459	Binding affinity to N-terminal His-tagged recombinant human CDK2 (1 to 298 amino acid residues) expressed in Escherichia coli BL21 assessed as inhibition of interaction with cyclin A3 by measuring HHASPRK phosphorylation at 100 uM by ADP-Glo Max assay relative to control	B	CC(=O)C1=C(O)C(=O)N(CO)C1c1ccccc1		CHEMBL3616864	<	Inhibition	%	5.0	CHEMBL301	Homo sapiens	INH	%	5.0
	15722852	CHEMBL3619459	Binding affinity to N-terminal His-tagged recombinant human CDK2 (1 to 298 amino acid residues) expressed in Escherichia coli BL21 assessed as inhibition of interaction with cyclin A3 by measuring HHASPRK phosphorylation at 100 uM by ADP-Glo Max assay relative to control	B	CCOC(=O)C(Cc1ccc(OC)c([N+](=O)[O-])c1)NC(=O)CCC(=O)Nc1ccc(S(N)(=O)=O)cc1		CHEMBL3616863	<	Inhibition	%	5.0	CHEMBL301	Homo sapiens	INH	%	5.0
Dose-dependent effect	15722853	CHEMBL3619866	Binding affinity to GST-tagged recombinant human CDK2 (1 to 298 amino acid residues) expressed in Escherichia coli BL21 assessed as inhibition of interaction with His-tagged cyclin A3 preincubated overnight with GST-tagged protein followed by His-tagged cyclin A3 addition by GST pull down assay	B	CSc1ccc(/C=N/c2cc([N+](=O)[O-])ccc2O)cc1		CHEMBL3616869		Activity			CHEMBL301	Homo sapiens	Activity		
	15728396	CHEMBL3624237	Inhibition of CDK2 (unknown origin) at 10 uM	B	COc1ccc(-c2cnccc2-c2cnc(NC(=O)C(C)C)s2)c(C(F)(F)F)c1		CHEMBL3623443	>	Inhibition	%	90.0	CHEMBL301	Homo sapiens	INH	%	90.0
	15730408	CHEMBL3627429	Inhibition of CDK2 (unknown origin)	B	CN1CCN(C(=O)c2ccc3c(c2)[nH]c2c(C(N)=O)ccc(-c4ccccc4F)c23)CC1		CHEMBL3621496	=	IC50	nM	610.0	CHEMBL301	Homo sapiens	IC50	nM	610.0
	15730409	CHEMBL3627429	Inhibition of CDK2 (unknown origin)	B	CC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c4cc(C(=O)N5CCN(C)CC5)ccc4c23)c1C		CHEMBL3621515	=	IC50	nM	2700.0	CHEMBL301	Homo sapiens	IC50	nM	2700.0
	15730410	CHEMBL3627429	Inhibition of CDK2 (unknown origin)	B	CN1CCN(C(=O)c2ccc3c(c2)[nH]c2c(C(N)=O)ccc(-c4cccc(NC(=O)c5ccc(N(C)C)cc5)c4F)c23)CC1		CHEMBL3622193	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	nM	50000.0
	15736621	CHEMBL3625830	Inhibition of human recombinant CDK2	B	CN(C)CCCNC(=O)c1csc2nc(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)cn12		CHEMBL3623375	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	15755226	CHEMBL3630640	Inhibition of CDK2 (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	B	O=C1c2ccccc2-c2c1oc1ccccc1c2=O		CHEMBL3629616	=	Activity	%	82.0	CHEMBL301	Homo sapiens	Activity	%	82.0
	15756134	CHEMBL3631906	Inhibition of CDK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	67.35	CHEMBL301	Homo sapiens	INH	%	67.35
	15757965	CHEMBL3631906	Inhibition of CDK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	75.74	CHEMBL301	Homo sapiens	INH	%	75.74
	15759677	CHEMBL3631906	Inhibition of CDK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	7.06	CHEMBL301	Homo sapiens	INH	%	7.06
Active	15761573	CHEMBL3636422	Inhibition of CDK2 phosphorylation in human Hep2 cells at 100 uM after 24 hrs by Western blot analysis relative to control	B	Cc1[nH]c2c(c1C1(C)NC3=C(C(=O)CC(c4ccccc4)C3)C1=O)C(=O)CC(c1ccccc1)C2		CHEMBL3634037		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	15761574	CHEMBL3636423	Inhibition of CDK2 phosphorylation in HEK293T cells at 100 uM after 24 hrs by Western blot analysis relative to control	B	Cc1[nH]c2c(c1C1(C)NC3=C(C(=O)CC(c4ccccc4)C3)C1=O)C(=O)CC(c1ccccc1)C2		CHEMBL3634037		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	15761582	CHEMBL3636451	Binding affinity to CDK2 allosteric site (unknown origin)	B	Cc1[nH]c2c(c1C1(C)NC3=C(C(=O)CC(c4ccccc4)C3)C1=O)C(=O)CC(c1ccccc1)C2		CHEMBL3634037	>	IC50	nM	91000.0	CHEMBL301	Homo sapiens	IC50	uM	91.0
	15761583	CHEMBL3636451	Binding affinity to CDK2 allosteric site (unknown origin)	B	O=S(=O)(O)c1cccc2cccc(Nc3ccccc3)c12		CHEMBL285527	=	IC50	nM	91000.0	CHEMBL301	Homo sapiens	IC50	uM	91.0
Not Active	15774412	CHEMBL3636786	Inhibition of CDK2 (unknown origin) after 120 mins by HotSpot assay	B	CC(=O)Nc1ccc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2c1		CHEMBL3633929		IC50			CHEMBL301	Homo sapiens	IC50		
6371	16259680	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	C[C@H](O)[C@@H](C)Nc1nc(Nc2ccc(S(=N)(=O)CCO)cc2)ncc1Br		CHEMBL3648110	=	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	nM	3.0
226126	16261061	CHEMBL3705547	Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK.	B	CC[C@H](Nc1nc(NCc2ncccc2C)c2ncn(C(C)C)c2n1)[C@@H](C)O		CHEMBL3655774	=	IC50	nM	770.0	CHEMBL301	Homo sapiens	IC50	nM	770.0
10847	16261111	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CC(C)Nc1nc(Nc2ccc(S(C)(=N)=O)cc2)ncc1Br		CHEMBL3648126	=	IC50	nM	16.0	CHEMBL301	Homo sapiens	IC50	nM	16.0
7805	16265273	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CCS(=N)(=O)c1ccc(Nc2ncc(Br)c(N[C@@H](COC)[C@H](C)O)n2)cc1		CHEMBL3648121	=	IC50	nM	9.0	CHEMBL301	Homo sapiens	IC50	nM	9.0
8957	16266355	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	Cc1cc(Nc2ncc(Br)c(N[C@H](C)C(C)(C)O)n2)ccc1S(C)(=N)=O		CHEMBL3639469	=	IC50	nM	7.0	CHEMBL301	Homo sapiens	IC50	nM	7.0
218119	16268378	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CC(C)(O)CSc1nc(Nc2ccc(S(C)(=N)=O)cc2)ncc1Br		CHEMBL3648128	=	IC50	nM	8.0	CHEMBL301	Homo sapiens	IC50	nM	8.0
218092	16269127	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CCOC(=O)N=S(=O)(CC)c1ccc(Nc2ncc(Br)c(N[C@H](C)C(C)(C)O)n2)cc1		CHEMBL3648088	=	IC50	nM	42.0	CHEMBL301	Homo sapiens	IC50	nM	42.0
218097	16269152	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CCS(=N)(=O)c1ccc(Nc2ncc(Br)c(N[C@H](C)C(C)(C)O)n2)cc1		CHEMBL3648123	=	IC50	nM	5.0	CHEMBL301	Homo sapiens	IC50	nM	5.0
218108	16269183	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CCS(=N)(=O)c1ccc(Nc2ncc(Br)c(N[C@H](C)[C@H](C)O)n2)cc1		CHEMBL3648095	=	IC50	nM	4.0	CHEMBL301	Homo sapiens	IC50	nM	4.0
267671	16270370	CHEMBL3705418	Kinase Assay: The compounds from the examples below were investigated for their CDK2/cyclin E, CDK1/cyclin B, CDK4/cyclin D1 and CDK7/cyclin H, ERK-2, and PKA inhibitory activity. His6-tagged recombinant human cyclin-dependent kinases CDK1/cyclin B1, CDK2/cyclin E, CDK4 and CDK7/cyclin H were expressed in sf9 cells using a baculovirus expression system. Recombinant cyclin D1 was expressed in E. coli. Proteins were purified by metal chelate affinity chromatography to greater than 90% homogeneity. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins, recombinant active ERK-2 (Upstate Biotechnology), or cyclic AMP-dependent kinase (PKA) catalytic subunit (Calbiochem Cat. 539487). Assays were performed in assay buffer (25 mM beta -glycerophosphate, 20 mM MOPS, 5 mM EGTA, 1 mM DTT, 1 mM Na3VO3, pH 7.4), into which were added 2-4 ug of active enzyme with appropriate substrates (purified histone H1 for CDK2, recombinant GST-retinoblastoma protein (residues 773-928) for CDK4.	B	CC[C@@H](Nc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1)[C@H](C)O		CHEMBL1922218	=	IC50	nM	90.0	CHEMBL301	Homo sapiens	IC50	nM	90.0
267673	16271000	CHEMBL3705418	Kinase Assay: The compounds from the examples below were investigated for their CDK2/cyclin E, CDK1/cyclin B, CDK4/cyclin D1 and CDK7/cyclin H, ERK-2, and PKA inhibitory activity. His6-tagged recombinant human cyclin-dependent kinases CDK1/cyclin B1, CDK2/cyclin E, CDK4 and CDK7/cyclin H were expressed in sf9 cells using a baculovirus expression system. Recombinant cyclin D1 was expressed in E. coli. Proteins were purified by metal chelate affinity chromatography to greater than 90% homogeneity. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins, recombinant active ERK-2 (Upstate Biotechnology), or cyclic AMP-dependent kinase (PKA) catalytic subunit (Calbiochem Cat. 539487). Assays were performed in assay buffer (25 mM beta -glycerophosphate, 20 mM MOPS, 5 mM EGTA, 1 mM DTT, 1 mM Na3VO3, pH 7.4), into which were added 2-4 ug of active enzyme with appropriate substrates (purified histone H1 for CDK2, recombinant GST-retinoblastoma protein (residues 773-928) for CDK4.	B	CCC(O)[C@@H](CC)Nc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1		CHEMBL1922120	=	IC50	nM	220.0	CHEMBL301	Homo sapiens	IC50	nM	220.0
8430	16271068	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CCS(=N)(=O)c1ccc(Nc2ncc(Br)c(N[C@@H](C)C(C)(C)O)n2)cc1		CHEMBL3648124	=	IC50	nM	24.0	CHEMBL301	Homo sapiens	IC50	nM	24.0
218088	16271945	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	C[C@H](CO)Nc1nc(Nc2ccc(S(=O)(CC3CC3)=NS(=O)(=O)CC[Si](C)(C)C)cc2)ncc1Br		CHEMBL3648075	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
226115	16272313	CHEMBL3705547	Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK.	B	CC[C@H](Nc1nc(NCc2ccc(C)nc2)c2ncn(C(C)C)c2n1)[C@@H](C)O		CHEMBL3655763	=	IC50	nM	520.0	CHEMBL301	Homo sapiens	IC50	nM	520.0
226134	16273224	CHEMBL3705547	Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK.	B	CC[C@H](Nc1nc(NCc2cnc(C)cc2C)c2ncn(C(C)C)c2n1)[C@@H](C)O		CHEMBL3655762	=	IC50	nM	90.0	CHEMBL301	Homo sapiens	IC50	nM	90.0
218081	16273278	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	C[C@H](O)[C@@H](C)Oc1nc(Nc2ccc(S(C)(=N)=O)cc2)ncc1Br		CHEMBL3648073	=	IC50	nM	10.0	CHEMBL301	Homo sapiens	IC50	nM	10.0
7794	16275276	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CCS(=N)(=O)c1ccc(Nc2ncc(Br)c(N[C@H](COC)[C@@H](C)O)n2)cc1		CHEMBL3648120	=	IC50	nM	9.0	CHEMBL301	Homo sapiens	IC50	nM	9.0
226122	16276700	CHEMBL3705547	Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK.	B	CC[C@H](Nc1nc(NCc2ccncc2)c2ncn(C(C)C)c2n1)[C@@H](C)O		CHEMBL3655770	=	IC50	nM	40.0	CHEMBL301	Homo sapiens	IC50	nM	40.0
218090	16278602	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CCOC(=O)N=S(=O)(CC)c1ccc(Nc2ncc(Br)c(O[C@H](C)[C@H](C)O)n2)cc1		CHEMBL3648092	=	IC50	nM	19.0	CHEMBL301	Homo sapiens	IC50	nM	19.0
267675	16278634	CHEMBL3705418	Kinase Assay: The compounds from the examples below were investigated for their CDK2/cyclin E, CDK1/cyclin B, CDK4/cyclin D1 and CDK7/cyclin H, ERK-2, and PKA inhibitory activity. His6-tagged recombinant human cyclin-dependent kinases CDK1/cyclin B1, CDK2/cyclin E, CDK4 and CDK7/cyclin H were expressed in sf9 cells using a baculovirus expression system. Recombinant cyclin D1 was expressed in E. coli. Proteins were purified by metal chelate affinity chromatography to greater than 90% homogeneity. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins, recombinant active ERK-2 (Upstate Biotechnology), or cyclic AMP-dependent kinase (PKA) catalytic subunit (Calbiochem Cat. 539487). Assays were performed in assay buffer (25 mM beta -glycerophosphate, 20 mM MOPS, 5 mM EGTA, 1 mM DTT, 1 mM Na3VO3, pH 7.4), into which were added 2-4 ug of active enzyme with appropriate substrates (purified histone H1 for CDK2, recombinant GST-retinoblastoma protein (residues 773-928) for CDK4.	B	CC[C@@H](Nc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1)C(O)C(C)C		CHEMBL1922121	=	IC50	nM	690.0	CHEMBL301	Homo sapiens	IC50	nM	690.0
218107	16279156	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CCOC(=O)N=S(=O)(CC)c1ccc(Nc2ncc(Br)c(N[C@H](C)[C@H](C)O)n2)cc1		CHEMBL3648089	=	IC50	nM	11.0	CHEMBL301	Homo sapiens	IC50	nM	11.0
226137	16280060	CHEMBL3705547	Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK.	B	CC[C@H](Nc1nc(NCc2cccc(F)c2)c2ncn(C(C)C)c2n1)[C@@H](C)O		CHEMBL3655765	=	IC50	nM	120.0	CHEMBL301	Homo sapiens	IC50	nM	120.0
6372	16283635	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	C[C@H](O)[C@@H](C)Nc1nc(Nc2ccc(S(=N)(=O)CCO)cc2)ncc1Br		CHEMBL3648110	=	IC50	nM	7.0	CHEMBL301	Homo sapiens	IC50	nM	7.0
218096	16283834	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CCS(=N)(=O)c1ccc(Nc2ncc(Br)c(N[C@H](COC)[C@H](C)O)n2)cc1		CHEMBL3648094	=	IC50	nM	7.0	CHEMBL301	Homo sapiens	IC50	nM	7.0
218089	16283982	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	C[C@@H](Nc1nc(Nc2ccc(S(=O)(=NS(=O)(=O)CC[Si](C)(C)C)C3CCCC3)cc2)ncc1Br)C(C)(C)O		CHEMBL3648077	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
218087	16284104	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CCOC(=O)N=S(C)(=O)c1ccc(Nc2ncc(Br)c(N[C@H](C)C(C)(C)O)n2)cc1		CHEMBL3648084	=	IC50	nM	9.0	CHEMBL301	Homo sapiens	IC50	nM	9.0
218080	16290622	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	C[C@@H](Nc1nc(Nc2ccc(S(C)(=N)=O)cc2)ncc1Br)C(C)(C)O		CHEMBL3648072	=	IC50	nM	6.0	CHEMBL301	Homo sapiens	IC50	nM	6.0
254308	16291730	CHEMBL3707699	Kinase Screen Assay: KINOMEscan (Ambit Biosciences, San Diego, Calif.), a high-throughput method for screening small molecular agents against a large panel of human kinases, was utilized for compound 2. The technology is a competition binding assay that profiled the selectivity of compound 2 against 350 kinases, each fused to a proprietary tag. The quantity of each kinase bound to an immobilized, active site-directed ligand was measured in the presence and absence of compound 2.	B	Cc1nc(Nc2nc3ccc(-c4cccc(C(=O)Nc5cccc(C(F)(F)F)c5)c4)nc3s2)cc(N2CCNCC2)n1		CHEMBL2148120	=	Kd	nM	840.0	CHEMBL301	Homo sapiens	Kd	nM	840.0
218106	16292148	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CCOC(=O)N=S(C)(=O)c1ccc(Nc2ncc(Br)c(N[C@H](C)[C@H](C)O)n2)cc1C		CHEMBL3648091	=	IC50	nM	78.0	CHEMBL301	Homo sapiens	IC50	nM	78.0
6390	16292303	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	COc1cc(Nc2ncc(Br)c(N[C@H](C)C(C)(C)O)n2)ccc1S(C)(=N)=O		CHEMBL3648115	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	IC50	nM	2.0
308347	16292485	CHEMBL3707960	In Vitro Kinase Inhibition Assay: In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services providers in order to offer in vitro kinase activity assay services, e.g. the assays offered by Millipore Inc. (worldwide website www(dot)millipore.com), ProQinase GmbH (worldwide website www(dot)proqinase.de) and others. All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50ul reaction volume. The reaction mixture was pipetted in four steps in the following order: 20ul of assay buffer (standard buffer),5ul of ATP solution (in H2O, 5 ul of test compound (in 10% DMSO), 10ul of substrate/10ul of enzyme solution (premixed)The assay for all enzymes contained 60 mM HEPES-NaOH (pH 7.5), 3 mM MgCl2, 3 mM MnCl2, 3uM Na-Orthovanadate, 1.2 mM DTT, 50 ug/ml PEG2000, 1 uM [33P]-ATP (approx. 5x1005 cpm per well).	B	COc1cc(F)ccc1-c1ccnc(NC(=O)C2CCC(NC(C)=O)C2)c1		CHEMBL3673435	=	IC50	nM	913.0	CHEMBL301	Homo sapiens	IC50	nM	913.0
218086	16294023	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	COc1cc(Nc2ncc(Br)c(N[C@H](C)[C@H](C)O)n2)ccc1S(C)(=N)=O		CHEMBL3648112	=	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	nM	3.0
218111	16294030	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CN=S(C)(=O)c1ccc(Nc2ncc(Br)c(N[C@H](C)[C@H](C)O)n2)cc1		CHEMBL3648083	=	IC50	nM	7.0	CHEMBL301	Homo sapiens	IC50	nM	7.0
218100	16294610	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	C[C@@H](Nc1nc(Nc2ccc(S(=O)(CC=O)=NS(=O)(=O)CC[Si](C)(C)C)cc2)ncc1Br)C(C)(C)O		CHEMBL3648079	=	IC50	nM	49.0	CHEMBL301	Homo sapiens	IC50	nM	49.0
218093	16295013	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CCOC(=O)N=S(C)(=O)c1ccc(Nc2ncc(Br)c(N[C@@H](COC)[C@H](C)O)n2)cc1		CHEMBL3648087	=	IC50	nM	28.0	CHEMBL301	Homo sapiens	IC50	nM	28.0
226114	16296499	CHEMBL3705547	Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK.	B	CC[C@H](Nc1nc(NCc2cnc(C)cc2C)c2ncn(C(C)C)c2n1)[C@@H](C)O		CHEMBL3655762	=	IC50	nM	20.0	CHEMBL301	Homo sapiens	IC50	nM	20.0
218084	16297152	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	COc1cc(Nc2ncc(Br)c(N[C@H](C)C(C)(C)O)n2)ccc1S(C)(=N)=O		CHEMBL3648115	=	IC50	nM	6.0	CHEMBL301	Homo sapiens	IC50	nM	6.0
218117	16297318	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CCC(C)Sc1nc(Nc2ccc(S(C)(=N)=O)cc2)ncc1Br		CHEMBL3648100	=	IC50	nM	33.0	CHEMBL301	Homo sapiens	IC50	nM	33.0
218112	16298978	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CC(O)CSc1nc(Nc2ccc(S(C)(=N)=O)cc2)ncc1Br		CHEMBL3648101	=	IC50	nM	41.0	CHEMBL301	Homo sapiens	IC50	nM	41.0
226127	16300058	CHEMBL3705547	Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK.	B	CC(C)n1cnc2c(NCc3cccnc3)nc(NC[C@@H](C)O)nc21		CHEMBL3655775	=	IC50	nM	290.0	CHEMBL301	Homo sapiens	IC50	nM	290.0
218116	16300455	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CCC(Sc1nc(Nc2ccc(S(C)(=N)=O)cc2)ncc1Br)C(C)(C)O		CHEMBL3648105	=	IC50	nM	27.0	CHEMBL301	Homo sapiens	IC50	nM	27.0
218098	16300789	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	C[C@@H](Nc1nc(Nc2ccc(S(=N)(=O)C3CCCC3)cc2)ncc1Br)C(C)(C)O		CHEMBL3648078	=	IC50	nM	25.0	CHEMBL301	Homo sapiens	IC50	nM	25.0
226124	16300848	CHEMBL3705547	Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK.	B	CC[C@H](Nc1nc(NCc2ccc(C(F)(F)F)nc2)c2ncn(C(C)C)c2n1)[C@@H](C)O		CHEMBL3655772	=	IC50	nM	40.0	CHEMBL301	Homo sapiens	IC50	nM	40.0
7292	16301059	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	COC[C@@H](Nc1nc(Nc2ccc(S(C)(=N)=O)cc2)ncc1Br)[C@@H](C)O		CHEMBL3648118	=	IC50	nM	4.0	CHEMBL301	Homo sapiens	IC50	nM	4.0
267672	16301406	CHEMBL3705418	Kinase Assay: The compounds from the examples below were investigated for their CDK2/cyclin E, CDK1/cyclin B, CDK4/cyclin D1 and CDK7/cyclin H, ERK-2, and PKA inhibitory activity. His6-tagged recombinant human cyclin-dependent kinases CDK1/cyclin B1, CDK2/cyclin E, CDK4 and CDK7/cyclin H were expressed in sf9 cells using a baculovirus expression system. Recombinant cyclin D1 was expressed in E. coli. Proteins were purified by metal chelate affinity chromatography to greater than 90% homogeneity. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins, recombinant active ERK-2 (Upstate Biotechnology), or cyclic AMP-dependent kinase (PKA) catalytic subunit (Calbiochem Cat. 539487). Assays were performed in assay buffer (25 mM beta -glycerophosphate, 20 mM MOPS, 5 mM EGTA, 1 mM DTT, 1 mM Na3VO3, pH 7.4), into which were added 2-4 ug of active enzyme with appropriate substrates (purified histone H1 for CDK2, recombinant GST-retinoblastoma protein (residues 773-928) for CDK4.	B	CC[C@H](Nc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1)[C@@H](C)O		CHEMBL1922219	=	IC50	nM	30.0	CHEMBL301	Homo sapiens	IC50	nM	30.0
267674	16302543	CHEMBL3705418	Kinase Assay: The compounds from the examples below were investigated for their CDK2/cyclin E, CDK1/cyclin B, CDK4/cyclin D1 and CDK7/cyclin H, ERK-2, and PKA inhibitory activity. His6-tagged recombinant human cyclin-dependent kinases CDK1/cyclin B1, CDK2/cyclin E, CDK4 and CDK7/cyclin H were expressed in sf9 cells using a baculovirus expression system. Recombinant cyclin D1 was expressed in E. coli. Proteins were purified by metal chelate affinity chromatography to greater than 90% homogeneity. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins, recombinant active ERK-2 (Upstate Biotechnology), or cyclic AMP-dependent kinase (PKA) catalytic subunit (Calbiochem Cat. 539487). Assays were performed in assay buffer (25 mM beta -glycerophosphate, 20 mM MOPS, 5 mM EGTA, 1 mM DTT, 1 mM Na3VO3, pH 7.4), into which were added 2-4 ug of active enzyme with appropriate substrates (purified histone H1 for CDK2, recombinant GST-retinoblastoma protein (residues 773-928) for CDK4.	B	CCC(O)[C@H](CC)Nc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1		CHEMBL1922209	=	IC50	nM	110.0	CHEMBL301	Homo sapiens	IC50	nM	110.0
8160	16303354	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CCS(=N)(=O)c1ccc(Nc2ncc(Br)c(N[C@@H](C)[C@H](C)O)n2)cc1		CHEMBL3648122	=	IC50	nM	4.0	CHEMBL301	Homo sapiens	IC50	nM	4.0
218109	16307419	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	Cc1cc(Nc2ncc(Br)c(N[C@H](C)[C@H](C)O)n2)ccc1S(C)(=N)=O		CHEMBL3648096	=	IC50	nM	4.0	CHEMBL301	Homo sapiens	IC50	nM	4.0
226136	16307782	CHEMBL3705547	Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK.	B	CC[C@H](Nc1nc(NCc2cccc(Cl)c2)c2ncn(C(C)C)c2n1)[C@@H](C)O		CHEMBL3655764	=	IC50	nM	100.0	CHEMBL301	Homo sapiens	IC50	nM	100.0
226121	16308033	CHEMBL3705547	Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK.	B	CC[C@H](Nc1nc(NC2CCC2)c2ncn(C(C)C)c2n1)[C@@H](C)O		CHEMBL3655769	=	IC50	nM	160.0	CHEMBL301	Homo sapiens	IC50	nM	160.0
267677	16311987	CHEMBL3705418	Kinase Assay: The compounds from the examples below were investigated for their CDK2/cyclin E, CDK1/cyclin B, CDK4/cyclin D1 and CDK7/cyclin H, ERK-2, and PKA inhibitory activity. His6-tagged recombinant human cyclin-dependent kinases CDK1/cyclin B1, CDK2/cyclin E, CDK4 and CDK7/cyclin H were expressed in sf9 cells using a baculovirus expression system. Recombinant cyclin D1 was expressed in E. coli. Proteins were purified by metal chelate affinity chromatography to greater than 90% homogeneity. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins, recombinant active ERK-2 (Upstate Biotechnology), or cyclic AMP-dependent kinase (PKA) catalytic subunit (Calbiochem Cat. 539487). Assays were performed in assay buffer (25 mM beta -glycerophosphate, 20 mM MOPS, 5 mM EGTA, 1 mM DTT, 1 mM Na3VO3, pH 7.4), into which were added 2-4 ug of active enzyme with appropriate substrates (purified histone H1 for CDK2, recombinant GST-retinoblastoma protein (residues 773-928) for CDK4.	B	CC[C@@H](Nc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1)C(O)C(C)(C)C		CHEMBL1922122	=	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
226123	16312227	CHEMBL3705547	Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK.	B	CC[C@H](Nc1nc(NCc2cc(C)nc(C)c2)c2ncn(C(C)C)c2n1)[C@@H](C)O		CHEMBL3655771	=	IC50	nM	50.0	CHEMBL301	Homo sapiens	IC50	nM	50.0
267676	16313267	CHEMBL3705418	Kinase Assay: The compounds from the examples below were investigated for their CDK2/cyclin E, CDK1/cyclin B, CDK4/cyclin D1 and CDK7/cyclin H, ERK-2, and PKA inhibitory activity. His6-tagged recombinant human cyclin-dependent kinases CDK1/cyclin B1, CDK2/cyclin E, CDK4 and CDK7/cyclin H were expressed in sf9 cells using a baculovirus expression system. Recombinant cyclin D1 was expressed in E. coli. Proteins were purified by metal chelate affinity chromatography to greater than 90% homogeneity. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins, recombinant active ERK-2 (Upstate Biotechnology), or cyclic AMP-dependent kinase (PKA) catalytic subunit (Calbiochem Cat. 539487). Assays were performed in assay buffer (25 mM beta -glycerophosphate, 20 mM MOPS, 5 mM EGTA, 1 mM DTT, 1 mM Na3VO3, pH 7.4), into which were added 2-4 ug of active enzyme with appropriate substrates (purified histone H1 for CDK2, recombinant GST-retinoblastoma protein (residues 773-928) for CDK4.	B	CC[C@H](Nc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1)C(O)C(C)C		CHEMBL1922210	=	IC50	nM	1100.0	CHEMBL301	Homo sapiens	IC50	nM	1100.0
6385	16313695	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CN=S(C)(=O)c1ccc(Nc2ncc(Br)c(N[C@H](C)[C@H](C)O)n2)cc1OC		CHEMBL3648114	=	IC50	nM	6.0	CHEMBL301	Homo sapiens	IC50	nM	6.0
218085	16314572	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	COc1cc(Nc2ncc(Br)c(O[C@H](C)[C@H](C)O)n2)ccc1S(C)(=N)=O		CHEMBL3648082	=	IC50	nM	8.0	CHEMBL301	Homo sapiens	IC50	nM	8.0
226119	16314599	CHEMBL3705547	Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK.	B	CC[C@H](Nc1nc(NC2CC2)c2ncn(C(C)C)c2n1)[C@@H](C)O		CHEMBL3655767	=	IC50	nM	50.0	CHEMBL301	Homo sapiens	IC50	nM	50.0
267680	16314968	CHEMBL3705418	Kinase Assay: The compounds from the examples below were investigated for their CDK2/cyclin E, CDK1/cyclin B, CDK4/cyclin D1 and CDK7/cyclin H, ERK-2, and PKA inhibitory activity. His6-tagged recombinant human cyclin-dependent kinases CDK1/cyclin B1, CDK2/cyclin E, CDK4 and CDK7/cyclin H were expressed in sf9 cells using a baculovirus expression system. Recombinant cyclin D1 was expressed in E. coli. Proteins were purified by metal chelate affinity chromatography to greater than 90% homogeneity. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins, recombinant active ERK-2 (Upstate Biotechnology), or cyclic AMP-dependent kinase (PKA) catalytic subunit (Calbiochem Cat. 539487). Assays were performed in assay buffer (25 mM beta -glycerophosphate, 20 mM MOPS, 5 mM EGTA, 1 mM DTT, 1 mM Na3VO3, pH 7.4), into which were added 2-4 ug of active enzyme with appropriate substrates (purified histone H1 for CDK2, recombinant GST-retinoblastoma protein (residues 773-928) for CDK4.	B	CC[C@H](Nc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1)C(C)(C)O		CHEMBL1922212	=	IC50	nM	70.0	CHEMBL301	Homo sapiens	IC50	nM	70.0
6365	16315500	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	C[C@H](Nc1nc(Nc2ccc(S(=N)(=O)CCO)cc2)ncc1Br)C(C)(C)O		CHEMBL3648108	=	IC50	nM	4.0	CHEMBL301	Homo sapiens	IC50	nM	4.0
226135	16316842	CHEMBL3705547	Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK.	B	CC[C@H](Nc1nc(NCc2ccc(C)nc2)c2ncn(C(C)C)c2n1)[C@@H](C)O		CHEMBL3655763	=	IC50	nM	3250.0	CHEMBL301	Homo sapiens	IC50	nM	3250.0
267678	16316968	CHEMBL3705418	Kinase Assay: The compounds from the examples below were investigated for their CDK2/cyclin E, CDK1/cyclin B, CDK4/cyclin D1 and CDK7/cyclin H, ERK-2, and PKA inhibitory activity. His6-tagged recombinant human cyclin-dependent kinases CDK1/cyclin B1, CDK2/cyclin E, CDK4 and CDK7/cyclin H were expressed in sf9 cells using a baculovirus expression system. Recombinant cyclin D1 was expressed in E. coli. Proteins were purified by metal chelate affinity chromatography to greater than 90% homogeneity. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins, recombinant active ERK-2 (Upstate Biotechnology), or cyclic AMP-dependent kinase (PKA) catalytic subunit (Calbiochem Cat. 539487). Assays were performed in assay buffer (25 mM beta -glycerophosphate, 20 mM MOPS, 5 mM EGTA, 1 mM DTT, 1 mM Na3VO3, pH 7.4), into which were added 2-4 ug of active enzyme with appropriate substrates (purified histone H1 for CDK2, recombinant GST-retinoblastoma protein (residues 773-928) for CDK4.	B	CC[C@H](Nc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1)C(O)C(C)(C)C		CHEMBL1922211	=	IC50	nM	390.0	CHEMBL301	Homo sapiens	IC50	nM	390.0
226128	16317421	CHEMBL3705547	Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK.	B	CC(C)n1cnc2c(NCc3cccnc3)nc(NCC(O)C(F)(F)F)nc21		CHEMBL3655776	=	IC50	nM	570.0	CHEMBL301	Homo sapiens	IC50	nM	570.0
218094	16318032	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CCOC(=O)N=S(C)(=O)c1ccc(Nc2ncc(Br)c(O[C@H](C)[C@H](C)O)n2)cc1		CHEMBL3648093	=	IC50	nM	14.0	CHEMBL301	Homo sapiens	IC50	nM	14.0
11308	16319088	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CCC(CO)Sc1nc(Nc2ccc(S(C)(=N)=O)cc2)ncc1Br		CHEMBL3648127	=	IC50	nM	16.0	CHEMBL301	Homo sapiens	IC50	nM	16.0
218103	16319563	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	Cc1cc(Nc2ncc(Br)c(N[C@H](C)C(C)(C)O)n2)ccc1S(C)(=N)=O		CHEMBL3639469	=	IC50	nM	4.0	CHEMBL301	Homo sapiens	IC50	nM	4.0
218110	16319994	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CCOC(=O)N=S(C)(=O)c1ccc(Nc2ncc(Br)c(N[C@H](C)[C@H](C)O)n2)cc1		CHEMBL3648085	=	IC50	nM	12.0	CHEMBL301	Homo sapiens	IC50	nM	12.0
8174	16325012	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CCS(=N)(=O)c1ccc(Nc2ncc(Br)c(N[C@H](C)C(C)(C)O)n2)cc1		CHEMBL3648123	=	IC50	nM	27.0	CHEMBL301	Homo sapiens	IC50	nM	27.0
218082	16325701	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	C[C@@H](O)[C@@H](C)Nc1nc(Nc2ccc(S(C)(=N)=O)cc2)ncc1Br		CHEMBL3648071	=	IC50	nM	20.0	CHEMBL301	Homo sapiens	IC50	nM	20.0
6379	16325891	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	COc1cc(Nc2ncc(Br)c(N[C@H](C)[C@H](C)O)n2)ccc1S(C)(=N)=O		CHEMBL3648112	=	IC50	nM	4.0	CHEMBL301	Homo sapiens	IC50	nM	4.0
308346	16325916	CHEMBL3707960	In Vitro Kinase Inhibition Assay: In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services providers in order to offer in vitro kinase activity assay services, e.g. the assays offered by Millipore Inc. (worldwide website www(dot)millipore.com), ProQinase GmbH (worldwide website www(dot)proqinase.de) and others. All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50ul reaction volume. The reaction mixture was pipetted in four steps in the following order: 20ul of assay buffer (standard buffer),5ul of ATP solution (in H2O, 5 ul of test compound (in 10% DMSO), 10ul of substrate/10ul of enzyme solution (premixed)The assay for all enzymes contained 60 mM HEPES-NaOH (pH 7.5), 3 mM MgCl2, 3 mM MnCl2, 3uM Na-Orthovanadate, 1.2 mM DTT, 50 ug/ml PEG2000, 1 uM [33P]-ATP (approx. 5x1005 cpm per well).	B	COc1cc(F)ccc1-c1ccnc(NC(=O)[C@H]2CCC[C@@H](NC(C)=O)C2)c1		CHEMBL3673434	=	IC50	nM	168.0	CHEMBL301	Homo sapiens	IC50	nM	168.0
226117	16326832	CHEMBL3705547	Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK.	B	CC[C@H](Nc1nc(NCc2cccc(F)c2)c2ncn(C(C)C)c2n1)[C@@H](C)O		CHEMBL3655765	=	IC50	nM	20.0	CHEMBL301	Homo sapiens	IC50	nM	20.0
218113	16329389	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CC(O)C(C)Sc1nc(Nc2ccc(S(C)(=N)=O)cc2)ncc1Br		CHEMBL3648102	=	IC50	nM	8.0	CHEMBL301	Homo sapiens	IC50	nM	8.0
218083	16329867	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	C[C@H](CO)Nc1nc(Nc2ccc(S(C)(=O)=NS(=O)(=O)CC[Si](C)(C)C)cc2)ncc1Br		CHEMBL3648098	=	IC50	nM	390.0	CHEMBL301	Homo sapiens	IC50	nM	390.0
218091	16330067	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CCOC(=O)N=S(=O)(CC)c1ccc(Nc2ncc(Br)c(N[C@@H](COC)[C@H](C)O)n2)cc1		CHEMBL3648086	=	IC50	nM	51.0	CHEMBL301	Homo sapiens	IC50	nM	51.0
6375	16331133	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	COc1cc(Nc2ncc(Br)c(N[C@H](C)[C@@H](C)O)n2)ccc1S(C)(=N)=O		CHEMBL3648111	=	IC50	nM	4.0	CHEMBL301	Homo sapiens	IC50	nM	4.0
226116	16333513	CHEMBL3705547	Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK.	B	CC[C@H](Nc1nc(NCc2cccc(Cl)c2)c2ncn(C(C)C)c2n1)[C@@H](C)O		CHEMBL3655764	=	IC50	nM	10.0	CHEMBL301	Homo sapiens	IC50	nM	10.0
6361	16333599	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	C[C@@H](Nc1nc(Nc2ccc(S(=N)(=O)CCO)cc2)ncc1Br)C(C)(C)O		CHEMBL3648107	=	IC50	nM	4.0	CHEMBL301	Homo sapiens	IC50	nM	4.0
6373	16334204	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	C[C@H](O)[C@@H](C)Nc1nc(Nc2ccc(S(=N)(=O)CCO)cc2)ncc1Br		CHEMBL3648110	=	IC50	nM	6.0	CHEMBL301	Homo sapiens	IC50	nM	6.0
218104	16336865	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	C[C@H](O)[C@@H](C)Nc1nc(Nc2ccc(S(=O)(CC=O)=NS(=O)(=O)CC[Si](C)(C)C)cc2)ncc1Br		CHEMBL3648080	=	IC50	nM	130.0	CHEMBL301	Homo sapiens	IC50	nM	130.0
7490	16336979	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	COC[C@H](Nc1nc(Nc2ccc(S(C)(=N)=O)cc2)ncc1Br)[C@H](C)O		CHEMBL3648119	=	IC50	nM	6.0	CHEMBL301	Homo sapiens	IC50	nM	6.0
218099	16338213	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	C[C@@H](Nc1nc(Nc2ccc(S(=N)(=O)CC3CC3)cc2)ncc1Br)C(C)(C)O		CHEMBL3648076	=	IC50	nM	4.0	CHEMBL301	Homo sapiens	IC50	nM	4.0
218105	16340133	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	C[C@H](O)[C@@H](C)Oc1nc(Nc2ccc(S(=O)(CCO)=NS(=O)(=O)CC[Si](C)(C)C)cc2)ncc1Br		CHEMBL3648081	=	IC50	nM	54.0	CHEMBL301	Homo sapiens	IC50	nM	54.0
9502	16340619	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	Cc1cc(Nc2ncc(Br)c(N[C@@H](C)C(C)(C)O)n2)ccc1S(C)(=N)=O		CHEMBL3648125	=	IC50	nM	7.0	CHEMBL301	Homo sapiens	IC50	nM	7.0
226120	16341125	CHEMBL3705547	Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK.	B	CC[C@H](Nc1nc(NCC2CC2)c2ncn(C(C)C)c2n1)[C@@H](C)O		CHEMBL3655768	=	IC50	nM	40.0	CHEMBL301	Homo sapiens	IC50	nM	40.0
218115	16342019	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CC(Sc1nc(Nc2ccc(S(C)(=N)=O)cc2)ncc1Br)C(C)(C)O		CHEMBL3648104	=	IC50	nM	11.0	CHEMBL301	Homo sapiens	IC50	nM	11.0
11499	16343285	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CC(C)(O)CSc1nc(Nc2ccc(S(C)(=N)=O)cc2)ncc1Br		CHEMBL3648128	=	IC50	nM	8.0	CHEMBL301	Homo sapiens	IC50	nM	8.0
226129	16343828	CHEMBL3705547	Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK.	B	CCC(Nc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1)C(O)C(F)(F)F		CHEMBL3655777	=	IC50	nM	90.0	CHEMBL301	Homo sapiens	IC50	nM	90.0
6382	16343985	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CN=S(C)(=O)c1ccc(Nc2ncc(Br)c(N[C@H](C)[C@@H](C)O)n2)cc1OC		CHEMBL3648113	=	IC50	nM	4.0	CHEMBL301	Homo sapiens	IC50	nM	4.0
267679	16346426	CHEMBL3705418	Kinase Assay: The compounds from the examples below were investigated for their CDK2/cyclin E, CDK1/cyclin B, CDK4/cyclin D1 and CDK7/cyclin H, ERK-2, and PKA inhibitory activity. His6-tagged recombinant human cyclin-dependent kinases CDK1/cyclin B1, CDK2/cyclin E, CDK4 and CDK7/cyclin H were expressed in sf9 cells using a baculovirus expression system. Recombinant cyclin D1 was expressed in E. coli. Proteins were purified by metal chelate affinity chromatography to greater than 90% homogeneity. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins, recombinant active ERK-2 (Upstate Biotechnology), or cyclic AMP-dependent kinase (PKA) catalytic subunit (Calbiochem Cat. 539487). Assays were performed in assay buffer (25 mM beta -glycerophosphate, 20 mM MOPS, 5 mM EGTA, 1 mM DTT, 1 mM Na3VO3, pH 7.4), into which were added 2-4 ug of active enzyme with appropriate substrates (purified histone H1 for CDK2, recombinant GST-retinoblastoma protein (residues 773-928) for CDK4.	B	CC[C@@H](Nc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1)C(C)(C)O		CHEMBL1922123	=	IC50	nM	200.0	CHEMBL301	Homo sapiens	IC50	nM	200.0
218118	16346601	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CC(CO)Sc1nc(Nc2ccc(S(C)(=N)=O)cc2)ncc1Br		CHEMBL3648106	=	IC50	nM	4.0	CHEMBL301	Homo sapiens	IC50	nM	4.0
218102	16346651	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CCOC(=O)N=S(C)(=O)c1ccc(Nc2ncc(Br)c(N[C@H](C)C(C)(C)O)n2)cc1C		CHEMBL3648090	=	IC50	nM	48.0	CHEMBL301	Homo sapiens	IC50	nM	48.0
218079	16347100	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	C=S(N)(=O)c1ccc(Nc2ncc(Br)c(N[C@H](C)CO)n2)cc1		CHEMBL3648099	<	IC50	nM	10.0	CHEMBL301	Homo sapiens	IC50	nM	10.0
226118	16348800	CHEMBL3705547	Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK.	B	CC[C@H](Nc1nc(NCc2cccnc2)c2ncn(CC3CC3)c2n1)[C@@H](C)O		CHEMBL3655766	=	IC50	nM	830.0	CHEMBL301	Homo sapiens	IC50	nM	830.0
6395	16350666	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	C[C@H](Nc1nc(Nc2ccc(S(C)(=N)=O)cc2)ncc1Br)C(C)(C)O		CHEMBL3648116	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	IC50	nM	2.0
218101	16350734	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	C[C@@H](Nc1nc(Nc2ccc(S(=N)(=O)C3CC3)cc2)ncc1Br)C(C)(C)O		CHEMBL3648074	=	IC50	nM	8.0	CHEMBL301	Homo sapiens	IC50	nM	8.0
226125	16350799	CHEMBL3705547	Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK.	B	CC[C@H](Nc1nc(NCc2cccc(C)n2)c2ncn(C(C)C)c2n1)[C@@H](C)O		CHEMBL3655773	=	IC50	nM	50.0	CHEMBL301	Homo sapiens	IC50	nM	50.0
218114	16354682	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CCC(Sc1nc(Nc2ccc(S(C)(=N)=O)cc2)ncc1Br)C(C)O		CHEMBL3648103	=	IC50	nM	18.0	CHEMBL301	Homo sapiens	IC50	nM	18.0
6398	16354698	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	C[C@H](O)[C@@H](C)Nc1nc(Nc2ccc(S(C)(=N)=O)cc2)ncc1Br		CHEMBL3648117	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	IC50	nM	2.0
218095	16354984	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CCOc1nc(Nc2ccc(S(=N)(=O)CC)cc2)ncc1Br		CHEMBL3648097	=	IC50	nM	63.0	CHEMBL301	Homo sapiens	IC50	nM	63.0
6368	16356044	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	C[C@@H](O)[C@@H](C)Nc1nc(Nc2ccc(S(=N)(=O)CCO)cc2)ncc1Br		CHEMBL3648109	=	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	nM	3.0
	16413421	CHEMBL3743723	Inhibition of CDK2 (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
Active	16435507	CHEMBL3757901	Binding affinity to N-terminal His-tagged human CDK2 expressed in Escherichia coli BL21-AI by STD-NMR analysis	B	c1ccc(CNc2ncnc3[nH]cnc23)cc1		CHEMBL228862		Activity			CHEMBL301	Homo sapiens	Activity		
Active	16435508	CHEMBL3757901	Binding affinity to N-terminal His-tagged human CDK2 expressed in Escherichia coli BL21-AI by STD-NMR analysis	B	N=C(N)NCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL143054		Activity			CHEMBL301	Homo sapiens	Activity		
Active	16435509	CHEMBL3757901	Binding affinity to N-terminal His-tagged human CDK2 expressed in Escherichia coli BL21-AI by STD-NMR analysis	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380		Activity			CHEMBL301	Homo sapiens	Activity		
Active	16435510	CHEMBL3757901	Binding affinity to N-terminal His-tagged human CDK2 expressed in Escherichia coli BL21-AI by STD-NMR analysis	B	CNc1ncnc2ccc([N+](=O)[O-])cc12		CHEMBL3754754		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	16435511	CHEMBL3757901	Binding affinity to N-terminal His-tagged human CDK2 expressed in Escherichia coli BL21-AI by STD-NMR analysis	B	Cc1ccc(Cn2cc(-n3c(-c4ccc(Cn5nc(C)c(Cl)c5C)o4)n[nH]c3=S)cn2)cc1		CHEMBL3754761		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	16435512	CHEMBL3757901	Binding affinity to N-terminal His-tagged human CDK2 expressed in Escherichia coli BL21-AI by STD-NMR analysis	B	Cc1ccc(Cn2cc(-n3c(-c4ccc(Cn5cc(Cl)cn5)cc4)n[nH]c3=S)cn2)cc1		CHEMBL3754280		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	16435513	CHEMBL3757901	Binding affinity to N-terminal His-tagged human CDK2 expressed in Escherichia coli BL21-AI by STD-NMR analysis	B	Cc1ccc(Cn2cc(-n3c(-c4ccc(Cn5nc(C)cc5C)o4)n[nH]c3=S)cn2)cc1		CHEMBL3753964		Activity			CHEMBL301	Homo sapiens	Activity		
Active	16435514	CHEMBL3757901	Binding affinity to N-terminal His-tagged human CDK2 expressed in Escherichia coli BL21-AI by STD-NMR analysis	B	Cc1ccc(Cn2nccc2-n2c(-c3cc(C)n(C)n3)n[nH]c2=S)cc1		CHEMBL3754128		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	16435515	CHEMBL3757901	Binding affinity to N-terminal His-tagged human CDK2 expressed in Escherichia coli BL21-AI by STD-NMR analysis	B	Cc1ccc(Cn2cc(-n3c(-c4ccc(Cn5cccn5)cc4)n[nH]c3=S)cn2)cc1		CHEMBL3752834		Activity			CHEMBL301	Homo sapiens	Activity		
Active	16435516	CHEMBL3757901	Binding affinity to N-terminal His-tagged human CDK2 expressed in Escherichia coli BL21-AI by STD-NMR analysis	B	CC(C)=CCNc1ncnc2[nH]cnc12		CHEMBL476189		Activity			CHEMBL301	Homo sapiens	Activity		
	16435517	CHEMBL3757902	Binding affinity to human CDK2 by isothermal titration calorimetric analysis	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	Outside typical range	CHEMBL477	=	Kd	nM	184000.0	CHEMBL301	Homo sapiens	Kd	uM	184.0
	16435518	CHEMBL3757902	Binding affinity to human CDK2 by isothermal titration calorimetric analysis	B	c1ccc(CNc2ncnc3[nH]cnc23)cc1		CHEMBL228862	=	Kd	nM	62000.0	CHEMBL301	Homo sapiens	Kd	uM	62.0
	16435519	CHEMBL3757902	Binding affinity to human CDK2 by isothermal titration calorimetric analysis	B	N=C(N)NCCNS(=O)(=O)c1cccc2cnccc12	Outside typical range	CHEMBL143054	=	Kd	nM	286000.0	CHEMBL301	Homo sapiens	Kd	uM	286.0
	16435520	CHEMBL3757902	Binding affinity to human CDK2 by isothermal titration calorimetric analysis	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1	Outside typical range	CHEMBL38380	=	Kd	nM	460000.0	CHEMBL301	Homo sapiens	Kd	uM	460.0
	16435521	CHEMBL3757902	Binding affinity to human CDK2 by isothermal titration calorimetric analysis	B	CNc1ncnc2ccc([N+](=O)[O-])cc12	Outside typical range	CHEMBL3754754	=	Kd	nM	208000.0	CHEMBL301	Homo sapiens	Kd	uM	208.0
	16435522	CHEMBL3757902	Binding affinity to human CDK2 by isothermal titration calorimetric analysis	B	CC(C)=CCNc1ncnc2[nH]cnc12		CHEMBL476189	=	Kd	nM	35000.0	CHEMBL301	Homo sapiens	Kd	uM	35.0
	16485708	CHEMBL3774133	Inhibition of human recombinant CDK2 assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3		CHEMBL3771285	=	Activity	%	100.0	CHEMBL301	Homo sapiens	Activity	%	100.0
Active	16507201	CHEMBL3777891	Inhibition of CDK2 in human G361 cells assessed as reduction in phosphorylation of RNA polymerase 2 at C-terminus at 15 uM incubated for 0.5 to 24 hrs by immunoblotting analysis	B	CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(N[C@H]3CC[C@H](N)CC3)nc12		CHEMBL3774503		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	16507202	CHEMBL3777890	Inhibition of CDK2 in human G361 cells assessed as reduction in phosphorylation of RNA polymerase 2 at C-terminus at 0.75 uM incubated for 0.5 to 24 hrs by immunoblotting analysis	B	CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(NCC(C)(C)O)nc12		CHEMBL3775792		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	16507203	CHEMBL3777889	Inhibition of CDK2 in human G361 cells assessed as reduction in phosphorylation of RNA polymerase 2 at C-terminus at 1 uM incubated for 0.5 to 24 hrs by immunoblotting analysis	B	CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(N3CCOCC3)nc12		CHEMBL3775509		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	16507204	CHEMBL3777889	Inhibition of CDK2 in human G361 cells assessed as reduction in phosphorylation of RNA polymerase 2 at C-terminus at 1 uM incubated for 0.5 to 24 hrs by immunoblotting analysis	B	CC(O)CNc1nc(NCc2ccc(-c3ccccn3)cc2)c2[nH]nc(C(C)C)c2n1		CHEMBL3774632		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	16507205	CHEMBL3777888	Inhibition of CDK2 in human G361 cells assessed as reduction in phosphorylation of RNA polymerase 2 at C-terminus at 2.4 to 24 uM incubated for 24 hrs by immunoblotting analysis	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2[nH]nc(C(C)C)c2n1		CHEMBL1738742		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	16507206	CHEMBL3777887	Inhibition of CDK2 in human G361 cells assessed as reduction in phosphorylation of RNA polymerase 2 at C-terminus at 0.25 to 2.5 uM incubated for 24 hrs by immunoblotting analysis	B	CC[C@H](CO)Nc1nc(NCc2ccc(-c3ccccn3)cc2)c2ncn(C(C)C)c2n1		CHEMBL518800		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	16507207	CHEMBL3777886	Inhibition of CDK2 in human G361 cells assessed as reduction in phosphorylation of RNA polymerase 2 at C-terminus at 1.5 to 15 uM incubated for 24 hrs by immunoblotting analysis	B	CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(N[C@H]3CC[C@H](N)CC3)nc12		CHEMBL3774503		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	16507208	CHEMBL3777885	Inhibition of CDK2 in human G361 cells assessed as reduction in phosphorylation of RNA polymerase 2 at C-terminus at 0.075 to 0.75 uM incubated for 24 hrs by immunoblotting analysis	B	CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(NCC(C)(C)O)nc12		CHEMBL3775792		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	16507209	CHEMBL3776182	Inhibition of CDK2 in human G361 cells assessed as reduction in phosphorylation of RNA polymerase 2 at C-terminus at 0.1 to 1 uM incubated for 24 hrs by immunoblotting analysis	B	CC(O)CNc1nc(NCc2ccc(-c3ccccn3)cc2)c2[nH]nc(C(C)C)c2n1		CHEMBL3774632		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	16514107	CHEMBL3782155	Inhibition of partial length human CDK2 expressed in bacterial system at 1 uM	B	Cc1cnc(N)nc1OCC(C)(C)CO		CHEMBL3780032		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	16540749	CHEMBL3789977	Inhibition of CDK2A (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL1614712	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	16540750	CHEMBL3789977	Inhibition of CDK2A (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OC[C@@H]3CCCO3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787614	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	16540751	CHEMBL3789977	Inhibition of CDK2A (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787112	=	IC50	nM	410.0	CHEMBL301	Homo sapiens	IC50	uM	0.41
	16540752	CHEMBL3789977	Inhibition of CDK2A (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCC34CCC(CC3)O4)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3785500	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	16540753	CHEMBL3789977	Inhibition of CDK2A (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cccc(OC[C@@H]5CCCO5)c4F)c4c(N)ncnc43)C2)CC1		CHEMBL3786167	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	16540754	CHEMBL3789977	Inhibition of CDK2A (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL3785951	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	16566143	CHEMBL3803166	Inhibition of CDK2 (unknown origin)	B	Nc1ncccc1-c1nc2ccccc2[nH]1		CHEMBL3797559	=	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	16566144	CHEMBL3803166	Inhibition of CDK2 (unknown origin)	B	Nc1ncc(-c2ccccc2)cc1-c1nc2ccccc2[nH]1		CHEMBL3799935	=	IC50	nM	1300.0	CHEMBL301	Homo sapiens	IC50	uM	1.3
	16566145	CHEMBL3803166	Inhibition of CDK2 (unknown origin)	B	CN(C)C(=O)c1cccc(-c2cnc(N)c(-c3nc4ccccc4[nH]3)c2)c1		CHEMBL3797574	=	IC50	nM	5700.0	CHEMBL301	Homo sapiens	IC50	uM	5.7
	16566146	CHEMBL3803166	Inhibition of CDK2 (unknown origin)	B	CN(C)C(=O)c1cccc(-c2cnc(N)c(-c3nc4cccc(N5CCNCC5)c4[nH]3)c2)c1		CHEMBL3797828	=	IC50	nM	4000.0	CHEMBL301	Homo sapiens	IC50	uM	4.0
	16566147	CHEMBL3803166	Inhibition of CDK2 (unknown origin)	B	CN(C)C(=O)c1cccc(-c2cnc(N)c(-c3nc4cccc(N5CCNCC5)c4[nH]3)n2)c1		CHEMBL3798066	=	IC50	nM	11000.0	CHEMBL301	Homo sapiens	IC50	uM	11.0
	16566148	CHEMBL3803166	Inhibition of CDK2 (unknown origin)	B	CN(C)C(=O)c1cccc(-c2cnc(N)c(-c3nc4cccc(N5CCNCC5)c4n3C)n2)c1		CHEMBL3798762	=	IC50	nM	1400.0	CHEMBL301	Homo sapiens	IC50	uM	1.4
	16566149	CHEMBL3803166	Inhibition of CDK2 (unknown origin)	B	C[C@H]1CN(c2cccc3nc(-c4nc(-c5cccc(C(=O)N(C)C)c5)cnc4N)n(C)c23)CCN1		CHEMBL3797873	=	IC50	nM	3400.0	CHEMBL301	Homo sapiens	IC50	uM	3.4
	16566150	CHEMBL3803166	Inhibition of CDK2 (unknown origin)	B	C[C@H]1CN(c2cccc3nc(-c4nc(-c5cc(C(=O)N(C)C)ccn5)cnc4N)n(C)c23)CCN1		CHEMBL3800585	>	IC50	nM	25000.0	CHEMBL301	Homo sapiens	IC50	uM	25.0
	16578381	CHEMBL3802253	Inhibition of full length wild type human CDK2 expressed in bacterial system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	99.0	CHEMBL301	Homo sapiens	Activity	%	99.0
	16594907	CHEMBL3812232	Inhibition of full length human CDK2 expressed in bacterial system assessed as enzyme activity at 10 uM by KINOMEScan assay	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Activity	%	92.0	CHEMBL301	Homo sapiens	Activity	%	92.0
	16610776	CHEMBL3817693	Inhibition of CDK2 (unknown origin)	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	IC50	nM	170.0	CHEMBL301	Homo sapiens	IC50	uM	0.17
	16621482	CHEMBL3820475	Inhibition of CDK2 (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21		CHEMBL3818247	>	IC50	nM	30000.0	CHEMBL301	Homo sapiens	IC50	nM	30000.0
	16622197	CHEMBL3820475	Inhibition of CDK2 (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.6	CHEMBL301	Homo sapiens	IC50	nM	2.6
	16625353	CHEMBL3821727	Inhibition of CDK-2 (unknown origin) at 10 uM	B	COc1cccc(Nc2nccc(Nc3ccc4[nH]ncc4c3)n2)c1		CHEMBL3818017	=	Inhibition	%	76.0	CHEMBL301	Homo sapiens	INH	%	76.0
	16625354	CHEMBL3821727	Inhibition of CDK-2 (unknown origin) at 10 uM	B	COc1ccc(Nc2nccc(Nc3ccc4[nH]ncc4c3)n2)cc1		CHEMBL3819461	=	Inhibition	%	71.0	CHEMBL301	Homo sapiens	INH	%	71.0
	16628479	CHEMBL3820182	Inhibition of human recombinant full-length CDK2 expressed in Escherichia coli at 1 uM after 30 mins	B	O=C(Nc1cc(Nc2c(Cl)cnc3c2OCO3)ccn1)C1CC1		CHEMBL3818173	<	Inhibition	%	80.0	CHEMBL301	Homo sapiens	INH	%	80.0
	16636595	CHEMBL3825084	Inhibition of CDK2 (unknown origin)	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1		CHEMBL3823297	=	IC50	nM	1030.0	CHEMBL301	Homo sapiens	IC50	uM	1.03
	16636596	CHEMBL3825084	Inhibition of CDK2 (unknown origin)	B	CC(=O)N1CCC(n2cc(Nc3ncc(Cl)c(-c4cnc5ccccn45)n3)cn2)CC1		CHEMBL3823659	=	IC50	nM	25.0	CHEMBL301	Homo sapiens	IC50	uM	0.025
	16636597	CHEMBL3825084	Inhibition of CDK2 (unknown origin)	B	COc1nn(C2CCN(C(C)=O)CC2)cc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1		CHEMBL3822858	=	IC50	nM	494.0	CHEMBL301	Homo sapiens	IC50	uM	0.494
	16636598	CHEMBL3825084	Inhibition of CDK2 (unknown origin)	B	CC(=O)N1CCC(n2cc(Nc3ncc(Cl)c(-c4cnc5ccccn45)n3)c(C)n2)CC1		CHEMBL3823278	=	IC50	nM	135.0	CHEMBL301	Homo sapiens	IC50	uM	0.135
	16636599	CHEMBL3825084	Inhibition of CDK2 (unknown origin)	B	Cc1nn(C2CCNCC2)cc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1		CHEMBL3823007	=	IC50	nM	392.0	CHEMBL301	Homo sapiens	IC50	uM	0.392
	16636600	CHEMBL3825084	Inhibition of CDK2 (unknown origin)	B	CC(=O)N1CCC(n2ncc(Nc3ncc(Cl)c(-c4cnc5ccccn45)n3)c2C)CC1		CHEMBL3822583	=	IC50	nM	232.0	CHEMBL301	Homo sapiens	IC50	uM	0.232
	16636601	CHEMBL3825084	Inhibition of CDK2 (unknown origin)	B	Cc1c(Nc2ncc(Cl)c(-c3cnc4ccccn34)n2)cnn1C1CCNCC1		CHEMBL3822543	=	IC50	nM	392.0	CHEMBL301	Homo sapiens	IC50	uM	0.392
	16636602	CHEMBL3825084	Inhibition of CDK2 (unknown origin)	B	CC(=O)N1CCC(n2nc(C)c(Nc3ncc(Cl)c(-c4cnc5ccccn45)n3)c2C)CC1		CHEMBL3823929	=	IC50	nM	1680.0	CHEMBL301	Homo sapiens	IC50	uM	1.68
	16636603	CHEMBL3825084	Inhibition of CDK2 (unknown origin)	B	COc1nn(C2CCN(C(C)=O)CC2)cc1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1		CHEMBL3823522	=	IC50	nM	361.0	CHEMBL301	Homo sapiens	IC50	uM	0.361
	16636604	CHEMBL3825084	Inhibition of CDK2 (unknown origin)	B	CC(=O)N1CCC(n2cc(Nc3ncc(Cl)c(-c4cnn5ccccc45)n3)c(C)n2)CC1		CHEMBL3822989	=	IC50	nM	63.0	CHEMBL301	Homo sapiens	IC50	uM	0.063
	16636605	CHEMBL3825084	Inhibition of CDK2 (unknown origin)	B	CC(=O)N1CCC(n2ncc(Nc3ncc(Cl)c(-c4cnn5ccccc45)n3)c2C)CC1		CHEMBL3823301	=	IC50	nM	254.0	CHEMBL301	Homo sapiens	IC50	uM	0.254
	16636606	CHEMBL3825084	Inhibition of CDK2 (unknown origin)	B	Cc1nn(C2CCNCC2)c(C)c1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1		CHEMBL3824296	=	IC50	nM	1520.0	CHEMBL301	Homo sapiens	IC50	uM	1.52
	16636607	CHEMBL3825084	Inhibition of CDK2 (unknown origin)	B	CC(=O)N1CCC(n2nc(C)c(Nc3ncc(Cl)c(-c4cnn5ccccc45)n3)c2C)CC1		CHEMBL3823914	=	IC50	nM	1380.0	CHEMBL301	Homo sapiens	IC50	uM	1.38
	16636608	CHEMBL3825084	Inhibition of CDK2 (unknown origin)	B	CCOc1nn(C2CCN(C(C)=O)CC2)cc1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1		CHEMBL3822943	=	IC50	nM	545.0	CHEMBL301	Homo sapiens	IC50	uM	0.545
	16636609	CHEMBL3825084	Inhibition of CDK2 (unknown origin)	B	CCc1nn(C2CCN(C(C)=O)CC2)cc1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1		CHEMBL3822619	=	IC50	nM	113.0	CHEMBL301	Homo sapiens	IC50	uM	0.113
	16636610	CHEMBL3825084	Inhibition of CDK2 (unknown origin)	B	CCc1c(Nc2ncc(Cl)c(-c3cnn4ccccc34)n2)cnn1C1CCN(C(C)=O)CC1		CHEMBL3822962	=	IC50	nM	832.0	CHEMBL301	Homo sapiens	IC50	uM	0.832
	16636611	CHEMBL3825084	Inhibition of CDK2 (unknown origin)	B	Cc1nn(C2CCN(C(=O)[C@@H](C)O)CC2)c(C)c1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1		CHEMBL3823030	=	IC50	nM	700.0	CHEMBL301	Homo sapiens	IC50	uM	0.7
	16737070	CHEMBL3856528	Binding affinity to full length human CDK2 (1 to 298 residues) expressed in bacterial expression system by KINOMEscan competition assay	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnc2ccc(Br)cn12		CHEMBL393525	=	Kd	nM	540.0	CHEMBL301	Homo sapiens	Kd	nM	540.0
	16737071	CHEMBL3856528	Binding affinity to full length human CDK2 (1 to 298 residues) expressed in bacterial expression system by KINOMEscan competition assay	B	COc1ccccc1-c1cc(Nc2ccc(F)c(NS(C)(=O)=O)c2)ncn1		CHEMBL3895785	>	Ki	nM	1000.0	CHEMBL301	Homo sapiens	Ki	nM	1000.0
	16737084	CHEMBL3856516	Inhibition of recombinant CDK2 (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotinylated Histone H1 as substrate after 1 hr in presence of 33P-ATP by liquid scintillation counting analysis	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	=	IC50	nM	1.0	CHEMBL301	Homo sapiens	IC50	nmol/L	1.0
	16737151	CHEMBL3856547	Inhibition of CDK2 (unknown origin)	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	=	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	nM	3.0
	16737152	CHEMBL3856547	Inhibition of CDK2 (unknown origin)	B	Cc1c(-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)sc(=O)n1C		CHEMBL3932121	=	Ki	nM	149.0	CHEMBL301	Homo sapiens	Ki	nM	149.0
	16737153	CHEMBL3856547	Inhibition of CDK2 (unknown origin)	B	Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL298445	=	Ki	nM	2.0	CHEMBL301	Homo sapiens	Ki	nM	2.0
	16743312	CHEMBL3858028	Inhibition of GST-tagged human recombinant CDK2 assessed as residual activity at 2 uM using Ser/Thr12 peptide as substrate by Z' LYTE assay relative to control	B	O=C1N/C(=N/c2ccccc2)S/C1=C\c1ccc(O)cc1		CHEMBL3968891	=	Activity	%	69.63	CHEMBL301	Homo sapiens	Activity	%	69.63
	16743313	CHEMBL3858028	Inhibition of GST-tagged human recombinant CDK2 assessed as residual activity at 2 uM using Ser/Thr12 peptide as substrate by Z' LYTE assay relative to control	B	O=C1N/C(=N/c2ccccc2)S/C1=C\c1ccc(F)cc1		CHEMBL3969996	=	Activity	%	68.93	CHEMBL301	Homo sapiens	Activity	%	68.93
	16743314	CHEMBL3858028	Inhibition of GST-tagged human recombinant CDK2 assessed as residual activity at 2 uM using Ser/Thr12 peptide as substrate by Z' LYTE assay relative to control	B	O=C1N/C(=N/Cc2ccccc2)S/C1=C\c1ccc(Cl)c([N+](=O)[O-])c1		CHEMBL3940448	=	Activity	%	68.4	CHEMBL301	Homo sapiens	Activity	%	68.4
	16743315	CHEMBL3858028	Inhibition of GST-tagged human recombinant CDK2 assessed as residual activity at 2 uM using Ser/Thr12 peptide as substrate by Z' LYTE assay relative to control	B	O=C1N=C(NCc2ccccc2)S/C1=C\c1ccc(O)cc1		CHEMBL2206750	=	Activity	%	63.23	CHEMBL301	Homo sapiens	Activity	%	63.23
	16743316	CHEMBL3858028	Inhibition of GST-tagged human recombinant CDK2 assessed as residual activity at 2 uM using Ser/Thr12 peptide as substrate by Z' LYTE assay relative to control	B	COc1ccc(/C=C2\S/C(=N\Cc3ccccc3)NC2=O)cc1[N+](=O)[O-]		CHEMBL3949218	=	Activity	%	73.01	CHEMBL301	Homo sapiens	Activity	%	73.01
	16743317	CHEMBL3858028	Inhibition of GST-tagged human recombinant CDK2 assessed as residual activity at 2 uM using Ser/Thr12 peptide as substrate by Z' LYTE assay relative to control	B	CCOc1cc(/C=C2\S/C(=N\Cc3ccccc3)NC2=O)ccc1O		CHEMBL3950215	=	Activity	%	39.1	CHEMBL301	Homo sapiens	Activity	%	39.1
	16743318	CHEMBL3858028	Inhibition of GST-tagged human recombinant CDK2 assessed as residual activity at 2 uM using Ser/Thr12 peptide as substrate by Z' LYTE assay relative to control	B	COc1ccc(/C=C2\S/C(=N\Cc3ccccc3)NC2=O)cc1OC		CHEMBL3922494	=	Activity	%	53.83	CHEMBL301	Homo sapiens	Activity	%	53.83
	16786966	CHEMBL3866487	Inhibition of CDK2 (unknown origin)	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Br)cc32)cc1		CHEMBL411491	=	IC50	nM	60.0	CHEMBL301	Homo sapiens	IC50	nM	60.0
	16815452	CHEMBL3871613	Inhibition of CDK2 (unknown origin) at 1 uM	B	O=C(O)/C=C\C(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccccc4)cc23)c1		CHEMBL3986609	=	Inhibition	%	17.0	CHEMBL301	Homo sapiens	INH	%	17.0
	16837391	CHEMBL3876049	Inhibition of CDK2 (unknown origin)	B	CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884319	=	IC50	nM	605.0	CHEMBL301	Homo sapiens	IC50	nM	605.0
	16844138	CHEMBL3877184	Inhibition of CDK2 (unknown origin)	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	=	IC50	nM	1.0	CHEMBL301	Homo sapiens	IC50	nM	1.0
11305	17601219	CHEMBL3705313	Kinase Assay: Kinase assay using either CDK1, CDK2 or VEGFR-2.	B	CS(=N)(=O)c1ccc(Nc2ncc(Br)c(Nc3ccccc3)n2)cc1		CHEMBL3940661	=	IC50	nM	33.0	CHEMBL301	Homo sapiens	IC50	nM	33.0
12927	17601254	CHEMBL3705461	Kinase Assay: CDK2/CycE (50 mg/measuring point) was incubated for 10 min at 22 C. in the presence of different concentrations of test substances (0 uM, and within the range 0.001-10 uM) in assay buffer [50 mM Tris/HCl pH 8.0; 10 mM MgCl2; 0.1 mM Na ortho-vanadate; 1.0 mM dithiothreitol; 0.5 uM adenosine trisphosphate (ATP); 10 ug/measuring point histone IIIS; 0.2 uCi/measuring point 33P-gamma ATP; 0.05% NP40; 1.25% dimethyl sulphoxide]. The reaction was stopped by adding EDTA solution (250 mM; pH 8.0; 15 ul/measuring point).From each reaction mixture, 15 ul were applied to P30 filter strips (Wallac), and unincorporated 33P-ATP was removed by washing the filter strips three times, for 10 min in each case, in 0.5% phosphoric acid. After drying the filter strips for 1 hour at 70 C., the filter strips were covered with scintillator strips (MeltiLex A, Wallac) and stoved for 1 hour at 90 C. The amount of incorporated 33P (substrate phosphorylation) was determined.	B	C[C@@H](O)[C@@H](C)Oc1nc(Nc2ccc(S(=O)(=O)C3CC3)cc2)ncc1C(F)(F)F		CHEMBL3644032	=	IC50	nM	6.0	CHEMBL301	Homo sapiens	IC50	nM	6.0
12939	17601258	CHEMBL3705461	Kinase Assay: CDK2/CycE (50 mg/measuring point) was incubated for 10 min at 22 C. in the presence of different concentrations of test substances (0 uM, and within the range 0.001-10 uM) in assay buffer [50 mM Tris/HCl pH 8.0; 10 mM MgCl2; 0.1 mM Na ortho-vanadate; 1.0 mM dithiothreitol; 0.5 uM adenosine trisphosphate (ATP); 10 ug/measuring point histone IIIS; 0.2 uCi/measuring point 33P-gamma ATP; 0.05% NP40; 1.25% dimethyl sulphoxide]. The reaction was stopped by adding EDTA solution (250 mM; pH 8.0; 15 ul/measuring point).From each reaction mixture, 15 ul were applied to P30 filter strips (Wallac), and unincorporated 33P-ATP was removed by washing the filter strips three times, for 10 min in each case, in 0.5% phosphoric acid. After drying the filter strips for 1 hour at 70 C., the filter strips were covered with scintillator strips (MeltiLex A, Wallac) and stoved for 1 hour at 90 C. The amount of incorporated 33P (substrate phosphorylation) was determined.	B	C[C@@H](O)[C@@H](C)Oc1nc(Nc2ccc(S(C)(=O)=O)cc2)ncc1C(F)(F)F		CHEMBL3644033	=	IC50	nM	4.0	CHEMBL301	Homo sapiens	IC50	nM	4.0
12980	17601262	CHEMBL3705461	Kinase Assay: CDK2/CycE (50 mg/measuring point) was incubated for 10 min at 22 C. in the presence of different concentrations of test substances (0 uM, and within the range 0.001-10 uM) in assay buffer [50 mM Tris/HCl pH 8.0; 10 mM MgCl2; 0.1 mM Na ortho-vanadate; 1.0 mM dithiothreitol; 0.5 uM adenosine trisphosphate (ATP); 10 ug/measuring point histone IIIS; 0.2 uCi/measuring point 33P-gamma ATP; 0.05% NP40; 1.25% dimethyl sulphoxide]. The reaction was stopped by adding EDTA solution (250 mM; pH 8.0; 15 ul/measuring point).From each reaction mixture, 15 ul were applied to P30 filter strips (Wallac), and unincorporated 33P-ATP was removed by washing the filter strips three times, for 10 min in each case, in 0.5% phosphoric acid. After drying the filter strips for 1 hour at 70 C., the filter strips were covered with scintillator strips (MeltiLex A, Wallac) and stoved for 1 hour at 90 C. The amount of incorporated 33P (substrate phosphorylation) was determined.	B	C[C@@H](Oc1nc(Nc2ccc(S(C)(=O)=O)cc2)ncc1C(F)(F)F)C(C)(C)O		CHEMBL3644034	=	IC50	nM	8.0	CHEMBL301	Homo sapiens	IC50	nM	8.0
221987	17610895	CHEMBL3887049	HTS Assay: The GSK3beta primary screen was conducted in assay ready 1536 plates (Aurora 29847) that contain 2.5 mL/well of 10 mM compound. Human GSK3beta as a GST fusion expressed in baculoviral system was purchased from BPS Bioscience (San Diego, Calif.). The GSK3beta peptide substrate was from American Peptide (Sunnyvale, Calif.; Cat 311153). 1 L/well of CABPE (22.5 nM GSK3beta , 8 uM peptide in AB buffer (12.5 mM DTT, 0.25 mg/mL BSA, 0.5 unit/mL Heparin)), 0.5 L/well of 125 uM of ATP, and 1 L/well of positive control 50 uM of GW8510 (positive control) or AB (DMSO only neutral control) in respective wells according to plate design using BioRAPTR (Beckman, Brea, Calif.). Reactions were incubated at room temperature for 60 minutes. 2.5 uL/well of ADP-Glo (Promega, V9103) was added with BioRAPTR, and incubated at room temperature for 40 minutes followed by addition of 5 uL/well of ADP-Glo detection reagent (Promega, V9103) with Combi nL (Thermo, Waltham, Mass.).	B	Cc1nccc(-c2ccc(C(=O)N3CCOCC3)c(Cl)c2)c1C#Cc1ccc(N)nc1		CHEMBL3701062	=	IC50	nM	1500.0	CHEMBL301	Homo sapiens	IC50	nM	1500.0
222108	17610990	CHEMBL3887049	HTS Assay: The GSK3beta primary screen was conducted in assay ready 1536 plates (Aurora 29847) that contain 2.5 mL/well of 10 mM compound. Human GSK3beta as a GST fusion expressed in baculoviral system was purchased from BPS Bioscience (San Diego, Calif.). The GSK3beta peptide substrate was from American Peptide (Sunnyvale, Calif.; Cat 311153). 1 L/well of CABPE (22.5 nM GSK3beta , 8 uM peptide in AB buffer (12.5 mM DTT, 0.25 mg/mL BSA, 0.5 unit/mL Heparin)), 0.5 L/well of 125 uM of ATP, and 1 L/well of positive control 50 uM of GW8510 (positive control) or AB (DMSO only neutral control) in respective wells according to plate design using BioRAPTR (Beckman, Brea, Calif.). Reactions were incubated at room temperature for 60 minutes. 2.5 uL/well of ADP-Glo (Promega, V9103) was added with BioRAPTR, and incubated at room temperature for 40 minutes followed by addition of 5 uL/well of ADP-Glo detection reagent (Promega, V9103) with Combi nL (Thermo, Waltham, Mass.).	B	Cc1nccc(-c2ccc(C(=O)N(C)C)c(Cl)c2)c1C#Cc1ccc(N)nc1		CHEMBL3701063	=	IC50	nM	3900.0	CHEMBL301	Homo sapiens	IC50	nM	3900.0
222321	17610991	CHEMBL3887050	HTS Assay: The GSK3beta primary screen was conducted in assay ready 1536 plates (Aurora 29847) that contain 2.5 mL/well of 10 mM compound. Human GSK3beta as a GST fusion expressed in baculoviral system was purchased from BPS Bioscience (San Diego, Calif.). The GSK3beta peptide substrate was from American Peptide (Sunnyvale, Calif.; Cat 311153). 1 L/well of CABPE (22.5 nM GSK3beta , 8 uM peptide in AB buffer (12.5 mM DTT, 0.25 mg/mL BSA, 0.5 unit/mL Heparin)), 0.5 L/well of 125 uM of ATP, and 1 L/well of positive control 50 uM of GW8510 (positive control) or AB (DMSO only neutral control) in respective wells according to plate design using BioRAPTR (Beckman, Brea, Calif.). Reactions were incubated at room temperature for 60 minutes. 2.5 uL/well of ADP-Glo (Promega, V9103) was added with BioRAPTR, and incubated at room temperature for 40 minutes followed by addition of 5 uL/well of ADP-Glo detection reagent (Promega, V9103) with Combi nL (Thermo, Waltham, Mass.).	B	Cc1nccc(-c2ccc(C(=O)N3CCOCC3)c(Cl)c2)c1C#Cc1ccc(N)nc1		CHEMBL3701062	=	IC50	nM	2200.0	CHEMBL301	Homo sapiens	IC50	nM	2200.0
222322	17610992	CHEMBL3887050	HTS Assay: The GSK3beta primary screen was conducted in assay ready 1536 plates (Aurora 29847) that contain 2.5 mL/well of 10 mM compound. Human GSK3beta as a GST fusion expressed in baculoviral system was purchased from BPS Bioscience (San Diego, Calif.). The GSK3beta peptide substrate was from American Peptide (Sunnyvale, Calif.; Cat 311153). 1 L/well of CABPE (22.5 nM GSK3beta , 8 uM peptide in AB buffer (12.5 mM DTT, 0.25 mg/mL BSA, 0.5 unit/mL Heparin)), 0.5 L/well of 125 uM of ATP, and 1 L/well of positive control 50 uM of GW8510 (positive control) or AB (DMSO only neutral control) in respective wells according to plate design using BioRAPTR (Beckman, Brea, Calif.). Reactions were incubated at room temperature for 60 minutes. 2.5 uL/well of ADP-Glo (Promega, V9103) was added with BioRAPTR, and incubated at room temperature for 40 minutes followed by addition of 5 uL/well of ADP-Glo detection reagent (Promega, V9103) with Combi nL (Thermo, Waltham, Mass.).	B	Cc1nccc(-c2ccc(C(=O)N(C)C)c(Cl)c2)c1C#Cc1ccc(N)nc1		CHEMBL3701063	=	IC50	nM	4400.0	CHEMBL301	Homo sapiens	IC50	nM	4400.0
224866	17613387	CHEMBL3705130	In Vitro Kinase Assay: CDK2 kinase assays (either cyclin A or cyclin E-dependent) were performed in low protein binding 96-well plates (Corning Inc., Corning, N.Y.).	B	Brc1cnn2c(NCc3ccncc3)cc(-c3ccccc3)nc12		CHEMBL401377	=	IC50	nM	20.0	CHEMBL301	Homo sapiens	IC50	nM	20.0
224867	17613388	CHEMBL3705130	In Vitro Kinase Assay: CDK2 kinase assays (either cyclin A or cyclin E-dependent) were performed in low protein binding 96-well plates (Corning Inc., Corning, N.Y.).	B	Brc1cnn2c(NCc3ccncc3)cc(-c3ccccc3)nc12		CHEMBL401377	=	IC50	nM	29.0	CHEMBL301	Homo sapiens	IC50	nM	29.0
224868	17613389	CHEMBL3705130	In Vitro Kinase Assay: CDK2 kinase assays (either cyclin A or cyclin E-dependent) were performed in low protein binding 96-well plates (Corning Inc., Corning, N.Y.).	B	Fc1ccccc1-c1cc(NCc2ccncc2)n2ncc(Br)c2n1		CHEMBL3642646	=	IC50	nM	32.0	CHEMBL301	Homo sapiens	IC50	nM	32.0
224869	17613390	CHEMBL3705130	In Vitro Kinase Assay: CDK2 kinase assays (either cyclin A or cyclin E-dependent) were performed in low protein binding 96-well plates (Corning Inc., Corning, N.Y.).	B	Fc1ccccc1-c1cc(NCc2ccncc2)n2ncc(Br)c2n1		CHEMBL3642646	=	IC50	nM	24.0	CHEMBL301	Homo sapiens	IC50	nM	24.0
224870	17613391	CHEMBL3705130	In Vitro Kinase Assay: CDK2 kinase assays (either cyclin A or cyclin E-dependent) were performed in low protein binding 96-well plates (Corning Inc., Corning, N.Y.).	B	Fc1ccccc1-c1cc(NCc2cccnc2)n2ncc(Br)c2n1		CHEMBL3642647	=	IC50	nM	11.0	CHEMBL301	Homo sapiens	IC50	nM	11.0
224871	17613392	CHEMBL3705130	In Vitro Kinase Assay: CDK2 kinase assays (either cyclin A or cyclin E-dependent) were performed in low protein binding 96-well plates (Corning Inc., Corning, N.Y.).	B	Fc1ccccc1-c1cc(NCc2cccnc2)n2ncc(Cl)c2n1		CHEMBL3642648	=	IC50	nM	21.0	CHEMBL301	Homo sapiens	IC50	nM	21.0
224872	17613393	CHEMBL3705130	In Vitro Kinase Assay: CDK2 kinase assays (either cyclin A or cyclin E-dependent) were performed in low protein binding 96-well plates (Corning Inc., Corning, N.Y.).	B	Clc1ccccc1-c1cc(NCc2cccnc2)n2ncc(Br)c2n1		CHEMBL401303	=	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	nM	3.0
224873	17613394	CHEMBL3705130	In Vitro Kinase Assay: CDK2 kinase assays (either cyclin A or cyclin E-dependent) were performed in low protein binding 96-well plates (Corning Inc., Corning, N.Y.).	B	Fc1ccccc1-c1cc(NCc2ccncc2)n2ncc(Cl)c2n1		CHEMBL3642649	=	IC50	nM	64.0	CHEMBL301	Homo sapiens	IC50	nM	64.0
224874	17613395	CHEMBL3705130	In Vitro Kinase Assay: CDK2 kinase assays (either cyclin A or cyclin E-dependent) were performed in low protein binding 96-well plates (Corning Inc., Corning, N.Y.).	B	Fc1ccccc1-c1cc(NCc2ccncc2)n2ncc(Cl)c2n1		CHEMBL3642649	=	IC50	nM	29.0	CHEMBL301	Homo sapiens	IC50	nM	29.0
224875	17613396	CHEMBL3705130	In Vitro Kinase Assay: CDK2 kinase assays (either cyclin A or cyclin E-dependent) were performed in low protein binding 96-well plates (Corning Inc., Corning, N.Y.).	B	Clc1ccccc1-c1cc(NCc2ccncc2)n2ncc(Br)c2n1		CHEMBL3642650	=	IC50	nM	10.0	CHEMBL301	Homo sapiens	IC50	nM	10.0
224876	17613397	CHEMBL3705130	In Vitro Kinase Assay: CDK2 kinase assays (either cyclin A or cyclin E-dependent) were performed in low protein binding 96-well plates (Corning Inc., Corning, N.Y.).	B	Clc1ccccc1-c1cc(NCc2ccncc2)n2ncc(Br)c2n1		CHEMBL3642650	=	IC50	nM	6.0	CHEMBL301	Homo sapiens	IC50	nM	6.0
224877	17613398	CHEMBL3705130	In Vitro Kinase Assay: CDK2 kinase assays (either cyclin A or cyclin E-dependent) were performed in low protein binding 96-well plates (Corning Inc., Corning, N.Y.).	B	CC(C)c1cc(NCc2ccncc2)n2ncc(Br)c2n1		CHEMBL3642651	=	IC50	nM	42.0	CHEMBL301	Homo sapiens	IC50	nM	42.0
224878	17613399	CHEMBL3705130	In Vitro Kinase Assay: CDK2 kinase assays (either cyclin A or cyclin E-dependent) were performed in low protein binding 96-well plates (Corning Inc., Corning, N.Y.).	B	CC(C)(C)c1cc(NCc2ccncc2)n2ncc(Br)c2n1		CHEMBL3642652	=	IC50	nM	170.0	CHEMBL301	Homo sapiens	IC50	nM	170.0
224879	17613400	CHEMBL3705130	In Vitro Kinase Assay: CDK2 kinase assays (either cyclin A or cyclin E-dependent) were performed in low protein binding 96-well plates (Corning Inc., Corning, N.Y.).	B	N#Cc1cnn2c(NCc3ccncc3)cc(-c3ccccc3)nc12		CHEMBL3642653	=	IC50	nM	620.0	CHEMBL301	Homo sapiens	IC50	nM	620.0
224880	17613401	CHEMBL3705130	In Vitro Kinase Assay: CDK2 kinase assays (either cyclin A or cyclin E-dependent) were performed in low protein binding 96-well plates (Corning Inc., Corning, N.Y.).	B	CN1CCN(c2cc(NCc3cccnc3)n3nccc3n2)CC1		CHEMBL3642654	=	IC50	nM	5600.0	CHEMBL301	Homo sapiens	IC50	nM	5600.0
224881	17613402	CHEMBL3705130	In Vitro Kinase Assay: CDK2 kinase assays (either cyclin A or cyclin E-dependent) were performed in low protein binding 96-well plates (Corning Inc., Corning, N.Y.).	B	CN1CCN(c2cc(NCc3cccnc3)n3ncc(Br)c3n2)CC1		CHEMBL3642655	=	IC50	nM	140.0	CHEMBL301	Homo sapiens	IC50	nM	140.0
260741	17643269	CHEMBL3705461	Kinase Assay: CDK2/CycE (50 mg/measuring point) was incubated for 10 min at 22 C. in the presence of different concentrations of test substances (0 uM, and within the range 0.001-10 uM) in assay buffer [50 mM Tris/HCl pH 8.0; 10 mM MgCl2; 0.1 mM Na ortho-vanadate; 1.0 mM dithiothreitol; 0.5 uM adenosine trisphosphate (ATP); 10 ug/measuring point histone IIIS; 0.2 uCi/measuring point 33P-gamma ATP; 0.05% NP40; 1.25% dimethyl sulphoxide]. The reaction was stopped by adding EDTA solution (250 mM; pH 8.0; 15 ul/measuring point).From each reaction mixture, 15 ul were applied to P30 filter strips (Wallac), and unincorporated 33P-ATP was removed by washing the filter strips three times, for 10 min in each case, in 0.5% phosphoric acid. After drying the filter strips for 1 hour at 70 C., the filter strips were covered with scintillator strips (MeltiLex A, Wallac) and stoved for 1 hour at 90 C. The amount of incorporated 33P (substrate phosphorylation) was determined.	B	C[C@@H](O)[C@@H](C)Oc1nc(Nc2ccc(S(=O)(=O)C3CC3)cc2)ncc1C(F)(F)F		CHEMBL3644032	=	IC50	nM	16.0	CHEMBL301	Homo sapiens	IC50	nM	16.0
260742	17643270	CHEMBL3705461	Kinase Assay: CDK2/CycE (50 mg/measuring point) was incubated for 10 min at 22 C. in the presence of different concentrations of test substances (0 uM, and within the range 0.001-10 uM) in assay buffer [50 mM Tris/HCl pH 8.0; 10 mM MgCl2; 0.1 mM Na ortho-vanadate; 1.0 mM dithiothreitol; 0.5 uM adenosine trisphosphate (ATP); 10 ug/measuring point histone IIIS; 0.2 uCi/measuring point 33P-gamma ATP; 0.05% NP40; 1.25% dimethyl sulphoxide]. The reaction was stopped by adding EDTA solution (250 mM; pH 8.0; 15 ul/measuring point).From each reaction mixture, 15 ul were applied to P30 filter strips (Wallac), and unincorporated 33P-ATP was removed by washing the filter strips three times, for 10 min in each case, in 0.5% phosphoric acid. After drying the filter strips for 1 hour at 70 C., the filter strips were covered with scintillator strips (MeltiLex A, Wallac) and stoved for 1 hour at 90 C. The amount of incorporated 33P (substrate phosphorylation) was determined.	B	C[C@@H](O)[C@@H](C)Oc1nc(Nc2ccc(S(C)(=O)=O)cc2)ncc1C(F)(F)F		CHEMBL3644033	=	IC50	nM	8.0	CHEMBL301	Homo sapiens	IC50	nM	8.0
260743	17643271	CHEMBL3705461	Kinase Assay: CDK2/CycE (50 mg/measuring point) was incubated for 10 min at 22 C. in the presence of different concentrations of test substances (0 uM, and within the range 0.001-10 uM) in assay buffer [50 mM Tris/HCl pH 8.0; 10 mM MgCl2; 0.1 mM Na ortho-vanadate; 1.0 mM dithiothreitol; 0.5 uM adenosine trisphosphate (ATP); 10 ug/measuring point histone IIIS; 0.2 uCi/measuring point 33P-gamma ATP; 0.05% NP40; 1.25% dimethyl sulphoxide]. The reaction was stopped by adding EDTA solution (250 mM; pH 8.0; 15 ul/measuring point).From each reaction mixture, 15 ul were applied to P30 filter strips (Wallac), and unincorporated 33P-ATP was removed by washing the filter strips three times, for 10 min in each case, in 0.5% phosphoric acid. After drying the filter strips for 1 hour at 70 C., the filter strips were covered with scintillator strips (MeltiLex A, Wallac) and stoved for 1 hour at 90 C. The amount of incorporated 33P (substrate phosphorylation) was determined.	B	C[C@@H](Oc1nc(Nc2ccc(S(C)(=O)=O)cc2)ncc1C(F)(F)F)C(C)(C)O		CHEMBL3644034	=	IC50	nM	12.0	CHEMBL301	Homo sapiens	IC50	nM	12.0
260744	17643272	CHEMBL3705461	Kinase Assay: CDK2/CycE (50 mg/measuring point) was incubated for 10 min at 22 C. in the presence of different concentrations of test substances (0 uM, and within the range 0.001-10 uM) in assay buffer [50 mM Tris/HCl pH 8.0; 10 mM MgCl2; 0.1 mM Na ortho-vanadate; 1.0 mM dithiothreitol; 0.5 uM adenosine trisphosphate (ATP); 10 ug/measuring point histone IIIS; 0.2 uCi/measuring point 33P-gamma ATP; 0.05% NP40; 1.25% dimethyl sulphoxide]. The reaction was stopped by adding EDTA solution (250 mM; pH 8.0; 15 ul/measuring point).From each reaction mixture, 15 ul were applied to P30 filter strips (Wallac), and unincorporated 33P-ATP was removed by washing the filter strips three times, for 10 min in each case, in 0.5% phosphoric acid. After drying the filter strips for 1 hour at 70 C., the filter strips were covered with scintillator strips (MeltiLex A, Wallac) and stoved for 1 hour at 90 C. The amount of incorporated 33P (substrate phosphorylation) was determined.	B	C[C@@H](Oc1nc(Nc2ccc(S(=O)(=O)C3CC3)cc2)ncc1C(F)(F)F)C(C)(C)O		CHEMBL3644019	=	IC50	nM	21.0	CHEMBL301	Homo sapiens	IC50	nM	21.0
260745	17643273	CHEMBL3705461	Kinase Assay: CDK2/CycE (50 mg/measuring point) was incubated for 10 min at 22 C. in the presence of different concentrations of test substances (0 uM, and within the range 0.001-10 uM) in assay buffer [50 mM Tris/HCl pH 8.0; 10 mM MgCl2; 0.1 mM Na ortho-vanadate; 1.0 mM dithiothreitol; 0.5 uM adenosine trisphosphate (ATP); 10 ug/measuring point histone IIIS; 0.2 uCi/measuring point 33P-gamma ATP; 0.05% NP40; 1.25% dimethyl sulphoxide]. The reaction was stopped by adding EDTA solution (250 mM; pH 8.0; 15 ul/measuring point).From each reaction mixture, 15 ul were applied to P30 filter strips (Wallac), and unincorporated 33P-ATP was removed by washing the filter strips three times, for 10 min in each case, in 0.5% phosphoric acid. After drying the filter strips for 1 hour at 70 C., the filter strips were covered with scintillator strips (MeltiLex A, Wallac) and stoved for 1 hour at 90 C. The amount of incorporated 33P (substrate phosphorylation) was determined.	B	C[C@@H](O)[C@@H](C)Oc1nc(Nc2ccc(S(=O)(=O)c3ccccc3)cc2)ncc1C(F)(F)F		CHEMBL3644020	=	IC50	nM	36.0	CHEMBL301	Homo sapiens	IC50	nM	36.0
260746	17643274	CHEMBL3705461	Kinase Assay: CDK2/CycE (50 mg/measuring point) was incubated for 10 min at 22 C. in the presence of different concentrations of test substances (0 uM, and within the range 0.001-10 uM) in assay buffer [50 mM Tris/HCl pH 8.0; 10 mM MgCl2; 0.1 mM Na ortho-vanadate; 1.0 mM dithiothreitol; 0.5 uM adenosine trisphosphate (ATP); 10 ug/measuring point histone IIIS; 0.2 uCi/measuring point 33P-gamma ATP; 0.05% NP40; 1.25% dimethyl sulphoxide]. The reaction was stopped by adding EDTA solution (250 mM; pH 8.0; 15 ul/measuring point).From each reaction mixture, 15 ul were applied to P30 filter strips (Wallac), and unincorporated 33P-ATP was removed by washing the filter strips three times, for 10 min in each case, in 0.5% phosphoric acid. After drying the filter strips for 1 hour at 70 C., the filter strips were covered with scintillator strips (MeltiLex A, Wallac) and stoved for 1 hour at 90 C. The amount of incorporated 33P (substrate phosphorylation) was determined.	B	C[C@@H](O)[C@@H](C)Oc1nc(Nc2ccc(S(=O)(=O)C(F)F)cc2)ncc1C(F)(F)F		CHEMBL3644021	=	IC50	nM	12.0	CHEMBL301	Homo sapiens	IC50	nM	12.0
260747	17643275	CHEMBL3705461	Kinase Assay: CDK2/CycE (50 mg/measuring point) was incubated for 10 min at 22 C. in the presence of different concentrations of test substances (0 uM, and within the range 0.001-10 uM) in assay buffer [50 mM Tris/HCl pH 8.0; 10 mM MgCl2; 0.1 mM Na ortho-vanadate; 1.0 mM dithiothreitol; 0.5 uM adenosine trisphosphate (ATP); 10 ug/measuring point histone IIIS; 0.2 uCi/measuring point 33P-gamma ATP; 0.05% NP40; 1.25% dimethyl sulphoxide]. The reaction was stopped by adding EDTA solution (250 mM; pH 8.0; 15 ul/measuring point).From each reaction mixture, 15 ul were applied to P30 filter strips (Wallac), and unincorporated 33P-ATP was removed by washing the filter strips three times, for 10 min in each case, in 0.5% phosphoric acid. After drying the filter strips for 1 hour at 70 C., the filter strips were covered with scintillator strips (MeltiLex A, Wallac) and stoved for 1 hour at 90 C. The amount of incorporated 33P (substrate phosphorylation) was determined.	B	C[C@@H](O)[C@@H](C)Oc1nc(Nc2ccc(S(=O)(=O)C3CCCC3)cc2)ncc1C(F)(F)F		CHEMBL3644022	=	IC50	nM	21.0	CHEMBL301	Homo sapiens	IC50	nM	21.0
260748	17643276	CHEMBL3705461	Kinase Assay: CDK2/CycE (50 mg/measuring point) was incubated for 10 min at 22 C. in the presence of different concentrations of test substances (0 uM, and within the range 0.001-10 uM) in assay buffer [50 mM Tris/HCl pH 8.0; 10 mM MgCl2; 0.1 mM Na ortho-vanadate; 1.0 mM dithiothreitol; 0.5 uM adenosine trisphosphate (ATP); 10 ug/measuring point histone IIIS; 0.2 uCi/measuring point 33P-gamma ATP; 0.05% NP40; 1.25% dimethyl sulphoxide]. The reaction was stopped by adding EDTA solution (250 mM; pH 8.0; 15 ul/measuring point).From each reaction mixture, 15 ul were applied to P30 filter strips (Wallac), and unincorporated 33P-ATP was removed by washing the filter strips three times, for 10 min in each case, in 0.5% phosphoric acid. After drying the filter strips for 1 hour at 70 C., the filter strips were covered with scintillator strips (MeltiLex A, Wallac) and stoved for 1 hour at 90 C. The amount of incorporated 33P (substrate phosphorylation) was determined.	B	C=CCS(=O)(=O)c1ccc(Nc2ncc(C(F)(F)F)c(O[C@H](C)C(C)(C)O)n2)cc1		CHEMBL3644023	=	IC50	nM	11.0	CHEMBL301	Homo sapiens	IC50	nM	11.0
260749	17643277	CHEMBL3705461	Kinase Assay: CDK2/CycE (50 mg/measuring point) was incubated for 10 min at 22 C. in the presence of different concentrations of test substances (0 uM, and within the range 0.001-10 uM) in assay buffer [50 mM Tris/HCl pH 8.0; 10 mM MgCl2; 0.1 mM Na ortho-vanadate; 1.0 mM dithiothreitol; 0.5 uM adenosine trisphosphate (ATP); 10 ug/measuring point histone IIIS; 0.2 uCi/measuring point 33P-gamma ATP; 0.05% NP40; 1.25% dimethyl sulphoxide]. The reaction was stopped by adding EDTA solution (250 mM; pH 8.0; 15 ul/measuring point).From each reaction mixture, 15 ul were applied to P30 filter strips (Wallac), and unincorporated 33P-ATP was removed by washing the filter strips three times, for 10 min in each case, in 0.5% phosphoric acid. After drying the filter strips for 1 hour at 70 C., the filter strips were covered with scintillator strips (MeltiLex A, Wallac) and stoved for 1 hour at 90 C. The amount of incorporated 33P (substrate phosphorylation) was determined.	B	CC(C)S(=O)(=O)c1ccc(Nc2ncc(C(F)(F)F)c(O[C@H](C)[C@@H](C)O)n2)cc1		CHEMBL3644024	=	IC50	nM	6.0	CHEMBL301	Homo sapiens	IC50	nM	6.0
260750	17643278	CHEMBL3705461	Kinase Assay: CDK2/CycE (50 mg/measuring point) was incubated for 10 min at 22 C. in the presence of different concentrations of test substances (0 uM, and within the range 0.001-10 uM) in assay buffer [50 mM Tris/HCl pH 8.0; 10 mM MgCl2; 0.1 mM Na ortho-vanadate; 1.0 mM dithiothreitol; 0.5 uM adenosine trisphosphate (ATP); 10 ug/measuring point histone IIIS; 0.2 uCi/measuring point 33P-gamma ATP; 0.05% NP40; 1.25% dimethyl sulphoxide]. The reaction was stopped by adding EDTA solution (250 mM; pH 8.0; 15 ul/measuring point).From each reaction mixture, 15 ul were applied to P30 filter strips (Wallac), and unincorporated 33P-ATP was removed by washing the filter strips three times, for 10 min in each case, in 0.5% phosphoric acid. After drying the filter strips for 1 hour at 70 C., the filter strips were covered with scintillator strips (MeltiLex A, Wallac) and stoved for 1 hour at 90 C. The amount of incorporated 33P (substrate phosphorylation) was determined.	B	C#CCS(=O)(=O)c1ccc(Nc2ncc(C(F)(F)F)c(O[C@H](C)C(C)(C)O)n2)cc1		CHEMBL3644025	=	IC50	nM	43.0	CHEMBL301	Homo sapiens	IC50	nM	43.0
260751	17643279	CHEMBL3705461	Kinase Assay: CDK2/CycE (50 mg/measuring point) was incubated for 10 min at 22 C. in the presence of different concentrations of test substances (0 uM, and within the range 0.001-10 uM) in assay buffer [50 mM Tris/HCl pH 8.0; 10 mM MgCl2; 0.1 mM Na ortho-vanadate; 1.0 mM dithiothreitol; 0.5 uM adenosine trisphosphate (ATP); 10 ug/measuring point histone IIIS; 0.2 uCi/measuring point 33P-gamma ATP; 0.05% NP40; 1.25% dimethyl sulphoxide]. The reaction was stopped by adding EDTA solution (250 mM; pH 8.0; 15 ul/measuring point).From each reaction mixture, 15 ul were applied to P30 filter strips (Wallac), and unincorporated 33P-ATP was removed by washing the filter strips three times, for 10 min in each case, in 0.5% phosphoric acid. After drying the filter strips for 1 hour at 70 C., the filter strips were covered with scintillator strips (MeltiLex A, Wallac) and stoved for 1 hour at 90 C. The amount of incorporated 33P (substrate phosphorylation) was determined.	B	C[C@@H](O)[C@@H](C)Oc1nc(Nc2ccc(S(=O)(=O)CCO)cc2)ncc1C(F)(F)F		CHEMBL3644026	=	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	nM	3.0
260752	17643280	CHEMBL3705461	Kinase Assay: CDK2/CycE (50 mg/measuring point) was incubated for 10 min at 22 C. in the presence of different concentrations of test substances (0 uM, and within the range 0.001-10 uM) in assay buffer [50 mM Tris/HCl pH 8.0; 10 mM MgCl2; 0.1 mM Na ortho-vanadate; 1.0 mM dithiothreitol; 0.5 uM adenosine trisphosphate (ATP); 10 ug/measuring point histone IIIS; 0.2 uCi/measuring point 33P-gamma ATP; 0.05% NP40; 1.25% dimethyl sulphoxide]. The reaction was stopped by adding EDTA solution (250 mM; pH 8.0; 15 ul/measuring point).From each reaction mixture, 15 ul were applied to P30 filter strips (Wallac), and unincorporated 33P-ATP was removed by washing the filter strips three times, for 10 min in each case, in 0.5% phosphoric acid. After drying the filter strips for 1 hour at 70 C., the filter strips were covered with scintillator strips (MeltiLex A, Wallac) and stoved for 1 hour at 90 C. The amount of incorporated 33P (substrate phosphorylation) was determined.	B	COC[C@@H](C)Oc1nc(Nc2ccc(S(C)(=O)=O)cc2)ncc1C(F)(F)F		CHEMBL3644027	=	IC50	nM	12.0	CHEMBL301	Homo sapiens	IC50	nM	12.0
260753	17643281	CHEMBL3705461	Kinase Assay: CDK2/CycE (50 mg/measuring point) was incubated for 10 min at 22 C. in the presence of different concentrations of test substances (0 uM, and within the range 0.001-10 uM) in assay buffer [50 mM Tris/HCl pH 8.0; 10 mM MgCl2; 0.1 mM Na ortho-vanadate; 1.0 mM dithiothreitol; 0.5 uM adenosine trisphosphate (ATP); 10 ug/measuring point histone IIIS; 0.2 uCi/measuring point 33P-gamma ATP; 0.05% NP40; 1.25% dimethyl sulphoxide]. The reaction was stopped by adding EDTA solution (250 mM; pH 8.0; 15 ul/measuring point).From each reaction mixture, 15 ul were applied to P30 filter strips (Wallac), and unincorporated 33P-ATP was removed by washing the filter strips three times, for 10 min in each case, in 0.5% phosphoric acid. After drying the filter strips for 1 hour at 70 C., the filter strips were covered with scintillator strips (MeltiLex A, Wallac) and stoved for 1 hour at 90 C. The amount of incorporated 33P (substrate phosphorylation) was determined.	B	C#CCOc1nc(Nc2ccc(S(C)(=O)=O)cc2)ncc1C(F)(F)F		CHEMBL3644028	=	IC50	nM	25.0	CHEMBL301	Homo sapiens	IC50	nM	25.0
260754	17643282	CHEMBL3705461	Kinase Assay: CDK2/CycE (50 mg/measuring point) was incubated for 10 min at 22 C. in the presence of different concentrations of test substances (0 uM, and within the range 0.001-10 uM) in assay buffer [50 mM Tris/HCl pH 8.0; 10 mM MgCl2; 0.1 mM Na ortho-vanadate; 1.0 mM dithiothreitol; 0.5 uM adenosine trisphosphate (ATP); 10 ug/measuring point histone IIIS; 0.2 uCi/measuring point 33P-gamma ATP; 0.05% NP40; 1.25% dimethyl sulphoxide]. The reaction was stopped by adding EDTA solution (250 mM; pH 8.0; 15 ul/measuring point).From each reaction mixture, 15 ul were applied to P30 filter strips (Wallac), and unincorporated 33P-ATP was removed by washing the filter strips three times, for 10 min in each case, in 0.5% phosphoric acid. After drying the filter strips for 1 hour at 70 C., the filter strips were covered with scintillator strips (MeltiLex A, Wallac) and stoved for 1 hour at 90 C. The amount of incorporated 33P (substrate phosphorylation) was determined.	B	CS(=O)(=O)c1ccc(Nc2ncc(C(F)(F)F)c(OCCC(F)(F)F)n2)cc1		CHEMBL3644029	=	IC50	nM	94.0	CHEMBL301	Homo sapiens	IC50	nM	94.0
260755	17643283	CHEMBL3705461	Kinase Assay: CDK2/CycE (50 mg/measuring point) was incubated for 10 min at 22 C. in the presence of different concentrations of test substances (0 uM, and within the range 0.001-10 uM) in assay buffer [50 mM Tris/HCl pH 8.0; 10 mM MgCl2; 0.1 mM Na ortho-vanadate; 1.0 mM dithiothreitol; 0.5 uM adenosine trisphosphate (ATP); 10 ug/measuring point histone IIIS; 0.2 uCi/measuring point 33P-gamma ATP; 0.05% NP40; 1.25% dimethyl sulphoxide]. The reaction was stopped by adding EDTA solution (250 mM; pH 8.0; 15 ul/measuring point).From each reaction mixture, 15 ul were applied to P30 filter strips (Wallac), and unincorporated 33P-ATP was removed by washing the filter strips three times, for 10 min in each case, in 0.5% phosphoric acid. After drying the filter strips for 1 hour at 70 C., the filter strips were covered with scintillator strips (MeltiLex A, Wallac) and stoved for 1 hour at 90 C. The amount of incorporated 33P (substrate phosphorylation) was determined.	B	C=CCOc1nc(Nc2ccc(S(C)(=O)=O)cc2)ncc1C(F)(F)F		CHEMBL3644030	=	IC50	nM	49.0	CHEMBL301	Homo sapiens	IC50	nM	49.0
260756	17643284	CHEMBL3705461	Kinase Assay: CDK2/CycE (50 mg/measuring point) was incubated for 10 min at 22 C. in the presence of different concentrations of test substances (0 uM, and within the range 0.001-10 uM) in assay buffer [50 mM Tris/HCl pH 8.0; 10 mM MgCl2; 0.1 mM Na ortho-vanadate; 1.0 mM dithiothreitol; 0.5 uM adenosine trisphosphate (ATP); 10 ug/measuring point histone IIIS; 0.2 uCi/measuring point 33P-gamma ATP; 0.05% NP40; 1.25% dimethyl sulphoxide]. The reaction was stopped by adding EDTA solution (250 mM; pH 8.0; 15 ul/measuring point).From each reaction mixture, 15 ul were applied to P30 filter strips (Wallac), and unincorporated 33P-ATP was removed by washing the filter strips three times, for 10 min in each case, in 0.5% phosphoric acid. After drying the filter strips for 1 hour at 70 C., the filter strips were covered with scintillator strips (MeltiLex A, Wallac) and stoved for 1 hour at 90 C. The amount of incorporated 33P (substrate phosphorylation) was determined.	B	CS(=O)(=O)c1ccc(Nc2ncc(C(F)(F)F)c(OC3CCCCC3)n2)cc1		CHEMBL3644031	=	IC50	nM	480.0	CHEMBL301	Homo sapiens	IC50	nM	480.0
286672	17669017	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccccn3)nc2n1C1CCCC1		CHEMBL3654234	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286673	17669018	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286674	17669019	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CCN1CCN(c2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CC1		CHEMBL3658063	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286675	17669020	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCN(CCF)CC4)cn3)nc2n1C1CCCC1		CHEMBL3658071	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286676	17669021	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCN(CCO)CC4)cn3)nc2n1C1CCCC1		CHEMBL3654258	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286677	17669022	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	COCCN1CCN(c2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CC1		CHEMBL3654246	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286678	17669023	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CC(C)OCCN1CCN(c2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CC1		CHEMBL3658078	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286679	17669024	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCN(CCOCCO)CC4)cn3)nc2n1C1CCCC1		CHEMBL3658021	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286680	17669025	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	C[C@@H](O)CN1CCN(c2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CC1		CHEMBL3658044	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286681	17669026	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	C[C@H](O)CN1CCN(c2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CC1		CHEMBL3658043	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286682	17669027	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCN(CC(C)(C)O)CC4)cn3)nc2n1C1CCCC1		CHEMBL3658057	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286683	17669028	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCN(CCCO)CC4)cn3)nc2n1C1CCCC1		CHEMBL3654253	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286684	17669029	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCN(CC(O)CO)CC4)cn3)nc2n1C1CCCC1		CHEMBL3658031	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286685	17669030	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCN(C[C@@H](O)CO)CC4)cn3)nc2n1C1CCCC1		CHEMBL3658033	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286686	17669031	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCN(C[C@H](O)CO)CC4)cn3)nc2n1C1CCCC1		CHEMBL3654260	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286687	17669032	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCN(C5CCCC5)CC4)cn3)nc2n1C1CCCC1		CHEMBL3658064	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286688	17669033	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CC(C)N1CCN(c2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CC1		CHEMBL3658050	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286689	17669034	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CC(CO)N1CCN(c2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CC1		CHEMBL3658024	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286690	17669035	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	COC(=O)C(C)N1CCN(c2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CC1		CHEMBL3658082	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286691	17669036	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CC(C(=O)O)N1CCN(c2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CC1		CHEMBL3658083	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286692	17669037	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCN(CC5CCCCC5)CC4)cn3)nc2n1C1CCCC1		CHEMBL3658055	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286693	17669038	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CC(C)CN1CCN(c2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CC1		CHEMBL3658076	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286694	17669039	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CCC(C)CN1CCN(c2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CC1		CHEMBL3658080	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286695	17669040	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCN(C(=O)CC5CCCCC5)CC4)cn3)nc2n1C1CCCC1		CHEMBL3658074	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286696	17669041	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CC(C)CCCN1CCN(c2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CC1		CHEMBL3658054	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286697	17669042	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCN(CC(F)(F)F)CC4)cn3)nc2n1C1CCCC1		CHEMBL3654257	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286698	17669043	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCN(CC(N)=O)CC4)cn3)nc2n1C1CCCC1		CHEMBL3654241	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286699	17669044	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCN(CC#N)CC4)cn3)nc2n1C1CCCC1		CHEMBL3658069	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286700	17669045	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCN(CCC#N)CC4)cn3)nc2n1C1CCCC1		CHEMBL3654240	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286701	17669046	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CC(=O)N1CCN(c2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CC1		CHEMBL3654238	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286702	17669047	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCN(C(=O)C5CC5)CC4)cn3)nc2n1C1CCCC1		CHEMBL3654259	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286703	17669048	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCN(C(=O)C5CCCCC5)CC4)cn3)nc2n1C1CCCC1		CHEMBL3654255	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286704	17669049	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCN(C(=O)CC5CCCCC5)CC4)cn3)nc2n1C1CCCC1		CHEMBL3658074	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286705	17669050	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCN(C(=O)CCC5CCCC5)CC4)cn3)nc2n1C1CCCC1		CHEMBL3658075	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286706	17669051	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCN(C(=O)CN)CC4)cn3)nc2n1C1CCCC1		CHEMBL3654244	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286707	17669052	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)CC(=O)N1CCN(c2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CC1		CHEMBL3658073	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286708	17669053	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCN(C(=O)N5CCCC5)CC4)cn3)nc2n1C1CCCC1		CHEMBL3654254	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286709	17669054	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCN(C(=O)N5CCCCC5)CC4)cn3)nc2n1C1CCCC1		CHEMBL3658077	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286710	17669055	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCN(C(=O)N5CCOCC5)CC4)cn3)nc2n1C1CCCC1		CHEMBL3658025	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286711	17669056	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	C[C@@H]1CN(c2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CCN1C(=O)OC(C)(C)C		CHEMBL3654261	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286712	17669057	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	C[C@H]1CN(c2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CCN1C(=O)OC(C)(C)C		CHEMBL3654262	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286713	17669058	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CC1CN(c2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CCN1		CHEMBL3654251	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286714	17669059	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	C[C@@H]1CN(c2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CCN1		CHEMBL3654248	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286715	17669060	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	C[C@@H]1CN(c2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CCN1CCO		CHEMBL3658066	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286716	17669061	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	C[C@H]1CN(c2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CCN1		CHEMBL3654249	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286717	17669062	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	C[C@H]1CN(c2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CCN1CCO		CHEMBL3658067	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286718	17669063	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNC(C)(C)C4)cn3)nc2n1C1CCCC1		CHEMBL3658058	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286719	17669064	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CC1CN(c2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CC(C)N1		CHEMBL3654256	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286720	17669065	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNC(=O)C4)cn3)nc2n1C1CCCC1		CHEMBL3654236	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286721	17669066	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3654239	=	IC50	nM	8000.0	CHEMBL301	Homo sapiens	IC50	nM	8000.0
286722	17669067	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCC(N)C4)cn3)nc2n1C1CCCC1		CHEMBL3654245	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286723	17669068	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CC[C@H](O)C4)cn3)nc2n1C1CCCC1		CHEMBL3658026	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286724	17669069	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CC(O)C4)cn3)nc2n1C1CCCC1		CHEMBL3639531	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286725	17669070	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N(C)CCN)cn3)nc2n1C1CCCC1		CHEMBL3658046	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286726	17669071	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N(C)CCO)cn3)nc2n1C1CCCC1		CHEMBL3658068	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286727	17669072	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(CN4CC(O)C4)cn3)nc2n1C1CCCC1		CHEMBL3654242	=	IC50	nM	14000.0	CHEMBL301	Homo sapiens	IC50	nM	14000.0
286728	17669073	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(CN4CCN(S(C)(=O)=O)CC4)cn3)nc2n1C1CCCC1		CHEMBL3658022	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286729	17669074	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(CN4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3658029	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286730	17669075	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN1CCN(Cc2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CC1		CHEMBL3658030	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286731	17669076	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CC1CN(Cc2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CCN1		CHEMBL3658041	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286732	17669077	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	C[C@H]1CN(Cc2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CCN1		CHEMBL3658042	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286733	17669078	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(CN4CCN(C)C(=O)C4)cn3)nc2n1C1CCCC1		CHEMBL3658047	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286734	17669079	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CC(=O)N1CCN(Cc2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CC1		CHEMBL3658048	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286735	17669080	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CC(C)N1CCN(Cc2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CC1		CHEMBL3658049	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286736	17669081	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(CN4CCN(C(=O)CN)CC4)cn3)nc2n1C1CCCC1		CHEMBL3658051	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286737	17669082	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(CN4CC5CCC(C4)N5)cn3)nc2n1C1CCCC1		CHEMBL3658059	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286738	17669083	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	C[C@H]1CN(Cc2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)C[C@@H](C)N1		CHEMBL3658060	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286739	17669084	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(CN4CCC(O)CC4)cn3)nc2n1C1CCCC1		CHEMBL3658061	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286740	17669085	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	COCCN1CCN(Cc2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CC1		CHEMBL3658062	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286741	17669086	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(CN4CCN(CCO)CC4)cn3)nc2n1C1CCCC1		CHEMBL3658070	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286742	17669087	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	C[C@H](CO)NCc1ccc(Nc2ncc3cc(C(=O)N(C)C)n(C4CCCC4)c3n2)nc1		CHEMBL3658052	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286743	17669088	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(C(=O)NC4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3654235	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286744	17669089	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(C(=O)N(C)C4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3658040	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286745	17669090	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(C(=O)N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3658036	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286746	17669091	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(C(=O)N4CCN(CCO)CC4)cn3)nc2n1C1CCCC1		CHEMBL3658079	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286747	17669092	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(C(=O)N4CCC(N(C)C)CC4)cn3)nc2n1C1CCCC1		CHEMBL3658037	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286748	17669093	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(C(=O)N4CCC(O)CC4)cn3)nc2n1C1CCCC1		CHEMBL3658072	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286749	17669094	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(C(=O)N(C)CCN)cn3)nc2n1C1CCCC1		CHEMBL3658028	=	IC50	nM	4700.0	CHEMBL301	Homo sapiens	IC50	nM	4700.0
286750	17669095	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCC(N(C)C)CC4)cn3)nc2n1C1CCCC1		CHEMBL3654237	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286751	17669096	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCC(O)CC4)cn3)nc2n1C1CCCC1		CHEMBL3654252	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286752	17669097	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCC(CCO)CC4)cn3)nc2n1C1CCCC1		CHEMBL3658023	=	IC50	nM	2900.0	CHEMBL301	Homo sapiens	IC50	nM	2900.0
286753	17669098	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(C4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3658039	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286754	17669099	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CC(C)N1CCC(c2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CC1		CHEMBL3658065	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286755	17669100	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(C4CCN(CCO)CC4)cn3)nc2n1C1CCCC1		CHEMBL3658081	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286756	17669101	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCN(C(=O)OC(C)(C)C)CC4)nn3)nc2n1C1CCCC1		CHEMBL3658032	=	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	nM	20000.0
286757	17669102	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)nn3)nc2n1C1CCCC1		CHEMBL3658053	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286758	17669103	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CC(C)N1CCN(c2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nn2)CC1		CHEMBL3658056	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286759	17669104	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCN(CCO)CC4)nn3)nc2n1C1CCCC1		CHEMBL3639568	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286760	17669105	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3cnc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3658035	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286761	17669106	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3cnc(N4CCN(CCO)CC4)cn3)nc2n1C1CCCC1		CHEMBL3654247	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286762	17669107	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccccn3)nc2n1C1CCC(C)(O)CC1		CHEMBL3658027	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286763	17669108	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C1CCN(c2ccc(Nc3ncc4cc(C#N)n(C5CCCC5)c4n3)nc2)CC1		CHEMBL3658034	=	IC50	nM	8300.0	CHEMBL301	Homo sapiens	IC50	nM	8300.0
286764	17669109	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CNC(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3658045	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286765	17669110	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CNC(=O)c1cc2cnc(Nc3ccc(N4CCN(C(C)C)CC4)cn3)nc2n1C1CCCC1		CHEMBL3658038	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286766	17669111	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	c1ncc(-c2cc3cnc(Nc4ccc(N5CCNCC5)cn4)nc3n2C2CCCC2)o1		CHEMBL3654243	=	IC50	nM	3500.0	CHEMBL301	Homo sapiens	IC50	nM	3500.0
286767	17669112	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	c1ncc(-c2cc3cnc(Nc4ccc(CN5CCNCC5)cn4)nc3n2C2CCCC2)o1		CHEMBL3654250	=	IC50	nM	2800.0	CHEMBL301	Homo sapiens	IC50	nM	2800.0
286768	17669113	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4=O)cn3)nc2n1C1CCCC1		CHEMBL3658084	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286769	17669114	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCOCC4)cn3)nc2n1C1CCCC1		CHEMBL3658085	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286772	17669117	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	=	IC50	nM	76000.0	CHEMBL301	Homo sapiens	IC50	nM	76000.0
286775	17669120	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CC(C)N1CCN(c2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CC1		CHEMBL3658050	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
286778	17669123	CHEMBL3705366	IMAP-FPT (Molecular Devices Trade Mark Technology) Endpoint Assay: The assay was run under the conditions identical to that for CDK1/cyclin B except 0.25 nM CDK1/cyclin B was replaced with 0.3 nM CDK2/cyclin A. A 384-well microtiter IMAP-FPT (Molecular Devices Trade Mark Technology) endpoint assay was used for CDK1/cyclin B kinase activity measurements. The same assay was used for IC50 determination of small molecule inhibitors. In general, the kinase reactions were carried out in 20 μL volumes in the reaction solution, which is composed of 2 μL compound (in 20% DMSO), 8 μL CDK1/cyclin B in the 1× Reaction Buffer (Molecular Devices, Cat. No. R8139), 10 μL substrate mixture of Tamra Histone-H1 peptide (Molecular Devices, Cat. No. R7384) and ATP (Amersham Pharmacia, Cat. No. 27-2056-01) in the 1× Reaction Buffer with 1 mM DTT freshly added. The final reaction mixture contains compound (inhibitor) with the concentration varying from 0.005-10 μM, 2% DMSO, 0.25 nM CDK1/cyclin B, 100 nM Tamra Histone-H1 peptide, and 20 μM ATP.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCN(CCO)CC4)cn3)nc2n1C1CCCC1		CHEMBL3654258	>	IC50	nM	15000.0	CHEMBL301	Homo sapiens	IC50	nM	15000.0
327527	17706254	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	CCOC(=O)N=S(C)(=O)Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1		CHEMBL3906489	=	IC50	nM	780.0	CHEMBL301	Homo sapiens	IC50	nM	780.0
327528	17706255	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(F)ccc1-c1nc(Nc2cccc(CS(C)(=N)=O)c2)ncc1F		CHEMBL3965161	=	IC50	nM	1100.0	CHEMBL301	Homo sapiens	IC50	nM	1100.0
327529	17706256	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	CCOC(=O)N=S(C)(=O)Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OCc3ccccc3)n2)c1		CHEMBL3900262	=	IC50	nM	1100.0	CHEMBL301	Homo sapiens	IC50	nM	1100.0
327530	17706257	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	CS(=N)(=O)Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OCc3ccccc3)n2)c1		CHEMBL3927078	=	IC50	nM	850.0	CHEMBL301	Homo sapiens	IC50	nM	850.0
327531	17706258	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	CCOC(=O)N=S(C)(=O)Cc1cccc(Nc2ncc(F)c(-c3cccc4c3OCCC4)n2)c1		CHEMBL3949057	=	IC50	nM	330.0	CHEMBL301	Homo sapiens	IC50	nM	330.0
327532	17706259	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	CS(=N)(=O)Cc1cccc(Nc2ncc(F)c(-c3cccc4c3OCCC4)n2)c1		CHEMBL3978185	=	IC50	nM	270.0	CHEMBL301	Homo sapiens	IC50	nM	270.0
327533	17706260	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	CS(=O)(Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OCc3ccccc3)n2)c1)=NC#N		CHEMBL3892285	=	IC50	nM	20000.0	CHEMBL301	Homo sapiens	IC50	nM	20000.0
327534	17706261	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	CNC(=O)N=S(C)(=O)Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1		CHEMBL3916775	=	IC50	nM	430.0	CHEMBL301	Homo sapiens	IC50	nM	430.0
327535	17706262	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	CCOC(=O)N=S(C)(=O)Cc1cc(F)cc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1		CHEMBL3934755	=	IC50	nM	560.0	CHEMBL301	Homo sapiens	IC50	nM	560.0
327536	17706263	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(C)(=N)=O)c2)ncc1F		CHEMBL3962241	=	IC50	nM	220.0	CHEMBL301	Homo sapiens	IC50	nM	220.0
327537	17706264	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(F)ccc1-c1nc(Nc2cccc(CS(C)(=N)=O)c2)ncc1F		CHEMBL3965161	=	IC50	nM	470.0	CHEMBL301	Homo sapiens	IC50	nM	470.0
327538	17706265	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(F)ccc1-c1nc(Nc2cccc(CS(C)(=N)=O)c2)ncc1F		CHEMBL3965161	=	IC50	nM	540.0	CHEMBL301	Homo sapiens	IC50	nM	540.0
327539	17706266	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	CS(=N)(=O)Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OCc3ccccc3)n2)c1		CHEMBL3927078	=	IC50	nM	280.0	CHEMBL301	Homo sapiens	IC50	nM	280.0
327540	17706267	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	CS(=N)(=O)Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OCc3ccccc3)n2)c1		CHEMBL3927078	=	IC50	nM	480.0	CHEMBL301	Homo sapiens	IC50	nM	480.0
327541	17706268	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(C)(=N)=O)c2)ncc1F		CHEMBL3962241	=	IC50	nM	320.0	CHEMBL301	Homo sapiens	IC50	nM	320.0
327542	17706269	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(C)(=N)=O)c2)ncc1F		CHEMBL3962241	=	IC50	nM	310.0	CHEMBL301	Homo sapiens	IC50	nM	310.0
327543	17706270	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(F)ccc1-c1nc(Nc2cccc(CS(C)(=O)=NC#N)c2)ncc1F		CHEMBL3960348	=	IC50	nM	240.0	CHEMBL301	Homo sapiens	IC50	nM	240.0
327544	17706271	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(F)ccc1-c1nc(Nc2cccc(CS(C)(=O)=NC#N)c2)ncc1F		CHEMBL3960348	=	IC50	nM	330.0	CHEMBL301	Homo sapiens	IC50	nM	330.0
327545	17706272	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(F)ccc1-c1nc(Nc2cccc(CS(C)(=O)=NC#N)c2)ncc1F		CHEMBL3960348	=	IC50	nM	570.0	CHEMBL301	Homo sapiens	IC50	nM	570.0
327546	17706273	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	CCS(=O)(Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1)=NC#N		CHEMBL3959283	=	IC50	nM	170.0	CHEMBL301	Homo sapiens	IC50	nM	170.0
327547	17706274	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	CCS(=N)(=O)Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1		CHEMBL3976450	=	IC50	nM	380.0	CHEMBL301	Homo sapiens	IC50	nM	380.0
327548	17706275	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	CCS(=N)(=O)Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1		CHEMBL3976450	=	IC50	nM	410.0	CHEMBL301	Homo sapiens	IC50	nM	410.0
327549	17706276	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	CCS(=N)(=O)Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1		CHEMBL3976450	=	IC50	nM	350.0	CHEMBL301	Homo sapiens	IC50	nM	350.0
327550	17706277	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(F)ccc1-c1nc(Nc2cc(F)c(F)c(CS(C)(=O)=NC#N)c2)ncc1F		CHEMBL3973367	=	IC50	nM	73.0	CHEMBL301	Homo sapiens	IC50	nM	73.0
327551	17706278	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(F)ccc1-c1nc(Nc2cc(F)c(F)c(CS(C)(=N)=O)c2)ncc1F		CHEMBL3897217	=	IC50	nM	170.0	CHEMBL301	Homo sapiens	IC50	nM	170.0
327552	17706279	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(F)ccc1-c1nc(Nc2cc(F)c(F)c(CS(C)(=N)=O)c2)ncc1F		CHEMBL3897217	=	IC50	nM	210.0	CHEMBL301	Homo sapiens	IC50	nM	210.0
327553	17706280	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(F)ccc1-c1nc(Nc2cc(F)c(F)c(CS(C)(=N)=O)c2)ncc1F		CHEMBL3897217	=	IC50	nM	180.0	CHEMBL301	Homo sapiens	IC50	nM	180.0
327554	17706281	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(F)ccc1-c1nc(Nc2cc(Br)cc(CS(C)(=O)=NC#N)c2)ncc1F		CHEMBL3919796	=	IC50	nM	120.0	CHEMBL301	Homo sapiens	IC50	nM	120.0
327555	17706282	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(F)ccc1-c1nc(Nc2cc(Br)cc(CS(C)(=N)=O)c2)ncc1F		CHEMBL3946675	=	IC50	nM	86.0	CHEMBL301	Homo sapiens	IC50	nM	86.0
327556	17706283	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(F)ccc1-c1nc(Nc2cc(Br)cc(CS(C)(=N)=O)c2)ncc1F		CHEMBL3946675	=	IC50	nM	110.0	CHEMBL301	Homo sapiens	IC50	nM	110.0
327557	17706284	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(F)ccc1-c1nc(Nc2cc(Br)cc(CS(C)(=N)=O)c2)ncc1F		CHEMBL3946675	=	IC50	nM	120.0	CHEMBL301	Homo sapiens	IC50	nM	120.0
327558	17706285	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(CS(C)(=O)=NC#N)cc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1		CHEMBL3934141	=	IC50	nM	130.0	CHEMBL301	Homo sapiens	IC50	nM	130.0
327559	17706286	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(CS(C)(=N)=O)cc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1		CHEMBL3960677	=	IC50	nM	150.0	CHEMBL301	Homo sapiens	IC50	nM	150.0
327560	17706287	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(CS(C)(=N)=O)cc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1		CHEMBL3960677	=	IC50	nM	210.0	CHEMBL301	Homo sapiens	IC50	nM	210.0
327561	17706288	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(CS(C)(=N)=O)cc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1		CHEMBL3960677	=	IC50	nM	190.0	CHEMBL301	Homo sapiens	IC50	nM	190.0
327562	17706289	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	CCOc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(C)(=O)=NC#N)c2)ncc1F		CHEMBL3923419	=	IC50	nM	290.0	CHEMBL301	Homo sapiens	IC50	nM	290.0
327563	17706290	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	CCOc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(C)(=N)=O)c2)ncc1F		CHEMBL3959867	=	IC50	nM	510.0	CHEMBL301	Homo sapiens	IC50	nM	510.0
327564	17706291	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	CCOc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(C)(=N)=O)c2)ncc1F		CHEMBL3959867	=	IC50	nM	260.0	CHEMBL301	Homo sapiens	IC50	nM	260.0
327565	17706292	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	CCOc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(C)(=N)=O)c2)ncc1F		CHEMBL3959867	=	IC50	nM	240.0	CHEMBL301	Homo sapiens	IC50	nM	240.0
327566	17706293	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(F)ccc1-c1nc(Nc2cc(CS(C)(=O)=NC#N)cc(C(F)(F)F)c2)ncc1F		CHEMBL3937866	=	IC50	nM	200.0	CHEMBL301	Homo sapiens	IC50	nM	200.0
327567	17706294	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(F)ccc1-c1nc(Nc2cc(CS(C)(=N)=O)cc(C(F)(F)F)c2)ncc1F		CHEMBL3905335	=	IC50	nM	180.0	CHEMBL301	Homo sapiens	IC50	nM	180.0
327568	17706295	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	CCS(=O)(Cc1cc(F)cc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1)=NC#N		CHEMBL3979266	=	IC50	nM	160.0	CHEMBL301	Homo sapiens	IC50	nM	160.0
327569	17706296	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	CCS(=N)(=O)Cc1cc(F)cc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1		CHEMBL3917892	=	IC50	nM	290.0	CHEMBL301	Homo sapiens	IC50	nM	290.0
327570	17706297	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	CCS(=N)(=O)Cc1cc(F)cc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1		CHEMBL3917892	=	IC50	nM	220.0	CHEMBL301	Homo sapiens	IC50	nM	220.0
327571	17706298	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	CCS(=N)(=O)Cc1cc(F)cc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1		CHEMBL3917892	=	IC50	nM	250.0	CHEMBL301	Homo sapiens	IC50	nM	250.0
327572	17706299	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(F)ccc1-c1nc(Nc2cc(CS(C)(=O)=NC#N)cc(C(F)(F)C(F)(F)F)c2)ncc1F		CHEMBL3984385	=	IC50	nM	630.0	CHEMBL301	Homo sapiens	IC50	nM	630.0
327573	17706300	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(F)ccc1-c1nc(Nc2cc(CS(C)(=N)=O)cc(C(F)(F)C(F)(F)F)c2)ncc1F		CHEMBL3912866	=	IC50	nM	230.0	CHEMBL301	Homo sapiens	IC50	nM	230.0
327574	17706301	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(F)ccc1-c1nc(Nc2cccc(CS(=O)(=NC#N)C3CC3)c2)ncc1F		CHEMBL3944304	=	IC50	nM	220.0	CHEMBL301	Homo sapiens	IC50	nM	220.0
327575	17706302	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(F)ccc1-c1nc(Nc2cccc(CS(=N)(=O)C3CC3)c2)ncc1F		CHEMBL3921855	=	IC50	nM	410.0	CHEMBL301	Homo sapiens	IC50	nM	410.0
327576	17706303	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(=O)(=NC#N)C3CC3)c2)ncc1F		CHEMBL3949630	=	IC50	nM	250.0	CHEMBL301	Homo sapiens	IC50	nM	250.0
327577	17706304	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(=N)(=O)C3CC3)c2)ncc1F		CHEMBL3934257	=	IC50	nM	410.0	CHEMBL301	Homo sapiens	IC50	nM	410.0
327578	17706305	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(=N)(=O)C3CC3)c2)ncc1F		CHEMBL3934257	=	IC50	nM	580.0	CHEMBL301	Homo sapiens	IC50	nM	580.0
327579	17706306	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(=N)(=O)C3CC3)c2)ncc1F		CHEMBL3934257	=	IC50	nM	380.0	CHEMBL301	Homo sapiens	IC50	nM	380.0
327580	17706307	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	CCOC(=O)N=S(C)(=O)Cc1cccc(Nc2ncc(F)c(-c3cccc4c3OCC4)n2)c1		CHEMBL3972796	=	IC50	nM	350.0	CHEMBL301	Homo sapiens	IC50	nM	350.0
327581	17706308	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	CS(=N)(=O)Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OCc3ccc(F)cc3)n2)c1		CHEMBL3892881	=	IC50	nM	770.0	CHEMBL301	Homo sapiens	IC50	nM	770.0
327582	17706309	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(F)ccc1-c1nc(Nc2cc(Cl)cc(CS(C)(=O)=NC#N)c2)ncc1F		CHEMBL3967588	=	IC50	nM	160.0	CHEMBL301	Homo sapiens	IC50	nM	160.0
327583	17706310	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(F)ccc1-c1nc(Nc2cc(Cl)cc(CS(C)(=N)=O)c2)ncc1F		CHEMBL3981911	=	IC50	nM	180.0	CHEMBL301	Homo sapiens	IC50	nM	180.0
327584	17706311	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COc1cc(F)ccc1-c1nc(Nc2cc(C)cc(CS(C)(=O)=NC#N)c2)ncc1F		CHEMBL3953160	=	IC50	nM	220.0	CHEMBL301	Homo sapiens	IC50	nM	220.0
327585	17706312	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B			CHEMBL4115908	=	IC50	nM	320.0	CHEMBL301	Homo sapiens	IC50	nM	320.0
327586	17706313	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B			CHEMBL4115909	=	IC50	nM	290.0	CHEMBL301	Homo sapiens	IC50	nM	290.0
327587	17706314	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B			CHEMBL4115909	=	IC50	nM	170.0	CHEMBL301	Homo sapiens	IC50	nM	170.0
327588	17706315	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B			CHEMBL4115909	=	IC50	nM	200.0	CHEMBL301	Homo sapiens	IC50	nM	200.0
327589	17706316	CHEMBL3887263	CDK2/CycE Kinase Assay: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sepharose affinity chromatography, were purchased from ProQinase GmbH (Freiburg, Germany). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany)For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK2/CycE in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.	B	COCCOC(=O)N=S(C)(=O)Cc1cc(F)cc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1		CHEMBL3932396	=	IC50	nM	330.0	CHEMBL301	Homo sapiens	IC50	nM	330.0
335749	17713967	CHEMBL3887396	LanthaScreen TR-FRET Assay: Compound 1 was also assayed to determine the IC50 values for three different kinases (PCTAIRE1, DYRK1a, and CDK2) in comparison to Gsk3beta. The assay was conducted with the same method described below in the second assay. Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266). In a first screening assay, compounds were tested in duplicate at a concentration of 10 Î¼M.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um).	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(CCc4ccc(O)cc4)CC3)c2c1		CHEMBL3736216	=	IC50	nM	36000.0	CHEMBL301	Homo sapiens	IC50	nM	36000.0
412009	17776724	CHEMBL3888653	Mobility Shift Assay: Agents: 1-fold kinase buffer without MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 2 mM DTT. 1-fold kinase buffer with MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 10 mM MnCl2, 2 mM DTT. Termination solution: 100 mM HEPES, pH 7.5, 0.0015% Brij-35, 0.2% Coating Reagent#3, 50 mM EDTA. 2.5-fold kinase solution: The kinase was added to the 1-fold kinase buffer to form a 2.5-fold kinase solution. 2.5-fold substrate solution: FAM fluorescence-labelled polypeptide and ATP were added to the 1-fold kinase buffer to form a 2.5-fold substrate solution. Compounds: The final test concentration of the compound was 10 μM at maximum. Firstly, a 50-fold concentration (i.e. 500 μM) was prepared with 100% DMSO. The compound was diluted with 100% DMSO by 5 folds at 5 concentrations (successively 500 μM, 100 μM, 20 μM, 4 μM, and 0.8 μM). After diluting with 1-fold kinase buffer by 10 folds, 5 μl of the samples were transferred to a 384-well reaction plate. Two negative control wells and two positive control wells were set at each line respectively. Replication was made in a 96-well plate in five concentrations of 5-fold compound. 10% DMSO was added to the positive control well, and 5 μl of EDTA (250 mM) was added to the negative control well. Procedure: To the 384-well reaction plate was added 5-fold compound dissolved in 10% DMSO at 5 μl/well. To the 384-well reaction plate was added 2.5-fold kinase solution at 10 Î¼l/well. The plate was incubated at room temperature for 10 mins. To the 384-well reaction plate was added 2.5-fold substrate solution at 10 μl/well. The plate was incubated at 28° C. for a certain period. 25 μl termination solution was added to terminate the reaction.	B	Nc1ccc(-c2ccc3ncc4c(=O)[nH]c(=O)n(-c5cccc(C(F)(F)F)c5)c4c3n2)cn1		CHEMBL3903725	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
441606	17801350	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@H](O)CN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1		CHEMBL3929399	=	IC50	nM	6350.0	CHEMBL301	Homo sapiens	IC50	nM	6350.0
441607	17801351	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@H]1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CCN1CC1CC1		CHEMBL3917699	=	IC50	nM	3040.0	CHEMBL301	Homo sapiens	IC50	nM	3040.0
441608	17801352	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@H](O)CN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)C[C@@H]1C		CHEMBL3955667	=	IC50	nM	1920.0	CHEMBL301	Homo sapiens	IC50	nM	1920.0
441609	17801353	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1(C)C		CHEMBL3973056	=	IC50	nM	3480.0	CHEMBL301	Homo sapiens	IC50	nM	3480.0
441610	17801354	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(C)C1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CCN1		CHEMBL3943554	=	IC50	nM	695.0	CHEMBL301	Homo sapiens	IC50	nM	695.0
441611	17801355	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	O=C1NCC2(CCCCC2)n2c1cc1cnc(Nc3ccc(N4CCN(C5CCC5)CC4)cn3)nc12		CHEMBL3967732	=	IC50	nM	628.0	CHEMBL301	Homo sapiens	IC50	nM	628.0
441612	17801356	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CCN1CCC(C)(C)C		CHEMBL3934575	=	IC50	nM	2580.0	CHEMBL301	Homo sapiens	IC50	nM	2580.0
441613	17801357	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC1(C)CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CCN1CC1CC1		CHEMBL3956661	=	IC50	nM	1520.0	CHEMBL301	Homo sapiens	IC50	nM	1520.0
441614	17801358	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC1(C)CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CCN1		CHEMBL3929122	=	IC50	nM	2120.0	CHEMBL301	Homo sapiens	IC50	nM	2120.0
441615	17801359	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@@H](O)CN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)C[C@H]1C		CHEMBL4113081	=	IC50	nM	5110.0	CHEMBL301	Homo sapiens	IC50	nM	5110.0
441616	17801360	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC1CCN(C2CCN(c3ccc(Nc4ncc5cc6n(c5n4)C4(CCCCC4)CNC6=O)nc3)CC2)C1		CHEMBL3920205	=	IC50	nM	1070.0	CHEMBL301	Homo sapiens	IC50	nM	1070.0
441617	17801361	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(C)N1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)C[C@H]1C		CHEMBL4109276	=	IC50	nM	4530.0	CHEMBL301	Homo sapiens	IC50	nM	4530.0
441618	17801362	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@H]1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CCN1CCC(C)(C)C		CHEMBL3981462	=	IC50	nM	2280.0	CHEMBL301	Homo sapiens	IC50	nM	2280.0
441619	17801363	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	O=C1NCC2(CCCCC2)n2c1cc1cnc(Nc3ccc(N4CCC(N5CCCCC5)CC4)cn3)nc12		CHEMBL3915889	=	IC50	nM	1500.0	CHEMBL301	Homo sapiens	IC50	nM	1500.0
441620	17801364	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CN(C)C1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1		CHEMBL3943841	=	IC50	nM	41410.0	CHEMBL301	Homo sapiens	IC50	nM	41410.0
441621	17801365	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@H]1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)C[C@@H](C)N1		CHEMBL3906916	=	IC50	nM	3560.0	CHEMBL301	Homo sapiens	IC50	nM	3560.0
441622	17801366	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	O=C1NCC2(CCCCC2)n2c1cc1cnc(Nc3ccc(N4CCNCC4)cn3)nc12		CHEMBL3890528	=	IC50	nM	1080.0	CHEMBL301	Homo sapiens	IC50	nM	1080.0
441623	17801367	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@H]1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CCN1C		CHEMBL3901454	=	IC50	nM	1920.0	CHEMBL301	Homo sapiens	IC50	nM	1920.0
441624	17801368	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@@H](O)CN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1		CHEMBL4115060	=	IC50	nM	1250.0	CHEMBL301	Homo sapiens	IC50	nM	1250.0
441625	17801369	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1		CHEMBL3894860	=	IC50	nM	1660.0	CHEMBL301	Homo sapiens	IC50	nM	1660.0
441626	17801370	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	O=C1NCC2(CCCCC2)n2c1cc1cnc(Nc3ccc(N4CCC(N5CCOCC5)CC4)cn3)nc12		CHEMBL3919361	=	IC50	nM	1460.0	CHEMBL301	Homo sapiens	IC50	nM	1460.0
441627	17801371	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@@H]1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CCN1		CHEMBL4111196	=	IC50	nM	3500.0	CHEMBL301	Homo sapiens	IC50	nM	3500.0
441628	17801372	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CCN1CC(C)(C)O		CHEMBL3925377	=	IC50	nM	3970.0	CHEMBL301	Homo sapiens	IC50	nM	3970.0
441629	17801373	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	O=C1NCC2(CCCCC2)n2c1cc1cnc(Nc3ccc(N4CCC(N5CCC(C(F)(F)F)CC5)CC4)cn3)nc12		CHEMBL3892888	=	IC50	nM	11600.0	CHEMBL301	Homo sapiens	IC50	nM	11600.0
441630	17801374	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	O=C1NCC2(CCCCC2)n2c1cc1cnc(Nc3ccc(C(=O)N4CCNCC4)cn3)nc12		CHEMBL3967592	=	IC50	nM	124.0	CHEMBL301	Homo sapiens	IC50	nM	124.0
441631	17801375	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@H](O)CN1[C@@H](C)CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)C[C@H]1C		CHEMBL3938919	=	IC50	nM	3710.0	CHEMBL301	Homo sapiens	IC50	nM	3710.0
441632	17801376	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(C)N1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)C[C@@H]1C		CHEMBL3910976	=	IC50	nM	6100.0	CHEMBL301	Homo sapiens	IC50	nM	6100.0
441633	17801377	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC1(C)CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CCN1C1CC1		CHEMBL3947713	=	IC50	nM	1680.0	CHEMBL301	Homo sapiens	IC50	nM	1680.0
441634	17801378	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CCN(CC)C1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1		CHEMBL3916385	=	IC50	nM	1250.0	CHEMBL301	Homo sapiens	IC50	nM	1250.0
441635	17801379	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@H]1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)C[C@@H](C)N1C		CHEMBL3919835	=	IC50	nM	9620.0	CHEMBL301	Homo sapiens	IC50	nM	9620.0
441636	17801380	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(C)N1CCN(Cc2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1		CHEMBL3891784	=	IC50	nM	1660.0	CHEMBL301	Homo sapiens	IC50	nM	1660.0
441637	17801381	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CCN1[C@@H](C)CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)C[C@H]1C		CHEMBL3975426	=	IC50	nM	4620.0	CHEMBL301	Homo sapiens	IC50	nM	4620.0
441638	17801382	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(C)N1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1		CHEMBL3904602	=	IC50	nM	3580.0	CHEMBL301	Homo sapiens	IC50	nM	3580.0
441639	17801383	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	O=C1NCC2(CCCCC2)n2c1cc1cnc(Nc3ccc(N4CCN(CC5CC5)CC4)cn3)nc12		CHEMBL3986852	=	IC50	nM	1280.0	CHEMBL301	Homo sapiens	IC50	nM	1280.0
441640	17801384	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(C)N1CCN(C(=O)c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1		CHEMBL3913590	=	IC50	nM	367.0	CHEMBL301	Homo sapiens	IC50	nM	367.0
441641	17801385	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CCN(CC)C1CCN(C(=O)c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)C1		CHEMBL3890286	=	IC50	nM	288.0	CHEMBL301	Homo sapiens	IC50	nM	288.0
441642	17801386	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@H]1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CCN1		CHEMBL3918318	=	IC50	nM	1760.0	CHEMBL301	Homo sapiens	IC50	nM	1760.0
441643	17801387	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	O=C1NCC2(CCCCC2)n2c1cc1cnc(Nc3ccc(C(=O)N4CCN(C5CCC5)CC4)cn3)nc12		CHEMBL3895782	=	IC50	nM	202.0	CHEMBL301	Homo sapiens	IC50	nM	202.0
441644	17801388	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@H]1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)C[C@@H](C)N1C[C@@H](C)O		CHEMBL4114182	=	IC50	nM	3390.0	CHEMBL301	Homo sapiens	IC50	nM	3390.0
441645	17801389	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@@H]1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CCN1C		CHEMBL4112645	=	IC50	nM	4700.0	CHEMBL301	Homo sapiens	IC50	nM	4700.0
441646	17801390	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC(C)N1CC1CC1		CHEMBL3896827	=	IC50	nM	3980.0	CHEMBL301	Homo sapiens	IC50	nM	3980.0
441647	17801391	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(C)N1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1C		CHEMBL3931143	=	IC50	nM	3600.0	CHEMBL301	Homo sapiens	IC50	nM	3600.0
441648	17801392	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CCN(CC)C1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)C1		CHEMBL3899618	=	IC50	nM	3060.0	CHEMBL301	Homo sapiens	IC50	nM	3060.0
441649	17801393	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CCN(CC)C1CCN(C2CCN(c3ccc(Nc4ncc5cc6n(c5n4)C4(CCCCC4)CNC6=O)nc3)CC2)C1		CHEMBL3890659	=	IC50	nM	1580.0	CHEMBL301	Homo sapiens	IC50	nM	1580.0
441650	17801394	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CN(C)C1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nn2)CC1		CHEMBL3894204	=	IC50	nM	1460.0	CHEMBL301	Homo sapiens	IC50	nM	1460.0
441651	17801395	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(C)N1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nn2)CC1		CHEMBL3975020	=	IC50	nM	1260.0	CHEMBL301	Homo sapiens	IC50	nM	1260.0
441652	17801396	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CCN(CC)C1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)C1		CHEMBL3949088	=	IC50	nM	3960.0	CHEMBL301	Homo sapiens	IC50	nM	3960.0
441653	17801397	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@H]1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)CCN1C[C@@H](C)O		CHEMBL3897592	=	IC50	nM	2630.0	CHEMBL301	Homo sapiens	IC50	nM	2630.0
441654	17801398	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	O=C1NCC2(CCCC2)n2c1cc1cnc(Nc3ccc(N4CCC(N5CCOCC5)CC4)cn3)nc12		CHEMBL3908669	=	IC50	nM	1350.0	CHEMBL301	Homo sapiens	IC50	nM	1350.0
441655	17801399	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@H](O)CN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)C[C@H]1C		CHEMBL4114427	=	IC50	nM	7300.0	CHEMBL301	Homo sapiens	IC50	nM	7300.0
441656	17801400	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CN(C)C1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)CC1		CHEMBL3963064	=	IC50	nM	6900.0	CHEMBL301	Homo sapiens	IC50	nM	6900.0
441657	17801401	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)CC1		CHEMBL3977652	=	IC50	nM	9960.0	CHEMBL301	Homo sapiens	IC50	nM	9960.0
441658	17801402	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CCC(C)CN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)CC1		CHEMBL3980597	=	IC50	nM	6010.0	CHEMBL301	Homo sapiens	IC50	nM	6010.0
441659	17801403	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CN1CCN(C(=O)c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)CC1		CHEMBL3972676	=	IC50	nM	187.0	CHEMBL301	Homo sapiens	IC50	nM	187.0
441660	17801404	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(C)(C)CCN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)CC1(C)C		CHEMBL3961663	=	IC50	nM	2170.0	CHEMBL301	Homo sapiens	IC50	nM	2170.0
441661	17801405	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@H]1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)C[C@@H](C)N1		CHEMBL3971523	=	IC50	nM	9350.0	CHEMBL301	Homo sapiens	IC50	nM	9350.0
441662	17801406	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(C)(O)CN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)CC1		CHEMBL3896841	=	IC50	nM	2950.0	CHEMBL301	Homo sapiens	IC50	nM	2950.0
441663	17801407	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CCC(C)CN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)CC1		CHEMBL3980597	=	IC50	nM	4540.0	CHEMBL301	Homo sapiens	IC50	nM	4540.0
441664	17801408	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(C)N1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)CC1C		CHEMBL3985649	=	IC50	nM	7610.0	CHEMBL301	Homo sapiens	IC50	nM	7610.0
441665	17801409	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	O=C1NCC2(CCCC2)n2c1cc1cnc(Nc3ccc(N4CCC(N5CCCCC5)CC4)cn3)nc12		CHEMBL3940741	=	IC50	nM	2840.0	CHEMBL301	Homo sapiens	IC50	nM	2840.0
441666	17801410	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(C)N1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)CC1		CHEMBL3973664	=	IC50	nM	3770.0	CHEMBL301	Homo sapiens	IC50	nM	3770.0
441667	17801411	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CCC(C)CN1[C@@H](C)CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)C[C@H]1C		CHEMBL3984435	=	IC50	nM	5200.0	CHEMBL301	Homo sapiens	IC50	nM	5200.0
441668	17801412	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(C)(C)CCN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)CC1		CHEMBL3955818	=	IC50	nM	291.0	CHEMBL301	Homo sapiens	IC50	nM	291.0
441669	17801413	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CCN(CC)C1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)CC1		CHEMBL3966804	=	IC50	nM	1620.0	CHEMBL301	Homo sapiens	IC50	nM	1620.0
441670	17801414	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CCOCCN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)CC1		CHEMBL3961115	=	IC50	nM	1890.0	CHEMBL301	Homo sapiens	IC50	nM	1890.0
441671	17801415	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)CCN1CC1CC1		CHEMBL3972093	=	IC50	nM	2930.0	CHEMBL301	Homo sapiens	IC50	nM	2930.0
441672	17801416	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	O=C1NCC2(CCCC2)n2c1cc1cnc(Nc3ccc(C(=O)N4CCN(CC5CC5)CC4)cn3)nc12		CHEMBL3942483	=	IC50	nM	393.0	CHEMBL301	Homo sapiens	IC50	nM	393.0
441673	17801417	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)CC(C)N1CCC(C)(C)C		CHEMBL3980145	=	IC50	nM	16500.0	CHEMBL301	Homo sapiens	IC50	nM	16500.0
441674	17801418	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	O=C1NCC2(CCCC2)n2c1cc1cnc(Nc3ccc(N4CCNCC4)cn3)nc12		CHEMBL3954643	=	IC50	nM	11100.0	CHEMBL301	Homo sapiens	IC50	nM	11100.0
441675	17801419	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(C)N1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nn2)CC1		CHEMBL3948158	=	IC50	nM	4500.0	CHEMBL301	Homo sapiens	IC50	nM	4500.0
441676	17801420	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	O=C1NCC2(CCCC2)n2c1cc1cnc(Nc3ccc(N4CCOCC4)nn3)nc12		CHEMBL3920345	=	IC50	nM	2280.0	CHEMBL301	Homo sapiens	IC50	nM	2280.0
441677	17801421	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CN(C)C1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nn2)CC1		CHEMBL3950849	=	IC50	nM	3030.0	CHEMBL301	Homo sapiens	IC50	nM	3030.0
441678	17801422	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(C)[C@H]1CNC(=O)c2cc3cnc(Nc4ccc(N5CCNCC5)cn4)nc3n21		CHEMBL4106830	=	IC50	nM	16460.0	CHEMBL301	Homo sapiens	IC50	nM	16460.0
441679	17801423	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CCC(C)[C@@H]1CNC(=O)c2cc3cnc(Nc4ccc(N5CCN(C)CC5)cn4)nc3n21		CHEMBL3986691	=	IC50	nM	4380.0	CHEMBL301	Homo sapiens	IC50	nM	4380.0
441680	17801424	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(C)C[C@@H]1CNC(=O)c2cc3cnc(Nc4ccc(N5CCNCC5)cn4)nc3n21		CHEMBL4106617	=	IC50	nM	2500.0	CHEMBL301	Homo sapiens	IC50	nM	2500.0
441681	17801425	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(C)C[C@@H]1CNC(=O)c2cc3cnc(Nc4ccc(N5CCN(C)CC5)cn4)nc3n21		CHEMBL4107086	=	IC50	nM	6620.0	CHEMBL301	Homo sapiens	IC50	nM	6620.0
441682	17801426	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@H](O)CN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1		CHEMBL3929399	=	IC50	nM	3160.0	CHEMBL301	Homo sapiens	IC50	nM	3160.0
441683	17801427	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@H]1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CCN1CC1CC1		CHEMBL3917699	=	IC50	nM	1890.0	CHEMBL301	Homo sapiens	IC50	nM	1890.0
441684	17801428	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@H](O)CN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)C[C@@H]1C		CHEMBL3955667	=	IC50	nM	616.0	CHEMBL301	Homo sapiens	IC50	nM	616.0
441685	17801429	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1(C)C		CHEMBL3973056	=	IC50	nM	1500.0	CHEMBL301	Homo sapiens	IC50	nM	1500.0
441686	17801430	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(C)C1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CCN1		CHEMBL3943554	=	IC50	nM	204.0	CHEMBL301	Homo sapiens	IC50	nM	204.0
441687	17801431	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	O=C1NCC2(CCCCC2)n2c1cc1cnc(Nc3ccc(N4CCN(C5CCC5)CC4)cn3)nc12		CHEMBL3967732	=	IC50	nM	190.0	CHEMBL301	Homo sapiens	IC50	nM	190.0
441688	17801432	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CCN1CCC(C)(C)C		CHEMBL3934575	=	IC50	nM	646.0	CHEMBL301	Homo sapiens	IC50	nM	646.0
441689	17801433	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC1(C)CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CCN1CC1CC1		CHEMBL3956661	=	IC50	nM	377.0	CHEMBL301	Homo sapiens	IC50	nM	377.0
441690	17801434	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC1(C)CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CCN1		CHEMBL3929122	=	IC50	nM	1130.0	CHEMBL301	Homo sapiens	IC50	nM	1130.0
441691	17801435	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@@H](O)CN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)C[C@H]1C		CHEMBL4113081	=	IC50	nM	4340.0	CHEMBL301	Homo sapiens	IC50	nM	4340.0
441692	17801436	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC1CCN(C2CCN(c3ccc(Nc4ncc5cc6n(c5n4)C4(CCCCC4)CNC6=O)nc3)CC2)C1		CHEMBL3920205	=	IC50	nM	738.0	CHEMBL301	Homo sapiens	IC50	nM	738.0
441693	17801437	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(C)N1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)C[C@H]1C		CHEMBL4109276	=	IC50	nM	1490.0	CHEMBL301	Homo sapiens	IC50	nM	1490.0
441694	17801438	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@H]1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CCN1CCC(C)(C)C		CHEMBL3981462	=	IC50	nM	1410.0	CHEMBL301	Homo sapiens	IC50	nM	1410.0
441695	17801439	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CN(C)C1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1		CHEMBL3943841	=	IC50	nM	3150.0	CHEMBL301	Homo sapiens	IC50	nM	3150.0
441696	17801440	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@H]1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)C[C@@H](C)N1		CHEMBL3906916	=	IC50	nM	1010.0	CHEMBL301	Homo sapiens	IC50	nM	1010.0
441697	17801441	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	O=C1NCC2(CCCCC2)n2c1cc1cnc(Nc3ccc(N4CCNCC4)cn3)nc12		CHEMBL3890528	=	IC50	nM	3030.0	CHEMBL301	Homo sapiens	IC50	nM	3030.0
441698	17801442	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@H]1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CCN1C		CHEMBL3901454	=	IC50	nM	1360.0	CHEMBL301	Homo sapiens	IC50	nM	1360.0
441699	17801443	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@@H](O)CN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1		CHEMBL4115060	=	IC50	nM	342.0	CHEMBL301	Homo sapiens	IC50	nM	342.0
441700	17801444	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1		CHEMBL3894860	=	IC50	nM	1670.0	CHEMBL301	Homo sapiens	IC50	nM	1670.0
441701	17801445	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	O=C1NCC2(CCCCC2)n2c1cc1cnc(Nc3ccc(N4CCC(N5CCOCC5)CC4)cn3)nc12		CHEMBL3919361	=	IC50	nM	857.0	CHEMBL301	Homo sapiens	IC50	nM	857.0
441702	17801446	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@@H]1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CCN1		CHEMBL4111196	=	IC50	nM	2130.0	CHEMBL301	Homo sapiens	IC50	nM	2130.0
441703	17801447	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CCN1CC(C)(C)O		CHEMBL3925377	=	IC50	nM	539.0	CHEMBL301	Homo sapiens	IC50	nM	539.0
441704	17801448	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	O=C1NCC2(CCCCC2)n2c1cc1cnc(Nc3ccc(N4CCC(N5CCC(C(F)(F)F)CC5)CC4)cn3)nc12		CHEMBL3892888	=	IC50	nM	1840.0	CHEMBL301	Homo sapiens	IC50	nM	1840.0
441705	17801449	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	O=C1NCC2(CCCCC2)n2c1cc1cnc(Nc3ccc(C(=O)N4CCNCC4)cn3)nc12		CHEMBL3967592	=	IC50	nM	61.0	CHEMBL301	Homo sapiens	IC50	nM	61.0
441706	17801450	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@H](O)CN1[C@@H](C)CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)C[C@H]1C		CHEMBL3938919	=	IC50	nM	647.0	CHEMBL301	Homo sapiens	IC50	nM	647.0
441707	17801451	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(C)N1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)C[C@@H]1C		CHEMBL3910976	=	IC50	nM	4630.0	CHEMBL301	Homo sapiens	IC50	nM	4630.0
441708	17801452	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC1(C)CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CCN1C1CC1		CHEMBL3947713	=	IC50	nM	502.0	CHEMBL301	Homo sapiens	IC50	nM	502.0
441709	17801453	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CCN(CC)C1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1		CHEMBL3916385	=	IC50	nM	755.0	CHEMBL301	Homo sapiens	IC50	nM	755.0
441710	17801454	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@H]1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)C[C@@H](C)N1C		CHEMBL3919835	=	IC50	nM	8360.0	CHEMBL301	Homo sapiens	IC50	nM	8360.0
441711	17801455	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(C)N1CCN(Cc2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1		CHEMBL3891784	=	IC50	nM	1110.0	CHEMBL301	Homo sapiens	IC50	nM	1110.0
441712	17801456	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CCN1[C@@H](C)CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)C[C@H]1C		CHEMBL3975426	=	IC50	nM	1400.0	CHEMBL301	Homo sapiens	IC50	nM	1400.0
441713	17801457	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(C)N1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1		CHEMBL3904602	=	IC50	nM	1510.0	CHEMBL301	Homo sapiens	IC50	nM	1510.0
441714	17801458	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	O=C1NCC2(CCCCC2)n2c1cc1cnc(Nc3ccc(N4CCN(CC5CC5)CC4)cn3)nc12		CHEMBL3986852	=	IC50	nM	265.0	CHEMBL301	Homo sapiens	IC50	nM	265.0
441715	17801459	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(C)N1CCN(C(=O)c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1		CHEMBL3913590	=	IC50	nM	239.0	CHEMBL301	Homo sapiens	IC50	nM	239.0
441716	17801460	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@H]1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CCN1		CHEMBL3918318	=	IC50	nM	915.0	CHEMBL301	Homo sapiens	IC50	nM	915.0
441717	17801461	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	O=C1NCC2(CCCCC2)n2c1cc1cnc(Nc3ccc(C(=O)N4CCN(C5CCC5)CC4)cn3)nc12		CHEMBL3895782	=	IC50	nM	108.0	CHEMBL301	Homo sapiens	IC50	nM	108.0
441718	17801462	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@H]1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)C[C@@H](C)N1C[C@@H](C)O		CHEMBL4114182	=	IC50	nM	597.0	CHEMBL301	Homo sapiens	IC50	nM	597.0
441719	17801463	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@@H]1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CCN1C		CHEMBL4112645	=	IC50	nM	1560.0	CHEMBL301	Homo sapiens	IC50	nM	1560.0
441720	17801464	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC(C)N1CC1CC1		CHEMBL3896827	=	IC50	nM	570.0	CHEMBL301	Homo sapiens	IC50	nM	570.0
441721	17801465	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(C)N1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1C		CHEMBL3931143	=	IC50	nM	3090.0	CHEMBL301	Homo sapiens	IC50	nM	3090.0
441722	17801466	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CCN(CC)C1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)C1		CHEMBL3899618	=	IC50	nM	2570.0	CHEMBL301	Homo sapiens	IC50	nM	2570.0
441723	17801467	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CCN(CC)C1CCN(C2CCN(c3ccc(Nc4ncc5cc6n(c5n4)C4(CCCCC4)CNC6=O)nc3)CC2)C1		CHEMBL3890659	=	IC50	nM	693.0	CHEMBL301	Homo sapiens	IC50	nM	693.0
441724	17801468	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CN(C)C1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nn2)CC1		CHEMBL3894204	=	IC50	nM	1390.0	CHEMBL301	Homo sapiens	IC50	nM	1390.0
441725	17801469	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(C)N1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nn2)CC1		CHEMBL3975020	=	IC50	nM	596.0	CHEMBL301	Homo sapiens	IC50	nM	596.0
441726	17801470	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@H]1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)CCN1C[C@@H](C)O		CHEMBL3897592	=	IC50	nM	789.0	CHEMBL301	Homo sapiens	IC50	nM	789.0
441727	17801471	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	C[C@H](O)CN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)C[C@H]1C		CHEMBL4114427	=	IC50	nM	6290.0	CHEMBL301	Homo sapiens	IC50	nM	6290.0
441728	17801472	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CCC(C)CN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)CC1		CHEMBL3980597	=	IC50	nM	2130.0	CHEMBL301	Homo sapiens	IC50	nM	2130.0
441729	17801473	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CN1CCN(C(=O)c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)CC1		CHEMBL3972676	=	IC50	nM	85.0	CHEMBL301	Homo sapiens	IC50	nM	85.0
441730	17801474	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(C)(C)CCN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)CC1(C)C		CHEMBL3961663	=	IC50	nM	457.0	CHEMBL301	Homo sapiens	IC50	nM	457.0
441731	17801475	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(C)(O)CN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)CC1		CHEMBL3896841	=	IC50	nM	943.0	CHEMBL301	Homo sapiens	IC50	nM	943.0
441732	17801476	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CCC(C)CN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)CC1		CHEMBL3980597	=	IC50	nM	1370.0	CHEMBL301	Homo sapiens	IC50	nM	1370.0
441733	17801477	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CCC(C)CN1[C@@H](C)CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)C[C@H]1C		CHEMBL3984435	=	IC50	nM	2830.0	CHEMBL301	Homo sapiens	IC50	nM	2830.0
441734	17801478	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(C)(C)CCN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)CC1		CHEMBL3955818	=	IC50	nM	87.3	CHEMBL301	Homo sapiens	IC50	nM	87.3
441735	17801479	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CCN(CC)C1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)CC1		CHEMBL3966804	=	IC50	nM	4530.0	CHEMBL301	Homo sapiens	IC50	nM	4530.0
441736	17801480	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CCOCCN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)CC1		CHEMBL3961115	=	IC50	nM	990.0	CHEMBL301	Homo sapiens	IC50	nM	990.0
441737	17801481	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)CCN1CC1CC1		CHEMBL3972093	=	IC50	nM	1010.0	CHEMBL301	Homo sapiens	IC50	nM	1010.0
441738	17801482	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	O=C1NCC2(CCCC2)n2c1cc1cnc(Nc3ccc(C(=O)N4CCN(CC5CC5)CC4)cn3)nc12		CHEMBL3942483	=	IC50	nM	203.0	CHEMBL301	Homo sapiens	IC50	nM	203.0
441739	17801483	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC1CN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCC3)CNC5=O)nc2)CC(C)N1CCC(C)(C)C		CHEMBL3980145	=	IC50	nM	2640.0	CHEMBL301	Homo sapiens	IC50	nM	2640.0
441740	17801484	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	O=C1NCC2(CCCC2)n2c1cc1cnc(Nc3ccc(N4CCOCC4)nn3)nc12		CHEMBL3920345	=	IC50	nM	1880.0	CHEMBL301	Homo sapiens	IC50	nM	1880.0
441746	17801490	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	=	IC50	nM	10.0	CHEMBL301	Homo sapiens	IC50	nM	10.0
441747	17801491	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1		CHEMBL3894860	=	IC50	nM	1.66	CHEMBL301	Homo sapiens	IC50	nM	1.66
441748	17801492	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	O=C1NCC2(CCCCC2)n2c1cc1cnc(Nc3ccc(N4CCNCC4)cn3)nc12		CHEMBL3890528	=	IC50	nM	1.08	CHEMBL301	Homo sapiens	IC50	nM	1.08
441749	17801493	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(C)N1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1		CHEMBL3904602	=	IC50	nM	3.58	CHEMBL301	Homo sapiens	IC50	nM	3.58
441750	17801494	CHEMBL3889221	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	O=C1NCC2(CCCCC2)n2c1cc1cnc(Nc3ccc(N4CCC(N5CCOCC5)CC4)cn3)nc12		CHEMBL3919361	=	IC50	nM	1.46	CHEMBL301	Homo sapiens	IC50	nM	1.46
441751	17801495	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1		CHEMBL3894860	=	IC50	nM	1.67	CHEMBL301	Homo sapiens	IC50	nM	1.67
441752	17801496	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	O=C1NCC2(CCCCC2)n2c1cc1cnc(Nc3ccc(N4CCNCC4)cn3)nc12		CHEMBL3890528	=	IC50	nM	3.03	CHEMBL301	Homo sapiens	IC50	nM	3.03
441753	17801497	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	CC(C)N1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1		CHEMBL3904602	=	IC50	nM	1.51	CHEMBL301	Homo sapiens	IC50	nM	1.51
441754	17801498	CHEMBL3889222	Caliper Assay: Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determine their inhibitory effect on these CDKs. The assays were performed using microfluidic kinase detection technology (Caliper Assay Platform). The compounds were tested in 12-point dose-response format in singlicate at Km for ATP. Phosphoacceptor substrate peptide concentration used was 1 μM for all assays and Staurosporine was used as the reference compound for all assays. Specifics of each assay are as described below:CDK2/CyclinA: Enzyme concentration: 0.2 nM; ATP concentration: 50 μM; Incubation time: 3 hr.CDK2/CyclinE: Enzyme concentration: 0.28 nM; ATP concentration: 100 μM; Incubation time: 1 hr.CDK4/CyclinD1: Enzyme concentration: 1 nM; ATP concentration: 200 μM; Incubation time: 10 hr.CDK6/CyclinD3: Enzyme concentration: 1 nM; ATP concentration: 300 μM; Incubation time: 3 hr.	B	O=C1NCC2(CCCCC2)n2c1cc1cnc(Nc3ccc(N4CCC(N5CCOCC5)CC4)cn3)nc12		CHEMBL3919361	=	IC50	nM	0.857	CHEMBL301	Homo sapiens	IC50	nM	0.857
Inactive	17889711	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889712	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889713	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889714	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889715	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889716	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Active	17889717	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	4232.0	CHEMBL301	Homo sapiens	Kd apparent	nM	4232.0
Inactive	17889718	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889719	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889720	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889721	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889722	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889723	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889724	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889725	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889726	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889727	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889728	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889729	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889730	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889731	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889732	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889733	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Active	17889734	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	=	Kd	nM	243.0	CHEMBL301	Homo sapiens	Kd apparent	nM	243.0
Active	17889735	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	=	Kd	nM	19.0	CHEMBL301	Homo sapiens	Kd apparent	nM	19.0
Inactive	17889736	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889737	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889738	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889739	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889740	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889741	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Active	17889742	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	=	Kd	nM	169.0	CHEMBL301	Homo sapiens	Kd apparent	nM	169.0
Inactive	17889743	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889744	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889745	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889746	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889747	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889748	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889749	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889750	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889751	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889752	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889753	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889754	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889755	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889756	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889757	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889758	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889759	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889760	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889761	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889762	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889763	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889764	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889765	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889766	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889767	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Active	17889768	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Kd	nM	10487.0	CHEMBL301	Homo sapiens	Kd apparent	nM	10487.0
Inactive	17889769	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889770	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889771	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Active	17889772	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Kd	nM	1775.0	CHEMBL301	Homo sapiens	Kd apparent	nM	1775.0
Inactive	17889773	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889774	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889775	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889776	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889777	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889778	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889779	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889780	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889781	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889782	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889783	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889784	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889785	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889786	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Active	17889787	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	=	Kd	nM	721.0	CHEMBL301	Homo sapiens	Kd apparent	nM	721.0
Inactive	17889788	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889789	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889790	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889791	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Active	17889792	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Kd	nM	1073.0	CHEMBL301	Homo sapiens	Kd apparent	nM	1073.0
Inactive	17889793	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889794	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Active	17889795	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	=	Kd	nM	128.0	CHEMBL301	Homo sapiens	Kd apparent	nM	128.0
Inactive	17889796	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889797	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Active	17889798	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	=	Kd	nM	5.0	CHEMBL301	Homo sapiens	Kd apparent	nM	5.0
Inactive	17889799	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889800	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889801	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889802	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889803	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889804	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889805	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889806	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889807	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889808	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889809	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889810	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889811	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889812	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889813	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889814	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889815	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Active	17889816	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	91.0	CHEMBL301	Homo sapiens	Kd apparent	nM	91.0
Inactive	17889817	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889818	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889819	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889820	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889821	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889822	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889823	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889824	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889825	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889826	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889827	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889828	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889829	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Active	17889830	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	=	Kd	nM	199.0	CHEMBL301	Homo sapiens	Kd apparent	nM	199.0
Inactive	17889831	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889832	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889833	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889834	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Active	17889835	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	=	Kd	nM	1688.0	CHEMBL301	Homo sapiens	Kd apparent	nM	1688.0
Inactive	17889836	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889837	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889838	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889839	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889840	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889841	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889842	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889843	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Active	17889844	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	=	Kd	nM	2113.0	CHEMBL301	Homo sapiens	Kd apparent	nM	2113.0
Inactive	17889845	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889846	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17889847	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	=	Kd	nM	1656.0	CHEMBL301	Homo sapiens	Kd apparent	nM	1656.0
Active	17889848	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	739.0	CHEMBL301	Homo sapiens	Kd apparent	nM	739.0
Inactive	17889849	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889850	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889851	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889852	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889853	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889854	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889855	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889856	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889857	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889858	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889859	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Active	17889860	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	=	Kd	nM	72.0	CHEMBL301	Homo sapiens	Kd apparent	nM	72.0
Inactive	17889861	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889862	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889863	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889864	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889865	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889866	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889867	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889868	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889869	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889870	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889871	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889872	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889873	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889874	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889875	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889876	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889877	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889878	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Active	17889879	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	1337.0	CHEMBL301	Homo sapiens	Kd apparent	nM	1337.0
Inactive	17889880	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889881	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889882	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889883	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889884	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Active	17889885	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	101.0	CHEMBL301	Homo sapiens	Kd apparent	nM	101.0
Inactive	17889886	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889887	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889888	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889889	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889890	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889891	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889892	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889893	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Active	17889894	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	330.0	CHEMBL301	Homo sapiens	Kd apparent	nM	330.0
Inactive	17889895	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Active	17889896	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	=	Kd	nM	98.0	CHEMBL301	Homo sapiens	Kd apparent	nM	98.0
Inactive	17889897	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889898	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889899	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889900	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889901	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889902	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889903	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889904	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889905	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889906	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889907	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889908	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889909	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889910	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889911	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889912	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889913	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889914	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889915	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889916	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889917	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889918	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889919	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889920	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889921	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889922	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889923	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Active	17889924	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	205.0	CHEMBL301	Homo sapiens	Kd apparent	nM	205.0
Inactive	17889925	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889926	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Active	17889927	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	=	Kd	nM	90.0	CHEMBL301	Homo sapiens	Kd apparent	nM	90.0
Inactive	17889928	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889929	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889930	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889931	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889932	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889933	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889934	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889935	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889936	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889937	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889938	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889939	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889940	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889941	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889942	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889943	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889944	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889945	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889946	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889947	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889948	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889949	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889950	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889951	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889952	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889953	CHEMBL3991657	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL301	Homo sapiens	Kd apparent	nM	30000.0
	17964882	CHEMBL3994991	Inhibition of full length human CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	48.0	CHEMBL301	Homo sapiens	Activity	%	48.0
	18008356	CHEMBL4003709	Inhibition of CDK2 (unknown origin)	B	CN(C)CCn1cc(-c2ccn3c(-c4ccc(C(N)=O)c(OCc5cccc(F)c5)c4)cnc3c2)cn1		CHEMBL4062453	=	IC50	nM	370.0	CHEMBL301	Homo sapiens	IC50	nM	370.0
	18012409	CHEMBL4004229	Inhibition of CDK2 (unknown origin)	B	COc1cc2ncccc2cc1NC(=O)c1csc2cncnc12		CHEMBL3822972	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	18014704	CHEMBL4004555	Inhibition of CDK2 (unknown origin) at 1 uM	B	CN(C)Cc1ccc2ccc(Cl)c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL4077967	>	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	18014705	CHEMBL4004556	Inhibition of CDK2 (unknown origin)	B	CN(C)Cc1ccc2ccc(Cl)c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL4077967	=	IC50	nM	220.0	CHEMBL301	Homo sapiens	IC50	nM	220.0
	18015822	CHEMBL4004948	Inhibition of CDK2 (unknown origin)	B	Nc1nc(OCC2CCCCC2)c2nc[nH]c2n1		CHEMBL269881	=	IC50	nM	17000.0	CHEMBL301	Homo sapiens	IC50	uM	17.0
	18015823	CHEMBL4004948	Inhibition of CDK2 (unknown origin)	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	IC50	nM	5.0	CHEMBL301	Homo sapiens	IC50	uM	0.005
	18015824	CHEMBL4004948	Inhibition of CDK2 (unknown origin)	B	COc1nc(N)nc2nc[nH]c12		CHEMBL226395	>	IC50	nM	100000.0	CHEMBL301	Homo sapiens	IC50	uM	100.0
	18015825	CHEMBL4004948	Inhibition of CDK2 (unknown origin)	B	CCC(C)Oc1nc(N)nc2[nH]cnc12		CHEMBL259244	=	IC50	nM	49000.0	CHEMBL301	Homo sapiens	IC50	uM	49.0
	18015826	CHEMBL4004948	Inhibition of CDK2 (unknown origin)	B	CC[C@@H](C)Oc1nc(Nc2ccc(S(N)(=O)=O)cc2)nc(N)c1C=O		CHEMBL4088242	=	IC50	nM	0.8	CHEMBL301	Homo sapiens	IC50	nM	0.8
	18031638	CHEMBL4007692	Inhibition of CDK2 (unknown origin) after 60 mins by TR-FRET assay	B	CC1(C)OCC(=O)Nc2cc(Nc3nc(NCC(F)(F)F)c4occc4n3)ccc21		CHEMBL4069365	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	18033111	CHEMBL4007927	Inhibition of human CDK2 at 0.1 uM relative to control	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)[C@H]1CCCN1.Cl		CHEMBL4093614	=	Inhibition	%	8.0	CHEMBL301	Homo sapiens	INH	%	8.0
	18048937	CHEMBL4011135	Inhibition of CDK2 (unknown origin)	B	COCCn1cc(NC(=O)c2csc(-c3nncn3C(C)C)n2)cn1		CHEMBL4073198	=	IC50	nM	1000.0	CHEMBL301	Homo sapiens	pIC50		6.0
	18048938	CHEMBL4011135	Inhibition of CDK2 (unknown origin)	B	CC(C)(C)c1ccc(C(=O)Nc2cn3cc(-n4ccnc4)ccc3n2)cc1		CHEMBL1642655	=	IC50	nM	154.88	CHEMBL301	Homo sapiens	pIC50		6.81
Not Determined	18066711	CHEMBL4014529	Inhibition of human CDK2	B	COc1ccc(-c2cnc3scc(NC(=O)C4CCCCC4)c3c2)cc1OC		CHEMBL3334979		IC50			CHEMBL301	Homo sapiens	IC50		
	18066712	CHEMBL4014530	Inhibition of human CDK2 at 10 uM relative to control	B	CCOc1cc(/C=C2\Oc3ccc(OC)cc3C2=O)ccc1O		CHEMBL4105195	<	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	18066713	CHEMBL4014530	Inhibition of human CDK2 at 10 uM relative to control	B	COc1ccc2c(c1)C(=O)/C(=C/c1ccc(O)c(O)c1)O2		CHEMBL4087337	<	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	18066714	CHEMBL4014530	Inhibition of human CDK2 at 10 uM relative to control	B	O=C1/C(=C/c2ccc(O)c(O)c2)Oc2cc(O)ccc21		CHEMBL490355	<	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
Not Active	18099890	CHEMBL4021797	Inhibition of CDK2 (unknown origin) at 48 uM	B	Cc1ccc(CNc2nc(N)nc3[nH]c4cc(C)c(O)cc4c23)cc1		CHEMBL4098682		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	18114443	CHEMBL4025051	Inhibition of wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	99.0	CHEMBL301	Homo sapiens	Activity	%	99.0
	18153121	CHEMBL4034290	Inhibition of CDK2 Lysine 2 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	-6.6	CHEMBL301	Homo sapiens	INH	%	-6.6
	18153333	CHEMBL4034289	Inhibition of CDK2 Lysine 1 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	-2.3	CHEMBL301	Homo sapiens	INH	%	-2.3
	18203575	CHEMBL4043862	Inhibition of wild-type human full length CDK2 (M1 to L298 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL301	Homo sapiens	Activity	%	100.0
	18211592	CHEMBL4045658	Inhibition of CDK2 labeling at conserved Lys1 (LTGEVVALKK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	11.3	CHEMBL301	Homo sapiens	INH	%	11.3
	18211693	CHEMBL4045659	Inhibition of CDK2 labeling at conserved Lys2 (DLKPQNLLINTEGAIK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	16.8	CHEMBL301	Homo sapiens	INH	%	16.8
	18211805	CHEMBL4045901	Inhibition of CDK2 labeling at conserved Lys1 (LTGEVVALKK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	23.4	CHEMBL301	Homo sapiens	INH	%	23.4
	18211806	CHEMBL4045902	Inhibition of CDK2 labeling at conserved Lys2 (DLKPQNLLINTEGAIK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	19.2	CHEMBL301	Homo sapiens	INH	%	19.2
	18212150	CHEMBL4046168	Inhibition of CDK2 (unknown origin) at 1 uM relative to control	B	Cc1c(-c2ccncc2)c[nH]c1C(N)=O		CHEMBL4100387	<	Inhibition	%	20.0	CHEMBL301	Homo sapiens	INH	%	20.0
	18214071	CHEMBL4046600	Inhibition of CDK2 (unknown origin) at 70 nM relative to control	B	Cc1cc(Nc2nccc3nc(-c4c(Cl)cc(C#N)cc4Cl)[nH]c23)ncn1		CHEMBL4076947	>	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	18214073	CHEMBL4046602	Inhibition of CDK2 (unknown origin)	B	Cc1cc(Nc2nccc3nc(-c4c(Cl)cc(C#N)cc4Cl)[nH]c23)ncn1		CHEMBL4076947	=	Ki	nM	89.0	CHEMBL301	Homo sapiens	Ki	nM	89.0
	18225274	CHEMBL4048638	Inhibition of CDK2 (unknown origin) at 1 uM relative to control	B	N[C@H]1C[C@H](Oc2ccc3ncc(-c4ccc5cnccc5c4)n3n2)C1		CHEMBL4094080	=	Inhibition	%	17.0	CHEMBL301	Homo sapiens	INH	%	17.0
	18253755	CHEMBL4055162	Inhibition of wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL301	Homo sapiens	Activity	%	100.0
	18253756	CHEMBL4055162	Inhibition of wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	88.0	CHEMBL301	Homo sapiens	Activity	%	88.0
	18265768	CHEMBL4057218	Inhibition of CDK2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	6.0	CHEMBL301	Homo sapiens	INH	%	6.0
	18266016	CHEMBL4057466	Inhibition of CDK2 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	1.3	CHEMBL301	Homo sapiens	INH	%	1.3
	18266192	CHEMBL4057642	Inhibition of CDK2 (unknown origin) at 0.078 uM relative to control	B	COC(=O)Nc1noc2cc(-c3c(-c4ccccn4)n[nH]c3C)ccc12		CHEMBL4066592	=	Inhibition	%	-4.3	CHEMBL301	Homo sapiens	INH	%	-4.3
	18274827	CHEMBL4118321	Inhibition of CDK2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPQNLLINTEGAIK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	18.7	CHEMBL301	Homo sapiens	INH	%	18.7
	18274828	CHEMBL4118321	Inhibition of CDK2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPQNLLINTEGAIK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	33.1	CHEMBL301	Homo sapiens	INH	%	33.1
	18274829	CHEMBL4118321	Inhibition of CDK2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPQNLLINTEGAIK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	18276517	CHEMBL4119167	Binding affinity to CDK2 (unknown origin) by surface plasmon resonance analysis	B	C=C1CCC[C@@H]2[C@]1(C)CC[C@@]1(C)OC3=C(C[C@@]21C)C(=O)C(NC)=CC3=O		CHEMBL4126111	=	Kd	nM	4800.0	CHEMBL301	Homo sapiens	Kd	uM	4.8
	18282719	CHEMBL4120304	Inhibition of CDK2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	6.0	CHEMBL301	Homo sapiens	INH	%	6.0
	18282946	CHEMBL4120531	Inhibition of CDK2 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	-1.7	CHEMBL301	Homo sapiens	INH	%	-1.7
	18283170	CHEMBL4120755	Inhibition of CDK2 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	9.0	CHEMBL301	Homo sapiens	INH	%	9.0
Active	18299165	CHEMBL4124381	Inhibition of CDK2 in human MDA-MB-468 cells assessed as decrease in CDK2 phosphorylation at Thr180 residues at 15 uM after 12 to 26 hrs by Western blot analysis	B	COc1ccc(C(=O)NC2CCN(c3nccc(Nc4ccc(F)cc4)n3)CC2)cc1		CHEMBL4127826		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	18299166	CHEMBL4124382	Inhibition of CDK2 in human MDA-MB-468 cells assessed as decrease in cyclin E phosphorylation at Thr62 residues at 15 uM after 12 to 26 hrs by Western blot analysis	B	COc1ccc(C(=O)NC2CCN(c3nccc(Nc4ccc(F)cc4)n3)CC2)cc1		CHEMBL4127826		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	18299180	CHEMBL4124396	Inhibition of CDK2 in human MDA-MB-468 cells assessed as increase in bax expression level at 15 uM measured up to 36 hrs by Western blot analysis	B	COc1ccc(C(=O)NC2CCN(c3nccc(Nc4ccc(F)cc4)n3)CC2)cc1		CHEMBL4127826		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	18299181	CHEMBL4124397	Inhibition of CDK2 in human MDA-MB-468 cells assessed as increase in bim expression level at 15 uM measured up to 36 hrs by Western blot analysis	B	COc1ccc(C(=O)NC2CCN(c3nccc(Nc4ccc(F)cc4)n3)CC2)cc1		CHEMBL4127826		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	18299182	CHEMBL4124369	Inhibition of CDK2 in human MDA-MB-468 cells assessed as decrease in caspase 3 expression level at 15 uM measured up to 36 hrs by Western blot analysis	B	COc1ccc(C(=O)NC2CCN(c3nccc(Nc4ccc(F)cc4)n3)CC2)cc1		CHEMBL4127826		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	18299183	CHEMBL4124368	Inhibition of CDK2 in human MDA-MB-468 cells assessed as increase in cleaved caspase 3 expression level at 15 uM measured up to 36 hrs by Western blot analysis	B	COc1ccc(C(=O)NC2CCN(c3nccc(Nc4ccc(F)cc4)n3)CC2)cc1		CHEMBL4127826		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	18299184	CHEMBL4124367	Inhibition of CDK2 in human MDA-MB-468 cells assessed as increase in cleaved PARP expression level at 15 uM measured up to 36 hrs by Western blot analysis	B	COc1ccc(C(=O)NC2CCN(c3nccc(Nc4ccc(F)cc4)n3)CC2)cc1		CHEMBL4127826		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	18299187	CHEMBL4124400	Inhibition of CDK2 (unknown origin) expressed in baculovirus infected Sf9 insect cells using histone H1 as substrate after 1 hr by liquid scintillation counting analysis	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	=	IC50	nM	1.0	CHEMBL301	Homo sapiens	IC50	nM	1.0
	18307860	CHEMBL4131143	Inhibition of CDK2 (unknown origin) at 0.004 uM by CDKN2A antibody-based spectrophotometry	B	N=c1[nH]c(=O)[nH]c2c1cnn2-c1ccc(S(N)(=O)=O)cc1		CHEMBL4161364	=	Inhibition	%	12.59	CHEMBL301	Homo sapiens	INH	%	12.591523
	18307861	CHEMBL4131144	Inhibition of CDK2 (unknown origin) at 0.02 uM by CDKN2A antibody-based spectrophotometry	B	N=c1[nH]c(=O)[nH]c2c1cnn2-c1ccc(S(N)(=O)=O)cc1		CHEMBL4161364	=	Inhibition	%	39.03	CHEMBL301	Homo sapiens	INH	%	39.032691
	18307862	CHEMBL4131145	Inhibition of CDK2 (unknown origin) at 0.1 uM by CDKN2A antibody-based spectrophotometry	B	N=c1[nH]c(=O)[nH]c2c1cnn2-c1ccc(S(N)(=O)=O)cc1		CHEMBL4161364	=	Inhibition	%	53.13	CHEMBL301	Homo sapiens	INH	%	53.129834
	18307863	CHEMBL4131146	Inhibition of CDK2 (unknown origin) at 0.4 uM by CDKN2A antibody-based spectrophotometry	B	N=c1[nH]c(=O)[nH]c2c1cnn2-c1ccc(S(N)(=O)=O)cc1		CHEMBL4161364	=	Inhibition	%	68.8	CHEMBL301	Homo sapiens	INH	%	68.79842
	18307864	CHEMBL4131147	Inhibition of CDK2 (unknown origin) at 0.5 uM by CDKN2A antibody-based spectrophotometry	B	N=c1[nH]c(=O)[nH]c2c1cnn2-c1ccc(S(N)(=O)=O)cc1		CHEMBL4161364	=	Inhibition	%	81.81	CHEMBL301	Homo sapiens	INH	%	81.808807
	18307865	CHEMBL4131148	Inhibition of CDK2 (unknown origin) by CDKN2A antibody-based spectrophotometry	B	N=c1[nH]c(=O)[nH]c2c1cnn2-c1ccc(S(N)(=O)=O)cc1		CHEMBL4161364	=	IC50	nM	190.0	CHEMBL301	Homo sapiens	IC50	uM	0.19
Active	18409916	CHEMBL4151785	Inhibition of human full length CDK2 expressed in bacterial expression system at 1 uM	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	18409917	CHEMBL4151785	Inhibition of human full length CDK2 expressed in bacterial expression system at 1 uM	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	18409918	CHEMBL4151785	Inhibition of human full length CDK2 expressed in bacterial expression system at 1 uM	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	18409919	CHEMBL4151785	Inhibition of human full length CDK2 expressed in bacterial expression system at 1 uM	B	O=C(N[C@H]1CC[C@H](O)CC1)c1n[nH]cc1NC(=O)c1c(F)cccc1F		CHEMBL457177		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	18409920	CHEMBL4151786	Inhibition of human full length CDK3 expressed in bacterial expression system at 1 uM	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	18409921	CHEMBL4151786	Inhibition of human full length CDK3 expressed in bacterial expression system at 1 uM	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	18409922	CHEMBL4151786	Inhibition of human full length CDK3 expressed in bacterial expression system at 1 uM	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	18409923	CHEMBL4151786	Inhibition of human full length CDK3 expressed in bacterial expression system at 1 uM	B	O=C(N[C@H]1CC[C@H](O)CC1)c1n[nH]cc1NC(=O)c1c(F)cccc1F		CHEMBL457177		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	18420972	CHEMBL4153933	Inhibition of DNA-tagged CDK2 (unknown origin) expressed in HEK293 cells at 10 uM after 1 hr by real-time fluorescent quantitative PCR analysis	B	Fc1ccc(Nc2nc(N3CCOCC3)c3nc[nH]c3n2)cc1		CHEMBL4175978	=	Inhibition	%	73.0	CHEMBL301	Homo sapiens	INH	%	73.0
	18432274	CHEMBL4155881	Inhibition of CDK2 (unknown origin) by Hotspot assay	A	CN1CCN(Cc2ccc(NC(=O)c3n[nH]cc3Nc3ncnc4sccc34)cc2)CC1		CHEMBL4075720	=	IC50	nM	9.1	CHEMBL301	Homo sapiens	IC50	nM	9.1
	18432275	CHEMBL4155881	Inhibition of CDK2 (unknown origin) by Hotspot assay	A	Cc1nc(Nc2c[nH]nc2C(=O)Nc2ccc(CN3CCOCC3)cc2)c2cc(C(C)C)sc2n1		CHEMBL4171138	=	IC50	nM	25.4	CHEMBL301	Homo sapiens	IC50	nM	25.4
	18432276	CHEMBL4155881	Inhibition of CDK2 (unknown origin) by Hotspot assay	A	Cc1nc(Nc2c[nH]nc2C(=O)Nc2ccc(CN3CCN(C)CC3)cc2)c2cc(C(C)C)sc2n1		CHEMBL4160544	=	IC50	nM	21.5	CHEMBL301	Homo sapiens	IC50	nM	21.5
	18432277	CHEMBL4155881	Inhibition of CDK2 (unknown origin) by Hotspot assay	A	Cc1nc(Nc2c[nH]nc2C(=O)Nc2ccc(N3CCNCC3)cc2)c2ccsc2n1		CHEMBL4164331	=	IC50	nM	81.54	CHEMBL301	Homo sapiens	IC50	nM	81.54
	18432282	CHEMBL4155883	Inhibition of CDK2 (unknown origin) assessed as residual activity at 0.123 uM by Hotspot assay relative to control	A	CN1CCN(Cc2ccc(NC(=O)c3nn(C)cc3Nc3ncnc4[nH]ccc34)cc2)CC1		CHEMBL4161156	=	Activity	%	98.55	CHEMBL301	Homo sapiens	Activity	%	98.55
	18432283	CHEMBL4155883	Inhibition of CDK2 (unknown origin) assessed as residual activity at 0.123 uM by Hotspot assay relative to control	A	Cc1[nH]nc(C(=O)Nc2ccc(CN3CCN(C)CC3)cc2)c1Nc1ncnc2[nH]ccc12		CHEMBL4172459	=	Activity	%	99.9	CHEMBL301	Homo sapiens	Activity	%	99.9
	18432284	CHEMBL4155883	Inhibition of CDK2 (unknown origin) assessed as residual activity at 0.123 uM by Hotspot assay relative to control	A	Cc1[nH]nc(C(=O)Nc2ccc(CN3CCN(C)CC3)cc2)c1Nc1ncnc2sccc12		CHEMBL4164573	=	Activity	%	99.65	CHEMBL301	Homo sapiens	Activity	%	99.65
	18432285	CHEMBL4155883	Inhibition of CDK2 (unknown origin) assessed as residual activity at 0.123 uM by Hotspot assay relative to control	A	Cc1nc(Nc2c[nH]nc2C(=O)Nc2ccc(CN3CCN(C)CC3)cc2)c2ccsc2n1		CHEMBL4175865	=	Activity	%	51.1	CHEMBL301	Homo sapiens	Activity	%	51.1
	18432286	CHEMBL4155883	Inhibition of CDK2 (unknown origin) assessed as residual activity at 0.123 uM by Hotspot assay relative to control	A	Cc1nc(Nc2c[nH]nc2C(=O)Nc2ccc(CN3CCOCC3)cc2)c2ccsc2n1		CHEMBL4168002	=	Activity	%	51.96	CHEMBL301	Homo sapiens	Activity	%	51.96
	18432287	CHEMBL4155883	Inhibition of CDK2 (unknown origin) assessed as residual activity at 0.123 uM by Hotspot assay relative to control	A	CN1CCN(Cc2ccc(NC(=O)c3n[nH]cc3Nc3nc(C4CC4)nc4sccc34)cc2)CC1		CHEMBL4167778	=	Activity	%	89.75	CHEMBL301	Homo sapiens	Activity	%	89.75
	18432288	CHEMBL4155883	Inhibition of CDK2 (unknown origin) assessed as residual activity at 0.123 uM by Hotspot assay relative to control	A	O=C(Nc1ccc(CN2CCOCC2)cc1)c1n[nH]cc1Nc1nc(C2CC2)nc2sccc12		CHEMBL4175644	=	Activity	%	81.41	CHEMBL301	Homo sapiens	Activity	%	81.41
	18432289	CHEMBL4155883	Inhibition of CDK2 (unknown origin) assessed as residual activity at 0.123 uM by Hotspot assay relative to control	A	Cc1nc(Nc2c[nH]nc2C(=O)Nc2ccc(N3CCN(C)CC3)cc2)c2ccsc2n1		CHEMBL4160930	=	Activity	%	71.23	CHEMBL301	Homo sapiens	Activity	%	71.23
	18432290	CHEMBL4155883	Inhibition of CDK2 (unknown origin) assessed as residual activity at 0.123 uM by Hotspot assay relative to control	A	Cc1nc(Nc2c[nH]nc2C(=O)Nc2ccc(N3CCOCC3)cc2)c2ccsc2n1		CHEMBL4168869	=	Activity	%	78.81	CHEMBL301	Homo sapiens	Activity	%	78.81
	18432291	CHEMBL4155883	Inhibition of CDK2 (unknown origin) assessed as residual activity at 0.123 uM by Hotspot assay relative to control	A	O=C(Nc1ccc(N2CCNCC2)cc1)c1n[nH]cc1Nc1nc(Cl)nc2sccc12		CHEMBL4172223	=	Activity	%	56.82	CHEMBL301	Homo sapiens	Activity	%	56.82
	18432292	CHEMBL4155883	Inhibition of CDK2 (unknown origin) assessed as residual activity at 0.123 uM by Hotspot assay relative to control	A	O=C(Nc1ccc(N2CCNCC2)cc1)c1n[nH]cc1Nc1nc(C2CC2)nc2sccc12		CHEMBL4172658	=	Activity	%	97.44	CHEMBL301	Homo sapiens	Activity	%	97.44
	18432293	CHEMBL4155883	Inhibition of CDK2 (unknown origin) assessed as residual activity at 0.123 uM by Hotspot assay relative to control	A	CCc1nc(Nc2c[nH]nc2C(=O)Nc2ccc(N3CCNCC3)cc2)c2ccsc2n1		CHEMBL4162003	=	Activity	%	86.59	CHEMBL301	Homo sapiens	Activity	%	86.59
	18432294	CHEMBL4155883	Inhibition of CDK2 (unknown origin) assessed as residual activity at 0.123 uM by Hotspot assay relative to control	A	CC(C)c1nc(Nc2c[nH]nc2C(=O)Nc2ccc(N3CCNCC3)cc2)c2ccsc2n1		CHEMBL4167321	=	Activity	%	100.89	CHEMBL301	Homo sapiens	Activity	%	100.89
	18432295	CHEMBL4155883	Inhibition of CDK2 (unknown origin) assessed as residual activity at 0.123 uM by Hotspot assay relative to control	A	CC(C)(C)c1nc(Nc2c[nH]nc2C(=O)Nc2ccc(N3CCNCC3)cc2)c2ccsc2n1		CHEMBL4159414	=	Activity	%	100.32	CHEMBL301	Homo sapiens	Activity	%	100.32
	18432296	CHEMBL4155883	Inhibition of CDK2 (unknown origin) assessed as residual activity at 0.123 uM by Hotspot assay relative to control	A	Cc1nc2c(c(Nc3c[nH]nc3C(=O)Nc3ccc(N4CCNCC4)cc3)n1)CCC2		CHEMBL4163870	=	Activity	%	86.3	CHEMBL301	Homo sapiens	Activity	%	86.3
	18432297	CHEMBL4155883	Inhibition of CDK2 (unknown origin) assessed as residual activity at 0.123 uM by Hotspot assay relative to control	A	Cc1nc2c(c(Nc3c[nH]nc3C(=O)Nc3ccc(N4CCNCC4)cc3)n1)CCCC2		CHEMBL4159478	=	Activity	%	79.38	CHEMBL301	Homo sapiens	Activity	%	79.38
	18432335	CHEMBL4155886	Inhibition of CDK2 (unknown origin) at 0.123 uM by Hotspot assay relative to control	A	CN1CCN(Cc2ccc(NC(=O)c3n[nH]cc3Nc3ncnc4sccc34)cc2)CC1		CHEMBL4075720	>	Inhibition	%	80.0	CHEMBL301	Homo sapiens	INH	%	80.0
	18432336	CHEMBL4155886	Inhibition of CDK2 (unknown origin) at 0.123 uM by Hotspot assay relative to control	A	Cc1nc(Nc2c[nH]nc2C(=O)Nc2ccc(CN3CCOCC3)cc2)c2cc(C(C)C)sc2n1		CHEMBL4171138	>	Inhibition	%	80.0	CHEMBL301	Homo sapiens	INH	%	80.0
	18432337	CHEMBL4155886	Inhibition of CDK2 (unknown origin) at 0.123 uM by Hotspot assay relative to control	A	Cc1nc(Nc2c[nH]nc2C(=O)Nc2ccc(CN3CCN(C)CC3)cc2)c2cc(C(C)C)sc2n1		CHEMBL4160544	>	Inhibition	%	80.0	CHEMBL301	Homo sapiens	INH	%	80.0
	18432338	CHEMBL4155886	Inhibition of CDK2 (unknown origin) at 0.123 uM by Hotspot assay relative to control	A	Cc1nc(Nc2c[nH]nc2C(=O)Nc2ccc(N3CCNCC3)cc2)c2ccsc2n1		CHEMBL4164331	>	Inhibition	%	80.0	CHEMBL301	Homo sapiens	INH	%	80.0
	18440117	CHEMBL4156941	Binding affinity to wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	98.0	CHEMBL301	Homo sapiens	Activity	%	98.0
	18470574	CHEMBL4182568	Inhibition of human CDK2 at 10 uM by ADP-Glo kinase assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Inhibition	%	58.0	CHEMBL301	Homo sapiens	INH	%	58.0
	18470739	CHEMBL4182568	Inhibition of human CDK2 at 10 uM by ADP-Glo kinase assay	B	Cc1nc(N)c2ccn(C3CCN(C(=O)c4ccc(S(=O)(=O)F)cc4)CC3)c2n1		CHEMBL4206295	=	Inhibition	%	10.0	CHEMBL301	Homo sapiens	INH	%	10.0
	18470740	CHEMBL4182568	Inhibition of human CDK2 at 10 uM by ADP-Glo kinase assay	B	Nc1ncnc2c1ccn2C1CCN(C(=O)c2ccc(S(=O)(=O)F)cc2)CC1		CHEMBL4218073	=	Inhibition	%	0.0	CHEMBL301	Homo sapiens	INH	%	0.0
	18484557	CHEMBL4185720	Binding affinity to wild-type human full length CDK2 (M1 to L298 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	97.0	CHEMBL301	Homo sapiens	Activity	%	97.0
	18485064	CHEMBL4185720	Binding affinity to wild-type human full length CDK2 (M1 to L298 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL301	Homo sapiens	Activity	%	100.0
	18489497	CHEMBL4187238	Inhibition of wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	Activity	%	97.0	CHEMBL301	Homo sapiens	Activity	%	97.0
	18526976	CHEMBL4194447	Inhibition of CDK2 (unknown origin)	B	CN1CCN(CCCCOc2c(OCc3ccc(C#N)cc3)cc(O)c3c(=O)cc(-c4ccccc4)oc23)CC1		CHEMBL4206957	=	IC50	nM	6700.0	CHEMBL301	Homo sapiens	IC50	uM	6.7
	18577635	CHEMBL4222220	Inhibition of recombinant human CDK2 at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(N4CCC(N5CCOCC5)CC4)cc3OC)n2)c1		CHEMBL4225781	=	Inhibition	%	2.9	CHEMBL301	Homo sapiens	INH	%	2.9
	18577659	CHEMBL4222220	Inhibition of recombinant human CDK2 at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	=	Inhibition	%	5.1	CHEMBL301	Homo sapiens	INH	%	5.1
	18577683	CHEMBL4222220	Inhibition of recombinant human CDK2 at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3699588	=	Inhibition	%	1.2	CHEMBL301	Homo sapiens	INH	%	1.2
	18578788	CHEMBL4222455	Inhibition of CDK2 (unknown origin)	B	CCN(CCO)Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL4228240	>	IC50	nM	500.0	CHEMBL301	Homo sapiens	IC50	nM	500.0
	18578789	CHEMBL4222455	Inhibition of CDK2 (unknown origin)	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3ccccn3)ns2)n1		CHEMBL4227082	>	IC50	nM	500.0	CHEMBL301	Homo sapiens	IC50	nM	500.0
	18578790	CHEMBL4222455	Inhibition of CDK2 (unknown origin)	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(NC(C)(C)C)c3ccccn3)ns2)n1		CHEMBL4225923	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	uM	1.0
	18580285	CHEMBL4222685	Inhibition of CDK2 (unknown origin)	B	CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(C(=O)O)cc4)n3)c2c1		CHEMBL4228654	=	IC50	nM	3800.0	CHEMBL301	Homo sapiens	IC50	uM	3.8
	18580312	CHEMBL4222706	Inhibition of CDK2 (unknown origin) at 1 uM	B	CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(C(=O)O)cc4)n3)c2c1		CHEMBL4228654	>	Inhibition	%	70.0	CHEMBL301	Homo sapiens	INH	%	70.0
	18653725	CHEMBL4230041	Inhibition of CDK2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	3.0	CHEMBL301	Homo sapiens	INH	%	3.0
	18653726	CHEMBL4230041	Inhibition of CDK2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	1.0	CHEMBL301	Homo sapiens	INH	%	1.0
	18655615	CHEMBL4230620	Binding affinity to wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	95.0	CHEMBL301	Homo sapiens	Activity	%	95.0
	18663772	CHEMBL4232876	Inhibition of full length human CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	=	Activity	%	97.0	CHEMBL301	Homo sapiens	Activity	%	97.0
	18663989	CHEMBL4232973	Binding affinity to full length human CDK2 (M1 to L298 residues) expressed in bacterial expression system by KINOMEscan assay	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	>=	Kd	nM	5000.0	CHEMBL301	Homo sapiens	Kd	uM	5.0
	18665490	CHEMBL4233297	Inhibition of CDK2 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4251324	>	IC50	nM	3300.0	CHEMBL301	Homo sapiens	IC50	nM	3300.0
	18665555	CHEMBL4233297	Inhibition of CDK2 (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	5000.0	CHEMBL301	Homo sapiens	IC50	nM	5000.0
	18697618	CHEMBL4254291	Inhibition of wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	98.0	CHEMBL301	Homo sapiens	Activity	%	98.0
	18737035	CHEMBL4261255	Binding affinity to CDK2 (unknown origin) assessed as remaining unbound target protein level at 10 uM relative to control	B	COc1cc2c(=O)n(CCCN(C)C)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4280783	=	Activity	%	100.0	CHEMBL301	Homo sapiens	Activity	%	100.0
	18751159	CHEMBL4263755	Inhibition of CDK2 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	2.0	CHEMBL301	Homo sapiens	INH	%	2.0
	18751694	CHEMBL4264209	Binding affinity to wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	100.0	CHEMBL301	Homo sapiens	Activity	%	100.0
	18753842	CHEMBL4264839	Binding affinity to wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 0.1 uM after 1 hr by KinomeScan assay	B	O=C(Nc1ccc(Oc2c(Br)cnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4285809	=	Activity	%	0.0	CHEMBL301	Homo sapiens	Activity	%	0.0
	18753843	CHEMBL4264839	Binding affinity to wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 0.1 uM after 1 hr by KinomeScan assay	B	O=C(Nc1ccc(Oc2ccnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4277499	=	Activity	%	0.0	CHEMBL301	Homo sapiens	Activity	%	0.0
	18753844	CHEMBL4264839	Binding affinity to wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 0.1 uM after 1 hr by KinomeScan assay	B	CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2[nH]1		CHEMBL4285448	=	Activity	%	41.0	CHEMBL301	Homo sapiens	Activity	%	41.0
	18753845	CHEMBL4264839	Binding affinity to wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 0.1 uM after 1 hr by KinomeScan assay	B	Cc1cnc2[nH]cnc2c1Oc1ccc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc1F		CHEMBL4293688	=	Activity	%	0.0	CHEMBL301	Homo sapiens	Activity	%	0.0
	18753846	CHEMBL4264840	Binding affinity to wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 1 uM after 1 hr by KinomeScan assay	B	O=C(Nc1ccc(Oc2c(Br)cnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4285809	=	Activity	%	0.0	CHEMBL301	Homo sapiens	Activity	%	0.0
	18753847	CHEMBL4264840	Binding affinity to wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 1 uM after 1 hr by KinomeScan assay	B	O=C(Nc1ccc(Oc2ccnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4277499	=	Activity	%	0.0	CHEMBL301	Homo sapiens	Activity	%	0.0
	18753848	CHEMBL4264840	Binding affinity to wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 1 uM after 1 hr by KinomeScan assay	B	CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2[nH]1		CHEMBL4285448	=	Activity	%	95.5	CHEMBL301	Homo sapiens	Activity	%	95.5
	18753849	CHEMBL4264840	Binding affinity to wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 1 uM after 1 hr by KinomeScan assay	B	Cc1cnc2[nH]cnc2c1Oc1ccc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc1F		CHEMBL4293688	=	Activity	%	0.0	CHEMBL301	Homo sapiens	Activity	%	0.0
	18753850	CHEMBL4264841	Binding affinity to wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 10 uM after 1 hr by KinomeScan assay	B	O=C(Nc1ccc(Oc2c(Br)cnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4285809	=	Activity	%	32.0	CHEMBL301	Homo sapiens	Activity	%	32.0
	18753851	CHEMBL4264841	Binding affinity to wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 10 uM after 1 hr by KinomeScan assay	B	O=C(Nc1ccc(Oc2ccnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4277499	=	Activity	%	48.0	CHEMBL301	Homo sapiens	Activity	%	48.0
	18753852	CHEMBL4264841	Binding affinity to wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 10 uM after 1 hr by KinomeScan assay	B	CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2[nH]1		CHEMBL4285448	=	Activity	%	99.7	CHEMBL301	Homo sapiens	Activity	%	99.7
	18753853	CHEMBL4264841	Binding affinity to wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 10 uM after 1 hr by KinomeScan assay	B	Cc1cnc2[nH]cnc2c1Oc1ccc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc1F		CHEMBL4293688	=	Activity	%	3.0	CHEMBL301	Homo sapiens	Activity	%	3.0
	18766459	CHEMBL4267423	Inhibition of CDK2 (unknown origin)	B	CSc1ncc2c(n1)CCc1cnc(Nc3ccc(C(=O)N(C)CCN(C)C)cc3)nc1-2		CHEMBL4294760	=	IC50	nM	90.0	CHEMBL301	Homo sapiens	IC50	uM	0.09
	18784869	CHEMBL4271325	Inhibition of CDK2 (unknown origin)	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	IC50	nM	700.0	CHEMBL301	Homo sapiens	IC50	uM	0.7
	18784870	CHEMBL4271325	Inhibition of CDK2 (unknown origin)	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	IC50	nM	45.0	CHEMBL301	Homo sapiens	IC50	nM	45.0
	18784871	CHEMBL4271325	Inhibition of CDK2 (unknown origin)	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	IC50	nM	48.0	CHEMBL301	Homo sapiens	IC50	nM	48.0
	18784872	CHEMBL4271325	Inhibition of CDK2 (unknown origin)	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	IC50	nM	170.0	CHEMBL301	Homo sapiens	IC50	nM	170.0
	18784873	CHEMBL4271325	Inhibition of CDK2 (unknown origin)	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	=	IC50	nM	47.0	CHEMBL301	Homo sapiens	IC50	nM	47.0
	18784874	CHEMBL4271325	Inhibition of CDK2 (unknown origin)	B	C[C@@H](O)[C@@H](C)Oc1nc(Nc2ccc([S@](=N)(=O)C3CC3)cc2)ncc1C(F)(F)F		CHEMBL4282338	=	IC50	nM	9.0	CHEMBL301	Homo sapiens	IC50	nM	9.0
	18784883	CHEMBL4271330	Inhibition of recombinant CDK2 (unknown origin) expressed in Sf9 cells using histone H1 derived biotinylated peptide and 33P-ATP incubated for 1 hr by liquid scintillation counting method	B	Cc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@@H]3CCO)nc12		CHEMBL4292930	=	IC50	nM	1.0	CHEMBL301	Homo sapiens	IC50	nM	1.0
Not Active	18847335	CHEMBL4304885	Inhibition of wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl		CHEMBL4517719		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	18857879	CHEMBL4307725	Binding affinity to wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	92.0	CHEMBL301	Homo sapiens	Activity	%	92.0
	18871043	CHEMBL4310013	Inhibition of CDK2 (unknown origin)	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	IC50	nM	400.0	CHEMBL301	Homo sapiens	IC50	uM	0.4
	18871044	CHEMBL4310013	Inhibition of CDK2 (unknown origin)	B	O=C1Nc2ccc3ncsc3c2/C1=C/Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1276446	=	IC50	nM	10.0	CHEMBL301	Homo sapiens	IC50	nM	10.0
	18895097	CHEMBL4315522	Inhibition of CDK2 (unknown origin) incubated for 40 mins by ADP-glo assay	B	CC(C)C/C=N/c1c(C#N)c2n(c1C(=O)Nc1ccc(Br)cc1)CCC2		CHEMBL4592358	=	IC50	nM	1270.0	CHEMBL301	Homo sapiens	IC50	uM	1.27
	18895098	CHEMBL4315522	Inhibition of CDK2 (unknown origin) incubated for 40 mins by ADP-glo assay	B	CC/C=N/c1c(C#N)c2n(c1C(=O)Nc1ccccc1)CCC2		CHEMBL4527978	=	IC50	nM	580.0	CHEMBL301	Homo sapiens	IC50	uM	0.58
	18895099	CHEMBL4315522	Inhibition of CDK2 (unknown origin) incubated for 40 mins by ADP-glo assay	B	CCC1SCC(=O)N1c1c(C#N)c2n(c1C(=O)Nc1ccccc1)CCC2		CHEMBL4471323	=	IC50	nM	630.0	CHEMBL301	Homo sapiens	IC50	uM	0.63
	18895100	CHEMBL4315522	Inhibition of CDK2 (unknown origin) incubated for 40 mins by ADP-glo assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	IC50	nM	100000.0	CHEMBL301	Homo sapiens	IC50	uM	100.0
	18928760	CHEMBL4325176	Inhibition of human CDK2 using biotinylated-aminohexyl-Ala-Ala-Ala-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser(PO3)-Tyr-Arg-amide as substrate after 40 mins in presence of [gamma-32P]ATP by scintillation proximity assay	A	c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359554	=	IC50	nM	5.012	CHEMBL301	Homo sapiens	pIC50		8.3
	18928761	CHEMBL4325176	Inhibition of human CDK2 using biotinylated-aminohexyl-Ala-Ala-Ala-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser(PO3)-Tyr-Arg-amide as substrate after 40 mins in presence of [gamma-32P]ATP by scintillation proximity assay	A	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189665	<	IC50	nM	19952.62	CHEMBL301	Homo sapiens	pIC50		4.7
	18928762	CHEMBL4325176	Inhibition of human CDK2 using biotinylated-aminohexyl-Ala-Ala-Ala-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser(PO3)-Tyr-Arg-amide as substrate after 40 mins in presence of [gamma-32P]ATP by scintillation proximity assay	A	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	IC50	nM	1.995	CHEMBL301	Homo sapiens	pIC50		8.7
	18928763	CHEMBL4325176	Inhibition of human CDK2 using biotinylated-aminohexyl-Ala-Ala-Ala-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser(PO3)-Tyr-Arg-amide as substrate after 40 mins in presence of [gamma-32P]ATP by scintillation proximity assay	A	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	IC50	nM	199.53	CHEMBL301	Homo sapiens	pIC50		6.7
	18928764	CHEMBL4325176	Inhibition of human CDK2 using biotinylated-aminohexyl-Ala-Ala-Ala-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser(PO3)-Tyr-Arg-amide as substrate after 40 mins in presence of [gamma-32P]ATP by scintillation proximity assay	A	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	IC50	nM	15.85	CHEMBL301	Homo sapiens	pIC50		7.8
	18928765	CHEMBL4325176	Inhibition of human CDK2 using biotinylated-aminohexyl-Ala-Ala-Ala-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser(PO3)-Tyr-Arg-amide as substrate after 40 mins in presence of [gamma-32P]ATP by scintillation proximity assay	A	Cc1cc(C)cc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL186101	=	IC50	nM	3.162	CHEMBL301	Homo sapiens	pIC50		8.5
	18928766	CHEMBL4325176	Inhibition of human CDK2 using biotinylated-aminohexyl-Ala-Ala-Ala-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser(PO3)-Tyr-Arg-amide as substrate after 40 mins in presence of [gamma-32P]ATP by scintillation proximity assay	A	Fc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1F		CHEMBL364370	=	IC50	nM	1.995	CHEMBL301	Homo sapiens	pIC50		8.7
	18928767	CHEMBL4325176	Inhibition of human CDK2 using biotinylated-aminohexyl-Ala-Ala-Ala-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser(PO3)-Tyr-Arg-amide as substrate after 40 mins in presence of [gamma-32P]ATP by scintillation proximity assay	A	Fc1ccc(Nc2nccc(-c3c(C4CC4)nn4ncccc34)n2)cc1F		CHEMBL185516	<	IC50	nM	19952.62	CHEMBL301	Homo sapiens	pIC50		4.7
	18928768	CHEMBL4325176	Inhibition of human CDK2 using biotinylated-aminohexyl-Ala-Ala-Ala-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser(PO3)-Tyr-Arg-amide as substrate after 40 mins in presence of [gamma-32P]ATP by scintillation proximity assay	A	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	IC50	nM	6.31	CHEMBL301	Homo sapiens	pIC50		8.2
	18928769	CHEMBL4325176	Inhibition of human CDK2 using biotinylated-aminohexyl-Ala-Ala-Ala-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser(PO3)-Tyr-Arg-amide as substrate after 40 mins in presence of [gamma-32P]ATP by scintillation proximity assay	A	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	<	IC50	nM	19952.62	CHEMBL301	Homo sapiens	pIC50		4.7
	18928770	CHEMBL4325176	Inhibition of human CDK2 using biotinylated-aminohexyl-Ala-Ala-Ala-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser(PO3)-Tyr-Arg-amide as substrate after 40 mins in presence of [gamma-32P]ATP by scintillation proximity assay	A	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	<	IC50	nM	19952.62	CHEMBL301	Homo sapiens	pIC50		4.7
	18928771	CHEMBL4325176	Inhibition of human CDK2 using biotinylated-aminohexyl-Ala-Ala-Ala-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser(PO3)-Tyr-Arg-amide as substrate after 40 mins in presence of [gamma-32P]ATP by scintillation proximity assay	A	CC(C)(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL364587	=	IC50	nM	158.49	CHEMBL301	Homo sapiens	pIC50		6.8
	18928772	CHEMBL4325176	Inhibition of human CDK2 using biotinylated-aminohexyl-Ala-Ala-Ala-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser(PO3)-Tyr-Arg-amide as substrate after 40 mins in presence of [gamma-32P]ATP by scintillation proximity assay	A	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	<	IC50	nM	19952.62	CHEMBL301	Homo sapiens	pIC50		4.7
	18958797	CHEMBL4333316	Binding affinity to wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	66.0	CHEMBL301	Homo sapiens	Activity	%	66.0
	19015991	CHEMBL4346821	Binding affinity to wild-type CDK2 (unknown origin) expressed in baculovirus infected Sf9 insect cells by isothermal titration calorimetric method	B	CN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4ccnc(N)n4)cc3)cc2C(F)(F)F)CC1		CHEMBL4472486	=	Kd	nM	52.7	CHEMBL301	Homo sapiens	Kd	nM	52.7
	19016007	CHEMBL4346796	Inhibition of CDK2 (unknown origin)	B	Cc1nc(C)c(-c2ccnc(Nc3cccc([N+](=O)[O-])c3)n2)s1		CHEMBL45408	=	Ki	nM	110.0	CHEMBL301	Homo sapiens	Ki	nM	110.0
	19016008	CHEMBL4346796	Inhibition of CDK2 (unknown origin)	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Br)cc32)cc1		CHEMBL411491	=	IC50	nM	60.0	CHEMBL301	Homo sapiens	IC50	nM	60.0
	19016009	CHEMBL4346796	Inhibition of CDK2 (unknown origin)	B	Cc1cc(C)c(CNc2nc(N[C@@H](C)[C@@H](C)O)nc3c2ncn3C(C)C)cn1		CHEMBL4579344	=	IC50	nM	5.0	CHEMBL301	Homo sapiens	IC50	nM	5.0
	19016050	CHEMBL4346796	Inhibition of CDK2 (unknown origin)	B	Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL298445	=	Ki	nM	396.0	CHEMBL301	Homo sapiens	Ki	nM	396.0
	19016051	CHEMBL4346796	Inhibition of CDK2 (unknown origin)	B	Cc1nc(C)c(-c2ccnc(N)n2)s1		CHEMBL47302	=	Ki	nM	396.0	CHEMBL301	Homo sapiens	Ki	nM	396.0
	19016052	CHEMBL4346796	Inhibition of CDK2 (unknown origin)	B	COc1cc[nH]c1/C=C1\C(=O)Nc2ccc(F)c(C#C[C@@H](O)[C@@H](N)[C@@H](C)O)c21		CHEMBL354634	=	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	nM	3.0
	19016053	CHEMBL4346796	Inhibition of CDK2 (unknown origin)	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2C1=O		CHEMBL1276127	=	IC50	nM	2200.0	CHEMBL301	Homo sapiens	IC50	nM	2200.0
	19016063	CHEMBL4346788	Inhibition of recombinant CDK2 (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotinylated-histone H1 as substrate incubated for 1 hr in presence of cyclin by [33P]-ATP-based liquid scintillation counting method	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	=	IC50	nM	1.0	CHEMBL301	Homo sapiens	IC50	nM	1.0
	19016080	CHEMBL4346822	Binding affinity to CDK2 (unknown origin)	B	C=CS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL4518287	=	Kd	nM	1310.0	CHEMBL301	Homo sapiens	Kd	uM	1.31
	19027205	CHEMBL4348716	Inhibition of CDK2 (unknown origin)	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	IC50	nM	170.0	CHEMBL301	Homo sapiens	IC50	nM	170.0
	19027206	CHEMBL4348716	Inhibition of CDK2 (unknown origin)	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	IC50	nM	220.0	CHEMBL301	Homo sapiens	IC50	nM	220.0
	19027207	CHEMBL4348716	Inhibition of CDK2 (unknown origin)	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	19027208	CHEMBL4348716	Inhibition of CDK2 (unknown origin)	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	19027209	CHEMBL4348716	Inhibition of CDK2 (unknown origin)	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	IC50	nM	500.0	CHEMBL301	Homo sapiens	IC50	nM	500.0
	19027227	CHEMBL4348723	Inhibition of recombinant CDK2 (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotinylated peptide as substrate after 1 hr in presence of [33P]ATP by TopCount scintillation counting method	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	=	IC50	nM	1.0	CHEMBL301	Homo sapiens	IC50	nM	1.0
	19059497	CHEMBL4357798	Binding affinity to wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL301	Homo sapiens	Activity	%	100.0
	19090069	CHEMBL4365643	Inhibition of wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL301	Homo sapiens	Activity	%	100.0
	19108021	CHEMBL4369887	Inhibition of CDK2 (unknown origin)	B	CNc1ncc2c(-c3ccc(N4CCNCC4)cc3)nn(CC3CCC(N)CC3)c2n1		CHEMBL2036792	=	IC50	nM	114.0	CHEMBL301	Homo sapiens	IC50	uM	0.114
Not Active	19108046	CHEMBL4369911	Inhibition of human CDK2 by kinobeads-based assay	B	C[C@H]1CN(c2n[nH]c3nc(N[C@H]4CC[C@H](NS(=O)(=O)CCC(F)(F)F)CC4)ncc23)CCO1		CHEMBL4563818		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	19108047	CHEMBL4369911	Inhibition of human CDK2 by kinobeads-based assay	B	COc1ccccc1-c1n[nH]c2nc(N[C@H]3CC[C@H](NS(=O)(=O)CCC(F)(F)F)CC3)nc(OC)c12		CHEMBL4516798		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	19108048	CHEMBL4369911	Inhibition of human CDK2 by kinobeads-based assay	B	COc1nc(N[C@H]2CC[C@H](NS(=O)(=O)CCC(C)C)CC2)nc2[nH]nc(N3CCOC[C@H]3C)c12		CHEMBL4572962		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	19112047	CHEMBL4370680	Inhibition of CDK2 (unknown origin)	B	COc1c(O)cc(O)c2c(=O)cc(-c3ccccc3)oc12		CHEMBL16171	=	IC50	nM	1460.0	CHEMBL301	Homo sapiens	IC50	uM	1.46
	19112048	CHEMBL4370680	Inhibition of CDK2 (unknown origin)	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Ki	nM	40.0	CHEMBL301	Homo sapiens	Ki	nM	40.0
	19121968	CHEMBL4373026	Inhibition of CDK2 (unknown origin) at 0.1 uM relative to control	B	COCCC#Cc1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1[C@H]1CCCNC1		CHEMBL4540910	=	Inhibition	%	26.0	CHEMBL301	Homo sapiens	INH	%	26.0
	19121976	CHEMBL4373034	Inhibition of CDK2 (unknown origin) at 1 uM relative to control	B	COCCC#Cc1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1[C@H]1CCCNC1		CHEMBL4540910	=	Inhibition	%	71.0	CHEMBL301	Homo sapiens	INH	%	71.0
	19133279	CHEMBL4375324	Binding affinity to wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system measured after 1 hr by kinomescan method	B	O=C(Nc1ccc2cc(C(=O)Nc3nccs3)ccc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL4445812	=	Kd	nM	8020.0	CHEMBL301	Homo sapiens	Kd	uM	8.02
	19159325	CHEMBL4382429	Binding affinity to wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	83.0	CHEMBL301	Homo sapiens	Activity	%	83.0
Tde	19176761	CHEMBL4386198	Inhibition of CDK2 in human Mino cells assessed as decrease in phosphorylation of RNA polymerase 2 C-terminal domain at Ser 2 residue at 12.5 nM by immunoblotting analysis	B	CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(SCCN)nc12		CHEMBL4540226		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Tde	19176762	CHEMBL4386199	Inhibition of CDK2 in human Mino cells assessed as decrease in phosphorylation of RNA polymerase 2 C-terminal domain at Ser 5 residue at 12.5 nM by immunoblotting analysis	B	CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(SCCN)nc12		CHEMBL4540226		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Tde	19176767	CHEMBL4386204	Inhibition of CDK2 in human Mino cells assessed as decrease in phosphorylation of Rb at Ser 608 residue at 12.5 nM by immunoblotting analysis	B	CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(SCCN)nc12		CHEMBL4540226		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Tde	19176768	CHEMBL4386205	Inhibition of CDK2 in human Mino cells assessed as decrease in phosphorylation of Rb at Ser 780 residue at 12.5 nM by immunoblotting analysis	B	CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(SCCN)nc12		CHEMBL4540226		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	19191682	CHEMBL4389148	Inhibition of wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	67.0	CHEMBL301	Homo sapiens	INH	%	67.0
	19191811	CHEMBL4389625	Inhibition of wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	99.0	CHEMBL301	Homo sapiens	INH	%	99.0
	19199971	CHEMBL4391251	Binding affinity to wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	74.0	CHEMBL301	Homo sapiens	Activity	%	74.0
Dose-dependent effect	19204642	CHEMBL4392061	Binding affinity to full-length human CDK2 expressed in Escherichia coli BL21 (DE3) pLysS cells by isothermal titration calorimetry	B	Nc1nc(-c2cccc(CC(=O)O)c2)c2nc[nH]c2n1		CHEMBL4564592		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	19204643	CHEMBL4392063	Binding affinity to full-length human CDK2 expressed in Escherichia coli BL21 (DE3) pLysS cells at 1 to 5 mM by isothermal titration calorimetry	B	Nc1nc(Oc2cccc(CC(=O)O)c2)c2nc[nH]c2n1		CHEMBL4464064		Activity			CHEMBL301	Homo sapiens	Activity		
Nd(Insoluble)	19204644	CHEMBL4392063	Binding affinity to full-length human CDK2 expressed in Escherichia coli BL21 (DE3) pLysS cells at 1 to 5 mM by isothermal titration calorimetry	B	Nc1cccc(N)n1		CHEMBL339234		Activity			CHEMBL301	Homo sapiens	Activity		
Not Active	19204645	CHEMBL4392062	Binding affinity to full-length human CDK2 expressed in Escherichia coli BL21 (DE3) pLysS cells at 5 mM by isothermal titration calorimetry	B	NS(=O)(=O)c1ccc(Br)cc1		CHEMBL178852		Activity			CHEMBL301	Homo sapiens	Activity		
	19204646	CHEMBL4392061	Binding affinity to full-length human CDK2 expressed in Escherichia coli BL21 (DE3) pLysS cells by isothermal titration calorimetry	B	Nc1nc(I)c2nc[nH]c2n1		CHEMBL4449374	=	Kd	nM	350000.0	CHEMBL301	Homo sapiens	Kd	uM	350.0
	19204647	CHEMBL4392061	Binding affinity to full-length human CDK2 expressed in Escherichia coli BL21 (DE3) pLysS cells by isothermal titration calorimetry	B	Nc1nc(-c2cccc(CC(=O)O)c2)c2nc[nH]c2n1		CHEMBL4564592	=	Kd	nM	50000.0	CHEMBL301	Homo sapiens	Kd	uM	50.0
Not Active	19204648	CHEMBL4392062	Binding affinity to full-length human CDK2 expressed in Escherichia coli BL21 (DE3) pLysS cells at 5 mM by isothermal titration calorimetry	B	Brc1cn[nH]c1		CHEMBL4440111		Activity			CHEMBL301	Homo sapiens	Activity		
	19219387	CHEMBL4394704	Inhibition of CDK2 (unknown origin) using biotin-labelled STK substrate-1 as substrate incubated for 60 mins by HTRF assay	B	CC(=O)O.CNc1nc(Nc2cnc(C#N)c(O[C@@H]3CCCNC3)c2)ncc1-c1cnn(C)c1		CHEMBL4577258	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	19219489	CHEMBL4394704	Inhibition of CDK2 (unknown origin) using biotin-labelled STK substrate-1 as substrate incubated for 60 mins by HTRF assay	B	COc1cccc(OCCCN)c1-c1cc(Nc2cnc(C#N)cn2)n[nH]1		CHEMBL3544911	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	19225454	CHEMBL4395874	Inhibition of human recombinant CDK2 at 1 uM using Ulight-CFFKNIVTPRTPPPSQGK-amide as substrate incubated for 30 mins in presence of ATP by LANCE assay relative to control	B	CCc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4536012	=	Inhibition	%	11.15	CHEMBL301	Homo sapiens	INH	%	11.15
	19230864	CHEMBL4397157	Inhibition of CDK2 (unknown origin) at 100 nM by [gamma-33P]ATP-based radiometric or Alphascreen assay relative to control	B	Cc1cc(-n2cc(C(=O)N3CCO[C@@H](C)C3)c3ccc(O[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL4440381	=	Inhibition	%	5.0	CHEMBL301	Homo sapiens	INH	%	5.0
	19258237	CHEMBL4403340	Inhibition of CDK2 (unknown origin)	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	IC50	nM	170.0	CHEMBL301	Homo sapiens	IC50	nM	170.0
	19258244	CHEMBL4403340	Inhibition of CDK2 (unknown origin)	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	IC50	nM	90.0	CHEMBL301	Homo sapiens	IC50	nM	90.0
	19258251	CHEMBL4403340	Inhibition of CDK2 (unknown origin)	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	IC50	nM	48.0	CHEMBL301	Homo sapiens	IC50	nM	48.0
	19258253	CHEMBL4403340	Inhibition of CDK2 (unknown origin)	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	=	IC50	nM	1.0	CHEMBL301	Homo sapiens	IC50	nM	1.0
	19258277	CHEMBL4403340	Inhibition of CDK2 (unknown origin)	B	CC(C)c1cnn2c(NCc3ccccc3)cc(NC[C@H]3CCNC[C@@H]3O)nc12		CHEMBL4297488	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	19258280	CHEMBL4403340	Inhibition of CDK2 (unknown origin)	B	CC(C)c1cnn2c(NCc3ccccc3N(C)C)nc(OC3CCN(C)CC3)nc12		CHEMBL4454044	=	IC50	nM	3900.0	CHEMBL301	Homo sapiens	IC50	nM	3900.0
	19258286	CHEMBL4403340	Inhibition of CDK2 (unknown origin)	B	CC(C)c1cnn2c(NCc3ccccc3-n3cccn3)nc(OC3CCCNC3)nc12		CHEMBL4562323	=	IC50	nM	6.4	CHEMBL301	Homo sapiens	IC50	nM	6.4
	19258291	CHEMBL4403340	Inhibition of CDK2 (unknown origin)	B	CC(C)c1cnn2c(NCc3cccc4[nH]ncc34)nc(OC3CCCNC3)nc12		CHEMBL4552441	<	IC50	nM	50.0	CHEMBL301	Homo sapiens	IC50	nM	50.0
	19258294	CHEMBL4403340	Inhibition of CDK2 (unknown origin)	B	CC(C)c1cnn2c(NCc3cccc4c3cnn4C)nc(OC3CCCNC3)nc12		CHEMBL4440386	<	IC50	nM	50.0	CHEMBL301	Homo sapiens	IC50	nM	50.0
	19258297	CHEMBL4403340	Inhibition of CDK2 (unknown origin)	B	Clc1cnc(N[C@H]2CCCNC2)nc1-c1c[nH]c2ccccc12		CHEMBL4555799	>	IC50	nM	200.0	CHEMBL301	Homo sapiens	IC50	nM	200.0
	19258300	CHEMBL4403340	Inhibition of CDK2 (unknown origin)	B	Clc1cnc(N[C@@H]2CCCNC2)nc1-c1c[nH]c2ccccc12		CHEMBL4533453	>	IC50	nM	200.0	CHEMBL301	Homo sapiens	IC50	nM	200.0
	19258303	CHEMBL4403353	Inhibition of CDK2 (unknown origin) after 4 hrs	B	FC(F)(F)c1cnc(N[C@H]2CCCNC2)nc1-c1n[nH]c2ccccc12		CHEMBL4474655	>	IC50	nM	200.0	CHEMBL301	Homo sapiens	IC50	nM	200.0
	19258312	CHEMBL4403340	Inhibition of CDK2 (unknown origin)	B	CN(C)C/C=C/C(=O)Nc1cccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)c1		CHEMBL4303287	=	IC50	nM	96.9	CHEMBL301	Homo sapiens	IC50	nM	96.9
	19272029	CHEMBL4406974	Inhibition of wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as enzyme remaining activity at 1000 nM by Kinomescan method relative to control	B	O=C(Nc1cccc(Br)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4465561	=	Activity	%	93.0	CHEMBL301	Homo sapiens	Activity	%	93.0
	19272136	CHEMBL4407029	Inhibition of CDK2 (unknown origin)	B	COc1ccc(-c2n[nH]c3c2C(=O)c2c(C=O)cccc2-3)cc1		CHEMBL4453997	=	IC50	nM	57.0	CHEMBL301	Homo sapiens	IC50	nM	57.0
	19272137	CHEMBL4407029	Inhibition of CDK2 (unknown origin)	B	COc1ccc(-c2[nH]nc3c2C(=O)c2c(NC(=O)CN4CCN(C(=N)N)CC4)cccc2-3)cc1		CHEMBL148580	=	IC50	nM	13.0	CHEMBL301	Homo sapiens	IC50	nM	13.0
	19272138	CHEMBL4407029	Inhibition of CDK2 (unknown origin)	B	NC(=O)Nc1cccc2c1C(=O)c1c(-c3csc(Cl)c3)n[nH]c1-2		CHEMBL151546	=	IC50	nM	46.0	CHEMBL301	Homo sapiens	IC50	nM	46.0
	19272139	CHEMBL4407029	Inhibition of CDK2 (unknown origin)	B	O=C(Nc1cccc2c1C(=O)c1c(-c3ccc(C(=O)N4CCNCC4)s3)n[nH]c1-2)NN1CCOCC1		CHEMBL334285	=	IC50	nM	8.0	CHEMBL301	Homo sapiens	IC50	nM	8.0
	19279474	CHEMBL4408800	Binding affinity to CDK2 (unknown origin)	B	C=CS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL4518287	=	Kd	nM	1300.0	CHEMBL301	Homo sapiens	Kd	uM	1.3
	19279475	CHEMBL4408799	Binding affinity to CDK2 (unknown origin) assessed as inactivation constant	B	C=CS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL4518287	=	Kinact	10'3/M/s	5.0	CHEMBL301	Homo sapiens	Kinact	10'3/M/s	5.0
	19279476	CHEMBL4408798	Binding affinity to CDK2 (unknown origin) assessed as dissociation rate constant	B	C=CS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1	Non standard unit for type	CHEMBL4518287	=	K	/s	0.07	CHEMBL301	Homo sapiens	K	/s	0.07
	19279477	CHEMBL4408797	Binding affinity to CDK2 (unknown origin) assessed as association rate constant	B	C=CS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1	Non standard unit for type	CHEMBL4518287	=	K	10'6/M/s	0.55	CHEMBL301	Homo sapiens	K	10'6/M/s	0.55
	19279483	CHEMBL4408771	Competitive reversible inhibition of CDK2 (unknown origin)	B	CC(C)c1cnn2c(NCc3ccccc3)cc(NC[C@H]3CCNC[C@@H]3O)nc12		CHEMBL4297488	=	IC50	nM	620.0	CHEMBL301	Homo sapiens	IC50	nM	620.0
	19279513	CHEMBL4408759	Inhibition of CDK2 (unknown origin)	B	O=C1Nc2ccc([N+](=O)[O-])cc2/C1=C1/Nc2ccc(O)cc2/C1=N\O		CHEMBL4457608	=	IC50	nM	2.0	CHEMBL301	Homo sapiens	IC50	nM	2.0
	19279515	CHEMBL4408786	Inhibition of CDK2 (unknown origin) relative to control	B	C=CC(=O)N1CCN(C(=O)OC(C)(C)C)c2ccccc21		CHEMBL4544461	=	Inhibition	%	83.0	CHEMBL301	Homo sapiens	INH	%	83.0
	19279516	CHEMBL4408786	Inhibition of CDK2 (unknown origin) relative to control	B	C=CC(=O)N1CCN(C(=O)OC)c2ccccc21		CHEMBL4578788	=	Inhibition	%	5.0	CHEMBL301	Homo sapiens	INH	%	5.0
	19279530	CHEMBL4408771	Competitive reversible inhibition of CDK2 (unknown origin)	B	CC(C)c1cnn2c(NCc3ccccc3)cc(NCCCCCCN)nc12		CHEMBL1801932	=	IC50	nM	900.0	CHEMBL301	Homo sapiens	IC50	nM	900.0
	19279536	CHEMBL4408771	Competitive reversible inhibition of CDK2 (unknown origin)	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833	=	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	nM	3.0
	19368538	CHEMBL4424361	Inhibition of CDK2 (unknown origin) at 5 uM after 3 hrs by kinase-glo luminescent assay relative to control	B	CC(C)n1cnc2c(NCc3cccc(C(F)(F)F)c3)ncnc21		CHEMBL4471178	>	Inhibition	%	30.0	CHEMBL301	Homo sapiens	INH	%	30.0
	19368564	CHEMBL4424379	Inhibition of CDK2 (unknown origin) after 3 hrs by kinase-glo luminescent assay relative to control	B	CC(C)n1cnc2c(NCc3cccc(C(F)(F)F)c3)ncnc21		CHEMBL4471178	=	IC50	nM	13000.0	CHEMBL301	Homo sapiens	IC50	uM	13.0
	19368565	CHEMBL4424379	Inhibition of CDK2 (unknown origin) after 3 hrs by kinase-glo luminescent assay relative to control	B	CC(C1CC1)n1cnc2c(NCc3cccc(C(F)(F)F)c3)nc(NCCN(C)C)nc21		CHEMBL4462126	=	IC50	nM	37000.0	CHEMBL301	Homo sapiens	IC50	uM	37.0
	19368566	CHEMBL4424379	Inhibition of CDK2 (unknown origin) after 3 hrs by kinase-glo luminescent assay relative to control	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	IC50	nM	400.0	CHEMBL301	Homo sapiens	IC50	uM	0.4
	19439581	CHEMBL4431135	Inhibition of CDK2 (unknown origin) assessed as remaining enzyme activity at 1 uM	B	CC(=O)c1ccc(-c2c[nH]c3ncc(/C=C/C(=O)NCCc4ccccn4)cc23)cc1		CHEMBL4521500	=	Activity	%	85.0	CHEMBL301	Homo sapiens	Activity	%	85.0
	19439582	CHEMBL4431135	Inhibition of CDK2 (unknown origin) assessed as remaining enzyme activity at 1 uM	B	COc1ccc(-c2c[nH]c3ncc(/C=C/C(=O)NCc4ccncc4)cc23)cc1		CHEMBL4468662	=	Activity	%	97.0	CHEMBL301	Homo sapiens	Activity	%	97.0
	19476555	CHEMBL4479703	Inhibition of full-length recombinant human His-tagged CDK2 expressed in baculovirus expression system by Z'-LYTE assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	=	IC50	nM	12.0	CHEMBL301	Homo sapiens	IC50	nM	12.0
	19476655	CHEMBL4479703	Inhibition of full-length recombinant human His-tagged CDK2 expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	<	IC50	nM	10.0	CHEMBL301	Homo sapiens	IC50	nM	10.0
	19476755	CHEMBL4479703	Inhibition of full-length recombinant human His-tagged CDK2 expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	=	IC50	nM	2.2	CHEMBL301	Homo sapiens	IC50	nM	2.2
	19476855	CHEMBL4479703	Inhibition of full-length recombinant human His-tagged CDK2 expressed in baculovirus expression system by Z'-LYTE assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	=	IC50	nM	51.0	CHEMBL301	Homo sapiens	IC50	nM	51.0
	20636330	CHEMBL4611859	Inhibition of CDK2 (unknown origin)	B	CC(C)c1cnn2c(NCc3ccccc3)cc(NCCCCCCN)nc12		CHEMBL1801932	=	IC50	nM	880.0	CHEMBL301	Homo sapiens	IC50	nM	880.0
	20636336	CHEMBL4611859	Inhibition of CDK2 (unknown origin)	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@@H](O)CO)nc12		CHEMBL4644434	=	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	nM	3.0
	20636339	CHEMBL4611859	Inhibition of CDK2 (unknown origin)	B	CC(C)c1cnn2c(NCc3ccccc3)cc(NC[C@H]3CCNC[C@@H]3O)nc12		CHEMBL4297488	=	IC50	nM	620.0	CHEMBL301	Homo sapiens	IC50	nM	620.0
	20636349	CHEMBL4611859	Inhibition of CDK2 (unknown origin)	B	Cc1cc(NC2CCN(C(=O)O[C@H]3CCN(C(=O)/C=C/CN(C)C)C3)CC2)n2ncc(C(C)C)c2n1		CHEMBL4635959	>	IC50	nM	8000.0	CHEMBL301	Homo sapiens	IC50	uM	8.0
	20636367	CHEMBL4611859	Inhibition of CDK2 (unknown origin)	B	CN(C)C/C=C/C(=O)Nc1ccc(C(=O)N[C@@]2(C)CCC[C@@H](Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)C2)nc1		CHEMBL4582951	=	IC50	nM	2117.0	CHEMBL301	Homo sapiens	IC50	nM	2117.0
	20636383	CHEMBL4611859	Inhibition of CDK2 (unknown origin)	B	CN(C)C/C=C/C(=O)Nc1cccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)c1		CHEMBL4303287	=	IC50	nM	222.0	CHEMBL301	Homo sapiens	IC50	nM	222.0
	20636391	CHEMBL4611859	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)Nc1ccc(C(=O)Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)cc1		CHEMBL4450322	=	IC50	nM	1300.0	CHEMBL301	Homo sapiens	IC50	nM	1300.0
	20636395	CHEMBL4611859	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)Nc1ccc(C(=O)Nc2cccc(Nc3n[nH]c4c3CN(C(=O)N[C@H](CN(C)C)c3ccccc3)C4(C)C)c2)cc1		CHEMBL4434871	=	IC50	nM	1140.0	CHEMBL301	Homo sapiens	IC50	nM	1140.0
	20641493	CHEMBL4613377	Inhibition of CDK2 (unknown origin)	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	IC50	nM	50000.0	CHEMBL301	Homo sapiens	IC50	uM	50.0
	20641496	CHEMBL4613377	Inhibition of CDK2 (unknown origin)	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	IC50	nM	500.0	CHEMBL301	Homo sapiens	IC50	nM	500.0
	20641515	CHEMBL4613377	Inhibition of CDK2 (unknown origin)	B	O=S1(=O)NCCCNc2nc(ncc2Br)Nc2cccc1c2		CHEMBL1235529	=	IC50	nM	140.0	CHEMBL301	Homo sapiens	IC50	nM	140.0
	20641529	CHEMBL4613414	Inhibition of CDK2 (unknown origin) in presence of high ATP	B	CCn1cnc2c(NCc3nc4ccc(F)c(F)c4[nH]3)nc(N3CCCC[C@H]3CCO)nc21		CHEMBL4649135	=	IC50	nM	321.0	CHEMBL301	Homo sapiens	IC50	nM	321.0
	20641532	CHEMBL4613397	Binding affinity to CDK2 (unknown origin)	B	O=S(=O)(O)c1cccc2cccc(Nc3ccccc3)c12		CHEMBL285527	=	Kd	nM	37000.0	CHEMBL301	Homo sapiens	Kd	uM	37.0
	20641544	CHEMBL4613377	Inhibition of CDK2 (unknown origin)	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	IC50	nM	250.0	CHEMBL301	Homo sapiens	IC50	nM	250.0
	20643855	CHEMBL4613743	Inhibition of CDK2 (unknown origin)	B	COc1cc(/C=C2\Oc3cc4occc4c(OC)c3C2=O)ccc1OCC(=O)Nc1ccccc1		CHEMBL4637085	=	IC50	nM	1110.0	CHEMBL301	Homo sapiens	IC50	uM	1.11
	20643956	CHEMBL4613743	Inhibition of CDK2 (unknown origin)	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	IC50	nM	1140.0	CHEMBL301	Homo sapiens	IC50	uM	1.14
	20680047	CHEMBL4622606	Inhibition of CDK2 (unknown origin) at 1 uM by PanQinase assay relative to control	B	c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359554	=	Inhibition	%	98.0	CHEMBL301	Homo sapiens	INH	%	98.0
	20680048	CHEMBL4622606	Inhibition of CDK2 (unknown origin) at 1 uM by PanQinase assay relative to control	B	CN(c1ccccc1)c1nccc(-c2cnn3ncccc23)n1		CHEMBL360866	=	Inhibition	%	33.0	CHEMBL301	Homo sapiens	INH	%	33.0
	20680067	CHEMBL4622615	Inhibition of recombinant human full length CDK2 (1 to 298 residues) expressed in bacterial expression system at 1 uM by DiscoverX competition binding assay relative to control	B	Cc1cccc(N(C)c2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL4637319	=	Inhibition	%	12.0	CHEMBL301	Homo sapiens	INH	%	12.0
	20681265	CHEMBL4623168	Inhibition of CDK2 (unknown origin) using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2c(C)ccc2CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL4644718	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	20681266	CHEMBL4623168	Inhibition of CDK2 (unknown origin) using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
Not Active	20681273	CHEMBL4623172	Inhibition of CDK2 (unknown origin) at 1 uM using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2c(C)ccc2CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL4644718		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	22388098	CHEMBL4666410	Inhibition of CDK2 (unknown origin) at 500 nM relative to control	B	Cc1cc(Nc2cc(N3CCN(CCCN(C)C)CC3)ncn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4757546	=	Inhibition	%	7.0	CHEMBL301	Homo sapiens	INH	%	7.0
	22410777	CHEMBL4671422	Inhibition of human CDK2 expressed in sf9 insect cells	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	IC50	nM	400.0	CHEMBL301	Homo sapiens	IC50	uM	0.4
	22410778	CHEMBL4671422	Inhibition of human CDK2 expressed in sf9 insect cells	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4)oc23)[C@H](O)C1		CHEMBL3898028	=	IC50	nM	2400.0	CHEMBL301	Homo sapiens	IC50	uM	2.4
	22419397	CHEMBL4673017	Inhibition of CDK2 (unknown origin) at 0.1 uM in presence of ATP at Km concentration by TR-FRET assay relative to control	B	Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CCC(O)CC3)co2)ccn1		CHEMBL4750630	=	Inhibition	%	44.0	CHEMBL301	Homo sapiens	INH	%	44.0
	22419398	CHEMBL4673017	Inhibition of CDK2 (unknown origin) at 0.1 uM in presence of ATP at Km concentration by TR-FRET assay relative to control	B	Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CCC(F)CC3)co2)ccn1		CHEMBL4784665	=	Inhibition	%	20.0	CHEMBL301	Homo sapiens	INH	%	20.0
	22419399	CHEMBL4673017	Inhibition of CDK2 (unknown origin) at 0.1 uM in presence of ATP at Km concentration by TR-FRET assay relative to control	B	Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CC[C@@H](O)C3)co2)ccn1		CHEMBL4783351	=	Inhibition	%	0.0	CHEMBL301	Homo sapiens	INH	%	0.0
	22419400	CHEMBL4673017	Inhibition of CDK2 (unknown origin) at 0.1 uM in presence of ATP at Km concentration by TR-FRET assay relative to control	B	Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CC[C@H](O)C3)co2)ccn1		CHEMBL4741488	=	Inhibition	%	9.0	CHEMBL301	Homo sapiens	INH	%	9.0
	22419401	CHEMBL4673018	Inhibition of CDK2 (unknown origin) at 1 uM in presence of ATP at Km concentration by TR-FRET assay relative to control	B	Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CCC(O)CC3)co2)ccn1		CHEMBL4750630	=	Inhibition	%	81.0	CHEMBL301	Homo sapiens	INH	%	81.0
	22419402	CHEMBL4673018	Inhibition of CDK2 (unknown origin) at 1 uM in presence of ATP at Km concentration by TR-FRET assay relative to control	B	Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CCC(F)CC3)co2)ccn1		CHEMBL4784665	=	Inhibition	%	69.0	CHEMBL301	Homo sapiens	INH	%	69.0
	22419403	CHEMBL4673018	Inhibition of CDK2 (unknown origin) at 1 uM in presence of ATP at Km concentration by TR-FRET assay relative to control	B	Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CC[C@@H](O)C3)co2)ccn1		CHEMBL4783351	=	Inhibition	%	10.0	CHEMBL301	Homo sapiens	INH	%	10.0
	22419404	CHEMBL4673018	Inhibition of CDK2 (unknown origin) at 1 uM in presence of ATP at Km concentration by TR-FRET assay relative to control	B	Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CC[C@H](O)C3)co2)ccn1		CHEMBL4741488	=	Inhibition	%	15.0	CHEMBL301	Homo sapiens	INH	%	15.0
	22421638	CHEMBL4673640	Inhibition of human CDK2 (2 to 298 residues) at 10 uM incubated for 5 mins in presence of [gamma33P]ATP by scintillation counting analysis relative to control	B	O=C(Cc1ccc(F)c(F)c1)N1CCC(Nc2ncc3c(N4CCOCC4)n[nH]c3n2)CC1		CHEMBL4762609	>	Inhibition	%	40.0	CHEMBL301	Homo sapiens	INH	%	40.0
Not Active	22443469	CHEMBL4679161	Inhibition of CDK2 (unknown origin) at 1 uM	B	O=C(Nc1ccccc1)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1Cc1ccccc1		CHEMBL4781000		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	22446958	CHEMBL4679708	Inhibition of CDK2 (unknown origin)	B	Cc1nc(NC(=O)NCCc2cn(CC(F)F)cn2)sc1C#Cc1cccnc1		CHEMBL4795990	>	Ki	nM	4000.0	CHEMBL301	Homo sapiens	Ki	uM	4.0
	22446959	CHEMBL4679708	Inhibition of CDK2 (unknown origin)	B	COc1cc(C#Cc2sc(NC(=O)NCCOCC3CC3)nc2C)cnc1OC		CHEMBL4759283	>	Ki	nM	4000.0	CHEMBL301	Homo sapiens	Ki	uM	4.0
	22446960	CHEMBL4679708	Inhibition of CDK2 (unknown origin)	B	Cc1nc(NC(=O)NCCOCC2CC2)sc1C#Cc1ccc2cncn2c1		CHEMBL4764646	>	Ki	nM	4000.0	CHEMBL301	Homo sapiens	Ki	uM	4.0
	22446961	CHEMBL4679708	Inhibition of CDK2 (unknown origin)	B	Cc1cncc(C#Cc2sc(NC(=O)NC[C@H](C)OCC3CC3)nc2C)c1		CHEMBL4784202	>	Ki	nM	4000.0	CHEMBL301	Homo sapiens	Ki	uM	4.0
	22446962	CHEMBL4679708	Inhibition of CDK2 (unknown origin)	B	Cc1cc(C#Cc2sc(NC(=O)NC[C@H](C)OCC3CC3)nc2C)cnc1C		CHEMBL4756664	>	Ki	nM	4000.0	CHEMBL301	Homo sapiens	Ki	uM	4.0
Active	22469388	CHEMBL4684811	Inhibition of CDK2 in human A375 cells at 1 uM measured after 12 hr by DAPI staining based immunofluorescence analysis	B	Nc1ccccc1NC(=O)c1ccc(CNC(=O)c2n[nH]cc2NC(=O)c2c(Cl)cccc2Cl)cc1		CHEMBL4761880		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	22469389	CHEMBL4684811	Inhibition of CDK2 in human A375 cells at 1 uM measured after 12 hr by DAPI staining based immunofluorescence analysis	B	Nc1ccccc1NC(=O)Cc1ccc(NC(=O)c2n[nH]cc2NC(=O)c2c(Cl)cccc2Cl)cc1		CHEMBL4745240		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	22485836	CHEMBL4688584	Inhibition of CDK2 (unknown origin) by ATP competitive based analysis	B	NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCC1CCN(Cc2ccc(F)cc2)CC1		CHEMBL4747992	>	IC50	nM	300.0	CHEMBL301	Homo sapiens	IC50	nM	300.0
	22758198	CHEMBL4701384	Inhibition of CDK2 (unknown origin)	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	IC50	nM	70.0	CHEMBL301	Homo sapiens	IC50	nM	70.0
	22758199	CHEMBL4701384	Inhibition of CDK2 (unknown origin)	B	C[C@H](CO)Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)ncc1Br		CHEMBL4741442	=	IC50	nM	4.0	CHEMBL301	Homo sapiens	IC50	nM	4.0
	22758200	CHEMBL4701384	Inhibition of CDK2 (unknown origin)	B	C[C@@H](O)[C@@H](C)Oc1nc(Nc2ccc(S(=N)(=O)C3CC3)cc2)ncc1C(F)(F)F		CHEMBL4442620	=	IC50	nM	9.0	CHEMBL301	Homo sapiens	IC50	nM	9.0
	22758201	CHEMBL4701384	Inhibition of CDK2 (unknown origin)	B	COc1cc(F)ccc1-c1cc(NC(=O)[C@H]2CCC[C@@H](NC(C)=O)C2)ncc1Cl		CHEMBL4755256	=	IC50	nM	2460.0	CHEMBL301	Homo sapiens	IC50	uM	2.46
	22758202	CHEMBL4701384	Inhibition of CDK2 (unknown origin)	B	COc1cc(F)ccc1-c1ncnc(Nc2cccc(CS(C)(=N)=O)c2)n1		CHEMBL4286578	=	IC50	nM	470.0	CHEMBL301	Homo sapiens	IC50	nM	470.0
	22758203	CHEMBL4701384	Inhibition of CDK2 (unknown origin)	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	IC50	nM	100.0	CHEMBL301	Homo sapiens	IC50	nM	100.0
	22758204	CHEMBL4701384	Inhibition of CDK2 (unknown origin)	B	CC[C@H](Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1)[C@@H](C)O		CHEMBL4764173	=	IC50	nM	5.0	CHEMBL301	Homo sapiens	IC50	nM	5.0
	22758205	CHEMBL4701384	Inhibition of CDK2 (unknown origin)	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	=	IC50	nM	1.0	CHEMBL301	Homo sapiens	IC50	nM	1.0
	22758206	CHEMBL4701384	Inhibition of CDK2 (unknown origin)	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	=	IC50	nM	47.0	CHEMBL301	Homo sapiens	IC50	nM	47.0
	22758257	CHEMBL4701408	Inhibition of human CDK2	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	=	IC50	nM	5.0	CHEMBL301	Homo sapiens	IC50	nM	5.0
	22758296	CHEMBL4701433	Inhibition of CDK2 in human MCF7 cells assessed as reduction in Rb phosphorylation at T821 residue incubated for 6 hrs by immunoblot analysis	B	CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(Cl)cn2)C1		CHEMBL4462530	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	uM	10.0
	22758315	CHEMBL4701446	Inhibition of CDK2 (unknown origin) using Ulight-labeled substrate by TR-FRET LANCE method	B	COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(CC(O)CO)CC3)cc12		CHEMBL3668457	>	IC50	nM	1360.0	CHEMBL301	Homo sapiens	IC50	uM	1.36
	22758316	CHEMBL4701446	Inhibition of CDK2 (unknown origin) using Ulight-labeled substrate by TR-FRET LANCE method	B	COc1ccc(F)cc1-c1c(F)cnc2[nH]c(C3=CCN([C@H]4CC[C@H](C(=O)O)CC4)CC3)cc12		CHEMBL4777981	>	IC50	nM	320.0	CHEMBL301	Homo sapiens	IC50	uM	0.32
	22783367	CHEMBL4707897	Inhibition of CDK2 (unknown origin) at 20 uM relative to control	B	CCCSc1nc2c(nnn2CCNC(=S)Nc2cccc3ccccc23)c(=O)[nH]1		CHEMBL4742820	<	Inhibition	%	10.0	CHEMBL301	Homo sapiens	INH	%	10.0
	22798837	CHEMBL4711081	Inhibition of CDK2 (unknown origin) at 300 nM relative to control	B	CNC(=O)c1sc(-c2ccnc(NC(=O)CNCCNc3c4c(nc5ccccc35)CCCC4)c2)nc1OCC1CC1		CHEMBL4789145	=	Inhibition	%	3.8	CHEMBL301	Homo sapiens	INH	%	3.8
	22822930	CHEMBL4716839	Inhibition of CDK2 (unknown origin)	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN(C)CC1		CHEMBL3651854	=	IC50	nM	920.0	CHEMBL301	Homo sapiens	IC50	uM	0.92
	22883468	CHEMBL4727554	Inhibition of CDK2 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(N2Cc3ccccc3C2=O)n1		CHEMBL3952214	=	IC50	nM	63.1	CHEMBL301	Homo sapiens	pIC50		7.2
	22883469	CHEMBL4727554	Inhibition of CDK2 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)C2CCCCO2)n1		CHEMBL4759397	=	IC50	nM	3162.28	CHEMBL301	Homo sapiens	pIC50		5.5
	22887505	CHEMBL4728485	Inhibition of human CDK2 at 1 uM by kinome scan method relative to control	B	CC(C)N1c2cc(Nc3nccc(-c4cncc5ccccc45)n3)ccc2N(C)C(=O)[C@H]1C		CHEMBL4742169	=	Inhibition	%	90.0	CHEMBL301	Homo sapiens	INH	%	90.0
	22887506	CHEMBL4728486	Inhibition of human CDK2 by kinome scan method	B	CC(C)N1c2cc(Nc3nccc(-c4cncc5ccccc45)n3)ccc2N(C)C(=O)[C@H]1C		CHEMBL4742169	=	IC50	nM	168.9	CHEMBL301	Homo sapiens	IC50	nM	168.9
Not Active	22889493	CHEMBL4729012	Inhibition of wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	22922112	CHEMBL4736843	Inhibition of CDK2 (unknown origin) assessed as enzyme remaining activity at 5 uM relative to control	B	COc1ccc(-c2ccnc(N[C@H]3CO[C@@H]4[C@@H](NC(=O)Nc5ccc(C(C)=O)cc5)CO[C@H]34)n2)cc1		CHEMBL4758751	>	Activity	%	50.0	CHEMBL301	Homo sapiens	Activity	%	50.0
	22925366	CHEMBL4737457	Binding affinity to T7-tagged CDK2 (unknown origin) expressed in bacteriophage infected Escherichia coli BL21 incubated for 30 mins by magnetic beads based qPCR anlaysis	B	Cc1nn(-c2ccccn2)c2c1C(=O)CC(C)(C)C2Br		CHEMBL1906448	=	Kd	nM	5000.0	CHEMBL301	Homo sapiens	Kd	uM	5.0
	22925367	CHEMBL4737457	Binding affinity to T7-tagged CDK2 (unknown origin) expressed in bacteriophage infected Escherichia coli BL21 incubated for 30 mins by magnetic beads based qPCR anlaysis	B	Cc1nn(-c2nccs2)c2c1C(=O)CC(C)(C)C2Br		CHEMBL1708376	=	Kd	nM	4800.0	CHEMBL301	Homo sapiens	Kd	uM	4.8
	22925368	CHEMBL4737457	Binding affinity to T7-tagged CDK2 (unknown origin) expressed in bacteriophage infected Escherichia coli BL21 incubated for 30 mins by magnetic beads based qPCR anlaysis	B	Cc1nn(-c2ccncn2)c2c1C(=O)CC(C)(C)C2Br		CHEMBL4763182	=	Kd	nM	4500.0	CHEMBL301	Homo sapiens	Kd	uM	4.5
Dose-dependent effect	22930687	CHEMBL4738638	Inhibition of CDK2 in human MV4-11 cells assessed as reduction in Rb phosphorylation at Ser807/811 after 24 to 48 hrs by immunoblot analysis	B	NC(=O)c1ccc(-c2ccc(F)c(C(=O)Nc3c[nH]nc3C(=O)Nc3ccc(F)cc3)c2F)cn1		CHEMBL4757951		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Tde	22930688	CHEMBL4738639	Inhibition of CDK2 in human MV4-11 cells assessed as reduction in Rb phosphorylation at Ser807/811 at 0.375 to 6 uM by immunoblot analysis	B	NC(=O)c1ccc(-c2ccc(F)c(C(=O)Nc3c[nH]nc3C(=O)Nc3ccc(F)cc3)c2F)cn1		CHEMBL4757951		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Dose-dependent effect	22930689	CHEMBL4738640	Inhibition of CDK2 in human MV4-11 cells assessed as reduction in Rb phosphorylation at Ser780 after 24 to 48 hrs by immunoblot analysis	B	NC(=O)c1ccc(-c2ccc(F)c(C(=O)Nc3c[nH]nc3C(=O)Nc3ccc(F)cc3)c2F)cn1		CHEMBL4757951		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Tde	22930690	CHEMBL4738641	Inhibition of CDK2 in human MV4-11 cells assessed as reduction in Rb phosphorylation at Ser780 at 0.375 to 6 uM by immunoblot analysis	B	NC(=O)c1ccc(-c2ccc(F)c(C(=O)Nc3c[nH]nc3C(=O)Nc3ccc(F)cc3)c2F)cn1		CHEMBL4757951		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	22930691	CHEMBL4738642	Inhibition of CDK2 in human MV4-11 cells assessed as downregulation of Mcl-1 expression at 0.1875 to 3 uM after 24 hrs by immunoblot analysis	B	NC(=O)c1ccc(-c2ccc(F)c(C(=O)Nc3c[nH]nc3C(=O)Nc3ccc(F)cc3)c2F)cn1		CHEMBL4757951		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	22930692	CHEMBL4738643	Inhibition of CDK2 in human A2058 cells assessed as downregulation of Mcl-1 expression at 0.1875 to 1.5 uM after 24 hrs by immunoblot analysis	B	NC(=O)c1ccc(-c2ccc(F)c(C(=O)Nc3c[nH]nc3C(=O)Nc3ccc(F)cc3)c2F)cn1		CHEMBL4757951		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	22930712	CHEMBL4738663	Inhibition of recombinant CDK2 (unknown origin) expressed in baculovirus infected Sf9 cells using biotinylated Histone H1 peptide as substrate incubated for 1 hr in presence of [33P]ATP by liquid scintillation counting method	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	=	IC50	nM	1.0	CHEMBL301	Homo sapiens	IC50	uM	0.001
	22934929	CHEMBL4739342	Binding affinity to CDK2 (unknown origin) by isothermal titration calorimetry	B	O=c1[nH]cc(C2CCCCC2)c2nccn12		CHEMBL4762791	=	Kd	nM	4100.0	CHEMBL301	Homo sapiens	Kd	uM	4.1
	22934930	CHEMBL4739342	Binding affinity to CDK2 (unknown origin) by isothermal titration calorimetry	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	=	Kd	nM	18.4	CHEMBL301	Homo sapiens	Kd	nM	18.4
	22934931	CHEMBL4739343	Binding affinity to CDK2 (unknown origin) assessed as gibbs free energy change by isothermal titration calorimetry	B	O=c1[nH]cc(C2CCCCC2)c2nccn12		CHEMBL4762791	=	deltaG	kcal/mol	-7.48	CHEMBL301	Homo sapiens	deltaG	kcal/mol	-7.48
	22934932	CHEMBL4739343	Binding affinity to CDK2 (unknown origin) assessed as gibbs free energy change by isothermal titration calorimetry	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	=	deltaG	kcal/mol	-10.8	CHEMBL301	Homo sapiens	deltaG	kcal/mol	-10.8
	22934933	CHEMBL4739344	Binding affinity to CDK2 (unknown origin) assessed as change in enthalpy by isothermal titration calorimetry	B	O=c1[nH]cc(C2CCCCC2)c2nccn12		CHEMBL4762791	=	deltaH	kcal/mol	-11.4	CHEMBL301	Homo sapiens	deltaH	kcal/mol	-11.4
	22934934	CHEMBL4739345	Binding affinity to CDK2 (unknown origin) assessed as change in entropy by isothermal titration calorimetry	B	O=c1[nH]cc(C2CCCCC2)c2nccn12		CHEMBL4762791	=	-TdeltaS	kcal/mol	3.92	CHEMBL301	Homo sapiens	-TdeltaS	kcal/mol	3.92
	22936140	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)Nc1cccc(C(=O)Nc2ncc(N3CCOCC3)s2)c1		CHEMBL4777761	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	22936141	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)Nc1cccc(C(=O)Nc2ncc(N3CCN(C)CC3)s2)c1		CHEMBL4790868	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	22936142	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)Nc1cccc(C(=O)Nc2ncc(N3CCN(CC)CC3)s2)c1		CHEMBL4749580	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	22936143	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)Nc1cccc(C(=O)Nc2ncc(N3CCN(C(=O)OC(C)(C)C)CC3)s2)c1		CHEMBL4763994	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	22936144	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)Nc1cccc(C(=O)Nc2ncc(N3CCC(N(C)C)CC3)s2)c1		CHEMBL4743840	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	22936145	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)NC1CCC(C(=O)N2CCCC(Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)CC1		CHEMBL4793573	=	IC50	nM	185.0	CHEMBL301	Homo sapiens	IC50	nM	185.0
	22936146	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)NC1CCN(C(=O)N2CCCC(Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)CC1		CHEMBL4776271	=	IC50	nM	174.0	CHEMBL301	Homo sapiens	IC50	nM	174.0
	22936147	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)Nc1ccc(C(=O)N2CCCC(Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)c(OC)c1		CHEMBL4746993	=	IC50	nM	126.0	CHEMBL301	Homo sapiens	IC50	nM	126.0
	22936148	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)Nc1ccc(O[C@@H]2CCC[C@@H](Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)cc1		CHEMBL4788401	=	IC50	nM	334.0	CHEMBL301	Homo sapiens	IC50	nM	334.0
	22936149	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)Nc1ccc(C(=O)N2CCCC(Nc3ncc(CNc4cc(C(F)(F)F)c(Cl)cn4)s3)C2)cc1		CHEMBL4763202	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	22936150	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)Nc1ccc(C(=O)N2CCCC(Nc3ncc(/C=C/c4ncc(C(C)(C)C)o4)s3)C2)cc1		CHEMBL4753350	=	IC50	nM	22.9	CHEMBL301	Homo sapiens	IC50	nM	22.9
	22936151	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)Nc1ccc(C(=O)N2CCCC(Nc3ncc(CCc4ncc(C(C)(C)C)o4)s3)C2)cc1		CHEMBL4794338	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	22936152	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)Nc1ccc(C(=O)N2CCCC(Nc3ncc(COCc4ncc(C(C)(C)C)o4)s3)C2)cc1		CHEMBL4764719	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	22936153	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)Nc1ccc(C(=O)N2CCCC(Nc3ncc(CNCc4ncc(C(C)(C)C)o4)s3)C2)cc1		CHEMBL4781334	=	IC50	nM	3170.0	CHEMBL301	Homo sapiens	IC50	nM	3170.0
	22936154	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)Nc1ccc(S(=O)(=O)N2CCCC(Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)cc1		CHEMBL4756935	=	IC50	nM	264.0	CHEMBL301	Homo sapiens	IC50	nM	264.0
	22936155	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)Nc1ccc([S+]([O-])N2CCCC(Nc3ncc(SCc4cccnc4)s3)C2)cc1		CHEMBL4786324	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	22936156	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)Nc1ccc(C(=O)N2CCCC(Nc3ncc(SCc4ccccn4)s3)C2)cc1		CHEMBL4789890	>	IC50	nM	370.0	CHEMBL301	Homo sapiens	IC50	nM	370.0
	22936157	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)Nc1ccc(C(=O)N2CCCC(Nc3ncc(SCc4cnc(C(F)(F)F)nc4)s3)C2)cc1		CHEMBL4789917	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	22936158	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)N1CCc2cc(S(=O)(=O)N3CCCC(Nc4ncc(SCc5ncc(C(C)(C)C)o5)s4)C3)ccc21		CHEMBL4744627	=	IC50	nM	124.0	CHEMBL301	Homo sapiens	IC50	nM	124.0
	22936159	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)Nc1ccc(O[C@@H]2CCC[C@@H](Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)c(C(F)(F)F)c1		CHEMBL4752238	=	IC50	nM	251.0	CHEMBL301	Homo sapiens	IC50	nM	251.0
	22936160	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)Nc1ccc(C(=O)N2CCC[C@@H](Nc3ncc(SCC4CCOCC4)s3)C2)cc1		CHEMBL4643754	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	22936161	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)Nc1ccc(C(=O)N2CCC[C@@H](Nc3ncc(SCc4cncnc4)s3)C2)cc1		CHEMBL4797288	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	22936162	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	CN(C)C/C=C/C(=O)Nc1ccc(C(=O)N2CC[C@@H](Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)cc1		CHEMBL4758168	=	IC50	nM	11.9	CHEMBL301	Homo sapiens	IC50	nM	11.9
	22936163	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	CN(C)C/C=C/C(=O)N1CCC(C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)CC1		CHEMBL4777844	=	IC50	nM	11.5	CHEMBL301	Homo sapiens	IC50	nM	11.5
	22936164	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)N1CCC(C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)CC1		CHEMBL4641226	=	IC50	nM	10.8	CHEMBL301	Homo sapiens	IC50	nM	10.8
	22936165	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	CN(C)CC/C=C/C(=O)Nc1ccc(C(=O)N2CCCC(C(=O)Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)cc1		CHEMBL4753717	=	IC50	nM	23.3	CHEMBL301	Homo sapiens	IC50	nM	23.3
	22936166	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)Nc1ccc(C(=O)N2CCCC(C(=O)Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)cc1		CHEMBL4644893	=	IC50	nM	11.0	CHEMBL301	Homo sapiens	IC50	nM	11.0
	22936167	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)Nc1cccc(C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)c1		CHEMBL4643057	=	IC50	nM	58.8	CHEMBL301	Homo sapiens	IC50	nM	58.8
	22936168	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	CN(C)C/C=C/C(=O)Nc1cccc(C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)c1		CHEMBL4786429	=	IC50	nM	29.0	CHEMBL301	Homo sapiens	IC50	nM	29.0
	22936169	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	CN(C)C/C=C/C(=O)Nc1ccc(C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)cc1		CHEMBL4756353	=	IC50	nM	7.8	CHEMBL301	Homo sapiens	IC50	nM	7.8
	22936170	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)Nc1cccc(C(=O)N2CCCC(Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)c1		CHEMBL4797409	=	IC50	nM	312.0	CHEMBL301	Homo sapiens	IC50	nM	312.0
	22936171	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	CN(C)C/C=C/C(=O)Nc1cccc(C(=O)N2CCCC(Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)c1		CHEMBL4752989	=	IC50	nM	286.0	CHEMBL301	Homo sapiens	IC50	nM	286.0
	22936172	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)Nc1ccc(C(=O)Nc2cccc(C(=O)Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)c2)cc1		CHEMBL4761637	=	IC50	nM	162.0	CHEMBL301	Homo sapiens	IC50	nM	162.0
	22936173	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)Nc1ccc(C(=O)N2CCCC(Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)cc1		CHEMBL4781539	=	IC50	nM	108.0	CHEMBL301	Homo sapiens	IC50	nM	108.0
	22936174	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	CN(C)C/C=C/C(=O)Nc1ccc(C(=O)N2CCCC(Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)cc1		CHEMBL4761001	=	IC50	nM	92.3	CHEMBL301	Homo sapiens	IC50	nM	92.3
	22936175	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	CN(C)C/C=C/C(=O)Nc1ccc(S(=O)(=O)N2CCCC(Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)cc1		CHEMBL4744850	=	IC50	nM	689.0	CHEMBL301	Homo sapiens	IC50	nM	689.0
	22936176	CHEMBL4739783	Inhibition of CDK2 (unknown origin)	B	C=CC(=O)Nc1ccc(C(=O)N2CC[C@@H](Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)cc1		CHEMBL4788136	=	IC50	nM	9.86	CHEMBL301	Homo sapiens	IC50	nM	9.86
	22955543	CHEMBL4767600	Inhibition of human CDK2 at 1 uM by Selectscreen kinase assay	B	COc1ccccc1-c1csc2cnc(Nc3ccc(C(=O)NC4CCNCC4)c(F)c3)nc12		CHEMBL4785582	=	Inhibition	%	97.0	CHEMBL301	Homo sapiens	INH	%	97.0
	22960888	CHEMBL4768803	Inhibition of human CDK2 at 100 nM in presence of ATP relative to control	B	Cl.O=C1Nc2ccc(F)cc2/C1=C1/Nc2ccccc2/C1=N\OCCN1CCNCC1		CHEMBL4791998	=	Inhibition	%	43.0	CHEMBL301	Homo sapiens	INH	%	43.0
Active	22965457	CHEMBL4769373	Inhibition of CDK2 in human A-375 cells at 1 uM incubated for 12 hrs by DAPI and immunofluorescence staining based confocal microscopic analysis	B	Cc1ccc(Nc2nc(Cl)nc3c2ncn3Cc2ccc(C(=O)Nc3ccccc3N)cc2)cc1		CHEMBL4795802		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	23120271	CHEMBL4804359	Inhibition of CDK2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	33300.0	CHEMBL301	Homo sapiens	IC50	uM	33.3
	23120272	CHEMBL4804359	Inhibition of CDK2 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	27600.0	CHEMBL301	Homo sapiens	IC50	uM	27.6
	23120273	CHEMBL4804359	Inhibition of CDK2 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	17300.0	CHEMBL301	Homo sapiens	IC50	uM	17.3
	23120274	CHEMBL4804359	Inhibition of CDK2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	35000.0	CHEMBL301	Homo sapiens	IC50	uM	35.0
	23120275	CHEMBL4804359	Inhibition of CDK2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	21600.0	CHEMBL301	Homo sapiens	IC50	uM	21.6
	23120276	CHEMBL4804359	Inhibition of CDK2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	68500.0	CHEMBL301	Homo sapiens	IC50	uM	68.5
	23121313	CHEMBL4804541	Inhibition of CDK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL301	Homo sapiens	INH	%	0.0
	23121314	CHEMBL4804541	Inhibition of CDK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL301	Homo sapiens	INH	%	0.0
	23121315	CHEMBL4804541	Inhibition of CDK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL301	Homo sapiens	INH	%	0.0
	23121316	CHEMBL4804541	Inhibition of CDK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	35.0	CHEMBL301	Homo sapiens	INH	%	35.0
	23121317	CHEMBL4804541	Inhibition of CDK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL301	Homo sapiens	INH	%	0.0
	23121318	CHEMBL4804541	Inhibition of CDK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	50.0	CHEMBL301	Homo sapiens	INH	%	50.0
	23122483	CHEMBL4804834	Inhibition of human CDK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	95.0	CHEMBL301	Homo sapiens	Activity	%	95.0
	23123178	CHEMBL4805422	Inhibition of human CDK2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	91.0	CHEMBL301	Homo sapiens	Activity	%	91.0
	23123711	CHEMBL4805955	Inhibition of DNA-tagged human CDK2 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL301	Homo sapiens	Activity	%	100.0
	23124212	CHEMBL4806309	Inhibition of CDK2 (unknown origin) at 10 uM relative to control	B	Cn1cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)cn1		CHEMBL4852083	=	Inhibition	%	6.0	CHEMBL301	Homo sapiens	INH	%	6.0
	23124213	CHEMBL4806309	Inhibition of CDK2 (unknown origin) at 10 uM relative to control	B	Fc1cccc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4211454	=	Inhibition	%	1.0	CHEMBL301	Homo sapiens	INH	%	1.0
	23124214	CHEMBL4806309	Inhibition of CDK2 (unknown origin) at 10 uM relative to control	B	Cc1cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)no1		CHEMBL4847754	=	Inhibition	%	3.0	CHEMBL301	Homo sapiens	INH	%	3.0
	23124446	CHEMBL4806439	Inhibition of human CDK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL301	Homo sapiens	Activity	%	100.0
	23124447	CHEMBL4806439	Inhibition of human CDK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	99.0	CHEMBL301	Homo sapiens	Activity	%	99.0
	23152053	CHEMBL4810639	Inhibition of wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	CN(C)c1nccc(-c2cnn3ncccc23)n1		CHEMBL4848254	=	Activity	%	100.0	CHEMBL301	Homo sapiens	Activity	%	100.0
	23152054	CHEMBL4810639	Inhibition of wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	CN(c1nccc(-c2cnn3ncccc23)n1)C1CC1		CHEMBL4848696	=	Activity	%	100.0	CHEMBL301	Homo sapiens	Activity	%	100.0
	23152055	CHEMBL4810639	Inhibition of wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	c1cnn2ncc(-c3ccnc(N4CCC45COC5)n3)c2c1		CHEMBL4845809	=	Activity	%	100.0	CHEMBL301	Homo sapiens	Activity	%	100.0
	23152056	CHEMBL4810639	Inhibition of wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	CC1CCCN1c1nccc(-c2cnn3ncccc23)n1		CHEMBL4859912	=	Activity	%	100.0	CHEMBL301	Homo sapiens	Activity	%	100.0
	23152057	CHEMBL4810639	Inhibition of wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	C[C@H]1CCN(c2nccc(-c3cnn4ncccc34)n2)C1		CHEMBL4853444	=	Activity	%	100.0	CHEMBL301	Homo sapiens	Activity	%	100.0
	23152058	CHEMBL4810639	Inhibition of wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	C[C@@H]1CCN(c2nccc(-c3cnn4ncccc34)n2)C1		CHEMBL4870121	=	Activity	%	95.0	CHEMBL301	Homo sapiens	Activity	%	95.0
	23152059	CHEMBL4810639	Inhibition of wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	F[C@@H]1CCN(c2nccc(-c3cnn4ncccc34)n2)C1		CHEMBL4852944	=	Activity	%	95.0	CHEMBL301	Homo sapiens	Activity	%	95.0
	23152060	CHEMBL4810639	Inhibition of wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	N[C@H]1CCN(c2nccc(-c3cnn4ncccc34)n2)C1		CHEMBL4877372	=	Activity	%	100.0	CHEMBL301	Homo sapiens	Activity	%	100.0
	23152061	CHEMBL4810639	Inhibition of wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	N[C@@H]1CCN(c2nccc(-c3cnn4ncccc34)n2)C1		CHEMBL4876980	=	Activity	%	86.0	CHEMBL301	Homo sapiens	Activity	%	86.0
	23152062	CHEMBL4810639	Inhibition of wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	Cc1cnn2ncc(-c3ccnc(N(C)C)n3)c2c1		CHEMBL4851717	=	Activity	%	89.0	CHEMBL301	Homo sapiens	Activity	%	89.0
	23152063	CHEMBL4810639	Inhibition of wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	COc1ccnn2ncc(-c3ccnc(N(C)C)n3)c12		CHEMBL4874923	=	Activity	%	100.0	CHEMBL301	Homo sapiens	Activity	%	100.0
	23152064	CHEMBL4810639	Inhibition of wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	CN(C)c1nccc(-c2cnc3ncccn23)n1		CHEMBL4872408	=	Activity	%	86.0	CHEMBL301	Homo sapiens	Activity	%	86.0
	23152065	CHEMBL4810639	Inhibition of wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	CN(C)c1ncc(F)c(-c2cnn3ncccc23)n1		CHEMBL4861396	=	Activity	%	100.0	CHEMBL301	Homo sapiens	Activity	%	100.0
	23154604	CHEMBL4811104	Inhibition of human CDK2 at 1 uM measured after 30 mins by [gamma-33P]-ATP assay	A	CN1CCN(c2ccc(Nc3nccc(Nc4ccc5nc[nH]c5c4)n3)cc2)CC1		CHEMBL4858727	=	Inhibition	%	85.0	CHEMBL301	Homo sapiens	INH	%	85.0
	23154605	CHEMBL4811104	Inhibition of human CDK2 at 1 uM measured after 30 mins by [gamma-33P]-ATP assay	A	Cc1cc(Nc2nccc(Nc3ccc4nc[nH]c4c3)n2)ccc1N1CCN(C)CC1		CHEMBL4850121	=	Inhibition	%	57.3	CHEMBL301	Homo sapiens	INH	%	57.3
	23154606	CHEMBL4811104	Inhibition of human CDK2 at 1 uM measured after 30 mins by [gamma-33P]-ATP assay	A	Cc1cccc(Nc2ncc([N+](=O)[O-])c(Nc3ccc4nc[nH]c4c3)n2)c1		CHEMBL4855763	=	Inhibition	%	25.3	CHEMBL301	Homo sapiens	INH	%	25.3
	23159496	CHEMBL4812199	Inhibition of human CDK2 expressed in baculovirus infected Sf9 cells using Histone H1 as substrate incubated for 10 mins by scintillation counting method	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833	=	IC50	nM	3.0	CHEMBL301	Homo sapiens	IC50	nM	3.0
	23159497	CHEMBL4812200	Inhibition of human CDK2	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	=	IC50	nM	1.0	CHEMBL301	Homo sapiens	IC50	nM	1.0
	23196899	CHEMBL4819977	Inhibition of GST-tagged CDK2/cyclinE (unknown origin) expressed in Sf9 cells assessed as residual activity using histone H1 as substrate in presence of ATP and Ci(gamma33-P) ATP at 1 uM measured by microplate reader assay	B	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cc2[nH]cnc2c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1		CHEMBL4858294	=	Activity	%	92.1	CHEMBL301	Homo sapiens	Activity	%	92.1
	23196900	CHEMBL4819977	Inhibition of GST-tagged CDK2/cyclinE (unknown origin) expressed in Sf9 cells assessed as residual activity using histone H1 as substrate in presence of ATP and Ci(gamma33-P) ATP at 1 uM measured by microplate reader assay	B	CC(C)(C)c1ccc(C(=O)Nc2cccc(-c3cc4[nH]cnc4c(Nc4ccc(C(=O)N5CCOCC5)cc4)n3)c2)cc1		CHEMBL4865664	=	Activity	%	98.7	CHEMBL301	Homo sapiens	Activity	%	98.7
	23196901	CHEMBL4819977	Inhibition of GST-tagged CDK2/cyclinE (unknown origin) expressed in Sf9 cells assessed as residual activity using histone H1 as substrate in presence of ATP and Ci(gamma33-P) ATP at 1 uM measured by microplate reader assay	B	Cc1c(NC(=O)c2ccccc2)cccc1-c1cc2[nH]cnc2c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1		CHEMBL4867619	=	Activity	%	85.2	CHEMBL301	Homo sapiens	Activity	%	85.2
	23196902	CHEMBL4819977	Inhibition of GST-tagged CDK2/cyclinE (unknown origin) expressed in Sf9 cells assessed as residual activity using histone H1 as substrate in presence of ATP and Ci(gamma33-P) ATP at 1 uM measured by microplate reader assay	B	Cc1c(NC(=O)c2cccc(C(C)(C)C)c2)cccc1-c1cc2[nH]cnc2c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1		CHEMBL4868893	=	Activity	%	95.3	CHEMBL301	Homo sapiens	Activity	%	95.3
	23196903	CHEMBL4819977	Inhibition of GST-tagged CDK2/cyclinE (unknown origin) expressed in Sf9 cells assessed as residual activity using histone H1 as substrate in presence of ATP and Ci(gamma33-P) ATP at 1 uM measured by microplate reader assay	B	Cc1c(NC(=O)c2cccnc2)cccc1-c1cc2[nH]cnc2c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1		CHEMBL4879055	=	Activity	%	89.0	CHEMBL301	Homo sapiens	Activity	%	89.0
	23196904	CHEMBL4819977	Inhibition of GST-tagged CDK2/cyclinE (unknown origin) expressed in Sf9 cells assessed as residual activity using histone H1 as substrate in presence of ATP and Ci(gamma33-P) ATP at 1 uM measured by microplate reader assay	B	Cc1c(NC(=O)c2ccccn2)cccc1-c1cc2[nH]cnc2c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1		CHEMBL4852053	=	Activity	%	93.7	CHEMBL301	Homo sapiens	Activity	%	93.7
	23196905	CHEMBL4819977	Inhibition of GST-tagged CDK2/cyclinE (unknown origin) expressed in Sf9 cells assessed as residual activity using histone H1 as substrate in presence of ATP and Ci(gamma33-P) ATP at 1 uM measured by microplate reader assay	B	Cc1c(NC(=O)C2CCCCC2)cccc1-c1cc2[nH]cnc2c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1		CHEMBL4869977	=	Activity	%	93.0	CHEMBL301	Homo sapiens	Activity	%	93.0
	23196906	CHEMBL4819977	Inhibition of GST-tagged CDK2/cyclinE (unknown origin) expressed in Sf9 cells assessed as residual activity using histone H1 as substrate in presence of ATP and Ci(gamma33-P) ATP at 1 uM measured by microplate reader assay	B	CC(=O)Nc1cccc(-c2cc3[nH]cnc3c(Nc3ccc(C(=O)N4CCOCC4)cc3)n2)c1C		CHEMBL4859682	=	Activity	%	94.5	CHEMBL301	Homo sapiens	Activity	%	94.5
	23196907	CHEMBL4819977	Inhibition of GST-tagged CDK2/cyclinE (unknown origin) expressed in Sf9 cells assessed as residual activity using histone H1 as substrate in presence of ATP and Ci(gamma33-P) ATP at 1 uM measured by microplate reader assay	B	Cc1c(NC(=O)c2ncc[nH]2)cccc1-c1cc2[nH]cnc2c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1		CHEMBL4852342	=	Activity	%	93.6	CHEMBL301	Homo sapiens	Activity	%	93.6
	23196908	CHEMBL4819977	Inhibition of GST-tagged CDK2/cyclinE (unknown origin) expressed in Sf9 cells assessed as residual activity using histone H1 as substrate in presence of ATP and Ci(gamma33-P) ATP at 1 uM measured by microplate reader assay	B	Cc1c(NC(=O)c2c[nH]cn2)cccc1-c1cc2[nH]cnc2c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1		CHEMBL4873565	=	Activity	%	94.6	CHEMBL301	Homo sapiens	Activity	%	94.6
	23196909	CHEMBL4819977	Inhibition of GST-tagged CDK2/cyclinE (unknown origin) expressed in Sf9 cells assessed as residual activity using histone H1 as substrate in presence of ATP and Ci(gamma33-P) ATP at 1 uM measured by microplate reader assay	B	Cc1c(NC(=O)c2nc3ccccc3[nH]2)cccc1-c1cc2[nH]cnc2c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1		CHEMBL4875035	=	Activity	%	97.9	CHEMBL301	Homo sapiens	Activity	%	97.9
	23196910	CHEMBL4819977	Inhibition of GST-tagged CDK2/cyclinE (unknown origin) expressed in Sf9 cells assessed as residual activity using histone H1 as substrate in presence of ATP and Ci(gamma33-P) ATP at 1 uM measured by microplate reader assay	B	C=CC(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3647964	=	Activity	%	69.8	CHEMBL301	Homo sapiens	Activity	%	69.8
	23196911	CHEMBL4819977	Inhibition of GST-tagged CDK2/cyclinE (unknown origin) expressed in Sf9 cells assessed as residual activity using histone H1 as substrate in presence of ATP and Ci(gamma33-P) ATP at 1 uM measured by microplate reader assay	B	COc1ccc(Cn2cnc3c(Nc4ccc(C(=O)N5CCOCC5)cc4)nc(-c4cccc(NC(=O)c5ccc(C(C)(C)C)cc5)c4C)cc32)cc1		CHEMBL4854403	=	Activity	%	96.7	CHEMBL301	Homo sapiens	Activity	%	96.7
	23196912	CHEMBL4819977	Inhibition of GST-tagged CDK2/cyclinE (unknown origin) expressed in Sf9 cells assessed as residual activity using histone H1 as substrate in presence of ATP and Ci(gamma33-P) ATP at 1 uM measured by microplate reader assay	B	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cc2c(ncn2C)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1		CHEMBL4855825	=	Activity	%	95.6	CHEMBL301	Homo sapiens	Activity	%	95.6
	23209016	CHEMBL4822303	Inhibition of CDK2 (unknown origin)	B	O=C(CCCOc1ccc(CC(=O)Nc2cc(C3CCC3)[nH]n2)cc1)NCCCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O		CHEMBL4864688	=	IC50	nM	155.0	CHEMBL301	Homo sapiens	IC50	nM	155.0
	23209017	CHEMBL4822303	Inhibition of CDK2 (unknown origin)	B	COc1ccc(CC(=O)Nc2cc(C3CCC3)[nH]n2)cc1		CHEMBL4846069	=	IC50	nM	44.0	CHEMBL301	Homo sapiens	IC50	nM	44.0
	23209041	CHEMBL4822325	Binding affinity to CDK2 (unknown origin)	B	O=C(CCCOc1ccc(CC(=O)Nc2cc(C3CCC3)[nH]n2)cc1)NCCCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O		CHEMBL4864688	=	Kd	nM	385.0	CHEMBL301	Homo sapiens	Kd	nM	385.0
	23209042	CHEMBL4822325	Binding affinity to CDK2 (unknown origin)	B	COc1ccc(CC(=O)Nc2cc(C3CCC3)[nH]n2)cc1		CHEMBL4846069	=	Kd	nM	135.0	CHEMBL301	Homo sapiens	Kd	nM	135.0
	23234030	CHEMBL4827609	Inhibition of wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	O=C(O)c1ccc(-c2ccnc3[nH]c(-c4ccccc4)nc23)cc1C1CCCC1		CHEMBL4870467	<	Activity	%	10.0	CHEMBL301	Homo sapiens	Activity	%	10.0
	23246359	CHEMBL4830051	Inhibition of CDK2 (unknown origin)	B	Cl.Cn1nccc1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(F)c(F)c2)c(F)c1		CHEMBL4556790	>	IC50	nM	10000.0	CHEMBL301	Homo sapiens	IC50	nM	10000.0
	23250054	CHEMBL4830975	Inhibition of human recombinant CDK2 at 1 uM by Z'-LYTE assay	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(NCc3ccc(S(=O)(=O)F)cc3)cc2)n1		CHEMBL4866162	=	Inhibition	%	100.0	CHEMBL301	Homo sapiens	INH	%	100.0
Not Active	23250055	CHEMBL4830975	Inhibition of human recombinant CDK2 at 1 uM by Z'-LYTE assay	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2cccc(NC(C)=O)c2)n1		CHEMBL4856343		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Active	23250108	CHEMBL4831002	Inhibition of human recombinant CDK2 at 100 nM by Z'-LYTE assay	B	C#CCNC(=O)c1cc(Nc2cc(C3CC3)[nH]n2)nc(N2CCN(Cc3ccc(S(=O)(=O)F)cc3)CC2)n1		CHEMBL4855850		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	23250109	CHEMBL4831002	Inhibition of human recombinant CDK2 at 100 nM by Z'-LYTE assay	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(NCc3ccc(S(=O)(=O)F)cc3)cc2)n1		CHEMBL4866162		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	23256049	CHEMBL4832000	Inhibition of CDK2 (unknown origin) at 0.3 uM	B	O=C(Nc1cncc(OCC2CCN(Cc3ccc(F)cc3)CC2)c1)c1ccnc(NC(=O)C2CC2)c1		CHEMBL4873612		Inhibition	%		CHEMBL301	Homo sapiens	INH		
	23295521	CHEMBL4840533	Inhibition of recombinant His-tagged human full length CDK2 expressed in baculovirus expression system at 1 uM measured by select screen assay relative to control	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4c3CN(Cc3cc(F)cc(F)c3)C4(C)C)cc2)CC1		CHEMBL4849505	=	Inhibition	%	3.0	CHEMBL301	Homo sapiens	INH	%	3.0
	23297713	CHEMBL4841249	Inhibition of CDK2 (unknown origin) expressed in Sf9 insect cells using biotinylated peptide derived Histone H1 as substrate incubated for 1 hr in presence of [gamma33P]ATP by liquid scintillation counter method	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	=	IC50	nM	1.0	CHEMBL301	Homo sapiens	IC50	nM	1.0
	23297747	CHEMBL4841255	Inhibition of CDK2 (unknown origin)	B	Cc1n[nH]c2ccc(-c3cncc(NC(CO)c4ccccc4)n3)cc12		CHEMBL4855785	=	IC50	nM	146.85	CHEMBL301	Homo sapiens	IC50	nM	146.85
	23297748	CHEMBL4841255	Inhibition of CDK2 (unknown origin)	B	Cc1n[nH]c2ccc(-c3cncc(N[C@@H](CO)c4ccccc4)n3)cc12		CHEMBL4856767	=	IC50	nM	67.44	CHEMBL301	Homo sapiens	IC50	nM	67.44
	23297749	CHEMBL4841255	Inhibition of CDK2 (unknown origin)	B	Cc1n[nH]c2ccc(-c3cncc(N[C@@H](CO)c4ccc(F)cc4)n3)cc12		CHEMBL4860265	=	IC50	nM	56.13	CHEMBL301	Homo sapiens	IC50	nM	56.13
	23297750	CHEMBL4841255	Inhibition of CDK2 (unknown origin)	B	Cc1n[nH]c2ccc(-c3cncc(N[C@@H](CO)c4cccc(F)c4)n3)cc12		CHEMBL4872952	=	IC50	nM	34.48	CHEMBL301	Homo sapiens	IC50	nM	34.48
	23297751	CHEMBL4841255	Inhibition of CDK2 (unknown origin)	B	Cc1n[nH]c2ccc(-c3cncc(NC4CCCC(O)C4)n3)cc12		CHEMBL4863726	=	IC50	nM	52.86	CHEMBL301	Homo sapiens	IC50	nM	52.86
	23297752	CHEMBL4841255	Inhibition of CDK2 (unknown origin)	B	Cc1n[nH]c2ncc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3Cl)cc12		CHEMBL4857229	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
	23297753	CHEMBL4841255	Inhibition of CDK2 (unknown origin)	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3Cl)cc12		CHEMBL4876497	=	IC50	nM	163.95	CHEMBL301	Homo sapiens	IC50	nM	163.95
	23297754	CHEMBL4841255	Inhibition of CDK2 (unknown origin)	B	COC[C@H](C)N[C@H]1CC[C@H](Nc2cc(-c3cccc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4786559	>	IC50	nM	1000.0	CHEMBL301	Homo sapiens	IC50	nM	1000.0
Not Active	23309944	CHEMBL4843871	Inhibition of CDK2 (unknown origin) at 100 uM	B	COc1cc(NC(=O)Nc2ccc(O)c3ccccc23)cc(OC)c1OC		CHEMBL4855557		Inhibition	%		CHEMBL301	Homo sapiens	INH		
Not Active	23317318	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	82.0	CHEMBL301	Homo sapiens	% Control	%	82.0
Not Active	23317786	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	96.0	CHEMBL301	Homo sapiens	% Control	%	96.0
Not Active	23318457	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	95.0	CHEMBL301	Homo sapiens	% Control	%	95.0
Not Active	23318936	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	89.0	CHEMBL301	Homo sapiens	% Control	%	89.0
Not Active	23319575	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23320048	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23320726	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23321194	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	95.0	CHEMBL301	Homo sapiens	% Control	%	95.0
Not Active	23321824	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	87.0	CHEMBL301	Homo sapiens	% Control	%	87.0
Not Active	23322292	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	87.0	CHEMBL301	Homo sapiens	% Control	%	87.0
Not Active	23322981	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	99.0	CHEMBL301	Homo sapiens	% Control	%	99.0
Not Active	23323449	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23324303	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23324938	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23325406	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23326053	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23326521	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	82.0	CHEMBL301	Homo sapiens	% Control	%	82.0
Not Active	23327221	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	85.0	CHEMBL301	Homo sapiens	% Control	%	85.0
Not Active	23327689	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23328276	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	91.0	CHEMBL301	Homo sapiens	% Control	%	91.0
Not Active	23328744	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	88.0	CHEMBL301	Homo sapiens	% Control	%	88.0
Not Active	23329690	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23330158	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	87.0	CHEMBL301	Homo sapiens	% Control	%	87.0
Not Active	23330914	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23331382	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23331969	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	99.0	CHEMBL301	Homo sapiens	% Control	%	99.0
Not Active	23332437	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23333153	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23333792	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	82.0	CHEMBL301	Homo sapiens	% Control	%	82.0
Not Active	23334260	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	91.0	CHEMBL301	Homo sapiens	% Control	%	91.0
Not Active	23335239	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	99.0	CHEMBL301	Homo sapiens	% Control	%	99.0
Not Active	23335707	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23336334	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23336802	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	77.0	CHEMBL301	Homo sapiens	% Control	%	77.0
Not Active	23337883	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	96.0	CHEMBL301	Homo sapiens	% Control	%	96.0
Not Active	23338351	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23338963	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	94.0	CHEMBL301	Homo sapiens	% Control	%	94.0
Not Active	23339431	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	96.0	CHEMBL301	Homo sapiens	% Control	%	96.0
Not Active	23340068	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	94.0	CHEMBL301	Homo sapiens	% Control	%	94.0
Not Active	23340536	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23341193	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23341661	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23342277	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23342745	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23343375	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	90.0	CHEMBL301	Homo sapiens	% Control	%	90.0
Not Active	23343843	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	91.0	CHEMBL301	Homo sapiens	% Control	%	91.0
Not Active	23344481	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23345054	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	99.0	CHEMBL301	Homo sapiens	% Control	%	99.0
Not Active	23345522	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	87.0	CHEMBL301	Homo sapiens	% Control	%	87.0
Not Active	23346099	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	94.7	CHEMBL301	Homo sapiens	% Control	%	94.7
Not Active	23346568	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	98.8	CHEMBL301	Homo sapiens	% Control	%	98.8
Not Active	23347084	CHEMBL4882611	Invitrogen kinase screen (CDK2)	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1	Non standard unit for type	CHEMBL4538174		IC50	µM	0.79	CHEMBL301	Homo sapiens	IC50	µM	0.79
Not Active	23347178	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	75.7	CHEMBL301	Homo sapiens	% Control	%	75.7
Not Active	23347659	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23348238	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23348706	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23349293	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23349911	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23350379	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23350984	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23351452	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23352476	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	96.0	CHEMBL301	Homo sapiens	% Control	%	96.0
Not Active	23352944	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	73.0	CHEMBL301	Homo sapiens	% Control	%	73.0
Not Active	23353826	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23354294	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23355026	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	82.0	CHEMBL301	Homo sapiens	% Control	%	82.0
Not Active	23355494	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	80.0	CHEMBL301	Homo sapiens	% Control	%	80.0
Not Active	23356130	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23356598	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23357207	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23357854	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23358322	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23358908	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23359506	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23359974	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23360559	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23361027	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23361600	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	94.0	CHEMBL301	Homo sapiens	% Control	%	94.0
Not Active	23362136	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23362604	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23364246	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23364714	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23365453	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23365996	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23366586	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	96.0	CHEMBL301	Homo sapiens	% Control	%	96.0
Not Active	23367054	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	96.0	CHEMBL301	Homo sapiens	% Control	%	96.0
Not Active	23367932	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23368400	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	90.0	CHEMBL301	Homo sapiens	% Control	%	90.0
Not Active	23368999	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23369467	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23370435	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23370903	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	86.0	CHEMBL301	Homo sapiens	% Control	%	86.0
Not Active	23371712	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	88.0	CHEMBL301	Homo sapiens	% Control	%	88.0
Not Active	23372180	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
	23372689	CHEMBL4884654	CDK2(CDK2CGS1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL301	Homo sapiens	pIC50		6.0
	23373098	CHEMBL4884945	CDK2(CDK2CGS1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL301	Homo sapiens	pIC50		6.0
	23373459	CHEMBL4885236	CDK2(CDK2CGS1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL301	Homo sapiens	pIC50		6.0
Not Active	23375607	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	88.0	CHEMBL301	Homo sapiens	% Control	%	88.0
Not Active	23376075	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	93.0	CHEMBL301	Homo sapiens	% Control	%	93.0
Not Active	23376653	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	96.0	CHEMBL301	Homo sapiens	% Control	%	96.0
Not Active	23377122	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	81.0	CHEMBL301	Homo sapiens	% Control	%	81.0
Not Active	23377980	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23378448	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23379615	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23380083	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	86.0	CHEMBL301	Homo sapiens	% Control	%	86.0
Not Active	23380777	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	91.0	CHEMBL301	Homo sapiens	% Control	%	91.0
Not Active	23381425	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23381893	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
Not Active	23382517	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	97.0	CHEMBL301	Homo sapiens	% Control	%	97.0
Not Active	23382985	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	89.0	CHEMBL301	Homo sapiens	% Control	%	89.0
Not Active	23384900	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	88.0	CHEMBL301	Homo sapiens	% Control	%	88.0
Not Active	23385367	CHEMBL4879624	KinomeScan assay: inhibition of CDK2	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL301	Homo sapiens	% Control	%	100.0
